Citrus Sinensis ID: 016117
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 395 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.815 | 0.777 | 0.494 | 3e-83 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.721 | 0.625 | 0.523 | 4e-82 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.713 | 0.379 | 0.510 | 9e-81 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.746 | 0.598 | 0.474 | 2e-78 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.784 | 0.732 | 0.482 | 4e-78 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.751 | 0.763 | 0.471 | 8e-78 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.721 | 0.695 | 0.488 | 9e-77 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.713 | 0.392 | 0.5 | 1e-76 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.729 | 0.422 | 0.496 | 1e-76 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.870 | 0.485 | 0.439 | 5e-76 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 308 bits (790), Expect = 3e-83, Method: Compositional matrix adjust.
Identities = 165/334 (49%), Positives = 220/334 (65%), Gaps = 12/334 (3%)
Query: 38 YIRN-KVSKRLNT------PKRVDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKS 90
Y RN +V+ R N PK V+ + K EVT + Q F+F++L +AT F +
Sbjct: 23 YRRNGEVTGRDNNKTHPENPKTVNEQNKNNDEDKEVTNNIAAQTFSFRELATATKNFRQE 82
Query: 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 149
++G GGFG VY+G L G VA+K +D+ G QG EF +EV +L L +L+ L+GY
Sbjct: 83 CLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGY 142
Query: 150 CSD-RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
C+D ++LLVY+YM+ G L++HL LDW+TR+RIAL AA GLE+LH+ +
Sbjct: 143 CADGDQRLLVYEYMSRGSLEDHLLDLTPDQI---PLDWDTRIRIALGAAMGLEYLHDKAN 199
Query: 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 268
PPVI+RD K++NILLD F+AK+SDFGLAK+G HVS+RV+GT GY APEY TG
Sbjct: 200 PPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQ 259
Query: 269 LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQ 328
LTTKSDVYS+GVVLLEL+TGR ID +P E LV+WA P + + E+ DP+LEG
Sbjct: 260 LTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGV 319
Query: 329 YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
+ K + Q A+AAMC+Q EA RPLM+DVV +L
Sbjct: 320 FPEKALNQAVAVAAMCLQEEATVRPLMSDVVTAL 353
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 305 bits (781), Expect = 4e-82, Method: Compositional matrix adjust.
Identities = 154/294 (52%), Positives = 203/294 (69%), Gaps = 9/294 (3%)
Query: 73 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKME 131
F F++L +AT F +G GGFG VY+G L S G+ VA+K +D+ G QG EF +E
Sbjct: 72 HTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVE 131
Query: 132 VELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLY--PANGSNSVASKLDWET 188
V +L L P L+ L+GYC+D ++LLVY++M G L++HL+ P + LDW
Sbjct: 132 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-----KEALDWNM 186
Query: 189 RLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV 248
R++IA AAKGLEFLH+ +PPVI+RDFKSSNILLD+ FH K+SDFGLAK+G HV
Sbjct: 187 RMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHV 246
Query: 249 STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 308
STRV+GT GY APEYA+TG LT KSDVYS+GVV LEL+TGR ID P GE LV+WA
Sbjct: 247 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWAR 306
Query: 309 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
P DR K +++ DP L+G++ + + Q A+A+MC+Q +A RPL+ADVV +L
Sbjct: 307 PLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTAL 360
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 300 bits (769), Expect = 9e-81, Method: Compositional matrix adjust.
Identities = 149/292 (51%), Positives = 207/292 (70%), Gaps = 10/292 (3%)
Query: 72 LQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKME 131
++ FT +L AT FS V+G GGFG VY+G + +G +VA+KL+ + + + EF E
Sbjct: 334 VKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIAE 393
Query: 132 VELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 190
VE+L RL L+ L+G C + R + L+Y+ + NG ++ HL+ LDW+ RL
Sbjct: 394 VEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH--------EGTLDWDARL 445
Query: 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 250
+IAL AA+GL +LHE +P VIHRDFK+SN+LL+ +F KVSDFGLA+ ++ + H+ST
Sbjct: 446 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-HIST 504
Query: 251 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 310
RV+GT GYVAPEYA+TGHL KSDVYSYGVVLLELLTGR P+D+++PSGE LV+WA P
Sbjct: 505 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPL 564
Query: 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
L +RE + +++DPAL G Y+ ++ +VAAIA+MCV E +RP M +VVQ+L
Sbjct: 565 LANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQAL 616
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (748), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 148/312 (47%), Positives = 202/312 (64%), Gaps = 17/312 (5%)
Query: 65 EVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS----------NGRKVAI 114
E+ + L+ FTF L +T F +++G GGFG V++G + G VA+
Sbjct: 120 ELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAV 179
Query: 115 KLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYP 173
K ++ G QG E+ E+ LG L P L+ L+GYC D ++LLVY++M G L+ HL+
Sbjct: 180 KTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF- 238
Query: 174 ANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 233
+ L W R++IAL AAKGL FLHE PVI+RDFK+SNILLD +++AK+SD
Sbjct: 239 -----RRSLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSD 293
Query: 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 293
FGLAK D+ HVSTRV+GT GY APEY +TGHLT+KSDVYS+GVVLLE+LTGR +D
Sbjct: 294 FGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 353
Query: 294 VNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP 353
N+P+GE LV WA P L D+ + ++DP LEG +S+K +V +AA C+ + RP
Sbjct: 354 KNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRP 413
Query: 354 LMADVVQSLVPL 365
M+DVV++L PL
Sbjct: 414 KMSDVVEALKPL 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (746), Expect = 4e-78, Method: Compositional matrix adjust.
Identities = 154/319 (48%), Positives = 211/319 (66%), Gaps = 9/319 (2%)
Query: 73 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKME 131
Q FTF++L ATG F +G GGFG V++G + + VAIK +D+ G QG EF +E
Sbjct: 89 QTFTFQELAEATGNFRSDCFLGEGGFGKVFKGTIEKLDQVVAIKQLDRNGVQGIREFVVE 148
Query: 132 VELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 190
V L P L+ L+G+C++ ++LLVY+YM G L++HL+ S LDW TR+
Sbjct: 149 VLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLP---SGKKPLDWNTRM 205
Query: 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 250
+IA AA+GLE+LH+ +PPVI+RD K SNILL +++ K+SDFGLAK+G HVST
Sbjct: 206 KIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSGDKTHVST 265
Query: 251 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 310
RV+GT GY AP+YA+TG LT KSD+YS+GVVLLEL+TGR ID K + LV WA P
Sbjct: 266 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRKDQNLVGWARPL 325
Query: 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV--KY 368
DR +++DP L+GQY ++ + Q AI+AMCVQ + RP+++DVV +L L KY
Sbjct: 326 FKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVVLALNFLASSKY 385
Query: 369 NRSTPKISS--SPSFHASR 385
+ ++P SS +PSFH R
Sbjct: 386 DPNSPSSSSGKNPSFHRDR 404
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 291 bits (744), Expect = 8e-78, Method: Compositional matrix adjust.
Identities = 147/312 (47%), Positives = 205/312 (65%), Gaps = 15/312 (4%)
Query: 65 EVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS----------NGRKVAI 114
E+ + L+ F+ +L SAT F +VVG GGFG V++G + G +A+
Sbjct: 46 EILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAV 105
Query: 115 KLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYP 173
K ++Q G QG E+ E+ LG+L P L+ L+GYC + +LLVY++M G L+ HL+
Sbjct: 106 KRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFR 165
Query: 174 ANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 233
+ L W TR+R+AL AA+GL FLH + P VI+RDFK+SNILLD N++AK+SD
Sbjct: 166 ---RGTFYQPLSWNTRVRMALGAARGLAFLH-NAQPQVIYRDFKASNILLDSNYNAKLSD 221
Query: 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 293
FGLA+ G HVSTRV+GTQGY APEY TGHL+ KSDVYS+GVVLLELL+GR ID
Sbjct: 222 FGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAID 281
Query: 294 VNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP 353
N+P GE LV WA P LT++ ++L +MDP L+GQYS+ +++A +A C+ +A RP
Sbjct: 282 KNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRP 341
Query: 354 LMADVVQSLVPL 365
M ++V+++ L
Sbjct: 342 TMNEIVKTMEEL 353
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 287 bits (735), Expect = 9e-77, Method: Compositional matrix adjust.
Identities = 146/299 (48%), Positives = 197/299 (65%), Gaps = 14/299 (4%)
Query: 75 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKV-------AIKLMDQAGKQGEDE 127
FT +L + T F ++G GGFG VY+G + + +V A+K++++ G QG E
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 128 FKMEVELLGRLRSPYLLALLGYCS-DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDW 186
+ EV LG+LR P L+ L+GYC D +LLVY++M G L+ HL+ + L W
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLF-----RKTTAPLSW 171
Query: 187 ETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 246
R+ IAL AAKGL FLH + PVI+RDFK+SNILLD ++ AK+SDFGLAK G
Sbjct: 172 SRRMMIALGAAKGLAFLH-NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 230
Query: 247 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 306
HVSTRV+GT GY APEY +TGHLT +SDVYS+GVVLLE+LTGR +D +PS E LV W
Sbjct: 231 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDW 290
Query: 307 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365
A P+L D+ K+L+I+DP LE QYS++ + ++A C+ RPLM+DVV++L PL
Sbjct: 291 ARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 287 bits (734), Expect = 1e-76, Method: Compositional matrix adjust.
Identities = 146/292 (50%), Positives = 199/292 (68%), Gaps = 10/292 (3%)
Query: 75 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVEL 134
FT+++L T GF KS VVG GGFG VY+G+L G+ VAIK + +G EFK EVE+
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417
Query: 135 LGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIA 193
+ R+ +L++L+GYC S++ + L+Y+++ N L HL+ N L+W R+RIA
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKN-----LPVLEWSRRVRIA 472
Query: 194 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 253
+ AAKGL +LHE C P +IHRD KSSNILLD F A+V+DFGLA++ +D A H+STRV+
Sbjct: 473 IGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARL-NDTAQSHISTRVM 531
Query: 254 GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL-- 311
GT GY+APEYA +G LT +SDV+S+GVVLLEL+TGR P+D ++P GE LV WA PRL
Sbjct: 532 GTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIE 591
Query: 312 -TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
++ I E++DP LE Y EV ++ AA CV+ A RP M VV++L
Sbjct: 592 AIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 287 bits (734), Expect = 1e-76, Method: Compositional matrix adjust.
Identities = 148/298 (49%), Positives = 203/298 (68%), Gaps = 10/298 (3%)
Query: 70 NGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFK 129
N F++ +L T GFS+ N++G GGFG VY+GVLS+GR+VA+K + G QGE EFK
Sbjct: 322 NQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFK 381
Query: 130 MEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWET 188
EVE++ R+ +L+ L+GYC S++ +LLVYDY+ N L HL+ A G + WET
Sbjct: 382 AEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLH-APGR----PVMTWET 436
Query: 189 RLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-KAGGH 247
R+R+A AA+G+ +LHE C P +IHRD KSSNILLD +F A V+DFGLAKI + H
Sbjct: 437 RVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTH 496
Query: 248 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 307
VSTRV+GT GY+APEYA +G L+ K+DVYSYGV+LLEL+TGR P+D ++P G+ LV WA
Sbjct: 497 VSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWA 556
Query: 308 LPRL---TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
P L + E+ E++DP L + E+ ++ AA CV+ A RP M+ VV++L
Sbjct: 557 RPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL 614
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (729), Expect = 5e-76, Method: Compositional matrix adjust.
Identities = 159/362 (43%), Positives = 230/362 (63%), Gaps = 18/362 (4%)
Query: 8 RRKERVALVVIVVVASLALASLLVAFSYYCYIRNKVSKRLNTPKRVDREEKGESGKLEVT 67
+R++R++ V V ++S A S + R + S + KR + +SG L
Sbjct: 305 KREKRLSAVSGGDVTPSPMSS--TARSDSAFFRMQSSAPVGASKRSGSYQS-QSGGL--- 358
Query: 68 TDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDE 127
N +F++++L AT GFS+ N++G GGFG VY+G+L +GR VA+K + G QG+ E
Sbjct: 359 -GNSKALFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDRE 417
Query: 128 FKMEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDW 186
FK EVE L R+ +L++++G+C S R+LL+YDY++N L HL+ G SV LDW
Sbjct: 418 FKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLH---GEKSV---LDW 471
Query: 187 ETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 246
TR++IA AA+GL +LHE C P +IHRD KSSNILL+ NF A+VSDFGLA++ D
Sbjct: 472 ATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALD-CNT 530
Query: 247 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 306
H++TRV+GT GY+APEYA +G LT KSDV+S+GVVLLEL+TGR P+D ++P G+ LV W
Sbjct: 531 HITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEW 590
Query: 307 ALPRLT---DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363
A P ++ + E+ + DP L G Y E+ ++ A CV+ A RP M +V++
Sbjct: 591 ARPLISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFE 650
Query: 364 PL 365
L
Sbjct: 651 SL 652
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 395 | ||||||
| 225446643 | 398 | PREDICTED: serine/threonine-protein kina | 0.979 | 0.972 | 0.837 | 0.0 | |
| 255558744 | 397 | Serine/threonine-protein kinase PBS1, pu | 0.972 | 0.967 | 0.806 | 0.0 | |
| 297817182 | 400 | kinase family protein [Arabidopsis lyrat | 0.992 | 0.98 | 0.794 | 0.0 | |
| 42566031 | 400 | protein kinase family protein [Arabidops | 0.992 | 0.98 | 0.789 | 1e-179 | |
| 312283495 | 400 | unnamed protein product [Thellungiella h | 0.992 | 0.98 | 0.784 | 1e-179 | |
| 224128764 | 382 | predicted protein [Populus trichocarpa] | 0.954 | 0.986 | 0.817 | 1e-178 | |
| 7630064 | 386 | serine/threonine-specific protein kinase | 0.956 | 0.979 | 0.769 | 1e-173 | |
| 363808298 | 396 | uncharacterized protein LOC100804893 [Gl | 0.964 | 0.962 | 0.760 | 1e-172 | |
| 255636997 | 396 | unknown [Glycine max] | 0.984 | 0.982 | 0.760 | 1e-171 | |
| 358248154 | 382 | serine/threonine-protein kinase PBS1-lik | 0.946 | 0.979 | 0.783 | 1e-170 |
| >gi|225446643|ref|XP_002281166.1| PREDICTED: serine/threonine-protein kinase PBS1 isoform 1 [Vitis vinifera] gi|302143438|emb|CBI21999.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 674 bits (1740), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 325/388 (83%), Positives = 356/388 (91%), Gaps = 1/388 (0%)
Query: 1 MEGDDEYRRKERVALVVIVVVASLALASLLVAFSYYCYIRNKVSKRLNTPKRVDREEKGE 60
ME D+ YRRKER ALV IVV+AS+ALASLLVAFSYYCYIRNKVS+RL KR+D E+KG
Sbjct: 1 MEADESYRRKERTALVAIVVLASVALASLLVAFSYYCYIRNKVSRRLKNQKRIDYEDKGG 60
Query: 61 SGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQA 120
L+V T+ GLQVFTFKQLHSATGGF KSNVVGHGGFGLVYRGVL +GRKVA+KLMD+A
Sbjct: 61 FANLQVATEKGLQVFTFKQLHSATGGFGKSNVVGHGGFGLVYRGVLHDGRKVAVKLMDRA 120
Query: 121 GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPANGSNS 179
GKQGE+EFK+EVELL RLRSPYLLALLGYCSD KLLVY++MANGGLQEHLYP +GSNS
Sbjct: 121 GKQGEEEFKVEVELLSRLRSPYLLALLGYCSDSNHKLLVYEFMANGGLQEHLYPISGSNS 180
Query: 180 VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239
V+S+LDWETRLRIAL+AAKGLE+LHEH SPPVIHRDFKSSNILLDKNFHAKVSDFGLAK+
Sbjct: 181 VSSRLDWETRLRIALDAAKGLEYLHEHVSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKL 240
Query: 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 299
GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP+D+ + SG
Sbjct: 241 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRASG 300
Query: 300 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVV 359
EGVLVSWALP LTDREK+++IMDPALEGQYSMKEVIQVAAIA MCVQPEADYRPLMADVV
Sbjct: 301 EGVLVSWALPHLTDREKVVQIMDPALEGQYSMKEVIQVAAIATMCVQPEADYRPLMADVV 360
Query: 360 QSLVPLVKYNRSTPKISSSPSFHASRSP 387
QSLVPLVK +R T K+ S SFHA++SP
Sbjct: 361 QSLVPLVKNHRPTSKVGSCSSFHATKSP 388
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558744|ref|XP_002520396.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223540443|gb|EEF42012.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 643 bits (1658), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 313/388 (80%), Positives = 346/388 (89%), Gaps = 4/388 (1%)
Query: 5 DEYRRKERVALVVIVVVASLALASLLVAFSYYCYIRNKVSKRLNTPKRVDREEKGESGKL 64
D+Y RK+R+ALV IVV+ASLA+ SLLVAFSYYCYIRNK+SKR +T KR EEKG L
Sbjct: 7 DDYSRKQRIALVAIVVIASLAVTSLLVAFSYYCYIRNKLSKRFDTQKRFKYEEKGNFENL 66
Query: 65 EVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG 124
+V T+ GLQVFTFKQL+SATGGFSKSNVVGHGGFG VYRGVL++GRKVA+KLMDQ GKQG
Sbjct: 67 QVATEKGLQVFTFKQLYSATGGFSKSNVVGHGGFGSVYRGVLNDGRKVAVKLMDQGGKQG 126
Query: 125 EDEFKMEVELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPANGSNSVASK 183
E+EFK+EVELL LRSPYLLAL+G+CSD KLLVYD+M NGGLQEHLYP ++++ +
Sbjct: 127 EEEFKVEVELLSHLRSPYLLALIGFCSDSNHKLLVYDFMENGGLQEHLYP---TSAMHLR 183
Query: 184 LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243
LDWETRLRIALEAAKGLE+LHEH SPPVIHRDFKSSNILLDK FHAKVSDFGLAK+G DK
Sbjct: 184 LDWETRLRIALEAAKGLEYLHEHVSPPVIHRDFKSSNILLDKYFHAKVSDFGLAKLGPDK 243
Query: 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL 303
AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP+D+ +P GEGVL
Sbjct: 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRPPGEGVL 303
Query: 304 VSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363
VSW LPRLTDREK+++IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV
Sbjct: 304 VSWVLPRLTDREKVVQIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363
Query: 364 PLVKYNRSTPKISSSPSFHASRSPAFPD 391
PLVK RST K+ S SF+A RSPA D
Sbjct: 364 PLVKTQRSTSKLGSYSSFNALRSPASQD 391
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297817182|ref|XP_002876474.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297322312|gb|EFH52733.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 640 bits (1650), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 313/394 (79%), Positives = 345/394 (87%), Gaps = 2/394 (0%)
Query: 1 MEGDDEYRRKERVALVVIVVVASLALASLLVAFSYYCYIRNKVSKRLNTPKRVDREEKGE 60
ME D+ Y++KER ALV IVV+A LAL+SL VAFSYYCYIRNKVSKR KR D EEKG+
Sbjct: 1 METDEAYQKKERAALVAIVVLACLALSSLFVAFSYYCYIRNKVSKRHRISKRFDCEEKGD 60
Query: 61 SGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQA 120
K++ TDNGLQ+FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL++GRKVAIK MD A
Sbjct: 61 CQKVQDVTDNGLQIFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLNDGRKVAIKFMDHA 120
Query: 121 GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNS 179
GKQGE+EFKMEVELL RLRSPYLLALLGYCSD KLLVY++MANGGLQEHLY N S S
Sbjct: 121 GKQGEEEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLYRTNRSGS 180
Query: 180 VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239
V +LDWETR+RIA+EAAKGLE+LHE SPPVIHRDFKSSNILLD+NF+AKVSDFGLAK+
Sbjct: 181 VPVRLDWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAKV 240
Query: 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 299
GSDKAGGHVSTRVL TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP+D+ + SG
Sbjct: 241 GSDKAGGHVSTRVLSTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRASG 300
Query: 300 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVV 359
EGVLVSWALP+L DREK+++IMDP LEGQYS KEV+QVAAIAAMCVQ EADYRPLMADVV
Sbjct: 301 EGVLVSWALPQLADREKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMADVV 360
Query: 360 QSLVPLVKYNRSTPKIS-SSPSFHASRSPAFPDK 392
QSLVPLV+ RS K+S S SF +RSP P K
Sbjct: 361 QSLVPLVRNRRSASKLSGCSSSFSLARSPNSPGK 394
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42566031|ref|NP_191428.3| protein kinase family protein [Arabidopsis thaliana] gi|332646297|gb|AEE79818.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 635 bits (1638), Expect = e-179, Method: Compositional matrix adjust.
Identities = 311/394 (78%), Positives = 347/394 (88%), Gaps = 2/394 (0%)
Query: 1 MEGDDEYRRKERVALVVIVVVASLALASLLVAFSYYCYIRNKVSKRLNTPKRVDREEKGE 60
ME D+ Y++KER ALV IVV+A LAL+SL VAFSYYCYIRNKVSKR KR D EEKG+
Sbjct: 1 METDEAYQKKERAALVAIVVLACLALSSLFVAFSYYCYIRNKVSKRHRISKRFDCEEKGD 60
Query: 61 SGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQA 120
K++ T+NGLQ+FTFKQLHSATGGFSKSNVVG+GGFGLVYRGVL++GRKVAIKLMD A
Sbjct: 61 CQKVQDVTENGLQIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIKLMDHA 120
Query: 121 GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNS 179
GKQGE+EFKMEVELL RLRSPYLLALLGYCSD KLLVY++MANGGLQEHLY N S S
Sbjct: 121 GKQGEEEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLYLPNRSGS 180
Query: 180 VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239
V +LDWETR+RIA+EAAKGLE+LHE SPPVIHRDFKSSNILLD+NF+AKVSDFGLAK+
Sbjct: 181 VPPRLDWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAKV 240
Query: 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 299
GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP+D+ + +G
Sbjct: 241 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRATG 300
Query: 300 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVV 359
EGVLVSWALP+L DR+K+++IMDP LEGQYS KEV+QVAAIAAMCVQ EADYRPLMADVV
Sbjct: 301 EGVLVSWALPQLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMADVV 360
Query: 360 QSLVPLVKYNRSTPKIS-SSPSFHASRSPAFPDK 392
QSLVPLV+ RS K+S S SF +RSP P K
Sbjct: 361 QSLVPLVRNRRSASKLSGCSSSFSLARSPNSPGK 394
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|312283495|dbj|BAJ34613.1| unnamed protein product [Thellungiella halophila] | Back alignment and taxonomy information |
|---|
Score = 633 bits (1632), Expect = e-179, Method: Compositional matrix adjust.
Identities = 309/394 (78%), Positives = 344/394 (87%), Gaps = 2/394 (0%)
Query: 1 MEGDDEYRRKERVALVVIVVVASLALASLLVAFSYYCYIRNKVSKRLNTPKRVDREEKGE 60
ME D+ Y+RKER ALV IVV+A LAL+SL VAFSYYCYIRNKVSKR KR + EEKG+
Sbjct: 1 METDEAYQRKERAALVAIVVLACLALSSLFVAFSYYCYIRNKVSKRHRISKRFNCEEKGD 60
Query: 61 SGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQA 120
+E T+NGLQ+F FKQLHSATGGFSKSNVVGHGGFGLVYRGVL++GRKVAIK MD
Sbjct: 61 CQIVEDVTENGLQIFNFKQLHSATGGFSKSNVVGHGGFGLVYRGVLNDGRKVAIKFMDNT 120
Query: 121 GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNS 179
GKQGEDEFK+EVELL RLRSPYLLALLGYCSD KLLVY++MANGGLQEHLYP + S S
Sbjct: 121 GKQGEDEFKIEVELLSRLRSPYLLALLGYCSDNNHKLLVYEFMANGGLQEHLYPNSRSGS 180
Query: 180 VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239
V +LDWE R+RIALEAAKGLE+LHE+ SPPVIHRDFKSSNILLD+NFHAKVSDFGLAK+
Sbjct: 181 VPPRLDWEIRMRIALEAAKGLEYLHENVSPPVIHRDFKSSNILLDRNFHAKVSDFGLAKV 240
Query: 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 299
GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYG+VLLELLTGRVP+D+ + +G
Sbjct: 241 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGIVLLELLTGRVPVDMKRANG 300
Query: 300 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVV 359
EGVLVSWALP+L DR+K+++IMDP LEGQYS KEV+QVAAIAAMCVQ EADYRPLMADVV
Sbjct: 301 EGVLVSWALPQLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMADVV 360
Query: 360 QSLVPLVKYNRSTPKIS-SSPSFHASRSPAFPDK 392
QSLVPLV+ RS K+S S SF +RSP P K
Sbjct: 361 QSLVPLVRSRRSASKLSGCSSSFSLARSPNSPGK 394
|
Source: Thellungiella halophila Species: Eutrema halophilum Genus: Eutrema Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128764|ref|XP_002320416.1| predicted protein [Populus trichocarpa] gi|222861189|gb|EEE98731.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 629 bits (1622), Expect = e-178, Method: Compositional matrix adjust.
Identities = 310/379 (81%), Positives = 337/379 (88%), Gaps = 2/379 (0%)
Query: 1 MEGDD-EYRRKERVALVVIVVVASLALASLLVAFSYYCYIRNKVSKRLNTPKRVDREEKG 59
ME ++ EY R+ER+ALV IVVVASL +ASLLVAFSYYCYIRNK+SKRL R E+KG
Sbjct: 1 METENGEYGRQERIALVAIVVVASLTVASLLVAFSYYCYIRNKLSKRLKNHSREGYEDKG 60
Query: 60 ESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQ 119
LEV GL VFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS+GRKVAIKLMDQ
Sbjct: 61 CFTDLEVVAGKGLNVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSDGRKVAIKLMDQ 120
Query: 120 AGKQGEDEFKMEVELLGRLRSPYLLALLGYCS-DRRKLLVYDYMANGGLQEHLYPANGSN 178
AGKQGEDEFK+EVELL L SPYLLALLGYCS D K+LVY++M NGGLQEHL+ SN
Sbjct: 121 AGKQGEDEFKVEVELLSHLHSPYLLALLGYCSGDNHKVLVYEFMPNGGLQEHLHRITSSN 180
Query: 179 SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238
+V+ LDWETRLRIALEAAKGLE+LHEH +PPVIHRDFKSSNILLD+N HAKVSDFGLAK
Sbjct: 181 TVSISLDWETRLRIALEAAKGLEYLHEHVNPPVIHRDFKSSNILLDRNLHAKVSDFGLAK 240
Query: 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPS 298
+G DKAGGHVSTRVLGTQGY+APEYALTGHLTTKSDVYSYGVVLLELLTGRVP+D+ +P+
Sbjct: 241 LGPDKAGGHVSTRVLGTQGYIAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDIKRPA 300
Query: 299 GEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADV 358
GEGVLVSWALPRLTDREK++EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADV
Sbjct: 301 GEGVLVSWALPRLTDREKVVEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADV 360
Query: 359 VQSLVPLVKYNRSTPKISS 377
VQSLVPLVK RST K+ S
Sbjct: 361 VQSLVPLVKTQRSTSKVGS 379
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7630064|emb|CAB88286.1| serine/threonine-specific protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1580), Expect = e-173, Method: Compositional matrix adjust.
Identities = 303/394 (76%), Positives = 339/394 (86%), Gaps = 16/394 (4%)
Query: 1 MEGDDEYRRKERVALVVIVVVASLALASLLVAFSYYCYIRNKVSKRLNTPKRVDREEKGE 60
ME D+ Y++KER ALV IVV+A LAL+SL VAFSYYCYIRNK EKG+
Sbjct: 1 METDEAYQKKERAALVAIVVLACLALSSLFVAFSYYCYIRNK--------------EKGD 46
Query: 61 SGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQA 120
K++ T+NGLQ+FTFKQLHSATGGFSKSNVVG+GGFGLVYRGVL++GRKVAIKLMD A
Sbjct: 47 CQKVQDVTENGLQIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIKLMDHA 106
Query: 121 GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNS 179
GKQGE+EFKMEVELL RLRSPYLLALLGYCSD KLLVY++MANGGLQEHLY N S S
Sbjct: 107 GKQGEEEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLYLPNRSGS 166
Query: 180 VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239
V +LDWETR+RIA+EAAKGLE+LHE SPPVIHRDFKSSNILLD+NF+AKVSDFGLAK+
Sbjct: 167 VPPRLDWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAKV 226
Query: 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 299
GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP+D+ + +G
Sbjct: 227 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRATG 286
Query: 300 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVV 359
EGVLVSWALP+L DR+K+++IMDP LEGQYS KEV+QVAAIAAMCVQ EADYRPLMADVV
Sbjct: 287 EGVLVSWALPQLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMADVV 346
Query: 360 QSLVPLVKYNRSTPKIS-SSPSFHASRSPAFPDK 392
QSLVPLV+ RS K+S S SF +RSP P K
Sbjct: 347 QSLVPLVRNRRSASKLSGCSSSFSLARSPNSPGK 380
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363808298|ref|NP_001241988.1| uncharacterized protein LOC100804893 [Glycine max] gi|255639199|gb|ACU19898.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 611 bits (1575), Expect = e-172, Method: Compositional matrix adjust.
Identities = 301/396 (76%), Positives = 339/396 (85%), Gaps = 15/396 (3%)
Query: 1 MEGDDEYRRKERVALVVIVVVASLALASLLVAFSYYCYIRNKVSKRLNTPKRV---DREE 57
ME D YRRK ++ALV I+V+AS+A+ +LLVAF+YYC+I NKVS R + K+V + E
Sbjct: 1 MEEDFGYRRKAKIALVAIMVLASVAVFALLVAFAYYCHILNKVSNRRKSLKKVGDANLNE 60
Query: 58 KGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLM 117
K + L+V + GLQVFTFKQLHSATGGFSKSNV+GHGGFGLVYRGVL++GRKVAIK M
Sbjct: 61 KSDFANLQVVAEKGLQVFTFKQLHSATGGFSKSNVIGHGGFGLVYRGVLNDGRKVAIKFM 120
Query: 118 DQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPANG 176
DQAGKQGE+EFK+EVELL RL SPYLLALLGYCSD KLLVY++MANGGLQEHLYP +
Sbjct: 121 DQAGKQGEEEFKVEVELLSRLHSPYLLALLGYCSDSNHKLLVYEFMANGGLQEHLYPVSN 180
Query: 177 SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236
S KLDWETRLRIALEAAKGLE+LHEH SPPVIHRDFKSSNILLDK FHAKVSDFGL
Sbjct: 181 SIITPVKLDWETRLRIALEAAKGLEYLHEHVSPPVIHRDFKSSNILLDKKFHAKVSDFGL 240
Query: 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296
AK+G D+AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP+D+ +
Sbjct: 241 AKLGPDRAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKR 300
Query: 297 PSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 356
P GEGVLVSWALP LTDREK+++IMDP+LEGQYSMKEV+QVAAIAAMCVQPEADYRPLMA
Sbjct: 301 PPGEGVLVSWALPLLTDREKVVKIMDPSLEGQYSMKEVVQVAAIAAMCVQPEADYRPLMA 360
Query: 357 DVVQSLVPLVKYNR-----------STPKISSSPSF 381
DVVQSLVPLVK R ++PK+S P+F
Sbjct: 361 DVVQSLVPLVKTQRSPSKVGSSSSFNSPKLSPGPTF 396
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255636997|gb|ACU18831.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1569), Expect = e-171, Method: Compositional matrix adjust.
Identities = 301/396 (76%), Positives = 338/396 (85%), Gaps = 7/396 (1%)
Query: 1 MEGDDEYRRKERVALVVIVVVASLALASLLVAFSYYCYIRNKVSKRLNTPKRVDR---EE 57
ME D YRR ++ALV I+V+AS+A+ +LLV F+YYCYI NKVS R + K+V+ E
Sbjct: 1 MEEDYGYRRTAKIALVAIMVLASVAVFALLVVFAYYCYILNKVSNRRKSLKKVEDANLNE 60
Query: 58 KGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLM 117
K + L+V + GLQVFTFKQLHSATGGFSKSNV+GHGGFGLVYRGVL++GRKVAIK M
Sbjct: 61 KSDFANLQVVAEKGLQVFTFKQLHSATGGFSKSNVIGHGGFGLVYRGVLNDGRKVAIKFM 120
Query: 118 DQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPANG 176
DQAGKQGE+EFK+EVELL RL SPYLLALLGYCSD KLLVY++MANGGLQEHLYP +
Sbjct: 121 DQAGKQGEEEFKVEVELLTRLHSPYLLALLGYCSDSNHKLLVYEFMANGGLQEHLYPVSN 180
Query: 177 SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236
S KLDWETRLRIALEAAKGLE+LHEH SPPVIHRDFKSSNILL K FHAKVSDFGL
Sbjct: 181 SIITPVKLDWETRLRIALEAAKGLEYLHEHVSPPVIHRDFKSSNILLGKKFHAKVSDFGL 240
Query: 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296
AK+G D+AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP+D+ +
Sbjct: 241 AKLGPDRAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKR 300
Query: 297 PSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 356
P GEGVLVSWALP LTDREK+++IMDP+LEGQYSMKEV+QVAAIAA+CVQPEADYRPLMA
Sbjct: 301 PPGEGVLVSWALPLLTDREKVVKIMDPSLEGQYSMKEVVQVAAIAAICVQPEADYRPLMA 360
Query: 357 DVVQSLVPLVKYNRSTPKISSSPSFHA---SRSPAF 389
DVVQSLVPLVK RS K+ S SF++ S P F
Sbjct: 361 DVVQSLVPLVKTQRSPSKVGSCSSFNSPKLSPGPTF 396
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358248154|ref|NP_001240082.1| serine/threonine-protein kinase PBS1-like [Glycine max] gi|223452402|gb|ACM89528.1| serine/threonine-specific protein kinase-like protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 603 bits (1555), Expect = e-170, Method: Compositional matrix adjust.
Identities = 296/378 (78%), Positives = 329/378 (87%), Gaps = 4/378 (1%)
Query: 1 MEGDDEYRRKERVALVVIVVVASLALASLLVAFSYYCYIRNKVSKRLNTPKRVDR---EE 57
ME D YRR ++ALV I+V+AS+A+ +LLV F+YYCYI NKVS R + K+V+ E
Sbjct: 1 MEEDYGYRRTAKIALVAIMVLASVAVFALLVVFAYYCYILNKVSNRRKSLKKVEDANLNE 60
Query: 58 KGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLM 117
K + L+V + GLQVFTFKQLHSATGGFSKSNV+GHGGFGLVYRGVL++GRKVAIK M
Sbjct: 61 KSDFANLQVVAEKGLQVFTFKQLHSATGGFSKSNVIGHGGFGLVYRGVLNDGRKVAIKFM 120
Query: 118 DQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPANG 176
DQAGKQGE+EFK+EVELL RL SPYLLALLGYCSD KLLVY++MANGGLQEHLYP +
Sbjct: 121 DQAGKQGEEEFKVEVELLTRLHSPYLLALLGYCSDSNHKLLVYEFMANGGLQEHLYPVSN 180
Query: 177 SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236
S KLDWETRLRIALEAAKGLE+LHEH SPPVIHRDFKSSNILL K FHAKVSDFGL
Sbjct: 181 SIITPVKLDWETRLRIALEAAKGLEYLHEHVSPPVIHRDFKSSNILLGKKFHAKVSDFGL 240
Query: 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296
AK+G D+AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP+D+ +
Sbjct: 241 AKLGPDRAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKR 300
Query: 297 PSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 356
P GEGVLVSWALP LTDREK+++IMDP+LEGQYSMKEV+QVAAIAAMCVQPEADYRPLMA
Sbjct: 301 PPGEGVLVSWALPLLTDREKVVKIMDPSLEGQYSMKEVVQVAAIAAMCVQPEADYRPLMA 360
Query: 357 DVVQSLVPLVKYNRSTPK 374
DVVQSLVPLVK RS K
Sbjct: 361 DVVQSLVPLVKTQRSPSK 378
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 395 | ||||||
| TAIR|locus:2099009 | 400 | AT3G58690 [Arabidopsis thalian | 0.949 | 0.937 | 0.765 | 3.2e-152 | |
| TAIR|locus:2010965 | 458 | AT1G54820 [Arabidopsis thalian | 0.756 | 0.652 | 0.596 | 3.4e-93 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.718 | 0.391 | 0.534 | 2e-79 | |
| TAIR|locus:504954886 | 1113 | AT5G56890 [Arabidopsis thalian | 0.726 | 0.257 | 0.537 | 1.2e-77 | |
| TAIR|locus:2036818 | 389 | AT1G61860 [Arabidopsis thalian | 0.736 | 0.748 | 0.526 | 5.5e-77 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.774 | 0.792 | 0.503 | 7.1e-77 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.784 | 0.748 | 0.504 | 9e-77 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.812 | 0.703 | 0.483 | 3.1e-76 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.726 | 0.759 | 0.527 | 2.7e-75 | |
| TAIR|locus:2038992 | 744 | ALE2 "Abnormal Leaf Shape 2" [ | 0.726 | 0.385 | 0.511 | 9.3e-75 |
| TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1485 (527.8 bits), Expect = 3.2e-152, P = 3.2e-152
Identities = 288/376 (76%), Positives = 321/376 (85%)
Query: 1 MEGDDEYRRKERXXXXXXXXXXXXXXXXXXXXFSYYCYIRNKVSKRLNTPKRVDREEKGE 60
ME D+ Y++KER FSYYCYIRNKVSKR KR D EEKG+
Sbjct: 1 METDEAYQKKERAALVAIVVLACLALSSLFVAFSYYCYIRNKVSKRHRISKRFDCEEKGD 60
Query: 61 SGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQA 120
K++ T+NGLQ+FTFKQLHSATGGFSKSNVVG+GGFGLVYRGVL++GRKVAIKLMD A
Sbjct: 61 CQKVQDVTENGLQIFTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIKLMDHA 120
Query: 121 GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNS 179
GKQGE+EFKMEVELL RLRSPYLLALLGYCSD KLLVY++MANGGLQEHLY N S S
Sbjct: 121 GKQGEEEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLYLPNRSGS 180
Query: 180 VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239
V +LDWETR+RIA+EAAKGLE+LHE SPPVIHRDFKSSNILLD+NF+AKVSDFGLAK+
Sbjct: 181 VPPRLDWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAKV 240
Query: 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 299
GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP+D+ + +G
Sbjct: 241 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRATG 300
Query: 300 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVV 359
EGVLVSWALP+L DR+K+++IMDP LEGQYS KEV+QVAAIAAMCVQ EADYRPLMADVV
Sbjct: 301 EGVLVSWALPQLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMADVV 360
Query: 360 QSLVPLVKYNRSTPKI 375
QSLVPLV+ RS K+
Sbjct: 361 QSLVPLVRNRRSASKL 376
|
|
| TAIR|locus:2010965 AT1G54820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 928 (331.7 bits), Expect = 3.4e-93, P = 3.4e-93
Identities = 186/312 (59%), Positives = 237/312 (75%)
Query: 71 GLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLM----DQAGKQGED 126
G++V+T+K+L AT FS+ +G+G VY+GVLS+G AIK + D A Q +
Sbjct: 131 GVEVYTYKELEIATNNFSEEKKIGNGD---VYKGVLSDGTVAAIKKLHMFNDNASNQKHE 187
Query: 127 E--FKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSN--SVA 181
E F++EV+LL RL+ PYL+ LLGYC+D+ ++L+Y++M NG ++ HL+ N N
Sbjct: 188 ERSFRLEVDLLSRLQCPYLVELLGYCADQNHRILIYEFMPNGTVEHHLHDHNFKNLKDRP 247
Query: 182 SKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241
LDW RLRIAL+ A+ LEFLHE+ VIHR+FK +NILLD+N AKVSDFGLAK GS
Sbjct: 248 QPLDWGARLRIALDCARALEFLHENTISTVIHRNFKCTNILLDQNNRAKVSDFGLAKTGS 307
Query: 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 301
DK G +STRV+GT GY+APEYA TG LTTKSDVYSYG+VLL+LLTGR PID +P G+
Sbjct: 308 DKLNGEISTRVIGTTGYLAPEYASTGKLTTKSDVYSYGIVLLQLLTGRTPIDSRRPRGQD 367
Query: 302 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361
VLVSWALPRLT+REKI E++DP ++GQYS K++IQVAAIAA+CVQPEA YRPLM DVV S
Sbjct: 368 VLVSWALPRLTNREKISEMVDPTMKGQYSQKDLIQVAAIAAVCVQPEASYRPLMTDVVHS 427
Query: 362 LVPLVK-YNRST 372
L+PLVK +N+ST
Sbjct: 428 LIPLVKAFNKST 439
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 798 (286.0 bits), Expect = 2.0e-79, P = 2.0e-79
Identities = 155/290 (53%), Positives = 211/290 (72%)
Query: 76 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELL 135
++++L AT F ++++G GGFG VYRG+L++G VAIK + G QG+ EF++E+++L
Sbjct: 369 SYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEFQVEIDML 428
Query: 136 GRLRSPYLLALLGYCSDR---RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI 192
RL L+ L+GY S R + LL Y+ + NG L+ L+ G N LDW+TR++I
Sbjct: 429 SRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGPLGLNC---PLDWDTRMKI 485
Query: 193 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRV 252
AL+AA+GL +LHE P VIHRDFK+SNILL+ NF+AKV+DFGLAK + G H+STRV
Sbjct: 486 ALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEGRGNHLSTRV 545
Query: 253 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312
+GT GYVAPEYA+TGHL KSDVYSYGVVLLELLTGR P+D+++PSG+ LV+W P L
Sbjct: 546 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWTRPVLR 605
Query: 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
D++++ E++D LEG+Y ++ I+V IAA CV PEA RP M +VVQSL
Sbjct: 606 DKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGEVVQSL 655
|
|
| TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 783 (280.7 bits), Expect = 1.2e-77, P = 1.2e-77
Identities = 157/292 (53%), Positives = 205/292 (70%)
Query: 73 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEV 132
+ FT ++ AT F +S V+G GGFG VY GV +G KVA+K++ + +QG EF EV
Sbjct: 709 KTFTASEIMKATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSREFLAEV 768
Query: 133 ELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR 191
E+L RL L+ L+G C DR + LVY+ + NG ++ HL+ G + +S LDW+ RL+
Sbjct: 769 EMLSRLHHRNLVNLIGICIEDRNRSLVYELIPNGSVESHLH---GIDKASSPLDWDARLK 825
Query: 192 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG-SDKAGGHVST 250
IAL AA+GL +LHE SP VIHRDFKSSNILL+ +F KVSDFGLA+ D+ H+ST
Sbjct: 826 IALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALDDEDNRHIST 885
Query: 251 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 310
RV+GT GYVAPEYA+TGHL KSDVYSYGVVLLELLTGR P+D+++P G+ LVSW P
Sbjct: 886 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVSWTRPF 945
Query: 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
LT E + I+D +L + S + +VAAIA+MCVQPE +RP M +VVQ+L
Sbjct: 946 LTSAEGLAAIIDQSLGPEISFDSIAKVAAIASMCVQPEVSHRPFMGEVVQAL 997
|
|
| TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 775 (277.9 bits), Expect = 5.5e-77, P = 5.5e-77
Identities = 157/298 (52%), Positives = 213/298 (71%)
Query: 73 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKME 131
++F FK+L +AT FS ++G GGFG VY+G L++ + VA+K +D+ G QG EF E
Sbjct: 71 RIFKFKELIAATDNFSMDCMIGEGGFGRVYKGFLTSLNQVVAVKRLDRNGLQGTREFFAE 130
Query: 132 VELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPA-NGSNSVASKLDWETR 189
V +L + P L+ L+GYC D +++LVY++M NG L++HL+ GS S LDW TR
Sbjct: 131 VMVLSLAQHPNLVNLIGYCVEDEQRVLVYEFMPNGSLEDHLFDLPEGSPS----LDWFTR 186
Query: 190 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS 249
+RI AAKGLE+LH++ PPVI+RDFK+SNILL +F++K+SDFGLA++G + HVS
Sbjct: 187 MRIVHGAAKGLEYLHDYADPPVIYRDFKASNILLQSDFNSKLSDFGLARLGPTEGKDHVS 246
Query: 250 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 309
TRV+GT GY APEYA+TG LT KSDVYS+GVVLLE+++GR ID ++P+ E L+SWA P
Sbjct: 247 TRVMGTYGYCAPEYAMTGQLTAKSDVYSFGVVLLEIISGRRAIDGDRPTEEQNLISWAEP 306
Query: 310 RLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367
L DR +I+DP L+G Y +K + Q AIAAMC+Q EA+ RPLM DVV +L L K
Sbjct: 307 LLKDRRMFAQIVDPNLDGNYPVKGLHQALAIAAMCLQEEAETRPLMGDVVTALEFLAK 364
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 774 (277.5 bits), Expect = 7.1e-77, P = 7.1e-77
Identities = 158/314 (50%), Positives = 213/314 (67%)
Query: 51 KRVDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGR 110
+R EE + GK ++ +FTF++L AT F+ N +G GGFG VY+G +
Sbjct: 50 RRYISEEIAKLGKGNISA----HIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPE 105
Query: 111 KV-AIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQ 168
+V A+K +D+ G QG EF +EV +L L L+ L+GYC+D +++LVY+YM NG L+
Sbjct: 106 QVVAVKQLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLE 165
Query: 169 EHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 228
+HL + + LDW+TR+++A AA+GLE+LHE PPVI+RDFK+SNILLD+ F+
Sbjct: 166 DHLLEL--ARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFN 223
Query: 229 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTG 288
K+SDFGLAK+G HVSTRV+GT GY APEYALTG LT KSDVYS+GVV LE++TG
Sbjct: 224 PKLSDFGLAKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITG 283
Query: 289 RVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPE 348
R ID KP+ E LV+WA P DR K + DP LEG+Y +K + Q A+AAMC+Q E
Sbjct: 284 RRVIDTTKPTEEQNLVTWASPLFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEE 343
Query: 349 ADYRPLMADVVQSL 362
A RP+M+DVV +L
Sbjct: 344 AATRPMMSDVVTAL 357
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 773 (277.2 bits), Expect = 9.0e-77, P = 9.0e-77
Identities = 159/315 (50%), Positives = 212/315 (67%)
Query: 50 PKRVDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSN- 108
PK V+ + K EVT + Q F+F++L +AT F + ++G GGFG VY+G L
Sbjct: 42 PKTVNEQNKNNDEDKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKT 101
Query: 109 GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 167
G VA+K +D+ G QG EF +EV +L L +L+ L+GYC+D ++LLVY+YM+ G L
Sbjct: 102 GMIVAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSL 161
Query: 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 227
++HL LDW+TR+RIAL AA GLE+LH+ +PPVI+RD K++NILLD F
Sbjct: 162 EDHLLDLTPDQI---PLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEF 218
Query: 228 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
+AK+SDFGLAK+G HVS+RV+GT GY APEY TG LTTKSDVYS+GVVLLEL+T
Sbjct: 219 NAKLSDFGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELIT 278
Query: 288 GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQP 347
GR ID +P E LV+WA P + + E+ DP+LEG + K + Q A+AAMC+Q
Sbjct: 279 GRRVIDTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQE 338
Query: 348 EADYRPLMADVVQSL 362
EA RPLM+DVV +L
Sbjct: 339 EATVRPLMSDVVTAL 353
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 768 (275.4 bits), Expect = 3.1e-76, P = 3.1e-76
Identities = 160/331 (48%), Positives = 219/331 (66%)
Query: 39 IRNKVSKRLNTPKRVDREEKGESGKLEVTTDNGL-QV----FTFKQLHSATGGFSKSNVV 93
+ N +S + +++ + G S + + +GL Q+ F F++L +AT F +
Sbjct: 33 VSNNISGLPSGGEKLSSKTNGGSKRELLLPRDGLGQIAAHTFAFRELAAATMNFHPDTFL 92
Query: 94 GHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152
G GGFG VY+G L S G+ VA+K +D+ G QG EF +EV +L L P L+ L+GYC+D
Sbjct: 93 GEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD 152
Query: 153 R-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 211
++LLVY++M G L++HL+ LDW R++IA AAKGLEFLH+ +PPV
Sbjct: 153 GDQRLLVYEFMPLGSLEDHLHDLPPDKEA---LDWNMRMKIAAGAAKGLEFLHDKANPPV 209
Query: 212 IHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTT 271
I+RDFKSSNILLD+ FH K+SDFGLAK+G HVSTRV+GT GY APEYA+TG LT
Sbjct: 210 IYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTV 269
Query: 272 KSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSM 331
KSDVYS+GVV LEL+TGR ID P GE LV+WA P DR K +++ DP L+G++
Sbjct: 270 KSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPT 329
Query: 332 KEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
+ + Q A+A+MC+Q +A RPL+ADVV +L
Sbjct: 330 RALYQALAVASMCIQEQAATRPLIADVVTAL 360
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 759 (272.2 bits), Expect = 2.7e-75, P = 2.7e-75
Identities = 154/292 (52%), Positives = 201/292 (68%)
Query: 73 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKME 131
Q FTF +L +AT F K ++G GGFG VY+G L S + AIK +D G QG EF +E
Sbjct: 59 QTFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNREFLVE 118
Query: 132 VELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 190
V +L L P L+ L+GYC+D ++LLVY+YM G L++HL+ + LDW TR+
Sbjct: 119 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQ---PLDWNTRM 175
Query: 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 250
+IA AAKGLE+LH+ PPVI+RD K SNILLD ++ K+SDFGLAK+G HVST
Sbjct: 176 KIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVST 235
Query: 251 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 310
RV+GT GY APEYA+TG LT KSDVYS+GVVLLE++TGR ID ++ +GE LV+WA P
Sbjct: 236 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPL 295
Query: 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
DR K ++ DP L+GQY + + Q A+AAMCVQ + + RPL+ADVV +L
Sbjct: 296 FKDRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTAL 347
|
|
| TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 754 (270.5 bits), Expect = 9.3e-75, P = 9.3e-75
Identities = 153/299 (51%), Positives = 212/299 (70%)
Query: 72 LQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKME 131
++ FT +L AT FS V+G GGFG VY+G + +G +VA+KL+ + + + EF E
Sbjct: 334 VKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLLTRDNQNRDREFIAE 393
Query: 132 VELLGRLRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 190
VE+L RL L+ L+G C + R + L+Y+ + NG ++ HL+ G+ LDW+ RL
Sbjct: 394 VEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH--EGT------LDWDARL 445
Query: 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 250
+IAL AA+GL +LHE +P VIHRDFK+SN+LL+ +F KVSDFGLA+ ++ H+ST
Sbjct: 446 KIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATE-GSQHIST 504
Query: 251 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 310
RV+GT GYVAPEYA+TGHL KSDVYSYGVVLLELLTGR P+D+++PSGE LV+WA P
Sbjct: 505 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPL 564
Query: 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369
L +RE + +++DPAL G Y+ ++ +VAAIA+MCV E +RP M +VVQ+L L+ YN
Sbjct: 565 LANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQAL-KLI-YN 621
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00018755001 | SubName- Full=Chromosome chr12 scaffold_18, whole genome shotgun sequence; (398 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 395 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-31 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-30 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-19 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-19 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-18 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-16 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-16 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-14 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 5e-50
Identities = 74/198 (37%), Positives = 108/198 (54%), Gaps = 16/198 (8%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMD-QAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G GGFG VY G+KVAIK++ + +E E+E+L +L P ++ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 151 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
D L LV +Y G L++ L KL + LRI L+ +GLE+LH +
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL------KENEGKLSEDEILRILLQILEGLEYLHSN--- 111
Query: 210 PVIHRDFKSSNILLDK-NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-TG 267
+IHRD K NILLD N K++DFGL+K+ + + ++GT Y+APE L G
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD--KSLLKTIVGTPAYMAPEVLLGKG 169
Query: 268 HLTTKSDVYSYGVVLLEL 285
+ + KSD++S GV+L EL
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 2e-47
Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 41/287 (14%)
Query: 91 NVVGHGGFGLVYRGVLSNG----RKVAIKLM-DQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+G G FG VY+G L +VA+K + + A ++ +F E ++ +L P ++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHL--YPANGSNSVASKLDWETRLRIALEAAKGLEF 202
LLG C++ L LV +YM G L ++L + S L + L A++ AKG+E+
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD------KAGGHVSTRVLGTQ 256
L +HRD + N L+ ++ K+SDFGL++ D K GG + R
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----- 172
Query: 257 GYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 315
++APE G T+KSDV+S+GV+L E+ T G P G+ L L
Sbjct: 173 -WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY-------PGLSNEEVLEYLRKGY 224
Query: 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
+ L + + ++ + C Q + + RP +++V+ L
Sbjct: 225 R-LPKPEYCPD---------ELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-46
Identities = 83/288 (28%), Positives = 130/288 (45%), Gaps = 45/288 (15%)
Query: 88 SKSNVVGHGGFGLVYRGVL-----SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSP 141
+ +G G FG VY+G L +VA+K L + A +Q +EF E ++ +L P
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 142 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
++ LLG C++ L +V +YM G L +L KL L AL+ A+G+
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL------RKNRPKLSLSDLLSFALQIARGM 115
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGT 255
E+L IHRD + N L+ +N K+SDFGL++ D K GG + R
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR---- 168
Query: 256 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 314
++APE G T+KSDV+S+GV+L E+ T G P G+ L L +
Sbjct: 169 --WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY-------PGMSNEEVLEYLKNG 219
Query: 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
+ L + + C + + RP +++V+ L
Sbjct: 220 YR-LPQPPNCPPE---------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 4e-46
Identities = 81/288 (28%), Positives = 131/288 (45%), Gaps = 44/288 (15%)
Query: 88 SKSNVVGHGGFGLVYRGVLSNG-----RKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSP 141
+ +G G FG VY+G L +VA+K L + A +Q +EF E ++ +L P
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 142 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
++ LLG C++ L +V +YM G L ++L + +L L AL+ A+G+
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL-----RKNRPKELSLSDLLSFALQIARGM 116
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGT 255
E+L IHRD + N L+ +N K+SDFGL++ D GG + R
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR---- 169
Query: 256 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 314
++APE G T+KSDV+S+GV+L E+ T G P G+ + L L
Sbjct: 170 --WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPY-------PGMSNAEVLEYLKKG 220
Query: 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
+ L + + C + + RP +++V+ L
Sbjct: 221 YR-LPKPPNCPPE---------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 6e-46
Identities = 81/244 (33%), Positives = 118/244 (48%), Gaps = 30/244 (12%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLLALLG 148
+G G FG VY+ G+ VA+K++ + + + E+ +L RL P ++ L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 149 YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
D+ L LV +Y G L ++L L + +IAL+ +GLE+LH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG-------PLSEDEAKKIALQILRGLEYLHSN- 117
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 267
+IHRD K NILLD+N K++DFGLAK K+ ++T V GT Y+APE L G
Sbjct: 118 --GIIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFV-GTPWYMAPEVLLGG 173
Query: 268 -HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALE 326
K DV+S GV+L ELLTG+ P L + I I+ P LE
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP-------------FSGENILDQLQLIRRILGPPLE 220
Query: 327 GQYS 330
Sbjct: 221 FDEP 224
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-45
Identities = 69/209 (33%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMD-QAGKQGEDEFKMEVELLGRLRSPYLL 144
+ +G G FG VY G+ VAIK++ + K+ + E+++L +L+ P ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 145 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEAAKGLEF 202
L D KL LV +Y G L + L S A + LE+
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF--------YLRQILSALEY 112
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
LH ++HRD K NILLD++ H K++DFGLA+ G ++T V GT Y+APE
Sbjct: 113 LHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFV-GTPEYMAPE 166
Query: 263 YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
L D++S GV+L ELLTG+ P
Sbjct: 167 VLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 154 bits (393), Expect = 1e-44
Identities = 69/213 (32%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 92 VVGHGGFGLVYRGVL-----SNGRKVAIKLM-DQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+G G FG VY+G L KVA+K + + A ++ +EF E ++ +L P ++
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
LLG C+ L +V +YM G L + L KL + L++AL+ AKG+E+L
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR------KHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV----- 259
+HRD + N L+ +N K+SDFGL++ + G +
Sbjct: 120 SK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYED-----DYYRKRGGGKLPIKWM 171
Query: 260 APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
APE G T+KSDV+S+GV+L E+ T G P
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 3e-35
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 18/212 (8%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE--DEFKMEVELLGRLRSPYL 143
+++ ++G G FG VY + G +A+K ++ +G E + + E+ +L L+ P +
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 144 LALLGYCSDRRKLLVY---DYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKG 199
+ G D K + +Y++ G L L G KL E +R + +G
Sbjct: 62 VRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFG------KLP-EPVIRKYTRQILEG 113
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
L +LH + ++HRD K +NIL+D + K++DFG AK D G + V GT ++
Sbjct: 114 LAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWM 170
Query: 260 APEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
APE +D++S G ++E+ TG+ P
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 68/228 (29%), Positives = 113/228 (49%), Gaps = 19/228 (8%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
F+ +G G FG V+ G+ N +VAIK++ + +F+ EV+ L RLR +L++L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 147 LGYCS-DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 205
CS ++ + M G L L G L + + +A + A+G+ +L E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-----LPVASLIDMACQVAEGMAYLEE 122
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 265
IHRD + NIL+ ++ KV+DFGLA++ + ++ + APE A
Sbjct: 123 Q---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAAS 177
Query: 266 TGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLT 312
G +TKSDV+S+G++L E+ T G+VP G+ ++T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPY-------PGMNNHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 8e-33
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 87 FSKSNVVGHGGFGLVYRG-VLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
F +G GGFG VY+ G++VAIK++ K+ +++ E+++L + + P ++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 146 LLG--YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
G D + V ++ + G L++ L S L + E KGLE+L
Sbjct: 62 YYGSYLKKDELWI-VMEFCSGGSLKDLL------KSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H + +IHRD K++NILL + K+ DFGL+ SD ++GT ++APE
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD---TKARNTMVGTPYWMAPEV 168
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVP 291
K+D++S G+ +EL G+ P
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-31
Identities = 64/210 (30%), Positives = 108/210 (51%), Gaps = 18/210 (8%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED--EFKMEVELLGRLRSPYL 143
+ +++G G FG+VY+G+ L G VAIK + + E E++LL L+ P +
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 144 LALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL-EAAKGLE 201
+ +G L ++ +Y NG L++ + E+ + + + + +GL
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP--------ESLVAVYVYQVLQGLA 113
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+LHE VIHRD K++NIL K+ K++DFG+A +D + V+GT ++AP
Sbjct: 114 YLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAP 168
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
E +T SD++S G ++ELLTG P
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 71/215 (33%), Positives = 116/215 (53%), Gaps = 20/215 (9%)
Query: 93 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152
+G G FGLV+ G RKVAIK + + G E++F E +++ +L P L+ L G C++
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 153 RRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 211
R + LV+++M +G L ++L G K ET L + L+ +G+ +L V
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRG------KFSQETLLGMCLDVCEGMAYLESSN---V 121
Query: 212 IHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ---GYVAPEYALTGH 268
IHRD + N L+ +N KVSDFG+ + D T GT+ + +PE
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWSSPEVFSFSK 177
Query: 269 LTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGV 302
++KSDV+S+GV++ E+ + G+ P + N+ + E V
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSEVV 211
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 14/201 (6%)
Query: 94 GHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR 153
G G FG V+ G + KVA+K + E F E +++ +LR L+ L CS+
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-FLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 154 RKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 212
+ +V +YM+ G L + L G KL + +A + A+G+ +L I
Sbjct: 74 EPIYIVTEYMSKGSLLDFLKSGEGK-----KLRLPQLVDMAAQIAEGMAYLESR---NYI 125
Query: 213 HRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTT 271
HRD + NIL+ +N K++DFGLA+ I D+ + + APE A G T
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTI 183
Query: 272 KSDVYSYGVVLLELLT-GRVP 291
KSDV+S+G++L E++T GRVP
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-30
Identities = 74/237 (31%), Positives = 119/237 (50%), Gaps = 22/237 (9%)
Query: 93 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152
+G G FG+V+ G VAIK++ + G ED+F E +++ +L P L+ L G C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 153 RRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 211
+R + +V +YMANG L +L G KL E L + + + +E+L +
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKG------KLGTEWLLDMCSDVCEAMEYLESNG---F 121
Query: 212 IHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ---GYVAPEYALTGH 268
IHRD + N L+ ++ KVSDFGLA+ D T GT+ + PE
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDYSR 177
Query: 269 LTTKSDVYSYGVVLLELLT-GRVPID--VNKPSGEGVLVSWALPRLTD-REKILEIM 321
++KSDV+S+GV++ E+ + G++P + N E V + L R ++ IM
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIM 234
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 9e-30
Identities = 67/207 (32%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 93 VGHGGFGLVY--RGVLSNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALL 147
+G G FG V R + G+ A+K++ + ++ + E +L R+ P+++ L
Sbjct: 1 LGKGSFGKVLLVRKKDT-GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL- 58
Query: 148 GYCS--DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
+ + KL LV +Y G L HL + E A E LE+LH
Sbjct: 59 -HYAFQTEEKLYLVLEYAPGGELFSHLSKEG-------RFSEERARFYAAEIVLALEYLH 110
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
+I+RD K NILLD + H K++DFGLAK S + G +T GT Y+APE
Sbjct: 111 SL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE-GSRTNTFC-GTPEYLAPEVL 165
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVP 291
L D +S GV+L E+LTG+ P
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 74/221 (33%), Positives = 114/221 (51%), Gaps = 25/221 (11%)
Query: 87 FSKSNV-----VGHGGFGLVYRG--VLSNGRK----VAIK-LMDQAGKQGEDEFKMEVEL 134
S V +G G FG VY+G N R VAIK L + A + + EF+ E EL
Sbjct: 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAEL 61
Query: 135 LGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLY---------PANGSNSVASKL 184
+ L+ P ++ LLG C+ + ++++Y+A+G L E L +G +V S L
Sbjct: 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL 121
Query: 185 DWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244
D L IA++ A G+E+L H +HRD + N L+ + K+SDFGL++
Sbjct: 122 DCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD 178
Query: 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLEL 285
V ++ L ++ PE L G TT+SD++S+GVVL E+
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 116 bits (290), Expect = 5e-29
Identities = 70/226 (30%), Positives = 108/226 (47%), Gaps = 22/226 (9%)
Query: 86 GFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGRLRSP- 141
+ +G G FG VY + + VA+K++ + + E F E+++L L P
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 142 YLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
++ L + D LV +Y+ G L++ L L L I + L
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK----KIGRKGPLSESEALFILAQILSAL 114
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAKI----GSDKAGGHVSTRVLGT 255
E+LH +IHRD K NILLD++ K+ DFGLAK+ GS + + + +GT
Sbjct: 115 EYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 256 QGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPS 298
GY+APE L + ++ SD++S G+ L ELLTG P + K S
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-29
Identities = 111/374 (29%), Positives = 173/374 (46%), Gaps = 59/374 (15%)
Query: 16 VVIVVVASLALASLLVAFSYYCYIRNKVSKRLNTPKRVDREEKGESGKLEVTTDNGLQVF 75
+ + A L LA LVAF + +IR + + L KRV+ E+ G E LQ F
Sbjct: 632 ITCTLGAFLVLA--LVAFGF-VFIRGRNNLEL---KRVENED----GTWE------LQFF 675
Query: 76 TFKQLHSAT-----GGFSKSNVVGHGGFGLVYRG-VLSNGRKVAIKLMDQAGKQGEDEFK 129
K S T + NV+ G G Y+G + NG + +K ++
Sbjct: 676 DSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS---- 731
Query: 130 MEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWET 188
E+ +G+L+ P ++ L+G C S++ L+++Y+ L E V L WE
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSE----------VLRNLSWER 781
Query: 189 RLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF--HAKVSDFGLAKIGSDKAGG 246
R +IA+ AK L FLH CSP V+ + I++D H ++S GL
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCT------- 834
Query: 247 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 306
T+ + YVAPE T +T KSD+Y +G++L+ELLTG+ P D + G +V W
Sbjct: 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGSIVEW 891
Query: 307 ALPRLTDREKILEIMDPALEGQYSM--KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364
A +D + I DP++ G S+ E+++V +A C + RP DV+++L
Sbjct: 892 ARYCYSDCHLDMWI-DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL-- 948
Query: 365 LVKYNRSTPKISSS 378
S + SSS
Sbjct: 949 -----ESASRSSSS 957
|
Length = 968 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 93 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152
+G G FG V+ G+ +N VA+K + + G +F E +++ +LR P L+ L C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 153 RRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 211
+ +V + M G L E+L L + +A + A G+ +L
Sbjct: 73 EEPIYIVTELMKYGSLLEYL-----QGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NY 124
Query: 212 IHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLT 270
IHRD + N+L+ +N KV+DFGLA+ I D + + APE AL +
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFS 182
Query: 271 TKSDVYSYGVVLLELLT-GRVP 291
KSDV+S+G++L E++T GR+P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 66/226 (29%), Positives = 99/226 (43%), Gaps = 38/226 (16%)
Query: 92 VVGHGGFGLVYRGVL-SNGRKVAIKLMD-----QAGKQGEDEFKMEVELLGRL-RSPYLL 144
++G G F V ++ AIK++D + K K+E E+L RL P ++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV--KYVKIEKEVLTRLNGHPGII 65
Query: 145 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
L D L V +Y NG L +++ GS TR A E LE+L
Sbjct: 66 KLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKC-----TRF-YAAEILLALEYL 118
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK----AGGHVSTRVL------ 253
H +IHRD K NILLDK+ H K++DFG AK+ + +T +
Sbjct: 119 HSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 254 --------GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
GT YV+PE SD+++ G ++ ++LTG+ P
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-28
Identities = 68/206 (33%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 89 KSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG 148
+G G FG V G G+KVA+K + F E ++ LR P L+ LLG
Sbjct: 10 LGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLG 67
Query: 149 YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
L +V +YMA G L ++L + + + +L AL+ +G+E+L E
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYL-----RSRGRAVITLAQQLGFALDVCEGMEYLEEK- 121
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK-AGGHVSTRVLGTQGYVAPEYALT 266
+HRD + N+L+ ++ AKVSDFGLAK S G + + + APE
Sbjct: 122 --NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK------WTAPEALRE 173
Query: 267 GHLTTKSDVYSYGVVLLELLT-GRVP 291
+TKSDV+S+G++L E+ + GRVP
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 93 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152
+G G FG V+ G + KVAIK + Q G + F E L+ +L+ P L+ L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 153 RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 212
++ +YM NG L + L G +KL + +A + A+G+ F+ I
Sbjct: 73 EPIYIITEYMENGSLVDFLKTPEGIKLTINKL-----IDMAAQIAEGMAFIERKNY---I 124
Query: 213 HRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG------YVAPEYALT 266
HRD +++NIL+ + K++DFGLA++ D +G + APE
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIED-------NEYTAREGAKFPIKWTAPEAINY 177
Query: 267 GHLTTKSDVYSYGVVLLELLT-GRVP 291
G T KSDV+S+G++L E++T GR+P
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 81/271 (29%), Positives = 129/271 (47%), Gaps = 31/271 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRSPYL 143
F N +G G FG+V++ V ++ R A+K +D + ++ +E E +L +L S Y+
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 144 LALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
+ D+ KL +V +Y NG L + L G + W R ++ GL
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVW----RFFIQILLGLAH 116
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
LH S ++HRD KS N+ LD + K+ D G+AK+ SD + + ++GT Y++PE
Sbjct: 117 LH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPE 171
Query: 263 YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322
KSDV++ GVVL E TG+ P D N +G L+ KI+ +
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALI----------LKIIRGVF 218
Query: 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRP 353
P + YS Q+A + C+ + RP
Sbjct: 219 PPVSQMYSQ----QLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 91 NVVGHGGFGLVYRGVLS-NGRK---VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
V+G G FG V RG L G+K VAIK L + + +F E ++G+ P ++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 146 LLGYCSDRRKLL-VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L G + R ++ + +YM NG L + L +G K + + A G+++L
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDG------KFTVGQLVGMLRGIASGMKYLS 123
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK------AGGHVSTRVLGTQGY 258
E +HRD + NIL++ N KVSDFGL++ D GG + R +
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR------W 174
Query: 259 VAPEYALTGHLTTKSDVYSYGVVLLELLT 287
APE T+ SDV+S+G+V+ E+++
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 28/220 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRS 140
K V+G G FG VY+GV + G K VAIK L ++ + E E ++ +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 141 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
P+++ LLG C + L+ M G L +++ + L+W ++ AKG+
Sbjct: 69 PHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGM 122
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK------AGGHVSTRVLG 254
+L E ++HRD + N+L+ H K++DFGLAK+ GG V +
Sbjct: 123 SYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK--- 176
Query: 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPID 293
++A E L T KSDV+SYGV + EL+T G P +
Sbjct: 177 ---WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 77/287 (26%), Positives = 125/287 (43%), Gaps = 53/287 (18%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---EVELLGRLRSPYLLAL 146
+G G FG VY S+G+ +K +D + E E + EV++L +L P ++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS-NMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 147 LGYCSDRRKLL-VYDYMANGGLQEHLYPANGSNSVASK---LDWETRLRIALEAAKGLEF 202
++ KL V +Y G L + + + LDW +L L++
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKY 118
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
LH ++HRD K NI L N K+ DFG++K+ S ++ V+GT Y++PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLSPE 173
Query: 263 ------YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316
Y KSD++S G VL EL T + P + L L K
Sbjct: 174 LCQNKPY------NYKSDIWSLGCVLYELCTLKHPFE-----------GENLLEL--ALK 214
Query: 317 ILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361
IL+ P + QYS ++ ++ +Q + + RP +A ++QS
Sbjct: 215 ILKGQYPPIPSQYSSELRNLVS------SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-26
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 89 KSNVVGHGGFGLVYRGVLSN-----GRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPY 142
+G G FG V G +VA+K L +Q +F+ E+E+L L
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 143 LLALLGYCSD---RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 199
++ G C R L+ +Y+ +G L+++L + +L L + + KG
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRL-----LLFSSQICKG 121
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST--RVLGTQG 257
+++L IHRD + NIL++ K+SDFGLAK+ + +
Sbjct: 122 MDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 258 YVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
Y APE T ++ SDV+S+GV L EL T
Sbjct: 179 Y-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-25
Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 23/206 (11%)
Query: 93 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152
+G+G FG V+ G + KVA+K + + G + F E +++ +LR L+ L S+
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 153 RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 212
+V +YM+ G L + L G L + +A + A G+ ++ I
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKDGEGRA-----LKLPNLVDMAAQVAAGMAYIERM---NYI 124
Query: 213 HRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG------YVAPEYALT 266
HRD +S+NIL+ K++DFGLA++ D QG + APE AL
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIED-------NEYTARQGAKFPIKWTAPEAALY 177
Query: 267 GHLTTKSDVYSYGVVLLELLT-GRVP 291
G T KSDV+S+G++L EL+T GRVP
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 75/292 (25%), Positives = 131/292 (44%), Gaps = 53/292 (18%)
Query: 92 VVGHGGFGLVYRGVLS-NGRKVAIK----LMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
V+G G G+VY+ G+ A+K D+ ++ + E++ L SPY++
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK---QLLRELKTLRSCESPYVVKC 64
Query: 147 LG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL-RIALEAAKGLEFLH 204
G + + +V +YM G L + L E L IA + KGL++LH
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKKVGKIP--------EPVLAYIARQILKGLDYLH 116
Query: 205 E--HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
H +IHRD K SN+L++ K++DFG++K+ + + +GT Y++PE
Sbjct: 117 TKRH----IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPE 170
Query: 263 YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322
+ +D++S G+ LLE G+ P P G+ + L + I D
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSF--FEL--------MQAICD 217
Query: 323 ---PAL-EGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368
P+L ++S ++ I + C+Q + RP A+++Q P +K
Sbjct: 218 GPPPSLPAEEFSPEFRDFI------SACLQKDPKKRPSAAELLQH--PFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 93 VGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQGED-EFKMEVELLGRLRSPYLLA 145
+G G FG+VY G+ +VAIK +++ E EF E ++ +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 146 LLGYCSD-RRKLLVYDYMANGGLQEHL---YPANGSNSVASKLDWETRLRIALEAAKGLE 201
LLG S + L+V + MA G L+ +L P +N + +++A E A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA----------KIGSDKAGGHVSTR 251
+L +HRD + N ++ ++ K+ DFG+ K G G + R
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG----KGLLPVR 186
Query: 252 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
++APE G TTKSDV+S+GVVL E+ T
Sbjct: 187 ------WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 29/221 (13%)
Query: 92 VVGHGGFGLVYRGVLSNGRK------VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLL 144
+G G FG V+ G + VA+K L + A +F+ E ELL + ++
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 145 ALLGYCSDRRKLL-VYDYMANGGLQEHLYPANGSNSVASK--------LDWETRLRIALE 195
G C++ + V++YM +G L + L ++G ++ K L L+IA++
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLR-SHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--IGSD--KAGGHVSTR 251
A G+ +L S +HRD + N L+ + K+ DFG+++ +D + GGH
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGH---T 184
Query: 252 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+L + ++ PE + TT+SDV+S+GVVL E+ T G+ P
Sbjct: 185 MLPIR-WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-24
Identities = 81/283 (28%), Positives = 137/283 (48%), Gaps = 51/283 (18%)
Query: 93 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152
+G G FG V+ G + KVAIK + + G + F E +++ +LR L+ L S+
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 153 RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 212
+V ++M G L + L +G +L + +A + A G+ ++ I
Sbjct: 73 EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL-----VDMAAQIADGMAYIERM---NYI 124
Query: 213 HRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYALTG 267
HRD +++NIL+ N K++DFGLA++ D + G + + APE AL G
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYG 178
Query: 268 HLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD---- 322
T KSDV+S+G++L EL+T GRVP P + +RE +LE ++
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVP----------------YPGMVNRE-VLEQVERGYR 221
Query: 323 -PALEG-QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363
P +G S+ E+++ +C + + D RP + +QS +
Sbjct: 222 MPCPQGCPESLHELMK------LCWKKDPDERPTF-EYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 8e-24
Identities = 66/215 (30%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 86 GFSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGEDEFKM------EVELLGRL 138
F V+G G FG V + +K+ A+K M+ KQ E E +L L
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN---KQKCVEKGSVRNVLNERRILQEL 57
Query: 139 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEA 196
P+L+ L D + LV D + G L+ HL S K E +++ E
Sbjct: 58 NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-------SQKVKFS-EEQVKFWICEI 109
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 256
LE+LH +IHRD K NILLD+ H ++DF +A + ++T GT
Sbjct: 110 VLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA---TKVTPDTLTTSTSGTP 163
Query: 257 GYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
GY+APE + D +S GV E L G+ P
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-23
Identities = 79/279 (28%), Positives = 132/279 (47%), Gaps = 37/279 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLL 144
F+K +G G FG V++G+ + +KV AIK++D + E ++ + E+ +L + SPY+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 145 ALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
G Y D + ++ +Y+ G + L P LD I E KGL++L
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--------PLDETQIATILREILKGLDYL 117
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H S IHRD K++N+LL ++ K++DFG+A +D +GT ++APE
Sbjct: 118 H---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEV 172
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323
+K+D++S G+ +EL G P P L+ P P
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------P 219
Query: 324 ALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360
LEG YS +KE ++ C+ E +RP ++++
Sbjct: 220 TLEGNYSKPLKEFVEA------CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-23
Identities = 65/205 (31%), Positives = 105/205 (51%), Gaps = 21/205 (10%)
Query: 93 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152
+G G FG V+ G + +VAIK + + G + F E +++ +LR L+ L S+
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 153 RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 212
+V +YM+ G L + L + L + +A + A G+ ++ +
Sbjct: 73 EPIYIVTEYMSKGSLLDFL-----KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYV 124
Query: 213 HRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYALTG 267
HRD +++NIL+ +N KV+DFGLA++ D + G + + APE AL G
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALYG 178
Query: 268 HLTTKSDVYSYGVVLLELLT-GRVP 291
T KSDV+S+G++L EL T GRVP
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 76/216 (35%), Positives = 114/216 (52%), Gaps = 20/216 (9%)
Query: 91 NVVGHGGFGLVYRGVL--SNGRKV--AIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLLA 145
V+G G FG VY G L S+G+K+ A+K +++ E ++F E ++ P +L+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 146 LLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
LLG C S+ L+V YM +G L+ + + N L + L+ AKG+E+L
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLR-NFIRSETHNPTVKDL-----IGFGLQVAKGMEYL 114
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA--GGHVSTRVLGTQGYVAP 261
S +HRD + N +LD++F KV+DFGLA+ DK H T ++A
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVP--IDVN 295
E T TTKSDV+S+GV+L EL+T P DV+
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 92 VVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG-Y 149
+G G G VY+ G++VAIK M KQ ++ E+ ++ + P ++ Y
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 150 CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL-RIALEAAKGLEFLHEHCS 208
+V +YM G L + + N V E ++ + E +GLE+LH S
Sbjct: 85 LVGDELWVVMEYMDGGSLTDIITQ----NFVRMN---EPQIAYVCREVLQGLEYLH---S 134
Query: 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 268
VIHRD KS NILL K+ K++DFG A + + S V+GT ++APE
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKD 192
Query: 269 LTTKSDVYSYGVVLLELLTGRVP 291
K D++S G++ +E+ G P
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 5e-23
Identities = 70/212 (33%), Positives = 108/212 (50%), Gaps = 31/212 (14%)
Query: 96 GGFGLVYRGVL----SNGRKVAIKLMDQAGKQGE---DEFKMEVELLGRLRSPYLLALLG 148
G +G V+ L S G AIK++ +A + D+ E ++L + +SPY++ L
Sbjct: 4 GAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58
Query: 149 YCS--DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 205
Y S ++ L LV +Y+ G L L +V S + R+ IA E LE+LH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLL------ENVGSLDEDVARIYIA-EIVLALEYLHS 111
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS------TRVLGTQGYV 259
+ +IHRD K NIL+D N H K++DFGL+K+G + +++ R++GT Y+
Sbjct: 112 N---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 260 APEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
APE L + D +S G +L E L G P
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 5e-23
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 32/216 (14%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGRLRSPY 142
F+ +G G FG VY+ + + VAIK++D ++ EDE + E++ L + RSPY
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL--EEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
+ G KL ++ +Y G + L P KLD I E GLE
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--------GKLDETYIAFILREVLLGLE 112
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL------GT 255
+LHE IHRD K++NILL + K++DFG++ G +++ + GT
Sbjct: 113 YLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS--------GQLTSTMSKRNTFVGT 161
Query: 256 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
++APE K+D++S G+ +EL G P
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-23
Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 89 KSNVVGHGGFGLVYRGV-LSNGRKVAIKLMD-QAGKQGE-DEFKMEVELLGRLRSPYLLA 145
+ N +G G FG VY V L G +A+K + Q E E+++L L+ P L+
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 146 LLGYCSDRRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
G R K+ ++ +Y + G L+E L +G LD L+ +GL +LH
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELL--EHGRI-----LDEHVIRVYTLQLLEGLAYLH 116
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI---GSDKAGGHVSTRVLGTQGYVAP 261
H ++HRD K +NI LD N K+ DFG A + G V + + GT Y+AP
Sbjct: 117 SH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS-LAGTPAYMAP 172
Query: 262 EYALTGHLTTK---SDVYSYGVVLLELLTGRVP 291
E G +D++S G V+LE+ TG+ P
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-22
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 93 VGHGGFGLVYRGVL-----SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
+G FG +Y+G L + + VAIK L D Q EF+ E L+ L P ++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 147 LGYCSDRRKL-LVYDYMANGGLQEHLY----------PANGSNSVASKLDWETRLRIALE 195
LG + + + ++++Y+ G L E L ++ +V S LD L IA++
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGT 255
A G+E+L H +H+D + NIL+ + H K+SD GL++ V + L
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 256 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
++ PE + G ++ SD++S+GVVL E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 46/291 (15%)
Query: 91 NVVGHGGFGLVYRGVLSNGR------KVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYL 143
+GHG FG VY G+ +VA+K L + +Q E +F ME ++ + +
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 144 LALLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
+ L+G +R + ++ + MA G L+ L S L + L A + AKG ++
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 203 LHEHCSPPVIHRDFKSSNILLD---KNFHAKVSDFGLAK--IGSD--KAGGHVSTRVLGT 255
L E+ IHRD + N LL AK++DFG+A+ + + GG R +
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG----RAMLP 184
Query: 256 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 314
++ PE L G T+K+DV+S+GV+L E+ + G +P P T++
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP----------------YPGRTNQ 228
Query: 315 EKILEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
E+M+ G V I C Q + RP A +++ +
Sbjct: 229 ----EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-22
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 93 VGHGGFGLVYRGVLSNGRKVAIKL--MDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G FG VY+GVL +VA+K +F E E+L + P ++ L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR-KFLQEAEILKQYDHPNIVKLIGVC 61
Query: 151 SDRRKLL-VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
++ + V + + G L L ++L + L+++L+AA G+E+L
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYLESKN-- 113
Query: 210 PVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ----GYVAPEYAL 265
IHRD + N L+ +N K+SDFG+++ ++ GG + T G + + APE
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSR---EEEGG-IYTVSDGLKQIPIKWTAPEALN 168
Query: 266 TGHLTTKSDVYSYGVVLLELLT-GRVP 291
G T++SDV+SYG++L E + G P
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTP 195
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 7e-22
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 89 KSNVVGHGGFGLVYRGV-LSNGRK----VAIKLM-DQAGKQGEDEFKMEVELLGRLRSPY 142
K ++G G FG V++G+ + G VAIK + D++G+Q E + +G L Y
Sbjct: 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAY 70
Query: 143 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
++ LLG C LV G L +H+ S L+W ++ AKG+ +
Sbjct: 71 IVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYY 124
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
L EH ++HR+ + NILL + +++DFG+A + + + ++A E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 263 YALTGHLTTKSDVYSYGVVLLELLT 287
L G T +SDV+SYGV + E+++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 59/191 (30%), Positives = 100/191 (52%), Gaps = 21/191 (10%)
Query: 112 VAIKLM-DQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQE 169
VA+K++ A K ++F EV++L RL+ P ++ LLG C D L ++ +YM NG L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 170 HL------------YPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK 217
L A + + + L +AL+ A G+++L S +HRD
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 218 SSNILLDKNFHAKVSDFGLAKIGSDKAGGH--VSTRVLGTQGYVAPEYALTGHLTTKSDV 275
+ N L+ +N K++DFG+++ + AG + + R + ++A E L G TT SDV
Sbjct: 166 TRNCLVGENLTIKIADFGMSR--NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223
Query: 276 YSYGVVLLELL 286
+++GV L E+L
Sbjct: 224 WAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-21
Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 48/282 (17%)
Query: 93 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152
+G G FG+V G VAIK M + G EDEF E +++ +L L+ L G C+
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 153 RRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 211
+R + +V +YM+NG L +L + L + + +G+ +L
Sbjct: 71 QRPIYIVTEYMSNGCLLNYL------REHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121
Query: 212 IHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---APEYALTGH 268
IHRD + N L+D KVSDFGL++ D T +G++ V PE L
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLLYSK 177
Query: 269 LTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD----- 322
++KSDV+++GV++ E+ + G++P + R + E + ++
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYE----------------RFNNSETVEKVSQGLRLY 221
Query: 323 -PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363
P L + +V AI C +A+ RP ++ S+
Sbjct: 222 RPHLASE-------KVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-21
Identities = 80/291 (27%), Positives = 140/291 (48%), Gaps = 38/291 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLL 144
F+K +G G FG VY+G+ + ++V AIK++D + E ++ + E+ +L + SPY+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 145 ALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
G Y + ++ +Y+ G + L P + + T LR E KGL++L
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILR---EILKGLDYL 117
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H S IHRD K++N+LL + K++DFG+A +D +GT ++APE
Sbjct: 118 H---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEV 172
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323
K+D++S G+ +EL G P P + V + +P+ + P
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP----MRVLFLIPKNS---------PP 219
Query: 324 ALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 372
LEGQYS KE ++ C+ + +RP ++++ + +Y + T
Sbjct: 220 TLEGQYSKPFKEFVEA------CLNKDPRFRPTAKELLKHKF-ITRYTKKT 263
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 5e-21
Identities = 61/219 (27%), Positives = 108/219 (49%), Gaps = 31/219 (14%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEF----KMEVELLGRLRSP 141
+ K +G G +G VY+ G VA+K + + ++ F E++LL +LR P
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIREIKLLQKLRHP 58
Query: 142 YLLALLGYCSDRRK---LLVYDYMAN--GGLQEHLYPANGSNSVASKLDWETRLR-IALE 195
++ L + + K +V++YM + GL + K E++++ +
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDS---------PEVKFT-ESQIKCYMKQ 108
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGT 255
+GL++LH + ++HRD K SNIL++ + K++DFGLA+ + + + RV+ T
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164
Query: 256 QGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPI 292
Y PE L G + D++S G +L EL G+ PI
Sbjct: 165 LWYRPPEL-LLGATRYGPEVDMWSVGCILAELFLGK-PI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 70/235 (29%), Positives = 102/235 (43%), Gaps = 41/235 (17%)
Query: 80 LHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL 138
L TG F V+G G +G VY+ G+ VAIK+MD + E+E K E +L +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKY 59
Query: 139 RSPYLLALLGYCSDRRKLLVY--DYMANG--GLQEHL-----YPANGS--NSVASKLDWE 187
S+ + + ++ G + L GS + V
Sbjct: 60 ------------SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG 107
Query: 188 TRLR------IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241
RL+ I E +GL +LHE+ VIHRD K NILL KN K+ DFG++
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA-QL 163
Query: 242 DKAGGHVSTRVLGTQGYVAPE-----YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
D G +T + GT ++APE +SDV+S G+ +EL G+ P
Sbjct: 164 DSTLGRRNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 71/216 (32%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLLALLG 148
V+G G +VY + L N KVAIK +D Q DE + EV+ + + P ++
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-- 64
Query: 149 YCS---DRRKLLVYDYMANGGLQE---HLYPANG--SNSVASKLDWETRLRIALEAAKGL 200
Y S LV Y++ G L + YP G +A T L+ E KGL
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA------TVLK---EVLKGL 115
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG----LAKIGSDKAGGHVSTRVLGTQ 256
E+LH + IHRD K+ NILL ++ K++DFG LA G V +GT
Sbjct: 116 EYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK--VRKTFVGTP 170
Query: 257 GYVAPEYALTGH-LTTKSDVYSYGVVLLELLTGRVP 291
++APE H K+D++S+G+ +EL TG P
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 7e-20
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 93 VGHGGFGLVYR-GVLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLG 148
+G GGFG V V + G+ A K +D+ ++GE E ++L ++ S ++++L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 149 YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLHEH 206
+ L LV M G L+ H+Y +V E R A + GLE LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIY------NVGEPGFPEARAIFYAAQIICGLEHLHQR 114
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 266
+++RD K N+LLD + + ++SD GLA + GG GT GY+APE
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLA---VELKGGKKIKGRAGTPGYMAPEVLQG 168
Query: 267 GHLTTKSDVYSYGVVLLELLTGRVP 291
D ++ G L E++ GR P
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 8e-20
Identities = 70/212 (33%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 93 VGHGGFGLVY--RGVLSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLALL 147
+GHG FG VY R V VAIK M +GKQ ++++ EV L +LR P +
Sbjct: 23 IGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 148 G-YCSDRRKLLVYDYM---ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
G Y + LV +Y A+ L+ H P A I A +GL +L
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA----------ICHGALQGLAYL 131
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H H IHRD K+ NILL + K++DFG A + S + +GT ++APE
Sbjct: 132 HSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSP------ANSFVGTPYWMAPEV 182
Query: 264 ALT---GHLTTKSDVYSYGVVLLELLTGRVPI 292
L G K DV+S G+ +EL + P+
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 8e-20
Identities = 67/220 (30%), Positives = 111/220 (50%), Gaps = 28/220 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKV----AIKLMDQA-GKQGEDEFKMEVELLGRLRS 140
+ V+G G FG VY+G+ + G V AIK++++ G + EF E ++ +
Sbjct: 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68
Query: 141 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
P+L+ LLG C LV M +G L ++++ + L+W ++ AKG+
Sbjct: 69 PHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGM 122
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI--GSDKA----GGHVSTRVLG 254
+L E ++HRD + N+L+ H K++DFGLA++ G +K GG + +
Sbjct: 123 MYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK--- 176
Query: 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPID 293
++A E T +SDV+SYGV + EL+T G P D
Sbjct: 177 ---WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 9e-20
Identities = 60/202 (29%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG-Y 149
+G G +G VY+ + G+ VAIK++ E E+ +L + SPY++ G Y
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 150 CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
+ +V +Y G + + + L E I + KGLE+LH S
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIM------KITNKTLTEEEIAAILYQTLKGLEYLH---SN 118
Query: 210 PVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL 269
IHRD K+ NILL++ AK++DFG++ +D +T V+GT ++APE
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-TMAKRNT-VIGTPFWMAPEVIQEIGY 176
Query: 270 TTKSDVYSYGVVLLELLTGRVP 291
K+D++S G+ +E+ G+ P
Sbjct: 177 NNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-19
Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 93 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152
+G G FG+V+ G KVAIK +++ G E++F E +++ +L P L+ L G C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 153 RRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 211
++ L +V ++M NG L +L G KL + L + + +G+E+L +
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQG------KLSKDMLLSMCQDVCEGMEYLERN---SF 121
Query: 212 IHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ---GYVAPEYALTGH 268
IHRD + N L+ KVSDFG+ + D + S+ G + + PE
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--YTSSS--GAKFPVKWSPPEVFNFSK 177
Query: 269 LTTKSDVYSYGVVLLELLT-GRVPID 293
++KSDV+S+GV++ E+ T G++P +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 70/239 (29%), Positives = 102/239 (42%), Gaps = 29/239 (12%)
Query: 62 GKLEVTTDNGLQVFTFKQLHSA-TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIK-LMDQ 119
L G F ++H G + VL VA+K L
Sbjct: 5 QPLNFVEKLG--EGQFGEVHLCEADGLQDFSEKAFAENDNADAPVL-----VAVKVLRPD 57
Query: 120 AGKQGEDEFKMEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGL----QEHLYPA 174
A ++F EV++L RL P + LLG C D ++ +YM NG L Q+H+
Sbjct: 58 ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAET 117
Query: 175 NGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234
+G + L + T L +A + A G+ +L +HRD + N L+ KN+ K++DF
Sbjct: 118 SGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADF 174
Query: 235 GLAKIGSDKAGGHVSTRVLGTQGYVAP------EYALTGHLTTKSDVYSYGVVLLELLT 287
G+ S RV G P E L G TTKSDV+++GV L E+LT
Sbjct: 175 GM----SRNLYSSDYYRVQGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (219), Expect = 1e-19
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM----EVELLGRLRSP 141
+ K +G G +G+VY+ G VA+K + E+ E+ LL L+ P
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHP 58
Query: 142 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
++ LL RKL LV++Y L+++L + L I + +GL
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDMD-LKKYL------DKRPGPLSPNLIKSIMYQLLRGL 111
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYV 259
+ H H ++HRD K NIL++++ K++DFGLA+ G T + T Y
Sbjct: 112 AYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPL---RTYTHEVVTLWYR 165
Query: 260 APEYAL-TGHLTTKSDVYSYGVVLLELLTGR 289
APE L + H +T D++S G + E++TG+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-19
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLAL 146
+G G G+V + + G+ +A+K + E K E+++L + SPY++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGF 64
Query: 147 LGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 205
G ++ + +YM G L + + V ++ +IA+ KGL +LHE
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILK-----EVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTRVLGTQGYVAPEYA 264
+IHRD K SNIL++ K+ DFG++ ++ + A V GT Y+APE
Sbjct: 119 KHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERI 171
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVPID 293
+ KSD++S G+ L+EL TGR P
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 1e-19
Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 93 VGHGGFGLVYR-GVLSNGRKVAIKLMD----QAGKQGEDEFKMEVELLGRLRSPYLLALL 147
+G GGFG V V S R A+K + Q ++ E E+L P+++ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59
Query: 148 GYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIA--LEAAKGLEFLH 204
D++ + ++ +Y G L L G ++ R IA + A E+LH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILR-DRGLFD-----EYTARFYIACVVLA---FEYLH 110
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GTQGYVAPEY 263
+I+RD K N+LLD N + K+ DFG AK K T GT YVAPE
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGYVKLVDFGFAK----KLKSGQKTWTFCGTPEYVAPEI 163
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVP 291
L D +S G++L ELLTGR P
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 72/282 (25%), Positives = 132/282 (46%), Gaps = 48/282 (17%)
Query: 93 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152
+G G FG V+ G +N KVA+K + + G F E L+ L+ L+ L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 153 RRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 211
+ ++ +YMA G L + L G + KL + + + A+G+ ++
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL-----IDFSAQIAEGMAYIERK---NY 124
Query: 212 IHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYALT 266
IHRD +++N+L+ ++ K++DFGLA++ D + G + + APE
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK------WTAPEAINF 178
Query: 267 GHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 325
G T KSDV+S+G++L E++T G++P P +++ + + AL
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIP----------------YPGMSNSDVMS-----AL 217
Query: 326 EGQYSMKEV----IQVAAIAAMCVQPEADYRPLMADVVQSLV 363
+ Y M + ++ I C + +A+ RP D +QS++
Sbjct: 218 QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTF-DYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 32/218 (14%)
Query: 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRK---VAIKLMDQAG---KQGEDEFKMEVELLGR 137
+K V+G G FG V+RG+L GRK VAIK + + G KQ +D F E ++G+
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQD-FLSEASIMGQ 62
Query: 138 LRSPYLLALLGYCSD-RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 196
++ L G + + +++ +YM NG L ++L +G S LR
Sbjct: 63 FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSS---YQLVGMLR---GI 116
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-------KAGGHVS 249
A G+++L + +HRD + NIL++ N KVSDFGL+++ D +GG +
Sbjct: 117 AAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173
Query: 250 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
R + APE T+ SDV+S+G+V+ E+++
Sbjct: 174 IR------WTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-19
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 89 KSNVVGHGGFGLVYRGV-LSNGRKVAIKLM-----DQAGKQGEDEFKMEVELLGRLRSPY 142
+ ++G G FG VY + GR++A+K + K+ + + E++LL L+
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 143 LLALLGYCSDRRKLLVY-DYMANGGLQEHLYPANG--SNSVASKLDWETRLRIALEAAKG 199
++ G D L ++ +YM G +++ L A G + +V K R LE G
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYT-----RQILE---G 116
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGY 258
+E+LH + ++HRD K +NIL D + K+ DFG +K + + + G V GT +
Sbjct: 117 VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 259 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
++PE K+DV+S G ++E+LT + P
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 93 VGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
+G G FG V+ N VA+K + +A + +F+ E ELL L+ +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 147 LGYCSDRRKLL-VYDYMANGGLQEHLYP--------ANGSNSVASKLDWETRLRIALEAA 197
G C++ R LL V++YM +G L L A G + +L L IA + A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
G+ +L S +HRD + N L+ + K+ DFG+++ V R +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 258 YVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
++ PE L TT+SD++S+GVVL E+ T G+ P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 72/222 (32%), Positives = 113/222 (50%), Gaps = 32/222 (14%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRK----VAIKLMDQA-GKQGEDEFKMEVELLGRLRS 140
F K V+G G FG VY+G+ + G K VAIK + +A + E E ++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 141 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASK--LDWETRLRIALEAAK 198
P++ LLG C L+ M G L + Y +++ S+ L+W ++ AK
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNW------CVQIAK 120
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKA-----GGHVSTRV 252
G+ +L E ++HRD + N+L+ H K++DFGLAK +G+D+ GG V +
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK- 176
Query: 253 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPID 293
++A E L T +SDV+SYGV + EL+T G P D
Sbjct: 177 -----WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 32/211 (15%)
Query: 92 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRLRSPYLLAL 146
+G G FG V +G+ A+K++ +A KQ + E +L +R P+L+ L
Sbjct: 8 TLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLVNL 66
Query: 147 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 205
G D L LV +Y+ G L HL + + A + LE+LH
Sbjct: 67 YGSFQDDSNLYLVMEYVPGGELFSHLRKSG-------RFPEPVARFYAAQVVLALEYLH- 118
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR---VLGTQGYVAPE 262
+++RD K N+LLD + + K++DFG AK V R + GT Y+APE
Sbjct: 119 SLD--IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPEYLAPE 168
Query: 263 YAL-TGHLTTKS-DVYSYGVVLLELLTGRVP 291
L G+ K+ D ++ G+++ E+L G P
Sbjct: 169 IILSKGY--GKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-19
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 87 FSKSNVVGHGGFGLVY--RGVLSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPY 142
+ K VVG G FG+V+ R ++ + V IK + +Q K + E ++L L P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 143 LLALL-GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
++ + D+ ++V +Y G L E++ S LD +T L ++ L
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYI-----QKRCNSLLDEDTILHFFVQILLALH 115
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHA-KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260
+H ++HRD K+ NILLDK+ K+ DFG++KI S K+ + V+GT Y++
Sbjct: 116 HVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYIS 169
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLT 287
PE KSD+++ G VL EL +
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 6e-19
Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 22/207 (10%)
Query: 92 VVGHGGFGLVYRGVLSN-GRK---VAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLA 145
V+G G FG V RG L G++ VAIK + ++G ++ +F E ++G+ P ++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 146 LLGYCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA-AKGLEFL 203
L G + R +++ ++M NG L L +G +V +L L A G+++L
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTV-------IQLVGMLRGIAAGMKYL 122
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ---GYVA 260
E +HRD + NIL++ N KVSDFGL++ D T LG + + A
Sbjct: 123 SEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLT 287
PE T+ SDV+SYG+V+ E+++
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 6e-19
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 93 VGHGGFGLVYRGV--LSNGR--KVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALL 147
+GHG FG V +GV + +G+ +VA+K L + G+ EF E ++ +L P ++ L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 148 GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
G C +LV + G L ++L V+ + A + A G+ +L
Sbjct: 63 GVCKGEPLMLVMELAPLGPLLKYLK-KRREIPVSDLKEL------AHQVAMGMAYLESK- 114
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG------YVAP 261
+HRD + N+LL AK+SDFG++ +A G S T + AP
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMS-----RALGAGSDYYRATTAGRWPLKWYAP 167
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLT 287
E G ++KSDV+SYGV L E +
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-19
Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 27/206 (13%)
Query: 92 VVGHGGFGLVYRGVLSNGRKVAIKLMD-----QAGKQGEDEFKMEVELLGRLRSPYLLAL 146
++G G FG V +G + G+KVA+K + QA F E ++ +L L+ L
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA-------FLEETAVMTKLHHKNLVRL 64
Query: 147 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
LG +V + M+ G L L + +L L+ +L+ A+G+E+L
Sbjct: 65 LGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLE-- 117
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 266
S ++HRD + NIL+ ++ AKVSDFGLA++GS V L + + APE
Sbjct: 118 -SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKLPVK-WTAPEALKH 171
Query: 267 GHLTTKSDVYSYGVVLLELLT-GRVP 291
++KSDV+SYGV+L E+ + GR P
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 7e-19
Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 89 KSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGED---EFKMEVELLGRLRSPY 142
K ++G G FG VY G+ L +G A+K + G+ G++ + + E+ LL +L+ P
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63
Query: 143 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA-KGLE 201
++ LG + L ++ + GG L GS E +R+ GLE
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFP-------EPVIRLYTRQILLGLE 116
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-----GTQ 256
+LH +HRD K +NIL+D N K++DFG+AK V G+
Sbjct: 117 YLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSP 165
Query: 257 GYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVP 291
++APE G +D++S G +LE+ TG+ P
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 7e-19
Identities = 53/182 (29%), Positives = 95/182 (52%), Gaps = 9/182 (4%)
Query: 112 VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQE 169
VA+K L + A K ++F E++++ RL+ P ++ LL C L ++ +YM NG L +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 170 ----HLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK 225
H + + + T + +A + A G+++L S +HRD + N L+ K
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGK 165
Query: 226 NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLEL 285
N+ K++DFG+++ + R + +++ E L G TT SDV+++GV L E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 286 LT 287
LT
Sbjct: 226 LT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 8e-19
Identities = 71/215 (33%), Positives = 113/215 (52%), Gaps = 27/215 (12%)
Query: 91 NVVGHGGFGLVYRG-VLSNGRKV--AIKLM-DQAGKQGEDEFKMEVELLGRL-RSPYLLA 145
+V+G G FG V + + +G ++ AIK M + A K +F E+E+L +L P ++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHLY--------PANG-SNSVASKLDWETRLRIALE 195
LLG C R L L +Y +G L + L PA +NS AS L + L A +
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK---IGSDKAGGHVSTRV 252
A+G+++L + IHRD + NIL+ +N+ AK++DFGL++ + K G + R
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 189
Query: 253 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
+ + Y TT SDV+SYGV+L E+++
Sbjct: 190 MAIESLNYSVY------TTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 69/218 (31%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 89 KSNVVGHGGFGLVYRGV-LSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPY 142
K V+G G FG VY+G+ + +G VAIK L + + E E ++ + SPY
Sbjct: 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 143 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
+ LLG C LV M G L +++ L+W ++ AKG+ +
Sbjct: 71 VCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSY 124
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKA-----GGHVSTRVLGTQ 256
L E ++HRD + N+L+ H K++DFGLA+ + D+ GG V +
Sbjct: 125 LEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK----- 176
Query: 257 GYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPID 293
++A E L T +SDV+SYGV + EL+T G P D
Sbjct: 177 -WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-18
Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 21/204 (10%)
Query: 92 VVGHGGFGLVYRGVLSNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G FG V G G KVA+K + + A Q F E ++ +LR L+ LLG
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 151 SDRRKLL--VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
+ + L V +YMA G L ++L + S L + L+ +L+ + +E+L +
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL-----RSRGRSVLGGDCLLKFSLDVCEAMEYLE---A 120
Query: 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 268
+HRD + N+L+ ++ AKVSDFGL K +A T L + + APE
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK-WTAPEALREKK 175
Query: 269 LTTKSDVYSYGVVLLELLT-GRVP 291
+TKSDV+S+G++L E+ + GRVP
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 67/215 (31%), Positives = 113/215 (52%), Gaps = 27/215 (12%)
Query: 91 NVVGHGGFGLVYRGVLS-NGRKV--AIKLMDQ-AGKQGEDEFKMEVELLGRL-RSPYLLA 145
+V+G G FG V R ++ +G K+ AIK++ + A + +F E+E+L +L P ++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 146 LLGYCSDRRKLLV-YDYMANGGLQEHLY--------PANG-SNSVASKLDWETRLRIALE 195
LLG C +R L + +Y G L + L PA + AS L + L+ A +
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK---IGSDKAGGHVSTRV 252
A G+++L E IHRD + N+L+ +N +K++DFGL++ + K G + R
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRW 184
Query: 253 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
+ + Y TTKSDV+S+GV+L E+++
Sbjct: 185 MAIESLNYSVY------TTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---EVELLGRLRSPYLLALLG 148
+G G +G+VY+ G VAIK + + E K E++LL L P ++ LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKL-RFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 149 YCSDRRKL-LVYDYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEAAKGLEFLHEH 206
+ L LV+++M + G S+ ++ +GL F H H
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQL--------LQGLAFCHSH 117
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG---GHVSTRVLGTQGYVAPEY 263
++HRD K N+L++ K++DFGLA+ +V TR Y APE
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPEL 169
Query: 264 ALT-GHLTTKSDVYSYGVVLLELLTGR 289
L +T D++S G + ELL+ R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 2e-18
Identities = 70/215 (32%), Positives = 113/215 (52%), Gaps = 27/215 (12%)
Query: 91 NVVGHGGFGLVYRGVLS-NGRKV--AIKLMDQ-AGKQGEDEFKMEVELLGRL-RSPYLLA 145
+V+G G FG V + + +G ++ AIK M + A K +F E+E+L +L P ++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 146 LLGYCSDRRKLLV-YDYMANGGLQEHLY--------PANG-SNSVASKLDWETRLRIALE 195
LLG C R L + +Y +G L + L PA +NS AS L + L A +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK---IGSDKAGGHVSTRV 252
A+G+++L + IHRD + NIL+ +N+ AK++DFGL++ + K G + R
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177
Query: 253 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
+ + Y TT SDV+SYGV+L E+++
Sbjct: 178 MAIESLNYSVY------TTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 66/224 (29%), Positives = 108/224 (48%), Gaps = 38/224 (16%)
Query: 93 VGHGGFGLVYR----GVLSNGRK--VAIKLM-DQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+G G FG V++ G+L VA+K++ ++A + +F+ E L+ P ++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQE---HLYPANGSNSVASK------------LDWETR 189
LLG C+ + + L+++YMA G L E H P + S L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 190 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSD---KAG 245
L IA + A G+ +L E +HRD + N L+ +N K++DFGL+ I S KA
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 246 GH--VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
+ + R ++ PE TT+SDV++YGVVL E+ +
Sbjct: 190 ENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 70/274 (25%), Positives = 123/274 (44%), Gaps = 35/274 (12%)
Query: 94 GHGGFGLVYR-GVLSNGRKVAIKLMD-QAGKQGEDEFKM-EVELLGRLRSPYLLALLGYC 150
G G +G VY+ LS+ + A+K +D + Q E E + E+ +L + P +++
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 151 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASK--LDWETRLRIALEAAKGLEFLHEHC 207
D KL +V +Y G L + + S + + + RI ++ +GL+ LHE
Sbjct: 69 LDGNKLCIVMEYAPFGDLSKAI-----SKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 267
++HRD KS+NILL N K+ D G++K+ +++ +GT Y+APE
Sbjct: 123 --KILHRDLKSANILLVANDLVKIGDLGISKV----LKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 268 HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327
+ KSD++S G +L E+ T P S + + R K+ P +
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPF--EARSMQDL-----------RYKVQRGKYPPIPP 223
Query: 328 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361
YS +++ +Q + RP ++ S
Sbjct: 224 IYS-QDLQN---FIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 27/218 (12%)
Query: 93 VGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
+G G FG V+ N VA+K + A +F E ELL L+ +++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 147 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSV-------ASKLDWETRLRIALEAAK 198
G C + L +V++YM +G L + L A+G ++V ++L L IA + A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLR-AHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--IGSD--KAGGHVSTRVLG 254
G+ +L S +HRD + N L+ +N K+ DFG+++ +D + GGH +
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR- 187
Query: 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
++ PE + TT+SDV+S GVVL E+ T G+ P
Sbjct: 188 ---WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 24/205 (11%)
Query: 93 VGHGGFGLVYRGVLSNGRK---VAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLG 148
+G G FG V +GV +K VAIK++ K DE E E++ +L +PY++ ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 149 YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL---EAAKGLEFLHE 205
C +LV + MA+GG P N ++ K D T + + + G+++L
Sbjct: 63 VCEAEALMLVME-MASGG------PLN--KFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQ--GYVAPE 262
+HRD + N+LL +AK+SDFGL+K +G+D + + R G + APE
Sbjct: 114 K---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS--YYKARSAGKWPLKWYAPE 168
Query: 263 YALTGHLTTKSDVYSYGVVLLELLT 287
+++SDV+SYG+ + E +
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 93 VGHGGFGLV----YRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALL 147
+G G FG V Y + N G VA+K + + + +F+ E+E+L L+ ++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 148 GYC--SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
G C + RR L LV +Y+ G L+++L +LD L A + KG+E+L
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL------QKHRERLDHRKLLLYASQICKGMEYLG 125
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI-GSDKAGGHVSTRVLGTQGYVAPEY 263
S +HRD + NIL++ K+ DFGL K+ DK V + APE
Sbjct: 126 ---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182
Query: 264 ALTGHLTTKSDVYSYGVVLLELLT 287
+ SDV+S+GVVL EL T
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 84/279 (30%), Positives = 120/279 (43%), Gaps = 57/279 (20%)
Query: 109 GRKVAIKLMDQAGKQGEDE---FKMEVELLGRLRSPYLLALL--GYCSDRRKLLVYDYMA 163
G +VAIKL+ + E + F+ E L RL P ++ALL G V++Y+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 223
L+E L A+G+ L R+ L+ L H ++HRD K NI++
Sbjct: 63 GRTLREVL-AADGA------LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMV 112
Query: 224 ---DKNFHAKVSDFGLAKIGS-----DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDV 275
HAKV DFG+ + D A +T VLGT Y APE +T SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 276 YSYGVVLLELLTGRV----------------PIDVNKPSG-----EGVLVSWAL------ 308
Y++G++ LE LTG+ P+DV+ P G ++ AL
Sbjct: 173 YAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQ 232
Query: 309 -----PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAA 342
P L +R + LE+ AL G M E AIAA
Sbjct: 233 RAASAPALAERFRALEL--CALVGILRMGEGAGREAIAA 269
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 4e-18
Identities = 78/297 (26%), Positives = 139/297 (46%), Gaps = 42/297 (14%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGEDEF---KMEVELLGRLRSPY 142
F+K +G G FG V++G+ + ++V AIK++D ++ EDE + E+ +L + SPY
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL--EEAEDEIEDIQQEITVLSQCDSPY 63
Query: 143 LLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
+ G Y + ++ +Y+ G + L A D + E KGL+
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLR--------AGPFDEFQIATMLKEILKGLD 115
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+LH S IHRD K++N+LL + K++DFG+A +D + +GT ++AP
Sbjct: 116 YLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAP 170
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321
E +K+D++S G+ +EL G P P + V + +P+
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP----MRVLFLIPKNN--------- 217
Query: 322 DPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKIS 376
P L G++S KE I C+ + +RP ++++ +VK + T ++
Sbjct: 218 PPTLTGEFSKPFKEFIDA------CLNKDPSFRPTAKELLKHKF-IVKNAKKTSYLT 267
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 101 VYRGVLSNGRKVAIKLM--DQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---- 153
+Y+G+ N ++V I+ G K D + E++ L R+ S +L + G+ D
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 154 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 212
R L+ +Y G L+E L L ++T+L +A++ KGL L+++ + P
Sbjct: 95 PRLSLILEYCTRGYLREVLD-------KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP-- 145
Query: 213 HRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT--GHLT 270
+++ S + L+ +N+ K+ GL KI S +V+ V Y + + T
Sbjct: 146 YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYT 200
Query: 271 TKSDVYSYGVVLLELLTGRVPID 293
K D+YS GVVL E+ TG++P +
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-18
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 93 VGHGGFGLVYRGVLSNGRK-VAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLALLG 148
+GHG FG VY S+ + VA+K M +GKQ ++++ EV+ L +L+ P + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 149 -YCSDRRKLLVYDYM---ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
Y + LV +Y A+ L+ H P A I A +GL +LH
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----------ITHGALQGLAYLH 138
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
H +IHRD K+ NILL + K++DFG A S + +GT ++APE
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVI 189
Query: 265 LT---GHLTTKSDVYSYGVVLLELLTGRVPI 292
L G K DV+S G+ +EL + P+
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 6e-18
Identities = 62/213 (29%), Positives = 90/213 (42%), Gaps = 21/213 (9%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---EVELLGRLRSPYLLAL 146
+G G FG V + S+G+ + K +D G E E + EV +L L+ P ++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDY-GNMTEKEKQQLVSEVNILRELKHPNIVRY 64
Query: 147 LGYCSDRRKLLVYDYM---ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
DR +Y M G L + + ++ E RI + L
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK---YIEEEFIWRILTQLLLALYEC 121
Query: 204 H--EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI---GSDKAGGHVSTRVLGTQGY 258
H V+HRD K +NI LD N + K+ DFGLAKI S A +V GT Y
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----GTPYY 176
Query: 259 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
++PE KSD++S G ++ EL P
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 7e-18
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 45/226 (19%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---------EVELLG 136
+ K +G G + +VY+ GR VAIK + K GE + E++LL
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKI----KLGERKEAKDGINFTALREIKLLQ 57
Query: 137 RLRSPYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR---- 191
L+ P ++ LL + LV+++M L E + D L
Sbjct: 58 ELKHPNIIGLLDVFGHKSNINLVFEFME-TDL-EKVIK-----------DKSIVLTPADI 104
Query: 192 --IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI-GSDKAGGHV 248
L +GLE+LH + ++HRD K +N+L+ + K++DFGLA+ GS +
Sbjct: 105 KSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NRKM 159
Query: 249 STRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPI 292
+ +V+ T+ Y APE L G H D++S G + ELL RVP
Sbjct: 160 THQVV-TRWYRAPEL-LFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 8e-18
Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 33/223 (14%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLM-------DQAGKQGEDEFKMEVELLGRLR 139
++K V+G G +G VY G+ + G+ +A+K + A K+ E + + EV+LL L+
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYE-KLQEEVDLLKSLK 60
Query: 140 SPYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL------RIA 193
++ LG C D + ++ GG S++S L+ L +
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGG------------SISSILNRFGPLPEPVFCKYT 108
Query: 194 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK----IGSDKAGGHVS 249
+ G+ +LH +C V+HRD K +N++L N K+ DFG A+ +G ++
Sbjct: 109 KQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165
Query: 250 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 292
+ GT ++APE KSD++S G + E+ TG+ P+
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 8e-18
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGR----KVAIKLMDQAGKQGED--EFKMEVELLGRLRS 140
++G G FG V G LS KVA+K M + EF E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 141 PYLLALLGYC---SDRRK----LLVYDYMANGGLQEHL-YPANGSNSVASKLDWETRLRI 192
P ++ L+G C S +K +++ +M +G L L Y G KL +T L+
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE--KLPLQTLLKF 118
Query: 193 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI---GSDKAGGHVS 249
++ A G+E+L + IHRD + N +L ++ V+DFGL+K G G ++
Sbjct: 119 MVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 250 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+ ++A E T+KSDV+++GV + E+ T G+ P
Sbjct: 176 KMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 74/218 (33%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 91 NVVGHGGFGLVYRGVL-------SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPY 142
N +G G FG VY G S +VA+K L A Q + EF E L+ P
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
++ LLG C ++ + M G L +L A L + L I L+ AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 202 FLHE-HCSPPVIHRDFKSSNILL-DKNFHA----KVSDFGLAK--IGSD---KAG-GHVS 249
+L + H IHRD + N L+ +K + A K+ DFGLA+ SD K G G +
Sbjct: 121 YLEQMH----FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 250 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
R ++APE L G TT+SDV+S+GV++ E+LT
Sbjct: 177 VR------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 53/184 (28%), Positives = 98/184 (53%), Gaps = 12/184 (6%)
Query: 112 VAIKLM-DQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYMANGGL-- 167
VA+K++ K ++F E++++ RL++P ++ LLG C SD ++ +YM NG L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 168 ---QEHLYPA-NGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 223
Q + +N++ S + L +A++ A G+++L S +HRD + N L+
Sbjct: 107 FLSQREIESTFTHANNIPS-VSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 224 DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLL 283
++ K++DFG+++ + R + ++A E L G TT SDV+++GV L
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 284 ELLT 287
E+ T
Sbjct: 223 EMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 93 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152
+G G FG V+ + KVA+K M + G + F E ++ L+ L+ L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 153 RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 212
++ ++MA G L + L GS KL + + + A+G+ F+ + I
Sbjct: 73 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQR---NYI 124
Query: 213 HRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYALTG 267
HRD +++NIL+ + K++DFGLA++ D + G + + APE G
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK------WTAPEAINFG 178
Query: 268 HLTTKSDVYSYGVVLLELLT-GRVP 291
T KSDV+S+G++L+E++T GR+P
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 91 NVVGHGGFGLVYRG-VLSNGRKVAIKLMD-QAGKQGEDEFKMEVELLGRLRSPYLLALLG 148
++GHG G VY+ L R +A+K++ + + + E+E+L + SPY++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 149 -YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
+ + R + ++M G L V K+ RIA+ KGL +L
Sbjct: 67 AFFVENRISICTEFMDGGSL-----------DVYRKIPEHVLGRIAVAVVKGLTYL---W 112
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 267
S ++HRD K SN+L++ K+ DFG+ S + ++ +GT Y+APE
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGV----STQLVNSIAKTYVGTNAYMAPERISGE 168
Query: 268 HLTTKSDVYSYGVVLLELLTGRVP 291
SDV+S G+ +EL GR P
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 71/218 (32%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 87 FSKSNVVGHGGFGLVY--RGVLSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSP 141
FS +GHG FG VY R V ++ VAIK M +GKQ ++++ EV L +LR P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 142 YLLALLG-YCSDRRKLLVYDYM---ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 197
+ G Y + LV +Y A+ L+ H P A + A
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----------VTHGAL 125
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
+GL +LH H +IHRD K+ NILL + K+ DFG A I + + +GT
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPY 176
Query: 258 YVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPI 292
++APE L G K DV+S G+ +EL + P+
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 93 VGHGGFGLVYR-GVLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLAL-L 147
+G GGFG V V + G+ A K +D+ K GE +E E+L ++ SP+++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 148 GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
+ S LV M G L+ H+Y N L+ E + + + G+ LH
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIY-----NVGERGLEMERVIHYSAQITCGILHLH--- 112
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 267
S +++RD K N+LLD + ++SD GLA + G T+ GT GY+APE
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLA---VELKDGKTITQRAGTNGYMAPEILKEE 169
Query: 268 HLTTKSDVYSYGVVLLELLTGRVP 291
+ D ++ G + E++ GR P
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-17
Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 30/221 (13%)
Query: 93 VGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
+G G FG V+ N VA+K + +F+ E ELL L+ +++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 147 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSV----------ASKLDWETRLRIALE 195
G C D L +V++YM +G L + L A+G +++ +L L IA +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLR-AHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--IGSD--KAGGHVSTR 251
A G+ +L S +HRD + N L+ N K+ DFG+++ +D + GGH
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 252 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+ ++ PE + TT+SDV+S+GV+L E+ T G+ P
Sbjct: 189 IR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-17
Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 91 NVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 149
+ +G G +G VY GV VA+K + + + +EF E ++ ++ P L+ LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
C+ ++ ++M G L ++L N +++ L +A + + +E+L
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---K 122
Query: 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEY 263
IHRD + N L+ +N KV+DFGL+++ + AG + + APE
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPES 176
Query: 264 ALTGHLTTKSDVYSYGVVLLELLT 287
+ KSDV+++GV+L E+ T
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-17
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 93 VGHGGFGLVYRGVLSNGRK------VAIKLMDQAGKQGED-EFKMEVELLGRLRSPYLLA 145
+G G FG+VY G+ K VAIK +++A E EF E ++ +++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 146 LLGYCSD-RRKLLVYDYMANGGLQEHLY---PANGSNSVASKLDWETRLRIALEAAKGLE 201
LLG S + L++ + M G L+ +L P +N V + + +++A E A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+L+ + +HRD + N ++ ++F K+ DFG+ + + + L +++P
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLT 287
E G TT SDV+S+GVVL E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 4e-17
Identities = 70/219 (31%), Positives = 109/219 (49%), Gaps = 37/219 (16%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKM-EVELLGRLRSPY 142
F K N +G G +G+VYR ++G VA+K MD + G + E+ LL LR P
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPN 67
Query: 143 LLALLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLD------WETRLR-I 192
++ L + LV +Y E +AS LD E++++ +
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYC------EQ--------DLASLLDNMPTPFSESQVKCL 113
Query: 193 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRV 252
L+ +GL++LHE+ +IHRD K SN+LL K++DFGLA+ A ++ +V
Sbjct: 114 MLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKV 169
Query: 253 LGTQGYVAPEYAL--TGHLTTKSDVYSYGVVLLELLTGR 289
+ T Y APE L T + TT D+++ G +L ELL +
Sbjct: 170 V-TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 4e-17
Identities = 72/218 (33%), Positives = 104/218 (47%), Gaps = 32/218 (14%)
Query: 87 FSKSNVVGHGGFGLVY--RGVLSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSP 141
F+ +GHG FG VY R V +N VAIK M +GKQ ++++ EV+ L R++ P
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 142 YLLALLG-YCSDRRKLLVYDYM---ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 197
+ G Y + LV +Y A+ L+ H P A I A
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----------ITHGAL 135
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
+GL +LH H +IHRD K+ NILL + K++DFG A I S + +GT
Sbjct: 136 QGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPY 186
Query: 258 YVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPI 292
++APE L G K DV+S G+ +EL + P+
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 92 VVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFK---MEVELLG-RLRSPYLLAL 146
++G G FG V+ L + AIK + + +D+ + +E +L P+L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 147 LGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
YC+ + K V +Y+ G L H+ + K D A E GL+FL
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCH-------KFDLPRATFYAAEIICGLQFL 112
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H S +++RD K NILLD + H K++DFG+ K + G + GT Y+APE
Sbjct: 113 H---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEI 167
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVP 291
L T D +S+GV+L E+L G+ P
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 6e-17
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 22/213 (10%)
Query: 93 VGHGGFGLVYRGVL------SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+G FG VY+G L + VAIK L D+A +EFK E + RL+ P ++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHLY---------PANGSNSVASKLDWETRLRIALE 195
LLG + + L +++ Y ++ L E L + +V S L+ + I +
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLG 254
A G+EFL H V+H+D + N+L+ + K+SD GL + + + + +L
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
+ +++PE + G + SD++SYGVVL E+ +
Sbjct: 190 IR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 7e-17
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 37/224 (16%)
Query: 89 KSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDE-------FKMEVELLGRL 138
K ++G G FG VY G+ S+G +A+K + +D E+ LL L
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 139 RSPYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL---- 194
+ ++ LG D L ++ GG SVA+ L+ L
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGG------------SVAALLNNYGAFEETLVRNF 111
Query: 195 --EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-----IGSDKAGGH 247
+ KGL +LH + +IHRD K +NIL+D K+SDFG++K S K G
Sbjct: 112 VRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168
Query: 248 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
+ + G+ ++APE T K+D++S G +++E+LTG+ P
Sbjct: 169 RPS-LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-17
Identities = 69/240 (28%), Positives = 112/240 (46%), Gaps = 27/240 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLR---SP 141
+ + ++G G +G VYRG + GR VA+K+++ + + + EV LL +LR P
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 142 YLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
+ G Y R ++ +Y G ++ + A + + I E L
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVR--------TLMKAGPIAEKYISVIIREVLVAL 114
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA---KIGSDKAGGHVSTRVLGTQG 257
+++H VIHRD K++NIL+ + K+ DFG+A S K ST V GT
Sbjct: 115 KYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR----STFV-GTPY 166
Query: 258 YVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPI-DVNKPSGEGVLVSWALPRLTDRE 315
++APE G TK+D++S G+ + E+ TG P DV+ ++ PRL D
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNG 226
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 7e-17
Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 96 GGFGLVY--RGVLSNGRKVAIKLM---DQAGKQGEDEFKMEVELLGRLR-SPYLLALLGY 149
G FG VY + + G AIK++ D K K E ++ SPY+ L
Sbjct: 7 GAFGSVYLAKKRST-GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
+ L LV +Y+ NGG L G DW + IA E G+E LH+
Sbjct: 66 FQSKDYLYLVMEYL-NGGDCASLIKTLGGLP----EDW-AKQYIA-EVVLGVEDLHQR-- 116
Query: 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 268
+IHRD K N+L+D+ H K++DFGL++ G + + +GT Y+APE L
Sbjct: 117 -GIIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILGVG 169
Query: 269 LTTKSDVYSYGVVLLELLTGRVPIDVNKP 297
SD +S G V+ E L G P P
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-17
Identities = 46/135 (34%), Positives = 61/135 (45%), Gaps = 19/135 (14%)
Query: 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 250
+IA KGL +LH +IHRD K SNILL + K+ DFG+ S + ++
Sbjct: 109 KIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLAG 161
Query: 251 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL------- 303
GT Y+APE + SDV+S G+ LLE+ R P P GE L
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF---PPEGEPPLGPIELLS 218
Query: 304 --VSWALPRLTDREK 316
V+ P L D
Sbjct: 219 YIVNMPNPELKDEPG 233
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 71/279 (25%), Positives = 120/279 (43%), Gaps = 35/279 (12%)
Query: 92 VVGHGGFG--LVYRGVLSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALL 147
V+G G FG +YR + V K ++ ++ + E+ +L L+ P ++A
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 148 GYCSDRRKLLVYDYMANGG-LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
+ D LL+ ANGG L + + + E L + + ++H+
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI-----VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI-GSDKAGGHVSTRVLGTQGYVAPEYAL 265
++HRD K+ NI L K K+ DFG++KI GS+ + V+GT Y++PE
Sbjct: 121 ---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET---VVGTPYYMSPELCQ 174
Query: 266 TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 325
KSD+++ G VL ELLT + D P LV KI++ +
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---LVV----------KIVQGNYTPV 221
Query: 326 EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364
YS E+I + +Q + + RP +V+ +
Sbjct: 222 VSVYS-SELISL---VHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 1e-16
Identities = 68/227 (29%), Positives = 108/227 (47%), Gaps = 25/227 (11%)
Query: 80 LHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL 138
L G F +VG+G +G VY+G + G+ AIK+MD G + E+E K E+ +L +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKY 59
Query: 139 R-----SPYLLALLGYCS---DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 190
+ Y A + D + LV ++ G + + + N+ + L E
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-----KNTKGNTLKEEWIA 114
Query: 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 250
I E +GL LH+H VIHRD K N+LL +N K+ DFG++ D+ G +T
Sbjct: 115 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNT 170
Query: 251 RVLGTQGYVAPEYALTGH-----LTTKSDVYSYGVVLLELLTGRVPI 292
+GT ++APE KSD++S G+ +E+ G P+
Sbjct: 171 -FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 77/287 (26%), Positives = 134/287 (46%), Gaps = 42/287 (14%)
Query: 89 KSNVVGHGGFGLVY--RGVLSNGRKVAIKLMDQ----AGKQGE--DEFKMEVELLGRLRS 140
K +G G F Y R V + G +A+K + + +Q E + + E+ L+ RL
Sbjct: 4 KGQQLGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 141 PYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANG--SNSVASKLDWETRLRIALEAA 197
P+++ +LG C D L ++MA GG HL G +V + +
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMA-GGSVSHLLSKYGAFKEAVI--------INYTEQLL 113
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLA-KIGSDKAG-GHVSTRVLG 254
+GL +LHE+ +IHRD K +N+L+D +++DFG A ++ + G G ++LG
Sbjct: 114 RGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLG 170
Query: 255 TQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313
T ++APE L G +S DV+S G V++E+ T + P + K S L+ + + T
Sbjct: 171 TIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI-FKIASATT 228
Query: 314 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360
I E + P L + C++ + + RP ++++
Sbjct: 229 APSIPEHLSPGLRD------------VTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 72/282 (25%), Positives = 137/282 (48%), Gaps = 28/282 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+++ +G G G VY + ++ G++VAI+ M+ + ++ E+ ++ ++P ++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 146 LL-GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L Y +V +Y+A G L + + + +D + E + LEFLH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVV--------TETCMDEGQIAAVCRECLQALEFLH 133
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTRVLGTQGYVAPEY 263
S VIHRD KS NILL + K++DFG A+I +++ + ++GT ++APE
Sbjct: 134 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 187
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLVSWALPRLTDREKILEI-- 320
K D++S G++ +E++ G P ++ N ++ + P L + EK+ I
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247
Query: 321 ------MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 356
+D +E + S KE++Q + +P + PL+A
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLK--IAKPLSSLTPLIA 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-16
Identities = 86/310 (27%), Positives = 136/310 (43%), Gaps = 69/310 (22%)
Query: 89 KSNVVGHGGFGLV--YRGVLSN---GRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPY 142
K V+G G FG V Y +N G VA+K L + G+Q +K E+ +L L
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 143 LLALLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 199
++ G CS++ L+ +Y+ G L+++L P + KL+ L A + +G
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKH-------KLNLAQLLLFAQQICEG 119
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG-- 257
+ +LH S IHRD + N+LLD + K+ DFGLAK + GH RV G
Sbjct: 120 MAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE---GHEYYRV-REDGDS 172
Query: 258 ---YVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314
+ A E + SDV+S+GV L ELLT + +
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELLTH------------------CDSKQSPP 214
Query: 315 EKILEIMDPALEGQYSMKEVI-----------------QVAAIAAMCVQPEADYRPLMAD 357
+K E++ P +GQ ++ +I +V + C + EA +RP
Sbjct: 215 KKFEEMIGPK-QGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRP---- 269
Query: 358 VVQSLVPLVK 367
+SL+P++K
Sbjct: 270 TFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 67/215 (31%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 92 VVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGEDEF------KMEVELLGRLRSPYLL 144
V+G G FG V L ++ A+K++ + +D+ K + L G+ P+L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFLT 59
Query: 145 ALLGYC---SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGL 200
L + + R V +Y+ G L H+ + + D E R R A E GL
Sbjct: 60 QL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-------RFD-EPRARFYAAEIVLGL 109
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GTQGYV 259
+FLHE +I+RD K N+LLD H K++DFG+ K G G V+T GT Y+
Sbjct: 110 QFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG---ILGGVTTSTFCGTPDYI 163
Query: 260 APEYALTGHLTTKS-DVYSYGVVLLELLTGRVPID 293
APE L+ + D ++ GV+L E+L G+ P +
Sbjct: 164 APE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 3e-16
Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 38/219 (17%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---------EVELLGRLRS 140
+G G +G+V V GRKVAIK + + F E++LL LR
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 141 PYLLALL-----GYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR-IA 193
++ LL D + +V + M + L+ S + + ++
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT----DDHIQYFL 109
Query: 194 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRV 252
+ +GL++LH S VIHRD K SNIL++ N K+ DFGLA+ + D+ T
Sbjct: 110 YQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 253 LGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRV 290
+ T+ Y APE L+ TK+ D++S G + ELLT +
Sbjct: 167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 37/223 (16%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM-------EVELLGRL 138
+ + +G G +G+V G KVAIK K E + E+++L R
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIK------KISPFEHQTFCQRTLREIKILRRF 60
Query: 139 RSPYLLALL------GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI 192
+ ++ +L + S +V + M L + + + SN ++ LR
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETD-LYKLIKTQHLSNDHIQYFLYQI-LR- 117
Query: 193 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS--T 250
GL+++H S V+HRD K SN+LL+ N K+ DFGLA+I +D H T
Sbjct: 118 ------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI-ADPEHDHTGFLT 167
Query: 251 RVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVPI 292
+ T+ Y APE L TK+ D++S G +L E+L+ R P+
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 92 VVGHGGFGLVYRGVLSN-GRKVAIKLMDQAG---KQGED---EFKMEVELLGRLRSPYLL 144
++G GGFG VY ++ G+ A+K +D+ KQGE ++ + L+ P+++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 145 AL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEF 202
+ + + + + D M G L HL + V S E +R A E GLE
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFS----EKEMRFYATEIILGLEH 112
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
+H V++RD K +NILLD++ H ++SD GLA S K H S +GT GY+APE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS---VGTHGYMAPE 165
Query: 263 YALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNK 296
G + +D +S G +L +LL G P +K
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 92 VVGHGGFGLVYRG-VLSNGRKVAIKLMDQAGKQGEDEFKM-----EVELLGRLRSPYLLA 145
VVG G +G+V + + G VAIK ++ +DE EV++L +LR ++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESE---DDEDVKKTALREVKVLRQLRHENIVN 64
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQE-HLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
L + +L LV++Y+ L+ P G L + + + + +
Sbjct: 65 LKEAFRRKGRLYLVFEYVERTLLELLEASP-GG-------LPPDAVRSYIWQLLQAIAYC 116
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H H +IHRD K NIL+ ++ K+ DFG A+ + ++ V T+ Y APE
Sbjct: 117 HSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPEL 172
Query: 264 ALTGHLTTKS-DVYSYGVVLLELLTGR 289
+ K DV++ G ++ ELL G
Sbjct: 173 LVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-16
Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 25/210 (11%)
Query: 92 VVGHGGFGLVYRGVLSN-GRKVAIKLMDQAG---KQGED---EFKMEVELLGRLRSPYLL 144
++G GGFG VY ++ G+ A+K +D+ KQGE ++ + L+ P+++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 145 AL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEF 202
+ + + + + D M G L HL + V S E +R A E GLE
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFS----EAEMRFYAAEIILGLEH 112
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
+H V++RD K +NILLD++ H ++SD GLA S K H S +GT GY+APE
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHAS---VGTHGYMAPE 165
Query: 263 YALTG-HLTTKSDVYSYGVVLLELLTGRVP 291
G + +D +S G +L +LL G P
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 5e-16
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 36/223 (16%)
Query: 89 KSNVVGHGGFGLVYRGV-LSNGRKVAIKLM----------DQAGKQGEDEFKMEVELLGR 137
K ++G G +G VY + ++ G +A+K + D K + E+E L
Sbjct: 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 138 LRSPYLLALLGYCSDRRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL-- 194
L ++ LG+ + L ++ +Y+ G S+ S L R L
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGG-------------SIGSCLRTYGRFEEQLVR 111
Query: 195 ----EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 250
+ +GL +LH S ++HRD K+ N+L+D + K+SDFG++K D +
Sbjct: 112 FFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM 168
Query: 251 RVLGTQGYVAPEYALTGH--LTTKSDVYSYGVVLLELLTGRVP 291
+ G+ ++APE + + K D++S G V+LE+ GR P
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 6e-16
Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRK-VAIKLM---DQAGKQGEDEFKMEVELLGRLRSPY 142
+ VG G FG V+ A+K+M + + E E +L + P+
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
++ L D+R L ++ +Y+ G L +L + ++ T L A E LE
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN-------STGLFYASEIVCALE 115
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+LH S +++RD K NILLDK H K++DFG AK D+ + + GT Y+AP
Sbjct: 116 YLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAP 167
Query: 262 E-YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 299
E GH D ++ G+++ E+L G P + P G
Sbjct: 168 EVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 6e-16
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 94 GHGGFGLVYRGVLSN-GRKVAIKLMD-QAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS 151
G G FG VY+ G A K++ ++ ++ ED F +E+++L + P ++ L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED-FMVEIDILSECKHPNIVGLYEAYF 72
Query: 152 DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDW---ETRLR-IALEAAKGLEFLHEHC 207
KL + +GG +S+ +L+ E ++R + + + L FLH H
Sbjct: 73 YENKLWILIEFCDGG---------ALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH- 122
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTRVLGTQGYVAPEYALT 266
VIHRD K+ NILL + K++DFG+ AK S +GT ++APE
Sbjct: 123 --KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVAC 177
Query: 267 GHLTT-----KSDVYSYGVVLLELLTGRVP 291
K+D++S G+ L+EL P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 75/260 (28%), Positives = 106/260 (40%), Gaps = 54/260 (20%)
Query: 90 SNVVGHGGFGLV-YRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL-- 146
S V+G G G V +S+G A+K++D G D+ + + E+ L + +
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 147 ---LGYCSDRRK-------LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 196
D R LV DY G L++ + +N R E
Sbjct: 97 HEDFAK-KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN------------RTFREH 143
Query: 197 AKGLEFL-------HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS 249
GL F+ H H S +IHRD KS+NILL N K+ DFG +K+ + V
Sbjct: 144 EAGLLFIQVLLAVHHVH-SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVG 202
Query: 250 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 309
GT YVAPE + K+D++S GV+L ELLT L
Sbjct: 203 RTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT--------------------LK 242
Query: 310 RLTDREKILEIMDPALEGQY 329
R D E + E+M L G+Y
Sbjct: 243 RPFDGENMEEVMHKTLAGRY 262
|
Length = 496 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-16
Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 25/227 (11%)
Query: 80 LHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL 138
L G F VVG+G +G VY+G + G+ AIK+MD + E+E K+E+ +L +
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKY 69
Query: 139 R-----SPYLLALLGYC---SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 190
+ Y A + D + LV ++ G + + + G+ A K DW
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN---ALKEDWIAY- 125
Query: 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 250
I E +GL LH H VIHRD K N+LL +N K+ DFG++ D+ G +T
Sbjct: 126 -ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNT 180
Query: 251 RVLGTQGYVAPEYALTGH-----LTTKSDVYSYGVVLLELLTGRVPI 292
+GT ++APE +SD++S G+ +E+ G P+
Sbjct: 181 -FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 8e-16
Identities = 68/208 (32%), Positives = 109/208 (52%), Gaps = 21/208 (10%)
Query: 92 VVGHGGFGLVY--RGVL--SNGRKVAIKLMDQAGKQGEDEF--KMEVELLGRLRSPYLLA 145
V+G G FG V+ R + G+ A+K++ +A + D KME ++L + P+++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 146 L-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L + ++ + L+ D++ G L L S V + + + +A E A L+ LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEE-DVKFYLA-ELALALDHLH 115
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
S +I+RD K NILLD+ H K++DFGL+K D S GT Y+APE
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVV 170
Query: 265 -LTGHLTTKSDVYSYGVVLLELLTGRVP 291
GH T +D +S+GV++ E+LTG +P
Sbjct: 171 NRRGH-TQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-16
Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 23/208 (11%)
Query: 93 VGHGGFGLVYRGVL-SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G FG V+ G L ++ VA+K + + +F E +L + P ++ L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 151 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH-EHCS 208
+ ++ + +V + + G L + +L + +++ AA G+E+L +HC
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL------RTEGPRLKVKELIQMVENAAAGMEYLESKHC- 115
Query: 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD----KAGGHVSTRVLGTQGYVAPEYA 264
IHRD + N L+ + K+SDFG+++ D GG V + APE
Sbjct: 116 ---IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV----KWTAPEAL 168
Query: 265 LTGHLTTKSDVYSYGVVLLELLT-GRVP 291
G +++SDV+S+G++L E + G VP
Sbjct: 169 NYGRYSSESDVWSFGILLWEAFSLGAVP 196
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 9e-16
Identities = 56/184 (30%), Positives = 97/184 (52%), Gaps = 14/184 (7%)
Query: 109 GRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD---RRKLLVYDYMAN 164
G +VA+K L ++G + K E+E+L L ++ G C++ L+ +++ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224
G L+E+L P N +K++ + +L+ A++ KG+++L S +HRD + N+L++
Sbjct: 93 GSLKEYL-PRN-----KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVE 143
Query: 225 KNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLL 283
K+ DFGL K I +DK V + + APE + SDV+S+GV L
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203
Query: 284 ELLT 287
ELLT
Sbjct: 204 ELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 9e-16
Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 92 VVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLLALLGYC 150
++G G FG V++G L + VA+K + Q + +F E +L + P ++ L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 151 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
+ R+ + +V + + G L +L + ++ AL+AA G+ +L S
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFL------RKKKDELKTKQLVKFALDAAAGMAYLE---SK 112
Query: 210 PVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL 269
IHRD + N L+ +N K+SDFG+++ D + + + + APE G
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALNYGRY 171
Query: 270 TTKSDVYSYGVVLLELLT 287
+++SDV+SYG++L E +
Sbjct: 172 SSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 67/213 (31%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 92 VVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGEDEFK---MEVELLGRLRS-PYLLAL 146
V+G G FG V L +V AIK++ + +D+ E +L P+L AL
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 147 LGYCS---DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEF 202
+C R V +Y+ G L + + K D E R R A E L F
Sbjct: 62 --HCCFQTKDRLFFVMEYVNGGDLMFQI-------QRSRKFD-EPRSRFYAAEVTLALMF 111
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
LH H VI+RD K NILLD H K++DFG+ K G G +T GT Y+APE
Sbjct: 112 LHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGI--LNGVTTTTFCGTPDYIAPE 166
Query: 263 YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVN 295
D ++ GV++ E++ G+ P + +
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 29/208 (13%)
Query: 92 VVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKM-------EVELLGRLRSPYL 143
+VG G +G+V + G+ VAIK + ED+ KM E+ +L +LR L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDD-KMVKKIAMREIRMLKQLRHENL 62
Query: 144 LALLGYCSDRRKL-LVYDYMANGGLQE-HLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
+ L+ +++L LV++++ + L + YP NG LD + + +G+E
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP-NG-------LDESRVRKYLFQILRGIE 114
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
F H H +IHRD K NIL+ ++ K+ DFG A+ + A G V T + T+ Y AP
Sbjct: 115 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAP 169
Query: 262 EYALTGHLTTKS-DVYSYGVVLLELLTG 288
E + ++ D+++ G ++ E+LTG
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 93 VGHGGFGLVYR-GVLSNGRKVAIKLMDQAGKQGEDEFKM----EVELLGRLRSPYLLALL 147
+G G G+V++ G VA+K + A ++ E E++ L + PY++ LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV--ALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 148 G-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
+ +LV +YM L E L + + + + KG+ ++H +
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVL-----RDEERPLPEAQVK-SYMRMLLKGVAYMHAN 118
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 266
++HRD K +N+L+ + K++DFGLA++ S++ S +V T+ Y APE L
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPEL-LY 173
Query: 267 G--HLTTKSDVYSYGVVLLELLTGR 289
G D+++ G + ELL G
Sbjct: 174 GARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 47/173 (27%), Positives = 86/173 (49%), Gaps = 16/173 (9%)
Query: 131 EVELLGRLRSPYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETR 189
E++++ RSPY+++ G + ++ + ++M G L + + E
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-------DRIYKKGGPIPVEIL 105
Query: 190 LRIALEAAKGLEFLH-EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV 248
+IA+ +GL +L+ H ++HRD K SNIL++ K+ DFG+ S + +
Sbjct: 106 GKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGV----SGELINSI 158
Query: 249 STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 301
+ +GT Y++PE G T KSDV+S G+ ++EL G+ P + +G
Sbjct: 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 69/216 (31%), Positives = 101/216 (46%), Gaps = 18/216 (8%)
Query: 87 FSKSNVVGHGGFGLVYR-GVLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPY 142
F + V+G GGFG V V + G+ A K +++ ++GE E ++L ++ S +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 143 LLAL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
++ L Y + LV M G L+ H+Y N + E L A E GLE
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIY-----NMGNPGFEEERALFYAAEILCGLE 116
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTRVLGTQGYVA 260
LH ++RD K NILLD H ++SD GLA KI G + RV GT GY+A
Sbjct: 117 DLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI---PEGESIRGRV-GTVGYMA 169
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296
PE T D + G ++ E++ G+ P K
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 32/211 (15%)
Query: 92 VVGHGGFGLVYRGVLSNGRK----VAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLL 144
V+G G FG V G L K VAIK + +AG KQ D F E ++G+ P ++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRD-FLSEASIMGQFDHPNII 68
Query: 145 ALLGYCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
L G + + ++V +YM NG L L +G +V + LR A G+++L
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVG---MLR---GIASGMKYL 122
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-------KAGGHVSTRVLGTQ 256
+ +HRD + NIL++ N KVSDFGL+++ D GG + R
Sbjct: 123 SDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR----- 174
Query: 257 GYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
+ APE T+ SDV+SYG+V+ E+++
Sbjct: 175 -WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 90 SNVVGHGGFGLVYRGV-LSNGRKVAIKLMD-QAGKQGEDEFKM-EVELLGRLRS---PYL 143
+G G +G VY+ L+ GR VA+K + ++G + E+ LL +L S P +
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 144 LALLGYCS---DRRKL---LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 197
+ LL C R+L LV++++ + L +L S L ET + +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-----SKCPKPGLPPETIKDLMRQLL 117
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS-TRVLGTQ 256
+G++FLH H ++HRD K NIL+ + K++DFGLA+I S ++ T V+ T
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF----EMALTSVVVTL 170
Query: 257 GYVAPEYALTGHLTTKSDVYSYGVVLLEL 285
Y APE L T D++S G + EL
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 67/211 (31%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 87 FSKSNVVGHGGFGLVYR-GVLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPY 142
F V+G GGFG V V + G+ A K +++ ++GE E ++L ++ S +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 143 LLAL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
+++L Y + LV M G L+ H+Y N D E + A E GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIY-----NMGNPGFDEERAVFYAAEITCGLE 116
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTRVLGTQGYVA 260
LH +++RD K NILLD H ++SD GLA +I G + RV GT GY+A
Sbjct: 117 DLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEI---PEGETIRGRV-GTVGYMA 169
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
PE T D + G ++ E++ G+ P
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 23/216 (10%)
Query: 92 VVGHGGFGLVY----RGVLSNGRKVAIKLMDQAG---KQGEDEFKM-EVELLGRLR-SPY 142
V+G G +G V+ G G+ A+K++ +A K E E ++L +R P+
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 143 LLAL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
L+ L + +D + L+ DY+ G L HLY E R+ IA E L+
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLY-----QREHFTES-EVRVYIA-EIVLALD 119
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
LH+ +I+RD K NILLD H ++DFGL+K + + GT Y+AP
Sbjct: 120 HLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAP 175
Query: 262 EYALTGHLTTKS--DVYSYGVVLLELLTGRVPIDVN 295
E G D +S GV+ ELLTG P V+
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 29/212 (13%)
Query: 92 VVGHGGFGLV----YRGVLSNGRKVAIKLMDQAGKQGEDEF------KMEVELLGRLRSP 141
V+G G FG V Y+ G AIK + + DE K E R P
Sbjct: 6 VLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 142 YLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKG 199
+L+ L + ++ V +Y A G L H++ V S E R A G
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFS----EPRAVFYAACVVLG 113
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
L++LHE+ +++RD K N+LLD K++DFGL K G ++ GT ++
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFL 168
Query: 260 APEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
APE T D + GV++ E+L G P
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 4e-15
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 24/202 (11%)
Query: 93 VGHGGFGLVYRGVLS---NGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLLALL 147
+G G FG V +G+ + + VA+K++ D +DE E ++ +L +PY++ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 148 GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
G C +LV + G L + L + V K + + + G+++L E
Sbjct: 63 GICEAESWMLVMELAELGPLNKFL---QKNKHVTEK----NITELVHQVSMGMKYLEET- 114
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD----KAGGHVSTRVLGTQGYVAPE 262
+HRD + N+LL +AK+SDFGL+K +G+D KA H V + APE
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPV----KWYAPE 168
Query: 263 YALTGHLTTKSDVYSYGVVLLE 284
++KSDV+S+GV++ E
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 4e-15
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 93 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLALLG- 148
+G G +G VY+ VL V + + + + E +F ME+++L + SPY++ G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 149 YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
+ + + +YM + G + LY + + RI KGL+FL E +
Sbjct: 68 FFIEGAVYMCMEYM-DAGSLDKLY---AGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 268
+IHRD K +N+L++ N K+ DFG+ S ++ +G Q Y+APE +G
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGV----SGNLVASLAKTNIGCQSYMAPERIKSGG 177
Query: 269 L------TTKSDVYSYGVVLLELLTGRVP 291
T +SDV+S G+ +LE+ GR P
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM------EVELLGRLRSPYLLA 145
+G G +G+V++ G+ VAIK ++ ED+ + E+ +L +L+ P L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVES----EDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L+ +RKL LV++Y + L E G K +I + + + F H
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-------KIIWQTLQAVNFCH 117
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
+H IHRD K NIL+ K K+ DFG A+I + G T + T+ Y APE
Sbjct: 118 KH---NCIHRDVKPENILITKQGQIKLCDFGFARILT--GPGDDYTDYVATRWYRAPEL- 171
Query: 265 LTGHLT--TKSDVYSYGVVLLELLTG 288
L G DV++ G V ELLTG
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 93 VGHGGFGLVYRG--VLSNGR--KVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALL 147
+G G FG+V RG S G+ VA+K L D+F E ++ L L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 148 GYCSDRRKLLVYDYMANGGLQEHLY-PANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
G ++V + G L + L A G +++ D+ A++ A G+ +L
Sbjct: 63 GVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDY------AVQIANGMRYLE-- 114
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ-GYVAPEYAL 265
S IHRD + NILL + K+ DFGL + +V L + APE
Sbjct: 115 -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 266 TGHLTTKSDVYSYGVVLLELLT-GRVP 291
T + SDV+ +GV L E+ T G P
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 5e-15
Identities = 83/293 (28%), Positives = 123/293 (41%), Gaps = 59/293 (20%)
Query: 93 VGHGGFGLVYRG----VLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG 148
+G+G FG V G +S R V +L A + F EV+ L P +L LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 149 YCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
C + LLV ++ G L+ +L G + ++ D R+A E A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD--VLQRMACEVASGLLWLHQA- 119
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--------IGSDKAGGHVSTRVLGTQGYV 259
IH D N L + K+ D+GLA I D V R ++
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHA--VPLR------WL 169
Query: 260 APEYA-------LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKP----SGEGVLVSWAL 308
APE L T KS+++S GV + EL T ++P S E VL
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLSDEQVL----- 219
Query: 309 PRLTDREKILEIMDPALEGQYSMK--EVIQVAAIAAMC-VQPEADYRPLMADV 358
+ RE+ +++ P L+ +YS + EV+Q C + PE RP +V
Sbjct: 220 -KQVVREQDIKLPKPQLDLKYSDRWYEVMQ------FCWLDPET--RPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 55/156 (35%), Positives = 82/156 (52%), Gaps = 21/156 (13%)
Query: 141 PYLLALLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEA 196
P+L L +C+ + K V +Y+ G L H+ + + D E R R A E
Sbjct: 56 PFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHI-------QSSGRFD-EARARFYAAEI 105
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 256
GL+FLH +I+RD K N+LLDK+ H K++DFG+ K + G ++ GT
Sbjct: 106 ICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTP 160
Query: 257 GYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
Y+APE L G +S D +S+GV+L E+L G+ P
Sbjct: 161 DYIAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 28/212 (13%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 149
+G G +G VY+ ++ G VAIK++ + + E+ +L R P ++A G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL---EAAKGLEFLHE 205
R KL +V +Y G LQ+ G S L+IA E KGL +LHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS---------ELQIAYVCRETLKGLAYLHE 119
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTR--VLGTQGYVAPE 262
IHRD K +NILL ++ K++DFG+ A++ + ++ R +GT ++APE
Sbjct: 120 T---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-----IAKRKSFIGTPYWMAPE 171
Query: 263 YA---LTGHLTTKSDVYSYGVVLLELLTGRVP 291
A G K D+++ G+ +EL + P
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 87 FSKSNVVGHGGFGLVYR-GVLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPY 142
F + V+G GGFG V V + G+ A K +++ ++GE E ++L ++ S +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 143 LLAL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
+++L Y + LV M G L+ H+Y + + + A E GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-----FEEGRAVFYAAEICCGLE 116
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
LH+ +++RD K NILLD + H ++SD GLA + G + RV GT GY+AP
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGYMAP 170
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296
E T D ++ G +L E++ G+ P K
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 5e-15
Identities = 64/262 (24%), Positives = 130/262 (49%), Gaps = 26/262 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+++ +G G G V+ + ++ G++VAIK ++ + ++ E+ ++ L++P ++
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 146 LL-GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L + +V +Y+A G L + + + +D + E + LEFLH
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVV--------TETCMDEAQIAAVCRECLQALEFLH 132
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTRVLGTQGYVAPEY 263
+ VIHRD KS N+LL + K++DFG A+I +++ + ++GT ++APE
Sbjct: 133 AN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 186
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLVSWALPRLTDREKILEI-- 320
K D++S G++ +E++ G P ++ N ++ + P L + EK+ I
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR 246
Query: 321 ------MDPALEGQYSMKEVIQ 336
++ +E + S KE++Q
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 7e-15
Identities = 70/288 (24%), Positives = 126/288 (43%), Gaps = 39/288 (13%)
Query: 84 TGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKMEVELLG 136
G F +G G F +VY+ + L +GR VA+K +MD K +D K E++LL
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA--KARQDCLK-EIDLLK 57
Query: 137 RLRSPYLLALLGYCSDRRKLLVYDYMANGGLQEHL--YPANGSNSVASKLDWETRLRIAL 194
+L P ++ L + +L + +A+ G + + + + W+ +++
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC- 116
Query: 195 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLG 254
LE +H ++HRD K +N+ + K+ D GL + S K S ++G
Sbjct: 117 ---SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVG 168
Query: 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314
T Y++PE KSD++S G +L E+ + P +K + L
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------------LYSL 216
Query: 315 EKILEIMD--PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360
K +E D P YS ++ + + C+ P+ + RP ++ V+Q
Sbjct: 217 CKKIEKCDYPPLPADHYSE----ELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 8e-15
Identities = 72/282 (25%), Positives = 136/282 (48%), Gaps = 28/282 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+++ +G G G VY + ++ G++VAIK M+ + ++ E+ ++ + P ++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 146 LL-GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L Y +V +Y+A G L + + + +D + E + LEFLH
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVV--------TETCMDEGQIAAVCRECLQALEFLH 132
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTRVLGTQGYVAPEY 263
S VIHRD KS NILL + K++DFG A+I +++ + ++GT ++APE
Sbjct: 133 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 186
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLVSWALPRLTDREKILEI-- 320
K D++S G++ +E++ G P ++ N ++ + P L + EK+ I
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246
Query: 321 ------MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 356
++ +E + S KE++Q + +P + PL+A
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHPFLK--IAKPLSSLTPLIA 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 9e-15
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 92 VVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFK---MEVELLG-RLRSPYLLAL 146
V+G G FG V L G A+K + + +D+ + +E +L +P+L L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 147 LGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
YC+ + K V +++ G L H+ + D A E GL+FL
Sbjct: 62 --YCTFQTKEHLFFVMEFLNGGDLMFHIQDK-------GRFDLYRATFYAAEIVCGLQFL 112
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK---IGSDKAGGHVSTRVLGTQGYVA 260
H S +I+RD K N++LD++ H K++DFG+ K G ++A + GT Y+A
Sbjct: 113 H---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA-----STFCGTPDYIA 164
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
PE T D +S+GV+L E+L G+ P
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 20/207 (9%)
Query: 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM--EVELLGRLRSPYLLALL 147
+ VG G +G V + GRKVAIK + + + + E+ LL + ++ LL
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 148 G-YCSDRRKLLVYD-YMANGGLQEHLYPANGSNSVAS-KLDWETRLRIALEAAKGLEFLH 204
+ D Y+ HL A+ +N V KL + + + +GL+++H
Sbjct: 81 DVFTPASSLEDFQDVYLVT-----HLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH 135
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
S +IHRD K SNI ++++ K+ DFGLA+ D+ G+V+TR Y APE
Sbjct: 136 ---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIM 187
Query: 265 LT-GHLTTKSDVYSYGVVLLELLTGRV 290
L H D++S G ++ ELLTG+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 38/93 (40%), Positives = 56/93 (60%), Gaps = 9/93 (9%)
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
+GL+++H S V+HRD K SNIL+++N K+ DFGLA+I + G+VSTR
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 258 YVAPEYALTGH-LTTKSDVYSYGVVLLELLTGR 289
Y APE LT + D++S G + E+L G+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 67/245 (27%), Positives = 98/245 (40%), Gaps = 54/245 (22%)
Query: 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLM--DQAGKQGEDE-FKMEVELLGRLRS 140
F V+G G FG V+ + +V A+K++ K+ + + E ++L S
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 141 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDW----ETRLRIALE 195
P+++ L D L LV +YM G L L + D R IA E
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL----------IRKDVFPEETARFYIA-E 109
Query: 196 AAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK---------------- 238
L+ +H+ IHRD K NIL+D + H K++DFGL K
Sbjct: 110 LVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 239 IGSDKAGGHVSTR-----------VLGTQGYVAPEYALTGH-LTTKSDVYSYGVVLLELL 286
+ V R +GT Y+APE L G + D +S GV+L E+L
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEML 224
Query: 287 TGRVP 291
G P
Sbjct: 225 YGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 42/112 (37%), Positives = 59/112 (52%), Gaps = 19/112 (16%)
Query: 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH--- 247
+IA+ K LE+LH S VIHRD K SN+L+++N K+ DFG++ G+
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--------GYLVD 156
Query: 248 --VSTRVLGTQGYVAPEY----ALTGHLTTKSDVYSYGVVLLELLTGRVPID 293
T G + Y+APE KSDV+S G+ ++EL TGR P D
Sbjct: 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 48/163 (29%), Positives = 85/163 (52%), Gaps = 14/163 (8%)
Query: 131 EVELLGRLRSPYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETR 189
E+++L SPY++ G + SD + ++M G L + L A ++ E
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-------KEAKRIPEEIL 105
Query: 190 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS 249
++++ +GL +L E ++HRD K SNIL++ K+ DFG+ S + ++
Sbjct: 106 GKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMA 159
Query: 250 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 292
+GT+ Y++PE H + +SD++S G+ L+EL GR PI
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 58/209 (27%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLL 144
F K + +G G G+V++ +G +A KL+ K ++ E+++L SPY++
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 145 ALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
G + SD + ++M G L + L A ++ + ++++ KGL +L
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVL-------KKAGRIPEQILGKVSIAVIKGLTYL 119
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
E ++HRD K SNIL++ K+ DFG+ S + ++ +GT+ Y++PE
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGTRSYMSPER 173
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVPI 292
H + +SD++S G+ L+E+ GR PI
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 87 FSKSNVVGHGGFGLVYR-GVLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPY 142
F V+G GGFG V V + G+ A K +++ ++GE E +L ++ S +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 143 LLALLGYCSDRRK--LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
+++L Y + + LV M G L+ H+Y N D + + A E GL
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIY-----NMGNPGFDEQRAIFYAAELCCGL 115
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260
E L +++RD K NILLD H ++SD GLA G V RV GT GY+A
Sbjct: 116 EDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAV--QIPEGETVRGRV-GTVGYMA 169
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
PE T D + G ++ E++ G+ P
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPY 142
F+ V+G G FG V AIK++ + +D+ + +E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 143 LLALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
L L C + R V +Y+ G L H+ K + A E + GL
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPQAVFYAAEISVGL 114
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GTQGYV 259
FLH +I+RD K N++LD H K++DFG+ K + V+TR GT Y+
Sbjct: 115 FFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYI 168
Query: 260 APEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 293
APE D ++YGV+L E+L G+ P D
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-14
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 92 VVGHGGFGLVYRG-VLSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRSPYLLALLG 148
+G G FG +Y S+ IK +D + + ++ K EV LL +++ P ++
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 149 YCSDRRKL-LVYDYMANGGLQEHLYPANGSN-SVASKLDWETRLRIALEAAKGLEFLHEH 206
+ +L +V +Y G L + + G S L W ++I+L GL+ +H+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISL----GLKHIHDR 120
Query: 207 CSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 265
++HRD KS NI L KN AK+ DFG+A+ +D ++ +GT Y++PE
Sbjct: 121 ---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--ELAYTCVGTPYYLSPEICQ 175
Query: 266 TGHLTTKSDVYSYGVVLLELLTGRVPIDVN 295
K+D++S G VL EL T + P + N
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 49/156 (31%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 140 SPYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 198
+P+L+ L + + R LV +Y+ G L H+ KL E A E
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHM-------QRQRKLPEEHARFYAAEICI 107
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
L FLHE +I+RD K N+LLD + H K++D+G+ K G G ++ GT Y
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNY 162
Query: 259 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDV 294
+APE D ++ GV++ E++ GR P D+
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 93 VGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLG 148
+G GGFG V + + G+ A K +++ ++G + +E +L ++ S ++++L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 149 YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
+ L LV M G L+ H+Y + N + GLE LH+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP---GFPEPRACFYTAQIISGLEHLHQR- 116
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLA---KIGSDKAGGHVSTRVLGTQGYVAPEYA 264
+I+RD K N+LLD + + ++SD GLA K G K G+ GT G++APE
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMAPELL 169
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVP 291
D ++ GV L E++ R P
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 50/164 (30%), Positives = 86/164 (52%), Gaps = 16/164 (9%)
Query: 131 EVELLGRLRSPYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETR 189
E+++L SPY++ G + SD + ++M G L + L A ++
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-------KKAGRIPENIL 101
Query: 190 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS 249
+I++ +GL +L E ++HRD K SNIL++ K+ DFG++ D ++
Sbjct: 102 GKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MA 155
Query: 250 TRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPI 292
+GT+ Y++PE L G H T +SD++S G+ L+E+ GR PI
Sbjct: 156 NSFVGTRSYMSPE-RLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 60/235 (25%), Positives = 117/235 (49%), Gaps = 18/235 (7%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+++ +G G G VY + ++ G++VAIK M+ + ++ E+ ++ ++P ++
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 146 LL-GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L Y +V +Y+A G L + + + +D + E + L+FLH
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVV--------TETCMDEGQIAAVCRECLQALDFLH 132
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTRVLGTQGYVAPEY 263
S VIHRD KS NILL + K++DFG A+I +++ + ++GT ++APE
Sbjct: 133 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEV 186
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLVSWALPRLTDREKI 317
K D++S G++ +E++ G P ++ N ++ + P L + E++
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 92 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLALL 147
V+G G FG V L +GR A+K++ + +D+ + E +L R+ L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 148 GYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLH 204
C + R V +++ G L H+ + + D E R R A E L FLH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-------RFD-EARARFYAAEITSALMFLH 113
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
+ +I+RD K N+LLD H K++DFG+ K G G ++ GT Y+APE
Sbjct: 114 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYIAPEIL 168
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVPID 293
D ++ GV+L E+L G P +
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 27/210 (12%)
Query: 92 VVGHGGFGLVYRGVL----SNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLL 144
++G G FG V +L + GR A+K++ + +DE E +L R P+L
Sbjct: 2 LLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 58
Query: 145 AL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEF 202
AL + + R V +Y G L HL ++ E R R E LE+
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGELFFHL--------SRERVFTEERARFYGAEIVSALEY 110
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG-SDKAGGHVSTRVLGTQGYVAP 261
LH S V++RD K N++LDK+ H K++DFGL K G SD A GT Y+AP
Sbjct: 111 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYLAP 164
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
E D + GVV+ E++ GR+P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPY 142
G F K VV +GL + KVA+K++ E E M E++++ L +
Sbjct: 45 AGAFGK--VVEATAYGLSKSDAVM---KVAVKMLKPTAHSSEREALMSELKIMSHL-GNH 98
Query: 143 L--LALLGYCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 199
+ LLG C+ L++ +Y G L L S L E L + + AKG
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-----RKRESFLTLEDLLSFSYQVAKG 153
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHV---STRVLGT 255
+ FL S IHRD + N+LL K+ DFGLA+ I +D +V + R+
Sbjct: 154 MAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDS--NYVVKGNARL--P 206
Query: 256 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
++APE T +SDV+SYG++L E+ +
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 65/209 (31%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 92 VVGHGGFGLVYRGVL----SNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLL 144
++G G FG V +L + G+ A+K++ + +DE E +L R P+L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 145 AL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEF 202
AL + + R V +Y G L HL V S E R R E L +
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHL----SRERVFS----EDRARFYGAEIVSALGY 110
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
LH S V++RD K N++LDK+ H K++DFGL K + G GT Y+APE
Sbjct: 111 LH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPE 165
Query: 263 YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
D + GVV+ E++ GR+P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMDQ-AGKQGED-EFKM-EVELLGRLRSPY 142
F+ V+G G FG V ++ AIK++ + Q +D E M E +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 143 LLALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
L L C + R V +Y+ G L H+ K + A E A GL
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPHAVFYAAEIAIGL 114
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GTQGYV 259
FLH S +I+RD K N++LD H K++DFG+ K + G +TR GT Y+
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDYI 168
Query: 260 APEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 293
APE D +++GV+L E+L G+ P D
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 61/222 (27%), Positives = 108/222 (48%), Gaps = 30/222 (13%)
Query: 92 VVGHGGFGLVYRGVLSN--GR----KVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLL 144
+G G FG V + GR VA+K++ + E + E LL ++ P+++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 145 ALLGYCS-DRRKLLVYDYMANGGLQEHL---------YPANGSNSVASKLDWETR----- 189
L G CS D LL+ +Y G L+ L Y + N +S LD
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 190 ---LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 246
+ A + ++G+++L E ++HRD + N+L+ + K+SDFGL++ ++
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 247 HVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLT 287
++ ++A E +L H+ TT+SDV+S+GV+L E++T
Sbjct: 184 VKRSKGRIPVKWMAIE-SLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 92 VVGHGGFG-LVYRGVLSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLAL- 146
++G G FG ++ ++G+ A+K++ + +DE E +L R P+L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 147 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLHE 205
+ + R V +Y+ G L HL ++ E R R E L++LH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL--------SRERVFSEDRTRFYGAEIVSALDYLH- 112
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 265
S +++RD K N++LDK+ H K++DFGL K G A GT Y+APE
Sbjct: 113 --SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLE 168
Query: 266 TGHLTTKSDVYSYGVVLLELLTGRVP 291
D + GVV+ E++ GR+P
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 7e-14
Identities = 52/218 (23%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 87 FSKSN-----VVGHGGFGLVYRGVLSNGRK------VAIKLMDQAGKQG-EDEFKMEVEL 134
F +SN +G G FG V+ + V +K + + + + EF+ E+++
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 135 LGRLRSPYLLALLGYCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASK---LDWETRL 190
+L ++ LLG C + ++ +Y G L++ L A S K L + ++
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEKLKPPPLSTKQKV 120
Query: 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVS 249
+ + A G++ L +HRD + N L+ KVS L+K + + + +
Sbjct: 121 ALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177
Query: 250 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
+ ++APE +TKSDV+S+GV++ E+ T
Sbjct: 178 ALI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 8e-14
Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 93 VGHGGFGLVYRGVL------SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRL-RSPYLL 144
+G G FG V + + VA+K L D A ++ + E+E++ + + ++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 145 ALLGYCSDRRKL-LVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLRIAL 194
LLG C+ L +V +Y A+G L++ L + L + + A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 195 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGS-----DKAGGHV 248
+ A+G+EFL S IHRD + N+L+ ++ K++DFGLA+ I G +
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 249 STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
+ ++APE T +SDV+S+GV+L E+ T
Sbjct: 197 PVK------WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 27/211 (12%)
Query: 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL 143
TG F + + H G G Y + +K I M Q E +L L P++
Sbjct: 28 TGSFGRVRIAKHKGTGEYY--AIKCLKKREILKMKQV-----QHVAQEKSILMELSHPFI 80
Query: 144 LALL-GYCSDRRKLLVYDYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEAAKGLE 201
+ ++ + + R + +++ G L HL A N VA E L E
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL--------AFE 132
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+LH S +I+RD K N+LLD H KV+DFG AK D+ + + GT Y+AP
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAP 184
Query: 262 EYALT-GHLTTKSDVYSYGVVLLELLTGRVP 291
E + GH D ++ GV+L E + G P
Sbjct: 185 EVIQSKGH-GKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 93 VGHGGFGLVYRG-VLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG-YC 150
+G G G+V S GR+VA+K MD +Q + EV ++ + P ++ + Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 151 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 210
+V +++ G L + + ++++ E + L K L FLH
Sbjct: 87 VGDELWVVMEFLEGGALTDIV--------THTRMNEEQIATVCLAVLKALSFLHAQ---G 135
Query: 211 VIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTR--VLGTQGYVAPEYALTG 267
VIHRD KS +ILL + K+SDFG A++ + V R ++GT ++APE
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-----VPRRKSLVGTPYWMAPEVISRL 190
Query: 268 HLTTKSDVYSYGVVLLELLTGRVP 291
T+ D++S G++++E++ G P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMD---QAGKQGEDEFKMEVELLGRLRSPYLLALLG 148
VG G +G V G +VA+K + Q+ + ++ E+ LL ++ ++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 149 YCSDRRKLLVYDYMANGGLQEHLYPANGSNSV-ASKLDWETRLRIALEAAKGLEFLHEHC 207
+ R L ++ + L HL A+ +N V KL + + + +GL+++H
Sbjct: 84 VFTPARSLEEFNDVY---LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 137
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 267
S +IHRD K SN+ ++++ K+ DFGLA+ D+ G+V+TR Y APE L
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 192
Query: 268 -HLTTKSDVYSYGVVLLELLTGR 289
H D++S G ++ ELLTGR
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 92 VVGHGGFG-LVYRGVLSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLAL- 146
++G G FG ++ + GR A+K++ + +DE E +L R P+L AL
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 147 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLHE 205
+ + R V +Y G L HL V S E R R E L++LH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL----SRERVFS----EDRARFYGAEIVSALDYLHS 113
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 265
+ V++RD K N++LDK+ H K++DFGL K G K G + T GT Y+APE
Sbjct: 114 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI-KDGATMKT-FCGTPEYLAPEVLE 169
Query: 266 TGHLTTKSDVYSYGVVLLELLTGRVP 291
D + GVV+ E++ GR+P
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 31/209 (14%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRS-PYLLALLGY 149
+G G FG VY G VAIK M + E+ + EV+ L +L P ++ L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR-IALEAAKGLEFLHEHC 207
+ +L V++YM Q L + E+ +R I + +GL +H+H
Sbjct: 67 FRENDELYFVFEYMEGNLYQ--LMKDRKGKPFS-----ESVIRSIIYQILQGLAHIHKH- 118
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGS-----DKAGGHVSTRVLGTQGYVAP 261
HRD K N+L+ K++DFGLA+ I S D +VSTR Y AP
Sbjct: 119 --GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD----YVSTR-----WYRAP 167
Query: 262 EYAL-TGHLTTKSDVYSYGVVLLELLTGR 289
E L + ++ D+++ G ++ EL T R
Sbjct: 168 EILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 49/172 (28%), Positives = 76/172 (44%), Gaps = 34/172 (19%)
Query: 192 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV--- 248
IA+ K L +L E +IHRD K SNILLD+N + K+ DFG++ G +
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS--------GQLVDS 161
Query: 249 --STRVLGTQGYVAPEYALTGHLT---TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV- 302
TR G + Y+APE +SDV+S G+ L E+ TG+ P + +
Sbjct: 162 IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT 221
Query: 303 -LVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP 353
+V P I+ + E ++S V + +C+ + RP
Sbjct: 222 QVVKGDPP----------ILSNSEEREFSPSFVNFI----NLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 37/278 (13%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+G G F VYR L + + VA+K +MD +Q D K E++LL +L P ++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ--DCVK-EIDLLKQLNHPNVIK 66
Query: 146 LL-GYCSDRRKLLVYDYMANGGLQEHL-YPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
L + D +V + G L + + Y + + W + ++ +E +
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW----KYFVQLCSAVEHM 122
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H S V+HRD K +N+ + K+ D GL + S K S ++GT Y++PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323
KSD++S G +L E+ + P +K + + +KI + P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----------MNLFSLCQKIEQCDYP 226
Query: 324 ALEGQ-YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360
L + YS K + + +MC+ P+ D RP + V Q
Sbjct: 227 PLPTEHYSEK----LRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLM--DQAGKQGEDEFKMEV-ELLGRLRSPY 142
F V+G G FG V + ++V A+KL+ + K+ + F E +++ S +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
++ L D + L +V +YM G L + SN + W R A E L+
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-----SNYDIPE-KW-ARFYTA-EVVLALD 156
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+H S IHRD K N+LLDK+ H K++DFG + D G +GT Y++P
Sbjct: 157 AIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTAVGTPDYISP 212
Query: 262 EYALT----GHLTTKSDVYSYGVVLLELLTGRVP 291
E + G+ + D +S GV L E+L G P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 38/102 (37%), Positives = 57/102 (55%), Gaps = 7/102 (6%)
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
+GL++LH S ++HRD K N+L++ N K+ DFGLA++ H++ V+ TQ
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 258 YVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPIDVNKP 297
Y APE L G H T+ D++S G + ELL R+ P
Sbjct: 170 YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI---GSDKAGGHVSTRVLG 254
K L+++H S VIHRD K SNILL+ + K++DFGLA+ + V T +
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 255 TQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGR 289
T+ Y APE L TK D++S G +L E+L G+
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 93 VGHGGFGLVYRGVLSNGRKV-AIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLAL-L 147
+G G FG V + + +++ A+K + +A + E +L ++ P+++ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 148 GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
+ S + LV ++ G L HL + ++ + L ALE LH+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARF-YTAELLCALEN------LHKF- 112
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 267
VI+RD K NILLD H + DFGL K+ + + GT Y+APE L G
Sbjct: 113 --NVIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPEL-LLG 167
Query: 268 HLTTKS-DVYSYGVVLLELLTGRVPI---DVNK 296
H TK+ D ++ GV+L E+LTG P +VN+
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 93 VGHGGFGLVYRGVLSN--GRKVAIKLMDQAGKQGEDEFKM---EVELLGR---LRSPYLL 144
+G G FG VY+ V R A+K++ + + E E +L R SP+++
Sbjct: 1 IGKGTFGQVYQ-VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 145 AL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL-EAAKGLEF 202
L + +D LV DYM+ G L HL G S E R + + E LE
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHL-QKEGRFS-------EDRAKFYIAELVLALEH 111
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
LH++ +++RD K NILLD H + DFGL+K ++ + GT Y+APE
Sbjct: 112 LHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPE 166
Query: 263 YALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
L TK D +S GV++ E+ G P
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 93 VGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQGED-EFKMEVELLGRLRSPYLLA 145
+G G FG+VY G + +VA+K ++++ E EF E ++ +++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 146 LLGYCSDRR-KLLVYDYMANGGLQEHLY---PANGSNSVASKLDWETRLRIALEAAKGLE 201
LLG S + L+V + MA+G L+ +L P +N + +++A E A G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+L+ + +HRD + N ++ +F K+ DFG+ + + + L ++AP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLT 287
E G TT SD++S+GVVL E+ +
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 5e-13
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGRLRSPY 142
F ++VG G FG V + G A+K+M ++ ++ F+ E ++L SP+
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL-EAAKGL 200
+ L D+ L LV +Y G L L N + D E + L E +
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLL------NRYEDQFD-EDMAQFYLAELVLAI 115
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG-LAKIGSDKAGGHV-STRVLGTQGY 258
+H+ +HRD K N+L+D+ H K++DFG A++ ++K V S +GT Y
Sbjct: 116 HSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK---MVNSKLPVGTPDY 169
Query: 259 VAPEYALTGHLTTKS------DVYSYGVVLLELLTGRVP 291
+APE T + K D +S GV+ E++ GR P
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 141 PYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 199
P+L+ L + ++ R V +Y+ G L H+ KL E + E +
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-------QRQRKLPEEHARFYSAEISLA 108
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
L +LHE +I+RD K N+LLD H K++D+G+ K G G ++ GT Y+
Sbjct: 109 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYI 163
Query: 260 APEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDV 294
APE D ++ GV++ E++ GR P D+
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 8e-13
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 92 VVGHGGFG--LVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALL-G 148
VVG G FG L+ + V S+ + ++ ++ + E LL +++ P ++A
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 149 YCSDRRKLLVYDYMANGGLQEHLYPANGS-NSVASKLDWETRLRIALEAAKGLEFLHEHC 207
+ +D +V +Y G L + + G + L W ++ + G++ +HE
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK- 119
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 267
V+HRD KS NI L +N K+ DFG A++ + G + T V GT YV PE
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS-PGAYACTYV-GTPYYVPPEIWENM 175
Query: 268 HLTTKSDVYSYGVVLLELLTGRVPIDVN 295
KSD++S G +L EL T + P N
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAG--KQGEDEFKMEVE--LLGRLRSPYLLAL 146
V+G G FG V ++G+ A+K++ + K+ E + M LL ++ P+L+ L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 147 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLH 204
KL V DY+ G L HL + E R R A E A L +LH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQ--------RERSFPEPRARFYAAEIASALGYLH 113
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
S +I+RD K NILLD H ++DFGL K G + + ++ GT Y+APE
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVL 168
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVP 291
D + G VL E+L G P
Sbjct: 169 RKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 9e-13
Identities = 80/309 (25%), Positives = 136/309 (44%), Gaps = 52/309 (16%)
Query: 93 VGHGGFGLVY--RGVLSNGRKVAIKLMD-QAGKQGEDEFKM-EVELLGRLRS---PYLLA 145
+G G +G V+ R + + GR VA+K + Q G++G + EV +L L + P ++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 146 LLGYCSDRR-----KL-LVYDYMANGGLQEHL--YPANGSNSVASKLDWETRLRIALEAA 197
L C+ R KL LV++++ + L +L P G + ET + +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT-------ETIKDMMFQLL 120
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
+GL+FLH H V+HRD K NIL+ + K++DFGLA+I S + T V+ T
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLW 174
Query: 258 YVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI-----DVNKPSGEGVLVSWALPRLT 312
Y APE L T D++S G + E+ R P+ DV++
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQLG-------------- 219
Query: 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 372
KIL+++ E + + A + QP + + ++ + L+
Sbjct: 220 ---KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 276
Query: 373 PKISSSPSF 381
+IS+ +
Sbjct: 277 KRISAYSAL 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 30/215 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKMEVELLGRLRSPYL 143
F K +G G +G+VY+ G VA+K +D + E+ LL L P +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 144 LALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGS----NSVASKLDWETRLRIALEAAK 198
+ LL KL LV++++ + L++ + + S + S L + +
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYL---------FQLLQ 111
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG---HVSTRVLGT 255
GL F H H V+HRD K N+L++ K++DFGLA +A G T + T
Sbjct: 112 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-----RAFGVPVRTYTHEVVT 163
Query: 256 QGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGR 289
Y APE L + +T D++S G + E++T R
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-12
Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 20/232 (8%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS 151
+G G +G VY+ ++ G AIK++ + + E+ ++ + ++A G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 152 DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 211
R KL + GG + +Y G S S++ + +R E +GL +LH S
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLS-ESQIAYVSR-----ETLQGLYYLH---SKGK 127
Query: 212 IHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTRVLGTQGYVAPEYALT---G 267
+HRD K +NILL N H K++DFG+ A+I + A +GT ++APE A G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK---RKSFIGTPYWMAPEVAAVERKG 184
Query: 268 HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV---SWALPRLTDREK 316
D+++ G+ +EL + P+ P L+ ++ P+L D+ K
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 41/96 (42%), Positives = 56/96 (58%), Gaps = 7/96 (7%)
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
+GL+++H S V+HRD K SN+LL+ N K+ DFGLA+ S+K T + T+
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRW 173
Query: 258 YVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPI 292
Y APE L TT DV+S G + ELL GR P+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 67/230 (29%), Positives = 105/230 (45%), Gaps = 51/230 (22%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIK-LMDQAGKQGEDEFKM----EVELLGRLRSPYLLALL 147
G G FG VY+ + GR VA+K ++ K G F + E+++L +L+ P ++ L+
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILKKLKHPNVVPLI 73
Query: 148 GYCSDR------RKLLVY---DYMAN--GGLQE----HLYPANGSNSVASKLDWETRLRI 192
+R ++ VY YM + GL E L + + L+
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLE------- 126
Query: 193 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGH 247
G+ +LHE+ ++HRD K++NIL+D K++DFGLA+ K GG
Sbjct: 127 ------GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 248 VSTR----VLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPI 292
TR ++ T+ Y PE L TT D++ G V E+ T R PI
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 25/216 (11%)
Query: 93 VGHGGFGLVYRGVLSNGR---KVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALL 147
+G G FG V G L+ KVA+K M A + ++F E + P ++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 148 GYC---SDRRK----LLVYDYMANGGLQEHL-YPANGSNSVASKLDWETRLRIALEAAKG 199
G C + +++ +M +G L L Y G L + ++ + A G
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY--LPTQMLVKFMTDIASG 124
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI---GSDKAGGHVSTRVLGTQ 256
+E+L S IHRD + N +L++N + V+DFGL+K G G ++ +
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV--- 178
Query: 257 GYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
++A E TTKSDV+S+GV + E+ T G+ P
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM--EVELLGRLRSPYLLALLG 148
V+G G +G+V + G KVAIK ++ + D ++ E++LL LR P ++ +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 149 YC--SDRRKL----LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
RR+ +V++ M + L+ +N + + L L + L++
Sbjct: 67 IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLL---RALKY 118
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS-TRVLGTQGYVAP 261
+H + V HRD K NIL + + K+ DFGLA++ + + T + T+ Y AP
Sbjct: 119 IH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 262 EYALTGHLTTKS----DVYSYGVVLLELLTGR 289
E L G +K D++S G + E+LTG+
Sbjct: 176 E--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 13/155 (8%)
Query: 141 PYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 199
P+L+ L + ++ R V ++++ G L H+ KL E + E +
Sbjct: 56 PFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM-------QRQRKLPEEHARFYSAEISLA 108
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
L FLHE +I+RD K N+LLD H K++D+G+ K G G ++ GT Y+
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGTPNYI 163
Query: 260 APEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDV 294
APE D ++ GV++ E++ GR P D+
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 28/208 (13%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM----EVELLGRLRS---PYLL 144
+G G +G VY+ +G VA+K + + ED + EV LL RL + P ++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRV--QTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 145 ALLGYCSDRRK------LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 198
L+ C+ R LV++++ + L+ +L L ET + + +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-----DKVPPPGLPAETIKDLMRQFLR 119
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
GL+FLH +C ++HRD K NIL+ K++DFGLA+I S + T V+ T Y
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWY 173
Query: 259 VAPEYALTGHLTTKSDVYSYGVVLLELL 286
APE L T D++S G + E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRS 140
+ K +G G FG + +L +G++ IK ++ + + +E + EV +L ++
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 141 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASK----LDWETRLRIALE 195
P ++ + L +V DY G L + + N V LDW ++ +AL+
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKI---NAQRGVLFPEDQILDWFVQICLALK 115
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGT 255
H H ++HRD KS NI L K+ K+ DFG+A++ + ++ +GT
Sbjct: 116 --------HVH-DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--ELARTCIGT 164
Query: 256 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
Y++PE KSD+++ G VL E+ T
Sbjct: 165 PYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 40/111 (36%), Positives = 58/111 (52%), Gaps = 11/111 (9%)
Query: 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVS 249
++ + K L +L E VIHRD K SNILLD + + K+ DFG++ ++ KA
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA----K 171
Query: 250 TRVLGTQGYVAPEY----ALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296
TR G Y+APE ++DV+S G+ L+EL TG+ P K
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 62/210 (29%), Positives = 106/210 (50%), Gaps = 20/210 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLL 144
F + +G G + VY+G + G VA+K + ++G + E+ L+ L+ ++
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 145 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
L KL LV++YM + L++++ ++ V LD T + KG+ F
Sbjct: 62 RLHDVIHTENKLMLVFEYM-DKDLKKYM----DTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST---RVLGTQGYVA 260
HE+ V+HRD K N+L++K K++DFGLA+ G V+T V+ T Y A
Sbjct: 117 HEN---RVLHRDLKPQNLLINKRGELKLADFGLAR----AFGIPVNTFSNEVV-TLWYRA 168
Query: 261 PEYALTGHL-TTKSDVYSYGVVLLELLTGR 289
P+ L +T D++S G ++ E++TGR
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRS 140
F+ ++G G FG V L + +KVA+K++ D +EF E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 141 PYLLALLGYCSDRRK-------LLVYDYMANGGLQEHLYPAN-GSNSVASKLDWETRLRI 192
P ++ L+G R +++ +M +G L L + G L +T +R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF--TLPLQTLVRF 118
Query: 193 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTR 251
++ A G+E+L S IHRD + N +L++N V+DFGL+ KI S
Sbjct: 119 MIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 252 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
L + ++A E TT SDV+++GV + E++T G+ P
Sbjct: 176 KLPVK-WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 71/223 (31%), Positives = 109/223 (48%), Gaps = 27/223 (12%)
Query: 87 FSKSNVVGHGGFGLVY--RGVLSN--GRKVAIKLMDQA----GKQGEDEFKMEVELLGRL 138
F V+G G +G V+ R V + G+ A+K++ +A + + + E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 139 R-SPYLLAL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 196
R SP+L+ L + +D + L+ DY+ G L HL S K + E ++ E
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-----SQRERFK-EQEVQIYSG-EI 114
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGT 255
LE LH+ +I+RD K NILLD N H ++DFGL+K D+ S GT
Sbjct: 115 VLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCGT 169
Query: 256 QGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVN 295
Y+AP+ GH D +S GV++ ELLTG P V+
Sbjct: 170 IEYMAPDIVRGGDGGH-DKAVDWWSMGVLMYELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 6e-12
Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 25/194 (12%)
Query: 111 KVAIKLM-DQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRKL-LVYDYMANGGL 167
KVA+K++ A ++ + E+E++ + + ++ LLG C+ L ++ +Y + G L
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 168 QEHL---------YPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKS 218
+E+L Y N + +L ++ + A + A+G+E+L S IHRD +
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168
Query: 219 SNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG-----YVAPEYALTGHLTTKS 273
N+L+ ++ K++DFGLA + H+ T G ++APE T +S
Sbjct: 169 RNVLVTEDNVMKIADFGLA-----RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 223
Query: 274 DVYSYGVVLLELLT 287
DV+S+GV+L E+ T
Sbjct: 224 DVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 92 VVGHGGFGLVYRGVLSNGRKV-AIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLALL 147
V+G G FG V ++ AIK++ + +D+ + +E +L P L L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 148 GYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 205
C + R V +Y+ G L + + + A E A GL FLH
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQI-------QQVGRFKEPHAVFYAAEIAIGLFFLH- 118
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 265
S +I+RD K N++LD H K++DFG+ K + G + GT Y+APE
Sbjct: 119 --SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 266 TGHLTTKSDVYSYGVVLLELLTGRVPID 293
D +++GV+L E+L G+ P +
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLM-----DQAGKQGEDEFKMEVELLGRLRSPYLLA 145
++G G FG VY GR++A+K + Q + + + E++LL LR ++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 146 LLGYCSD--RRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
G D +KL ++ +YM G +++ L A G+ L R + +G+ +
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGA------LTENVTRRYTRQILQGVSY 121
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAP 261
LH S ++HRD K +NIL D + K+ DFG +K I + G V GT +++P
Sbjct: 122 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
E K+DV+S ++E+LT + P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 7e-12
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 22/216 (10%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLM--DQAGKQGEDE---FKMEVELLGRLRS 140
+ + ++G G FG VY + GR++A K + D + E + E++LL L+
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 141 PYLLALLGYCSDR--RKLLVY-DYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEA 196
++ G DR + L ++ +YM G +++ L + SV K TR +
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY---TR-----QI 115
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGT 255
+G+ +LH + ++HRD K +NIL D + K+ DFG +K + + G V GT
Sbjct: 116 LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 256 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
+++PE K+DV+S G ++E+LT + P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 63/207 (30%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 92 VVGHGGFGLVYRGVLSNGRKV-AIKLMDQAG--KQGEDEFKMEVE--LLGRLRSPYLLAL 146
V+G G FG V K A+K++ + K+ E++ M LL ++ P+L+ L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 147 -LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLH 204
+ + + V DY+ G L HL + E R R A E A L +LH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQ--------RERCFLEPRARFYAAEIASALGYLH 113
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
S +++RD K NILLD H ++DFGL K + G ++ GT Y+APE
Sbjct: 114 ---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVL 168
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVP 291
D + G VL E+L G P
Sbjct: 169 HKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 67/207 (32%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 92 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVE--LLGRLRSPYLLAL 146
V+G G FG V S+G A+K++ + K+ E M LL L+ P+L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 147 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLH 204
KL V DY+ G L HL + E R R A E A + +LH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQ--------RERCFLEPRARFYAAEVASAIGYLH 113
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
S +I+RD K NILLD H ++DFGL K G + ++ GT Y+APE
Sbjct: 114 ---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVL 168
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVP 291
D + G VL E+L G P
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 93 VGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPYLLALLG 148
VG GG+G V+ + G VA+K M ++ +E + E ++L +S +L+ LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 149 YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
D L L +Y+ G + L +N D R +A E + ++ LHE
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLL-----NNLGVLSED-HARFYMA-EMFEAVDALHEL- 120
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 267
IHRD K N L+D + H K++DFGL+K A V+G+ Y+APE
Sbjct: 121 --GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA-----NSVVGSPDYMAPEVLRGK 173
Query: 268 HLTTKSDVYSYGVVLLELLTGRVPIDVNKP 297
D +S G +L E L G P + P
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 42/116 (36%), Positives = 60/116 (51%), Gaps = 17/116 (14%)
Query: 189 RLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG-----SDK 243
R+ A E LE+LH + ++HRD K N+L+ H K++DFGL+KIG ++
Sbjct: 104 RMYFA-ETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 244 AGGHVS--TR------VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
GH+ TR V GT Y+APE L D ++ G++L E L G VP
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 40/228 (17%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKM----EVELLGRLR 139
+ K +G G FG V++ + VA+K LM+ K+G F + E+++L L+
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEG---FPITALREIKILQLLK 69
Query: 140 SPYLLALLGYCSDRRK---------LLVYDYMAN--GGLQEHLYPANGSNSVASKLDWET 188
++ L+ C + LV+++ + GL ++ K
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGL---------LSNKNVKFTLSE 120
Query: 189 RLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH- 247
++ GL ++H ++HRD K++NIL+ K+ K++DFGLA+ S
Sbjct: 121 IKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
Query: 248 --VSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPI 292
+ RV+ T Y PE L D++ G ++ E+ T R PI
Sbjct: 178 NRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 30/220 (13%)
Query: 87 FSKSNVVGHGGFGLVY--RGVLSN--GRKVAIKLMDQAG----KQGEDEFKMEVELLGRL 138
F V+G G +G V+ R V + G+ A+K++ +A + + + E +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 139 R-SPYLLAL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL-E 195
R SP+L+ L + ++ + L+ DY++ G + HLY + + E +R E
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS--------EDEVRFYSGE 113
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--IGSDKAGGHVSTRVL 253
LE LH+ +++RD K NILLD H ++DFGL+K + +K +
Sbjct: 114 IILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK---ERTYSFC 167
Query: 254 GTQGYVAPEY--ALTGHLTTKSDVYSYGVVLLELLTGRVP 291
GT Y+APE GH D +S G+++ ELLTG P
Sbjct: 168 GTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 92 VVGHGGFGLVYRGVLSNGRKV-AIKLM---DQAGKQGEDEFKMEVELLGRLRSPYLLALL 147
V+G G FG V + RKV A+KL+ + + F E +++ SP+++ L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 148 -GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
+ DR +V +YM G L + + A E L AL+A + F
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL--ALDAIHSMGF---- 163
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 266
IHRD K N+LLDK+ H K++DFG + +K G +GT Y++PE +
Sbjct: 164 -----IHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDTAVGTPDYISPEVLKS 217
Query: 267 ----GHLTTKSDVYSYGVVLLELLTGRVP 291
G+ + D +S GV L E+L G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 92 VVGHGGFGLVYRGVLSNGRKV-AIKLM---DQAGKQGEDEFKMEVELLGRLRSPYLLALL 147
V+G G FG V + +KV A+KL+ + + F E +++ SP+++ L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 148 GYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
D + L +V +YM G L N ++ W + A E L+ +H
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDL------VNLMSNYDVPEKW-AKFYTA-EVVLALDAIH-- 159
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 266
S +IHRD K N+LLDK+ H K++DFG + D+ G +GT Y++PE +
Sbjct: 160 -SMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPDYISPEVLKS 217
Query: 267 ----GHLTTKSDVYSYGVVLLELLTGRVP 291
G+ + D +S GV L E+L G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH--VSTRVLGT 255
+GL+++H S VIHRD K SN+L++++ ++ DFG+A+ S H T + T
Sbjct: 118 RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 256 QGYVAPEYALTGH-LTTKSDVYSYGVVLLELLTGRVPI 292
+ Y APE L+ TT D++S G + E+L GR +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 92 VVGHGGFGLVYRGV--LSNGRK--VAIKL--MDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+G G FG VY+GV K VA+K + E +F E ++ + P+++
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVRE-KFLQEAYIMRQFDHPHIVK 71
Query: 146 LLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 205
L+G ++ +V + G L+ +L S LD + + + + + L +L
Sbjct: 72 LIGVITENPVWIVMELAPLGELRSYLQVNKYS------LDLASLILYSYQLSTALAYLE- 124
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 265
S +HRD + N+L+ K+ DFGL++ D++ S L + ++APE
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK-WMAPESIN 181
Query: 266 TGHLTTKSDVYSYGVVLLELL 286
T+ SDV+ +GV + E+L
Sbjct: 182 FRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 69/251 (27%), Positives = 100/251 (39%), Gaps = 71/251 (28%)
Query: 92 VVGHGGFGLVYRGVL--SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLAL 146
V+G G FG V R V G A+K + ++ K+ + E ++L +P+++ L
Sbjct: 8 VIGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 147 LGYCS--DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDW----ETRLRIALEAAKG 199
Y S D L L+ +Y+ G + L K D ETR IA E
Sbjct: 67 --YYSFQDENYLYLIMEYLPGGDMMTLLM----------KKDTFTEEETRFYIA-ETILA 113
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST--------- 250
++ +H+ IHRD K N+LLD H K+SDFGL G K+ H +
Sbjct: 114 IDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCT-GLKKS--HRTEFYRILSHAL 167
Query: 251 -------------------------RVL-----GTQGYVAPEYALTGHLTTKSDVYSYGV 280
R L GT Y+APE L + D +S GV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227
Query: 281 VLLELLTGRVP 291
++ E+L G P
Sbjct: 228 IMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 38/98 (38%), Positives = 57/98 (58%), Gaps = 9/98 (9%)
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK---IGSDKAGGHVSTRVLGT 255
GL+++H S V+HRD K N+L++ + K+ DFGLA+ + G + T + T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 256 QGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVPI 292
+ Y APE L+ TK+ DV+S G +L ELL GR P+
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 21/152 (13%)
Query: 96 GGFGLVYRGVLSNGRKV-AIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYC- 150
G FG VY G N K+ A+K++ +A K + + E + L +SP+++ L Y
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YSL 73
Query: 151 -SDRRKLLVYDYMANGGLQE--HLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
S LV +Y+ G ++ H+Y D E ++ E A L++LH H
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIY---------GYFDEEMAVKYISEVALALDYLHRH- 123
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239
+IHRD K N+L+ H K++DFGL+K+
Sbjct: 124 --GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 69/269 (25%), Positives = 124/269 (46%), Gaps = 28/269 (10%)
Query: 108 NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALL-GYCSDRRKLLVYDYMANGG 166
+GR+VA+K+MD +Q + EV ++ + ++ + Y ++ +++ G
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104
Query: 167 LQEHLYPANGSNSVAS-KLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK 225
L ++ V+ +L+ E + + L +LH S VIHRD KS +ILL
Sbjct: 105 L---------TDIVSQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTL 152
Query: 226 NFHAKVSDFGL-AKIGSDKAGGHVSTR--VLGTQGYVAPEYALTGHLTTKSDVYSYGVVL 282
+ K+SDFG A+I D V R ++GT ++APE T+ D++S G+++
Sbjct: 153 DGRVKLSDFGFCAQISKD-----VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMV 207
Query: 283 LELLTGRVPIDVNKP-SGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIA 341
+E++ G P + P L P+L + KI ++ LE + +E + A
Sbjct: 208 IEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT-REPQERATAQ 266
Query: 342 AMCVQPEADYRPLMADVVQSLVPLVKYNR 370
+ P L + + LVPL++ R
Sbjct: 267 ELLDHPFL----LQTGLPECLVPLIQQYR 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 49/188 (26%), Positives = 98/188 (52%), Gaps = 15/188 (7%)
Query: 112 VAIKLM-DQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRKL-LVYDYMANGGLQ 168
VA+K++ D A ++ + E+E++ + + ++ LLG C+ L ++ +Y + G L+
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 169 EHL---------YPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSS 219
E+L Y + + ++ ++ + + A+G+E+L S IHRD +
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166
Query: 220 NILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYG 279
N+L+ +N K++DFGLA+ ++ +T ++APE T +SDV+S+G
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226
Query: 280 VVLLELLT 287
V++ E+ T
Sbjct: 227 VLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 52/188 (27%), Positives = 95/188 (50%), Gaps = 15/188 (7%)
Query: 112 VAIKLM-DQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRKLLVY-DYMANGGLQ 168
VA+K++ D A + + E+E++ + + ++ LLG C+ L V +Y + G L+
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 169 EHL---------YPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSS 219
E+L Y + +L ++ + A + A+G+E+L S IHRD +
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAAR 163
Query: 220 NILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYG 279
N+L+ ++ K++DFGLA+ + +T ++APE T +SDV+S+G
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 280 VVLLELLT 287
V+L E+ T
Sbjct: 224 VLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 41/219 (18%)
Query: 92 VVGHGGFGLVY--RGVL--SNGRKVAIKLMDQA----GKQGEDEFKMEVELLGRLRSPYL 143
V+G GG+G V+ R V G+ A+K++ +A ++ K E +L ++ P++
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 144 LALL-GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK---- 198
+ L+ + + + L+ +Y++ G L HL R I +E
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL----------------EREGIFMEDTACFYL 106
Query: 199 -----GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 253
LE LH+ +I+RD K NILLD H K++DFGL K G V+
Sbjct: 107 SEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFC 161
Query: 254 GTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVP 291
GT Y+APE + +GH D +S G ++ ++LTG P
Sbjct: 162 GTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 35/221 (15%)
Query: 93 VGHGGFGLVYRGVLSNGRK--------VAIKLM-DQAGKQGEDEFKMEVELLGRL-RSPY 142
+G G FG V R K VA+K++ D A + + E+EL+ + +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 143 LLALLGYCSDRRKLLV-YDYMANGGLQEHL---------YPANGSNSVASKLDWETRLRI 192
++ LLG C+ L V +Y A G L+E L Y + + +L ++ +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 193 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD------KAGG 246
A + A+G+E+L S IHRD + N+L+ ++ K++DFGLA+ D + G
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 247 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
+ + ++APE T +SDV+S+G+++ E+ T
Sbjct: 197 RLPVK------WMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 57/225 (25%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 86 GFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLR 139
+ S+++ G FG ++ G+L +V +K + D A + E LL L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 140 SPYLLALLGYCSDR--RKLLVYDYMANGGLQEHLY-----PANGSNSVASKLDWETR--L 190
+L +L C + ++Y YM G L+ L AN +++ T+ +
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS------TQQLV 120
Query: 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--IGSD-KAGGH 247
+A++ A G+ +LH+ VIH+D + N ++D+ K++D L++ D G
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 248 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
R + ++A E + ++ SDV+S+GV+L EL+T G+ P
Sbjct: 178 NENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 92 VVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVE----LLGRLRSPYLLAL 146
V+G G FG V +G+ A+K++ + E K + LL ++ P+L+ L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 147 -LGYCSDRRKLLVYDYMANGGLQEHL-----YPANGSNSVASKLDWETRLRI-ALEAAKG 199
+ + + V D++ G L HL +P E R R A E A
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP-------------EPRARFYAAEIASA 108
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
L +LH S +++RD K NILLD H ++DFGL K G ++ +T GT Y+
Sbjct: 109 LGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTTFCGTPEYL 163
Query: 260 APEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
APE D + G VL E+L G P
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 8e-11
Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 28/205 (13%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS 151
+G G FG VY+ G A K+++ ++ +++ +E+E+L PY++ LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 152 DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLD---WETRLR-IALEAAKGLEFLHEHC 207
KL + GG +++ +LD E +++ I + + L++LH
Sbjct: 80 WDGKLWIMIEFCPGG---------AVDAIMLELDRGLTEPQIQVICRQMLEALQYLH--- 127
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR--VLGTQGYVAPEYAL 265
S +IHRD K+ N+LL + K++DFG+ S K + R +GT ++APE +
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFGV----SAKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 266 TGHLTT-----KSDVYSYGVVLLEL 285
+ K+D++S G+ L+E+
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 69/239 (28%), Positives = 111/239 (46%), Gaps = 34/239 (14%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED--EFKMEVELLGRLRSPYLLALLGY 149
VG G +G VY+ L G A+K++ + G+D + E+ ++ + ++A G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKL--EPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 150 CSDRRKLLV-YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL---EAAKGLEFLHE 205
R KL + +Y G LQ+ +Y G S L+IA E +GL +LH
Sbjct: 75 YLSREKLWICMEYCGGGSLQD-IYHVTGPLS---------ELQIAYVCRETLQGLAYLH- 123
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR--VLGTQGYVAPEY 263
S +HRD K +NILL N K++DFG+A K ++ R +GT ++APE
Sbjct: 124 --SKGKMHRDIKGANILLTDNGDVKLADFGVAA----KITATIAKRKSFIGTPYWMAPEV 177
Query: 264 AL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS---WALPRLTDREK 316
A G D+++ G+ +EL + P+ P L+S + P+L D+ K
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 9e-11
Identities = 34/94 (36%), Positives = 55/94 (58%), Gaps = 9/94 (9%)
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
+GL+++H S +IHRD K SN+ ++++ ++ DFGLA+ D+ G+V+TR
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 258 YVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRV 290
Y APE L H D++S G ++ ELL G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 66/262 (25%), Positives = 107/262 (40%), Gaps = 45/262 (17%)
Query: 45 KRLNTPKRVDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRG 104
K+L+ +R GE E DN + S + N++G+G FG+VY
Sbjct: 33 KKLDEEERSHNNNAGEDEDEEKMIDNDIN-------RSPNKSYKLGNIIGNGSFGVVYEA 85
Query: 105 V-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-------- 155
+ + KVAIK + Q + E + ++ L + +L Y +K
Sbjct: 86 ICIDTSEKVAIKKVLQDPQYKNREL-LIMKNLNHINIIFLKDYY-YTECFKKNEKNIFLN 143
Query: 156 -------LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
V+ YM + H P KL + + + L ++H S
Sbjct: 144 VVMEFIPQTVHKYMKHYARNNHALPL-----FLVKL-------YSYQLCRALAYIH---S 188
Query: 209 PPVIHRDFKSSNILLDKNFHA-KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-T 266
+ HRD K N+L+D N H K+ DFG AK + G S + ++ Y APE L
Sbjct: 189 KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK---NLLAGQRSVSYICSRFYRAPELMLGA 245
Query: 267 GHLTTKSDVYSYGVVLLELLTG 288
+ TT D++S G ++ E++ G
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 34/211 (16%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMD---QAGKQGEDEFKMEVELLGRLRSPYLLALLG 148
VG G +G V + G KVAIK + Q+ + ++ E+ LL ++ ++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLD 81
Query: 149 YCSDRRKL-------LVYDYMAN--GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 199
+ L LV +M G L +H KL + + + KG
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-----------EKLSEDRIQFLVYQMLKG 130
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
L+++H + +IHRD K N+ ++++ K+ DFGLA+ + G+V TR Y
Sbjct: 131 LKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYR 182
Query: 260 APEYALTG-HLTTKSDVYSYGVVLLELLTGR 289
APE L H T D++S G ++ E+LTG+
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 26/217 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-----FKMEVELLGRL-R 139
+ K +G G +G VY+ + G+ VA+K + + ++E E+ LL L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSE 59
Query: 140 SPYLLALLGYCSDRRKL------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIA 193
S Y++ LL K LV++Y+ + L++ + L +T
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPG--RPLPAKTIKSFM 116
Query: 194 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-KVSDFGLAKIGSDKAGGHVSTRV 252
+ KG+ H+H V+HRD K N+L+DK K++D GL + S + T
Sbjct: 117 YQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THE 171
Query: 253 LGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTG 288
+ T Y APE L H +T D++S G + E+
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 57/209 (27%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
V+G G +G+VY LS ++AIK + + + E+ L L+ ++ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 151 SDRRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
S+ ++ + + G L L G K + +T + + +GL++LH++
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGP----LKDNEQTIIFYTKQILEGLKYLHDN--- 127
Query: 210 PVIHRDFKSSNILLDKNFHA---KVSDFGLAKIGSDKAGGHVSTRVL-GTQGYVAPE--- 262
++HRD K N+L+ N ++ K+SDFG +K AG + T GT Y+APE
Sbjct: 128 QIVHRDIKGDNVLV--NTYSGVVKISDFGTSK---RLAGINPCTETFTGTLQYMAPEVID 182
Query: 263 YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
G+ +D++S G ++E+ TG+ P
Sbjct: 183 KGPRGY-GAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGR--KVAIKLMDQAG--KQGE-DEFKMEVELLGRLRSP 141
F+ +G G FG V N VAIK +++ KQ + D E ++L + P
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 142 YLLALLGYCSDRRKL-LVYDYMANGGLQEHL-----YPANGSNSVASKLDWETRLRIALE 195
+ + L G D L LV +++ G L +P N V + ++ + E
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP----NDVGCF--YAAQIVLIFE 145
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR---V 252
+ L +++RD K N+LLDK+ K++DFG AK+ V TR +
Sbjct: 146 YLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTL 188
Query: 253 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKP 297
GT Y+APE L +D ++ G+ + E+L G P N+P
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 31/216 (14%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-----FKMEVELLGRLRS 140
++K +G G +G+VY+G G+ VA+K + + E+E E+ LL L+
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMK---KIRLESEEEGVPSTAIREISLLKELQH 58
Query: 141 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHL--YPANGSNSVASKLDWETRLRIALEAA 197
P ++ L +L L++++++ L+++L P +D E +
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSMD-LKKYLDSLPKGQY------MDAELVKSYLYQIL 111
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG---HVSTRVLG 254
+G+ F H V+HRD K N+L+D K++DFGLA +A G V T +
Sbjct: 112 QGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA-----RAFGIPVRVYTHEVV 163
Query: 255 TQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGR 289
T Y APE L +T D++S G + E+ T +
Sbjct: 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE-----DEFKMEVELLGRLRSPYLLA 145
++G G FG VY GR++A+K + + E + + E++LL L ++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 146 LLGYCSD--RRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
G D R L ++ ++M G +++ L S + + TR + + +G+ +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL------KSYGALTENVTR-KYTRQILEGVSY 121
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAP 261
LH S ++HRD K +NIL D + K+ DFG +K + + G V GT +++P
Sbjct: 122 LH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
E K+D++S G ++E+LT + P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 50/150 (33%), Positives = 71/150 (47%), Gaps = 24/150 (16%)
Query: 151 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL---EAAKGLEF----- 202
SD + LL+ +Y + G L + + + RL+ L E GL F
Sbjct: 136 SDDKLLLIMEYGSGGDLNKQI---------------KQRLKEHLPFQEYEVGLLFYQIVL 180
Query: 203 -LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
L E S ++HRD KS+NI L K+ DFG +K SD V++ GT Y+AP
Sbjct: 181 ALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAP 240
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
E + K+D++S GV+L ELLT P
Sbjct: 241 ELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 71/283 (25%), Positives = 127/283 (44%), Gaps = 25/283 (8%)
Query: 93 VGHGGFGLV-YRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALL-GYC 150
+G G G+V V S+G+ VA+K MD +Q + EV ++ + ++ + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 151 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 210
+V +++ G L + + ++++ E + L K L LH +
Sbjct: 88 VGDELWVVMEFLEGGALTDIV--------THTRMNEEQIAAVCLAVLKALSVLH---AQG 136
Query: 211 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLT 270
VIHRD KS +ILL + K+SDFG S + S ++GT ++APE
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYG 194
Query: 271 TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG--- 327
+ D++S G++++E++ G P P ++ LP + K L + P+L+G
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---PKLKNLHKVSPSLKGFLD 251
Query: 328 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370
+ +++ Q A A + P A +VPL++ NR
Sbjct: 252 RLLVRDPAQRATAAELLKHPFLA----KAGPPSCIVPLMRQNR 290
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 39/112 (34%), Positives = 58/112 (51%), Gaps = 15/112 (13%)
Query: 182 SKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IG 240
L E + + + A+G+EFL S IHRD + NILL +N K+ DFGLA+ I
Sbjct: 168 EPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 241 SD-----KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
D K + + ++APE TT+SDV+S+GV+L E+ +
Sbjct: 225 KDPDYVRKGDARLPLK------WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 35/276 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKMEVELLGRLR 139
F +G G F VYR L +G VA+K LMD + D K E++LL +L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA--DCIK-EIDLLKQLN 60
Query: 140 SPYLLALLGYCSDRRKLLVYDYMANGGLQEHL--YPANGSNSVASKLDWETRLRIALEAA 197
P ++ + +L + +A+ G + + + K W + ++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW----KYFVQLC 116
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
LE +H S V+HRD K +N+ + K+ D GL + S K S ++GT
Sbjct: 117 SALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPY 171
Query: 258 YVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317
Y++PE KSD++S G +L E+ + P +K + L S +KI
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-------KKI 220
Query: 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP 353
+ P L + +E+ Q + MC+ P+ + RP
Sbjct: 221 EQCDYPPLPSDHYSEELRQ---LVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 58/238 (24%), Positives = 110/238 (46%), Gaps = 18/238 (7%)
Query: 93 VGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALL-GYC 150
+G G G+V + G++VA+K MD +Q + EV ++ ++ + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 151 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 210
+V +++ G L + + ++++ E + L + L +LH
Sbjct: 90 VGDELWVVMEFLEGGALTDIV--------THTRMNEEQIATVCLSVLRALSYLHNQ---G 138
Query: 211 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLT 270
VIHRD KS +ILL + K+SDFG S + S ++GT ++APE
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYG 196
Query: 271 TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV--LVSWALPRLTDREKILEIMDPALE 326
T+ D++S G++++E++ G P N+P + + + PR+ D K+ ++ L+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPY-FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 39/116 (33%), Positives = 57/116 (49%), Gaps = 9/116 (7%)
Query: 184 LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243
LD E L + + AKG+ FL S IHRD + NILL K+ DFGLA+ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT------GRVPID 293
+ V ++APE T +SDV+SYG++L E+ + +P+D
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 32/226 (14%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLM--DQAG-KQGEDEFKMEVELLGRLRSPYLLALLG 148
+G GG G VY R+VA+K + D + + F E ++ L P ++ +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 149 YCSDRRKLLVY---DYMANGGLQEHLYPANGSNSVASKLDWETR----LRIALEAAKGLE 201
CSD VY Y+ L+ L S++ +L +T L I + +E
Sbjct: 70 ICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-----------IGSDKAGGHVST 250
++H S V+HRD K NILL + D+G A I D+ S+
Sbjct: 128 YVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 251 -----RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
+++GT Y+APE L + +D+Y+ GV+L ++LT P
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 6e-10
Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 16/115 (13%)
Query: 184 LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD 242
LD + LR + + A+G++FL S IHRD + N+LL AK+ DFGLA+ I +D
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 243 -----KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
K + + ++APE T +SDV+SYG++L E+ + G+ P
Sbjct: 266 SNYVVKGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 22/216 (10%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMD--QAGKQGEDE-FKMEVELLGRLRSPY 142
F V+G G FG V L N KV A+K+++ + K+ E F+ E ++L + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 143 LLAL-LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
+ L + + LV DY G L L + + IA+++ L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG-LAKIGSDKAGGHVSTRVLGTQGYVA 260
+ +HRD K NIL+D N H +++DFG K+ D G S+ +GT Y++
Sbjct: 123 Y---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMED--GTVQSSVAVGTPDYIS 171
Query: 261 PEYALT-----GHLTTKSDVYSYGVVLLELLTGRVP 291
PE G + D +S GV + E+L G P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-10
Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 27/176 (15%)
Query: 187 ETRL-RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 245
E R+ I ++ L +LH+ ++HRD +NI+L ++ ++DFGLAK K
Sbjct: 112 EERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQP 166
Query: 246 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS 305
T V+GT Y PE K+DV+++G +L ++ T + P ++S
Sbjct: 167 ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLS 220
Query: 306 WALPRLTDREKILE-IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360
A KI+E + +P EG YS V + C+ P+A+ RP D++Q
Sbjct: 221 LAT-------KIVEAVYEPLPEGMYSE----DVTDVITSCLTPDAEARP---DIIQ 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 7e-10
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 43/222 (19%)
Query: 93 VGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS 151
+G G GLV+ V S+ ++VA+K + Q E++++ RL ++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66
Query: 152 DRRKLLVYDYMANGG--LQEHLYPANGSNSVASKLDW-ETRLRIALEAA----------- 197
VY+ + G L E + NSV ++ ET L LE
Sbjct: 67 ------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM 120
Query: 198 ----KGLEFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKI----GSDKAGGHV 248
+GL+++H S V+HRD K +N+ ++ ++ K+ DFGLA+I S K G++
Sbjct: 121 YQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK--GYL 175
Query: 249 STRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGR 289
S ++ T+ Y +P L+ + T D+++ G + E+LTG+
Sbjct: 176 SEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 56/209 (26%), Positives = 85/209 (40%), Gaps = 37/209 (17%)
Query: 94 GHGGFGLVYRG-VLSNGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRS-PYLLALLGYC 150
G G F V + G+ AIK M + K E + E++ L RL P +L L+
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVL 67
Query: 151 SDR---RKLLV--------YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 199
DR R LV Y+ + P L + + K
Sbjct: 68 FDRKTGRLALVFELMDMNLYELIKG-----RKRP----------LPEKRVKSYMYQLLKS 112
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
L+ +H + + HRD K NIL+ + K++DFG + K T + T+ Y
Sbjct: 113 LDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSK---PPYTEYISTRWYR 165
Query: 260 APEYALT-GHLTTKSDVYSYGVVLLELLT 287
APE LT G+ K D+++ G V E+L+
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDE-----FKMEVELLGRL 138
+ K +G G +G+VY+ G VA+K ++ EDE E+ LL L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-----EDEGVPSTAIREISLLKEL 55
Query: 139 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVAS-KLDWETRLRIALEA 196
P ++ LL KL LV++++ + L++++ +S LD +
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYM------DSSPLTGLDPPLIKSYLYQL 108
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG---HVSTRVL 253
+G+ + H H V+HRD K N+L+D+ K++DFGLA +A G T +
Sbjct: 109 LQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA-----RAFGVPVRTYTHEV 160
Query: 254 GTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGR 289
T Y APE L +T D++S G + E++ R
Sbjct: 161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
GL+++H S +IHRD K N+ ++++ K+ DFGLA+ + G+V TR
Sbjct: 128 CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 258 YVAPEYALTG-HLTTKSDVYSYGVVLLELLTGR 289
Y APE L H D++S G ++ E+LTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 34/93 (36%), Positives = 52/93 (55%), Gaps = 8/93 (8%)
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTRVLGTQG 257
G+ LH++ ++HRD K+SN+LL+ K+ DFGLA + GS T+++ T
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL---KPYTQLVVTLW 171
Query: 258 YVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGR 289
Y APE L +T D++S G + ELLT +
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 42/225 (18%)
Query: 93 VGHGGFGLVYRGVLSN---GRKVAIKLMDQAGKQGEDEFKM----EVELLGRLRSPYLLA 145
+G G +G VY+ N G++ AIK +Q E+ LL L+ +++
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTG-ISQSACREIALLRELKHENVVS 66
Query: 146 LLGYC---SDRRKLLVYDYMANGGLQE-HLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
L+ +D+ L++DY + Q + S+ + + G+
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPS----MVKSLLWQILNGVH 122
Query: 202 FLHEHCSPPVIHRDFKSSNILL--DKNFHA--KVSDFGLAKI---------GSDKAGGHV 248
+LH + V+HRD K +NIL+ + K+ D GLA++ D
Sbjct: 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP----- 174
Query: 249 STRVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVPI 292
V+ T Y APE L TK+ D+++ G + ELLT PI
Sbjct: 175 ---VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE-PI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 84/350 (24%), Positives = 132/350 (37%), Gaps = 97/350 (27%)
Query: 92 VVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGKQGEDEFKME-------------- 131
V+GHG FG V S+ VA+K++ + E + M
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 132 VELLGRLRSPY--LLALLGYC----------SDRRKLLVY-------------------- 159
V LLG P L+ ++ +C + R Y
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 160 DYMANGG-----LQEHLYPANGSNSVASKLD--WETRLRI------ALEAAKGLEFLHEH 206
D G +GS + + D W++ L + + + A+G+EFL
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL--- 190
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPEYAL 265
S IHRD + NILL +N K+ DFGLA+ I D + L + ++APE
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK-WMAPESIF 249
Query: 266 TGHLTTKSDVYSYGVVLLELLT-GRVP---IDVNKPSGEGVLVSWALPRLTD--REKILE 319
TT+SDV+S+GV+L E+ + G P + +N+ + RL D R + E
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ---------RLKDGTRMRAPE 300
Query: 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369
P + I C Q + RP + +V+ L L++ N
Sbjct: 301 NATPEIYR------------IMLACWQGDPKERPTFSALVEILGDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 93 VGHGGFGLVYRGVLSNG---RKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG 148
+G+G FG V G +++G +V +K L A Q + +F E + L+ LL LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 149 YCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
C++ LLV ++ G L+ +L + + D T R+A E A GL LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP--DPTTLQRMACEIALGLLHLHKN- 119
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA--L 265
IH D N LL + K+ D+GL+ + ++ ++APE +
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 266 TGHL-----TTKSDVYSYGVVLLELL 286
G+L T +S+V+S GV + EL
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 51/205 (24%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 92 VVGHGGFGLVYRGVLSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
++G G FG + RG L K VAI L + F E LG+ ++ L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 147 LGYCSDRRKLL-VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 205
G + ++ V +YM+NG L L G + L A G+++L E
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGL------ASGMKYLSE 125
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---APE 262
+H+ + +L++ + K+S F ++ DK+ +T + + V APE
Sbjct: 126 M---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTT--MSGKSPVLWAAPE 178
Query: 263 YALTGHLTTKSDVYSYGVVLLELLT 287
H ++ SDV+S+G+V+ E+++
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 27/216 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSN-GRKVAIK---LMDQAGKQGEDEFKM-EVELLGRLRSP 141
+ K +G G +G V++ VA+K L D +G + E+ LL L+
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHK 59
Query: 142 YLLALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
++ L SD++ LV++Y + L+++ NG +D E + KGL
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEY-CDQDLKKYFDSCNG------DIDPEIVKSFMFQLLKGL 112
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV---STRVLGTQG 257
F H H V+HRD K N+L++KN K++DFGLA+ G V S V+ T
Sbjct: 113 AFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR----AFGIPVRCYSAEVV-TLW 164
Query: 258 YVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPI 292
Y P+ L +T D++S G + EL P+
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 67/265 (25%), Positives = 105/265 (39%), Gaps = 68/265 (25%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMDQAG---KQGEDEFKMEVELLGRLRSPY 142
F K +G G FG V + + A+K + +A + K E ++L + +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGL-----QEHLYPANGSNSVASKLDWETRLRIALEA 196
++ L D+ L V DY+ G + + ++ +A R IA E
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFE----EDLA-------RFYIA-EL 110
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA---KIGSD----KAGGHV- 248
+E +H+ IHRD K NIL+D++ H K++DFGL + D + G H
Sbjct: 111 TCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167
Query: 249 ----------------------------STRVL-----GTQGYVAPEYAL-TGHLTTKSD 274
R L GT Y+APE L TG+ T D
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCD 226
Query: 275 VYSYGVVLLELLTGRVPIDVNKPSG 299
+S GV+L E+L G+ P + P+
Sbjct: 227 WWSVGVILYEMLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 93 VGHGGFGLVYRGVLS--NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLALLG- 148
+G G +G V++ VL+ NG K A+K++D E E + E +L L P ++ G
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHPNVVKFYGM 83
Query: 149 -YCSDRR---KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
Y D + +L + + NGG L G +++ I EA GL+ LH
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDL--VKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTRVLGTQGYVAPEY 263
+ IHRD K +NILL K+ DFG+ A++ S + +GT ++APE
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEV 195
Query: 264 -----ALTGHLTTKSDVYSYGVVLLELLTGRVPI 292
L + DV+S G+ +EL G P+
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 66/252 (26%), Positives = 102/252 (40%), Gaps = 70/252 (27%)
Query: 87 FSKSNVVGHGGFGLVY----RGVLSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLR 139
F K ++G G G V+ +G G+ A+K++D+ ++ K E E+L L
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 140 SPYLLALLGYCS---DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 196
P+L L Y S + LV DY G L L G ++ E
Sbjct: 60 HPFLPTL--YASFQTETYLCLVMDYCPGGELFRLLQRQPGK-------------CLSEEV 104
Query: 197 AK--------GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV 248
A+ LE+LH +++RD K NILL ++ H +SDF L+K SD V
Sbjct: 105 ARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQ-SDVEPPPV 160
Query: 249 STRVL----------------------------GTQGYVAPEYALTGHLTTKS-DVYSYG 279
S + GT+ Y+APE ++G + D ++ G
Sbjct: 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLG 219
Query: 280 VVLLELLTGRVP 291
++L E+L G P
Sbjct: 220 ILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 92 VVGHGGFGLV----YRGVLSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRSPYLLA 145
VVG G +G V +R ++G++ IK ++ A ++ + E +LL +L+ P ++A
Sbjct: 7 VVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 146 LLGYCSDRRKLL--VYDYMANGGLQEHLYPANGSNSVASK-LDWETRLRIALEAAKGLEF 202
LL V + G L L G ++ ++W ++ +AL+ +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ------Y 117
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
LHE ++HRD K+ N+ L + KV D G+A++ ++ +++ ++GT Y++PE
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DMASTLIGTPYYMSPE 172
Query: 263 YALTGHLTTKSDVYSYGVVLLELLT 287
KSDV++ G + E+ T
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 54/211 (25%), Positives = 104/211 (49%), Gaps = 40/211 (18%)
Query: 93 VGHGGFGLVYR------GVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
+G G FG VY+ GVL+ A K++D ++ +++ +E+++L P ++ L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLA-----AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 67
Query: 147 L-GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLD---WETRLRIAL-EAAKGLE 201
L + + ++ ++ A G + ++V +L+ E ++R+ + + L
Sbjct: 68 LDAFYYENNLWILIEFCAGGAV----------DAVMLELERPLTEPQIRVVCKQTLEALN 117
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR--VLGTQGYV 259
+LHE+ +IHRD K+ NIL + K++DFG+ S K + R +GT ++
Sbjct: 118 YLHEN---KIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRTIQRRDSFIGTPYWM 170
Query: 260 APEYALTGH-----LTTKSDVYSYGVVLLEL 285
APE + K+DV+S G+ L+E+
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 15/101 (14%)
Query: 193 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD-----KAGG 246
+ + AKG+EFL S IHRD + NILL +N K+ DFGLA+ I D K
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 247 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
+ + ++APE T +SDV+S+GV+L E+ +
Sbjct: 242 RLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 33/87 (37%), Positives = 50/87 (57%), Gaps = 10/87 (11%)
Query: 212 IHRDFKSSNILLDKNFHAKVSDFG-LAKIGSDKAGGHVSTRV-LGTQGYVAPEY--AL-- 265
+HRD K N+LLDKN H +++DFG ++ +D G V + V +GT Y++PE A+
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD---GTVQSNVAVGTPDYISPEILQAMED 180
Query: 266 -TGHLTTKSDVYSYGVVLLELLTGRVP 291
G + D +S GV + E+L G P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 54/295 (18%)
Query: 93 VGHGGFGLVYRGVLSNG----RKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG 148
+G+G FG V + R V +L A + ++EF + + L+ P +L LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 149 YCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL--RIALEAAKGLEFLHE 205
C + LLV++Y G L+ +L S + + + L R+A E A G+ +H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYL-----SQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA- 264
H +H D N L + KV D+G+ + ++APE
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 265 ------LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE--- 315
+T T S+V++ GV L EL + +P L+DRE
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFE-----NAAQP----------YSHLSDREVLN 219
Query: 316 -----KILEIMDPALEGQYSMK--EVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363
+ +++ P LE YS + EV+Q C + R +V + L
Sbjct: 220 HVIKDQQVKLFKPQLELPYSERWYEVLQ------FCWLS-PEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMD--QAGKQGEDE-FKMEVELLGRLRSPY 142
F V+G G FG V + + ++ A+K+++ + K+ E F+ E +L +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
+ L D L LV DY G L L + +L + E +
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLL------SKFEDRLPEDMARFYIAEMVLAIH 116
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+H+ +HRD K N+LLD N H +++DFG + + ++ G S+ +GT Y++P
Sbjct: 117 SIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISP 172
Query: 262 EYALT-----GHLTTKSDVYSYGVVLLELLTGRVP 291
E G + D +S GV + E+L G P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDE-FKM----EVELLGRLRS 140
F +G G +G VY+ + G VA+K + E E F + E+++L +L
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 141 PYLLALLGYCSDR------RK-----LLVYDYMANG--GLQEHLYPANGSNSVASKLDWE 187
++ L +D+ +K LV++YM + GL E + + S
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS----- 120
Query: 188 TRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 247
+ +GL + H+ +HRD K SNILL+ K++DFGLA++ + +
Sbjct: 121 ----FMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173
Query: 248 VSTRVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVPI 292
+ +V+ T Y PE L + DV+S G +L EL T + PI
Sbjct: 174 YTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK-PI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 47/176 (26%), Positives = 69/176 (39%), Gaps = 17/176 (9%)
Query: 141 PYLLALLGY-CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 199
P ++ L Y S+ LV + G L H+ S + E R A E
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-------SKFLNIPEECVKRWAAEMVVA 97
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
L+ LH ++ RD +NILLD H +++ F D G + Y
Sbjct: 98 LDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149
Query: 260 APEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315
APE T D +S G +L ELLTG+ ++ + PSG + +P E
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECH-PSGINTHTTLNIPEWVSEE 204
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 190 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHV 248
L + A+G+EFL S +HRD + N+LL + K+ DFGLA+ I D
Sbjct: 240 LSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 249 STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
+ L + ++APE TT SDV+SYG++L E+ +
Sbjct: 297 GSTFLPVK-WMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 22/229 (9%)
Query: 77 FKQLHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELL 135
+ L T + +G G +G VY+ +G A+K++D E E + E +L
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNIL 72
Query: 136 GRLRS-PYLLALLG--YCSDR---RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETR 189
L + P ++ G Y +D+ +L + + NGG L G +LD
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTEL--VKGLLICGQRLDEAMI 130
Query: 190 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHV 248
I A GL+ LH + +IHRD K +NILL K+ DFG+ A++ S + +
Sbjct: 131 SYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 249 STRVLGTQGYVAPEYALTGH-----LTTKSDVYSYGVVLLELLTGRVPI 292
S +GT ++APE + DV+S G+ +EL G P+
Sbjct: 188 S---VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 60/251 (23%), Positives = 103/251 (41%), Gaps = 52/251 (20%)
Query: 87 FSKSNVVGHGGFG---LVYRGVLSNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRS 140
F V+G G FG LV + G A+K++ +A K+ + E ++L S
Sbjct: 3 FESLKVIGRGAFGEVRLVQKK--DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 141 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 199
+++ + D+ L L+ +++ G + L + + + ET+ IA E
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIA-ETVLA 113
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-----------------KIGSD 242
++ +H+ IHRD K N+LLD H K+SDFGL + SD
Sbjct: 114 IDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSD 170
Query: 243 KAGGHVSTR----------------VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELL 286
+++++ +GT Y+APE + D +S GV++ E+L
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 287 TGRVPIDVNKP 297
G P P
Sbjct: 231 IGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 38/120 (31%), Positives = 58/120 (48%), Gaps = 6/120 (5%)
Query: 171 LYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 230
L AN + +LD E + + G++ LH S +IHRD K SNI++ + K
Sbjct: 107 LMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 163
Query: 231 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 290
+ DFGLA+ + T + T+ Y APE L D++S G ++ EL+ G V
Sbjct: 164 ILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 57/217 (26%), Positives = 106/217 (48%), Gaps = 33/217 (15%)
Query: 87 FSKSNVVGHGGFGLVYRGV--LSNGRKVAIK--LMDQAGKQGEDEFKMEVELLGRLRSPY 142
+ K +G G +G+VY+ ++N +A+K ++Q + E+ LL ++
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 143 LLALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIA----LEAA 197
++ L S++R LV++Y+ + L++H+ S D+ R+ +
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYL-DLDLKKHM---------DSSPDFAKNPRLIKTYLYQIL 112
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-KVSDFGLAKIGSDKAGG---HVSTRVL 253
+G+ + H H V+HRD K N+L+D+ +A K++DFGLA +A G T +
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLA-----RAFGIPVRTFTHEV 164
Query: 254 GTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGR 289
T Y APE L + H +T D++S G + E++ +
Sbjct: 165 VTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 32/215 (14%)
Query: 93 VGHGGFGLVYRGVLSNGR---KVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL--- 146
VG G +G VY+ +G+ + A+K ++ G E+ LL L+ P ++AL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQKV 66
Query: 147 -LGYCSDRRKLLVYDYMANGGLQEH-------LYPANGSNSVASKLDWETRLRIALEAAK 198
L + SDR+ L++DY EH + A+ +N +L + +
Sbjct: 67 FLSH-SDRKVWLLFDY------AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLAKIGSDKAGGHVSTR-VL 253
G+ +LH + V+HRD K +NIL+ + K++D G A++ + V+
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 254 GTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLT 287
T Y APE L H T D+++ G + ELLT
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 6/92 (6%)
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
G++ LH S +IHRD K SNI++ + K+ DFGLA+ + T + T+ Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYY 183
Query: 259 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 290
APE L D++S G ++ E++ G V
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 60/252 (23%), Positives = 98/252 (38%), Gaps = 54/252 (21%)
Query: 87 FSKSNVVGHGGFG---LVYRGVLSNGRKVAIKLM---DQAGKQGEDEFKMEVELLGRLRS 140
F V+G G FG LV + G A+K++ D K+ + E ++L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKK--DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 141 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 199
+++ + D+R L L+ +++ G + L + + A++ + +A++A
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF-YIAETVLAIDAIHQ 119
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG-------------- 245
L F IHRD K N+LLD H K+SDFGL G KA
Sbjct: 120 LGF---------IHRDIKPDNLLLDAKGHVKLSDFGLCT-GLKKAHRTEFYRNLTHNPPS 169
Query: 246 --------------------GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLEL 285
++ +GT Y+APE + D +S GV++ E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 286 LTGRVPIDVNKP 297
L G P P
Sbjct: 230 LIGYPPFCSETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 61/262 (23%), Positives = 98/262 (37%), Gaps = 60/262 (22%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLM---DQAGKQGEDEFKMEVELLGRLRSPY 142
F K +G G FG V + A+K + D + K E ++L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
++ L D+ L V DY+ G + L V ++ + L +A+E+ +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARF-YIAELTLAIESVHKMG 121
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK----------------------- 238
F IHRD K NIL+D + H K++DFGL
Sbjct: 122 F---------IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172
Query: 239 -------IGSDKAGGHVST---------------RVLGTQGYVAPEYALTGHLTTKSDVY 276
+ + + G + T ++GT Y+APE L T D +
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232
Query: 277 SYGVVLLELLTGRVPIDVNKPS 298
S GV+L E+L G+ P P+
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPT 254
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 5/105 (4%)
Query: 184 LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD 242
L + + + + A G+EFL S +HRD + N+L+ + K+ DFGLA+ I D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287
+ L + ++APE TT SDV+S+G++L E+ T
Sbjct: 293 SNYISKGSTFLPLK-WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 34/118 (28%), Positives = 58/118 (49%), Gaps = 26/118 (22%)
Query: 192 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR 251
+A + G+ +LH ++HRD K SN+L++ + K++DFG+++I + S+
Sbjct: 173 VARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228
Query: 252 VLGTQGYVAPE-------------YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296
+GT Y++PE YA D++S GV +LE GR P V +
Sbjct: 229 -VGTIAYMSPERINTDLNHGAYDGYA--------GDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 10/89 (11%)
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--IGSDKAGGHVSTRVLGTQ 256
G+ ++H+ ++HRD K+ NI L N K+ DFG+++ +GS ++T GT
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS----CDLATTFTGTP 169
Query: 257 GYVAPEYALTGHLTTKSDVYSYGVVLLEL 285
Y++PE +KSD++S G +L E+
Sbjct: 170 YYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 64/262 (24%), Positives = 101/262 (38%), Gaps = 74/262 (28%)
Query: 87 FSKSNVVGHGGFGLVYRGV--LSNGRKVAIKLMDQAGKQGEDEF---KMEVELLGRLRSP 141
F V+G G FG V R V G+ A+K + ++ +D+ K E ++L SP
Sbjct: 3 FHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 142 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWE------TRLRIAL 194
++++L D + L L+ +++ G L L + ++ TR +A
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTML------------IKYDTFSEDVTRFYMA- 108
Query: 195 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL------------------ 236
E +E +H+ IHRD K NIL+D+ H K+SDFGL
Sbjct: 109 ECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165
Query: 237 ---AKIGSDKAGGHV-------------------STRVL-----GTQGYVAPEYALTGHL 269
K D + R++ GT Y+APE L
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY 225
Query: 270 TTKSDVYSYGVVLLELLTGRVP 291
+ D +S G ++ E L G P
Sbjct: 226 GQECDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 35/103 (33%), Positives = 50/103 (48%), Gaps = 14/103 (13%)
Query: 194 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST-RV 252
LEA L +LH +IHRD K+ NI LD+ +A + DFG A K H T +
Sbjct: 195 LEA---LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAAC----KLDAHPDTPQC 244
Query: 253 LGTQGYV---APEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 292
G G + +PE K+D++S G+VL E+ V +
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 12/120 (10%)
Query: 183 KLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242
L + L I + +GL +LH +IHRD K+ NI ++ + D G A+
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV- 208
Query: 243 KAGGHVSTRVLGTQGYV---APEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 299
V+ LG G V APE +K+D++S G+VL E+L I + PS
Sbjct: 209 -----VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263
|
Length = 357 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 66/271 (24%), Positives = 103/271 (38%), Gaps = 80/271 (29%)
Query: 87 FSKSNVVGHGGFGLV--YRGVLSNG-------RKVAIKLMDQAGKQGEDEFKMEVELLGR 137
F K +G G FG V R V + RK + L +Q K E ++L
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVA-----HVKAERDILAE 57
Query: 138 LRSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHL-----YPANGSNSVASKLDWETRLR 191
+ +++ L D+ L V DY+ G + L +P + + ++L
Sbjct: 58 ADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELT------ 111
Query: 192 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA---KIGSD----KA 244
A+E+ + F IHRD K NIL+D++ H K++DFGL + D ++
Sbjct: 112 CAVESVHKMGF---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQS 162
Query: 245 GGHV--------------------------------------STRVLGTQGYVAPEYALT 266
G HV + ++GT Y+APE L
Sbjct: 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 267 GHLTTKSDVYSYGVVLLELLTGRVPIDVNKP 297
T D +S GV+L E+L G+ P P
Sbjct: 223 TGYTQLCDWWSVGVILYEMLVGQPPFLAQTP 253
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLL 144
+ K +G G + VY+G NG+ VA+K++ ++G + E LL L+ ++
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66
Query: 145 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
L + L LV++Y+ Q G + KL + +GL ++
Sbjct: 67 LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-------FLFQLLRGLSYI 119
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H+ ++HRD K N+L+ K++DFGLA+ S H + + T Y P+
Sbjct: 120 HQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS--VPSHTYSNEVVTLWYRPPDV 174
Query: 264 AL-TGHLTTKSDVYSYGVVLLELLTG 288
L + +T D++ G + +E++ G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 93 VGHGGFGLV---YRGVLSNGRKVAIKLMD---QAGKQGEDEFKMEVELLGRLRSPYLLAL 146
+G G G+V Y VL R VAIK + Q + ++ E+ L+ + +++L
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 147 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
L + ++ L + + L L AN + +LD E + + G++ LH
Sbjct: 82 LNVFTPQKSL---EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH-- 136
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 266
S +IHRD K SNI++ + K+ DFGLA+ + T + T+ Y APE L
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILG 192
Query: 267 GHLTTKSDVYSYGVVLLELLTGRV 290
D++S G ++ E++ ++
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKI 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 52/236 (22%)
Query: 89 KSNVVGHGGFGLVYRGV-LSNGRKVAIKLM---DQAGKQGEDEFKM-----------EVE 133
K +G G +G V + G+ VAIK + + + +D + E++
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 134 LLGRLRSPYLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR- 191
++ ++ ++ L+ Y LV D MA+ + +D + RL
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMAS--------------DLKKVVDRKIRLTE 118
Query: 192 -----IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAG 245
I L+ GL LH+ +HRD +NI ++ K++DFGLA + G
Sbjct: 119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 246 GHVS-----------TRVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGR 289
+S T + T Y APE + + D++S G + ELLTG+
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 37/120 (30%), Positives = 58/120 (48%), Gaps = 6/120 (5%)
Query: 171 LYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 230
L AN + +LD E + + G++ LH S +IHRD K SNI++ + K
Sbjct: 110 LMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 166
Query: 231 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 290
+ DFGLA+ + T + T+ Y APE L D++S G ++ E++ G V
Sbjct: 167 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 63/290 (21%), Positives = 111/290 (38%), Gaps = 54/290 (18%)
Query: 94 GHGGFGLVYRGVL-------SNGR----KVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY 142
G G F +Y+GVL G V +K++ + F L+ +L +
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHKH 62
Query: 143 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
L+ L G C ++V +Y+ G L L+ + S+ KLD +A + A L +
Sbjct: 63 LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLD------VAKQLASALHY 116
Query: 203 LHEHCSPPVIHRDFKSSNILLDKN-------FHAKVSDFGLAKIGSDKAGGHVSTRVLGT 255
L + ++H + NIL+ + K+SD G+ RV
Sbjct: 117 LEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP-----ITVLSREERVERI 168
Query: 256 QGYVAPEY--ALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313
++APE LT +D +S+G LLE+ + + +P L L+
Sbjct: 169 P-WIAPECIRNGQASLTIAADKWSFGTTLLEICS-----NGEEP----------LSTLSS 212
Query: 314 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363
EK D + + M + ++A + C + RP +++ L
Sbjct: 213 SEKERFYQD---QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 37/217 (17%)
Query: 94 GHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGED--EFKMEVELLGRLRSPYLLALLGYCS 151
+ + VA+K ++ ED + E+ +L+ P +L +
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 152 DRRKL-LVYDYMANGG----LQEHLYPANGSNSVASKLDWETRLRIAL---EAAKGLEFL 203
+L +V MA G L+ H +P G +A IA + L+++
Sbjct: 70 VDSELYVVSPLMAYGSCEDLLKTH-FP-EGLPELA----------IAFILKDVLNALDYI 117
Query: 204 H-EHCSPPVIHRDFKSSNILLDKNFHAKVSDF----GLAKIGSDKAGGHVSTR-VLGTQG 257
H + IHR K+S+ILL + +S + K G + H + +
Sbjct: 118 HSKGF----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 258 YVAPEY---ALTGHLTTKSDVYSYGVVLLELLTGRVP 291
+++PE L G+ KSD+YS G+ EL G VP
Sbjct: 174 WLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 93 VGHGGFGLVYRGVLSNGRK---VAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL--- 146
VG G +G VY+ +G+ A+K ++ G E+ LL L+ P +++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQKV 66
Query: 147 -LGYCSDRRKLLVYDYMANGGLQEH-------LYPANGSNSVASKLDWETRLRIALEAAK 198
L + +DR+ L++DY EH + A+ +N +L + +
Sbjct: 67 FLSH-ADRKVWLLFDY------AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLAKIGSDKAGGHVSTR-VL 253
G+ +LH + V+HRD K +NIL+ + K++D G A++ + V+
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 254 GTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLT 287
T Y APE L H T D+++ G + ELLT
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 46/150 (30%), Positives = 69/150 (46%), Gaps = 19/150 (12%)
Query: 149 YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
+ + +L+ DY+ +G L + L G S A E + I + + L LH+H
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFD-LLKKEGKLSEA-----EVKK-IIRQLVEALNDLHKH-- 128
Query: 209 PPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 267
+IH D K N+L D + D+GL KI G S GT Y +PE + G
Sbjct: 129 -NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII-----GTPSCYD-GTLDYFSPE-KIKG 180
Query: 268 HLTTKS-DVYSYGVVLLELLTGRVPIDVNK 296
H S D ++ GV+ ELLTG+ P ++
Sbjct: 181 HNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 51/202 (25%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 93 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLLALLGYC 150
+G G + VY+G+ NG+ VA+K++ ++G + E LL L+ ++ L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 151 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
+ L V++YM Q + G + +L + +GL ++H
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIHGQ--- 122
Query: 210 PVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-- 267
++HRD K N+L+ K++DFGLA+ S + + S V T Y P+ L G
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGAT 179
Query: 268 HLTTKSDVYSYGVVLLELLTGR 289
++ D++ G + +E+L G+
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRK-VAIKLMDQAGKQGEDEFK----MEVELLGRLRSP 141
F VVG G +G+V + ++ VAIK + + +E K E+++L L+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQE 60
Query: 142 YLLALLGYCSDRRKL-LVYDYMANGGLQ--EHLYPANGSNSVASKLDWETRLRIALEAAK 198
++ L R KL LV++Y+ L+ E + V S + + K
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI---------YQLIK 111
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
+ + H++ ++HRD K N+L+ N K+ DFG A+ S+ + + T + T+ Y
Sbjct: 112 AIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWY 167
Query: 259 VAPEYALTGHLTTKSDVYSYGVVLLELLTGR 289
+PE L D++S G +L EL G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 59/286 (20%), Positives = 119/286 (41%), Gaps = 47/286 (16%)
Query: 93 VGHGGFGLVYRGV---LSNGRK-----VAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLL 144
+G G F +++G+ + + + V +K++D++ + + F ++ +L +L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 145 ALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
G C ++V +Y+ G L +L N + W +L +A + A L FL
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL----KKNKNLINISW--KLEVAKQLAWALHFL 116
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ------G 257
+ + H + + N+LL + K + K+ SD +S VL +
Sbjct: 117 EDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKL-SDPG---ISITVLPKEILLERIP 169
Query: 258 YVAPE-YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316
+V PE +L+ +D +S+G L E+ +G +KP D +K
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFSG-----GDKPLS-----------ALDSQK 213
Query: 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
L+ + Q + ++A + C+ E D+RP +++ L
Sbjct: 214 KLQFYEDRH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLL 144
+ K + +G G + VY+G VA+K + ++G + EV LL L+ ++
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 145 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
L + L LV++Y+ + L+++L + + ++ + +GL +
Sbjct: 68 TLHDIIHTEKSLTLVFEYL-DKDLKQYL------DDCGNSINMHNVKLFLFQLLRGLNYC 120
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H V+HRD K N+L+++ K++DFGLA+ S + + V T Y P+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDI 175
Query: 264 AL-TGHLTTKSDVYSYGVVLLELLTGR 289
L + +T+ D++ G + E+ TGR
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLL 144
+ K + +G G + V++G VA+K + ++G + EV LL L+ ++
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 145 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
L R L LV++Y+ + L+++L ++ + + + +GL +
Sbjct: 67 TLHDIIHTERCLTLVFEYLDSD-LKQYL------DNCGNLMSMHNVKIFMFQLLRGLSYC 119
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H+ ++HRD K N+L+++ K++DFGLA+ S + + V T Y P+
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV 174
Query: 264 AL-TGHLTTKSDVYSYGVVLLELLTGR 289
L + +T D++ G +L E+ TGR
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 50/207 (24%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLL 144
+ K +G G + V++G VA+K + ++G + EV LL L+ ++
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 145 ALLGYC-SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
L +D+ LV++Y+ + L++++ + ++ S + + L + +GL +
Sbjct: 68 TLHDIVHTDKSLTLVFEYL-DKDLKQYM---DDCGNIMSMHNVKIFL---YQILRGLAYC 120
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H V+HRD K N+L+++ K++DFGLA+ S + + V T Y P+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV 175
Query: 264 AL-TGHLTTKSDVYSYGVVLLELLTGR 289
L + +T+ D++ G + E+ +GR
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 31/104 (29%), Positives = 47/104 (45%), Gaps = 12/104 (11%)
Query: 190 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA----KIGSDKAG 245
L I + +++LHE+ +IHRD K+ NI ++ + DFG A I ++K
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 246 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR 289
G GT APE D++S G+VL E+ T
Sbjct: 242 GWA-----GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 38/113 (33%), Positives = 57/113 (50%), Gaps = 22/113 (19%)
Query: 192 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD----------KNFHAKVSDFGLAKIGS 241
I A +GL +LH++ IHR+ K+S+IL+ + ++ V + AK+
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 242 DKAGGHVSTRVLGTQGYVAPEYA---LTGHLTTKSDVYSYGVVLLELLTGRVP 291
D ST VL +++PE L G+ KSD+YS G+ EL TGRVP
Sbjct: 163 DFP--QFSTSVLP---WLSPELLRQDLYGY-NVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 32/101 (31%), Positives = 47/101 (46%), Gaps = 24/101 (23%)
Query: 211 VIHRDFKSSNILLDKNFH-----------------AKVSDFGLAK-IGSDKAGGHVSTRV 252
V+HRD K NI L AK+ DFGL+K IG + ++
Sbjct: 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSC 201
Query: 253 LGTQGYVAPEYAL--TGHLTTKSDVYSYGVVLLELLTGRVP 291
+GT Y +PE L T KSD+++ G ++ EL +G+ P
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 26/100 (26%), Positives = 38/100 (38%), Gaps = 18/100 (18%)
Query: 192 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR 251
+ L+ L LH R KS NILL + K+ G + +
Sbjct: 22 VCLQCLGALRELH---------RQAKSGNILLTWDGLLKL--DGSVAFKTPEQSR----- 65
Query: 252 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
++APE T K+D+YS G+ L E L +P
Sbjct: 66 --PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 35/163 (21%), Positives = 61/163 (37%), Gaps = 44/163 (26%)
Query: 138 LRSPYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 197
LRS ++ + + +Y +M + P L +TR I +
Sbjct: 232 LRSEANTYMI---TQKYDFDLYSFMYDEAFDWKDRP----------LLKQTR-AIMKQLL 277
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
+E++H +IHRD K NI L+ + + DFG A +
Sbjct: 278 CAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER------------- 321
Query: 258 YVAPEYALTGHLTTKS-------------DVYSYGVVLLELLT 287
A +Y G + T S D++S G++LL++L+
Sbjct: 322 -EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 14/97 (14%)
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLG--- 254
+GL + H+ V+HRD K N+L+ + K++DFGLA+ S V ++
Sbjct: 114 RGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS------VPSKTYSNEV 164
Query: 255 -TQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGR 289
T Y P+ L + +T D++ G + E+ TGR
Sbjct: 165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.004
Identities = 42/162 (25%), Positives = 62/162 (38%), Gaps = 25/162 (15%)
Query: 131 EVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANGGL--------QEHLYPANGSNSVAS 182
E LL RL P +LALL D GGL + LY G+
Sbjct: 210 EARLLRRLSHPAVLALL------------DVRVVGGLTCLVLPKYRSDLYTYLGAR--LR 255
Query: 183 KLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242
L +A + ++++H +IHRD K+ N+L++ + DFG A
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312
Query: 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLE 284
+ GT APE T D++S G+V+ E
Sbjct: 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 395 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.65 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.24 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.18 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.12 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.09 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.05 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.96 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.92 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.83 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.65 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.62 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.61 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.58 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.51 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.4 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.28 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.28 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.21 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.19 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.12 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.09 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.06 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.0 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.96 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.89 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.84 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.84 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.71 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.67 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.59 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.59 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.53 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.41 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.31 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.22 | |
| PLN02236 | 344 | choline kinase | 97.2 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.15 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.1 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.08 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.05 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.7 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.58 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.57 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.54 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.15 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.14 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.98 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.79 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.79 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.68 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.49 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.46 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.08 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 94.39 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-57 Score=416.62 Aligned_cols=291 Identities=56% Similarity=0.956 Sum_probs=252.8
Q ss_pred CcceecHHHHHHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEE
Q 016117 71 GLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150 (395)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 150 (395)
....|++.++..+|++|...++||+|+||+||+|.+.+|..||||++.....+...+|..|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999988765433145699999999999999999999999
Q ss_pred ecCc--eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc
Q 016117 151 SDRR--KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 228 (395)
Q Consensus 151 ~~~~--~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~ 228 (395)
.+.+ .++|||||++|+|.++|+..... .++|..+.+|+.++|+||+|||..+.++|+||||||+|||+|++++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 8774 78999999999999999865421 7899999999999999999999998888999999999999999999
Q ss_pred EEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhh
Q 016117 229 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 229 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~ 308 (395)
+||+|||++...... .........||.+|+|||+...+..+.++||||||++|.||+||+.|.+...+.....++.|..
T Consensus 216 aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 999999999765431 1111111179999999999999999999999999999999999999988766555666888886
Q ss_pred cccccchhhhhhcccccc-CCCCH-HHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 309 PRLTDREKILEIMDPALE-GQYSM-KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
+.+.+. .+.+++|+.+. ..+.. ++...+..++.+|++.+|.+||+|.+|+++|+.+...
T Consensus 295 ~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 295 PLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 666554 89999999987 66665 6788899999999999999999999999999665553
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-51 Score=373.50 Aligned_cols=255 Identities=33% Similarity=0.541 Sum_probs=211.5
Q ss_pred CCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCccc--HHHHHHHHHHHhccCCCcceeEEEEEecCc--eEEEEEccc
Q 016117 88 SKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG--EDEFKMEVELLGRLRSPYLLALLGYCSDRR--KLLVYDYMA 163 (395)
Q Consensus 88 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~lv~e~~~ 163 (395)
...+.||+|+||+||+|.+.....||+|++....... .+.|.+|+.+|.+++|||||+++|+|.+.. .++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3445699999999999999555559999997543222 458999999999999999999999999885 779999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceeCCCCCCCEEeCCCC-cEEEeccccccccC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP-VIHRDFKSSNILLDKNF-HAKVSDFGLAKIGS 241 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~ 241 (395)
+|+|.++++.. ....+++..++.++.|||+||.|||++ + |+||||||+|||++.++ ++||+|||+++...
T Consensus 124 ~GsL~~~l~~~-----~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 124 GGSLSVLLHKK-----RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred CCcHHHHHhhc-----ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 99999999764 235799999999999999999999999 7 99999999999999997 99999999998654
Q ss_pred CCCCCceeeccccccccccchhhc--cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYAL--TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
... ...+...||..|||||++. ...|+.|+||||||++||||+||+.||....+. .....
T Consensus 196 ~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~----------------~~~~~ 257 (362)
T KOG0192|consen 196 ISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV----------------QVASA 257 (362)
T ss_pred ccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH----------------HHHHH
Confidence 322 2233467999999999999 669999999999999999999999999865431 11222
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
+.....+...+..++..+..++.+||+.||+.||++.+++..|+.+...
T Consensus 258 v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 258 VVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 2222233333444667899999999999999999999999999988874
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=359.62 Aligned_cols=249 Identities=27% Similarity=0.442 Sum_probs=206.6
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecCc--eEEEEEcc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR--KLLVYDYM 162 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~lv~e~~ 162 (395)
.+..+.||+|..|+||++.++ +++.+|+|++... .....+++.+|+++++..+||+||.++|.|.... ..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 445678999999999999975 7889999999533 3445678899999999999999999999776553 67999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
++|+|.+++... ..+++....+++.++++||.|||+ + +|+||||||+|||++..|.+||||||.+....
T Consensus 161 DgGSLd~~~k~~-------g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 161 DGGSLDDILKRV-------GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred CCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 999999999533 469999999999999999999996 5 99999999999999999999999999998665
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
+. .....+||..|||||.+.+..|+.++||||||+.++|+++|+.||....+... .| -..+..++
T Consensus 231 nS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~----~~-------~~Ll~~Iv 295 (364)
T KOG0581|consen 231 NS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL----DI-------FELLCAIV 295 (364)
T ss_pred hh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC----CH-------HHHHHHHh
Confidence 44 45568899999999999999999999999999999999999999976522110 11 12233344
Q ss_pred cccccCCCCH-HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 322 DPALEGQYSM-KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 322 d~~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+.... ..+. ..+.++.+|+..||++||.+|||+.++++|
T Consensus 296 ~~ppP-~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 296 DEPPP-RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cCCCC-CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 42222 2222 467789999999999999999999999975
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=376.11 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=217.4
Q ss_pred CCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCc-eEEEEEcccCC
Q 016117 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANG 165 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g 165 (395)
+++.+.||+|.||.||.|.+.....||+|.+... ....+.|.+|+++|++|+|+|||+++|+|..+. .+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3456789999999999999988889999999865 344578899999999999999999999999865 77999999999
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCC
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 245 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 245 (395)
+|.++|... ....+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+++...+..
T Consensus 287 sLl~yLr~~-----~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~- 357 (468)
T KOG0197|consen 287 SLLDYLRTR-----EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE- 357 (468)
T ss_pred cHHHHhhhc-----CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc-
Confidence 999999652 235788999999999999999999999 99999999999999999999999999999543322
Q ss_pred CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 246 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
........-+..|.|||.+....++.+|||||||++||||+| |+.||..+. ...+-+.++..
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev~~~le~G 420 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEVLELLERG 420 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HHHHHHHHhcc
Confidence 112222334678999999999999999999999999999999 999987554 23344445555
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.+-..+..++..+++++..||+.+|++|||++.+...|+.+...+
T Consensus 421 yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 421 YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 555666778899999999999999999999999999999988753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=368.85 Aligned_cols=249 Identities=24% Similarity=0.443 Sum_probs=212.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
..|...++||+|+|+++|.++. .+|+.||+|++.+. .....+...+|+++.++|+|||||+++++|++. +.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999996 78999999999753 344567788999999999999999999999988 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
|+|.+++|..++. ....+++.+++.++.||+.||.|||++ +|+|||||..|+|++++.++||+|||+|..
T Consensus 98 ELC~~~sL~el~K-------rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~ 167 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-------RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQ 167 (592)
T ss_pred EecCCccHHHHHH-------hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeee
Confidence 9999999999995 235899999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... +.....||||-|.|||++....++..+||||+||+||.|+.|++||+... +.+
T Consensus 168 le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--------------------vke 225 (592)
T KOG0575|consen 168 LEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--------------------VKE 225 (592)
T ss_pred ecCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--------------------HHH
Confidence 76543 34457899999999999999999999999999999999999999997543 222
Q ss_pred hccccccCCC--CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 320 IMDPALEGQY--SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 320 ~~d~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.++..-..+| +...+.+..+||.++|+.||.+|||+++|+.+ .++.
T Consensus 226 ty~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h--~Ff~ 273 (592)
T KOG0575|consen 226 TYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH--PFFK 273 (592)
T ss_pred HHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC--Hhhh
Confidence 2222222222 23445678899999999999999999999965 5553
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=387.19 Aligned_cols=265 Identities=28% Similarity=0.445 Sum_probs=222.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcC------CcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCcceeEEEEEecCc-e
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDRR-K 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~ 155 (395)
..+....+.||+|.||.||+|...+ ...||||.++..... ...+|++|+++++.++|||||+++|+|.+++ .
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 3445667889999999999998532 356999999876555 6789999999999999999999999999885 5
Q ss_pred EEEEEcccCCChhhhcccCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSN-------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 228 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~ 228 (395)
++|+|||..|+|.+||....... ....+++..+.+.|+.|||.||.||-++ .++||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 69999999999999996543211 1134589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhh
Q 016117 229 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWA 307 (395)
Q Consensus 229 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~ 307 (395)
|||+|||+++...............-+.+|||||.+..++|+.+||||||||+|||+++ |+.|+....
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS----------- 710 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS----------- 710 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-----------
Confidence 99999999986554443333334456789999999999999999999999999999999 999987433
Q ss_pred hcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 308 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 308 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
+.+.++.+-+..+ -..+..++.+++.|+..||+.+|.+||++.||-..|+.+-..
T Consensus 711 -----n~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 711 -----NQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred -----hHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 2344555555555 466778889999999999999999999999999999998775
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=350.77 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=200.8
Q ss_pred HhCCCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccCCc-------ccHHHHHHHHHHHhccCCCcceeEEEEEecC-
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGK-------QGEDEFKMEVELLGRLRSPYLLALLGYCSDR- 153 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~- 153 (395)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++..... .......+|+++|++++|||||++++++.+.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34568888999999999999999 55899999999974311 1223456899999999999999999999877
Q ss_pred ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC---CcEE
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN---FHAK 230 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~k 230 (395)
..|+|+||+.+|.|.+++... ..+.+.....+++|++.|+.|||++ ||+||||||+|||+..+ ..+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-------k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-------KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-------cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEE
Confidence 558999999999999999543 4577778899999999999999999 99999999999999765 7899
Q ss_pred EeccccccccCCCCCCceeeccccccccccchhhccCCC---CccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh
Q 016117 231 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL---TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 307 (395)
Q Consensus 231 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~ 307 (395)
|+|||+|+.... ...+...|||+.|.|||++.+... ..+.|+||+||+||-+++|.+||...-...
T Consensus 320 ItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-------- 388 (475)
T KOG0615|consen 320 ITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-------- 388 (475)
T ss_pred ecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--------
Confidence 999999997653 335667899999999999986543 347899999999999999999997543221
Q ss_pred hcccccchhhhhhcccccc--CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 308 LPRLTDREKILEIMDPALE--GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 308 ~~~~~~~~~~~~~~d~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+.+...... ...-....++..+||.+||..||++|||+.|++++
T Consensus 389 -------sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 389 -------SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -------cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 011111111111 11112345788999999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=346.05 Aligned_cols=201 Identities=32% Similarity=0.554 Sum_probs=178.8
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
.++|.+.+.||+|.||+||+|++. ++..||||.+... .....+.+..|+.+|+.++|||||.+++++.+. ..++||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888889999999999999964 6899999998765 444556778899999999999999999999877 456999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC------CcEEEec
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN------FHAKVSD 233 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~------~~~kl~D 233 (395)
|||.+|+|.+|++.. ..+++.+++.++.|+|.||++||++ +|+||||||+|||++.. -.+||+|
T Consensus 89 EyC~gGDLs~yi~~~-------~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR-------GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred EeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecc
Confidence 999999999999654 3799999999999999999999999 99999999999999764 5689999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKP 297 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~ 297 (395)
||+|+.+... ......||++.|||||++..++|+.|+|+||+|+++|+|++|+.||....+
T Consensus 159 FGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 159 FGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred cchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9999987643 355678999999999999999999999999999999999999999985543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-49 Score=373.05 Aligned_cols=255 Identities=26% Similarity=0.456 Sum_probs=216.1
Q ss_pred CCCCCeeeccCCeEEEEEEEcC----CcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecCceE-EEEE
Q 016117 87 FSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYD 160 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-lv~e 160 (395)
..+.++||.|.||.||+|+++- ...||||.++.. .+....+|..|+.||.++.||||++|.|+.....++ +|+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 4567899999999999999752 357999999854 344567899999999999999999999999888654 9999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
||++|+|+.||.... ..|++-+...|+++||.||.||.+. +++||||.++||||+.+..+|++|||+++..
T Consensus 711 yMENGsLDsFLR~~D------GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 711 YMENGSLDSFLRQND------GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred hhhCCcHHHHHhhcC------CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999997655 4588899999999999999999999 9999999999999999999999999999977
Q ss_pred CCCCCCceeecccc--ccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 241 SDKAGGHVSTRVLG--TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 241 ~~~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
.+..... .+...| +.+|.|||.+..++++.++||||||++|||.++ |..||..++.+ ++
T Consensus 782 edd~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ-----------------dV 843 (996)
T KOG0196|consen 782 EDDPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----------------DV 843 (996)
T ss_pred ccCCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH-----------------HH
Confidence 6554222 222222 578999999999999999999999999999666 99999866532 22
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
-..++...+-+.+++++..|++|++.||++|-.+||++.+|+..|++++++
T Consensus 844 IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 844 IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 233334444566788999999999999999999999999999999999994
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=337.53 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=205.9
Q ss_pred CCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEE-E-ecCc-eEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGY-C-SDRR-KLLVY 159 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~-~~~~-~~lv~ 159 (395)
+|.+.+.||.|.||+||++. ..+|..+|.|.++-. +....+.+..|+.+|++|+|||||+++++ + .+.+ ..+||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46778899999999999998 568999999988632 33445678899999999999999999983 3 3334 45999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP--VIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
|||..|+|...+...+. ....+++..+|+++.|++.||.++|+. .+. ++||||||.||+++.+|.+||+|||++
T Consensus 100 E~c~~GDLsqmIk~~K~---qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKK---QKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLG 175 (375)
T ss_pred HhhcccCHHHHHHHHHh---ccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhH
Confidence 99999999999977653 346799999999999999999999984 224 999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
+...... ......+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||..++- ... ...+
T Consensus 176 r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L-------~~KI 240 (375)
T KOG0591|consen 176 RFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSL-------CKKI 240 (375)
T ss_pred hHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHH-------HHHH
Confidence 9876544 234568899999999999999999999999999999999999999986521 100 0111
Q ss_pred hhhccccccCCCC-HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 318 LEIMDPALEGQYS-MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 318 ~~~~d~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
.. .--...+ ...+.++..++..|+..||+.||+...++..+..
T Consensus 241 ~q----gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 241 EQ----GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred Hc----CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11 1001123 4567889999999999999999996555554443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=375.28 Aligned_cols=269 Identities=28% Similarity=0.448 Sum_probs=220.4
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc--CCc----EEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS--NGR----KVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~ 155 (395)
..+.++.+.||+|.||.||.|... .|. .||+|.+... +.+...+|.+|..+|+.++|||||+++|+|.+. ..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 345667789999999999999854 343 4899988764 345567899999999999999999999999876 57
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++++|||.+|+|..||...+-.......++....+.++.|||+|+.||+++ ++|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 799999999999999987755444567899999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
+|+...............-+..|||||.+..+.++.|+|||||||+|||++| |..||......
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---------------- 911 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---------------- 911 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----------------
Confidence 9995444333222222344678999999999999999999999999999999 99999754321
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 372 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~~ 372 (395)
..+..++... +-+.+..++..+++++..||+.+|++||++..|++.+.++.+...+.
T Consensus 912 ~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 912 EVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred HHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 1122122222 33456667888999999999999999999999999999999975554
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=331.61 Aligned_cols=241 Identities=27% Similarity=0.407 Sum_probs=199.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
.++|++.++||+|+||+||.++. .+++.+|+|++++.. ....+....|..+|..++||.||++.--|++. ..++|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 35689999999999999999995 468999999997642 23456778899999999999999998877776 67799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
++|+.||.|..+|. ....+++..+..++..|+.||.|||+. +|+||||||+|||+|++|.++|+|||+++
T Consensus 104 ld~~~GGeLf~hL~-------~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k 173 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ-------REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCK 173 (357)
T ss_pred EeccCCccHHHHHH-------hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccch
Confidence 99999999999994 345799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
..... +......+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+.. ....
T Consensus 174 ~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~----------------~~~~ 235 (357)
T KOG0598|consen 174 EDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK----------------KMYD 235 (357)
T ss_pred hcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH----------------HHHH
Confidence 54332 23344589999999999999999999999999999999999999999865421 1122
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP 353 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 353 (395)
.+....+ ...+.-...+..+++...|+.+|++|.
T Consensus 236 ~I~~~k~-~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 236 KILKGKL-PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred HHhcCcC-CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 2221111 112222345688999999999999996
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=347.48 Aligned_cols=267 Identities=28% Similarity=0.482 Sum_probs=216.4
Q ss_pred HHHHHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecCce
Q 016117 78 KQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK 155 (395)
Q Consensus 78 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 155 (395)
++.+...+.+.+...||+|.||+||+|+|.. .||||+++.... ...+.|++|+.+|++-+|.||+-+.|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4455555667788999999999999999742 499999985433 345789999999999999999999999999988
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
.+|+-+|.+.+|..+++..+ ..|+..+.+.|+.|||+||.|||.+ +|+|+|||..||++.++++|||+|||
T Consensus 463 AIiTqwCeGsSLY~hlHv~e------tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQE------TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred eeeehhccCchhhhhccchh------hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence 99999999999999997554 6799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
++..-..-..........|...|||||++.. .+|+.++||||||+++|||++|..||...........+.
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG------- 606 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG------- 606 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec-------
Confidence 9976444333333445567888999999975 479999999999999999999999998443221111100
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
++ .-..|.. .....++.++.+|+..||..++++||++.+|+..|+.+++.
T Consensus 607 -rG--~l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 607 -RG--YLMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -cc--ccCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 00 0001110 12234566899999999999999999999999999999885
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=344.19 Aligned_cols=266 Identities=25% Similarity=0.376 Sum_probs=204.7
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE------cCCcEEEEEEeccCCc-ccHHHHHHHHHHHhcc-CCCcceeEEEEEecC--
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-- 153 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-- 153 (395)
.++|.+.+.||+|+||.||+|.+ .+++.||+|++..... .....+..|+.++..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45789999999999999999974 2356799999875322 2345688899999999 899999999988754
Q ss_pred ceEEEEEcccCCChhhhcccCCCCC-------------------------------------------------------
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSN------------------------------------------------------- 178 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~------------------------------------------------------- 178 (395)
..+++|||+++|+|.+++.......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 4679999999999999986532110
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeecccccccc
Q 016117 179 SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258 (395)
Q Consensus 179 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y 258 (395)
.....+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0123588899999999999999999998 9999999999999999999999999999754332211112233456789
Q ss_pred ccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHH
Q 016117 259 VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQV 337 (395)
Q Consensus 259 ~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l 337 (395)
+|||++.+..++.++||||||+++|||++ |..||....... ... ..+.+.. ....+...+..+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~-------------~~~~~~~-~~~~~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC-------------QRLKDGT-RMRAPENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH-------------HHHhcCC-CCCCCCCCCHHH
Confidence 99999999999999999999999999997 999996533210 000 0000000 001122334568
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 338 AAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 338 ~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.+++.+||+.+|++|||+.++++.|++++..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 8999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=320.45 Aligned_cols=262 Identities=25% Similarity=0.327 Sum_probs=204.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecCc-eEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 160 (395)
+.|+...++|+|+||.||+++.+ +|+.||||.+..... ...+-..+|+++|++++|+|+|.++++|.... ..+|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35677789999999999999965 699999999875432 22345678999999999999999999998764 559999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
||+.--|.++- .. ...++...+..++.|++.|+.|+|++ +++||||||+|||++.++.+||||||.|+..
T Consensus 82 ~~dhTvL~eLe-~~------p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 82 YCDHTVLHELE-RY------PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTL 151 (396)
T ss_pred ecchHHHHHHH-hc------cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhh
Confidence 99885444443 22 24689999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.. .+...+..+.|.+|.|||.+.+ .+|+...||||+||++.||++|.+.|...+..+....+......+. ....+
T Consensus 152 ~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~--prhq~ 227 (396)
T KOG0593|consen 152 SA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLI--PRHQS 227 (396)
T ss_pred cC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccC--HHHHH
Confidence 64 3456778889999999999988 6899999999999999999999999877665544333332222211 11112
Q ss_pred hcc----------ccccCCCC-----HHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 320 IMD----------PALEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 320 ~~d----------~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
++. |.....-+ +....-+.+|+..|++.||++|++-++++.
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 221 11111111 223347889999999999999999999984
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=331.08 Aligned_cols=253 Identities=27% Similarity=0.430 Sum_probs=200.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~e 160 (395)
.++...+.||+|.||+||++... +|+..|||.+...+....+.+.+|+.+|++++|||||+++|..... ...+.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34667889999999999999965 5999999988754333356789999999999999999999974433 3559999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-CCcEEEeccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSDFGLAKI 239 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~ 239 (395)
|+++|+|.+++.... ..+++..+..+..|+++||.|||++ +++|+||||+|||++. ++.+||+|||++..
T Consensus 97 y~~~GsL~~~~~~~g------~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG------GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred ccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 999999999996543 1599999999999999999999999 9999999999999999 79999999999976
Q ss_pred cCC-CCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCC-CCCCCchhhhhhhcccccchh
Q 016117 240 GSD-KAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVN-KPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 240 ~~~-~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~ 316 (395)
... ...........||+.|||||++..+ ....++|||||||++.||+||+.||... .. . ..
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~------~----------~~ 231 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE------A----------EA 231 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch------H----------HH
Confidence 543 1112233457799999999999863 3345999999999999999999998642 10 0 01
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
+..+.........+...+.+..+|+..|++.+|++|||+.+++++.
T Consensus 232 ~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 232 LLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred HHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1111111111144455667899999999999999999999999763
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=337.90 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=207.2
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccC---CcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ce
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~ 155 (395)
....+|.+.+.||+|+|++|++|+ ..+++.||||++.+. .....+-...|-++|.+| .||.|++|+..|+|. ..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345679999999999999999999 457999999998643 122334456788999999 899999999988887 67
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
|+|+||+++|+|.++|.+.+ .|++...+.++.+|+.||+|||++ |||||||||+|||+|.|++++|+|||
T Consensus 150 YFvLe~A~nGdll~~i~K~G-------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFG 219 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG-------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFG 219 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC-------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecc
Confidence 89999999999999997654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC---------cee--eccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh
Q 016117 236 LAKIGSDKAGG---------HVS--TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 304 (395)
Q Consensus 236 ~~~~~~~~~~~---------~~~--~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~ 304 (395)
.|..+...... ... ..++||..|.+||++.....+..+|+|+|||+||.|+.|.+||...++-
T Consensus 220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------ 293 (604)
T KOG0592|consen 220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------ 293 (604)
T ss_pred ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH------
Confidence 99865432221 111 4588999999999999999999999999999999999999999765421
Q ss_pred hhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 305 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+.+++- .-.++.+.++.+.+|+.+.|-.||.+|+|..+|-++
T Consensus 294 ----------liFqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 294 ----------LIFQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ----------HHHHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 111122211 113334444678999999999999999999999876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=339.27 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=209.7
Q ss_pred CCCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEE-EEecCceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG-YCSDRRKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~~lv~e~~ 162 (395)
..|.....||+|..|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++ |...++.|.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 357777899999999999999 5578999999998766666677889999999999999999998 44556889999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++|+|.+.+. ...+++.++..|+..+++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+..
T Consensus 353 ~ggsLTDvVt--------~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 353 EGGSLTDVVT--------KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred CCCchhhhhh--------cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 9999999983 34699999999999999999999999 999999999999999999999999999987665
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
... .....+||+.|||||++....|+++.||||||++++||+.|.+||-.+.+.....++.- +
T Consensus 422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~---------------n 484 (550)
T KOG0578|consen 422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---------------N 484 (550)
T ss_pred ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh---------------c
Confidence 442 34567899999999999999999999999999999999999999976554321111110 1
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+.-..+...+..+.+|+.+||+.|+++|+++.|+|++
T Consensus 485 g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 485 GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 112223344556789999999999999999999999975
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=336.12 Aligned_cols=265 Identities=24% Similarity=0.305 Sum_probs=208.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccCCcccHH-HHHHHHHHHhccC-CCcceeEEEEEecC--ceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED-EFKMEVELLGRLR-SPYLLALLGYCSDR--RKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~lv 158 (395)
.++|.+.++||.|.||.||+|+ ..+|+.||||.++..-..+.+ .-.+|+..|++|+ ||||+++.+++.+. ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4578888999999999999999 457999999998765444332 2346999999998 99999999988765 46699
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
||||+ .+|.+++..++ ..|++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+
T Consensus 89 fE~Md-~NLYqLmK~R~------r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDRN------RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred HHhhh-hhHHHHHhhcC------CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccc
Confidence 99995 49999997553 6899999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCCceeeccccccccccchhhc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc----
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD---- 313 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 313 (395)
...... ..+..+.|.+|+|||++. ...|+.+.||||+||+++|+.+-++.|.+.++.+..+.+-.+......
T Consensus 159 ev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 159 EVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred ccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 765433 456788999999999876 567899999999999999999999999876654433333222211111
Q ss_pred -chhhhhhccccccC-------CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 -REKILEIMDPALEG-------QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 -~~~~~~~~d~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+...++-.+.. ..-+..+.+..+++.+|+.|||.+|||+.+++++
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11222222222211 1112255789999999999999999999999975
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=334.45 Aligned_cols=255 Identities=26% Similarity=0.421 Sum_probs=206.5
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC----Cc-ccHHHHHHHHHHHhccC-CCcceeEEEEEecC-
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA----GK-QGEDEFKMEVELLGRLR-SPYLLALLGYCSDR- 153 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~- 153 (395)
...++|.+.+.||+|.||+|+.|.. .+++.||+|++... .. ...+.+.+|+.+++.++ ||||++++.++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3456899999999999999999984 47899999977653 11 23456678999999998 99999999999876
Q ss_pred ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC-CcEEEe
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVS 232 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~ 232 (395)
..++||||+.+|+|.+++.. ...+.+..+..++.|+++|++|||++ +|+||||||+|+|++.+ +++||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-------~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~ 163 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-------KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLS 163 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-------cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEe
Confidence 56699999999999999964 24688899999999999999999999 99999999999999999 999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCC-CC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH-LT-TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 310 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~ 310 (395)
|||++.... .........+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||...+...
T Consensus 164 DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~----------- 230 (370)
T KOG0583|consen 164 DFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN----------- 230 (370)
T ss_pred ccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-----------
Confidence 999998763 2233556789999999999999877 76 78999999999999999999998643211
Q ss_pred cccchhhhhhccccccCCCCHHH-HHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 311 LTDREKILEIMDPALEGQYSMKE-VIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 311 ~~~~~~~~~~~d~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
....+..... .++... +.++..|+.+|+..||.+|+|+.+|+ ....+..
T Consensus 231 -----l~~ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~--~h~w~~~ 280 (370)
T KOG0583|consen 231 -----LYRKIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL--EHPWFQK 280 (370)
T ss_pred -----HHHHHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh--hChhhcc
Confidence 0111111111 111122 56789999999999999999999999 3455553
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=320.47 Aligned_cols=290 Identities=26% Similarity=0.381 Sum_probs=215.3
Q ss_pred CCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhc--cCCCcceeEEEEEecC-----ceEEEE
Q 016117 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGR--LRSPYLLALLGYCSDR-----RKLLVY 159 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~-----~~~lv~ 159 (395)
.++.++||+|+||.||+|.+ +++.||||++.. +..+.|.+|-++++. ++|+||++++++-.-. +.++|+
T Consensus 212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 34567899999999999998 569999999974 445688889988887 5899999999875422 577999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC------CCCCceeCCCCCCCEEeCCCCcEEEec
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH------CSPPVIHRDFKSSNILLDKNFHAKVSD 233 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~i~H~dlk~~Nill~~~~~~kl~D 233 (395)
+|.+.|+|.+||. ...++|....+|+..+++||+|||+. .+++|+|||||.+||||.+|+++.|+|
T Consensus 288 ~fh~kGsL~dyL~--------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 288 EFHPKGSLCDYLK--------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred eeccCCcHHHHHH--------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 9999999999994 35799999999999999999999964 477999999999999999999999999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccCC-CC-----ccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh--h
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH-LT-----TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV--S 305 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-----~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~--~ 305 (395)
||+|...............+||.+|||||++.+.- +. .+.||||+|.+||||++...-+.. .+.....+. .
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~ 438 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEA 438 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhH
Confidence 99998766544444444588999999999997642 22 368999999999999997766543 111111111 1
Q ss_pred hhhcccccchhhhhh-ccccccCCCCH-----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCCCCC
Q 016117 306 WALPRLTDREKILEI-MDPALEGQYSM-----KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSP 379 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~-~d~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~~~~~~~~~ 379 (395)
.+..+. .-+.+++. +....+..++. .....+++.+..||+.||+.|.|+.=+.+++.++..-.+. ....++.
T Consensus 439 evG~hP-t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~-~~~~s~~ 516 (534)
T KOG3653|consen 439 EVGNHP-TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED-SSGESSS 516 (534)
T ss_pred HhcCCC-CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc-cCCcccc
Confidence 111111 11122222 22222222221 2345789999999999999999999999999998886544 4445555
Q ss_pred CcccCCC--CCCCC
Q 016117 380 SFHASRS--PAFPD 391 (395)
Q Consensus 380 ~~~~~~~--~~~~~ 391 (395)
+...+.. ++.|.
T Consensus 517 ~~~~~~~~~~~~~~ 530 (534)
T KOG3653|consen 517 SLVTPVDVVTAPPK 530 (534)
T ss_pred ccCCCCccccCCCC
Confidence 5555555 44443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=322.41 Aligned_cols=262 Identities=24% Similarity=0.385 Sum_probs=204.3
Q ss_pred hCCCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.+.|++..+||.|..++||+|+ .+.++.||||++.-...+ ..+.+.+|+..++.++||||++.+..|..+ ..|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3578999999999999999999 457899999999754333 357889999999999999999999876554 7889999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
||.+|++.+.+...- ...+++..+..|++++++||.|||.+ |.+|||||+.||||+++|.|||+|||.+..+
T Consensus 105 fMa~GS~ldIik~~~-----~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYY-----PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred hhcCCcHHHHHHHHc-----cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeee
Confidence 999999999996553 34699999999999999999999999 9999999999999999999999999988655
Q ss_pred CCCCCCce-e-eccccccccccchhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 241 SDKAGGHV-S-TRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 241 ~~~~~~~~-~-~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
........ . ....||++|||||++.. ..|+.|+||||||++..||.+|..||....+-.. ....+.+..
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tLqn~p- 249 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTLQNDP- 249 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHhcCCC-
Confidence 44321111 1 45689999999999654 4799999999999999999999999986543210 000111100
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....-..+..+........+++++..||+.||++|||+++++++
T Consensus 250 -p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 250 -PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 00000001111111223478999999999999999999999953
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=331.07 Aligned_cols=280 Identities=25% Similarity=0.287 Sum_probs=209.6
Q ss_pred CCCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv 158 (395)
+.|+..++||+|.||.||+|+ ..+|+.||+|.+.... ........+|+.+|++|.||||+++.+...+. ..|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457777899999999999999 5689999999887543 33344567899999999999999999987655 67899
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
+|||++ +|.-++.. ..-.|+..++..+++|++.||.|||++ +++|||||.+|||||.+|.+||+|||+|+
T Consensus 197 FeYMdh-DL~GLl~~------p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr 266 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSS------PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLAR 266 (560)
T ss_pred Eecccc-hhhhhhcC------CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccccee
Confidence 999987 67777642 235799999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc-hh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR-EK 316 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 316 (395)
++...... ..+..+.|++|.|||++.+. .|+.+.|+||.||||.||+.|++.|......+....+-.......+. ..
T Consensus 267 ~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 267 FYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred eccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 76654432 35566789999999999875 79999999999999999999999998765443322221111000000 00
Q ss_pred -----hhhhccccccCCC-----CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCCC
Q 016117 317 -----ILEIMDPALEGQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISS 377 (395)
Q Consensus 317 -----~~~~~d~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~~~~~~~ 377 (395)
....+.+.....- ....+....+|+..+|..||.+|.|+.++++. +.+..++..+.+.+
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s--eyF~t~p~~~~p~~ 414 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS--EYFTTEPLPCDPSS 414 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC--cccccCCCCCCccc
Confidence 0011111110000 01123467889999999999999999999964 55554444444433
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=330.73 Aligned_cols=260 Identities=28% Similarity=0.424 Sum_probs=206.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCc----EEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGR----KVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv 158 (395)
.+|++.+.||+|+||+||+|.+. ++. .||+|.+.... ....+.+..|+.+++.++||||++++++|.....+++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 45888999999999999999853 343 48999987542 2345678899999999999999999999988888899
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
++|+.+|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++.+||+|||++.
T Consensus 87 ~e~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 87 TQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence 99999999999996432 3588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-----------------~~ 220 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EI 220 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----------------HH
Confidence 6543322211222334678999999999999999999999999999998 99998643211 01
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
..++........+..+..++.+++..||+.+|++|||+.+++..|.++.....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 221 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 11111111111122234568899999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=322.54 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=197.5
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCccc---HHHHHHHHHHHhccCCCcceeEEEEEec--C---ceEEEEEcc
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG---EDEFKMEVELLGRLRSPYLLALLGYCSD--R---RKLLVYDYM 162 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~--~---~~~lv~e~~ 162 (395)
..||+|++|.||+|.. +|+.||+|.+....... .+.+.+|+.++++++||||+++++++.+ . ..+++|||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 78999999987543332 3567899999999999999999998866 2 456999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++|+|.+++... ..+++.....++.|++.||.|||+.. +++||||||+|||+++++.+||+|||++.....
T Consensus 105 ~~g~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 105 TRGYLREVLDKE-------KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCcHHHHHhhC-------CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 999999999532 36889999999999999999999732 788999999999999999999999999875432
Q ss_pred CCCCceeeccccccccccchhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.. ....++..|+|||++.+ ..++.++|||||||++|||++|..||....... ....+
T Consensus 176 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~----------------~~~~i 234 (283)
T PHA02988 176 PP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE----------------IYDLI 234 (283)
T ss_pred cc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHH
Confidence 21 23457889999999976 689999999999999999999999997543110 00111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
.........+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 235 INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred HhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1111111222345567999999999999999999999999998875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=337.15 Aligned_cols=242 Identities=28% Similarity=0.427 Sum_probs=202.0
Q ss_pred CCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCc-eEEEEEcccCC
Q 016117 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANG 165 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g 165 (395)
...++.||+|+.|.||+|++ .++.||||.++.-. ..+++.|++|+|+||+.+.|+|.... .+||||||..|
T Consensus 126 IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 34467899999999999998 67889999775321 23788999999999999999999875 55999999999
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCC
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 245 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 245 (395)
-|.+.|.. ...++......|..+||.||.|||.+ .|||||||.-||||+.+..+||+|||.++...+..
T Consensus 198 qL~~VLka-------~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S- 266 (904)
T KOG4721|consen 198 QLYEVLKA-------GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS- 266 (904)
T ss_pred cHHHHHhc-------cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh-
Confidence 99999953 34788899999999999999999999 99999999999999999999999999998655432
Q ss_pred CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccc
Q 016117 246 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 325 (395)
Q Consensus 246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 325 (395)
....++||..|||||++.+.+.+.|.|||||||+||||+||..||..-+... .+..+=...+
T Consensus 267 --TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----------------IIwGVGsNsL 328 (904)
T KOG4721|consen 267 --TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----------------IIWGVGSNSL 328 (904)
T ss_pred --hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----------------eEEeccCCcc
Confidence 2345789999999999999999999999999999999999999996432110 1111112233
Q ss_pred cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 326 EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 326 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
.-..+..++.-+.-|++.||+..|..||++++|+.+|+=.
T Consensus 329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 3455666777888999999999999999999999998643
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=335.44 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=201.9
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE------cCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-c
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-R 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 154 (395)
.++|++.+.||+|+||.||+|.+ .++..||+|++.... ....+.+.+|+.+++.+ +||||++++++|.+. .
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688899999999999999973 235689999987432 23345688899999999 899999999998776 5
Q ss_pred eEEEEEcccCCChhhhcccCCCCC--------------------------------------------------------
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSN-------------------------------------------------------- 178 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~-------------------------------------------------------- 178 (395)
.++||||+++|+|.+++.......
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 679999999999999986432100
Q ss_pred ------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCC
Q 016117 179 ------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 246 (395)
Q Consensus 179 ------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 246 (395)
.....+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 0113578999999999999999999998 9999999999999999999999999999765432221
Q ss_pred ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccc
Q 016117 247 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 325 (395)
Q Consensus 247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 325 (395)
.......++..|+|||++.+..++.++||||||+++|||++ |..||....... ... ..+....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~--------------~~~~~~~ 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFY--------------KMIKEGY 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHH--------------HHHHhCc
Confidence 12222345667999999999999999999999999999998 888886432110 001 1111111
Q ss_pred cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 326 EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 326 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
....+...+.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1111112245788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=327.99 Aligned_cols=261 Identities=24% Similarity=0.364 Sum_probs=211.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecCc-eEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~ 162 (395)
....+.++||+|.||.|.++....+..||+|.++.... ...++|..|+++|.+++||||+.++|+|..++ .++++|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 45667889999999999999997889999999986543 44589999999999999999999999998665 55999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++|+|.+|+..... ..+.-.....|+.||++||+||.+. +++||||.++|+|++.++++||+|||+++-...
T Consensus 618 EnGDLnqFl~ahea-----pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 618 ENGDLNQFLSAHEL-----PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred hcCcHHHHHHhccC-----cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 99999999965532 1244455677999999999999998 999999999999999999999999999996655
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT--GRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
........+.+.+.+|||||.+..++++.++|||+||+++||+++ ...||..... ...++ ...++
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vve----------n~~~~ 756 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVE----------NAGEF 756 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHH----------hhhhh
Confidence 555556667778899999999999999999999999999999755 7888864321 11111 12222
Q ss_pred cccccc---CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 321 MDPALE---GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 321 ~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
++..-. -..+.-++..+++++.+||..+-++|||++++...|++..
T Consensus 757 ~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 757 FRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred cCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 222221 1234456778999999999999999999999999988753
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=335.45 Aligned_cols=259 Identities=29% Similarity=0.427 Sum_probs=208.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcC--C---cEEEEEEecc---CCcccHHHHHHHHHHHhccCCCcceeEEEEEecCc-e
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSN--G---RKVAIKLMDQ---AGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-K 155 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~ 155 (395)
++..+.++||+|+||.||+|.+.. + ..||+|.... .......+|..|++++++++|||||+++|++...+ .
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 345566899999999999999642 2 2389998874 23455678999999999999999999999998875 5
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++|||+|.+|+|.++|.... ..++..+...++.+.|.||+|||++ +++||||.++|+|++.++.+||+|||
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~------~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK------KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccc
Confidence 69999999999999996543 2599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
+++...... .......-+..|+|||.+....|+.++|||||||++||+++ |..||......
T Consensus 308 Ls~~~~~~~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---------------- 369 (474)
T KOG0194|consen 308 LSRAGSQYV--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---------------- 369 (474)
T ss_pred cccCCccee--eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----------------
Confidence 998654111 11111235778999999999999999999999999999999 88898755421
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
.....+.-...+...+...+..+..++..||..+|++||||.++.+.|+.+.....
T Consensus 370 ~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 370 EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11112212222223344566778889999999999999999999999999988644
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=325.92 Aligned_cols=267 Identities=25% Similarity=0.393 Sum_probs=200.4
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcC-----------------CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCccee
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSN-----------------GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLA 145 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 145 (395)
.++|.+.+.||+|+||.||++.+.+ +..||+|.+.... ......+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578889999999999999997532 3369999987542 233457889999999999999999
Q ss_pred EEEEEecC-ceEEEEEcccCCChhhhcccCCCC------------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCce
Q 016117 146 LLGYCSDR-RKLLVYDYMANGGLQEHLYPANGS------------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 212 (395)
Q Consensus 146 l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~ 212 (395)
+++++.+. ..+++|||+.+|+|.+++...... ......+++..++.++.|++.||.|||+. +++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99998766 567999999999999988543211 11224578899999999999999999998 999
Q ss_pred eCCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh--CCC
Q 016117 213 HRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT--GRV 290 (395)
Q Consensus 213 H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~ 290 (395)
||||||+|||++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999975433322222233445788999999998899999999999999999987 556
Q ss_pred CCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 291 PIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 291 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
||...... ............. ........+..++..+.+++.+||+.+|++|||+.+|.+.|+
T Consensus 241 p~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE---QVIENAGEFFRDQ-------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH---HHHHHHHHHhhhc-------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 77543211 1111110000000 000000112233457899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=299.21 Aligned_cols=269 Identities=23% Similarity=0.338 Sum_probs=206.9
Q ss_pred CCCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.+|...++||+|.||.||+|+ ..+|+.||||.+..... .......+|++.|+.++|+||+.++++|... +.-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 357777899999999999999 56899999999875422 2234677899999999999999999998776 5559999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
||+. +|...+.... ..++...+..++.++++|++|||++ .|+||||||.|+|++++|.+||+|||+++..
T Consensus 82 fm~t-dLe~vIkd~~------i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN------IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFF 151 (318)
T ss_pred eccc-cHHHHhcccc------cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhcc
Confidence 9965 8888885433 5788999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh--------hccc
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA--------LPRL 311 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~ 311 (395)
...... ....+.|..|.|||.+.| +.|+...||||.||++.||+-|.+-|.+++..+....+-.+ ++.+
T Consensus 152 ~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 152 GSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred CCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence 655432 233467899999999886 47999999999999999999999888765543322221111 1111
Q ss_pred c---cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 312 T---DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 312 ~---~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
. +-..+.....+.+ ...-.....++.+|+..++..||.+|+|+.|++++ ..+..
T Consensus 230 ~~lpdY~~~~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~ 286 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKS 286 (318)
T ss_pred cccccHHHHhcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhc
Confidence 1 1111111111111 12334556678999999999999999999999975 45543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=331.21 Aligned_cols=246 Identities=27% Similarity=0.410 Sum_probs=206.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|.+.+.||+|.||+||+|+.+ +.+.||+|.+.+..+ ...+.+.+|+++++.++||||+.++++|+.. +.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46778889999999999999954 788999999875433 3345688999999999999999999998877 6779999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+ +|..+|. ....++++.+..++.++..||.|||++ +|.|||+||+|||++.++.+|+||||+++..
T Consensus 82 ~a~g-~L~~il~-------~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 82 YAVG-DLFTILE-------QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAM 150 (808)
T ss_pred hhhh-hHHHHHH-------hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhc
Confidence 9977 9999994 346799999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
... ....+...||+.|||||++.+++|+..+|.||+||++||+.+|++||...+- . .-+..+
T Consensus 151 ~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si---~-------------~Lv~~I 212 (808)
T KOG0597|consen 151 STN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI---T-------------QLVKSI 212 (808)
T ss_pred ccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH---H-------------HHHHHH
Confidence 543 3456778999999999999999999999999999999999999999964321 0 111112
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..... .++......+..|+...|++||..|.|..+++.+
T Consensus 213 ~~d~v--~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 213 LKDPV--KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred hcCCC--CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 21111 2344666789999999999999999999999965
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=320.23 Aligned_cols=258 Identities=23% Similarity=0.327 Sum_probs=206.2
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCc--------------ccHHHHHHHHHHHhccCCCcceeE
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK--------------QGEDEFKMEVELLGRLRSPYLLAL 146 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l 146 (395)
..-++|++.+.||+|.||.|-+|+. .+++.||||++.+... ...+...+|+.+|+++.|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457899999999999999999995 4799999999864211 123578899999999999999999
Q ss_pred EEEEecC---ceEEEEEcccCCChhhhcccCCCCCCCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEE
Q 016117 147 LGYCSDR---RKLLVYDYMANGGLQEHLYPANGSNSVASK-LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNIL 222 (395)
Q Consensus 147 ~~~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil 222 (395)
+.+..+. ..|+|+|||..|.+...- ..+. +++.++++++.++..||.|||.+ +|+||||||+|+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p--------~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLL 242 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP--------PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLL 242 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC--------CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheE
Confidence 9998765 578999999988765543 2233 89999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeccccccccCCC---CCCceeeccccccccccchhhccCC----CCccchhHHHHHHHHHHHhCCCCCCCC
Q 016117 223 LDKNFHAKVSDFGLAKIGSDK---AGGHVSTRVLGTQGYVAPEYALTGH----LTTKSDVYSYGVVLLELLTGRVPIDVN 295 (395)
Q Consensus 223 l~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~~l~ell~g~~pf~~~ 295 (395)
|+++|++||+|||.+...... ..........||+.|+|||...++. .+.+.||||+|++||.|+.|+.||-.+
T Consensus 243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 999999999999998754221 1112234478999999999987632 356889999999999999999999754
Q ss_pred CCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 296 KPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
.. -.....+++..+.-...++..+.+.+|+.++|++||+.|.+..+|..+..-..
T Consensus 323 ~~----------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 323 FE----------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred hH----------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 31 12233445555544445566788999999999999999999999986654333
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=333.02 Aligned_cols=265 Identities=25% Similarity=0.399 Sum_probs=202.7
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR- 153 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 153 (395)
..++|.+.+.||+|+||.||++... ++..||+|++.... ......+.+|+.+++.+ +|+||+++++++.+.
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457889999999999999998842 23579999987532 22345678899999999 899999999998776
Q ss_pred ceEEEEEcccCCChhhhcccCCCC--------------------------------------------------------
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGS-------------------------------------------------------- 177 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 177 (395)
..+++|||+.+|+|.+++......
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 567999999999999988542210
Q ss_pred -------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCceee
Q 016117 178 -------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 250 (395)
Q Consensus 178 -------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 250 (395)
......+++..++.++.|++.||.|||++ +++||||||+|||+++++.++|+|||+++............
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 01123588899999999999999999998 99999999999999999999999999987543322111122
Q ss_pred ccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCC
Q 016117 251 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQY 329 (395)
Q Consensus 251 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 329 (395)
...++..|+|||++.+..++.++||||||+++|||++ |+.||....... ..............
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~----------------~~~~~~~~~~~~~~ 336 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS----------------KFYKMVKRGYQMSR 336 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH----------------HHHHHHHcccCccC
Confidence 2335667999999998899999999999999999997 999996533211 00111111111111
Q ss_pred CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 330 SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 330 ~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
+...+.++.+++.+||+.+|.+|||+.+|++.|++++
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1112356899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=299.10 Aligned_cols=265 Identities=24% Similarity=0.325 Sum_probs=211.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC------ceE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------RKL 156 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 156 (395)
.++|.+.+.||+|||+-||+++ ..++..+|+|++......+.+...+|++..++++|||++++++++..+ ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4679999999999999999999 668999999998876666778889999999999999999999876432 467
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
++++|+..|+|.+.+..... ....+++.+++.|+.++++||.+||+. .++++||||||.|||+.+++.++|.|||-
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~---kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKI---KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEeehhccccHHHHHHHHhh---cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 99999999999999966542 234699999999999999999999998 44699999999999999999999999999
Q ss_pred ccccCCCCCCce-------eeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhh
Q 016117 237 AKIGSDKAGGHV-------STRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 306 (395)
Q Consensus 237 ~~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~ 306 (395)
++...-...+.. .....+|..|+|||.+. +...++++|||||||+||+|+.|..||+..-..++.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS----- 250 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS----- 250 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-----
Confidence 875332111110 12245789999999886 456789999999999999999999999754332111
Q ss_pred hhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 307 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
....+....+..+-....++.+.+++.+|++.||.+||+..+++..++.++
T Consensus 251 ---------laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 ---------LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111112222221222225678999999999999999999999999998775
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=317.40 Aligned_cols=261 Identities=30% Similarity=0.502 Sum_probs=205.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcC-C-----cEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSN-G-----RKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~ 156 (395)
++|++.+.||+|+||.||+|.... + ..+++|.+..... .....+.+|+.+++.++|||++++++++.+. ..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357888999999999999998542 2 5799998864332 2345688999999999999999999998766 567
Q ss_pred EEEEcccCCChhhhcccCCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC
Q 016117 157 LVYDYMANGGLQEHLYPANGSN---------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 227 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~ 227 (395)
+++||+++|+|.+++....... .....+++..++.++.|++.||.|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 9999999999999986543211 1124688999999999999999999999 999999999999999999
Q ss_pred cEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhh
Q 016117 228 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSW 306 (395)
Q Consensus 228 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~ 306 (395)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-------- 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-------- 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence 999999999975433322222233456788999999988899999999999999999998 99998754321
Q ss_pred hhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 307 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
.+...+........+...+..+.+|+.+||+.+|.+|||+.+|+++|+++
T Consensus 234 ---------~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 234 ---------EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred ---------HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11111111111123344567899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=331.36 Aligned_cols=264 Identities=23% Similarity=0.384 Sum_probs=223.3
Q ss_pred HHHHHhCCCCCCCeeeccCCeEEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceE
Q 016117 79 QLHSATGGFSKSNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 79 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~ 156 (395)
+.+-...+.+..++||-|.||.||.|.|+. .-.||||.++.. ....++|..|..+|+.++|||+|+++|+|.-+ ..|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 333444556777899999999999999864 667999999765 45678999999999999999999999999877 567
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
||+|||..|+|.+||...++ ..++.-..+.|+.||++||.||... ++|||||.++|+||.++..+|++|||+
T Consensus 340 IiTEfM~yGNLLdYLRecnr-----~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNR-----SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred EEEecccCccHHHHHHHhch-----hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence 99999999999999976653 4577778899999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
++++..+..... ....-+..|.|||.+....++.|+|||+||++|||+.| |..||..-+ ..
T Consensus 412 sRlMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----------------lS 473 (1157)
T KOG4278|consen 412 SRLMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LS 473 (1157)
T ss_pred hhhhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----------------HH
Confidence 998665432211 11233567999999999999999999999999999999 888885321 34
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.+.+++....+-+.+..|+..+++|++.||+|+|.+||++.|+.+.++.++..+
T Consensus 474 qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 474 QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 566677776666777888899999999999999999999999999999998753
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=315.33 Aligned_cols=259 Identities=25% Similarity=0.418 Sum_probs=202.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCc----EEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGR----KVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv 158 (395)
++|.+.+.||+|+||+||+|.+. +++ .+++|.+..... ....++..|+..+++++||||+++++++.....+++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 35778899999999999999964 444 477787754322 223567778889999999999999999887777899
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
+||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++
T Consensus 87 ~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 87 TQLSPLGSLLDHVRQHR------DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEeCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccce
Confidence 99999999999996432 3689999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...............++..|+|||.+.+..++.++||||||+++|||++ |..||....+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----------------~ 220 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-----------------V 220 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-----------------H
Confidence 6433222222233456778999999998899999999999999999998 999986543211 0
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.+++........+..+...+.+++.+||..+|++|||+.++++.|..+.+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 221 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred HHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 1111110000111112346788999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=338.88 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=213.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCC-cEEEEEEeccCCcccHHHHHHHHHHHhccC-CCcceeEEE-EEe---cC----c
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNG-RKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLG-YCS---DR----R 154 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~---~~----~ 154 (395)
.++++.+.|.+|||+.||+|....+ ..+|+|++-..++...+...+|+++|+.|+ |+|||.+++ ... .. +
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4567788999999999999997655 999999987767778889999999999996 999999998 221 11 3
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++.||||.+|+|.+++..+. ...|++.++++|+.|+++|+++||.. .++|+|||||-+||||+.++..|||||
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rl-----q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRL-----QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred EEeehhhccCCcHHHHHHHHH-----hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 569999999999999997554 24599999999999999999999998 778999999999999999999999999
Q ss_pred ccccccCCCCC--Cce-----eeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh
Q 016117 235 GLAKIGSDKAG--GHV-----STRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 304 (395)
Q Consensus 235 g~~~~~~~~~~--~~~-----~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~ 304 (395)
|-+.-...... ... .-....|+.|+|||.+. +.++++|+|||+|||+||-|+....||+...
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------- 262 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------- 262 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------
Confidence 99864322211 010 01123689999999874 6789999999999999999999999997542
Q ss_pred hhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 305 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
...+++....-...+.+...+.+||..||+.||++||++-++++.+-++.....
T Consensus 263 ------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 263 ------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred ------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 123444444334446788899999999999999999999999999999888643
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=331.43 Aligned_cols=250 Identities=23% Similarity=0.399 Sum_probs=207.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
.+-|.+.+.||.|+.|.|-+|++ .+|+.+|||++.... ......+.+|+-+|+.+.|||++.+++++.+. +.|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 35678889999999999999995 589999999997652 22234577899999999999999999998877 67799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
.||+++|.|.+++... .++++.++.+++.||+.|+.|+|.. +|+||||||+|+|+|..+++||+|||+|.
T Consensus 91 lEyv~gGELFdylv~k-------G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK-------GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMAS 160 (786)
T ss_pred EEecCCchhHHHHHhh-------CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceee
Confidence 9999999999999644 4799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLT-TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
.... +......||++.|.|||++.+.+|. .++||||.|++||.|++|+.||++++ +
T Consensus 161 Le~~---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--------------------i 217 (786)
T KOG0588|consen 161 LEVP---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--------------------I 217 (786)
T ss_pred cccC---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--------------------H
Confidence 6433 3455678999999999999999884 68999999999999999999998543 1
Q ss_pred hhhccccccC--CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 318 LEIMDPALEG--QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 318 ~~~~d~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
..++.+..++ +.+...+.+..+|+.+|+..||+.|.|++||++| .++..
T Consensus 218 r~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH--P~l~g 268 (786)
T KOG0588|consen 218 RVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH--PFLSG 268 (786)
T ss_pred HHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC--chhhc
Confidence 1222222222 2223344567889999999999999999999987 44443
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=313.20 Aligned_cols=254 Identities=21% Similarity=0.328 Sum_probs=199.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc----CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+.++++++|||++++++++..+ ..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888899999999999999853 356899999875422 3345788999999999999999999988766 67799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.++++|||.+.
T Consensus 85 ~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 85 TEYMSNGALDSFLRKHE------GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEeCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 99999999999985432 3689999999999999999999998 99999999999999999999999999876
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
....... .......++..|+|||.+.+..++.++|||||||++||+++ |..||....... ..
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~------------- 218 (266)
T cd05064 156 EDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VI------------- 218 (266)
T ss_pred cccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HH-------------
Confidence 4322111 11112234578999999999999999999999999999775 999997543210 00
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
..+.+ ......+...+..+.+++..||+.+|++|||+.+|.+.|+++
T Consensus 219 ~~~~~-~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 219 KAVED-GFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHC-CCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01101 011112233456789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=321.00 Aligned_cols=247 Identities=26% Similarity=0.457 Sum_probs=202.7
Q ss_pred CCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
.|+..+.||+|.||.||+|.. ..++.||+|++.-. .....+++.+|+.+|.+++++||.++++.+..+ ..+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 466678999999999999995 47899999999743 334457888999999999999999999977666 566999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.+|++.+.|... ..+++..+..++.+++.|+.|||.+ +.+|||||+.|||+..+|.+|++|||++.....
T Consensus 94 ~gGsv~~lL~~~-------~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 94 GGGSVLDLLKSG-------NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred cCcchhhhhccC-------CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence 999999999432 3457888888999999999999999 999999999999999999999999999976554
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.... ...++||+.|||||++....|+.++||||||++.+||++|.+|+....|.....++. .-.-
T Consensus 164 ~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-------------k~~P 228 (467)
T KOG0201|consen 164 TVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-------------KSAP 228 (467)
T ss_pred hhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-------------CCCC
Confidence 4322 256889999999999998899999999999999999999999998766522111111 1111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
|.+.+ .....+.+|+..||+.||+.|||+.+++++
T Consensus 229 P~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred Ccccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22222 344568999999999999999999999964
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=299.64 Aligned_cols=234 Identities=26% Similarity=0.398 Sum_probs=197.2
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
+|+..+.||.|+||.|.+++.+ +|..+|+|++.... ....+...+|..+|+.+.||.++++.+-+.+. ..++|||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 5777889999999999999965 68899999997542 22345677899999999999999999888776 6679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|.++|.|.+++... .++++..++.++.||+.||.|||+. +|++|||||+|||+|.+|.+||+|||.|...
T Consensus 125 yv~GGElFS~Lrk~-------~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 125 YVPGGELFSYLRKS-------GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred ccCCccHHHHHHhc-------CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 99999999999543 4799999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.. .....|||+.|+|||++...+|..++|.||||+++|||+.|.+||...++. ..-+.+
T Consensus 195 ~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----------------~iY~KI 253 (355)
T KOG0616|consen 195 SG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----------------QIYEKI 253 (355)
T ss_pred cC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----------------HHHHHH
Confidence 43 245689999999999999999999999999999999999999999876542 111222
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCC
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYR 352 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 352 (395)
+.... .++.-...++.+|+...|+.|-.+|
T Consensus 254 ~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 254 LEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 22222 2344445678899999999999988
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=357.39 Aligned_cols=261 Identities=30% Similarity=0.555 Sum_probs=208.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
..|...++||+|+||.||+|.. .++..||+|.+...... ...|++.+++++||||++++++|.+. ..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577788999999999999996 57899999998654322 23468899999999999999999776 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++|+|.+++. .++|..+..++.|+++||+|||..+.++++||||||+||+++.++..++. ||.......
T Consensus 766 ~~g~L~~~l~----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 766 EGKNLSEVLR----------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred CCCcHHHHHh----------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 9999999993 48899999999999999999996656699999999999999999888875 665543211
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||+.... .....+.|...... ......++|
T Consensus 835 ~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~ 906 (968)
T PLN00113 835 D------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYS-DCHLDMWID 906 (968)
T ss_pred C------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcC-ccchhheeC
Confidence 1 123578899999999999999999999999999999999999964322 23344445432222 223445566
Q ss_pred ccccC--CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 323 PALEG--QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 323 ~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
+.+.. ....++..++.+++.+||+.+|++||||.++++.|+++.+.
T Consensus 907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 66543 33456677889999999999999999999999999998774
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=315.36 Aligned_cols=249 Identities=32% Similarity=0.547 Sum_probs=191.6
Q ss_pred CCCeeeccCCeEEEEEEEc-----CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 89 KSNVVGHGGFGLVYRGVLS-----NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 89 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+.+.||.|.||.||+|.+. .+..|+||.++... ....+.+.+|++.+++++||||++++|++... ..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999975 35789999996532 23467899999999999999999999999855 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++|+|.++|.... ...+++..+..|+.|++.||.|||+. +++|+||+++||++++++.+||+|||++....
T Consensus 83 ~~~g~L~~~L~~~~-----~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-----KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp -TTEBHHHHHHHTC-----TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccc-----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 99999999997652 24689999999999999999999999 99999999999999999999999999998653
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
............+...|+|||.+....++.++||||||+++|||++ |+.||..... ......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----------------~~~~~~~ 218 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----------------EEIIEKL 218 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----------------HHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------ccccccc
Confidence 2222222233456778999999999889999999999999999999 7788754321 0111111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
........+...+..+.+++..||+.+|++|||+.+|++.|
T Consensus 219 -~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 -KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11111122233456788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=316.07 Aligned_cols=250 Identities=28% Similarity=0.381 Sum_probs=197.7
Q ss_pred CCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 87 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
|+..+.||+|+||+||++.. .+|+.||+|.+.... ......+.+|+.+++.++|+|++++.+++.+. ..++++||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999995 578999999886432 22234577899999999999999999988766 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++|+|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+|||+++++.++|+|||++....
T Consensus 82 ~~~g~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 82 MNGGDLKFHIYNMG-----NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred cCCCcHHHHHHhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 99999998885332 23589999999999999999999998 99999999999999999999999999997643
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||............ ...+.
T Consensus 154 ~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~------------~~~~~ 218 (285)
T cd05631 154 EGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV------------DRRVK 218 (285)
T ss_pred CCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH------------HHHhh
Confidence 221 123456899999999999999999999999999999999999999754321110000 00000
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 361 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~vl~~ 361 (395)
.. ...++...+..+.+|+.+||+.||.+||+ +++++++
T Consensus 219 ~~--~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 219 ED--QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cc--cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 10 11222334557889999999999999997 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=327.93 Aligned_cols=265 Identities=23% Similarity=0.369 Sum_probs=204.7
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccC-CCcceeEEEEEecC-c
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-R 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~ 154 (395)
.++|.+.++||+|+||.||+|... .+..||+|++..... ...+.+.+|+++++++. ||||+++++++.+. .
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888999999999999999852 134699999975432 23457889999999995 99999999999776 5
Q ss_pred eEEEEEcccCCChhhhcccCCCCC--------------------------------------------------------
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSN-------------------------------------------------------- 178 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~-------------------------------------------------------- 178 (395)
.++||||+++|+|.+++.......
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 779999999999999886532100
Q ss_pred ---------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC
Q 016117 179 ---------------------------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK 225 (395)
Q Consensus 179 ---------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~ 225 (395)
.....+++..+..++.|++.||.|||+. +++|+||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 0113588899999999999999999998 9999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhh
Q 016117 226 NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLV 304 (395)
Q Consensus 226 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~ 304 (395)
++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence 99999999999976433222222223446778999999998899999999999999999997 9999864321100
Q ss_pred hhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 305 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
....+........+...+..+.+++.+||+.+|++|||+.+|.+.|+++++
T Consensus 349 ------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 ------------FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ------------HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 000000001111222345678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=322.47 Aligned_cols=265 Identities=24% Similarity=0.365 Sum_probs=203.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCCc-ccHHHHHHHHHHHhcc-CCCcceeEEEEEecC--c
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR--R 154 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~ 154 (395)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+..|+.++.++ +|+||++++++|... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46889999999999999999632 347899999874322 2234677899999999 899999999987643 4
Q ss_pred eEEEEEcccCCChhhhcccCCCCC------------------------------------------------------CC
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSN------------------------------------------------------SV 180 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~------------------------------------------------------~~ 180 (395)
.++++||+++++|.+++....... ..
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 669999999999999885432110 01
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeecccccccccc
Q 016117 181 ASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260 (395)
Q Consensus 181 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~a 260 (395)
...+++..+..++.|++.||.|||++ +|+||||||+||++++++.++|+|||++................++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 23689999999999999999999998 999999999999999999999999999976533221111223445678999
Q ss_pred chhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHH
Q 016117 261 PEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAA 339 (395)
Q Consensus 261 PE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 339 (395)
||++.+..++.++|||||||++|||++ |..||........ ....+........+.....++.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~ 307 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----------------FCRRLKEGTRMRAPEYATPEIYS 307 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH----------------HHHHHhccCCCCCCccCCHHHHH
Confidence 999999999999999999999999998 9999864322110 00000000011111223456899
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 340 IAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 340 li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
++.+||+.+|++||++.+++++|++++..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=312.64 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=207.9
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+..+|++.+.||.|+||.||+|...++..+++|.+..........+..|+.+++.++|+|++++++++.+. ..+++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568889999999999999999888999999998866554567889999999999999999999998776 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||+|+||++++++.++|+|||.+....
T Consensus 84 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 84 MEKGSLLAFLRSPE-----GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred cccCCHHHHHhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 99999999996432 24689999999999999999999998 99999999999999999999999999997653
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .... .
T Consensus 156 ~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~-------------~- 216 (261)
T cd05148 156 EDV--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYD-------------Q- 216 (261)
T ss_pred Ccc--ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH-------------H-
Confidence 321 11123345678999999998899999999999999999998 89999643311 0011 1
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
+........+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 217 ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111111122334456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=314.15 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=203.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcC------CcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~ 156 (395)
.+|.+.+.||+|+||.||+|...+ +..||+|.+...... ..+.+.+|+++++.++|+|++++++++... ..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457888999999999999998633 478999998755433 356889999999999999999999988766 577
Q ss_pred EEEEcccCCChhhhcccCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcE
Q 016117 157 LVYDYMANGGLQEHLYPANGS-------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 229 (395)
++|||+++++|.+++...... ......+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 999999999999999654321 12235688999999999999999999998 99999999999999999999
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhh
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~ 308 (395)
+|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||...... .....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~-- 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIEC-- 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH--
Confidence 9999999875432221112223345778999999999999999999999999999998 99998643321 11111
Q ss_pred cccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 309 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
+..... ...+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 237 -----------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 237 -----------ITQGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -----------HHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111111 11122344678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=319.37 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=201.4
Q ss_pred HHHhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ce
Q 016117 81 HSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 81 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~ 155 (395)
....++|.++..||+|+||.||+++- .+|..+|+|++++.. ....+..+.|-.+|....+|+||+++.-|++. ..
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 44567899999999999999999994 579999999998653 33456778899999999999999999988887 56
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
|+||||++||++..+|.. ...+++..+..++.+++.|+.-||+. |++||||||+|+|||..|++||+|||
T Consensus 217 YLiMEylPGGD~mTLL~~-------~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFG 286 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR-------KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFG 286 (550)
T ss_pred EEEEEecCCccHHHHHHh-------cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecccc
Confidence 799999999999999953 45799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCC-------------------CCCc-e-------------------------eeccccccccccchhhccCCCC
Q 016117 236 LAKIGSDK-------------------AGGH-V-------------------------STRVLGTQGYVAPEYALTGHLT 270 (395)
Q Consensus 236 ~~~~~~~~-------------------~~~~-~-------------------------~~~~~g~~~y~aPE~~~~~~~~ 270 (395)
++...... .... . ....+|||.|+|||++.+..|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 98522110 0000 0 1124699999999999999999
Q ss_pred ccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCC
Q 016117 271 TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEAD 350 (395)
Q Consensus 271 ~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~ 350 (395)
..+|.|||||++||||.|.+||..+.+......+..+...+. .+-......+..+||.+|+. ||+
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~--------------fP~~~~~s~eA~DLI~rll~-d~~ 431 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK--------------FPEEVDLSDEAKDLITRLLC-DPE 431 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc--------------CCCcCcccHHHHHHHHHHhc-CHH
Confidence 999999999999999999999998876544332222221111 11112233678899999999 999
Q ss_pred CCCC
Q 016117 351 YRPL 354 (395)
Q Consensus 351 ~RPt 354 (395)
+|.-
T Consensus 432 ~RLG 435 (550)
T KOG0605|consen 432 NRLG 435 (550)
T ss_pred HhcC
Confidence 9987
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=315.03 Aligned_cols=246 Identities=23% Similarity=0.395 Sum_probs=206.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCcceeEEEEEecCc-eEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv 158 (395)
..+|++.+.||+|.||.|-+|. ...|+.||||.+++..- ++.-.+++|+++|..|+||||+.++.+|.+.. .++|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3468888899999999999998 57899999999876533 33345788999999999999999999998875 5599
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||..+|.|.+|+. ....+++.+++.++.||.+|+.|+|.+ +++|||||.+|||+|.|+++||+|||++.
T Consensus 132 MEYaS~GeLYDYiS-------er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSN 201 (668)
T KOG0611|consen 132 MEYASGGELYDYIS-------ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSN 201 (668)
T ss_pred EEecCCccHHHHHH-------HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhh
Confidence 99999999999994 345799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
.+.... ....+||++-|.+||++++.+| ++..|.||||++||.|+.|..||+..+.
T Consensus 202 ly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-------------------- 258 (668)
T KOG0611|consen 202 LYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-------------------- 258 (668)
T ss_pred hhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------------------
Confidence 765443 4567899999999999999988 4789999999999999999999985431
Q ss_pred hhhccccccCCCC-HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 318 LEIMDPALEGQYS-MKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 318 ~~~~d~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
..++.+.-.+.|. ++.+.+..-||+|||..||++|-|+.+|..+-
T Consensus 259 k~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 259 KRLVRQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHHHHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1111111122222 22344677899999999999999999999875
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=309.43 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=202.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcC----CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
++|++.+.||+|+||+||+|.+.. ...+++|.+.... ......|..|+.+++.++||||+++++++.+. ..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468889999999999999999742 3579999886542 23345788899999999999999999988766 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++.
T Consensus 84 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 84 TEYMENGSLDKFLREND------GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred EEcCCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhh
Confidence 99999999999985432 3689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~------------ 219 (266)
T cd05033 155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIK------------ 219 (266)
T ss_pred cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHH------------
Confidence 6542222222222345678999999998899999999999999999998 99998543211 0000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
.+.+ ......+...+..+.+++.+||+.+|++||++.+|+++|++++
T Consensus 220 -~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 220 -AVED-GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred -HHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 0100 0011112234567899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=312.80 Aligned_cols=261 Identities=27% Similarity=0.407 Sum_probs=201.7
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcC------CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSN------GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~ 155 (395)
.++|.+.+.||+|+||.||+|.+.+ +..|++|.+.... ......+..|+.+++.++|+||+++++++.+. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568889999999999999999643 5678999876433 22345688899999999999999999987665 56
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC---cEEEe
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF---HAKVS 232 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~ 232 (395)
++++||+.+++|.+++............+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 799999999999999976543222334689999999999999999999998 999999999999998654 59999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
|||++.................+..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------------ 229 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------------ 229 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------------
Confidence 9999976532221111112233567999999998899999999999999999997 999997433210
Q ss_pred ccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
....+........+...+..+.+++.+||+.+|++|||+.+|+++|++
T Consensus 230 -----~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 230 -----VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred -----HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 111111111112223344678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=321.19 Aligned_cols=262 Identities=23% Similarity=0.346 Sum_probs=200.6
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.++|++.+.||+|+||.||++... ++..+|+|++.... ....+.+.+|++++++++||||+++++++.++ ..+++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357889999999999999999965 68889999887532 23345788999999999999999999988766 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.. +++||||||+|||++.++.++|+|||++...
T Consensus 84 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 84 HMDGGSLDQVLKEA-------KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred cCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 99999999998532 35889999999999999999999752 6999999999999999999999999998754
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc--------
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT-------- 312 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 312 (395)
.... .....|+..|+|||++.+..++.++|||||||++|||++|+.||....... +.........
T Consensus 155 ~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~ 227 (331)
T cd06649 155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPH 227 (331)
T ss_pred cccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCcc
Confidence 3221 233568999999999999999999999999999999999999996433211 0000000000
Q ss_pred ---------------------cchhhhhhcc----ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 ---------------------DREKILEIMD----PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 ---------------------~~~~~~~~~d----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.........+ ...........+.++.+|+.+||+.||++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 000111111244678999999999999999999999976
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=313.14 Aligned_cols=263 Identities=24% Similarity=0.399 Sum_probs=203.9
Q ss_pred CCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
+|++.+.||+|+||.||+|... ....+++|.+..... .....+..|+.+++.++||||+++++.+... ..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 235688888764332 2345788899999999999999999988766 5679
Q ss_pred EEEcccCCChhhhcccCCCC-----------------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCC
Q 016117 158 VYDYMANGGLQEHLYPANGS-----------------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSN 220 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~-----------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 220 (395)
++||+.+|+|.+++...... ......+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 99999999999998643211 01224688999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 016117 221 ILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSG 299 (395)
Q Consensus 221 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~ 299 (395)
||+++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 9999999999999999875433221111222345678999999988889999999999999999998 99998643321
Q ss_pred CchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 300 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.+............+...+..+.+++.+||+.+|++||++.++++.|++++..
T Consensus 237 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 ----------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred ----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 11111111111112223345788999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=313.37 Aligned_cols=264 Identities=25% Similarity=0.382 Sum_probs=206.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
.+|.+.+.||+|+||+||++... ++..+++|.+..........+..|++++++++|+|++++++++... ..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888899999999999999852 3456899988765555566789999999999999999999998766 5679
Q ss_pred EEEcccCCChhhhcccCCCC------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEE
Q 016117 158 VYDYMANGGLQEHLYPANGS------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 231 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl 231 (395)
++||+++++|.+++...... ......+++..++.++.|++.||+|||+. +++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 99999999999998643211 11223589999999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcc
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPR 310 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 310 (395)
+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~------ 232 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI------ 232 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH------
Confidence 99999875432221111222345678999999998899999999999999999998 899986433210 00
Q ss_pred cccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 311 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
..+...... ..+...+..+.+++.+||+.+|.+|||+.++...|+++...
T Consensus 233 -------~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 -------ECITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -------HHHHcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 011110000 01112334689999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=311.23 Aligned_cols=258 Identities=28% Similarity=0.445 Sum_probs=203.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCc----EEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGR----KVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv 158 (395)
.+|.+.+.||+|+||+||+|.+ .+|. .||+|++.... ......+..|..+++.++|+|++++++++.....+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 4578889999999999999985 3444 48999987532 2334578889999999999999999999988788899
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
++|+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||+++++.+||+|||+++
T Consensus 87 ~~~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 87 TQLMPYGCLLDYVRENK------DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEcCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 99999999999985432 3689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----------------~~ 220 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-----------------EI 220 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----------------HH
Confidence 6543222111112234678999999998899999999999999999998 89998643211 01
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
...+........+...+.++.+++..||+.||++||++.++++.|+++...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 221 PDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 111111111111223345788999999999999999999999999888664
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=318.81 Aligned_cols=244 Identities=26% Similarity=0.362 Sum_probs=197.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++++.+. ..+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999965 68999999986432 22345678899999999999999999988766 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 81 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 81 EYVPGGELFSYLRNS-------GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKK 150 (291)
T ss_pred eCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence 999999999998532 3688999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.... .....|++.|+|||++.+..++.++|||||||++|+|++|..||....... ....
T Consensus 151 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~----------------~~~~ 209 (291)
T cd05612 151 LRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG----------------IYEK 209 (291)
T ss_pred ccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHH
Confidence 4322 123468999999999999899999999999999999999999997543210 0111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~vl~~ 361 (395)
+....+ .++......+.+++.+||+.||.+||+ +.+++++
T Consensus 210 i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 210 ILAGKL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHhCCc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111111 112223456889999999999999995 8888866
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=315.65 Aligned_cols=266 Identities=21% Similarity=0.274 Sum_probs=197.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|++.+.||+|+||+||+++.. +++.+|+|++.... ....+.+.+|+++++.++||||+++++++.+. ..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999975 68899999986432 23345678899999999999999999988766 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.++.+..+.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~~~~l~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 81 YVEKNMLELLEE-------MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNL 150 (287)
T ss_pred cCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999877665442 123689999999999999999999998 9999999999999999999999999999764
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc-------
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD------- 313 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 313 (395)
..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||.....................
T Consensus 151 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 151 SEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred ccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 33221 1122356889999999999889999999999999999999999999754322111111100000000
Q ss_pred -chhhhhhccccccC------CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 -REKILEIMDPALEG------QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 -~~~~~~~~d~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.........+.... .+....+..+.+|+.+||+.||++|||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 0111234579999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=306.86 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=205.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccC
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMAN 164 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~ 164 (395)
++|++.+.||+|+||.||+|.+.++..|++|.+.... ...+.+..|+++++.++|+|++++++++.+...+++|||+.+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 5688999999999999999998777789999987532 334678899999999999999999998877788899999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+.......
T Consensus 85 ~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 85 GSLLDFLKGEM-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CcHHHHHhhcc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999995422 23578999999999999999999998 99999999999999999999999999997544322
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
. .......++..|+|||...+..++.++||||||+++|+|++ |..||....... ....+ ..
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~----------------~~~~~-~~ 218 (262)
T cd05071 157 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQV-ER 218 (262)
T ss_pred c-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH----------------HHHHH-hc
Confidence 1 11122345678999999988899999999999999999999 888886432110 00000 00
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
......+.+.+..+.+++.+||+.+|++|||+.++++.|++.+
T Consensus 219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 1111223345567899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=308.76 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=202.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
++|++.+.||+|+||.||+|...++..|++|.+... ....+.+..|+.+++.++|+|++++++++.+. ..++++||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 468889999999999999999888889999988653 23356888999999999999999999988766 5679999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 85 ~~~L~~~l~~~~-----~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 85 KGSLLDFLKSDE-----GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred CCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999985432 24688899999999999999999998 9999999999999999999999999999865432
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...... .....
T Consensus 157 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----------~~~~~ 222 (261)
T cd05072 157 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSAL----------QRGYR 222 (261)
T ss_pred ce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHH----------HcCCC
Confidence 21 11122335678999999998889999999999999999998 99998643211 111110 00000
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
.......+..+.+++.+||+.+|++|||++++.+.|+++
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 223 ----MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 011112345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=322.83 Aligned_cols=257 Identities=24% Similarity=0.386 Sum_probs=215.2
Q ss_pred CCCCCCeeeccCCeEEEEEEEc---CCc--EEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS---NGR--KVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVY 159 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~ 159 (395)
..++.+.||.|.||.||.|... .|+ .||||.-+.. .....+.|..|..+|++++||||++++|+|.+...++||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~Wivm 469 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVM 469 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEE
Confidence 3455678999999999999853 333 4788887753 345567899999999999999999999999999999999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
|.++.|.|..||.... ..++......++.|++.+|+|||+. .++||||.++||||....-+||+|||+++.
T Consensus 470 EL~~~GELr~yLq~nk------~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNK------DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ecccchhHHHHHHhcc------ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 9999999999996543 5688999999999999999999998 999999999999999999999999999998
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
..+...... +....+..|||||.++.+.++.++|||.||+.+||++. |..||..-.. .++-
T Consensus 541 ~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----------------sDVI 602 (974)
T KOG4257|consen 541 LEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----------------SDVI 602 (974)
T ss_pred ccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----------------cceE
Confidence 776553332 24445778999999999999999999999999999887 9999964322 1122
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
..+...-+-+.++.++..|+.|+.+||..+|.+||.+.++...|+.++..+
T Consensus 603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 222333334567778889999999999999999999999999999888843
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=307.12 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=203.2
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
.++|++.+.||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+|++++++++... ..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688889999999999999998778889999987543 3456788999999999999999999988766 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.....
T Consensus 84 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 84 KYGSLLEYLQGGA-----GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cCCcHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 9999999985432 24689999999999999999999998 999999999999999999999999999986542
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
.... .......+..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ..+
T Consensus 156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~--------------~~~ 217 (261)
T cd05068 156 DIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVL--------------QQV 217 (261)
T ss_pred Cccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHH--------------HHH
Confidence 2111 1111223457999999998899999999999999999999 99998643211 000 011
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
+.......+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 218 DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 11111112223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=306.49 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=203.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccC
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMAN 164 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~ 164 (395)
++|++.+.||+|+||.||++...++..+++|.+..... ..+.+.+|+.++++++|+|++++++++.+...+++|||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 46888899999999999999988888899999875433 35678999999999999999999999877788899999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 85 GSLLDFLKDGE-----GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999985432 24589999999999999999999998 99999999999999999999999999997543321
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .... .+..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~--------------~~~~ 218 (260)
T cd05070 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLE--------------QVER 218 (260)
T ss_pred cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHH--------------HHHc
Confidence 11 1112234567999999988889999999999999999999 88998643211 1111 1111
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
......+...+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11112223345679999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=324.23 Aligned_cols=252 Identities=24% Similarity=0.311 Sum_probs=200.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+..|++++..++||||+++++++.+. ..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 58999999987432 22345678899999999999999999988776 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 81 e~~~g~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 81 EYVPGGDFRTLLNNL-------GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKG 150 (333)
T ss_pred eCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence 999999999999432 3688999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
... ......|++.|+|||++.+..++.++|||||||++|||++|..||...........+... ..
T Consensus 151 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----------~~ 215 (333)
T cd05600 151 IVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW----------KE 215 (333)
T ss_pred ccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc----------cc
Confidence 433 223456899999999999999999999999999999999999999754321110000000 00
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+............+.++.+++.+||+.+|++||++.+++++
T Consensus 216 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 216 TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 010000000011235578899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=312.09 Aligned_cols=264 Identities=25% Similarity=0.382 Sum_probs=206.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
.+|.+.+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++|+|++++++++.+. ..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45778899999999999999842 3456899988765544556788999999999999999999998776 5679
Q ss_pred EEEcccCCChhhhcccCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc
Q 016117 158 VYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 228 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~ 228 (395)
+|||+++++|.+++...... ......+++..++.++.|++.||+|||++ +++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 99999999999999654311 11224589999999999999999999999 9999999999999999999
Q ss_pred EEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhh
Q 016117 229 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWA 307 (395)
Q Consensus 229 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~ 307 (395)
++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||...... ....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~-- 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---EVIE-- 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--
Confidence 99999999975433221112223446788999999999999999999999999999999 99998643321 0110
Q ss_pred hcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 308 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 308 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.+..... .......+..+.+++.+||+.+|++|||+.+|++.|+++.+.
T Consensus 237 -----------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 -----------CITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -----------HHhCCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 0111101 011122345688999999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=322.78 Aligned_cols=244 Identities=26% Similarity=0.375 Sum_probs=197.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++ ..+++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888899999999999999965 68999999986431 22345688899999999999999999988776 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+|+|.+++... ..+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 98 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 167 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-------GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167 (329)
T ss_pred cCCCCChHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence 999999999998532 3578899999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... ....|++.|+|||++.+..++.++|||||||++|||++|..||....+.. ....
T Consensus 168 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----------------~~~~ 226 (329)
T PTZ00263 168 VPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR----------------IYEK 226 (329)
T ss_pred cCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH----------------HHHH
Confidence 43321 23568999999999999999999999999999999999999996443210 0011
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~vl~~ 361 (395)
+....+ ..+......+.+|+.+||+.||.+||+ +.+++.+
T Consensus 227 i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 227 ILAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred HhcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111111 111122346789999999999999997 6888855
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=307.56 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=202.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
.+|.+.+.||+|+||.||+|... .++.+++|.+... ......+..|+++++.++|+|++++++++... ..++++||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34777889999999999999964 5889999998754 33456788999999999999999999988766 566999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.....
T Consensus 85 ~~~~L~~~~~~~~-----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 85 TYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCcHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 9999999985432 24589999999999999999999998 999999999999999999999999999876443
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
.... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....... ....+
T Consensus 157 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-----------------~~~~~ 218 (263)
T cd05052 157 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------VYELL 218 (263)
T ss_pred ceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----------------HHHHH
Confidence 2211 1111234567999999998999999999999999999998 999986432110 00111
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
........+...+..+.+++.+||+.+|++|||+.++++.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 219 EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 111111222233467899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=334.75 Aligned_cols=252 Identities=20% Similarity=0.256 Sum_probs=200.3
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-C-CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-N-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
.|.+.+.||+|+||.||+|... + ++.|++|.+..........+..|+.+++.++||||+++++++... ..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888899999999999999854 3 678899977654444455678899999999999999999988766 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++|+|.+++..... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 148 ~gg~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 148 SGGDLNKQIKQRLK---EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCHHHHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999998854321 234688999999999999999999998 999999999999999999999999999986544
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
..........+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~----------------~~~~~~~~ 285 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR----------------EIMQQVLY 285 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHh
Confidence 33222334567999999999999999999999999999999999999999643210 00111111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
... ...+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 286 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 286 GKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 100 0112223456899999999999999999999874
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=306.21 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=198.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
++|++.+.||+|+||.||++.+.++..+|+|.+... ....+.+..|+.+++.++|||++++++++.+. ..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 347788899999999999999888889999988643 33356788999999999999999999998776 5679999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+|+|.+++.... ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||+++.....
T Consensus 83 ~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 83 NGCLLNYLRQRQ------GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred CCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 999999985432 3588999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...... ..
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i-------------~~ 216 (256)
T cd05114 154 EYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMI-------------SR 216 (256)
T ss_pred cee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH-------------HC
Confidence 111 1112234567999999998889999999999999999999 89998654321 111110 00
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
.. ....+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 217 ~~-~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 217 GF-RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CC-CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 00 0001111234689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=306.06 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=196.7
Q ss_pred eeeccCCeEEEEEEE---cCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccCCC
Q 016117 92 VVGHGGFGLVYRGVL---SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANGG 166 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g~ 166 (395)
.||+|+||.||+|.+ .++..+|+|++.... ....+.+..|+.+++.++|+||+++++++.+...++++||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 589999999999974 357889999986432 223467889999999999999999999998778889999999999
Q ss_pred hhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCC
Q 016117 167 LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 246 (395)
Q Consensus 167 L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 246 (395)
|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.........
T Consensus 82 L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 82 LNKFLQKN-------KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred HHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 99998432 3588999999999999999999998 9999999999999999999999999999765433211
Q ss_pred ce-eeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 247 HV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 247 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
.. .....++..|+|||.+....++.++||||||+++|||++ |..||...... . ....+...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~--------------~~~~i~~~ 214 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---E--------------VTQMIESG 214 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---H--------------HHHHHHCC
Confidence 11 112234578999999988889999999999999999998 99999643321 0 11111111
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
.....+...+.++.+++.+||+.+|++||++.+|.+.|++.
T Consensus 215 ~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 215 ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11122333456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=335.71 Aligned_cols=257 Identities=24% Similarity=0.312 Sum_probs=202.8
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-----
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR----- 153 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 153 (395)
...++|.+.+.||+|+||+||++.. .+|+.||+|++.... ......+.+|+.++..++|+|++++...+...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3446899999999999999999985 478999999986432 23345677899999999999999998765422
Q ss_pred ----ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcE
Q 016117 154 ----RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 154 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 229 (395)
..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+|||++.++.+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~---~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAK---TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 14589999999999999865432 234689999999999999999999998 99999999999999999999
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhc
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 309 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~ 309 (395)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~---- 252 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------E---- 252 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------H----
Confidence 999999997654332222334467999999999999999999999999999999999999999643211 0
Q ss_pred ccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 310 RLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 310 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.......... ...+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 253 ------~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 253 ------VMHKTLAGRY-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ------HHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0011111000 11222344578999999999999999999999864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=313.41 Aligned_cols=265 Identities=21% Similarity=0.298 Sum_probs=196.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|.+.+.||.|+||+||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+. ..++|+||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999965 68899999986432 22345677899999999999999999988776 46699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+ +|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~-~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LDS-DLKQYLDNCG------NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCc-CHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 974 8988884322 3578999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh--------hcccc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA--------LPRLT 312 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~~ 312 (395)
... .......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||............... ++...
T Consensus 155 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 155 VPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred CCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 221 11223457889999998875 56899999999999999999999999754432111110000 00011
Q ss_pred cchhhhhhccccccCCC----CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 DREKILEIMDPALEGQY----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..........+...... ......++.+|+.+||+.||.+|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11111111111110000 01123467899999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=320.72 Aligned_cols=241 Identities=25% Similarity=0.353 Sum_probs=192.9
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANG 165 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 165 (395)
+.||+|+||.||++... +|+.||+|++.... ......+..|+.+++.++||||+++++++.+. ..++||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 78999999987432 22334677899999999999999999988776 566999999999
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCC
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 245 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 245 (395)
+|.+++.. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~L~~~l~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~- 149 (323)
T cd05571 81 ELFFHLSR-------ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG- 149 (323)
T ss_pred cHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-
Confidence 99999853 24689999999999999999999999 99999999999999999999999999987532211
Q ss_pred CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccc
Q 016117 246 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 325 (395)
Q Consensus 246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 325 (395)
.......||+.|+|||++.+..++.++|||||||++|||++|..||...... .. ...+....
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~-------------~~~~~~~~- 211 (323)
T cd05571 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KL-------------FELILMEE- 211 (323)
T ss_pred -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HH-------------HHHHHcCC-
Confidence 1223456999999999999999999999999999999999999999643211 00 00011000
Q ss_pred cCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 326 EGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 326 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
..++......+.+++.+||+.||++|| ++.+++++
T Consensus 212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 012223345688999999999999999 79999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=310.58 Aligned_cols=261 Identities=26% Similarity=0.405 Sum_probs=200.4
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-c
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R 154 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~ 154 (395)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+.... .....++.+|+.+++.++|+||+++++++.++ .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999998753 24679999886432 22345688899999999999999999998766 5
Q ss_pred eEEEEEcccCCChhhhcccCCCC---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEE
Q 016117 155 KLLVYDYMANGGLQEHLYPANGS---NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 231 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl 231 (395)
.++++||+++|+|.+++...... +.....+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 67999999999999998653321 11124578889999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcc
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPR 310 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 310 (395)
+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||...... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~----- 232 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR----- 232 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-----
Confidence 99999875433221111122345678999999998899999999999999999999 78888643211 0000
Q ss_pred cccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 311 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
.+..... ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 233 --------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 --------FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --------HHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0011100 0112223457899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=321.24 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=193.0
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
+|+..+.||+|+||+||++... +++.||+|++.... ......+.+|+++++.++|+||+++++++.+. ..++++||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4566789999999999999964 68999999986432 22345788999999999999999999988766 566999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.+|+|.+.. ..++..+..++.|++.||.|||++ +++||||||+|||+++++.+||+|||++.....
T Consensus 155 ~~~~L~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 155 DGGSLEGTH-----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCCcccccc-----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 999986543 345678889999999999999999 999999999999999999999999999976433
Q ss_pred CCCCceeeccccccccccchhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALT-----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
.. .......|+..|+|||++.. ...+.++|||||||++|||++|+.||.............
T Consensus 221 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~------------ 286 (353)
T PLN00034 221 TM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC------------ 286 (353)
T ss_pred cc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH------------
Confidence 21 11233568999999998743 234568999999999999999999997332211000000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.+. .............++.+|+.+||+.+|++|||+.|++++ .++...
T Consensus 287 -~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h--p~~~~~ 334 (353)
T PLN00034 287 -AIC-MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH--PFILRA 334 (353)
T ss_pred -HHh-ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC--cccccC
Confidence 000 000111122344578999999999999999999999975 455543
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.64 Aligned_cols=259 Identities=24% Similarity=0.361 Sum_probs=200.5
Q ss_pred CCCCCeeeccCCeEEEEEEEcC----CcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecCc------
Q 016117 87 FSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR------ 154 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 154 (395)
|.+.+.||+|+||.||+|.... +..+|+|+++... ......+..|++.++.++|+|++++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 3679999987532 223457889999999999999999999875542
Q ss_pred -eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEec
Q 016117 155 -KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 233 (395)
Q Consensus 155 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 233 (395)
.++++||+++|+|..++...... .....+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 47999999999999998654321 1234689999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccc
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||...... ....
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~------- 226 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYD------- 226 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHH-------
Confidence 999976543222111122334678999999988899999999999999999999 88888643211 0011
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
.+.+. .....+......+.+++.+||+.||++|||+.++++.|+++.
T Consensus 227 ------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 227 ------YLRHG-NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred ------HHHcC-CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 11111 011122234557899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.64 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=205.1
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEccc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMA 163 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~ 163 (395)
.++|.+.++||+|+||.||+|...+++.+|+|.+.... .....+.+|+.+++.++|+|++++++++.+...++++||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCC
Confidence 35688899999999999999998889999999987543 34567889999999999999999999987778889999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+++|.+++.... ...+++.++..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 84 ~~~L~~~~~~~~-----~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 84 NGSLVDFLKTPE-----GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999985432 24688999999999999999999998 9999999999999999999999999998754422
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.. .......++..|+|||.+....++.++||||||+++|||++ |+.||....... .. ..+.
T Consensus 156 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~--------------~~~~ 217 (260)
T cd05067 156 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VI--------------QNLE 217 (260)
T ss_pred Cc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HH--------------HHHH
Confidence 11 11122345678999999998889999999999999999999 999996433110 00 0011
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
.......+...+.++.+++.+||+.+|++|||++++++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 218 RGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 1111111222345799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=290.39 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=204.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|-||.||.|+. +++..||+|++.+.. .....++.+|+++-++|+||||+++++++.+. ..|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 4588999999999999999994 578899999987532 23346788999999999999999999999887 677999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||...|.|...|.... ...+++...+.++.|+|.|+.|+|.. +++||||||+|+|++..+.+||+|||.+..
T Consensus 102 Eya~~gel~k~L~~~~-----~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~ 173 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR-----MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 173 (281)
T ss_pred EecCCchHHHHHHhcc-----cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceee
Confidence 9999999999996433 35688889999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
... ......|||..|.+||...+..++...|+|++|++.||++.|.+||......+ ...+
T Consensus 174 ~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e----------------tYkr 233 (281)
T KOG0580|consen 174 APS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE----------------TYKR 233 (281)
T ss_pred cCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH----------------HHHH
Confidence 432 22346789999999999999999999999999999999999999998654211 1111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+..-.+ .++...+....++|.+|+..+|.+|.+..|++.+
T Consensus 234 I~k~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 234 IRKVDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHccc--cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111111 1222334568899999999999999999999875
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=310.00 Aligned_cols=260 Identities=27% Similarity=0.453 Sum_probs=200.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-----cCCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
.+|++.+.||+|+||+||+|.. ..+..+++|.+..... .....+.+|+++++.++|||++++++++..+ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3577889999999999999984 2457899999874332 2335788899999999999999999988766 5679
Q ss_pred EEEcccCCChhhhcccCCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC
Q 016117 158 VYDYMANGGLQEHLYPANGS----------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 227 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~ 227 (395)
+|||+.+++|.+++...... ......+++..++.++.|++.||.|||++ +++|+||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 99999999999998533211 01124588999999999999999999998 999999999999999999
Q ss_pred cEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhh
Q 016117 228 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSW 306 (395)
Q Consensus 228 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~ 306 (395)
.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||...... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~---- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---E---- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---H----
Confidence 999999999976433222222233445678999999988889999999999999999998 99898643211 0
Q ss_pred hhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 307 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
+.+.+........+...+..+.+++.+||+.+|++||++.+|.++|..
T Consensus 235 ----------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 ----------VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 011111100011122234568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=307.04 Aligned_cols=259 Identities=24% Similarity=0.361 Sum_probs=197.1
Q ss_pred CCCCCeeeccCCeEEEEEEEcC-Cc--EEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-------c
Q 016117 87 FSKSNVVGHGGFGLVYRGVLSN-GR--KVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------R 154 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------~ 154 (395)
|.+.+.||+|+||.||+|...+ +. .+|+|.++.. .....+.+..|+++++.++|+||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567889999999999999654 33 5899988643 233356788899999999999999999987431 3
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++++||+.+|+|.+++...... .....+++..+..++.|++.||+|||++ +++||||||+|||+++++.++|+||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhccc-CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence 57999999999999987433211 1234589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhccccc
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
|++................++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..... .
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~----~-- 227 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDY----L-- 227 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----H--
Confidence 99976543221111122345678999999999999999999999999999999 88888643211 10000 0
Q ss_pred chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 314 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 314 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
.... ....+...+..+.+++.+||+.+|++|||+.++++.|++++
T Consensus 228 -------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 228 -------RQGN-RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred -------HcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 0000 00111223456899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=315.10 Aligned_cols=265 Identities=22% Similarity=0.368 Sum_probs=203.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc--------CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR- 153 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 153 (395)
.+|++.+.||+|+||.||++... .+..+|+|.+.... ....+.+..|+++++++ +|+||+++++++...
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35888999999999999999742 12368999887432 23346788999999999 899999999998766
Q ss_pred ceEEEEEcccCCChhhhcccCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 224 (395)
..++++||+.+|+|.+++...... ......+++.++..++.|++.||.|||++ +++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 567999999999999998653311 11234688999999999999999999998 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchh
Q 016117 225 KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVL 303 (395)
Q Consensus 225 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~ 303 (395)
.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 999999999999875443221111122234567999999999999999999999999999998 888886432110
Q ss_pred hhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 304 VSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
....+........+...+..+.+++.+||+.+|++|||+.++++.|+++....
T Consensus 245 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 -------------LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 00001011111112233457889999999999999999999999999998644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=303.39 Aligned_cols=253 Identities=27% Similarity=0.428 Sum_probs=202.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccC
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMAN 164 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~ 164 (395)
++|.+.+.||+|++|.||++....+..+++|.+.... ...+.+.+|+.+++.++|+|++++++++.....+++|||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 4578889999999999999998777789999876542 345678899999999999999999999887788899999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 85 GSLLDFLKEGD-----GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999996432 23588999999999999999999998 99999999999999999999999999997543221
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
. .......++..|+|||...+..++.++||||||+++|||++ |..||...... ....+ + ..
T Consensus 157 ~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~-------------~-~~ 218 (260)
T cd05069 157 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQ-------------V-ER 218 (260)
T ss_pred c-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH-------------H-Hc
Confidence 1 11112335678999999998899999999999999999999 89998643321 00010 0 00
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
......+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 219 GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01111222345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=298.08 Aligned_cols=270 Identities=21% Similarity=0.257 Sum_probs=205.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc--cHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv 158 (395)
++|+..+.|++|.||.||+|+.+ +++.||+|+++..... ..-...+|+.+|.+.+|||||.+-.+.... ..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 35778899999999999999954 7899999999754321 112456799999999999999999987654 57899
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
||||++ +|.+.+.... ++|...++..+..|+++|++|||++ .|+|||||++|+|++..|.+||+|||+|+
T Consensus 156 Me~~Eh-DLksl~d~m~------q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR 225 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK------QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAR 225 (419)
T ss_pred HHHHHh-hHHHHHHhcc------CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhh
Confidence 999987 8888886443 5799999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhh--------hhc
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW--------ALP 309 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~--------~~~ 309 (395)
.+.... ...+..+-|.+|.|||.+.+. .|+.+.|+||+||++.||+++++.|......+....+-. .++
T Consensus 226 ~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 226 EYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred hhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 776542 345567789999999999875 699999999999999999999999987665433222111 111
Q ss_pred ccccchhh-----hhhccccccCCCCHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 310 RLTDREKI-----LEIMDPALEGQYSMK-EVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 310 ~~~~~~~~-----~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.+..-... ....-..++..+... ..+.-++|+...+..||.+|.|+++.+++ ..+..
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e 366 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRE 366 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--ccccc
Confidence 11110000 000111111111111 34667889999999999999999999975 55553
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=303.29 Aligned_cols=248 Identities=24% Similarity=0.413 Sum_probs=196.0
Q ss_pred eeeccCCeEEEEEEEc---CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccCCCh
Q 016117 92 VVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANGGL 167 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g~L 167 (395)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++|+||+++++++.....++|+||+++++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999853 355799999875432 234578899999999999999999999987788899999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCc
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 247 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 247 (395)
.+++... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..........
T Consensus 82 ~~~l~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 82 NKFLSGK------KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 9998532 24689999999999999999999998 99999999999999999999999999987543322111
Q ss_pred e-eeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccc
Q 016117 248 V-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 325 (395)
Q Consensus 248 ~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 325 (395)
. .....++..|+|||.+.+..++.++||||||+++||+++ |..||...... .....+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~ 215 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----------------EVMSFIEQGK 215 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----------------HHHHHHHCCC
Confidence 1 111223568999999988889999999999999999996 99999644321 0111111111
Q ss_pred cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 326 EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 326 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
....+...+.++.+++..||+.+|++||++.+|.+.|+.+
T Consensus 216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1122333456788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=308.92 Aligned_cols=264 Identities=22% Similarity=0.356 Sum_probs=206.7
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcC-----CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEec--Cce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSN-----GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSD--RRK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~ 155 (395)
.++|.+.+.||+|+||.||+|...+ +..|++|.+.... ....+.+.+|+.+++.++|+|++++++++.. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578889999999999999999765 6889999886432 2334668889999999999999999998765 356
Q ss_pred EEEEEcccCCChhhhcccCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 156 LLVYDYMANGGLQEHLYPANGS-NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
+++++|+.+++|.+++...... ......+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 7999999999999998654311 11224689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhccccc
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
|+++...............++..|+|||++.+..++.++||||||+++||+++ |+.||....+. ....+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~------- 231 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAY------- 231 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHH-------
Confidence 99975443322112222345678999999998889999999999999999999 99999654321 11111
Q ss_pred chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 314 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 314 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
+............+..+.+++.+||+.+|++|||+.++++.|+.+.+
T Consensus 232 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 232 -------LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -------HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00011111122234578999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=312.09 Aligned_cols=265 Identities=22% Similarity=0.369 Sum_probs=204.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc--------CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR- 153 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 153 (395)
++|.+.+.||+|+||.||++... ++..+|+|.+.... ......+..|+++++.+ +|+|++++++++.+.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56889999999999999999752 23469999987532 23345678899999999 799999999988766
Q ss_pred ceEEEEEcccCCChhhhcccCCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSN---------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 224 (395)
..++++||+.+|+|.+++....... .....+++.+++.++.|++.||+|||++ +++|+||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 5679999999999999996543211 1234689999999999999999999998 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchh
Q 016117 225 KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVL 303 (395)
Q Consensus 225 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~ 303 (395)
.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~----- 249 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----- 249 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----
Confidence 999999999999875432211111111224567999999998899999999999999999998 88888543210
Q ss_pred hhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 304 VSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.+...+........+...+..+.+++.+||+.+|++|||+.++++.|++++...
T Consensus 250 ------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 ------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred ------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 000111111111222234457889999999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=330.70 Aligned_cols=255 Identities=28% Similarity=0.424 Sum_probs=215.7
Q ss_pred CCCCeeeccCCeEEEEEEE-cCCc----EEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEc
Q 016117 88 SKSNVVGHGGFGLVYRGVL-SNGR----KVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDY 161 (395)
Q Consensus 88 ~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~ 161 (395)
...++||+|+||+||+|.+ ..|+ +||+|++... ......++..|+-+|..+.|||+++++|+|......+|++|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~ 778 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQL 778 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHh
Confidence 4467899999999999995 4444 6899988654 34456789999999999999999999999998888899999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
|+.|+|.+++...+ ..+-....+.|..|||+||.|||.+ .++||||.++||||.+-..+||.|||+++...
T Consensus 779 mP~G~LlDyvr~hr------~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR------DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred cccchHHHHHHHhh------ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 99999999997655 4688889999999999999999999 99999999999999999999999999999776
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
............-.+.|||-|.+....|+.++|||||||++||++| |..|+.... ...+.++
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-----------------~~eI~dl 912 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-----------------AEEIPDL 912 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-----------------HHHhhHH
Confidence 5544333333445678999999999999999999999999999998 999987543 2334445
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
+....+-..++-+..+++.++.+||..|+..||+++++...+.++.+.
T Consensus 913 le~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 913 LEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred HhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 544444456677888999999999999999999999999999888775
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=311.06 Aligned_cols=260 Identities=26% Similarity=0.430 Sum_probs=202.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCc----EEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGR----KVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv 158 (395)
++|+..+.||+|+||.||+|.+. +|. .+|+|.+..... .....+..|+.+++.++|||++++++++.....+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 45777889999999999999853 444 578888765422 223467889999999999999999999987777899
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
++|+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.
T Consensus 87 ~e~~~~g~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 87 TQLMPHGCLLDYVHEHK------DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred ehhcCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence 99999999999985432 3588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...............++..|+|||.+.+..++.++||||||+++|||++ |..||....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~------------- 221 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IP------------- 221 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-------------
Confidence 6543221111222335678999999998999999999999999999997 899986432110 01
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
.++........+......+.+++..||..+|++||++.++++.|+++.+...
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 222 -DLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred -HHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 1111000001112234568899999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=320.92 Aligned_cols=266 Identities=21% Similarity=0.362 Sum_probs=204.2
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccC-CCcceeEEEEEecC
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLR-SPYLLALLGYCSDR 153 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 153 (395)
...++|.+.+.||+|+||.||+|++. .+..||+|++..... ...+.+..|++++..+. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456788899999999999999853 346899999975422 22346888999999997 99999999998776
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCC------------------------------------------------------
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSN------------------------------------------------------ 178 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~------------------------------------------------------ 178 (395)
..++|+||+.+|+|.++++......
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 5679999999999999997542100
Q ss_pred -------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCE
Q 016117 179 -------------------------------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNI 221 (395)
Q Consensus 179 -------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni 221 (395)
.....+++..++.++.|++.||.|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 1123578889999999999999999988 999999999999
Q ss_pred EeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 016117 222 LLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGE 300 (395)
Q Consensus 222 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~ 300 (395)
|+++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~- 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE- 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-
Confidence 999999999999999975432221111223346788999999998889999999999999999998 888986432110
Q ss_pred chhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 301 GVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
.....+........+...+..+.+++..||+.+|++||++.+|++.|++++
T Consensus 350 ---------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 ---------------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 011111111111112223457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=309.92 Aligned_cols=258 Identities=26% Similarity=0.384 Sum_probs=199.8
Q ss_pred CCCCCeeeccCCeEEEEEEEcC------CcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 87 FSKSNVVGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
|.+.+.||+|+||.||+|...+ +..||+|++...... ..+.+..|+.++..++||||+++++++.+. ..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 5667889999999999998532 478999998754322 235688899999999999999999998776 56699
Q ss_pred EEcccCCChhhhcccCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcE
Q 016117 159 YDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 229 (395)
++|+.+++|.+++...... ......+++..+..++.|++.||.|||++ +++||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCce
Confidence 9999999999998532110 11224588999999999999999999998 99999999999999999999
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhh
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~ 308 (395)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---------- 233 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---------- 233 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH----------
Confidence 9999999875433222222223445778999999988889999999999999999998 88888643211
Q ss_pred cccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 309 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
.....+.+.. ....+.+.+..+.+++..||+.+|.+||++.+|+..|++
T Consensus 234 ------~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 234 ------DVIEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ------HHHHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0111111111 112233455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=321.65 Aligned_cols=240 Identities=28% Similarity=0.442 Sum_probs=202.6
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~ 156 (395)
.-++|.+.++||+|.||+|+++..+ +++.+|||++++.. ..+.+..+.|..++... +||.++.++..++.. +.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3457899999999999999999965 68899999998653 34556778888888877 599999999988877 567
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+||||+.||++..+. ....+++..+..++..|+.||+|||++ +|++||||.+|||+|.+|.+||+|||+
T Consensus 446 fvmey~~Ggdm~~~~--------~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI--------HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred EEEEecCCCcEEEEE--------ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccc
Confidence 999999999944444 235799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
++.... .+......|||+.|+|||++.+..|+.+.|.|||||+||||+.|..||..+++.
T Consensus 515 cKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe------------------ 574 (694)
T KOG0694|consen 515 CKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE------------------ 574 (694)
T ss_pred ccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH------------------
Confidence 986432 223567799999999999999999999999999999999999999999865431
Q ss_pred hhhhcccccc--CCCCHHHHHHHHHHHhhcCCCCCCCCCCH
Q 016117 317 ILEIMDPALE--GQYSMKEVIQVAAIAAMCVQPEADYRPLM 355 (395)
Q Consensus 317 ~~~~~d~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 355 (395)
+++|..+. -.|+...+.+...++.++|..||++|.-+
T Consensus 575 --e~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 --EVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --HHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 22332222 24666777889999999999999999977
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=303.57 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=198.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
++|++.+.||+|+||+||++...++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+. ..+++|||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 357788899999999999999877778999988754 33456789999999999999999999998766 4579999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 83 NGCLLNYLREHG------KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 999999985322 3589999999999999999999998 9999999999999999999999999998754332
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .. ..+..
T Consensus 154 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~-------------~~~~~ 216 (256)
T cd05113 154 EY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TV-------------EKVSQ 216 (256)
T ss_pred ce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HH-------------HHHhc
Confidence 11 11112235567999999988889999999999999999998 999986433110 00 01110
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
. .....+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 217 ~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 217 G-LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred C-CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 000111123457899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=302.24 Aligned_cols=247 Identities=24% Similarity=0.399 Sum_probs=192.9
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCCh
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 167 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L 167 (395)
+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+++++.++||||+++++++... ..++|+||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999964 78999999876432 23345788999999999999999999998776 56699999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCc
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 247 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 247 (395)
.+++... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 151 (252)
T cd05084 81 LTFLRTE------GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS 151 (252)
T ss_pred HHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccc
Confidence 9998532 23588999999999999999999998 99999999999999999999999999987533211111
Q ss_pred eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccccc
Q 016117 248 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALE 326 (395)
Q Consensus 248 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 326 (395)
.......+..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+.....
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-----------------~~~~~~~~~~~ 214 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-----------------QTREAIEQGVR 214 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-----------------HHHHHHHcCCC
Confidence 0111123456999999998889999999999999999998 88888643211 01111111111
Q ss_pred CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 327 GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 327 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
...+...+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1222233557899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.90 Aligned_cols=269 Identities=24% Similarity=0.371 Sum_probs=200.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+++++.++|+||+++++++.+. ..+++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367999999999999999999965 68889999886532 23345788999999999999999999988766 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+|+|.+++.. ...+++..+..++.|++.||.|||+.. +++|+||||+|||+++++.+||+|||++...
T Consensus 84 ~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 84 HMDGGSLDQVLKK-------AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred cCCCCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 9999999999853 235888999999999999999999742 6999999999999999999999999998754
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhh----hhh------cc
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS----WAL------PR 310 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~----~~~------~~ 310 (395)
.... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||............. ... ..
T Consensus 155 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred hhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 3221 223468899999999998899999999999999999999999997543211000000 000 00
Q ss_pred ccc--------------chhhhhhcccccc----CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 311 LTD--------------REKILEIMDPALE----GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 311 ~~~--------------~~~~~~~~d~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
... ......+.+.... .........++.+|+.+||+.||++|||+.+++.+ .++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h--~~~~ 303 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH--AFIK 303 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC--HHHh
Confidence 000 0000000000000 00001123568899999999999999999999854 5554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=318.75 Aligned_cols=265 Identities=23% Similarity=0.346 Sum_probs=194.2
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC------ceE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------RKL 156 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 156 (395)
+|++.+.||+|+||.||+|... ++..||+|.+... .......+.+|+++++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999964 7899999988643 122345678899999999999999999987532 357
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
++|||+. ++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+
T Consensus 81 lv~e~~~-~~L~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~ 149 (338)
T cd07859 81 VVFELME-SDLHQVIKA-------NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGL 149 (338)
T ss_pred EEEecCC-CCHHHHHHh-------cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcc
Confidence 9999995 688888842 23589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC-ceeeccccccccccchhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhh-----
Q 016117 237 AKIGSDKAGG-HVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL----- 308 (395)
Q Consensus 237 ~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~----- 308 (395)
+......... .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||................
T Consensus 150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229 (338)
T ss_pred ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9754322211 11234568999999999875 678999999999999999999999996543211000000000
Q ss_pred ---cccccc--hhhhhhccccccCCCC---HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 309 ---PRLTDR--EKILEIMDPALEGQYS---MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 309 ---~~~~~~--~~~~~~~d~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...... ......+......... ......+.+++.+||+.+|++|||+.+++++
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000 0000000000000000 0123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=310.38 Aligned_cols=267 Identities=21% Similarity=0.368 Sum_probs=206.1
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc--------CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR 153 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 153 (395)
..+|.+.+.||+|+||.||++... ++..+++|.+.... ....+.+..|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 346788899999999999999741 24579999886432 23346788999999999 899999999988766
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSN---------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 223 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill 223 (395)
..+++|||+.+|+|.+++....... .....+++..+..++.|++.||.|||++ +++|+||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 5679999999999999997543211 1234688999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCch
Q 016117 224 DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGV 302 (395)
Q Consensus 224 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~ 302 (395)
++++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---- 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 246 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence 9999999999999976543322222222345678999999998889999999999999999998 78888543211
Q ss_pred hhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 303 LVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
. +...+........+...+..+.+++.+||+.+|++|||+.++++.|++++...+
T Consensus 247 --~-----------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 247 --E-----------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred --H-----------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 0 000010001111122345678899999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=308.96 Aligned_cols=264 Identities=27% Similarity=0.419 Sum_probs=203.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcC-Cc--EEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSN-GR--KVAIKLMDQA-GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv 158 (395)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.+..|+++++++ +|||++++++++.+. ..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998653 33 4788887642 233446788899999999 799999999988766 56799
Q ss_pred EEcccCCChhhhcccCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcE
Q 016117 159 YDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 229 (395)
+||+++++|.+++...... ......+++..++.++.|++.||+|||++ +++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 9999999999999653211 11224689999999999999999999998 99999999999999999999
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhh
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~ 308 (395)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||....... .
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~----- 227 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---L----- 227 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H-----
Confidence 999999986322110 0111223457999999998889999999999999999997 999996443210 0
Q ss_pred cccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 309 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
. ..+........+...+..+.+|+.+||+.+|.+|||+.++++.|+.++...+.
T Consensus 228 --------~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 228 --------Y-EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred --------H-HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 00111111112223345688999999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=303.27 Aligned_cols=260 Identities=22% Similarity=0.329 Sum_probs=204.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+..|+++++.++|||++++++++.+. ..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999954 78999999875422 22335678899999999999999999987765 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++..... ....++...+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~ 155 (267)
T cd08228 82 ELADAGDLSQMIKYFKK---QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred EecCCCcHHHHHHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECcccccee
Confidence 99999999988854321 124588999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
...... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||....... ... ...
T Consensus 156 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~----------~~~ 219 (267)
T cd08228 156 FSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSL----------CQK 219 (267)
T ss_pred ccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHH----------HHH
Confidence 443221 1123457889999999998889999999999999999999999986433210 000 000
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
+.............+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00000111112234567899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=316.65 Aligned_cols=266 Identities=24% Similarity=0.357 Sum_probs=202.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE------cCCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC--
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-- 153 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-- 153 (395)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+..|+.++.++ +|+||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35789999999999999999973 346789999987532 22345678899999999 689999999987654
Q ss_pred ceEEEEEcccCCChhhhcccCCCCC-------------------------------------------------------
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSN------------------------------------------------------- 178 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~------------------------------------------------------- 178 (395)
..++++||+++|+|.+++.......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 4579999999999999986532110
Q ss_pred -----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeeccc
Q 016117 179 -----SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 253 (395)
Q Consensus 179 -----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 253 (395)
.....+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0113478889999999999999999998 99999999999999999999999999987543222111122234
Q ss_pred cccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHH
Q 016117 254 GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMK 332 (395)
Q Consensus 254 g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 332 (395)
++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... ..+........+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~--------------~~~~~~~~~~~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC--------------RRLKEGTRMRAPDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH--------------HHHhccCCCCCCCC
Confidence 5677999999998899999999999999999997 899986432110 000 00000000001111
Q ss_pred HHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 333 EVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 333 ~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
....+.+++..||+.+|++|||+.+|+++|++++..
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 234688999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=310.54 Aligned_cols=264 Identities=21% Similarity=0.316 Sum_probs=194.1
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.++|.+.+.||+|+||+||+|... +++.+|+|++..... .....+.+|+.+++.++||||+++++++.+. ..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999965 788999999874322 2234567899999999999999999998776 5669999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+. ++|.+++.... ..++...+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++...
T Consensus 84 ~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 153 (303)
T cd07869 84 YVH-TDLCQYMDKHP------GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAK 153 (303)
T ss_pred CCC-cCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence 995 68888775322 4588899999999999999999999 9999999999999999999999999998753
Q ss_pred CCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc--ch--
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD--RE-- 315 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~-- 315 (395)
.... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||....... ............ ..
T Consensus 154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 229 (303)
T cd07869 154 SVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTW 229 (303)
T ss_pred cCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhc
Confidence 3221 12233567899999999875 458889999999999999999999997532210 000000000000 00
Q ss_pred -hhhhh--cccc-cc--CCCCH-------HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 316 -KILEI--MDPA-LE--GQYSM-------KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 316 -~~~~~--~d~~-~~--~~~~~-------~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..... +++. .. ..... .....+.+|+.+||+.||.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000 0000 00 00000 012457899999999999999999999963
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=310.59 Aligned_cols=263 Identities=23% Similarity=0.395 Sum_probs=203.9
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-c
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-R 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 154 (395)
.++|++.+.||+|+||.||++... ....+++|.+.... ......+..|++++..+ +|+||+++++++..+ .
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 456888899999999999999863 23679999887532 23345688899999999 899999999988766 5
Q ss_pred eEEEEEcccCCChhhhcccCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC
Q 016117 155 KLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK 225 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~ 225 (395)
.+++|||+++|+|.+++...... ......+++..++.++.|++.||.|||+. +++||||||+||+++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 67999999999999998643210 02235689999999999999999999998 9999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhh
Q 016117 226 NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLV 304 (395)
Q Consensus 226 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~ 304 (395)
++.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------ 241 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE------ 241 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH------
Confidence 99999999999986543221111222334567999999988899999999999999999998 99998643211
Q ss_pred hhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 305 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
.....+........+......+.+|+.+||+.+|++|||+.++++.|+.++
T Consensus 242 -----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 -----------ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 011111111111222234557899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=315.65 Aligned_cols=238 Identities=26% Similarity=0.356 Sum_probs=189.6
Q ss_pred eeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCCh
Q 016117 93 VGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 167 (395)
Q Consensus 93 lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L 167 (395)
||+|+||.||++... +++.||+|++... .......+..|+.++++++||||+++++++.+. ..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 6889999998642 223345677899999999999999999988766 56799999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCc
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 247 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 247 (395)
.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 148 (312)
T cd05585 81 FHHLQRE-------GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--D 148 (312)
T ss_pred HHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--C
Confidence 9998532 3589999999999999999999998 99999999999999999999999999987533221 1
Q ss_pred eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccC
Q 016117 248 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327 (395)
Q Consensus 248 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 327 (395)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+.....
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~----------------~~~~~~~~~~~-- 210 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN----------------EMYRKILQEPL-- 210 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH----------------HHHHHHHcCCC--
Confidence 223456899999999999999999999999999999999999999743211 00111111111
Q ss_pred CCCHHHHHHHHHHHhhcCCCCCCCCCC---HHHHHH
Q 016117 328 QYSMKEVIQVAAIAAMCVQPEADYRPL---MADVVQ 360 (395)
Q Consensus 328 ~~~~~~~~~l~~li~~cl~~~p~~RPt---~~~vl~ 360 (395)
..+......+.+++.+||+.||.+||+ +.+++.
T Consensus 211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 122233456889999999999999986 455554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=318.86 Aligned_cols=244 Identities=23% Similarity=0.342 Sum_probs=196.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcC--CcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSN--GRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
++|.+.+.||+|+||.||+|...+ +..||+|.+... .....+.+..|+.+++.++||||+++++++.+. ..+++
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998543 368999988642 123345678899999999999999999998877 46699
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+.+|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.
T Consensus 110 ~Ey~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN-------KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 9999999999999532 3688999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
..... .....||+.|+|||++.+..++.++|||||||++|||++|..||....+.. ...
T Consensus 180 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----------------~~~ 238 (340)
T PTZ00426 180 VVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----------------IYQ 238 (340)
T ss_pred ecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----------------HHH
Confidence 64321 124568999999999999889999999999999999999999997543210 011
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
.+..... .++......+.+++.+||+.+|++|+ |+.+++++
T Consensus 239 ~i~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 239 KILEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111111 11222334578999999999999995 89998875
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=316.27 Aligned_cols=241 Identities=27% Similarity=0.371 Sum_probs=191.9
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANG 165 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 165 (395)
+.||+|+||.||++... +|..||+|++... .......+..|+.+++.++||||+++++++... ..++||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999954 7899999998743 122344667899999999999999999988766 567999999999
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCC
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 245 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 245 (395)
+|..++.. ...+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~- 149 (323)
T cd05595 81 ELFFHLSR-------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 149 (323)
T ss_pred cHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-
Confidence 99988843 23689999999999999999999999 99999999999999999999999999987532211
Q ss_pred CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccc
Q 016117 246 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 325 (395)
Q Consensus 246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 325 (395)
.......|++.|+|||++.+..++.++|||||||++|||++|..||...+... ....+.....
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~----------------~~~~~~~~~~ 212 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----------------LFELILMEEI 212 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH----------------HHHHHhcCCC
Confidence 11233568999999999999999999999999999999999999996433210 0011111110
Q ss_pred cCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 326 EGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 326 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
..+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 213 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred --CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 11222345688999999999999998 88888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=310.12 Aligned_cols=264 Identities=22% Similarity=0.275 Sum_probs=192.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc--CCcEEEEEEeccCC--cccHHHHHHHHHHHhcc---CCCcceeEEEEEec-----
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS--NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRL---RSPYLLALLGYCSD----- 152 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~----- 152 (395)
.+|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46889999886432 22234556677777665 69999999998752
Q ss_pred -CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEE
Q 016117 153 -RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 231 (395)
Q Consensus 153 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl 231 (395)
...++++||+. ++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl 151 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 151 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEE
Confidence 24679999996 68999885432 23589999999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchh-hhhhhcc
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL-VSWALPR 310 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~-~~~~~~~ 310 (395)
+|||++...... .......|++.|+|||.+.+..++.++|||||||++|||++|..||......+.... .......
T Consensus 152 ~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~ 228 (290)
T cd07862 152 ADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 228 (290)
T ss_pred ccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 999999764332 122345689999999999988999999999999999999999999975432211100 0000000
Q ss_pred cccc-hhh----hhhccccccC---CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 311 LTDR-EKI----LEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 311 ~~~~-~~~----~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
.... ... ...+.+.... ......+..+.+++.+||+.+|++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 000 0000000000 001123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=306.66 Aligned_cols=266 Identities=26% Similarity=0.372 Sum_probs=201.5
Q ss_pred CCCCeeeccCCeEEEEEEE-----cCCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEEE
Q 016117 88 SKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLV 158 (395)
Q Consensus 88 ~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv 158 (395)
.+.+.||+|+||+||++.. .++..+|+|.+..... .....+.+|+++++.++|||++++++++... ..+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7788999999999988653 3577899999875432 2356788899999999999999999987643 35699
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+.+++|.+++.. ..+++..++.++.|++.||.|||++ +++|+||||+||++++++.++|+|||++.
T Consensus 87 ~e~~~~~~l~~~~~~--------~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 87 MEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred ecCCCCCCHHHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence 999999999999842 3589999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCc-eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
......... ......++..|+|||.+.+..++.++||||||+++|||++|..||........ ......... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~~ 233 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVVRL 233 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchhhh
Confidence 654322111 11223356679999999888899999999999999999999999864322100 001000000 001111
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
....+.......+...+..+.+++..||+.+|++|||+.++++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 2222222222223334567999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=307.03 Aligned_cols=259 Identities=27% Similarity=0.403 Sum_probs=201.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
.+|...++||+|+||.||++... ++..+++|.+..........+.+|+++++.++|+||+++++++.+. ..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45777889999999999999742 3567899988766556667899999999999999999999988776 5679
Q ss_pred EEEcccCCChhhhcccCCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcE
Q 016117 158 VYDYMANGGLQEHLYPANGS--------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 229 (395)
++||+++++|.+++...... ......+++..++.++.|++.||+|||+. +++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 99999999999998654311 01123589999999999999999999998 99999999999999999999
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhh
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~ 308 (395)
+|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------- 232 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--------- 232 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---------
Confidence 9999999875432221111222335678999999999999999999999999999998 899986432110
Q ss_pred cccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 309 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
........ .....+...+..+.+++.+||+.+|++||++.+|.+.|+
T Consensus 233 -------~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 -------AIECITQG-RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -------HHHHHHcC-ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00111110 001111223456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=302.04 Aligned_cols=249 Identities=28% Similarity=0.425 Sum_probs=197.2
Q ss_pred CCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
+|++.+.||+|+||.||++.+.++..+++|.+.... .....+..|+++++.++|+|++++++++.+. ..++++||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477889999999999999998777889999886432 2345788899999999999999999988766 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 84 ~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 84 GCLLNYLRERK------GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 99999985432 3689999999999999999999999 99999999999999999999999999987543221
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ... .+.....
T Consensus 155 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~----------~~~~~~~- 219 (256)
T cd05059 155 YT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE----------SVSAGYR- 219 (256)
T ss_pred cc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH----------HHHcCCc-
Confidence 11 1111223457999999998899999999999999999999 899986432210 000 0001011
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
...+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 220 ---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 ---LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111122455789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=315.63 Aligned_cols=241 Identities=24% Similarity=0.362 Sum_probs=192.7
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANG 165 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 165 (395)
+.||+|+||.||++... +|+.||+|++.... ......+..|+.+++.++||||+++.+++.+. ..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999954 68999999987431 23345677899999999999999999988766 567999999999
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCC
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 245 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 245 (395)
+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~- 149 (328)
T cd05593 81 ELFFHLSR-------ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA- 149 (328)
T ss_pred CHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-
Confidence 99988843 23689999999999999999999999 99999999999999999999999999987532211
Q ss_pred CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccc
Q 016117 246 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 325 (395)
Q Consensus 246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 325 (395)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... . ...+....
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~-------------~~~~~~~~- 211 (328)
T cd05593 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---L-------------FELILMED- 211 (328)
T ss_pred -cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---H-------------HHHhccCC-
Confidence 12234568999999999999899999999999999999999999996432110 0 00000000
Q ss_pred cCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 326 EGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 326 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
...+...+.++.+++.+||+.||++|| ++.+++++
T Consensus 212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 -IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 011222345688999999999999997 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=305.47 Aligned_cols=268 Identities=23% Similarity=0.324 Sum_probs=201.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-----cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~ 156 (395)
.+|++.+.||+|+||+||++.. .++..|++|.+........+.+.+|+++++.++|||++++++++... ..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 25789999998766555567889999999999999999999976432 467
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+++||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +++|+||||+||++++++.++|+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR------ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred EEEEecCCCCHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence 9999999999999985332 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCce-eeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc---
Q 016117 237 AKIGSDKAGGHV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT--- 312 (395)
Q Consensus 237 ~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--- 312 (395)
+........... .....++..|+|||++.+..++.++||||||+++|||++|..|+...... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~ 230 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQM 230 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhccccccccc
Confidence 986543221111 11122345699999999889999999999999999999988775432211 0000000000
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
....+.+.+............+..+.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00011111111111112223445799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=301.75 Aligned_cols=261 Identities=27% Similarity=0.425 Sum_probs=202.5
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhc--cCCCcceeEEEEEecC-----ce
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGR--LRSPYLLALLGYCSDR-----RK 155 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~-----~~ 155 (395)
...+..+.+.||+|.||.||+|.+ .|+.||||++... +++.+.+|.++++. |+|+||+.+++.-..+ +.
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 345678889999999999999999 7899999999743 45678889999988 4999999999864332 46
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCceeCCCCCCCEEeCCCCcEE
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-----HCSPPVIHRDFKSSNILLDKNFHAK 230 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~i~H~dlk~~Nill~~~~~~k 230 (395)
++|++|.++|||.|||. ...++....++++..+|.||++||. +..|.|.|||||+.||||..++.+.
T Consensus 285 wLvTdYHe~GSL~DyL~--------r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLN--------RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEeeecccCCcHHHHHh--------hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 79999999999999994 3579999999999999999999994 3578999999999999999999999
Q ss_pred EeccccccccCCCCC--CceeeccccccccccchhhccCC----C--CccchhHHHHHHHHHHHhC----------CCCC
Q 016117 231 VSDFGLAKIGSDKAG--GHVSTRVLGTQGYVAPEYALTGH----L--TTKSDVYSYGVVLLELLTG----------RVPI 292 (395)
Q Consensus 231 l~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~----~--~~~~DvwslG~~l~ell~g----------~~pf 292 (395)
|+|+|+|........ .......+||.+|||||++...- + -..+||||||.++||++.. +.||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 999999975443321 12234568999999999987532 2 2368999999999998763 3566
Q ss_pred CCCCCCCCchhhhhhhcccccchhhhhh-----ccccccC-CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 293 DVNKPSGEGVLVSWALPRLTDREKILEI-----MDPALEG-QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~d~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
....+.+... +.+.++ +.|.+.. -.+.+....+.++++.||..||.-|.|+--|-+.|.++.
T Consensus 437 yd~Vp~DPs~------------eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 437 YDVVPSDPSF------------EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred ccCCCCCCCH------------HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 5433322111 111111 1122221 223455678999999999999999999999999998887
Q ss_pred h
Q 016117 367 K 367 (395)
Q Consensus 367 ~ 367 (395)
+
T Consensus 505 ~ 505 (513)
T KOG2052|consen 505 N 505 (513)
T ss_pred c
Confidence 5
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=303.69 Aligned_cols=267 Identities=24% Similarity=0.348 Sum_probs=199.0
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC----ceE--EEE
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR----RKL--LVY 159 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----~~~--lv~ 159 (395)
|...+++|.|+||.||.|... +++.||||..-...+ --..|+++|+.+.|||||++.-++... +.+ +|+
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 555789999999999999954 579999998754432 223599999999999999999877532 223 899
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC-CcEEEecccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAK 238 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~ 238 (395)
|||+. +|.+++..... ....++.-.+.-+..|+++||+|||+. +|+||||||.|+|+|.+ |.+||||||-|+
T Consensus 102 eymP~-tL~~~~r~~~~---~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTR---ANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HhchH-HHHHHHHHHhh---cCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 99976 88888865432 235688888899999999999999998 99999999999999976 999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...... ......+|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+++..+....+-........ ..+
T Consensus 175 ~L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~-e~I 250 (364)
T KOG0658|consen 175 VLVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR-EDI 250 (364)
T ss_pred eeccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH-HHH
Confidence 765543 23456688999999998875 7999999999999999999999999876544322222111111111 111
Q ss_pred hh-------hccccccC-----CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 318 LE-------IMDPALEG-----QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 318 ~~-------~~d~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
.. .-.+.+.. -.....+.++.+|+.++++.+|.+|.++.+++.+ .+.+..+
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h--~fFdelr 313 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH--PFFDELR 313 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc--hhhHHhh
Confidence 11 11111111 1223345689999999999999999999999954 4444433
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=303.08 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=204.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcC----CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~ 159 (395)
.+|.+.+.||+|+||.||+|...+ ...+++|...... ....+.+.+|+.+++.++|+|++++++++.+...++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 457888999999999999998643 2468999886543 33456788999999999999999999999888888999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 86 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 86 ELAPLGELRSYLQVNK------YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EcCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence 9999999999995422 3589999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... .......++..|+|||.+....++.++||||||+++||+++ |..||....... ..... .
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~----------~ 222 (270)
T cd05056 157 LEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIGRI----------E 222 (270)
T ss_pred cccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH----------H
Confidence 443211 11112234567999999988889999999999999999986 999996443211 00000 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
. ......+...+..+.+++.+|+..+|++|||+.++++.|+++...+
T Consensus 223 ~----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 223 N----GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred c----CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0 0000112233457899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=299.26 Aligned_cols=259 Identities=22% Similarity=0.377 Sum_probs=205.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||.||+|... +|+.+++|.++.. .....+.+.+|++++++++|+|++++++++.+. ..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999976 7899999988632 222345788999999999999999999988766 556999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++..... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 82 e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~ 155 (267)
T cd08224 82 ELADAGDLSRMIKHFKK---QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred ecCCCCCHHHHHHHhcc---cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeee
Confidence 99999999998854321 234589999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
...... ......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ... ..+
T Consensus 156 ~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-----------~~~ 218 (267)
T cd08224 156 FSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-----------LCK 218 (267)
T ss_pred ccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH-----------HHh
Confidence 433221 122345788899999999888999999999999999999999998643311 000 000
Q ss_pred hccccccCCCCH-HHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 320 IMDPALEGQYSM-KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 320 ~~d~~~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
.+........+. ..+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 219 KIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 000001111122 34557899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=308.30 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=201.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ce
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~ 155 (395)
++|.+.+.||+|+||.||++... .+..+|+|.+.... ....+.+.+|+.+++++ +|+||+++++++... ..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888999999999999999742 34579999887542 22345788999999999 799999999988766 56
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++++||+.+|+|.+++.... ...+++.++..++.|++.||.|||++ +++|+||||+|||++.++.++++|||
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~-----~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR-----ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 79999999999999995432 12489999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
++................++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------------- 251 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------------- 251 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---------------
Confidence 9975443321111222345678999999999999999999999999999998 999986433210
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
..............+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 252 -~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 252 -KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00111111111111112345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=304.96 Aligned_cols=259 Identities=25% Similarity=0.383 Sum_probs=201.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~ 156 (395)
++|.+.+.||+|+||.||+|... .+..+++|.+.... ......+.+|+.+++.++|+|++++++++... ..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 46888899999999999999864 23689999986442 23345788899999999999999999988766 567
Q ss_pred EEEEcccCCChhhhcccCCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEec
Q 016117 157 LVYDYMANGGLQEHLYPANGSN---SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 233 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 233 (395)
+++||+++|+|.+++....... .....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 9999999999999986543211 1234578999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccc
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
||+++...............++..|+|||.+.+..++.++||||||+++||+++ |..||....... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~------- 232 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLK------- 232 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHH-------
Confidence 999875443322122223446778999999988889999999999999999998 999986433211 000
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
.+.+. .....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 233 ------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 ------FVIDG-GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ------HHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 00000 011112223567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=305.50 Aligned_cols=265 Identities=24% Similarity=0.372 Sum_probs=202.3
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-c
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R 154 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~ 154 (395)
..++|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++|+|++++++++.+. .
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3467899999999999999999753 245799998764322 2234677899999999999999999988766 5
Q ss_pred eEEEEEcccCCChhhhcccCCCCC---CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEE
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSN---SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 231 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl 231 (395)
.+++|||+.+|+|.+++....... ......++..+..++.|++.||.|||++ +++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 679999999999999996543211 1124567888999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcc
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPR 310 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 310 (395)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------------ 228 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------------ 228 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 99999875433221111122335677999999998899999999999999999998 78888643211
Q ss_pred cccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 311 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.....+.+... ...+...+..+.+++.+||+.+|++|||+.++++.|++.+.
T Consensus 229 ----~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 229 ----QVLKFVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred ----HHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 00011111100 01112234579999999999999999999999998888754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=301.42 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=200.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CC---cEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NG---RKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
++|+..+.||+|+||.||+|... ++ ..+++|.+.... ....+.+..|+++++.++|+|++++.+++.+. ..+++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46778899999999999999964 33 369999886542 23346788999999999999999999988766 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+.+++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 85 TEYMENGALDKYLRDHD------GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred EEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccce
Confidence 99999999999985322 3689999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCCCcee-eccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 239 IGSDKAGGHVS-TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 239 ~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
........... .....+..|+|||++.+..++.++||||||+++|||++ |..||...... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~------------ 220 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVM------------ 220 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHH------------
Confidence 55432211111 11223457999999998889999999999999999997 99999643211 000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
..+ ..........+.+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 221 -~~i-~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 221 -KAI-NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -HHH-hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 011 111111122234567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=313.24 Aligned_cols=241 Identities=26% Similarity=0.406 Sum_probs=191.6
Q ss_pred CeeeccCCeEEEEEEE----cCCcEEEEEEeccCC----cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 91 NVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+.||+|+||.||++.. .+++.||+|++.... ......+..|+.+++.++||||+++++++..+ ..+++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 357899999986421 22334567899999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+|+|.+++... ..+.+..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (323)
T cd05584 82 LSGGELFMHLERE-------GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESI 151 (323)
T ss_pred CCCchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence 9999999998532 3578889999999999999999999 99999999999999999999999999987432
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
... .......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .....+.
T Consensus 152 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~----------------~~~~~~~ 213 (323)
T cd05584 152 HEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK----------------KTIDKIL 213 (323)
T ss_pred cCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH----------------HHHHHHH
Confidence 221 1223456899999999999888999999999999999999999999754321 0111111
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
.... ..+...+..+.+++.+||+.+|++|| ++.+++++
T Consensus 214 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 214 KGKL--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred cCCC--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1111 12222345688999999999999999 88888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=320.65 Aligned_cols=250 Identities=25% Similarity=0.343 Sum_probs=199.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||+||+|... +|+.||+|++.... ......+..|++++..++|+||+++++++.++ ..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999965 78999999987431 23445788899999999999999999988776 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+|||++.++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 150 (350)
T cd05573 81 EYMPGGDLMNLLIRK-------DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKK 150 (350)
T ss_pred cCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence 999999999999533 4689999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCC---------------------------CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCC
Q 016117 240 GSDKA---------------------------GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 292 (395)
Q Consensus 240 ~~~~~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf 292 (395)
..... .........||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf 230 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence 44322 001123356899999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhhhcccccchhhhhhcc--ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-HHHHHHH
Q 016117 293 DVNKPSGEGVLVSWALPRLTDREKILEIMD--PALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-MADVVQS 361 (395)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~~vl~~ 361 (395)
....... ....+.. ..+........+..+.+++.+|++ +|.+||+ +.+++++
T Consensus 231 ~~~~~~~----------------~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 231 YSDTLQE----------------TYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCCHHH----------------HHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 7543211 0111111 111111111135578899999997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.11 Aligned_cols=249 Identities=26% Similarity=0.400 Sum_probs=196.2
Q ss_pred CeeeccCCeEEEEEEEc-C---CcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccCC
Q 016117 91 NVVGHGGFGLVYRGVLS-N---GRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANG 165 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g 165 (395)
+.||+|+||.||+|... . +..+++|.+..... ...+.+..|+.+++.+.|+|++++++++.....++++||+.+|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 46999999999999843 2 26899999875433 2456788999999999999999999998877888999999999
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCC
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 245 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 245 (395)
+|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 81 PLLKYLKKR-------REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred cHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 999999532 2688999999999999999999998 999999999999999999999999999876533221
Q ss_pred Cce-eeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 246 GHV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 246 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...... ..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~--------------~~ 213 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAML--------------ES 213 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH--------------Hc
Confidence 111 111223467999999998899999999999999999998 99999644321 111111 00
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
......+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 214 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 214 GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0001112223457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=312.95 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=191.2
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHH---hccCCCcceeEEEEEecC-ceEEE
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELL---GRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
|++.+.||+|+||.||++... +++.||+|++.... ....+.+..|..++ +.++||||+++++++.+. ..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999964 68999999987432 22234566666554 566899999999998776 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+.+|+|..++.. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 81 ~E~~~~~~L~~~~~~--------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05589 81 MEYAAGGDLMMHIHT--------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK 149 (324)
T ss_pred EcCCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence 999999999988732 3589999999999999999999998 99999999999999999999999999986
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... .......|++.|+|||.+.+..++.++|||||||++|||++|..||....... ...
T Consensus 150 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~----------------~~~ 211 (324)
T cd05589 150 EGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE----------------VFD 211 (324)
T ss_pred cCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH----------------HHH
Confidence 432211 12234568999999999999999999999999999999999999997543210 011
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
.+..... .++...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 212 ~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 212 SIVNDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHhCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1111111 12222345688999999999999999 57777654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=317.07 Aligned_cols=202 Identities=26% Similarity=0.414 Sum_probs=171.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||++... +++.||+|++.... ......+..|+.++..++|+||+++++.+.+. ..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999854 68899999986432 22335677899999999999999999988877 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~ 150 (363)
T cd05628 81 EFLPGGDMMTLLMKK-------DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150 (363)
T ss_pred cCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence 999999999999532 4689999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCC---------------------------------CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHH
Q 016117 240 GSDKAG---------------------------------GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELL 286 (395)
Q Consensus 240 ~~~~~~---------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 286 (395)
...... .......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 230 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence 322110 00112357999999999999999999999999999999999
Q ss_pred hCCCCCCCCC
Q 016117 287 TGRVPIDVNK 296 (395)
Q Consensus 287 ~g~~pf~~~~ 296 (395)
+|..||....
T Consensus 231 ~G~~Pf~~~~ 240 (363)
T cd05628 231 IGYPPFCSET 240 (363)
T ss_pred hCCCCCCCCC
Confidence 9999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=299.07 Aligned_cols=254 Identities=27% Similarity=0.434 Sum_probs=203.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
.++|.+.+.||+|+||.||+|...++..+++|.+.... ...+.+.+|+.+++.++|+|++++++++.+. ..++++||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 45788999999999999999998888899999987543 3456789999999999999999999998775 677999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++++|.+++.... ...+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++|+|||++.....
T Consensus 84 ~~~~L~~~i~~~~-----~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 84 SKGSLLDFLKSGE-----GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred CCCCHHHHHhccc-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999995432 24689999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
... .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... .... .+.
T Consensus 156 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~-------------~~~ 218 (261)
T cd05034 156 DEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLE-------------QVE 218 (261)
T ss_pred hhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH-------------HHH
Confidence 211 11112234567999999998889999999999999999999 99998643211 0111 110
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
.......+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 219 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 219 -RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001111112234578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=302.36 Aligned_cols=255 Identities=26% Similarity=0.421 Sum_probs=198.7
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CC---cEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NG---RKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
.|.+.+.||+|+||.||+|.+. ++ ..|++|.+... .......|..|+.+++.++|||++++++++.++ ..++++
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4678899999999999999964 33 36999998754 233456789999999999999999999988766 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 85 e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 85 EFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred ecCCCCcHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccc
Confidence 9999999999985432 3589999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCCceeec-cc--cccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 240 GSDKAGGHVSTR-VL--GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 240 ~~~~~~~~~~~~-~~--g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
............ .. .+..|+|||.+.+..++.++||||||+++|||++ |..||...... ....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i-------- 224 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI-------- 224 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH--------
Confidence 433221111111 11 2357999999998899999999999999999886 99998643321 111110
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
.. ......+.+.+..+.+++.+||+.+|++||++.+|+..|++++
T Consensus 225 --~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 225 --EQ----DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred --Hc----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 00 0111112234456889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=307.92 Aligned_cols=264 Identities=22% Similarity=0.380 Sum_probs=203.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc--------CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR- 153 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 153 (395)
++|.+.+.||+|+||.||++... ....+|+|.+.... ......+..|+.+++.+ +||||+++++++.+.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56788899999999999999742 24568999887432 23345688899999999 699999999998766
Q ss_pred ceEEEEEcccCCChhhhcccCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 224 (395)
..++++||+++|+|.+++...... ......+++.++..++.|++.||.|||++ +++|+||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 467999999999999999654321 11234689999999999999999999998 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchh
Q 016117 225 KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVL 303 (395)
Q Consensus 225 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~ 303 (395)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---- 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---- 244 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 999999999999975443221111112234467999999998899999999999999999999 888886432110
Q ss_pred hhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 304 VSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
....+........+...+..+.+++.+||+.+|++|||+.++++.|+++...
T Consensus 245 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 245 -------------LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred -------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 0000000111112223345788999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=300.45 Aligned_cols=273 Identities=23% Similarity=0.305 Sum_probs=207.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEecc--CCcccHHHHHHHHHHHhccCCCcceeEEEEEec------Cc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQ--AGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD------RR 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 154 (395)
...|...+.||+|+||.|+.+... +|+.||||.+.. ......+...+|+.+|+.++|+||+.+.+++.. ..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 345555788999999999999954 789999998873 334456677889999999999999999998765 14
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++|+|+| ..+|...+.. ...++...+..+++|+++||.|+|+. +++||||||.|+|++.+..+||+||
T Consensus 101 vYiV~elM-etDL~~iik~-------~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKS-------QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred eEEehhHH-hhHHHHHHHc-------CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence 67999999 5588888842 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
|+|+...........+..+.|.+|.|||++. ...|+.+.||||.||++.||++|++-|.+.+......++-...+...
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~- 248 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS- 248 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC-
Confidence 9999875543333456678899999999876 56899999999999999999999999987665443333222221111
Q ss_pred chhhhh--------hccccc-cCCCC-----HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 314 REKILE--------IMDPAL-EGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 314 ~~~~~~--------~~d~~~-~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
...+.. .+.... ....+ +.......+|+.+||..||.+|+|++|++++ ..+...+
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h--PYl~~~h 317 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH--PYLAPYH 317 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC--hhhhhhc
Confidence 111111 111000 00111 1233578899999999999999999999975 4444433
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=313.26 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=209.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-c-eEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R-KLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~-~~lv~ 159 (395)
++|...+++|+|+||.+++.+++ ++..+++|.+... .....+...+|+.++++++|||||.+.+.+.++ . .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56888999999999999999865 6789999988643 233445678899999999999999999977655 4 56999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
+|++||+|.+.+...+ ...++++.+..++.|++.|+.|||++ .|+|||||+.||+++.+..++|+|||+++.
T Consensus 84 ~Y~eGg~l~~~i~~~k-----~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-----GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKI 155 (426)
T ss_pred eecCCCCHHHHHHHHh-----hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhh
Confidence 9999999999997655 35689999999999999999999988 999999999999999999999999999997
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... .......||+.|+.||.+.+.+|..|+|||||||++|||++-+.+|...+.. ..+..
T Consensus 156 l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~----------------~Li~k 217 (426)
T KOG0589|consen 156 LNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS----------------ELILK 217 (426)
T ss_pred cCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH----------------HHHHH
Confidence 66543 2345678999999999999999999999999999999999999999865432 11111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+.... -...+.....++..++..|++.+|+.||++.+++.+
T Consensus 218 i~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 218 INRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred Hhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11111 224455667789999999999999999999999965
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=301.84 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=203.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCc----EEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGR----KVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv 158 (395)
.+|.+.+.||+|+||.||+|.+. +|+ .+++|.+..... .....+.+|+.+++.++|+|++++++++.....+++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 45788899999999999999864 333 589998865432 234578889999999999999999999988888899
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
+||+.+|+|.+++.... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.
T Consensus 87 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 87 TQLMPLGCLLDYVRNHK------DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EecCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence 99999999999985432 3589999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...............++..|+|||.+....++.++|+||||+++||+++ |..||...... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~ 220 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-----------------EI 220 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-----------------HH
Confidence 6543221111112223567999999988889999999999999999998 99998653321 01
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
...+........+......+.+++.+||..+|.+|||+.++++.|.++.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 221 PDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 111111100111122335688999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=319.20 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=192.8
Q ss_pred CCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.|.+.+.||+|+||+||+|.. .+++.||+|++.... ......+..|+++++.++|+||+++++++.+. ..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999985 468899999986432 23345688899999999999999999998876 5669999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIRM-------EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 99999999998532 3588999999999999999999998 9999999999999999999999999997532
Q ss_pred CCCCC---------------------------------------------CceeeccccccccccchhhccCCCCccchh
Q 016117 241 SDKAG---------------------------------------------GHVSTRVLGTQGYVAPEYALTGHLTTKSDV 275 (395)
Q Consensus 241 ~~~~~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv 275 (395)
..... ........||+.|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di 231 (381)
T cd05626 152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231 (381)
T ss_pred ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence 11000 000123569999999999999899999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc--ccccCCCCHHHHHHHHHHHhh--cCCCCCCC
Q 016117 276 YSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD--PALEGQYSMKEVIQVAAIAAM--CVQPEADY 351 (395)
Q Consensus 276 wslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~l~~li~~--cl~~~p~~ 351 (395)
|||||++|||++|..||....+... ...+.+ ..+..........++.+++.+ |+..+|..
T Consensus 232 wSlG~il~elltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~ 295 (381)
T cd05626 232 WSVGVILFEMLVGQPPFLAPTPTET----------------QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLG 295 (381)
T ss_pred eehhhHHHHHHhCCCCCcCCCHHHH----------------HHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccC
Confidence 9999999999999999975432110 001110 001101111223457778877 55666777
Q ss_pred CCCHHHHHHH
Q 016117 352 RPLMADVVQS 361 (395)
Q Consensus 352 RPt~~~vl~~ 361 (395)
||++.+++.+
T Consensus 296 R~~~~~~l~h 305 (381)
T cd05626 296 RNGADDIKAH 305 (381)
T ss_pred CCCHHHHhcC
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=307.73 Aligned_cols=268 Identities=22% Similarity=0.338 Sum_probs=198.7
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcC---------------CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSN---------------GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALL 147 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~ 147 (395)
.++|.+.+.||+|+||.||++.... ...||+|.+.... ....+.+.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578899999999999999987532 2358999887542 23345788999999999999999999
Q ss_pred EEEecC-ceEEEEEcccCCChhhhcccCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCE
Q 016117 148 GYCSDR-RKLLVYDYMANGGLQEHLYPANGS-----NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNI 221 (395)
Q Consensus 148 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni 221 (395)
+++... ..+++|||+.+++|.+++...... ......+++..++.++.|++.||+|||++ +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 988766 567999999999999998543211 01123478999999999999999999998 999999999999
Q ss_pred EeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCCC
Q 016117 222 LLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT--GRVPIDVNKPSG 299 (395)
Q Consensus 222 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~pf~~~~~~~ 299 (395)
++++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~- 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE- 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence 999999999999999875433221122223345678999999998889999999999999999998 66777543211
Q ss_pred CchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 300 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
.......... ...........+...+..+.+|+.+||+.+|++|||+.+|++.|++
T Consensus 240 --~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 --QVIENTGEFF-------RNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHHhh-------hhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 0111000000 0000000001111234579999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=305.99 Aligned_cols=267 Identities=23% Similarity=0.365 Sum_probs=200.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-----------------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-----------------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLAL 146 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l 146 (395)
++|++.+.||+|+||.||++... ++..+|+|++.... ......+..|+.+++.++|+|++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999998532 23468999987542 3344678899999999999999999
Q ss_pred EEEEecC-ceEEEEEcccCCChhhhcccCCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCE
Q 016117 147 LGYCSDR-RKLLVYDYMANGGLQEHLYPANGS----NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNI 221 (395)
Q Consensus 147 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni 221 (395)
++++... ..++++||+.+|+|.+++...... ......+++.+++.++.|++.||+|||+. +++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9988766 567999999999999998654321 11224588899999999999999999999 999999999999
Q ss_pred EeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCCC
Q 016117 222 LLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT--GRVPIDVNKPSG 299 (395)
Q Consensus 222 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~pf~~~~~~~ 299 (395)
|++.++.++|+|||++................++..|+|||...+..++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999875433221112222344678999999888889999999999999999998 778886433211
Q ss_pred CchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 300 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
. ........... ..... ...+..++..+.+|+.+||+.+|++|||+.+|++.|++
T Consensus 242 ~---~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 V---IENTGEFFRDQ--GRQVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHhhc--ccccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 00000000000 00000 01112234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=319.95 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=195.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||++... +++.||+|++.... ......+..|++++..++||||+++++++.+. ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999964 68999999986431 22335677899999999999999999988877 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.++|+|||++..
T Consensus 81 E~~~~g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 81 EYLPGGDMMTLLMKK-------DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTG 150 (364)
T ss_pred CCCCCcHHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeeccccee
Confidence 999999999998532 3589999999999999999999999 999999999999999999999999999864
Q ss_pred cCCCCCC------------------------------------ceeeccccccccccchhhccCCCCccchhHHHHHHHH
Q 016117 240 GSDKAGG------------------------------------HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLL 283 (395)
Q Consensus 240 ~~~~~~~------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 283 (395)
....... ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 230 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence 3221100 0011246899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc--ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC---HHHH
Q 016117 284 ELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD--PALEGQYSMKEVIQVAAIAAMCVQPEADYRPL---MADV 358 (395)
Q Consensus 284 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~~v 358 (395)
||++|..||....+... ...+.. ..+........+..+.+++.+|+. +|.+|++ +.++
T Consensus 231 el~~G~~Pf~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l 293 (364)
T cd05599 231 EMLVGYPPFCSDNPQET----------------YRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI 293 (364)
T ss_pred HhhcCCCCCCCCCHHHH----------------HHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence 99999999975432110 000110 000000011123467889999996 9999998 8888
Q ss_pred HHH
Q 016117 359 VQS 361 (395)
Q Consensus 359 l~~ 361 (395)
+++
T Consensus 294 l~h 296 (364)
T cd05599 294 KSH 296 (364)
T ss_pred hcC
Confidence 864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=304.80 Aligned_cols=261 Identities=25% Similarity=0.395 Sum_probs=200.9
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~ 155 (395)
.++|++.+.||+|+||.||++... ++..+++|++.... ......+..|+.+++.++|||++++++++.++ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 456888999999999999999863 46789999886532 23346788899999999999999999998776 56
Q ss_pred EEEEEcccCCChhhhcccCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCC
Q 016117 156 LLVYDYMANGGLQEHLYPANGS---------------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSN 220 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 220 (395)
++++||+++|+|.+++...... ......+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 7999999999999999643211 11123578999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 016117 221 ILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSG 299 (395)
Q Consensus 221 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~ 299 (395)
|++++++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999875432221111122234567999999998899999999999999999998 88888543211
Q ss_pred CchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 300 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
.. ...+.+.... ..+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 --~~-------------~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --EV-------------IYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HH-------------HHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 00 0111111110 1122234578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=317.71 Aligned_cols=260 Identities=20% Similarity=0.237 Sum_probs=193.9
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
.++|++.+.||+|+||.||++.. .+++.||+|.... ..+.+|++++++++||||+++++++... ..++++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 35799999999999999999995 4788999996532 3467899999999999999999988766 56689998
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+. ++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 165 ~~-~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 165 YK-TDLYCYLAAK-------RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred CC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 85 6888887432 3588999999999999999999998 99999999999999999999999999986532
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc----hhhhhhhccc------
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG----VLVSWALPRL------ 311 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~----~~~~~~~~~~------ 311 (395)
... ........||+.|+|||++.+..++.++|||||||++|||++|..||......... ..........
T Consensus 234 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 234 DIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred ccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 221 11223457999999999999999999999999999999999999887543221110 0000000000
Q ss_pred ---ccchhhhhhc----cc---cccCCC----CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 312 ---TDREKILEIM----DP---ALEGQY----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 312 ---~~~~~~~~~~----d~---~~~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.........+ .. ...... ....+.++.+|+.+||+.||++|||+.|++++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000001100 00 000000 01234578899999999999999999999963
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.74 Aligned_cols=260 Identities=23% Similarity=0.343 Sum_probs=204.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||.||++.. .+++.+++|.+.... ......+.+|+.+++.++|+|++++++++.++ ..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999995 588999999876432 22345788899999999999999999987665 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+++|.+++..... ....+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd08229 82 ELADAGDLSRMIKHFKK---QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF 155 (267)
T ss_pred EecCCCCHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhc
Confidence 99999999998854321 234689999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
...... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ... ..+..
T Consensus 156 ~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~----------~~~~~ 222 (267)
T cd08229 156 FSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC----------KKIEQ 222 (267)
T ss_pred cccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHh----------hhhhc
Confidence 443221 12234688899999999988899999999999999999999999864322100 000 00001
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
...+. ......+..+.+++.+||+.+|++||||.+|.+.++++.
T Consensus 223 ~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 223 CDYPP---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCC---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11111 111234557899999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=304.68 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=198.3
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
+|+..+.||+|+||+||++... +++.||+|.+.... ......+.+|+.+++.++|+||+++++.+.++ ..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999964 68999999986432 12234567899999999999999999988766 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+|+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++...
T Consensus 81 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05605 81 LMNGGDLKFHIYNMG-----NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI 152 (285)
T ss_pred ccCCCcHHHHHHhcC-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence 999999998885322 24689999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.... ......|+..|+|||++.+..++.++||||+|+++|||++|..||......... ..+...
T Consensus 153 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-------------~~~~~~ 216 (285)
T cd05605 153 PEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-------------EEVERR 216 (285)
T ss_pred CCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-------------HHHHHH
Confidence 3221 112346889999999999889999999999999999999999999754321100 001111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
+.. ....++...+..+.+|+..||+.||.+|| ++.+++++
T Consensus 217 ~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 217 VKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred hhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111 01122333456789999999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=304.68 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=200.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
.+|++.+.||+|+||.||+|.. .+++.+++|.+........+.+..|+.+++.+.|+|++++++.+..+ ..++|+||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4688889999999999999995 47889999998765555567788999999999999999999987665 677999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++++|.+++.. ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 100 ~~~~L~~~~~~--------~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 100 AGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred CCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 99999999842 3478899999999999999999998 999999999999999999999999999875432
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
... ......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+.... ... ...
T Consensus 169 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~-------------~~~ 231 (296)
T cd06654 169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLI-------------ATN 231 (296)
T ss_pred ccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHH-------------hcC
Confidence 211 112345788999999999888999999999999999999999999754431100 000 000
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.......+......+.+++.+||+.+|++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 100111122344568899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=304.48 Aligned_cols=268 Identities=25% Similarity=0.368 Sum_probs=202.1
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcC-----------------CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCccee
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSN-----------------GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLA 145 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~ 145 (395)
.++|.+.+.||+|+||.||++.... +..||+|.+.... ....+.+.+|++++++++|||+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578899999999999999988542 2458999887543 234567889999999999999999
Q ss_pred EEEEEecC-ceEEEEEcccCCChhhhcccCCCCC----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCC
Q 016117 146 LLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSN----SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSN 220 (395)
Q Consensus 146 l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 220 (395)
+++++..+ ..++++||+.+++|.+++....... .....+++..++.++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99988775 6679999999999999986543110 1123689999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCCC
Q 016117 221 ILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT--GRVPIDVNKPS 298 (395)
Q Consensus 221 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~--g~~pf~~~~~~ 298 (395)
|+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999875433322222334456778999999988889999999999999999998 67777533211
Q ss_pred CCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 299 GEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
............ .........+...+.++.+++.+||+.+|++|||+.+|++.|++
T Consensus 241 ---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 ---QVIENAGHFFRD-------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---HHHHHHHhcccc-------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111000000 00000011122234579999999999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=317.72 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=197.1
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
.++|++.+.||+|+||.||++... +++.+|+|++... .......+..|+.+++.++||||+++++++.++ ..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457899999999999999999965 6889999998642 123344577899999999999999999988776 46799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+++|+|.+++.. ..++...+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 122 ~Ey~~gg~L~~~l~~--------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 122 MEYMPGGDLVNLMSN--------YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecccee
Confidence 999999999999842 2478888999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCCceeeccccccccccchhhccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTG----HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|..||......
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---------------- 253 (370)
T cd05596 191 KMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---------------- 253 (370)
T ss_pred eccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH----------------
Confidence 5432211 112345689999999998653 4788999999999999999999999754321
Q ss_pred hhhhhhcccc--ccCCCCHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 016117 315 EKILEIMDPA--LEGQYSMKEVIQVAAIAAMCVQPEADY--RPLMADVVQS 361 (395)
Q Consensus 315 ~~~~~~~d~~--~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~~vl~~ 361 (395)
.....+.+.. +........+..+.+++.+||+.+|.+ |||+.+++++
T Consensus 254 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 254 GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111111111 110111123457889999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=297.62 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=203.1
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEccc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMA 163 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~ 163 (395)
.++|.+.+.||+|+||.||++...++..+++|.+... ....+.+.+|+++++.++|+|++++.+++.+...++++||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCC
Confidence 4578889999999999999999877888999988753 223467888999999999999999999988877789999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 84 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 84 KGSLLDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred CCcHHHHHHhCC-----ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999995432 24578899999999999999999998 9999999999999999999999999998754322
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.. .......++..|+|||.+....++.++|+||||+++|++++ |..||...... ..... +.
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~--------------~~ 217 (260)
T cd05073 156 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRA--------------LE 217 (260)
T ss_pred Cc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHH--------------Hh
Confidence 11 11112335567999999998889999999999999999999 99998643211 01110 00
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
.......+...+..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 218 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 0111111223345788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=296.51 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=200.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
++|.+.+.||+|+||.||++.. .|+.+++|.+..... ..+.+.+|+.+++.++|+|++++++++.+. ..++++||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4678889999999999999987 478999999976533 456788999999999999999999988755 6779999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+......
T Consensus 84 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 84 KGSLVDYLRSRG-----RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred CCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 999999985432 13689999999999999999999999 9999999999999999999999999999765322
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.. ....+..|+|||.+....++.++||||||+++|+|++ |..||...... . +...+.
T Consensus 156 ~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~--------------~~~~~~ 213 (256)
T cd05039 156 QD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---D--------------VVPHVE 213 (256)
T ss_pred cc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---H--------------HHHHHh
Confidence 11 2234567999999988889999999999999999997 99998643211 0 000000
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
.......+...+..+.+++.+||+.+|++|||+.+++++|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 214 KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1111111222346788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.75 Aligned_cols=253 Identities=22% Similarity=0.332 Sum_probs=197.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
++|++.+.||+|+||.||+|.. .+++.+|+|++..........+..|+.++++++|||++++++++... ..++++||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688999999999999999996 47889999998755444556788899999999999999999988766 566999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.+++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 89 ~~~~L~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 89 GGGSLQDIYHV-------TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999998843 23588999999999999999999998 999999999999999999999999999975432
Q ss_pred CCCCceeeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
... ......++..|+|||.+. ...++.++||||||+++|||++|..||....+..... .... ..
T Consensus 159 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~----~~ 225 (267)
T cd06646 159 TIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSK----SN 225 (267)
T ss_pred ccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeec----CC
Confidence 211 112345788999999874 3457889999999999999999999986433211100 0000 00
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
...+... .....+..+.+++.+||+.+|++|||+++++++|
T Consensus 226 ~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 226 FQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0001110 0112345789999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=296.60 Aligned_cols=248 Identities=28% Similarity=0.424 Sum_probs=197.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEe-cC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS-DR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~-~~~lv~e~~ 162 (395)
.+|.+.+.||+|+||.||++.. .|..+++|.+... ...+.+..|+.++++++|+|++++++++. ++ ..++++||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 3678889999999999999987 4788999988643 23457889999999999999999999754 33 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++++|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||++.....
T Consensus 83 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 83 AKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 9999999985432 23588999999999999999999998 999999999999999999999999999875332
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
.. ....++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ..... +
T Consensus 155 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~--------------~ 212 (256)
T cd05082 155 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR--------------V 212 (256)
T ss_pred cC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH--------------H
Confidence 21 12234567999999998899999999999999999998 99998643211 00000 0
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
........+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 213 EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00111112223455788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=311.71 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=194.2
Q ss_pred CCCCCCeeeccCCeEEEEEEE----cCCcEEEEEEeccCC----cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ce
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~ 155 (395)
+|++.+.||+|+||+||+++. .+++.+|+|++.... ....+.+..|+.+++.+ +|+||+++++++.+. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999885 357899999986421 22335677899999999 589999999988766 45
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
+++|||+.+|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG 150 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-------DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFG 150 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCc
Confidence 6999999999999998532 3588999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
++........ .......||+.|+|||++.+. .++.++|||||||++|||++|..||.............
T Consensus 151 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--------- 220 (332)
T cd05614 151 LSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--------- 220 (332)
T ss_pred CCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH---------
Confidence 9875432221 122345789999999998865 47889999999999999999999996443221111000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
..+... ....+...+..+.+++.+||+.||++|| ++.+++++
T Consensus 221 ---~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 221 ---RRILKC--DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---HHHhcC--CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 011100 0111222345688999999999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=305.50 Aligned_cols=264 Identities=28% Similarity=0.426 Sum_probs=201.8
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCc--EEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGR--KVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~l 157 (395)
.++|++.+.||+|+||.||+|.+. ++. .+++|.+.... ......+.+|++++.++ +|+|++++++++.++ ..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 356888899999999999999964 454 45777765432 23345788899999999 899999999998766 5679
Q ss_pred EEEcccCCChhhhcccCCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc
Q 016117 158 VYDYMANGGLQEHLYPANGSN---------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 228 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~ 228 (395)
++||+++++|.+++....... .....+++..++.++.|++.||+|||++ +++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 999999999999996543111 1224689999999999999999999998 9999999999999999999
Q ss_pred EEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhh
Q 016117 229 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWA 307 (395)
Q Consensus 229 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~ 307 (395)
++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....... ..
T Consensus 163 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~--- 233 (303)
T cd05088 163 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY--- 233 (303)
T ss_pred EEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HH---
Confidence 9999999986321110 1111224567999999988889999999999999999998 999986433210 00
Q ss_pred hcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 308 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 308 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
..+ ........+...+..+.+++.+||+.+|++||++.+++..|++++....
T Consensus 234 ----------~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 234 ----------EKL-PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ----------HHH-hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 000 0000111111234468899999999999999999999999999888543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=298.44 Aligned_cols=251 Identities=23% Similarity=0.369 Sum_probs=198.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCc-----ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK-----QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
++|.+.+.||+|++|.||++.. .+++.+++|.+..... .....+.+|++++++++||||+++++++.+. ..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999995 4689999998764321 1234678899999999999999999998776 5669
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
++||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 82 v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~ 151 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-------GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGAS 151 (263)
T ss_pred EEEECCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 99999999999998532 3578899999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCce-eeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 238 KIGSDKAGGHV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 238 ~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
........... .....++..|+|||.+.+..++.++||||||+++|||++|+.||....... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------------~ 215 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA----------------A 215 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH----------------H
Confidence 75432211111 123457788999999999889999999999999999999999996432110 0
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.............+......+.+++.+||+.+|++|||+.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 216 IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011111111112233345578899999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.03 Aligned_cols=247 Identities=24% Similarity=0.354 Sum_probs=192.9
Q ss_pred eeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCCh
Q 016117 93 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 167 (395)
Q Consensus 93 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L 167 (395)
||+|+||+||++... +++.+|+|.+..... ...+.+..|+++++.++|+|++++.+++... ..+++|||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999964 788999999864322 2234567899999999999999999988766 56799999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCc
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 247 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 247 (395)
..++..... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~ 152 (280)
T cd05608 81 RYHIYNVDE---ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--S 152 (280)
T ss_pred HHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--c
Confidence 988754321 234689999999999999999999998 99999999999999999999999999987543322 1
Q ss_pred eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccC
Q 016117 248 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327 (395)
Q Consensus 248 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 327 (395)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... .....+.....
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~------------~~~~~~~~~~~-- 218 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK------------ELKQRILNDSV-- 218 (280)
T ss_pred cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH------------HHHHhhcccCC--
Confidence 1223568899999999999999999999999999999999999997543211000 00111111111
Q ss_pred CCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 328 QYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 328 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
.++...+..+.+++.+||+.+|++|| |+++++++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 22233456788999999999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=310.73 Aligned_cols=246 Identities=26% Similarity=0.372 Sum_probs=192.7
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCC-cceeEEEEEecC-ceEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSP-YLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~-~~~lv~ 159 (395)
+|++.+.||+|+||.||+|... +++.||+|++... .....+.+..|.+++..+.|+ +++.+++++.+. ..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999965 5789999998743 123345677899999999765 577888887665 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.++|+|||++..
T Consensus 81 E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05587 81 EYVNGGDLMYHIQQV-------GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKE 150 (324)
T ss_pred cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence 999999999998432 3588999999999999999999998 999999999999999999999999999864
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----------------~~~~~ 212 (324)
T cd05587 151 NIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----------------ELFQS 212 (324)
T ss_pred cCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHH
Confidence 32211 1223456899999999999999999999999999999999999999744311 00111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH-----HHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM-----ADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~~vl~~ 361 (395)
+.... ..++...+..+.+++.+||+.+|.+||+. .++.++
T Consensus 213 i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 213 IMEHN--VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred HHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11111 11122234568899999999999999986 566643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=313.43 Aligned_cols=241 Identities=26% Similarity=0.378 Sum_probs=191.1
Q ss_pred CeeeccCCeEEEEEEE-cCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCC
Q 016117 91 NVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANG 165 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 165 (395)
+.||+|+||.||++.. .+|+.||+|++... .......+..|+++++.++||||+++.+++.+. ..++||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 47899999998743 122345667899999999999999999988766 567999999999
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
+|..++.. ...+++..+..++.|++.||.|||+ . +++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~ 150 (325)
T cd05594 81 ELFFHLSR-------ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 150 (325)
T ss_pred cHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC
Confidence 99988843 2368999999999999999999997 6 89999999999999999999999999987532211
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
.......||+.|+|||++.+..++.++|||||||++|||++|..||....... . ...+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~-------------~~~i~~~~ 212 (325)
T cd05594 151 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---L-------------FELILMEE 212 (325)
T ss_pred --cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---H-------------HHHHhcCC
Confidence 12234568999999999999999999999999999999999999996433110 0 00011000
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
. .++.....++.+++.+||+.||++|+ ++.+++++
T Consensus 213 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 213 I--RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C--CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0 11222345688999999999999997 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=310.38 Aligned_cols=241 Identities=25% Similarity=0.403 Sum_probs=189.9
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
+.||+|+||+||++... +++.||+|++... .....+.+..|..++..+ +||||+++++++.+. ..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 6889999998643 123345667788888876 799999999988776 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.++|+|||++.......
T Consensus 81 g~L~~~i~~~-------~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~ 150 (320)
T cd05590 81 GDLMFHIQKS-------RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG 150 (320)
T ss_pred chHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence 9999988432 3688999999999999999999998 99999999999999999999999999987532211
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----------------~~~~~i~~~~ 212 (320)
T cd05590 151 --KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----------------DLFEAILNDE 212 (320)
T ss_pred --CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----------------HHHHHHhcCC
Confidence 1223456899999999999999999999999999999999999999754321 0011111111
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH------HHHHHH
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLM------ADVVQS 361 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~~vl~~ 361 (395)
. ..+...+.++.+++.+||+.||.+||++ ++++++
T Consensus 213 ~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 213 V--VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred C--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 1 1122234568899999999999999998 556543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=318.83 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=193.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||+||++.. .+++.||+|++.... ....+.+..|+++++.++||||+++++++.+. ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999985 478999999886421 22345678899999999999999999998877 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||+++.
T Consensus 81 E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 81 EFLPGGDLMTMLIKY-------DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999998532 4688999999999999999999999 999999999999999999999999999863
Q ss_pred cCCCCCC---------------------------------------------ceeeccccccccccchhhccCCCCccch
Q 016117 240 GSDKAGG---------------------------------------------HVSTRVLGTQGYVAPEYALTGHLTTKSD 274 (395)
Q Consensus 240 ~~~~~~~---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~D 274 (395)
....... .......||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 230 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD 230 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence 2110000 0001246899999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCC--
Q 016117 275 VYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYR-- 352 (395)
Q Consensus 275 vwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-- 352 (395)
||||||++|||++|..||....+.... .. +.... ..+.-........++.+|+.+|++ +|.+|
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~~~~---~~----------i~~~~-~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~ 295 (377)
T cd05629 231 WWSLGAIMFECLIGWPPFCSENSHETY---RK----------IINWR-ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLG 295 (377)
T ss_pred eEecchhhhhhhcCCCCCCCCCHHHHH---HH----------HHccC-CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence 999999999999999999754321100 00 00000 000000011123468889999998 66665
Q ss_pred -CCHHHHHHH
Q 016117 353 -PLMADVVQS 361 (395)
Q Consensus 353 -Pt~~~vl~~ 361 (395)
+|+.+++++
T Consensus 296 r~~~~~~l~h 305 (377)
T cd05629 296 RGGAHEIKSH 305 (377)
T ss_pred CCCHHHHhcC
Confidence 599999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=316.42 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=196.4
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceE
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~ 156 (395)
...++|++.+.||+|+||.||++... +++.+|+|++... .......+.+|+.+++.++||||+++++++.++ ..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34467999999999999999999965 6889999998642 122345677899999999999999999988776 567
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+||||+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 120 lv~Ey~~gg~L~~~l~~--------~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN--------YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999999842 2478899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTG----HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
+....... ........||+.|+|||++.+. .++.++|||||||++|||++|..||......
T Consensus 189 a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------------- 253 (370)
T cd05621 189 CMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------------- 253 (370)
T ss_pred ceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--------------
Confidence 97643221 1122345799999999998754 3788999999999999999999999754321
Q ss_pred cchhhhhhcccc--ccCCCCHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 016117 313 DREKILEIMDPA--LEGQYSMKEVIQVAAIAAMCVQPEADY--RPLMADVVQS 361 (395)
Q Consensus 313 ~~~~~~~~~d~~--~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~~vl~~ 361 (395)
.....+.+.. +........+..+.+++.+|++.++.+ |||+.+++++
T Consensus 254 --~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 254 --GTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --HHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111122111 111111123456788999999866543 8999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=315.04 Aligned_cols=250 Identities=24% Similarity=0.302 Sum_probs=197.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||+||++... +|+.+|+|++.... ......+..|+.+++.++|+||+++++++.+. ..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999964 78999999987532 22345678899999999999999999988776 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~ 151 (330)
T cd05601 81 EYQPGGDLLSLLNRYE------DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAAR 151 (330)
T ss_pred CCCCCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeE
Confidence 9999999999995432 4689999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCceeeccccccccccchhhc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYAL------TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
...... .......||+.|+|||++. ...++.++|||||||++|||++|..||.......
T Consensus 152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-------------- 216 (330)
T cd05601 152 LTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-------------- 216 (330)
T ss_pred CCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--------------
Confidence 543221 1223356899999999986 4567889999999999999999999997543211
Q ss_pred chhhhhhccc--cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 REKILEIMDP--ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 ~~~~~~~~d~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....++.. .+.-......+..+.+|+..|++ +|.+|||+.+++.+
T Consensus 217 --~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 217 --TYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred --HHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 01111110 00001111234568889999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=301.33 Aligned_cols=253 Identities=27% Similarity=0.426 Sum_probs=197.5
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC------
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR------ 153 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------ 153 (395)
.+.+.|++.+.||+|+||.||+|... +++.+|+|++... ......+..|+.+++.+ +|+|++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888999999999999999964 6889999998654 33456788899999998 799999999987642
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
..++++||+.+++|.+++.... ...+++..+..++.|++.||+|||++ +++|+||+|+||++++++.++|+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence 3579999999999999985432 24688999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 307 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~ 307 (395)
|||++........ ......|+..|+|||++. +..++.++|||||||++|||++|..||....+.....
T Consensus 154 Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~----- 226 (272)
T cd06637 154 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----- 226 (272)
T ss_pred cCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----
Confidence 9999875432211 123356888999999986 3457889999999999999999999996432211000
Q ss_pred hcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 308 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 308 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
......... ......+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 227 --------~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 227 --------LIPRNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --------HHhcCCCCC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 000000000 1111234568899999999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=318.66 Aligned_cols=249 Identities=23% Similarity=0.319 Sum_probs=191.2
Q ss_pred CCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.|+..+.||+|+||+||+|.. .+++.+|+|++.... ......+..|+++++.++|+||+++++.+.+. ..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999995 468899999986432 22345678899999999999999999988776 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIRM-------GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 99999999998532 3578899999999999999999999 9999999999999999999999999997532
Q ss_pred CCCC---------------------------------------------CCceeeccccccccccchhhccCCCCccchh
Q 016117 241 SDKA---------------------------------------------GGHVSTRVLGTQGYVAPEYALTGHLTTKSDV 275 (395)
Q Consensus 241 ~~~~---------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv 275 (395)
.... ........+||+.|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di 231 (382)
T cd05625 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence 1000 0000123468999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc--ccccCCCCHHHHHHHHHHHhhcCCCCCCCCC
Q 016117 276 YSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD--PALEGQYSMKEVIQVAAIAAMCVQPEADYRP 353 (395)
Q Consensus 276 wslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 353 (395)
|||||++|||++|+.||....+... ...+.. ..+..........++.+++.+|+ .+|.+|+
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~ 294 (382)
T cd05625 232 WSVGVILYEMLVGQPPFLAQTPLET----------------QMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRL 294 (382)
T ss_pred EechHHHHHHHhCCCCCCCCCHHHH----------------HHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcC
Confidence 9999999999999999975432110 001110 01110111122345667777765 5999999
Q ss_pred C---HHHHHHH
Q 016117 354 L---MADVVQS 361 (395)
Q Consensus 354 t---~~~vl~~ 361 (395)
+ +.+++++
T Consensus 295 ~~~~~~ei~~h 305 (382)
T cd05625 295 GKNGADEIKAH 305 (382)
T ss_pred CCCCHHHHhcC
Confidence 8 8887754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=300.18 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=194.6
Q ss_pred CCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
+|++.+.||+|+||.||+|.. .+++.+|+|.+... .....+.+.+|++++++++|||++++++++... ..++++||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577889999999999999985 57889999988643 223345788999999999999999999988766 556999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++++|..+. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~l~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 82 DGGSLDVYR-----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCChHHhh-----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999986553 467888999999999999999999 999999999999999999999999999875432
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||............ ......+.+
T Consensus 148 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~---------~~~~~~~~~ 214 (279)
T cd06619 148 SI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP---------LQLLQCIVD 214 (279)
T ss_pred cc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch---------HHHHHHHhc
Confidence 21 22356888999999999889999999999999999999999999653221111000 000111111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...........+.++.+++.+||+.+|++||++++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111111233468899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=323.06 Aligned_cols=264 Identities=21% Similarity=0.272 Sum_probs=191.6
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC--------
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------- 153 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 153 (395)
...+|.+.+.||+|+||.||+|... +++.||+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999964 68899999885432 2345699999999999999998876321
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC-cEEE
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKV 231 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl 231 (395)
..+++|||+++ +|.+++..... ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYAR---NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceee
Confidence 13489999975 67776643221 234689999999999999999999999 999999999999998664 7999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcc
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 310 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~ 310 (395)
+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||..................
T Consensus 213 ~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 289 (440)
T PTZ00036 213 CDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGT 289 (440)
T ss_pred eccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999997543221 12235689999999998764 6899999999999999999999999765432111100000000
Q ss_pred cccchhhh-------hh-----ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 311 LTDREKIL-------EI-----MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 311 ~~~~~~~~-------~~-----~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. ..... .+ ....+...++...+.++.+|+.+||+.+|.+|||+.+++++
T Consensus 290 p~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 290 PT-EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CC-HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 00000 00 00000111122234578999999999999999999999954
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=296.04 Aligned_cols=249 Identities=30% Similarity=0.475 Sum_probs=200.1
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+|++.+.||+|++|.||++... +++.+++|.+... .......+..|+++++.++|||++++++++.+. ..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999965 6899999988643 233456788899999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~ 152 (256)
T cd08529 81 AENGDLHKLLKMQR-----GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS 152 (256)
T ss_pred CCCCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence 99999999996432 24688999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
.... ......++..|+|||++.+..++.++|+||||+++|+|++|+.||...... .. ...+.
T Consensus 153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~-------------~~~~~ 214 (256)
T cd08529 153 DNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---AL-------------ILKII 214 (256)
T ss_pred Cccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HH-------------HHHHH
Confidence 3221 122345788999999999989999999999999999999999999744311 00 01111
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
... ....+......+.+++.+||+.+|++||++.+++++
T Consensus 215 ~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 215 RGV-FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCC-CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111 111222345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=310.31 Aligned_cols=241 Identities=27% Similarity=0.394 Sum_probs=190.9
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
++||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..+ +||||+++++++.+. ..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 57899999987431 22334567788888876 899999999998776 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|..++... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 150 (321)
T cd05591 81 GDLMFQIQRS-------RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG 150 (321)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence 9999888532 3588999999999999999999999 99999999999999999999999999987533221
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~----------------~~~~i~~~~ 212 (321)
T cd05591 151 --VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD----------------LFESILHDD 212 (321)
T ss_pred --ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH----------------HHHHHHcCC
Confidence 12234568999999999999999999999999999999999999997543210 011111111
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCC-------CHHHHHHH
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRP-------LMADVVQS 361 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-------t~~~vl~~ 361 (395)
. ..+...+.++.+++..||+.+|++|| ++.+++++
T Consensus 213 ~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 V--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred C--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0 11112345688999999999999999 88888755
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=309.77 Aligned_cols=248 Identities=24% Similarity=0.385 Sum_probs=192.1
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
++||+|+||.||++... +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+. ..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999964 68899999987532 22334577899999988 799999999998776 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 81 g~L~~~~~~-------~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 150 (329)
T cd05588 81 GDLMFHMQR-------QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG 150 (329)
T ss_pred CCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC
Confidence 999988843 24689999999999999999999999 99999999999999999999999999987422111
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC--chhhhhhhcccccchhhhhhcc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE--GVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .....+. ...+..
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~---------~~~~~~ 219 (329)
T cd05588 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL---------FQVILE 219 (329)
T ss_pred --CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH---------HHHHHc
Confidence 122345789999999999999999999999999999999999999964322110 0000110 111111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC------HHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPL------MADVVQS 361 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt------~~~vl~~ 361 (395)
... ..+...+..+.+++.+||+.||.+||| +.+++++
T Consensus 220 ~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 220 KQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 111 112223456889999999999999997 6777754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=295.21 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=200.3
Q ss_pred CeeeccCCeEEEEEEEcC----CcEEEEEEeccCCccc-HHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
+.||+|+||.||++.... +..+++|.+....... .+.+..|+++++.++|+|++++++++.+. ..++++||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999653 7889999987653332 56888999999999999999999988776 56799999999
Q ss_pred CChhhhcccCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 165 GGLQEHLYPANGS--NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 165 g~L~~~l~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++|.+++...... ......+++..++.++.|++.||+|||++ +++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999654211 01125789999999999999999999998 999999999999999999999999999986554
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
...........++..|+|||.+....++.++||||||+++|+|++ |..||...... .. ...+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~-------------~~~~~ 221 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EV-------------LEYLR 221 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HH-------------HHHHH
Confidence 332222334557888999999988889999999999999999999 69998754211 00 00111
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
+ ......+...+.++.+++.+||+.+|++|||+.+++++|+
T Consensus 222 ~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 K-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred c-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1 1111222333567999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=293.51 Aligned_cols=246 Identities=25% Similarity=0.422 Sum_probs=193.8
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCChh
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQ 168 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~ 168 (395)
++||+|+||.||+|...++..+|+|.+..... .....+.+|+++++.++|||++++++++... ..+++|||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999998875432 2234688899999999999999999998776 567999999999999
Q ss_pred hhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCce
Q 016117 169 EHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV 248 (395)
Q Consensus 169 ~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 248 (395)
+++.... ..+++..+..++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 150 (250)
T cd05085 81 SFLRKKK------DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SS 150 (250)
T ss_pred HHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccccc-cc
Confidence 9985322 3578999999999999999999998 999999999999999999999999999865332211 11
Q ss_pred eeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccC
Q 016117 249 STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327 (395)
Q Consensus 249 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 327 (395)
.....++..|+|||++.+..++.++||||||+++|++++ |..||....... ... .+ ......
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~----------~~----~~~~~~ 213 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---ARE----------QV----EKGYRM 213 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH----------HH----HcCCCC
Confidence 111234567999999998889999999999999999998 999996432210 000 00 001111
Q ss_pred CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 328 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 328 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 112233467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=297.73 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=199.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-C---CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-N---GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
++|.+.+.||+|+||.||+|.+. + +..+++|.+.... ....+.+..|+.++++++||||+++++++.++ ..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999863 2 3379999886432 22345788899999999999999999988765 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+++++|.+++.... ..+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 84 TEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred EEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccc
Confidence 99999999999995432 3589999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCCce-eeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 239 IGSDKAGGHV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 239 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
.......... .....++..|+|||.+.+..++.++|+||||+++||+++ |..||....... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~----------- 220 (267)
T cd05066 155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIK----------- 220 (267)
T ss_pred ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHH-----------
Confidence 6543221111 111223567999999998899999999999999999886 999986433210 011
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
.+.+. .....+...+..+.+++.+||+.+|++|||+.++++.|++++
T Consensus 221 --~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 221 --AIEEG-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred --HHhCC-CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 00000 001112233456889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=298.83 Aligned_cols=254 Identities=28% Similarity=0.408 Sum_probs=195.7
Q ss_pred CeeeccCCeEEEEEEEcC-------CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 91 NVVGHGGFGLVYRGVLSN-------GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+.||+|+||.||+|...+ +..+++|.+.... ......+.+|+.+++.++||||+++++++.+. ..++++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998642 2579999876432 23456788999999999999999999988765 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC-----cEEEecccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-----HAKVSDFGL 236 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-----~~kl~Dfg~ 236 (395)
+++++|.+++............+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999965432221234588999999999999999999988 999999999999999877 899999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
+................++..|+|||.+.+..++.++||||||+++|||++ |..||...... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~---------- 224 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQ---------- 224 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHH----------
Confidence 875433222111222345678999999998899999999999999999998 99998643211 0000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
.+........+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 225 ----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 225 ----HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ----HHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001001111222345678899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.50 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=190.5
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
+.||+|+||.||++... +++.+|+|++.... ......+..|..++.++ +||||+++++++.+. ..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 68899999987532 22334577788888776 899999999988766 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|..++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~L~~~~~~-------~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~ 150 (329)
T cd05618 81 GDLMFHMQR-------QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 150 (329)
T ss_pred CCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence 999988843 24689999999999999999999999 99999999999999999999999999987532211
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc--hhhhhhhcccccchhhhhhcc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG--VLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d 322 (395)
.......||..|+|||++.+..++.++|||||||++|||++|..||......... ....+. ...+..
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~---------~~~i~~ 219 (329)
T cd05618 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVILE 219 (329)
T ss_pred --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH---------HHHHhc
Confidence 1223456899999999999999999999999999999999999999632211100 000000 001111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC------HHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPL------MADVVQS 361 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt------~~~vl~~ 361 (395)
... ..+......+.+++.+||+.||++||+ +.+++++
T Consensus 220 ~~~--~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 220 KQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCC--CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 111 122233456889999999999999998 4677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=306.69 Aligned_cols=240 Identities=26% Similarity=0.390 Sum_probs=186.9
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|..++... +||||+++++++..+ ..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 68899999987431 22334455677777654 899999999988766 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 81 g~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~ 150 (316)
T cd05592 81 GDLMFHIQSS-------GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE 150 (316)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence 9999988432 3689999999999999999999998 99999999999999999999999999997543222
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
.......||+.|+|||++.+..++.++|||||||++|||++|..||...... . ....+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~-------------~~~~i~~~- 211 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---E-------------LFDSILND- 211 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---H-------------HHHHHHcC-
Confidence 2233456899999999999999999999999999999999999999754311 0 00011110
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHH-HHHH
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA-DVVQ 360 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-~vl~ 360 (395)
...++.....++.+++.+||+.+|++||++. ++++
T Consensus 212 -~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 212 -RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 0112222345678999999999999999975 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=330.38 Aligned_cols=267 Identities=24% Similarity=0.320 Sum_probs=204.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.++||+|+||.||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.++ ..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999965 68999999987432 22345788999999999999999999998776 567999
Q ss_pred EcccCCChhhhcccCCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 160 DYMANGGLQEHLYPANGS----NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
||+++|+|.+++...... ......+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998643211 11124567788999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCC----------------CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 016117 236 LAKIGSDKAG----------------GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 299 (395)
Q Consensus 236 ~~~~~~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~ 299 (395)
++........ ........||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9975421100 001123468999999999999999999999999999999999999996532210
Q ss_pred CchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHHHhhhhc
Q 016117 300 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-LMADVVQSLVPLVKYN 369 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~~vl~~L~~~~~~~ 369 (395)
. .. . ..+.++... ....+.+..+.+++.+||+.||++|| +++++.+.|++.+...
T Consensus 239 i----~~-------~---~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 239 I----SY-------R---DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred h----hh-------h---hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 0 00 0 000010000 00112345688999999999999996 6788888888887753
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=293.51 Aligned_cols=247 Identities=26% Similarity=0.418 Sum_probs=195.1
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCChh
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQ 168 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~ 168 (395)
++||+|+||.||++...+++.|++|.+...... ....+.+|++++++++|+||+++++++.+. ..++++||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999767999999988754333 456788999999999999999999988766 567999999999999
Q ss_pred hhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCce
Q 016117 169 EHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV 248 (395)
Q Consensus 169 ~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 248 (395)
+++.... ..+++..+..++.+++.||+|||++ +++||||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~l~~~~------~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 81 TFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred HHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec
Confidence 9985332 3578999999999999999999999 999999999999999999999999999875432111111
Q ss_pred eeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccC
Q 016117 249 STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327 (395)
Q Consensus 249 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 327 (395)
......+..|+|||.+.+..++.++|+||||+++|||++ |..||....... ....+......
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-----------------~~~~~~~~~~~ 214 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-----------------TRERIESGYRM 214 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-----------------HHHHHhcCCCC
Confidence 111223567999999988899999999999999999999 888886543211 00111111111
Q ss_pred CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 328 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 328 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
..+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 122234567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=309.15 Aligned_cols=245 Identities=25% Similarity=0.370 Sum_probs=192.2
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~ 159 (395)
+|.+.+.||+|+||.||+|... +++.+|+|++.... ....+.+..|..++..+ +|++++++++++.+. ..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999965 57899999987432 22234566688888777 578999999988766 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++..
T Consensus 81 E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 81 EYVNGGDLMYQIQQV-------GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred cCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence 999999999988432 3588999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... . ....
T Consensus 151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~-------------~~~~ 212 (323)
T cd05616 151 NMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---E-------------LFQS 212 (323)
T ss_pred cCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---H-------------HHHH
Confidence 32211 1223456899999999999999999999999999999999999999754321 0 1111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH-----HHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM-----ADVVQ 360 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~~vl~ 360 (395)
+..... .++...+.++.+++.+||+.+|++|++. .++.+
T Consensus 213 i~~~~~--~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 213 IMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred HHhCCC--CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 111111 1222334568899999999999999985 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=318.40 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=192.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||+++.. +++.||+|++.... ......+.+|+++++.++|+||+++++.+.++ ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999954 68999999986421 22345678899999999999999999988776 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++... ..++...+..++.|++.||+|||++ +|+||||||+|||++.++.++|+|||++..
T Consensus 81 E~~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 81 DYIPGGDMMSLLIRL-------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 999999999999532 3578899999999999999999999 999999999999999999999999999752
Q ss_pred cCCCCC-----------------------------------------CceeeccccccccccchhhccCCCCccchhHHH
Q 016117 240 GSDKAG-----------------------------------------GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSY 278 (395)
Q Consensus 240 ~~~~~~-----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl 278 (395)
...... ........||+.|+|||++.+..++.++|||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 230 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence 210000 000113468999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC---CH
Q 016117 279 GVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP---LM 355 (395)
Q Consensus 279 G~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~ 355 (395)
||++|||++|+.||....+......+ ... ...+........+..+.+++.+|+ .+|.+|+ |+
T Consensus 231 Gvilyell~G~~Pf~~~~~~~~~~~i-------------~~~-~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~ 295 (376)
T cd05598 231 GVILYEMLVGQPPFLADTPAETQLKV-------------INW-ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGA 295 (376)
T ss_pred cceeeehhhCCCCCCCCCHHHHHHHH-------------hcc-CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence 99999999999999754421100000 000 000000111122345677788876 5999999 89
Q ss_pred HHHHHH
Q 016117 356 ADVVQS 361 (395)
Q Consensus 356 ~~vl~~ 361 (395)
.+++++
T Consensus 296 ~ell~h 301 (376)
T cd05598 296 DEIKAH 301 (376)
T ss_pred HHHhCC
Confidence 999866
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=298.82 Aligned_cols=244 Identities=25% Similarity=0.375 Sum_probs=189.2
Q ss_pred eeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCCh
Q 016117 93 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 167 (395)
Q Consensus 93 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L 167 (395)
||+|+||+||++... +|+.+|+|.+.... ......+..|++++++++||||+++.+++.++ ..+++|||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999964 68999999886421 12234456799999999999999999988766 56799999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCc
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 247 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 247 (395)
.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--- 149 (277)
T cd05607 81 KYHIYNVG-----ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--- 149 (277)
T ss_pred HHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---
Confidence 98885332 23588999999999999999999998 99999999999999999999999999987643321
Q ss_pred eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccC
Q 016117 248 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327 (395)
Q Consensus 248 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 327 (395)
......|+..|+|||++.+..++.++|||||||++|||++|..||......... . .............
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~----------~~~~~~~~~~~~~ 217 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--E----------ELKRRTLEDEVKF 217 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--H----------HHHHHhhcccccc
Confidence 223456889999999999888999999999999999999999999643221110 0 0011111111110
Q ss_pred CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 328 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 328 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
.....+.++.+++..||+.||++||++.|+++
T Consensus 218 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 218 -EHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred -ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 01123456899999999999999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=296.24 Aligned_cols=254 Identities=30% Similarity=0.455 Sum_probs=194.0
Q ss_pred CeeeccCCeEEEEEEEcC-Cc--EEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLSN-GR--KVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
+.||+|+||.||+|...+ +. .+++|.+.... ....+.+..|++++.++ +|||++++++++... ..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999753 43 46888876432 33446788999999999 899999999998766 56799999999
Q ss_pred CChhhhcccCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 165 GGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 165 g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
|+|.+++...... ......+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 9999998653211 11224588999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
++....... .......+..|+|||++....++.++||||||+++|||++ |..||....... .
T Consensus 158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~----------- 220 (270)
T cd05047 158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L----------- 220 (270)
T ss_pred Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---H-----------
Confidence 985321110 1111223567999999988889999999999999999997 999996432110 0
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
. ..+........+......+.+++.+||+.+|.+|||+.+++..|+++++
T Consensus 221 --~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 221 --Y-EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred --H-HHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 0 0000101111112234568899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=294.78 Aligned_cols=250 Identities=29% Similarity=0.490 Sum_probs=197.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
.+|++.+.||+|+||.||++.+.++..+++|.+... ......+..|++++++++|||++++++++... ..++++||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 357788899999999999999877889999988643 33356788999999999999999999988766 5679999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+++|.+++.... ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 83 HGCLSDYLRAQR------GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred CCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 999999985332 3578999999999999999999998 9999999999999999999999999998754332
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...... .. ......
T Consensus 154 ~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~---~~~~~~ 222 (256)
T cd05112 154 QYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVETI----NA---GFRLYK 222 (256)
T ss_pred ccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHH----hC---CCCCCC
Confidence 111 1112234568999999998889999999999999999998 99998643311 001000 00 000011
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
+ ...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 223 ~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 P-------RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred C-------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1 11235689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=303.23 Aligned_cols=264 Identities=23% Similarity=0.366 Sum_probs=197.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|++.+.||+|+||.||++... ++..+++|.+.... ......+..|++++++++||||+++++++.++ ..++++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999964 67889999886432 22345688899999999999999999988766 66799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++... ..+++..+..++.|++.||.|||+.. +++|+||+|+|||++.++.++|+|||++....
T Consensus 81 ~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKKA-------GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999999532 45889999999999999999999732 89999999999999999999999999986543
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc-------
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR------- 314 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------- 314 (395)
.. ......++..|+|||.+.+..++.++||||||+++|+|++|..||......................
T Consensus 152 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 152 DS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred cc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence 22 1223467889999999988889999999999999999999999996443221110000000000000
Q ss_pred ---------hhhhhhccccc----cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 315 ---------EKILEIMDPAL----EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 315 ---------~~~~~~~d~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....+..+... ..........++.+|+.+||+.+|++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000010000 000001134568999999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=295.10 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=196.4
Q ss_pred CeeeccCCeEEEEEEEcC--C--cEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccCC
Q 016117 91 NVVGHGGFGLVYRGVLSN--G--RKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANG 165 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g 165 (395)
+.||+|++|.||+|.+.+ + ..+|+|.+..... ...+.+..|+.++++++|+|++++++++.+...++++||++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG 80 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence 468999999999998643 3 3689999886544 4556888999999999999999999988876677999999999
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCC
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 245 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 245 (395)
+|.+++..... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 81 SLLDRLRKDAL-----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred cHHHHHHhccc-----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 99999864321 4689999999999999999999998 999999999999999999999999999976543221
Q ss_pred C-ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 246 G-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 246 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
. .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ...... ...
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~-------------~~~ 216 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKI-------------DKE 216 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-------------Hhc
Confidence 1 11122446778999999998899999999999999999998 99998633211 011000 000
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
......+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 217 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 217 GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0011112233467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=306.93 Aligned_cols=240 Identities=28% Similarity=0.412 Sum_probs=187.7
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhc-cCCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGR-LRSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
+.||+|+||+||+|... +++.||+|++.... ......+..|..++.. ++||||+++++++.+. ..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57899999987531 2233456667788876 4999999999988776 56699999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 81 g~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 150 (316)
T cd05619 81 GDLMFHIQSC-------HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD 150 (316)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence 9999998432 3588999999999999999999998 99999999999999999999999999987432211
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
.......||..|+|||++.+..++.++|||||||++|||++|..||...... ...... ....+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i-----------~~~~~- 213 (316)
T cd05619 151 --AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSI-----------RMDNP- 213 (316)
T ss_pred --CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHH-----------HhCCC-
Confidence 1223456899999999999999999999999999999999999999753311 000000 00011
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHH-HHHH
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA-DVVQ 360 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-~vl~ 360 (395)
.++......+.+++.+||+.+|++||++. ++.+
T Consensus 214 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 ---CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11222345688999999999999999997 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=301.80 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=203.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
..+|++.+.||+|+||.||++.. .+++.||+|.+........+.+..|+.+++.++|+|++++++++..+ ..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35788999999999999999995 47899999998765555566788899999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 98 ~~~~~L~~~~~~--------~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 98 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred cCCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 999999999842 3578899999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....+...... ...
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~---------------~~~ 229 (297)
T cd06656 167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---------------IAT 229 (297)
T ss_pred CCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee---------------ecc
Confidence 3221 12234578899999999998899999999999999999999999965432111000 000
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
........+...+..+.+++.+||+.+|++||++.+++++ .++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~--~~~~ 273 (297)
T cd06656 230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH--PFLK 273 (297)
T ss_pred CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC--chhc
Confidence 0000011122334568899999999999999999999974 4444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=292.60 Aligned_cols=267 Identities=22% Similarity=0.270 Sum_probs=197.9
Q ss_pred CCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCc-ceeEEEEEecCc-------
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPY-LLALLGYCSDRR------- 154 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------- 154 (395)
.|...++||+|.||+||+|+. .+|+.||+|.+.-... .......+|+.++++++|+| |+.+++++...+
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 355566799999999999994 4789999998875433 12345678999999999999 999999987654
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++|+||+.. +|..++....... ..++...+..++.|++.||+|||++ +|+||||||+|||++++|.+||+||
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~---~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKP---QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeecc
Confidence 3489999854 8999986554221 4677789999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc-
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT- 312 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~- 312 (395)
|+|+...-.. ...+..++|..|.|||++.+. .|+...||||+||++.||++++.-|..+........+-.......
T Consensus 165 GlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 165 GLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred chHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence 9998544222 234556789999999999987 799999999999999999999999977654321111100000000
Q ss_pred -cchhhhhhcccc--cc-----CCCCHHHH---HHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 -DREKILEIMDPA--LE-----GQYSMKEV---IQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 -~~~~~~~~~d~~--~~-----~~~~~~~~---~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.-..+..+.+.. .. .......+ .+..+++.+|++.+|.+|.|+..++++
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000111111111 00 01111111 367889999999999999999999986
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=295.05 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=198.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccC
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMAN 164 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~ 164 (395)
++|++.+.||+|+||.||++.. +++.+++|.+... ...+.+.+|+.+++.++|||++++++++.....++++||+.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCC
Confidence 3588889999999999999975 6788999988643 234578899999999999999999999988888899999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 83 GNLVNFLRTRG-----RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCHHHHHHhcC-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 99999995432 23588999999999999999999998 99999999999999999999999999987533211
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |..||....... ....+..
T Consensus 155 -----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-----------------~~~~~~~ 212 (254)
T cd05083 155 -----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-----------------VKECVEK 212 (254)
T ss_pred -----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-----------------HHHHHhC
Confidence 12234567999999988899999999999999999998 999986443211 0011111
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
......+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus 213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 213 GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11111122334678899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=306.94 Aligned_cols=241 Identities=27% Similarity=0.410 Sum_probs=191.0
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
+.||+|+||+||++... +++.||+|++.... ......+..|.++++.+ +||||+++++++.+. ..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 57899999987431 23345567788888887 799999999988766 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|..++... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 150 (318)
T cd05570 81 GDLMFHIQRS-------GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG 150 (318)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence 9999888432 3689999999999999999999998 99999999999999999999999999986432211
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
......+|+..|+|||++.+..++.++|||||||++|+|++|..||...... .. ...+....
T Consensus 151 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~-------------~~~i~~~~ 212 (318)
T cd05570 151 --VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---EL-------------FQSILEDE 212 (318)
T ss_pred --CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HH-------------HHHHHcCC
Confidence 1223356899999999999999999999999999999999999999643311 00 01111111
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH-----HHHHHH
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLM-----ADVVQS 361 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~~vl~~ 361 (395)
. .++...+..+.+++.+||+.||.+|||+ .+++++
T Consensus 213 ~--~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 213 V--RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred C--CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1 1122234568899999999999999999 888754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=294.63 Aligned_cols=251 Identities=28% Similarity=0.431 Sum_probs=190.4
Q ss_pred CeeeccCCeEEEEEEEc----CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEec--CceEEEEEccc
Q 016117 91 NVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSD--RRKLLVYDYMA 163 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~lv~e~~~ 163 (395)
+.||+|+||.||+|.+. .+..+|+|.+.... ....+.+..|+.+++.++|||++++++++.. ...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 23579999875432 2335678889999999999999999997753 34679999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+|+|.+++.... ...++..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||++......
T Consensus 81 ~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 81 HGDLRNFIRSET------HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 999999985332 2467788899999999999999998 9999999999999999999999999998754322
Q ss_pred CCCc--eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 244 AGGH--VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTG-RVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 244 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.... ......++..|+|||.+.+..++.++||||||+++|||++| .+||...... ..... +
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~-------------~ 215 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVY-------------L 215 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH-------------H
Confidence 1100 11123456789999999888999999999999999999995 5555432211 11110 0
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
... .....+...+..+.+++..||+.+|++||++.++++.|+++..
T Consensus 216 ~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 216 LQG-RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred hcC-CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 000 0001111223568899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=299.20 Aligned_cols=270 Identities=21% Similarity=0.351 Sum_probs=199.9
Q ss_pred CCCCCCeeeccCCeEEEEEEE-----cCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKL 156 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~ 156 (395)
.|++.+.||+|+||.||++.. .++..|++|.+.... ......+.+|+.+++.++|||++++.+++.+. ..+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 367788999999999999974 357889999987442 33345788999999999999999999988764 467
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+++||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||+
T Consensus 85 lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred EEEEccCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcc
Confidence 9999999999999984321 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC-ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 237 AKIGSDKAGG-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 237 ~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
+......... .......++..|+|||.+.+..++.++||||||+++|||+++..|+......... .......... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~-~~~~~~~~~~-~~ 233 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK-MIGPTHGQMT-VT 233 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh-hccccccccc-HH
Confidence 9865432211 1112345677899999999888999999999999999999987765321110000 0000000000 00
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
.....+............+..+.+|+.+||+.+|++|||+.++++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 234 RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 000001000111112234567999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=305.93 Aligned_cols=239 Identities=26% Similarity=0.386 Sum_probs=187.2
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
+.||+|+||.||++... +|+.||+|.+.... ......+..|..++... +|||++++++++.+. ..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68899999987431 22334566677787754 899999999988776 56699999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|.+++... ..+++..+..++.|++.||+|||++ +++||||||+|||++.++.++|+|||++......
T Consensus 81 g~L~~~i~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 149 (316)
T cd05620 81 GDLMFHIQDK-------GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG- 149 (316)
T ss_pred CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-
Confidence 9999988432 3588999999999999999999999 9999999999999999999999999998642211
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
........||+.|+|||++.+..++.++|||||||++|||++|..||...... .. ...+....
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~-------------~~~~~~~~ 212 (316)
T cd05620 150 -DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---EL-------------FESIRVDT 212 (316)
T ss_pred -CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH-------------HHHHHhCC
Confidence 12233467899999999999999999999999999999999999999744311 00 00000000
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHH-HHH
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA-DVV 359 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-~vl 359 (395)
..++.....++.+++.+||+.||++||++. ++.
T Consensus 213 --~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 213 --PHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 011112345688999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=298.69 Aligned_cols=271 Identities=25% Similarity=0.374 Sum_probs=204.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-----CCcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCcceeEEEEEec--C-ce
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-----NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSD--R-RK 155 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~-~~ 155 (395)
..|++.+.||+|+||.||++.+. ++..+|+|++...... ..+.+..|+++++.++|+|++++++++.. . ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999853 3678999998765432 45688999999999999999999998875 3 46
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++++||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 154 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFG 154 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccc
Confidence 79999999999999995432 2589999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCc-eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 236 LAKIGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 236 ~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
++.......... ......++..|+|||.+.+..++.++||||||+++|||++|..|+.......... ..... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~-~~~~~ 232 (284)
T cd05038 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRM-IGIAQ-GQMIV 232 (284)
T ss_pred cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccc-ccccc-ccccH
Confidence 998654222111 1112234567999999988899999999999999999999999986432211000 00000 00001
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
......+........+...+..+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 233 TRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1111222222222222334567999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=309.95 Aligned_cols=237 Identities=27% Similarity=0.388 Sum_probs=188.5
Q ss_pred CeeeccCCeEEEEEEE----cCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 91 NVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
+.||+|+||.||++.. .+|+.+|+|++.... ......+..|++++++++||||+++++++.+. ..++||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999987432 12234567799999999999999999988776 5679999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+|+|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~-------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 151 (318)
T cd05582 82 GGDLFTRLSK-------EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 151 (318)
T ss_pred CCcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence 9999999843 23589999999999999999999999 9999999999999999999999999998754332
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...... .....+...
T Consensus 152 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----------------~~~~~i~~~ 213 (318)
T cd05582 152 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----------------ETMTMILKA 213 (318)
T ss_pred C--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH----------------HHHHHHHcC
Confidence 1 1223456899999999999888999999999999999999999999743311 001111111
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMAD 357 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~ 357 (395)
.. ..+...+..+.+++.+||+.||++|||+.+
T Consensus 214 ~~--~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 214 KL--GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11 122223456889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=293.96 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=198.0
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
+|++.+.||+|+||.||++... ++..+++|.+... .....+.+..|+.+++.++|+|++++++.+.+. ..++++||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999965 6889999988642 233456778899999999999999999988766 566999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++++|.+++.... ...++...+..++.|++.||.|||++ +++|+||+|+||++++++.++++|||.+.....
T Consensus 81 ~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQR-----GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 9999999885322 23578999999999999999999998 999999999999999999999999999875433
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.. .......++..|+|||++.+..++.++|+||||+++|+|++|..||....... ....+..
T Consensus 153 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----------------~~~~~~~ 214 (255)
T cd08219 153 PG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN----------------LILKVCQ 214 (255)
T ss_pred cc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH----------------HHHHHhc
Confidence 22 12233568889999999998889999999999999999999999997433110 0000100
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. ....+...+..+.+++.+||+.+|++|||+.+++..
T Consensus 215 ~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 GS-YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CC-CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00 011122334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.44 Aligned_cols=236 Identities=27% Similarity=0.394 Sum_probs=184.6
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHH-HHhccCCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVE-LLGRLRSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
+.||+|+||+||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++.+. ..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999965 78999999986431 122234444544 56789999999999988766 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 81 g~L~~~l~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 150 (323)
T cd05575 81 GELFFHLQR-------ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS 150 (323)
T ss_pred CCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC
Confidence 999998843 24688999999999999999999999 99999999999999999999999999987432211
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
.......||+.|+|||++.+..++.++|||||||++|||++|..||...+.. .....+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----------------~~~~~i~~~~ 212 (323)
T cd05575 151 --KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA----------------EMYDNILNKP 212 (323)
T ss_pred --CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH----------------HHHHHHHcCC
Confidence 1233456899999999999999999999999999999999999999754311 0011111111
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 356 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 356 (395)
. ......+..+.+++.+||+.+|.+||++.
T Consensus 213 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 L--RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1 11122345688999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.53 Aligned_cols=238 Identities=19% Similarity=0.369 Sum_probs=185.3
Q ss_pred CeeeccCCeEEEEEEEcC-------------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceE
Q 016117 91 NVVGHGGFGLVYRGVLSN-------------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~ 156 (395)
+.||+|+||.||+|.... ...+++|.+..........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 235889988765444556788899999999999999999998766 667
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc-------E
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH-------A 229 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-------~ 229 (395)
+++||+++|+|..++.... ..+++..++.++.|++.||+|||+. +++||||||+|||++.++. +
T Consensus 81 lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS------DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred EEEecccCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCcee
Confidence 9999999999998885322 3589999999999999999999998 9999999999999987664 8
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhc-cCCCCccchhHHHHHHHHHHH-hCCCCCCCCCCCCCchhhhhh
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELL-TGRVPIDVNKPSGEGVLVSWA 307 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell-~g~~pf~~~~~~~~~~~~~~~ 307 (395)
+++|||++...... ....++..|+|||++. +..++.++||||||+++|||+ .|..||........
T Consensus 152 ~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------- 218 (262)
T cd05077 152 KLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------- 218 (262)
T ss_pred EeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------
Confidence 99999998643221 1234678899999887 567899999999999999998 58888764321100
Q ss_pred hcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 308 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 308 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
......... .......++.+|+.+||+.+|++||++.+|++.|
T Consensus 219 ----------~~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 219 ----------ERFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----------HHHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000000000 0111235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=312.89 Aligned_cols=242 Identities=25% Similarity=0.381 Sum_probs=201.3
Q ss_pred eeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceE-EEEEcccCCChhh
Q 016117 92 VVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQE 169 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-lv~e~~~~g~L~~ 169 (395)
+||+|.||+||-|++. +...+|||.+........+.+.+|+.+.++++|.|||+++|.+.++..+ +.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999965 5667999999877777778899999999999999999999998877666 8999999999999
Q ss_pred hcccCCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC-CCCcEEEeccccccccCCCCCC
Q 016117 170 HLYPANGSNSVASKL--DWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAGG 246 (395)
Q Consensus 170 ~l~~~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~ 246 (395)
+|....+ ++ ++.++-.+.+||++||.|||++ .|+|||||-+||||+ -.|.+||+|||.++....-+
T Consensus 662 LLrskWG------PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-- 730 (1226)
T KOG4279|consen 662 LLRSKWG------PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-- 730 (1226)
T ss_pred HHHhccC------CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC--
Confidence 9976653 45 7788899999999999999999 999999999999995 47999999999997644322
Q ss_pred ceeeccccccccccchhhccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCC-CCCchhhhhhhcccccchhhhhhccc
Q 016117 247 HVSTRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPIDVNKP-SGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 247 ~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
.....+.||.-|||||++..+ .|+.++|||||||++.||.||++||-.... +.....+. --
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG----------------my 794 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG----------------MY 794 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc----------------ce
Confidence 233457799999999999864 589999999999999999999999963321 11000000 11
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
....+.+.+...+...|+++|+.++|.+||++.++++
T Consensus 795 KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 795 KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1234667788889999999999999999999999994
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=292.31 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=200.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
++|++.+.||+|+||.||+|... +++.+++|.+..... .+.+.+|+++++.++|+|++++++++.+. ..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57888999999999999999976 488999999875422 67899999999999999999999988766 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.+++|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~L~~~l~~~------~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 81 GAGSVSDIMKIT------NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCcHHHHHHhC------ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 999999998532 24689999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....+...... ......
T Consensus 152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~ 216 (256)
T cd06612 152 TMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------------IPNKPP 216 (256)
T ss_pred Ccc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------------hccCCC
Confidence 321 12234478889999999988999999999999999999999999975432210000 000000
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+ ....+......+.+++.+||+.+|++|||+.+++++
T Consensus 217 ~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 217 P--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred C--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0 011122334578999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=304.22 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=208.2
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc---cHHHHHHHHHHHhccC-CCcceeEEEEEecC-ceE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~~~ 156 (395)
....|++.+.||.|.||.||++..+ +|+.+|+|.+.+.... ..+.+.+|+.+|+++. |||+|.+.+++.+. ..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3456888899999999999999965 5999999999754332 3468899999999998 99999999999887 566
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC----CCcEEEe
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK----NFHAKVS 232 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~----~~~~kl~ 232 (395)
+|||++.+|.|.+.+... .+++..+..++.|++.++.|||+. +++||||||+|+|+.. ++.+|++
T Consensus 113 lvmEL~~GGeLfd~i~~~--------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~ 181 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLI 181 (382)
T ss_pred EEEEecCCchHHHHHHHc--------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEe
Confidence 999999999999999543 289999999999999999999998 9999999999999954 3579999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
|||++..... .......+||+.|+|||++....|+...||||+|+++|.|++|..||..........
T Consensus 182 DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---------- 248 (382)
T KOG0032|consen 182 DFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---------- 248 (382)
T ss_pred eCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH----------
Confidence 9999987655 345667899999999999999999999999999999999999999998665322111
Q ss_pred cchhhhhhccc--cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 DREKILEIMDP--ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 ~~~~~~~~~d~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+... ......-......+.+++..|+..||..|+|+.+++++
T Consensus 249 ------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 ------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11111 22223334456788999999999999999999999985
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=308.34 Aligned_cols=260 Identities=21% Similarity=0.298 Sum_probs=194.3
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC------
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------ 153 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 153 (395)
..++|++.+.||+|+||.||++... +|..||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999964 6899999998643 223345677899999999999999999987543
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
..+++|||+.+ +|.+.+. ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~ 165 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 165 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh---------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence 35799999965 5666552 2478889999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...... .......
T Consensus 166 Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~---~~~~~~~ 239 (359)
T cd07876 166 DFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN---KVIEQLG 239 (359)
T ss_pred cCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcC
Confidence 99999753321 12233568899999999999999999999999999999999999997543211000 0000000
Q ss_pred cc---------hhhhhhccc--ccc----------------CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 DR---------EKILEIMDP--ALE----------------GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 ~~---------~~~~~~~d~--~~~----------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. ......... ... ..........+.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 000000000 000 00001123568899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=300.39 Aligned_cols=253 Identities=24% Similarity=0.397 Sum_probs=201.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
.+|++.+.||.|++|+||+|.. .+++.|++|.+........+.+.+|+.+++.++|+|++++++++.+. ..++++||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3588889999999999999985 57899999998765555567788999999999999999999988766 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.+++|.+++.. ..+++.++..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 99 ~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 99 AGGSLTDVVTE--------TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred CCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 99999998832 3589999999999999999999999 999999999999999999999999999875433
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
... ......++..|+|||.+.+..++.++|||||||++|+|++|..||....+... .... .. .
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~---~~~~----------~~--~ 230 (296)
T cd06655 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---LYLI----------AT--N 230 (296)
T ss_pred ccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----------Hh--c
Confidence 221 12234578899999999988899999999999999999999999975432110 0000 00 0
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.......+...+..+.+++.+||..+|++|||+.+++.+ .+++
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~--~~~~ 273 (296)
T cd06655 231 GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH--PFLK 273 (296)
T ss_pred CCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC--hHhh
Confidence 000001122234568889999999999999999999954 4444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=303.13 Aligned_cols=265 Identities=20% Similarity=0.303 Sum_probs=195.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|.+.+.||+|+||+||+|... +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.++ ..+++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 67889999886432 22334677899999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+ +|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 86 ~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDCG------NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 975 8888874332 3578999999999999999999998 99999999999999999999999999987533
Q ss_pred CCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhh--------cccc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL--------PRLT 312 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~--------~~~~ 312 (395)
... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+......... +...
T Consensus 156 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 156 VPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred CCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 221 11223457889999998865 468899999999999999999999997554322111111000 0000
Q ss_pred cchhhhhhccccccC----CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 DREKILEIMDPALEG----QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
........-.+.... ......+.++.+++.+||+.||.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000000000000 0011234567899999999999999999999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=305.68 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=191.2
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
+.||+|+||+||++... +++.+|+|++.... ....+.+..|..++.++ +||||+.+++++.+. ..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 67899999997532 22335577899999888 699999999988766 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|..++.. ...+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~L~~~~~~-------~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 150 (327)
T cd05617 81 GDLMFHMQR-------QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG 150 (327)
T ss_pred CcHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence 999988843 24689999999999999999999998 99999999999999999999999999987432211
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
.......||+.|+|||++.+..++.++|||||||++|||++|..||................ ..+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~---------~~~~~~~ 219 (327)
T cd05617 151 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF---------QVILEKP 219 (327)
T ss_pred --CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH---------HHHHhCC
Confidence 12334678999999999999999999999999999999999999996433221111111110 0111111
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH------HHHHHH
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLM------ADVVQS 361 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~~vl~~ 361 (395)
. ..+...+..+.+++.+||+.||.+||++ .++.++
T Consensus 220 ~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 220 I--RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred C--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1 1222234567899999999999999985 566643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=311.72 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=194.8
Q ss_pred CCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC------ceE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------RKL 156 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 156 (395)
+|++.+.||+|+||.||++.. .+|+.||+|.+... .....+.+.+|+++++.++|+||+++++++... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999996 47899999988643 122345788899999999999999999988754 356
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+++||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+
T Consensus 81 lv~e~~~-~~l~~~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~ 149 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-------PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGL 149 (372)
T ss_pred EEeeccc-cCHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccc
Confidence 9999986 578877732 24689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc--
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD-- 313 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 313 (395)
+........ .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||....+......+.........
T Consensus 150 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 150 ARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred eeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 976433221 122234578899999998874 5789999999999999999999999765432111111000000000
Q ss_pred -----chhhhhhccccccC-------CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 -----REKILEIMDPALEG-------QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 -----~~~~~~~~d~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
......+....... ........++.+|+.+||+.||++|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000000 0111224578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=297.88 Aligned_cols=249 Identities=22% Similarity=0.386 Sum_probs=194.9
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
|++.+.||+|+||.||++... ++..+++|.+........+.+..|+++++.++|+|++++++++... ..++++||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999965 5788899998765555566788899999999999999999988766 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
++|..++... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 87 ~~l~~~~~~~------~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 87 GAVDAVMLEL------ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred CcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 9999887532 24689999999999999999999998 99999999999999999999999999987543221
Q ss_pred CCceeeccccccccccchhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 245 GGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.......++..|+|||++. +..++.++|||||||++|||++|..||....+.. ..... ..
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~-----------~~ 222 (282)
T cd06643 158 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKI-----------AK 222 (282)
T ss_pred --cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHH-----------hh
Confidence 1122346888999999874 3457889999999999999999999986433110 00000 00
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+.+ ..+...+..+.+++.+||+.+|++|||+.+++++
T Consensus 223 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 223 SEPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred cCCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 1112234578999999999999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=292.96 Aligned_cols=249 Identities=24% Similarity=0.403 Sum_probs=196.2
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCccc---------HHHHHHHHHHHhccCCCcceeEEEEEecC-c
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG---------EDEFKMEVELLGRLRSPYLLALLGYCSDR-R 154 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~ 154 (395)
+|.+...||+|++|.||+|... +++.+++|.+....... .+.+..|+.+++.++||||+++++++.+. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778889999999999999864 68899999886432221 24677899999999999999999988766 5
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++++||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+||
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~df 150 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY-------GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDF 150 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEeccc
Confidence 67999999999999999432 3588899999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCC----ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcc
Q 016117 235 GLAKIGSDKAGG----HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 310 (395)
Q Consensus 235 g~~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~ 310 (395)
|++......... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------------ 218 (267)
T cd06628 151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------------ 218 (267)
T ss_pred CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------------
Confidence 998765421111 1112345788999999999888999999999999999999999999743211
Q ss_pred cccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 311 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+..+.. ......+...+..+.+++.+||+.+|++||++.+++++
T Consensus 219 ----~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 219 ----QAIFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ----HHHHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 00011111 01112222345678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=313.62 Aligned_cols=261 Identities=20% Similarity=0.228 Sum_probs=191.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
.+|.+.+.||+|+||.||++... .++.||+|.... ..+.+|++++++++|+||+++++++..+ ..+++++++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 46899999999999999999965 578899996432 2456799999999999999999987665 567999998
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
. ++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++|+|||++.....
T Consensus 243 ~-~~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 243 R-SDLYTYLGARL------RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred C-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 4 78888884322 3689999999999999999999998 999999999999999999999999999976543
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC-CCc----hhhhhhh---ccccc-
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPS-GEG----VLVSWAL---PRLTD- 313 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~-~~~----~~~~~~~---~~~~~- 313 (395)
...........||..|+|||++.+..++.++|||||||++|||++|..|+...... ... .+..... .....
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 22222223456899999999999999999999999999999999988765322111 110 0111000 00000
Q ss_pred -----chhhhhhcc---ccccCCCC-------HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 -----REKILEIMD---PALEGQYS-------MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 -----~~~~~~~~d---~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
......... ........ ......+.+|+.+||+.||.+|||+.|++++
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 00000000 0122368889999999999999999999975
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=295.65 Aligned_cols=248 Identities=28% Similarity=0.465 Sum_probs=198.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|++.+.||.|++|.||+|... +++.+++|.+.... ......+..|+.+++.++|+|++++++++.++ ..++++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999965 68899999986543 33345788899999999999999999987766 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++...
T Consensus 81 ~~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 149 (274)
T cd06609 81 CGGGSCLDLLKP--------GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLT 149 (274)
T ss_pred eCCCcHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence 999999999842 2689999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
... .......++..|+|||.+.+..++.++||||||+++|+|++|..||....+... .. .+....
T Consensus 150 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~~----------~~~~~~ 214 (274)
T cd06609 150 STM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---LF----------LIPKNN 214 (274)
T ss_pred ccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---HH----------HhhhcC
Confidence 332 112234578889999999988899999999999999999999999965432100 00 000000
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+.+... ..+..+.+++.+||..+|++|||+++++++
T Consensus 215 ~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 215 PPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111111 134568899999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=311.30 Aligned_cols=257 Identities=23% Similarity=0.313 Sum_probs=198.0
Q ss_pred HHHHHHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC
Q 016117 78 KQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR 153 (395)
Q Consensus 78 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 153 (395)
.++....++|++.+.||+|+||.||++... +++.+|+|++... .......+.+|..+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344455678999999999999999999965 6889999998642 122334577899999999999999999988776
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
..++||||+++|+|.+++.. ..++...+..++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~ 184 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA 184 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEE
Confidence 46699999999999999842 3478889999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhh
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG----HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~ 308 (395)
|||++....... ........||+.|+|||++.+. .++.++|||||||++|||++|..||...+...
T Consensus 185 DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------- 254 (371)
T cd05622 185 DFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------- 254 (371)
T ss_pred eCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH---------
Confidence 999997653321 1122345699999999998754 37889999999999999999999997543210
Q ss_pred cccccchhhhhhcccc--ccCCCCHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHHH
Q 016117 309 PRLTDREKILEIMDPA--LEGQYSMKEVIQVAAIAAMCVQPEADY--RPLMADVVQSL 362 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~--~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~~vl~~L 362 (395)
....+.... +........+..+.+++..|++.++.+ ||++.+++++.
T Consensus 255 -------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 255 -------TYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -------HHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 011111100 110111223456888999999854443 78999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=304.67 Aligned_cols=240 Identities=27% Similarity=0.381 Sum_probs=188.9
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccC-CCcceeEEEEEecC-ceEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~~~lv~ 159 (395)
+|+..+.||+|+||+||++... +|+.||+|++.... ....+.+..|..+++.+. |++++++.+++.+. ..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3677889999999999999964 68999999987431 223355777888888885 56778888887766 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.++|+|||++..
T Consensus 81 Ey~~~g~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 81 EYVNGGDLMYHIQQV-------GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccc
Confidence 999999999998432 3689999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... .......||+.|+|||++.+..++.++|||||||++|||++|..||...... .....
T Consensus 151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----------------~~~~~ 212 (323)
T cd05615 151 HMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----------------ELFQS 212 (323)
T ss_pred cCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHH
Confidence 32221 1123356899999999999999999999999999999999999999754321 01111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM 355 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 355 (395)
+..... .++...+..+.+++.+||+.+|.+|++.
T Consensus 213 i~~~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 213 IMEHNV--SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHhCCC--CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111111 1222334568899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=294.27 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=197.0
Q ss_pred CCCCCeeeccCCeEEEEEEEc----CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-------
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 153 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 153 (395)
|.+.+.||+|+||.||+|.+. ++..+|+|++.... ....+.+.+|+.+++.++|||++++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999853 36889999886532 23345788899999999999999999987542
Q ss_pred ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEec
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 233 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 233 (395)
..+++++|+.+|+|.+++...... .....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG-EEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 135888999999999887533211 1123578999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccc
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
||+++...............++..|++||.+....++.++||||||+++|+|++ |..||...... ....+..
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---- 229 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI---- 229 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH----
Confidence 999875433221111222345678999999998889999999999999999999 88888643321 0111100
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
.. .....+...+..+.+++.+||+.+|++|||+.+++..|+++
T Consensus 230 ---------~~-~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 ---------KG-NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------cC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00011122345799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=294.09 Aligned_cols=255 Identities=26% Similarity=0.368 Sum_probs=188.3
Q ss_pred CeeeccCCeEEEEEEEcC---CcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCC
Q 016117 91 NVVGHGGFGLVYRGVLSN---GRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANG 165 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g 165 (395)
+.||+|+||.||+|...+ +..+++|.+..... .....+.+|+.++++++|||++++++++.+. ..+++|||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 45799998865432 2335788899999999999999999988766 567999999999
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCC
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 245 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 245 (395)
+|.+++...... .....++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 81 DLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred cHHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 999999654321 123467788889999999999999998 999999999999999999999999999865332221
Q ss_pred CceeeccccccccccchhhccC-------CCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 246 GHVSTRVLGTQGYVAPEYALTG-------HLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 246 ~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
........++..|+|||++.+. .++.++||||||+++|||++ |..||....... ...... ....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~-----~~~~ 227 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTV-----REQQ 227 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHh-----hccc
Confidence 1112234567889999988642 35789999999999999996 999996433211 000000 0000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
....++.+. ......+.+++..|| .+|++|||+.+|+..|+
T Consensus 228 ~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111112111 122345778999999 58999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=298.13 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=195.9
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
|+..+.||+|+||+||++... +++.+|+|.+..... .....+..|+.++++++|+|++++++.+.+. ..+++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999964 688999998864321 2234567899999999999999999988766 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~~g~~L~~~l~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 82 MNGGDLKFHIYHMG-----EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred cCCCcHHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 99999999885432 23588999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.......... ......
T Consensus 154 ~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-------------~~~~~~ 217 (285)
T cd05630 154 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-------------EVERLV 217 (285)
T ss_pred CCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH-------------HHHhhh
Confidence 221 1123468999999999999999999999999999999999999997543211000 001111
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 361 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~vl~~ 361 (395)
+. ....++......+.+|+..||+.||++||| +.+++++
T Consensus 218 ~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 218 KE-VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hh-hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 10 001122223456889999999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=319.90 Aligned_cols=266 Identities=18% Similarity=0.272 Sum_probs=191.3
Q ss_pred HHHHHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCC------CcceeEEEEEe
Q 016117 79 QLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS------PYLLALLGYCS 151 (395)
Q Consensus 79 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~ 151 (395)
++....++|.+.++||+|+||+||+|... .++.||||++.... .....+..|+.+++.++| .+++.+++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34445678999999999999999999964 67889999986432 223455667777777655 45888888887
Q ss_pred cC--ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCCEEeCCCC-
Q 016117 152 DR--RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNF- 227 (395)
Q Consensus 152 ~~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~- 227 (395)
.. ..++|++++ +++|.+++... ..+++..+..++.|++.||.|||+ . +|+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH-------GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDT 270 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCc
Confidence 54 456888877 77888888532 368999999999999999999997 5 899999999999998765
Q ss_pred ---------------cEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCC
Q 016117 228 ---------------HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 292 (395)
Q Consensus 228 ---------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf 292 (395)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 499999998753221 123467899999999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhhhhhccccc-------chhhhhhcccc--ccCCC---------------CHHHHHHHHHHHhhcCCCC
Q 016117 293 DVNKPSGEGVLVSWALPRLTD-------REKILEIMDPA--LEGQY---------------SMKEVIQVAAIAAMCVQPE 348 (395)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~d~~--~~~~~---------------~~~~~~~l~~li~~cl~~~ 348 (395)
...........+......+.. ......+++.. +.... ..-....+.+|+.+||+.|
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 754432111111111000000 00000000000 00000 0011346789999999999
Q ss_pred CCCCCCHHHHHHH
Q 016117 349 ADYRPLMADVVQS 361 (395)
Q Consensus 349 p~~RPt~~~vl~~ 361 (395)
|++|||+.|++++
T Consensus 426 P~~R~ta~e~L~H 438 (467)
T PTZ00284 426 RQKRLNARQMTTH 438 (467)
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999974
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=310.67 Aligned_cols=266 Identities=20% Similarity=0.248 Sum_probs=198.3
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc---CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
..+|.+.+.||+|+||.||++... .+..|++|.+... ....+|+++++.++||||+++++++... ..+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 356999999999999999999753 4578999987643 2346799999999999999999988765 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
|++. ++|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++|+|||++..
T Consensus 166 e~~~-~~l~~~l~~-------~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 166 PKYK-CDLFTYVDR-------SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred hhcC-CCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 9885 688888832 24689999999999999999999998 999999999999999999999999999975
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc-------
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT------- 312 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------- 312 (395)
..............||..|+|||++.+..++.++|||||||++|||++|+.||..................+.
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 5433322223346789999999999999999999999999999999999999976543322111111110000
Q ss_pred c--chhh-h--hhccccccCCCC-------HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 313 D--REKI-L--EIMDPALEGQYS-------MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 313 ~--~~~~-~--~~~d~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
. .... . ..+.......+. .....++.+++.+||+.+|++|||+.+++.+ .++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~--p~f~ 379 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL--PLFT 379 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC--chhh
Confidence 0 0000 0 000001111111 1123467889999999999999999999976 4444
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=297.40 Aligned_cols=251 Identities=23% Similarity=0.402 Sum_probs=196.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
+.|++.+.||+|+||.||+|... ++..+++|.+........+.+..|+.+++.++|+|++++++.+..+ ..+++|||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999965 5889999998766555567788999999999999999999987655 577999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++++|..++.... ..+++..+..++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 92 ~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 92 PGGAVDAIMLELD------RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred CCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 9999988874322 3589999999999999999999998 999999999999999999999999999865322
Q ss_pred CCCCceeeccccccccccchhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
.. .......++..|+|||.+. ...++.++|||||||++|||++|..||....+.. .... .
T Consensus 163 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~-----------~ 227 (292)
T cd06644 163 TL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLK-----------I 227 (292)
T ss_pred cc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHH-----------H
Confidence 21 1122345788999999885 3456889999999999999999999986433210 0000 0
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.....+.. ..+...+.++.+++.+||+.+|++||++.+++++
T Consensus 228 ~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 228 AKSEPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred hcCCCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000 1122334568899999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=292.21 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=192.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-----ccHHHHHHHHHHHhccCCCcceeEEEEEecC---ce
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-----QGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RK 155 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~ 155 (395)
.+|...+.||+|+||.||++... ++..+++|.+..... .....+.+|+.+++.++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999964 689999998763311 2234678899999999999999999987653 35
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++++||+++++|.+++... ..+++...+.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg 151 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-------GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCC
Confidence 6899999999999998432 3578899999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCC-CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 236 LAKIGSDKAG-GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 236 ~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
++........ ........++..|+|||.+.+..++.++||||||+++|||++|..||......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~---------------- 215 (266)
T cd06651 152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM---------------- 215 (266)
T ss_pred CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----------------
Confidence 9875432111 11112345788999999999888999999999999999999999999643211
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+............+......+.+++ +||..+|++||++++|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 216 AAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred HHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 011111111111122233344566676 6888999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=306.42 Aligned_cols=239 Identities=26% Similarity=0.343 Sum_probs=184.9
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHH-HHHhccCCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEV-ELLGRLRSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
+.||+|+||+||++... +++.+|+|++.... ......+..|. .+++.++|+||+++++++.+. ..+++|||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 67889999986431 12223344444 456788999999999988766 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|.+++... ..++...+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~ 150 (325)
T cd05602 81 GELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 150 (325)
T ss_pred CcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC
Confidence 9999998532 3578888999999999999999999 99999999999999999999999999987532221
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----------------~~~~i~~~~ 212 (325)
T cd05602 151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----------------MYDNILNKP 212 (325)
T ss_pred --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----------------HHHHHHhCC
Confidence 12234568999999999999999999999999999999999999997433210 011111111
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVV 359 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl 359 (395)
. ......+..+.+++.+||+.+|.+||++.+.+
T Consensus 213 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 213 L--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred c--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 1 11222345688999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=307.57 Aligned_cols=237 Identities=26% Similarity=0.371 Sum_probs=184.7
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHH-HHhccCCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVE-LLGRLRSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
+.||+|+||+||++... +|+.+|+|++.... ......+..|.. +++.++||||+++++++... ..+++|||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999954 78999999986431 222334455554 56778999999999988766 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|..++.. ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~L~~~l~~-------~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 150 (325)
T cd05604 81 GELFFHLQR-------ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS 150 (325)
T ss_pred CCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence 999988843 24689999999999999999999998 99999999999999999999999999987432211
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
.......|++.|+|||++.+..++.++|||||||++|||++|..||....... ....+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----------------~~~~~~~~~ 212 (325)
T cd05604 151 --DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE----------------MYDNILHKP 212 (325)
T ss_pred --CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH----------------HHHHHHcCC
Confidence 12234568999999999999999999999999999999999999997543210 011111111
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMAD 357 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~ 357 (395)
+ .........+.+++.+|++.+|.+||++.+
T Consensus 213 ~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 213 L--VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred c--cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 1 111123456788999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=293.10 Aligned_cols=253 Identities=22% Similarity=0.352 Sum_probs=196.0
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++..+ ..++++|
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 4455555678999999999999954 6788999998766555667889999999999999999999998776 4569999
Q ss_pred cccCCChhhhcccCCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-CCcEEEeccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKL--DWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSDFGLA 237 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~ 237 (395)
|+++++|.+++.... ..+ ++..+..++.|++.||+|||+. +++|+||||+||+++. ++.++|+|||++
T Consensus 86 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 86 QVPGGSLSALLRSKW------GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred cCCCCCHHHHHHHhc------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 999999999986432 234 7888899999999999999998 9999999999999976 679999999998
Q ss_pred cccCCCCCCceeeccccccccccchhhccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
....... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||....... ...+..
T Consensus 157 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~------- 224 (268)
T cd06624 157 KRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKV------- 224 (268)
T ss_pred eecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhh-------
Confidence 7543221 112234578899999998654 37889999999999999999999986432110 000000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
... ......+.....++.+++.+||+.+|++|||+.+++++
T Consensus 225 ---~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 225 ---GMF--KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---hhh--ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000 00112223344578899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=291.67 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=201.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
.++|++.+.||+|+||.||++... +++.+++|.+........+.+..|+++++.++|||++++++++.+. ..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888999999999999999964 6788999998765555567889999999999999999999988766 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+++|.+++.... ..++...+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 82 CGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred CCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhh
Confidence 99999999885431 4688999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCCceeeccccccccccchhhccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTG---HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||....+..... . ...
T Consensus 153 ~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~--~----------~~~ 218 (262)
T cd06613 153 ATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF--L----------ISK 218 (262)
T ss_pred hhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--H----------HHh
Confidence 321 112234578889999998776 78899999999999999999999996433211000 0 000
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+.+ .........+..+.+++.+||+.+|.+|||+.+|+.+
T Consensus 219 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 219 SNFPP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccCCC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0011223345678999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=292.45 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=196.4
Q ss_pred CCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCc------ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK------QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
+|...+.||+|+||+||+|...+++.+|+|.+..... .....+.+|+++++.++|+|++++++++.+. ..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999998864321 1224578899999999999999999998776 45699
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
+||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.
T Consensus 81 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 150 (265)
T cd06631 81 MEFVPGGSISSILNRF-------GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150 (265)
T ss_pred EecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhH
Confidence 9999999999998432 3578999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCC----CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 239 IGSDKA----GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 239 ~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
...... .........++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~---~~------- 220 (265)
T cd06631 151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF---YI------- 220 (265)
T ss_pred hhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH---Hh-------
Confidence 542211 1111223457889999999998889999999999999999999999996433211000 00
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
.. .....+ ..+......+.+++.+||+.+|++||++.++++
T Consensus 221 ~~-~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 221 GA-HRGLMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hh-ccCCCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 000011 112233456889999999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=287.25 Aligned_cols=250 Identities=20% Similarity=0.308 Sum_probs=197.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|++.+.||+|.|+.|+++.. .+|+.+|+|++... +..+.+++.+|+.+-+.|+||||+++..-+.+. -.++|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 4577778999999999999884 57999999987532 334667899999999999999999999876655 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC---CCcEEEeccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSDFGLA 237 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~ 237 (395)
+|.+++|..-+... ..+++..+-..+.||+.+|.|+|.+ +|+|||+||+|+|+.+ ..-+||+|||++
T Consensus 91 ~m~G~dl~~eIV~R-------~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR-------EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred cccchHHHHHHHHH-------HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceE
Confidence 99999998777432 3467778888999999999999999 9999999999999943 456999999999
Q ss_pred cccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
.... .+.......|||.|||||++...+|+..+|||+.|++||-|+.|.+||...+...-. . ...
T Consensus 161 i~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly---e---------~I~ 225 (355)
T KOG0033|consen 161 IEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY---E---------QIK 225 (355)
T ss_pred EEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH---H---------HHh
Confidence 8765 233445678999999999999999999999999999999999999999864321100 0 001
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+|- .+.+-....++..+|+.+||..||.+|.|+.|.+++
T Consensus 226 ~g~yd~--~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 226 AGAYDY--PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ccccCC--CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 111111 111112234568899999999999999999998843
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.49 Aligned_cols=250 Identities=25% Similarity=0.386 Sum_probs=206.7
Q ss_pred CCCCCeeeccCCeEEEEEEEc--CCc--EEEEEEeccCCcc-cHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS--NGR--KVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDY 161 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~ 161 (395)
.++.++||+|.||.|++|.|. +|+ .||||.+...... ...+|.+|+.+|.+|+|+|+++++|+..+....+|+|.
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~EL 191 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFEL 191 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhh
Confidence 345678999999999999975 344 5899999865444 56799999999999999999999999999777899999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
++.|+|.+.|+... ...|.......++.|||.||.||.++ ++|||||.++|+|+...-.+||+|||+.+.+.
T Consensus 192 aplGSLldrLrka~-----~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAK-----KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred cccchHHHHHhhcc-----ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence 99999999997622 35688889999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCce-eeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 242 DKAGGHV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 242 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
....... .....-...|.|||.+....++.++|||+|||++|||++ |..||-.-. .-.+.+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-----------------g~qIL~ 326 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-----------------GIQILK 326 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC-----------------HHHHHH
Confidence 4432222 222334667999999999999999999999999999999 788875432 123334
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+|..-+-.-+..+++++++++..||..+|.+|||+..|.+.
T Consensus 327 ~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 327 NIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred hccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 444444444566788899999999999999999999999743
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=305.14 Aligned_cols=191 Identities=24% Similarity=0.330 Sum_probs=160.5
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
...+|.+.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++|+||+++++++... ..++|++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999965 5788999975432 234689999999999999999988776 4669999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
++. ++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 138 ~~~-~~l~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 138 HYS-SDLYTYLTKR------SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred ccC-CcHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 984 6888888532 24689999999999999999999999 9999999999999999999999999998743
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCC
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPI 292 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf 292 (395)
.... ......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 208 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 208 VVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 2211 122356899999999999999999999999999999999865554
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=311.47 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=192.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||++... +++.||+|++... .......+..|+.++..++|+|++++++.+.+. ..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999965 6899999998642 122345678899999999999999999988776 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++..
T Consensus 81 E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~ 150 (360)
T cd05627 81 EFLPGGDMMTLLMKK-------DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150 (360)
T ss_pred eCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence 999999999998532 4689999999999999999999998 999999999999999999999999999864
Q ss_pred cCCCCC---------------------------------CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHH
Q 016117 240 GSDKAG---------------------------------GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELL 286 (395)
Q Consensus 240 ~~~~~~---------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 286 (395)
...... .......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~ 230 (360)
T cd05627 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230 (360)
T ss_pred cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence 321110 00112346899999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc--ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC---HHHHHHH
Q 016117 287 TGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD--PALEGQYSMKEVIQVAAIAAMCVQPEADYRPL---MADVVQS 361 (395)
Q Consensus 287 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~~vl~~ 361 (395)
+|..||....+... ...+.. ..+.-........++.+++.+|+ .+|.+|++ +.+++++
T Consensus 231 tG~~Pf~~~~~~~~----------------~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 231 IGYPPFCSETPQET----------------YRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred cCCCCCCCCCHHHH----------------HHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 99999975443210 001110 00000000112345777888876 49999995 6677654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=297.43 Aligned_cols=251 Identities=23% Similarity=0.385 Sum_probs=199.3
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
.++|++.+.||.|+||.||++... ++..+++|.+........+.+..|++++++++|+|++++++++.+. ..+++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 456888899999999999999964 6889999998765555566788999999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~~~~~L~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLELE------RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 99999999985432 3689999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCceeeccccccccccchhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
.... ......++..|+|||.+. ...++.++||||||+++|+|++|..||....... .
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~----------------~ 216 (280)
T cd06611 155 STLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR----------------V 216 (280)
T ss_pred cccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH----------------H
Confidence 3221 122345788999999875 3456789999999999999999999997543211 0
Q ss_pred hhhhcccc-ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPA-LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+.... ..-..+...+..+.+++..||+.+|.+||++.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 217 LLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00111000 0001122234568899999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=298.33 Aligned_cols=264 Identities=24% Similarity=0.277 Sum_probs=191.2
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhcc---CCCcceeEEEEEecC------
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRL---RSPYLLALLGYCSDR------ 153 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~------ 153 (395)
+|++.+.||+|+||+||+|... +++.||+|.+..... .....+..|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999965 688999998864321 2223455677777665 799999999987542
Q ss_pred ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEec
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 233 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 233 (395)
..++++||+. ++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~d 151 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP-----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLAD 151 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 3569999997 48888885332 23589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
||++....... ......++..|+|||++.+..++.++|||||||++|+|++|.+||.....................
T Consensus 152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 152 FGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred cCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 99997643321 122345788999999999889999999999999999999999999654322110000000000000
Q ss_pred ch---h---hhhhcccccc---CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 RE---K---ILEIMDPALE---GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 ~~---~---~~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. . ....+.+... .....+....+.+++.+||+.||++|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 0 0000000000 01111234568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=307.85 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=194.9
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC------
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------ 153 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 153 (395)
..++|.+.+.||+|+||.||++... .++.+|+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999954 6889999998643 223345677899999999999999999977532
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
..++||||+.+ +|.+.+. ..+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~ 168 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 168 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH---------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEE
Confidence 35799999965 6777662 2478899999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhh------
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW------ 306 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~------ 306 (395)
|||++....... ......+|..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+-.
T Consensus 169 DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 169 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred eCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999997543221 12335688999999999999999999999999999999999999975432211000000
Q ss_pred --hhcccc--------cch-----hhhhhccccc---cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 307 --ALPRLT--------DRE-----KILEIMDPAL---EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 307 --~~~~~~--------~~~-----~~~~~~d~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....+. +.. ....+..... ...........+.+|+.+||+.||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 000 0000000000 000111123468899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.44 Aligned_cols=238 Identities=22% Similarity=0.381 Sum_probs=183.8
Q ss_pred eeeccCCeEEEEEEEcC-------------------------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeE
Q 016117 92 VVGHGGFGLVYRGVLSN-------------------------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 146 (395)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13588998875544445678889999999999999999
Q ss_pred EEEEecC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC
Q 016117 147 LGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK 225 (395)
Q Consensus 147 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~ 225 (395)
++++.+. ..++||||+++|+|..++... ...+++..+..++.|++.||+|||+. +++||||||+|||++.
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~ 152 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE------KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence 9998766 567999999999999988532 24688999999999999999999998 9999999999999976
Q ss_pred CC-------cEEEeccccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHH-hCCCCCCCCC
Q 016117 226 NF-------HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELL-TGRVPIDVNK 296 (395)
Q Consensus 226 ~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell-~g~~pf~~~~ 296 (395)
.+ .++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||....
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 43 4899999987543221 12246778999998875 56899999999999999985 6999986543
Q ss_pred CCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 297 PSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
+... . ..+.... ..+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus 227 ~~~~---~--------------~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 227 PSEK---E--------------RFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred hHHH---H--------------HHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 2110 0 0000000 011112236889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=308.42 Aligned_cols=264 Identities=20% Similarity=0.256 Sum_probs=195.1
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-----
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR----- 153 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 153 (395)
...++|.+.+.||+|+||.||++... .++.+|+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34568999999999999999999854 68899999986432 22345677899999999999999999987542
Q ss_pred --ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEE
Q 016117 154 --RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 231 (395)
Q Consensus 154 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl 231 (395)
..+++|||+.+ +|.+.+. ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl 160 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEE
Confidence 35799999965 6666662 2478899999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh-hhhhc-
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV-SWALP- 309 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~-~~~~~- 309 (395)
+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|+.||............ .....
T Consensus 161 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (355)
T cd07874 161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_pred eeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999997543221 223356899999999999999999999999999999999999999754321110000 00000
Q ss_pred --ccc--cchhhhhhcc----------------cccc--CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 310 --RLT--DREKILEIMD----------------PALE--GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 310 --~~~--~~~~~~~~~d----------------~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
... ........++ .... ..........+.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 0000000000 0000 00111123568899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=296.70 Aligned_cols=250 Identities=28% Similarity=0.391 Sum_probs=194.8
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
|+..+.||+|+||+||++... +++.+|+|.+.... ......+..|+++++.++|+|++++.+++..+ ..++++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999964 68899999986432 12234567899999999999999999887766 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNMG-----NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 99999998885432 23699999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||............ ...+.
T Consensus 154 ~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~------------~~~~~ 218 (285)
T cd05632 154 EGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV------------DRRVL 218 (285)
T ss_pred CCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------HHhhh
Confidence 221 112346899999999999889999999999999999999999999754321100000 00011
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 361 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~vl~~ 361 (395)
.. ...+.......+.+|+..||+.+|++||| +.+++.+
T Consensus 219 ~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 219 ET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00 01122233456789999999999999999 6677754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=292.28 Aligned_cols=247 Identities=24% Similarity=0.419 Sum_probs=199.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
..|+..+.||+|+||.||+|... ++..+|+|.+.... ......+..|+.+++.+.|+|++++++++.++ ..+++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 34677788999999999999964 68899999887432 33456788899999999999999999988776 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+|+|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~~~~~L~~~i~~--------~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 84 LGGGSALDLLRA--------GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred CCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence 999999999842 3578889999999999999999998 99999999999999999999999999997543
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
... .......++..|+|||.+.+..++.++|+||||+++|||++|..||....+.... ...
T Consensus 153 ~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----------------~~~ 213 (277)
T cd06640 153 DTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----------------FLI 213 (277)
T ss_pred CCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----------------hhh
Confidence 322 1122345788899999998888999999999999999999999999754321100 001
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
............+..+.+++.+||+.+|++||++.+++.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 214 PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 1111122334556778999999999999999999999866
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=305.03 Aligned_cols=236 Identities=27% Similarity=0.371 Sum_probs=184.0
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHH-HHHhccCCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEV-ELLGRLRSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
++||+|+||.||+|+.. +++.+|+|++.... ......+..|. .+++.++||||+++++++.+. ..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 68899999986431 12223444454 467889999999999988766 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|...+.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~L~~~l~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 150 (321)
T cd05603 81 GELFFHLQR-------ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE 150 (321)
T ss_pred CCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC
Confidence 999888842 24688899999999999999999998 99999999999999999999999999987532221
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
.......|++.|+|||++.+..++.++|||||||++|||++|..||...+.. . ....+....
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~-------------~~~~i~~~~ 212 (321)
T cd05603 151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---Q-------------MYDNILHKP 212 (321)
T ss_pred --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---H-------------HHHHHhcCC
Confidence 1223456899999999999989999999999999999999999999754311 0 011111111
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 356 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 356 (395)
+ ..+......+.+++.+||+.+|.+||++.
T Consensus 213 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 L--QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred C--CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1 12223445688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=297.16 Aligned_cols=264 Identities=23% Similarity=0.366 Sum_probs=201.3
Q ss_pred ecHHHHHHHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEec
Q 016117 75 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSD 152 (395)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 152 (395)
..+..+..+.++|++.+.||+|+||.||++... +++.+++|++.... .....+..|+.+++.+ +|+|++++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334556667889999999999999999999864 68899999886432 2345678899999999 69999999998732
Q ss_pred ------CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC
Q 016117 153 ------RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN 226 (395)
Q Consensus 153 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~ 226 (395)
...+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+. +++||||||+||+++++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~ 160 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLK---RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE 160 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhc---cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC
Confidence 246799999999999998753221 224688999999999999999999998 99999999999999999
Q ss_pred CcEEEeccccccccCCCCCCceeeccccccccccchhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 016117 227 FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 301 (395)
Q Consensus 227 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~ 301 (395)
+.++|+|||++....... .......|+..|+|||.+.. ..++.++|||||||++|||++|..||....+....
T Consensus 161 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~ 238 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238 (286)
T ss_pred CCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH
Confidence 999999999987643321 11223458899999998753 45788999999999999999999999754321100
Q ss_pred hhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 302 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
.. .. ....+.. ..+......+.+++.+||+.+|++|||+.++++++
T Consensus 239 --~~-----~~------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 --FK-----IP------RNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred --hh-----cc------ccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 00 0000000 01111234688999999999999999999999763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=289.66 Aligned_cols=249 Identities=22% Similarity=0.380 Sum_probs=198.2
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC--ceEEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--RKLLVYD 160 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~lv~e 160 (395)
+|++.+.||+|++|.||++... +++.+++|.+.... ....+.+..|++++++++|+|++++.+.+... ..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999964 57899999986432 23345688899999999999999999877543 3579999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+++++|.+++.... ...+++.++..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~~l~~~l~~~~-----~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 81 FCEGGDLYHKLKEQK-----GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred ccCCCcHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEe
Confidence 999999999986422 24589999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... . ....+
T Consensus 153 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~----------~~~~~ 214 (257)
T cd08223 153 ENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------S----------LVYRI 214 (257)
T ss_pred cccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------H----------HHHHH
Confidence 3322 1223456788999999999999999999999999999999999998643211 0 00111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....+ ...+...+..+.+++.+||+.+|++|||+.+++++
T Consensus 215 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 215 IEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HhcCC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11111 11223345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=296.25 Aligned_cols=245 Identities=26% Similarity=0.451 Sum_probs=195.3
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+++++.++|+|++++++++... ..++|+||+.
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 555678999999999999864 67889999887432 23345788999999999999999999988766 5679999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+++|.+++.. ..+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++|+|||++......
T Consensus 86 ~~~L~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 86 GGSALDLLKP--------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 9999998832 3588999999999999999999998 9999999999999999999999999998754432
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
. .......++..|+|||.+.+..++.++||||||+++|||++|..||....+... .. .+..
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~--------------~~~~ 215 (277)
T cd06642 155 Q--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LF--------------LIPK 215 (277)
T ss_pred c--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hh--------------hhhc
Confidence 2 111224578889999999988899999999999999999999999864332110 00 0000
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..........+..+.+++.+||+.+|++|||+.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 216 NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 01111222344568899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=296.64 Aligned_cols=259 Identities=26% Similarity=0.394 Sum_probs=200.7
Q ss_pred cHHHHHHHhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEec-
Q 016117 76 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSD- 152 (395)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~- 152 (395)
++.++..+.+.|++.+.||+|+||.||+|.. .+++.+++|++.... .....+..|+.+++.+ +|+|++++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4556666778999999999999999999996 468899999886542 3345678899999998 79999999998742
Q ss_pred ------CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC
Q 016117 153 ------RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN 226 (395)
Q Consensus 153 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~ 226 (395)
...+++|||+.+|+|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-----GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 24579999999999999985433 23578888999999999999999998 99999999999999999
Q ss_pred CcEEEeccccccccCCCCCCceeeccccccccccchhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 016117 227 FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 301 (395)
Q Consensus 227 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~ 301 (395)
+.++|+|||++....... .......|+..|+|||.+. ...++.++||||||+++|||++|..||....+....
T Consensus 158 ~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 235 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235 (282)
T ss_pred CCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence 999999999987543211 1122356888999999876 346788999999999999999999999643321100
Q ss_pred hhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 302 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+.............+..+.+|+.+||+.+|.+|||+.+|+++
T Consensus 236 ----------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 ----------------FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ----------------hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00001101111111234578999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=292.68 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=184.8
Q ss_pred eeeccCCeEEEEEEEcC---CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCC
Q 016117 92 VVGHGGFGLVYRGVLSN---GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGG 166 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~ 166 (395)
.||+|+||.||+|...+ ...+++|.+.... ......+.+|+.+++.++|+||+++++.+.+. ..+++|||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3568888775432 22345678899999999999999999988766 5679999999999
Q ss_pred hhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCC
Q 016117 167 LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 246 (395)
Q Consensus 167 L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 246 (395)
|.+++...... .....++..+..++.|++.||+|||++ +++||||||+|||+++++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 82 LKNYLRSNRGM--VAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred HHHHHHhcccc--ccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999654421 123456788899999999999999999 9999999999999999999999999998643222111
Q ss_pred ceeeccccccccccchhhcc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 247 HVSTRVLGTQGYVAPEYALT-------GHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 247 ~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||....... ....... ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~~-----~~~~ 228 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQVVR-----EQDI 228 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhh-----ccCc
Confidence 11122345677999998753 356789999999999999999 788886432110 0000000 0000
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
.+..+. .....+..+.+++..|| .+|++|||+.+|++.|
T Consensus 229 ~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 111111 12233455677888898 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=289.23 Aligned_cols=249 Identities=23% Similarity=0.363 Sum_probs=199.7
Q ss_pred CCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+|+..+.||.|+||.||.++. .+++.+++|.+... .......+.+|++++++++|+|++++++++.+. ..++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999984 46889999987643 233456788999999999999999999988776 45699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++....
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~ 152 (256)
T cd08221 81 ANGGTLYDKIVRQK-----GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152 (256)
T ss_pred cCCCcHHHHHHhcc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence 99999999985432 24689999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
.... ......++..|+|||.+.+..++.++||||||+++|||++|..||....+.. ....+.
T Consensus 153 ~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----------------~~~~~~ 214 (256)
T cd08221 153 SEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN----------------LVVKIV 214 (256)
T ss_pred cccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH----------------HHHHHH
Confidence 3321 2233458899999999988889999999999999999999999996433210 011111
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..... ......+..+.+++.+||+.+|++|||+.+++++
T Consensus 215 ~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 215 QGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred cCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11111 1112334568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=290.84 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=205.0
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecCc-eEEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 160 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 160 (395)
.|++.+.||+|.-|+||++... ++..+|+|++.+.. .........|.+||+.+.||.++.+++.++.++ .+++||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 4677889999999999999975 46899999997543 233345667999999999999999999988775 569999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
||+||+|..+++.. ....+++..++.++..++-||.|||.. |||.|||||+||||-++|.+.|+||.++..+
T Consensus 158 yCpGGdL~~LrqkQ-----p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQ-----PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred cCCCccHHHHHhhC-----CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999998654 356899999999999999999999999 9999999999999999999999999987421
Q ss_pred CC---------------------------------C-C--------------------CCceeeccccccccccchhhcc
Q 016117 241 SD---------------------------------K-A--------------------GGHVSTRVLGTQGYVAPEYALT 266 (395)
Q Consensus 241 ~~---------------------------------~-~--------------------~~~~~~~~~g~~~y~aPE~~~~ 266 (395)
.. . . ........+||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 10 0 0 0011234679999999999999
Q ss_pred CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCC
Q 016117 267 GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQ 346 (395)
Q Consensus 267 ~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~ 346 (395)
...+.+.|.|+||+++|||+.|..||...+. ......++-+.+.-...+..+..+.+||++.|-
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence 9999999999999999999999999986543 233444444444333333556789999999999
Q ss_pred CCCCCCCC----HHHHHHH
Q 016117 347 PEADYRPL----MADVVQS 361 (395)
Q Consensus 347 ~~p~~RPt----~~~vl~~ 361 (395)
+||++|.- +.||-++
T Consensus 374 KdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred cChhhhhccccchHHhhcC
Confidence 99999998 8888754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=302.70 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=191.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||++... +++.||+|++... .....+.+.+|..++..++|+||+++++++.++ ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999964 6899999998642 122345678899999999999999999988776 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+|+|.+++... ...+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 81 e~~~g~~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 151 (331)
T cd05597 81 DYYVGGDLLTLLSKF------EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLR 151 (331)
T ss_pred ecCCCCcHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceee
Confidence 999999999999532 23588999999999999999999999 999999999999999999999999999865
Q ss_pred cCCCCCCceeeccccccccccchhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALT-----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
...... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||........ .. .....
T Consensus 152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~-~i~~~ 223 (331)
T cd05597 152 LLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YG-KIMNH 223 (331)
T ss_pred cCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HH-HHHcC
Confidence 433221 11223468999999999863 4578899999999999999999999975432110 00 00000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCC--CCCCCCHHHHHHH
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPE--ADYRPLMADVVQS 361 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~--p~~RPt~~~vl~~ 361 (395)
. ... .+. ......+..+.+++.+|+... +..||++.+++++
T Consensus 224 ~---~~~--~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 224 K---EHF--QFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C---Ccc--cCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 000 000 001113456778888877553 3448899999976
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.24 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=196.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
++|.+.+.||+|+||.||+|.. .+++.+++|.+..........+.+|+.+++.++|||++++++.+.+. ..++++||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4577778999999999999995 46889999998765444455678899999999999999999987665 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++++|.+++... ..+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 89 ~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 89 GGGSLQDIYHVT-------GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred CCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 999999998432 3689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCCceeeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.. .......|+..|+|||.+. ...++.++|||||||++|+|++|..||....+........ . ..
T Consensus 159 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~-------~----~~ 225 (267)
T cd06645 159 TI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT-------K----SN 225 (267)
T ss_pred cc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh-------c----cC
Confidence 21 1123356889999999874 4568889999999999999999999986443211100000 0 00
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+.... ....+..+.+++.+||+.+|++|||+.+|+++
T Consensus 226 ~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 226 FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00000000 01123468899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=296.58 Aligned_cols=261 Identities=24% Similarity=0.347 Sum_probs=201.0
Q ss_pred cHHHHHHHhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC
Q 016117 76 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR 153 (395)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 153 (395)
...++..+.++|.+.+.||+|+||.||++.. .+++.+++|++.... .....+..|+.+++++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3445556678899999999999999999996 468899999986532 2345677899999998 899999999987642
Q ss_pred ------ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC
Q 016117 154 ------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 227 (395)
Q Consensus 154 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~ 227 (395)
..++++||+++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLI---CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 36799999999999998854321 234689999999999999999999998 999999999999999999
Q ss_pred cEEEeccccccccCCCCCCceeeccccccccccchhhccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCch
Q 016117 228 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-----HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV 302 (395)
Q Consensus 228 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~ 302 (395)
.++|+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.||....+...
T Consensus 166 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-- 241 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-- 241 (291)
T ss_pred CEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--
Confidence 999999999875432221 11234578889999987643 368899999999999999999999975432110
Q ss_pred hhhhhhcccccchhhhhhccc-cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 303 LVSWALPRLTDREKILEIMDP-ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
. ..+... ...-..+......+.+++.+||+.+|++||++.+++++
T Consensus 242 ~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 L--------------FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H--------------HHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 000000 00001122234568999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=295.99 Aligned_cols=250 Identities=32% Similarity=0.517 Sum_probs=195.3
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHH--HHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGED--EFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
|++.+.||+|+||+||+++.. +++.+|+|++......... ....|+.++++++||||+++++++.+. ..+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999975 5678999999865433222 234599999999999999999998765 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.+++|.+++. ....+++..+..++.|++.||.+||+. +++|+||||+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~L~~~l~-------~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~ 150 (260)
T PF00069_consen 81 PGGSLQDYLQ-------KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE 150 (260)
T ss_dssp TTEBHHHHHH-------HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred cccccccccc-------ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999995 235689999999999999999999999 999999999999999999999999999875411
Q ss_pred CCCCceeeccccccccccchhhc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
.........++..|+|||++. +..++.++||||+|+++|+|++|..||.......... ......
T Consensus 151 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~-------------~~~~~~ 215 (260)
T PF00069_consen 151 --NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE-------------IIEKIL 215 (260)
T ss_dssp --TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH-------------HHHHHH
T ss_pred --cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhh-------------hhhhcc
Confidence 122334566889999999998 8889999999999999999999999997541100000 000000
Q ss_pred cccccC--CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 322 DPALEG--QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 322 d~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...... .........+.+++..||+.+|++|||+.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 216 KRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 0000112679999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=292.70 Aligned_cols=259 Identities=22% Similarity=0.364 Sum_probs=199.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~ 156 (395)
++|.+.+.||+|+||.||+|+.. +...+++|.+...... ..+.+..|++++++++|+|++++++++.+. ..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888899999999999999964 2467999988654332 346789999999999999999999998776 567
Q ss_pred EEEEcccCCChhhhcccCCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 157 LVYDYMANGGLQEHLYPANGSN--SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
+++||+++|+|.+++....... .....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999996443111 1123689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhccccc
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~-------- 229 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLN-------- 229 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHH--------
Confidence 99864332211 11122345677999999988888999999999999999999 78888532211 0111
Q ss_pred chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 314 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 314 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
...............+..+.+++.+||+.+|++|||+.+++..|.
T Consensus 230 -----~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 -----RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -----HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111111111112233457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=296.67 Aligned_cols=201 Identities=26% Similarity=0.380 Sum_probs=159.7
Q ss_pred CCeeeccCCeEEEEEEEc---CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEEEEEccc
Q 016117 90 SNVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLVYDYMA 163 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~e~~~ 163 (395)
.++||+|+||+||+|... +++.+|+|.+.... ....+.+|+.++++++||||+++++++... ..++++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999864 46789999986532 234577899999999999999999987542 4568999985
Q ss_pred CCChhhhcccCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe----CCCCcEEEeccccc
Q 016117 164 NGGLQEHLYPANGS--NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLA 237 (395)
Q Consensus 164 ~g~L~~~l~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~~ 237 (395)
++|.+++...... ......+++..+..++.|++.||.|||++ +++||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4787776432211 11224589999999999999999999999 99999999999999 45688999999999
Q ss_pred cccCCCCC-Cceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 016117 238 KIGSDKAG-GHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296 (395)
Q Consensus 238 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~ 296 (395)
........ ........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76433221 112234568999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=279.33 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=199.8
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC-----cc---cHHHHHHHHHHHhcc-CCCcceeEEEEEe
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG-----KQ---GEDEFKMEVELLGRL-RSPYLLALLGYCS 151 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 151 (395)
....+|...+.||.|..++|-++.. .+|..+|+|++.... +. -.+.-..|+.+|+++ .||+|+.+.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 3455788888999999999998885 478889999885321 11 123445799999997 7999999999998
Q ss_pred cCc-eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEE
Q 016117 152 DRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 230 (395)
Q Consensus 152 ~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k 230 (395)
.+. .++|++.|+.|.|.++|. ....+++...++|+.|+..|+.|||.. +|+||||||+|||++++.+++
T Consensus 94 s~sF~FlVFdl~prGELFDyLt-------s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLT-------SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred CcchhhhhhhhcccchHHHHhh-------hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceE
Confidence 775 459999999999999994 345789999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCceeeccccccccccchhhc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh
Q 016117 231 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL------TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 304 (395)
Q Consensus 231 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~ 304 (395)
|+|||.+..... +......|||++|+|||.+. ...|+...|+|++|++||.|+.|.+||....+
T Consensus 164 isDFGFa~~l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------- 233 (411)
T KOG0599|consen 164 ISDFGFACQLEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------- 233 (411)
T ss_pred EeccceeeccCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------
Confidence 999999986543 33556789999999999875 24688899999999999999999999964321
Q ss_pred hhhhcccccchhhhhhcccccc--CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 305 SWALPRLTDREKILEIMDPALE--GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~d~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+ -.+..++..... .+-=.+.+.+..+|+.+||+.||++|.|+.|++.+
T Consensus 234 ------m---lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 234 ------M---LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ------H---HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1 111122222111 11112345678999999999999999999999954
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=289.26 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=196.4
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-----KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
+|+..+.||+|++|.||+|... +++.|++|.+.... ....+.+..|+.+++.++|+|++++++++.+. ..+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999976 78999999886432 12345788899999999999999999998776 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
+||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~ 150 (258)
T cd06632 81 LELVPGGSLAKLLKKY-------GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK 150 (258)
T ss_pred EEecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccce
Confidence 9999999999998432 3588999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCCCceeeccccccccccchhhccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGH-LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...... ......++..|+|||.+.... ++.++|+||||+++|+|++|..||....+... .
T Consensus 151 ~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~---~------------- 211 (258)
T cd06632 151 QVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA---V------------- 211 (258)
T ss_pred eccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH---H-------------
Confidence 643322 123355788899999987766 89999999999999999999999965431100 0
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
............+......+.+++.+||+.+|++||++.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 212 FKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred HHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 00000000011222234568899999999999999999999853
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=294.29 Aligned_cols=266 Identities=22% Similarity=0.292 Sum_probs=194.6
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+|++.+.||+|++|.||+|... ++..||+|.+.... ......+.+|+.+++.++|||++++++++.++ ..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999964 68999999886432 22345778899999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+. ++|.+++.... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLP----KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCC----CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 68888885432 124689999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh-hhh-------hcccc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV-SWA-------LPRLT 312 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~-~~~-------~~~~~ 312 (395)
... .......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||............ ... ++...
T Consensus 153 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 153 IPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred CCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 221 112233568889999988754 5788999999999999999999999754321100000 000 00000
Q ss_pred cchhhhhhccccccC---CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 DREKILEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
............... ......+.++.+++.+||+.||++|||+.+|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000000000 0011134567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=307.92 Aligned_cols=243 Identities=30% Similarity=0.409 Sum_probs=196.7
Q ss_pred CCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccH---HHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 87 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGE---DEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
|+..+.||.|+||.||.|++ .+.+.||||.+.....+.. +++..|+..|++++|||.+.+-|+|..+ ..|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55667899999999999995 4788999999976554443 5678899999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
|-| +-.+++.-.+ +++-+.++..|+.+.+.||+|||++ +.+|||||+.|||+++.|.|||+|||.+....
T Consensus 108 ClG-SAsDlleVhk------KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 108 CLG-SASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred Hhc-cHHHHHHHHh------ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 954 5566664332 5788999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCceeeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
+. ..++|||.|||||++. .+.|+-+.||||||++..||...++|+-.++.-.. +.
T Consensus 178 PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA----------------LY 235 (948)
T KOG0577|consen 178 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------LY 235 (948)
T ss_pred ch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH----------------HH
Confidence 43 3578999999999986 57899999999999999999999999865542110 01
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
-+.......-...+.+..++.|+..||++-|.+|||.++++.+
T Consensus 236 HIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 236 HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1110011111245667789999999999999999999998754
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=297.55 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=194.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+..|+.+++.++||||+++++++.+. ..++++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888999999999999999964 68899999886432 22334677899999999999999999998766 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+. ++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++....
T Consensus 86 ~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDCG------NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 58988885432 3588999999999999999999998 99999999999999999999999999987533
Q ss_pred CCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+................ ......+
T Consensus 156 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 232 (301)
T cd07873 156 IPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGI 232 (301)
T ss_pred CCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-hhhchhh
Confidence 221 11223456889999998875 4578899999999999999999999975432111000000000000 0000000
Q ss_pred cc---------ccccC----CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 MD---------PALEG----QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~d---------~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
++ +.... ......+..+.+|+.+||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 00000 0011224467899999999999999999999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=289.95 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=199.6
Q ss_pred CCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLVY 159 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~ 159 (395)
+|++.+.||.|+||.||++.. .++..+++|.+.... ....+.+..|+++++.++|+|++++++++... ..++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999985 478899999886432 23345688899999999999999999977542 357999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH-----EHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
||+++++|.+++..... ....+++..++.++.|++.||.||| +. +++|+||+|+||++++++.++|+||
T Consensus 81 e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK---ERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred hhccCCCHHHHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecc
Confidence 99999999999865421 2356899999999999999999999 66 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
|++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...
T Consensus 155 g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~---------- 219 (265)
T cd08217 155 GLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA---------- 219 (265)
T ss_pred cccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH----------
Confidence 99986543321 122346888999999999888999999999999999999999999754311 111
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+........+...+..+.+++.+||+.+|++|||+.+|+++
T Consensus 220 ----~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 220 ----SKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111111112333445678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=290.56 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=195.9
Q ss_pred CCCCCCeeeccCCeEEEEEEEcC--CcEEEEEEeccCC----------cccHHHHHHHHHHHhc-cCCCcceeEEEEEec
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLSN--GRKVAIKLMDQAG----------KQGEDEFKMEVELLGR-LRSPYLLALLGYCSD 152 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 152 (395)
+|++.+.||+|+||.||++.... ++.+++|.+.... .....++..|+.++.+ ++|+|++++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999754 6889999875321 1122456678888765 799999999998876
Q ss_pred C-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEE
Q 016117 153 R-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 231 (395)
Q Consensus 153 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl 231 (395)
+ ..++++||+++++|.+++..... ....+++..++.++.|++.||.|||+.. +++|+||+|+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKE---KKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEE
Confidence 6 56799999999999998753221 2246899999999999999999999631 7999999999999999999999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 156 ~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------------ 220 (269)
T cd08528 156 TDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------------ 220 (269)
T ss_pred ecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------------
Confidence 9999997644332 2234567889999999998889999999999999999999999986432110
Q ss_pred ccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
....+.+..............+.+++.+||+.||++||++.++..+++
T Consensus 221 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 221 ----LATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----HHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000111111110011123356889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=288.66 Aligned_cols=238 Identities=24% Similarity=0.407 Sum_probs=187.3
Q ss_pred CeeeccCCeEEEEEEEcCCc-----------EEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEE
Q 016117 91 NVVGHGGFGLVYRGVLSNGR-----------KVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVY 159 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~ 159 (395)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++|||++++++++.....++++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEE
Confidence 36999999999999975432 5788877654332 67888999999999999999999988777778999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC-------cEEEe
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-------HAKVS 232 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-------~~kl~ 232 (395)
||+.+|+|.+++.... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++ .++|+
T Consensus 80 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 80 EYVKFGPLDVFLHREK------NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EcCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 9999999999995432 2688999999999999999999998 999999999999999887 79999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccC--CCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALP 309 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~ 309 (395)
|||++..... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||....... ...+..
T Consensus 151 Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~~- 220 (259)
T cd05037 151 DPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQ- 220 (259)
T ss_pred CCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHHh-
Confidence 9999875432 1123456779999998876 78999999999999999999 577775433211 000000
Q ss_pred ccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 310 RLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 310 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
... ..+......+.+++.+||..+|++|||+.++++.|+
T Consensus 221 ------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 ------------DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ------------cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 000011157889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=287.08 Aligned_cols=250 Identities=28% Similarity=0.475 Sum_probs=196.5
Q ss_pred CCCCCeeeccCCeEEEEEEEcC-----CcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 87 FSKSNVVGHGGFGLVYRGVLSN-----GRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
+++.+.||.|+||.||++...+ +..+|+|.+...... ..+.+..|+.+++.++|+|++++++++.+. ..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999653 388999998755333 456888999999999999999999988775 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++++|.+++..... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++..
T Consensus 81 e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-----KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred eccCCCCHHHHHHhhhh-----ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCcee
Confidence 99999999999854321 1289999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
......... ....++..|+|||.+.+..++.++||||+|+++|+|++ |..||...... ....
T Consensus 153 ~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~------------- 215 (258)
T smart00219 153 LYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLE------------- 215 (258)
T ss_pred ccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH-------------
Confidence 544321111 12236788999999988889999999999999999998 78888642211 0000
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
.+.. ......+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 216 ~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 216 YLKK-GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHhc-CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0000 001111222456789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=323.90 Aligned_cols=257 Identities=19% Similarity=0.312 Sum_probs=195.7
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC---ce
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RK 155 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~ 155 (395)
...++|.+.+.||+|+||+||++... ++..+|+|.+... .......+..|+.+++.++||||+++++++.+. ..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 44568999999999999999999965 5778999988643 223345788899999999999999999987543 36
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCceeCCCCCCCEEeCC------
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC----SPPVIHRDFKSSNILLDK------ 225 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----~~~i~H~dlk~~Nill~~------ 225 (395)
++||||+.+|+|.++|..... ....+++..++.|+.||+.||.|||+.. ..+|+|+||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~---~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYK---MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 799999999999999864321 1246999999999999999999999852 125999999999999964
Q ss_pred -----------CCcEEEeccccccccCCCCCCceeeccccccccccchhhcc--CCCCccchhHHHHHHHHHHHhCCCCC
Q 016117 226 -----------NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPI 292 (395)
Q Consensus 226 -----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf 292 (395)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||++|..||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 3458999999997643322 1234568999999999864 45889999999999999999999999
Q ss_pred CCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 293 DVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....... . +...+..... ......+.++.+|+..||+.+|.+||++.+++.+
T Consensus 244 ~~~~~~~--q--------------li~~lk~~p~-lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 244 HKANNFS--Q--------------LISELKRGPD-LPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CcCCcHH--H--------------HHHHHhcCCC-CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 6432110 0 0000000000 0001224568999999999999999999999953
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=290.27 Aligned_cols=254 Identities=23% Similarity=0.415 Sum_probs=194.9
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc---c-------cHHHHHHHHHHHhccCCCcceeEEEEEecC-
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---Q-------GEDEFKMEVELLGRLRSPYLLALLGYCSDR- 153 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~- 153 (395)
+|...+.||+|+||.||+|... +|+.+|+|.+..... . ..+.+..|+.+++.++|+|++++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999854 689999998753211 0 124577899999999999999999998776
Q ss_pred ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEec
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 233 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 233 (395)
..++|+||+.+++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d 151 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-------GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISD 151 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEee
Confidence 566999999999999998532 4688999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH--LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
||++................++..|+|||.+.... ++.++|+||||+++|++++|..||....... .... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~-----~ 224 (272)
T cd06629 152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--AMFK-----L 224 (272)
T ss_pred ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--HHHH-----h
Confidence 99987543322122223345788999999987654 7899999999999999999999986432110 0000 0
Q ss_pred ccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. ...............+..+.+++.+||+.+|++|||+.+++++
T Consensus 225 ~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 225 GN-----KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred hc-----cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00 0000111111112335678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=293.97 Aligned_cols=260 Identities=22% Similarity=0.345 Sum_probs=199.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|++.+.||+|+||+||++... +|..+|+|++.... ....+.+..|+++++.++||||+++++++.+. ..++++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777889999999999999954 68899999876432 33456788999999999999999999988776 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++.. ...+++..+..++.+++.||.|||+.. +++|+||+|+||++++++.++|+|||++....
T Consensus 85 ~~~~~L~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 85 MDCGSLDRIYKK-------GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred CCCCCHHHHHHh-------ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 999999998843 235899999999999999999999632 79999999999999999999999999986432
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
... .....|+..|+|||++.+..++.++|||||||++|+|++|..||................ ......+.
T Consensus 156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~ 226 (284)
T cd06620 156 NSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI-----LDLLQQIV 226 (284)
T ss_pred hhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHH-----HHHHHHHh
Confidence 221 123468899999999988899999999999999999999999997544321110000000 00111111
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
............+..+.+|+.+||+.+|++|||+.|++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111111122455789999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=288.36 Aligned_cols=249 Identities=21% Similarity=0.383 Sum_probs=198.3
Q ss_pred CCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+|++.+.||+|+||.+|++.. .+|+.+++|.+... .....+.+.+|+.+++.++|+|++++++++.+. ..++++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999995 46889999988643 223345788999999999999999999988766 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~~l~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~ 152 (256)
T cd08218 81 CEGGDLYKKINAQR-----GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152 (256)
T ss_pred CCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence 99999999885322 23578999999999999999999998 99999999999999999999999999997543
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
... .......++..|+|||++.+..++.++|+||||+++|+|++|..||...... .....+.
T Consensus 153 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----------------~~~~~~~ 214 (256)
T cd08218 153 STV--ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK----------------NLVLKII 214 (256)
T ss_pred cch--hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH----------------HHHHHHh
Confidence 321 1112345788899999999888999999999999999999999998643211 0111111
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.... ...+......+.+++.+||+.+|++||++.+|+++
T Consensus 215 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 215 RGSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cCCC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1110 11222345578999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=298.89 Aligned_cols=251 Identities=22% Similarity=0.293 Sum_probs=193.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||+||+++.. +++.||+|++... .......+.+|..++..++|+||+.+++++.+. ..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 6788999998642 122334577899999999999999999988776 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+|+|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 81 Ey~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~ 151 (331)
T cd05624 81 DYYVGGDLLTLLSKFE------DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLK 151 (331)
T ss_pred eCCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceee
Confidence 9999999999996432 3588999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCCceeeccccccccccchhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALT-----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
...... .......|++.|+|||++.+ ..++.++||||||+++|||++|+.||.......
T Consensus 152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------------- 215 (331)
T cd05624 152 MNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------------- 215 (331)
T ss_pred ccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH---------------
Confidence 433221 11223568999999999875 467889999999999999999999997543210
Q ss_pred hhhhhhcccccc---CCCCHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 016117 315 EKILEIMDPALE---GQYSMKEVIQVAAIAAMCVQPEADY--RPLMADVVQS 361 (395)
Q Consensus 315 ~~~~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~~vl~~ 361 (395)
....+...... .....+.+..+.+++.+|+...+.+ |+++++++++
T Consensus 216 -~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 216 -TYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -HHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 01111110000 0011123456888999999866544 5688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=288.14 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=194.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-----cccHHHHHHHHHHHhccCCCcceeEEEEEecC---ce
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-----KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RK 155 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~ 155 (395)
.+|++.+.||+|+||.||.+... +++.|++|.+.... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999964 68999999875321 11235678899999999999999999987653 35
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++++||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg 151 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-------GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFG 151 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCc
Confidence 5899999999999998432 3578889999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCC-ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 236 LAKIGSDKAGG-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 236 ~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
++......... .......++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---------------- 215 (265)
T cd06652 152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM---------------- 215 (265)
T ss_pred cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----------------
Confidence 98754321111 1122345788999999998888999999999999999999999999643211
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...............+......+.+++.+|+. +|++||++++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 216 AAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 01111111111122334455678889999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=292.19 Aligned_cols=265 Identities=24% Similarity=0.324 Sum_probs=196.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++|+|++++++++... ..++++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999975 68999999886432 22335678899999999999999999988766 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|++++.|..++.. ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~~~~~~l~~~~~~-------~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 81 YCDHTVLNELEKN-------PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARIL 150 (286)
T ss_pred ccCccHHHHHHhC-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceec
Confidence 9999888877632 23589999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc--------
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL-------- 311 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------- 311 (395)
..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......+............
T Consensus 151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 151 TGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred CCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 43221 1123457788999999876 567899999999999999999999997544321111000000000
Q ss_pred ccchhhhhhccccccCCCC-----HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 312 TDREKILEIMDPALEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...........+......+ ...+..+.+|+.+||+.+|++|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000000111110001 1124578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=298.87 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=192.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||++... +++.+|+|++... .......+..|..++..++|+||+++.+++.+. ..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999965 5788999998642 122234578899999999999999999988776 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+|+|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..
T Consensus 81 ey~~~g~L~~~l~~~~------~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~ 151 (332)
T cd05623 81 DYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLK 151 (332)
T ss_pred eccCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchhee
Confidence 9999999999995432 3588999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCCceeeccccccccccchhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
..... ........||+.|+|||++. ...++.++|||||||++|||++|+.||...+...
T Consensus 152 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~--------------- 215 (332)
T cd05623 152 LMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------------- 215 (332)
T ss_pred cccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH---------------
Confidence 43221 11223356899999999986 3467899999999999999999999997543211
Q ss_pred hhhhhhccccccCCC---CHHHHHHHHHHHhhcCCCCCC--CCCCHHHHHHH
Q 016117 315 EKILEIMDPALEGQY---SMKEVIQVAAIAAMCVQPEAD--YRPLMADVVQS 361 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~---~~~~~~~l~~li~~cl~~~p~--~RPt~~~vl~~ 361 (395)
....+......... ....+..+.+++.+|+..++. .|+++.+++++
T Consensus 216 -~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 216 -TYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -HHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 01111111000001 112345678889998865444 47899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=292.71 Aligned_cols=239 Identities=22% Similarity=0.404 Sum_probs=185.7
Q ss_pred CeeeccCCeEEEEEEEcC--------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 91 NVVGHGGFGLVYRGVLSN--------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+.||+|+||.||+|.... ...+++|.+........+.+.+|..+++.+.|||++++++++..+ ..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998532 234888887655444556788899999999999999999988764 67799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc--------EEEec
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH--------AKVSD 233 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--------~kl~D 233 (395)
+.+|+|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++. ++++|
T Consensus 81 ~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 81 VKFGSLDTYLKKNK------NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred CCCCcHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecc
Confidence 99999999996432 3588999999999999999999998 9999999999999987765 69999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCC-CCCCCCCCCCCchhhhhhhccc
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGR-VPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~-~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
||++...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .||....+..
T Consensus 152 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------------ 213 (258)
T cd05078 152 PGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------------ 213 (258)
T ss_pred cccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------------
Confidence 9988643221 22457788999999886 45789999999999999999985 5554322110
Q ss_pred ccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
........ ...+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 214 -----~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 214 -----KLQFYEDR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----HHHHHHcc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00001100 1112222356899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=288.83 Aligned_cols=253 Identities=24% Similarity=0.421 Sum_probs=198.4
Q ss_pred CCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCc------ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK------QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
+|+..+.||+|++|.||++.. .+++.+++|.+..... ...+.+..|+.++++++|+|++++++++.+. ..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999985 5789999998864321 1235788899999999999999999998776 5669
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC-cEEEecccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKVSDFGL 236 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~ 236 (395)
++||+.+++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||.
T Consensus 81 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-------GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred EEeccCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 99999999999998532 3688999999999999999999999 999999999999998775 599999999
Q ss_pred ccccCCCCCC--ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 237 AKIGSDKAGG--HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 237 ~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
+......... .......++..|+|||.+.+..++.++||||+|+++|+|++|..||...........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~----------- 219 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL----------- 219 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-----------
Confidence 8765432111 111234578899999999888899999999999999999999999964432111110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.............+......+.+++.+||+.+|++|||+.+++++
T Consensus 220 --~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 220 --IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred --HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 111111111123334455678899999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=290.79 Aligned_cols=255 Identities=28% Similarity=0.434 Sum_probs=199.3
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecCc-----
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR----- 154 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----- 154 (395)
.++++|++.+.||+|++|.||+|... +++.+++|++..... ..+.+..|+.+++++ .|+|++++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999974 678999999875433 346788999999999 7999999999986543
Q ss_pred --eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 155 --KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 155 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
.++++||+.+++|.+++..... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~ 155 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRK---KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLV 155 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEEC
Confidence 5799999999999998854321 124689999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 307 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~ 307 (395)
|||++....... .......++..|+|||.+.. ..++.++||||||+++|+|++|..||.......
T Consensus 156 d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------- 225 (275)
T cd06608 156 DFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-------- 225 (275)
T ss_pred CCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--------
Confidence 999987543322 11223457889999998753 346789999999999999999999996432110
Q ss_pred hcccccchhhhhhccc-cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 308 LPRLTDREKILEIMDP-ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 308 ~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....+... ......+......+.+++.+||..||++|||+.+++++
T Consensus 226 --------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 226 --------ALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred --------HHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00011110 00111122345678899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=292.87 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=199.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
++|.+.+.||+|+||.||++... ++..+++|.+........+.+.+|+.+++.++|||++++++++... ..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888999999999999999854 6889999998754445556788999999999999999999988765 677999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++++|.+++.. ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 99 ~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 99 AGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CCCcHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 99999999842 3578899999999999999999999 999999999999999999999999998865433
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
... ......+++.|+|||.+.+..++.++||||||+++|++++|..||....+....... ...
T Consensus 168 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---------------~~~ 230 (293)
T cd06647 168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---------------ATN 230 (293)
T ss_pred ccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---------------hcC
Confidence 221 122345788899999998888999999999999999999999999754332110000 000
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.......+......+.+++.+||+.+|++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 231 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111122234568899999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=302.66 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=191.9
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC------
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------ 153 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 153 (395)
..++|.+.+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 456899999999999999999995 478899999986432 22335677899999999999999999877532
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
..+++++++ +++|.+++. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK--------CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 346888877 778888773 23589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh-hhh---
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV-SWA--- 307 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~-~~~--- 307 (395)
|||++...... .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||............ ...
T Consensus 161 Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 161 DFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred CCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999754332 223468899999999876 57899999999999999999999999654321100000 000
Q ss_pred ----hcccccchhhhhhccccccCCCC-------HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 308 ----LPRLTDREKILEIMDPALEGQYS-------MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 308 ----~~~~~~~~~~~~~~d~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...... ......+. .+..... ......+.+|+.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISS-EHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcch-hhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00000000 0000000 0112347799999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=297.79 Aligned_cols=263 Identities=17% Similarity=0.215 Sum_probs=189.9
Q ss_pred CCCeeecc--CCeEEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 89 KSNVVGHG--GFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 89 ~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
+.++||+| +|++||++.. .+|+.||+|.+.... ....+.+.+|+++++.++||||+++++++..+ ..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 7899999985 478999999987532 22335677899999999999999999988766 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++|+|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.++++||+.......
T Consensus 82 ~~~~l~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~ 153 (327)
T cd08227 82 AYGSAKDLICTHF-----MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIN 153 (327)
T ss_pred CCCcHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence 9999999985432 23588999999999999999999998 999999999999999999999999986543221
Q ss_pred CCC-----Cceeeccccccccccchhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc---
Q 016117 243 KAG-----GHVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT--- 312 (395)
Q Consensus 243 ~~~-----~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--- 312 (395)
... ........++..|+|||++.+ ..++.++|||||||++|||++|..||........ ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 231 (327)
T cd08227 154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLL 231 (327)
T ss_pred ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccc
Confidence 110 001112346678999999876 4689999999999999999999999974322110 0000000000
Q ss_pred cch--hhhh--------hccc-----------------cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 DRE--KILE--------IMDP-----------------ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 ~~~--~~~~--------~~d~-----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
... ...+ ..+. .............+.+|+.+||+.||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 0000 0000 00001112234578899999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=284.28 Aligned_cols=271 Identities=23% Similarity=0.331 Sum_probs=217.9
Q ss_pred HHHHHHHhCCCCCCCeeeccCCeEEEEEEEcC------CcEEEEEEecc-CCcccHHHHHHHHHHHhccCCCcceeEEEE
Q 016117 77 FKQLHSATGGFSKSNVVGHGGFGLVYRGVLSN------GRKVAIKLMDQ-AGKQGEDEFKMEVELLGRLRSPYLLALLGY 149 (395)
Q Consensus 77 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 149 (395)
.+++.....+++...++-+|.||.||+|.+.+ .+.|.+|.++. .+.-....+..|.-++..+.|||+.++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 44555666778888899999999999997643 34566776654 334445677889989999999999999998
Q ss_pred EecC--ceEEEEEcccCCChhhhcccCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC
Q 016117 150 CSDR--RKLLVYDYMANGGLQEHLYPANGS-NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN 226 (395)
Q Consensus 150 ~~~~--~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~ 226 (395)
+.+. .++.+|.++.-|+|..||...++. ....+.++..+...++.|++.|++|||++ +++|.||.++|+++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 8765 577999999999999999754432 22345678888899999999999999999 99999999999999999
Q ss_pred CcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhh
Q 016117 227 FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVS 305 (395)
Q Consensus 227 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~ 305 (395)
.++||+|=.+++...+............+..||+||.+.+..|+.++||||||++||||+| |+.|+..-+|
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-------- 504 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-------- 504 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--------
Confidence 9999999999987766655544444556788999999999999999999999999999998 9999864332
Q ss_pred hhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 306 WALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
..++..+...-+-..+..++.+|+.++..||...|++||++++++..|.++--
T Consensus 505 ---------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 505 ---------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred ---------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 22223332223334566788899999999999999999999999999987654
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=286.44 Aligned_cols=257 Identities=27% Similarity=0.411 Sum_probs=200.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|++.+.||.|+||+||+|... ++..+++|++.... ......+.+|+++++.++|+|++++++.+.+. ..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999954 67899999986432 22456788999999999999999999987766 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++..... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 81 LSGGSLLDIMKSSYP----RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred cCCCcHHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 999999999954321 24689999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCc--eeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 242 DKAGGH--VSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 242 ~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... ......++..|+|||.+... .++.++|+||||+++|+|++|+.||........ ..... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~----------~ 221 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTL----------Q 221 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHh----------c
Confidence 433221 22334688899999998876 789999999999999999999999975433210 00000 0
Q ss_pred hhccccccCCC-CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPALEGQY-SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
. ..+...... ....+..+.+++..||+.||++|||+.+++++
T Consensus 222 ~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 222 N-DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred C-CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 001111100 11334678899999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=294.61 Aligned_cols=252 Identities=26% Similarity=0.332 Sum_probs=198.1
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc---cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
+|++.+.||+|++|+||++... +++.+|+|.+...... ..+.+..|+++++.++|+||+++++++.+. ..+++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6788899999999999999965 5899999998754322 345688899999999999999999988766 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~~~L~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 82 YCPGGELFRLLQRQP-----GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred ecCCCCHHHHHHhCC-----CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 999999999985332 24689999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCCCC---------------------------ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 016117 241 SDKAGG---------------------------HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 293 (395)
Q Consensus 241 ~~~~~~---------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~ 293 (395)
...... .......|+..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 221100 01112357889999999998889999999999999999999999997
Q ss_pred CCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC----HHHHHHH
Q 016117 294 VNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL----MADVVQS 361 (395)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~~vl~~ 361 (395)
..+.. .....+.+...........+..+.+++.+||+.+|++||| +.+++.+
T Consensus 234 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 234 GSNRD----------------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CCchH----------------HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 54321 1111111111111111124567999999999999999999 7777653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=305.68 Aligned_cols=199 Identities=29% Similarity=0.392 Sum_probs=169.2
Q ss_pred CCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-C-----CcceeEEEEEecC-ceEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-S-----PYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~-~~~l 157 (395)
+|.+.++||+|.||.|.+|. ..+++.||||+++.. ..-.++...|+.+|..|+ | -|+|++++++.-. +.|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78899999999999999999 457999999999865 334456677999999996 4 4899999998766 6779
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC--CCcEEEeccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK--NFHAKVSDFG 235 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg 235 (395)
|+|.+ .-+|.+++.... ...++...++.++.||+.||.+||+. +|||+||||+||||.+ ...+||+|||
T Consensus 266 VfELL-~~NLYellK~n~-----f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-----FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eehhh-hhhHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 99987 459999996543 35799999999999999999999999 9999999999999965 3479999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 299 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~ 299 (395)
.+....... ....-+..|+|||++.+.+|+.+.|||||||++.||++|.+.|.++++.+
T Consensus 337 SSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 337 SSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred cccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 998644332 24556778999999999999999999999999999999988887765543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=288.20 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=185.3
Q ss_pred eeeccCCeEEEEEEEcCC---cEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCC
Q 016117 92 VVGHGGFGLVYRGVLSNG---RKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGG 166 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~ 166 (395)
.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++|||++++++.+.+. ..+++|||+.+|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985433 346677665432 23456788999999999999999999998876 5679999999999
Q ss_pred hhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCC
Q 016117 167 LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 246 (395)
Q Consensus 167 L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 246 (395)
|.+++..... .....++..+..++.|++.||+|||+. +++|+||||+|||++.++.++|+|||++.........
T Consensus 82 L~~~l~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 82 LKSYLSQEQW---HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred HHHHHHhhhc---ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999965431 123567778889999999999999998 9999999999999999999999999997642221111
Q ss_pred ceeeccccccccccchhhcc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 247 HVSTRVLGTQGYVAPEYALT-------GHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 247 ~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
.......++..|+|||++.. ..++.++||||||+++|||++ |..||...... ....... .....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~-----~~~~~ 227 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHVI-----KDQQV 227 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH-----hhccc
Confidence 12233457889999998743 245789999999999999997 56677533211 0111000 01111
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
.+.++.+... ....+.+++..|| .+|++|||+.+|++.|.
T Consensus 228 ~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2233333222 3346778999999 67999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=294.98 Aligned_cols=265 Identities=24% Similarity=0.353 Sum_probs=196.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|++.+.||+|+||.||+|... +++.+|+|++..... ...+.+.+|+++++.++|||++++++++.+. ..++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888899999999999999975 589999998764322 2345678899999999999999999988766 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+++|.++... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 81 FVDHTVLDDLEKY-------PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 150 (286)
T ss_pred cCCccHHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence 9999988887632 23589999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc-----
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR----- 314 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 314 (395)
.... .......++..|+|||.+.+ ..++.++||||||+++|||++|..||..................+...
T Consensus 151 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 151 AAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred cCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 3322 11223457888999998875 457889999999999999999999986443211100000000000000
Q ss_pred ---hhhhhhccccccC-----CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 315 ---EKILEIMDPALEG-----QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 315 ---~~~~~~~d~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
........+.... ......+..+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000000 0011234678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=291.40 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=196.6
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
+|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++++++|+|++++++.+... ..++++||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5788899999999999999975 7899999988643 223345788899999999999999999977665 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++++|.+++.... ....+++..+..++.|++.||.|||+.. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~~l~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 82 DAGSLDKLYAGGV----ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred CCCCHHHHHHhcc----ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 9999999885321 1246899999999999999999999632 899999999999999999999999999875432
Q ss_pred CCCCceeeccccccccccchhhccC------CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTG------HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
.. .....++..|+|||.+.+. .++.++|||||||++|+|++|..||......... ..
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-------------~~ 218 (286)
T cd06622 156 SL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-------------AQ 218 (286)
T ss_pred Cc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-------------HH
Confidence 21 1234577889999998654 3578999999999999999999999643211100 01
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+.+.. ....+.....++.+++.+||+.+|++||++.+++.+
T Consensus 219 ~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 219 LSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11111111 112233456678999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=294.57 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=195.9
Q ss_pred CCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCCh
Q 016117 90 SNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 167 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L 167 (395)
...||+|+||.||++... ++..+|+|.+........+.+.+|+.+++.++|+|++++++.+... ..++++||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 356999999999999864 6889999998765445556788999999999999999999987665 56799999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCc
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 247 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 247 (395)
.+++.. ..+++..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||++........
T Consensus 107 ~~~~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 107 TDIVTH--------TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred HHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 998832 3588999999999999999999998 999999999999999999999999999875432221
Q ss_pred eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccC
Q 016117 248 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327 (395)
Q Consensus 248 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 327 (395)
......++..|+|||.+.+..++.++||||||+++|||++|..||....+... . ..+...+.+....
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~----------~~~~~~~~~~~~~ 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---M----------RRIRDNLPPRVKD 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H----------HHHHhcCCCcccc
Confidence 12234578899999999888899999999999999999999999974332110 0 0011111111111
Q ss_pred CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 328 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 328 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.......+.+++.+||+.+|.+|||+.+++++ .++.
T Consensus 241 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~--~~~~ 276 (292)
T cd06658 241 --SHKVSSVLRGFLDLMLVREPSQRATAQELLQH--PFLK 276 (292)
T ss_pred --ccccCHHHHHHHHHHccCChhHCcCHHHHhhC--hhhh
Confidence 11234468889999999999999999999974 4444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=292.04 Aligned_cols=200 Identities=27% Similarity=0.397 Sum_probs=158.7
Q ss_pred CeeeccCCeEEEEEEEc---CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEec---CceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD---RRKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---~~~~lv~e~~~~ 164 (395)
..||+|+||+||+|... ++..+|+|.+.... ....+.+|+++++.++||||+++++++.. ...++++||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999964 45789999886532 23467789999999999999999998753 245699999864
Q ss_pred CChhhhcccCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe----CCCCcEEEecccccc
Q 016117 165 GGLQEHLYPANGS--NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLAK 238 (395)
Q Consensus 165 g~L~~~l~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg~~~ 238 (395)
+|.+++...... ......+++..+..++.|++.||.|||+. +++||||||+|||+ +.++.+||+|||++.
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777776432211 11234588999999999999999999998 99999999999999 567899999999997
Q ss_pred ccCCCCCC-ceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 016117 239 IGSDKAGG-HVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296 (395)
Q Consensus 239 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~ 296 (395)
........ .......+|..|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 65432211 11233567899999999876 458899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=285.10 Aligned_cols=248 Identities=27% Similarity=0.406 Sum_probs=196.6
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+|+..+.||+|+||.||++... +++.+++|.+.... ......+..|+++++.++|||++++++.+..+ ..++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 78899999886432 23356788899999999999999999987665 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC-CcEEEecccccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAKIG 240 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~~~ 240 (395)
+++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++++ +.++|+|||++...
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 81 APGGTLAEYIQKRC-----NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred CCCCCHHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 99999999995432 23589999999999999999999998 99999999999999855 46899999999865
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... ... .+
T Consensus 153 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~-------------~~ 213 (256)
T cd08220 153 SSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVL-------------KI 213 (256)
T ss_pred CCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHH-------------HH
Confidence 4322 1223457889999999998889999999999999999999999996543211 010 11
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..... ...+...+..+.+++.+||+.+|++|||+.+++.+
T Consensus 214 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 214 MSGTF-APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HhcCC-CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11000 11112234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=287.27 Aligned_cols=245 Identities=26% Similarity=0.459 Sum_probs=195.7
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++|||++++++++.++ ..++|+||+.
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 667789999999999999864 68899999876432 23345788899999999999999999988776 5679999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 86 ~~~l~~~i~~--------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 86 GGSALDLLEP--------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred CCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 9999999832 3588999999999999999999998 9999999999999999999999999998754332
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....+. .... . +..
T Consensus 155 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~-------------~-~~~ 215 (277)
T cd06641 155 QI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KVLF-------------L-IPK 215 (277)
T ss_pred hh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HHHH-------------H-Hhc
Confidence 11 112345788899999998888899999999999999999999998643211 0000 0 000
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..........+..+.+++.+||+.+|++||++.+++++
T Consensus 216 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 216 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00111222334568899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=293.42 Aligned_cols=266 Identities=23% Similarity=0.343 Sum_probs=197.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|++.+.||+|+||.||+|... +++.|++|.+... .....+.+.+|+++++.++|+|++++++++.++ ..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999965 6889999988643 233346788999999999999999999988766 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.++.+..+... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~~~~~~l~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~ 150 (288)
T cd07833 81 YVERTLLELLEAS-------PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARAL 150 (288)
T ss_pred cCCCCHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence 9998777665522 23589999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc-------
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT------- 312 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------- 312 (395)
..... .......++..|+|||++.+. .++.++||||||+++|+|++|..||......+...........+.
T Consensus 151 ~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 151 RARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred CCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 44322 122335678889999999887 889999999999999999999999975432111100000000000
Q ss_pred -cchhhh--hhcccc----ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 -DREKIL--EIMDPA----LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 -~~~~~~--~~~d~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...... ...+.. ....++...+..+.+|+.+||+.+|++|||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 000000 0001112235679999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=302.71 Aligned_cols=239 Identities=25% Similarity=0.307 Sum_probs=181.7
Q ss_pred eeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhcc---CCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 93 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRL---RSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 93 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
||+|+||+||+|+.. +++.||+|++..... .....+..|..++... .||||+++++++.+. ..++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999964 689999999864211 1223344566666655 699999999988766 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|.+++.. ...+++..+..++.|++.||+|||++ +++||||||+|||++.++.++|+|||++.......
T Consensus 81 g~L~~~l~~-------~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 150 (330)
T cd05586 81 GELFWHLQK-------EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN 150 (330)
T ss_pred ChHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence 999998843 24689999999999999999999999 99999999999999999999999999987532221
Q ss_pred CCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
.......||..|+|||++.+. .++.++|||||||++|+|++|..||....... ....+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----------------~~~~i~~~ 212 (330)
T cd05586 151 --KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----------------MYRNIAFG 212 (330)
T ss_pred --CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----------------HHHHHHcC
Confidence 122345689999999998754 58999999999999999999999996533210 00011000
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCC----CHHHHHH
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRP----LMADVVQ 360 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP----t~~~vl~ 360 (395)
...- ........+.+++.+||+.+|.+|| ++.++++
T Consensus 213 ~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 213 KVRF-PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCC-CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0000 0011234678899999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=284.78 Aligned_cols=251 Identities=27% Similarity=0.425 Sum_probs=196.4
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc--cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+|.+.+.||+|+||.||++... +++.+++|.+...... ..+.+..|+++++.++|+||+++++++.+. ..++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999964 7899999998754332 556888999999999999999999988766 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++....
T Consensus 81 ~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~ 150 (264)
T cd06626 81 CSGGTLEELLEHG-------RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK 150 (264)
T ss_pred CCCCcHHHHHhhc-------CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence 9999999998532 3478899999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCce--eeccccccccccchhhccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 242 DKAGGHV--STRVLGTQGYVAPEYALTGH---LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 242 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
....... .....++..|+|||.+.+.. ++.++||||||+++|++++|..||...... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~~~~--------- 218 (264)
T cd06626 151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQIMFH--------- 218 (264)
T ss_pred CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHHHHH---------
Confidence 3322111 11345788999999998766 889999999999999999999999643211 000000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
+.....+.+. ........+.+++.+||+.+|++|||+.+++.
T Consensus 219 ~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 219 VGAGHKPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HhcCCCCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000001111 11112456789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=293.51 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=193.7
Q ss_pred CCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCCh
Q 016117 90 SNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 167 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L 167 (395)
...||+|+||.||++... +++.|++|.+........+.+.+|+.+++.++|||++++++++..+ ..++++||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 447999999999999964 6899999998755445556788899999999999999999987665 66799999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCc
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 247 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 247 (395)
.+++. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .
T Consensus 106 ~~~~~--------~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~ 172 (297)
T cd06659 106 TDIVS--------QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 172 (297)
T ss_pred HHHHh--------hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc--c
Confidence 98873 23588999999999999999999998 99999999999999999999999999987543322 1
Q ss_pred eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccC
Q 016117 248 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327 (395)
Q Consensus 248 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 327 (395)
......++..|+|||.+.+..++.++||||||+++|||++|..||....+... .... ........
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~----------~~~~~~~~-- 237 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRL----------RDSPPPKL-- 237 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH----------hccCCCCc--
Confidence 12235688999999999988899999999999999999999999974432110 0000 00000000
Q ss_pred CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 328 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 328 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.........+.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0111223468899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=287.21 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=198.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~ 159 (395)
++|...+.||.|++|.||++... +++.+|+|.+..... .....+.+|++++++++||||+++++++.+. ..+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777889999999999999964 688999998874322 3446788999999999999999999988643 467999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++++|.+++..... ....++...+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK---RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EecCCCCHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 99999999988753221 224588899999999999999999998 999999999999999999999999999865
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC--Cchhhhhhhcccccchhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG--EGVLVSWALPRLTDREKI 317 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 317 (395)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ......+..
T Consensus 155 ~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 221 (287)
T cd06621 155 LVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV--------- 221 (287)
T ss_pred ccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh---------
Confidence 43221 123456788999999998899999999999999999999999997553211 011111110
Q ss_pred hhhccccccCCC--CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 318 LEIMDPALEGQY--SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 318 ~~~~d~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....+.+.... .......+.+++.+||+.+|++|||+.|++++
T Consensus 222 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 222 -NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00001111111 11234578999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=286.77 Aligned_cols=251 Identities=26% Similarity=0.426 Sum_probs=196.9
Q ss_pred CCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHHHhccC---CCcceeEEEEEecC-ceEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLR---SPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~-~~~lv~ 159 (395)
.|+..+.||+|+||.||+|.. .+++.+++|.+... .......+.+|+.+++.++ |||++++++++.++ ..+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999995 57899999998643 2334567888999999986 99999999988766 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 150 (277)
T cd06917 82 EYAEGGSVRTLMKA--------GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAAL 150 (277)
T ss_pred ecCCCCcHHHHHHc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence 99999999998832 2688999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||......... . ...
T Consensus 151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~----------~~~ 215 (277)
T cd06917 151 LNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---M----------LIP 215 (277)
T ss_pred cCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh---h----------ccc
Confidence 543321 1223468889999998875 45789999999999999999999999754321100 0 000
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
....+.+... ..+.++.+++.+||+.+|++||++.+++++ +++.
T Consensus 216 ~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~--~~~~ 259 (277)
T cd06917 216 KSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS--KWIK 259 (277)
T ss_pred cCCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC--hHhh
Confidence 0000111110 134568899999999999999999999864 4444
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=291.50 Aligned_cols=262 Identities=21% Similarity=0.273 Sum_probs=191.6
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+|++.+.||+|+||.||+|... +|+.+++|.+.... ......+..|+++++.++|+|++++++++.+. ..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778889999999999999965 68999999886432 22234677899999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+. ++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CD-QDLKKYFDSCN------GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 97 57888774322 4589999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc--c---h
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD--R---E 315 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~---~ 315 (395)
... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||........ ........... . .
T Consensus 151 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 151 IPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWP 226 (284)
T ss_pred CCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhH
Confidence 221 112234568889999998764 478999999999999999999998643322110 00000000000 0 0
Q ss_pred hhhhhccccc----cC-----CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 316 KILEIMDPAL----EG-----QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 316 ~~~~~~d~~~----~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
......+... .. ......+..+.+++.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000001000 00 0111234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=283.48 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=202.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|.+.+.||+|++|.||++... +++.+++|++..... .....+..|+..+..++|+|++++++++... ..++++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999966 589999999876533 3456788999999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
+++++|.+++... ..+++..++.++.|++.|+.|||+ . +++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 ~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 81 MDGGSLADLLKKV-------GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVL 150 (264)
T ss_pred cCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999532 468999999999999999999999 8 9999999999999999999999999998765
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........... ...+
T Consensus 151 ~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~-------------~~~~ 215 (264)
T cd06623 151 ENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL-------------MQAI 215 (264)
T ss_pred ccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH-------------HHHH
Confidence 432211 1234578889999999988999999999999999999999999975542111111 1111
Q ss_pred ccccccCCCCHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 MDPALEGQYSMK-EVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..... ...+.. .+..+.+++.+||+.+|++|||+.+++++
T Consensus 216 ~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 216 CDGPP-PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred hcCCC-CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111 112222 45679999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=291.30 Aligned_cols=262 Identities=21% Similarity=0.295 Sum_probs=197.0
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+|++.+.||+|+||.||+|... +|+.+++|++.... ......+.+|+.++++++|+|++++++++.+. ..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999964 78999999987543 23346788999999999999999999988776 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+ +++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~-~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 81 M-PSDLSEVLRDEE------RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFS 150 (286)
T ss_pred c-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence 9 999999985432 4689999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc--------
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT-------- 312 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 312 (395)
.... .......++..|+|||.+.+. .++.++||||+|+++|||++|.+||....... ..........
T Consensus 151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07832 151 EEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWP 226 (286)
T ss_pred CCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHh
Confidence 3321 112234688899999988654 46899999999999999999988876443211 0100000000
Q ss_pred ---cchhhhhhcccccc----CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 ---DREKILEIMDPALE----GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 ---~~~~~~~~~d~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.......+..+... .....+....+.+++.+||+.+|++|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000000 00011234678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=287.40 Aligned_cols=252 Identities=25% Similarity=0.437 Sum_probs=198.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|+..+.||+|++|.||++... +++.+++|.+.... ......+.+|+++++.++|||++++++++... ..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999975 68999999887543 23446788899999999999999999988766 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
+.+++|.+++.... ..++...+..++.|++.||+|||+ . +++|+||+|+||++++++.++|+|||.+...
T Consensus 81 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 81 MDGGSLDKILKEVQ------GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151 (265)
T ss_pred cCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence 99999999985432 468899999999999999999999 7 9999999999999999999999999998654
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
..... ....++..|+|||.+.+..++.++||||||+++|+|++|..||......... .. .....+
T Consensus 152 ~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~----------~~~~~~ 216 (265)
T cd06605 152 VNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IF----------ELLQYI 216 (265)
T ss_pred HHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HH----------HHHHHH
Confidence 32211 1156788899999999999999999999999999999999999654321110 00 011111
Q ss_pred ccccccCCCCHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 MDPALEGQYSMK-EVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...... ..+.. .+..+.+++.+||..+|++|||+.+++.+
T Consensus 217 ~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 217 VNEPPP-RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hcCCCC-CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111111 11111 45678999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=290.73 Aligned_cols=245 Identities=29% Similarity=0.387 Sum_probs=192.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
..|...+.||+|+||+||+|... +++.|++|.+..... ...+.+.+|+++++.++|||++++.+++.+. ..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999964 689999998864322 2235688899999999999999999998766 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+. |++.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 95 e~~~-g~l~~~~~~~------~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 95 EYCL-GSASDILEVH------KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred HhhC-CCHHHHHHHc------ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCccee
Confidence 9996 5777776422 23589999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCCceeeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
.... ....++..|+|||++. ...++.++||||||+++|||++|..||........
T Consensus 165 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---------------- 222 (307)
T cd06607 165 VSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---------------- 222 (307)
T ss_pred cCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH----------------
Confidence 4322 1235778899999874 45688999999999999999999999864432100
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+.............+..+.+++.+||+.+|++||++.+|+.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 223 LYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000011122345678999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=289.12 Aligned_cols=263 Identities=21% Similarity=0.315 Sum_probs=192.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|++.+.||+|++|.||+|... +++.|++|.+..... .....+.+|+++++.++|+||+++++++.+. ..++|+||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999965 689999999864322 2234567899999999999999999998776 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+ +|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++...
T Consensus 85 ~~~-~L~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 85 LDT-DLKQYMDDCG------GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred CCC-CHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 984 8999885432 3688999999999999999999998 99999999999999999999999999986432
Q ss_pred CCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc--cchhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT--DREKIL 318 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~ 318 (395)
... .......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||........ ........+. ......
T Consensus 155 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 155 VPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWP 230 (291)
T ss_pred CCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhh
Confidence 211 11122346788999998875 4588999999999999999999999964431100 0000000000 000000
Q ss_pred h-------------hcc-ccccCCC-CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 E-------------IMD-PALEGQY-SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~-------------~~d-~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
. ... ..+.... .......+.+++.+||+.+|++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 000 0000000 00112567899999999999999999998853
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=287.60 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=190.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHH-HhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVEL-LGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|++.+.||+|+||.||++... +|+.||+|.+.... ......+..|+.. ++.++|||++++++++... ..++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999965 68999999987542 2223455556664 5667999999999988765 6779999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|++ |+|.+++..... ....+++..++.++.|++.||+|||++. +++||||||+||+++.++.+||+|||++...
T Consensus 81 ~~~-~~l~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 81 VMD-TSLDKFYKKVYD---KGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhc-ccHHHHHHHhcc---CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 996 688887754321 2256899999999999999999999753 7999999999999999999999999998754
Q ss_pred CCCCCCceeeccccccccccchhhcc----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALT----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
.... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... . ..
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~-------------~~ 216 (283)
T cd06617 155 VDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--F-------------QQ 216 (283)
T ss_pred cccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--H-------------HH
Confidence 3221 1122457888999998864 45688999999999999999999999632211 0 00
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.................+.++.+++.+||..+|++|||+.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 217 LKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111100000111234578999999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=289.59 Aligned_cols=244 Identities=25% Similarity=0.390 Sum_probs=197.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||.||++... +++.+|+|++.... ....+.+..|++++++++||||+++++++.++ ..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999965 68999999986432 22345688899999999999999999988776 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++++|.+++... ..++...+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 81 e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 150 (290)
T cd05580 81 EYVPGGELFSHLRKS-------GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKR 150 (290)
T ss_pred ecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence 999999999998432 4689999999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...... .....
T Consensus 151 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------~~~~~ 209 (290)
T cd05580 151 VKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----------------QIYEK 209 (290)
T ss_pred cCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHH
Confidence 5433 22346888999999998888899999999999999999999999644310 00111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
+..... ..+......+.+++.+||+.+|.+|| ++.+++++
T Consensus 210 ~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 210 ILEGKV--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred HhcCCc--cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 111111 11222345788999999999999999 77888754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=290.89 Aligned_cols=255 Identities=22% Similarity=0.331 Sum_probs=195.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||.||++... .++.|++|.+.... ......+.+|+++++.++||||+++++.+..+ ..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888899999999999999965 57899999886542 22345677899999999999999999988766 467999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 81 e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKNI-------GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 999999999999432 3589999999999999999999998 999999999999999999999999999864
Q ss_pred cCCCCC-------------CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhh
Q 016117 240 GSDKAG-------------GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 306 (395)
Q Consensus 240 ~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~ 306 (395)
...... ........++..|+|||.+.+..++.++|+||||+++|||++|..||....... ....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---~~~~ 227 (305)
T cd05609 151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQ 227 (305)
T ss_pred cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH
Confidence 211100 001112357788999999988889999999999999999999999996432210 0000
Q ss_pred hhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 307 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
........+.. ....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 228 --------~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 --------VISDDIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --------HHhcccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00000001110 11234568899999999999999997666666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=286.63 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=197.7
Q ss_pred CCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 87 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
|...+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++|+|++++++++... ..++++||+.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 34456899999999999995 47889999988654444456788899999999999999999987665 67799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
++|.+++.. ..+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||.+.......
T Consensus 101 ~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 101 GALTDIVTH--------TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred CCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 999999843 3588999999999999999999999 99999999999999999999999999886543322
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|..||....+.. ... .......+.
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~---~~~----------~~~~~~~~~ 234 (285)
T cd06648 170 P--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ---AMK----------RIRDNLPPK 234 (285)
T ss_pred c--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH---HHH----------HHHhcCCCC
Confidence 1 1123457889999999988889999999999999999999999996533210 000 000000011
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.. .....+..+.+++.+||+.+|++|||+.+++++ .++..
T Consensus 235 ~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~--~~~~~ 274 (285)
T cd06648 235 LK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH--PFLAK 274 (285)
T ss_pred Cc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC--ccccc
Confidence 11 111234578999999999999999999999964 44443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=288.99 Aligned_cols=269 Identities=22% Similarity=0.283 Sum_probs=197.1
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc-----cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ-----GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
+|.+.+.||+|+||.||+|... +++.|++|.+...... ....+..|+++++.++|+|++++++++.+. ..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999964 6899999998754322 234567899999999999999999998876 56699
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+ +|+|.+++.... ..+++..+..++.|+++||.|||++ +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~e~~-~~~L~~~i~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~ 150 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR 150 (298)
T ss_pred Eccc-CCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeee
Confidence 9999 999999985321 3689999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc---
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR--- 314 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 314 (395)
...... .......++..|+|||.+.+ ..++.++|||||||++|||++|..||......................
T Consensus 151 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 151 SFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred eccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 654322 11222345778999998864 467899999999999999999988776543211100000000000000
Q ss_pred --hhhhhhccccccCC-----CCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 315 --EKILEIMDPALEGQ-----YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 315 --~~~~~~~d~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.............. ........+.+++.+||+.+|++|||+.+++++ .++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~--~~~~~ 287 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH--PYFSN 287 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC--ccccC
Confidence 00000000000001 112234678899999999999999999999973 55554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=284.66 Aligned_cols=246 Identities=25% Similarity=0.397 Sum_probs=204.9
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEE-EEecCceEEEEEcccC
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG-YCSDRRKLLVYDYMAN 164 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~~lv~e~~~~ 164 (395)
|.++++||+|+||.||++.++ +|..+|||.+.- ..+.+++..|+.++++...+++|+++| ||.....++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 556788999999999999965 799999998864 345678899999999999999999999 5666789999999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+..+.+...+ +++++.++..++...+.||+|||.. .-+|||||+.|||++.+|..||+|||++..+.+..
T Consensus 113 GSiSDI~R~R~------K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 113 GSISDIMRARR------KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred CcHHHHHHHhc------CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999996543 6899999999999999999999998 88999999999999999999999999997554322
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc-cc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM-DP 323 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~ 323 (395)
.......||+.|||||++..-.|..++||||||++..||..|++||..-.+-.. +.-+. .+
T Consensus 184 --AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------------IFMIPT~P 245 (502)
T KOG0574|consen 184 --AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------------IFMIPTKP 245 (502)
T ss_pred --HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------------eEeccCCC
Confidence 223456799999999999999999999999999999999999999974332110 11111 11
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...-..+..-+.++-+|+++||-++|++|-|+.+++++
T Consensus 246 PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 246 PPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 11223345567789999999999999999999999875
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=278.53 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=199.9
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
.|+..+.||+|++|.||++... +++.+++|++..........+.+|+++++.++|+|++++++++... ..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999975 6889999999765444567889999999999999999999988766 5679999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+++|.+++.... ..+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKSTN------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 999999985432 4689999999999999999999998 9999999999999999999999999998765443
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ... .....-+
T Consensus 152 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~----------~~~~~~~ 215 (253)
T cd05122 152 KA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---LFK----------IATNGPP 215 (253)
T ss_pred cc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---HHH----------HHhcCCC
Confidence 21 2345678899999999988899999999999999999999999874421100 000 0000000
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. ......+..+.+++.+||+.+|++|||+.+++++
T Consensus 216 ~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 216 GL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred Cc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0111124568999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=279.67 Aligned_cols=251 Identities=24% Similarity=0.411 Sum_probs=201.8
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLVY 159 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~ 159 (395)
+|...+.||+|++|.||+|... +++.+++|++..... ...+.+.+|++++++++|+|++++++.+.+. ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999976 789999999875432 3456788999999999999999999988765 456999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+++|.+++... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 150 (260)
T cd06606 81 EYVSGGSLSSLLKKF-------GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKR 150 (260)
T ss_pred EecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence 999999999998532 2789999999999999999999998 999999999999999999999999999886
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..............++..|+|||.+.+...+.++||||||+++|+|++|..||...... . .....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~------------~~~~~ 215 (260)
T cd06606 151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP---M------------AALYK 215 (260)
T ss_pred cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---H------------HHHHh
Confidence 55433211123356788999999998888999999999999999999999999754310 0 00111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+.........+...+..+.+++.+|++.+|++||++.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 216 IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111111122333345679999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=287.50 Aligned_cols=266 Identities=20% Similarity=0.295 Sum_probs=192.6
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
+.++|.+.+.||+|+||.||+|... +|+.+++|++..... .....+.+|+.+++.++|+|++++.+++.++ ..++++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3567999999999999999999854 688999999864322 2234667899999999999999999988776 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 83 e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 83 EYMH-TDLAQYMIQHP------GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred eccc-CCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccc
Confidence 9995 67877764321 3577888999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc-----
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD----- 313 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----- 313 (395)
..... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.............|.......
T Consensus 153 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 153 KSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred cCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 33221 112234468899999998754 5788999999999999999999999744321100000000000000
Q ss_pred -----chhhhhhccccccCCC-----CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 314 -----REKILEIMDPALEGQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 314 -----~~~~~~~~d~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
................ .......+.+++.+|++.+|.+|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000000 0012356889999999999999999999885
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=285.77 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=199.9
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
..+.|+..+.||+|++|.||++... ++..+++|++..... ....+..|+++++.++|+|++++++++... ..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4456777889999999999999976 688999999876533 456788999999999999999999987665 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 96 ~~~~~~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 96 YMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred ccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 999999999995432 3689999999999999999999998 9999999999999999999999999988654
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
..... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....+.. .. ..+
T Consensus 167 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~---~~-------------~~~ 228 (286)
T cd06614 167 TKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---AL-------------FLI 228 (286)
T ss_pred ccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH---HH-------------HHH
Confidence 33221 1123447788999999988889999999999999999999999986433210 00 000
Q ss_pred cccccc-CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 MDPALE-GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~d~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...... .......+..+.+++.+||+.+|.+|||+.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 229 TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred HhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 000000 01111234578899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=288.99 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=205.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
+-|.+.+.||+|-|..|-+|++ -+|+.||||++.+..- .....+.+|+..|+.++|||||+++.+.... ..|+|.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 4467778899999999999984 4899999999976432 2345678899999999999999999998776 6679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC-CCCcEEEeccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKI 239 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~ 239 (395)
.-++|+|.+|+.++. ..+++..+.+++.||+.|+.|+|.. .++||||||+||.+- .-|-+||+|||++..
T Consensus 98 LGD~GDl~DyImKHe------~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE------EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNK 168 (864)
T ss_pred ecCCchHHHHHHhhh------ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecccccc
Confidence 999999999997654 5799999999999999999999999 899999999999875 568999999999875
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLT-TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
..+ +......||+..|.|||++.+..|+ ++.||||||++||-|++|+.||...+.. +.+.
T Consensus 169 f~P---G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------------ETLT 229 (864)
T KOG4717|consen 169 FQP---GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------------ETLT 229 (864)
T ss_pred CCC---cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------------hhhh
Confidence 443 3455678999999999999999887 5789999999999999999999744322 2233
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.++|=. -..+.....+..+||..||..||.+|-|.++|+..
T Consensus 230 mImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 230 MIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 333321 13455667788999999999999999999999853
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=288.10 Aligned_cols=249 Identities=29% Similarity=0.409 Sum_probs=194.1
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
|...+.||+|+||.||+++.. ++..+++|.+..... .....+..|+++++.++|+|++++++++.++ ..++++||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667789999999999999954 688999999864322 2234678899999999999999999988766 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+. |+|.+.+... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 107 ~~-g~l~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 107 CL-GSASDLLEVH------KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred CC-CCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 96 5777777432 24589999999999999999999998 99999999999999999999999999986533
Q ss_pred CCCCCceeeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
.. ....++..|+|||.+. ...++.++||||||+++|||++|..||...... ....
T Consensus 177 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----------------~~~~ 234 (317)
T cd06635 177 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------------SALY 234 (317)
T ss_pred Cc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH----------------HHHH
Confidence 21 2345788899999874 456889999999999999999999998643211 0011
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.+.............+..+.+++.+||+.+|.+||++.++++++-.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 235 HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 1111111111122334568999999999999999999999987655444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=294.58 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=195.5
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC------
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------ 153 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 153 (395)
..++|+..+.||+|+||.||++... +|+.||+|.+... .......+.+|+.+++.++|+|++++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4567999999999999999999954 7899999998642 223345677899999999999999999987533
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
..++|+||+. ++|.+.+. ..++...+..++.|++.||+|||++ +++||||||+||+++.++.++|+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~---------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQ---------MDLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred CcEEEEEeccC-CCHHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence 3579999995 58888772 2378889999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh-h------
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV-S------ 305 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~-~------ 305 (395)
|||++....... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+ .
T Consensus 161 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 161 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred cCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999997643321 122345788999999999999999999999999999999999999754321100000 0
Q ss_pred -------------hhhcccc-cchhhhhhccccc----cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 306 -------------WALPRLT-DREKILEIMDPAL----EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 306 -------------~~~~~~~-~~~~~~~~~d~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+...... .......++.... ........+..+.+++.+||+.||++|||+.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000001111000 000011235568899999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=302.69 Aligned_cols=248 Identities=21% Similarity=0.388 Sum_probs=199.9
Q ss_pred CCCCCeeeccCCeEEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEE-EEecCceEEEEEcccC
Q 016117 87 FSKSNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLG-YCSDRRKLLVYDYMAN 164 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~~lv~e~~~~ 164 (395)
|.+...||.|+||.||+|..++ +-..|.|++...+....++|.-|+++|+...||+||++++ ||.++..+++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4556789999999999999764 4445778888776777788999999999999999999998 5677788999999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|-....+.... ..+++.++..+++|++.||.|||++ .|+|||||+.|||++-+|.++|+|||++.....
T Consensus 114 GAVDaimlEL~------r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-- 182 (1187)
T KOG0579|consen 114 GAVDAIMLELG------RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-- 182 (1187)
T ss_pred chHhHHHHHhc------cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh--
Confidence 99999886544 5799999999999999999999999 999999999999999999999999999864322
Q ss_pred CCceeeccccccccccchhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 245 GGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.......+.||+.|||||++. ..+|+.++||||||++|.||..+.+|...-++- ..+..
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----------------RVllK 246 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------------RVLLK 246 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----------------HHHHH
Confidence 223344678999999999875 468999999999999999999999997533321 01111
Q ss_pred hcccccc-CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALE-GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+....+. --.+......+.+|+..||..||..||++.+++++
T Consensus 247 iaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 247 IAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1111111 11233445678999999999999999999999854
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=287.16 Aligned_cols=265 Identities=21% Similarity=0.279 Sum_probs=192.6
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+|+..+.||.|++|.||+|+.. +|..+++|.+.... ......+..|++++++++|||++++++++.+. ..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999964 68999999886432 22335788899999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+. ++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~-~~l~~~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDASP-----LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 95 68888885432 24689999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCch-hhhhhhcc-------cc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV-LVSWALPR-------LT 312 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~-~~~~~~~~-------~~ 312 (395)
... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+...... ........ ..
T Consensus 152 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 152 VPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred cCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 221 112223467889999988764 46889999999999999999999997543211100 00000000 00
Q ss_pred cchhhhhhccccccC---CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 DREKILEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
........+...... .........+.+++.+||+.||++|||+.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000000 0001123467899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=283.85 Aligned_cols=246 Identities=26% Similarity=0.336 Sum_probs=197.3
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
+|++.+.||.|+||.||++... ++..+++|.+.... ....+.+.+|++++++++|||++++++++.++ ..++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999965 68999999986432 23456788999999999999999999987766 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+++|.+++... ..+++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~ 150 (258)
T cd05578 81 LLLGGDLRYHLSQK-------VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV 150 (258)
T ss_pred CCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence 99999999998432 3688999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......... .. ...
T Consensus 151 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~----------~~~ 213 (258)
T cd05578 151 TPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QI----------RAK 213 (258)
T ss_pred CCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH----HH----------HHH
Confidence 4332 122345788899999999888999999999999999999999999755432100 00 001
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH--HHHH
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM--ADVV 359 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~~vl 359 (395)
... .....+...+..+.+++.+||+.+|.+||++ .|++
T Consensus 214 ~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 214 QET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred hcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 110 1112223344678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=280.59 Aligned_cols=241 Identities=26% Similarity=0.334 Sum_probs=192.8
Q ss_pred eeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCCh
Q 016117 93 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 167 (395)
Q Consensus 93 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L 167 (395)
||.|++|.||++... +++.+++|++.... ....+.+..|+.+++.++|||++++++++.++ ..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999965 58999999986432 22346788999999999999999999988766 56799999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCc
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 247 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 247 (395)
.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--- 147 (262)
T cd05572 81 WTILRDR-------GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--- 147 (262)
T ss_pred HHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---
Confidence 9999532 3588999999999999999999998 99999999999999999999999999998654332
Q ss_pred eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccC
Q 016117 248 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327 (395)
Q Consensus 248 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 327 (395)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||....... ......+.+.....
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~~~~~~~~~~~~~~ 213 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--------------MEIYNDILKGNGKL 213 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--------------HHHHHHHhccCCCC
Confidence 1223467889999999988889999999999999999999999997554210 01111122111112
Q ss_pred CCCHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHH
Q 016117 328 QYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQ 360 (395)
Q Consensus 328 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~vl~ 360 (395)
.++...+..+.+++.+||+.+|++||+ +.|+++
T Consensus 214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 233333567999999999999999999 677765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=292.59 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=202.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEec--cCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e 160 (395)
..|++.++||+||.+.||++...+.+.+|+|.+. ..+.+...-|.+|+..|.+| .|.+||.+++|-..+ -.++|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 3588899999999999999998888888888654 34455567899999999999 589999999997655 5568888
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|= ..+|..+|.+... ..+...+..+..|++.++.++|.+ +|||.||||.|+|+ -.|.+||+|||+|...
T Consensus 441 ~G-d~DL~kiL~k~~~------~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKS------IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANAI 509 (677)
T ss_pred cc-cccHHHHHHhccC------CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhccc
Confidence 64 5689999965542 334348889999999999999999 99999999999998 5689999999999988
Q ss_pred CCCCCCceeeccccccccccchhhccC-----------CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhc
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTG-----------HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 309 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~ 309 (395)
............+||+-||+||.+... +.+.++||||+||+||+|+.|+.||..-.
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------------- 576 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------------- 576 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------------
Confidence 877777777788999999999988532 24678999999999999999999996211
Q ss_pred ccccchhhhhhccccccCCCCHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 310 RLTDREKILEIMDPALEGQYSMK-EVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 310 ~~~~~~~~~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.....+..+.|+.-.-+++.- ...++.++++.||.+||.+|||..+++++
T Consensus 577 --n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 577 --NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 012355666666543333321 12238999999999999999999999964
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=279.51 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=196.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC-----CcccHHHHHHHHHHHhccCCCcceeEEEEEecC---ce
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA-----GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RK 155 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~ 155 (395)
.+|.+.+.||+|+||.||+|... ++..+++|.+... .......+.+|++++++++|+|++++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888999999999999999954 6899999987532 122335788899999999999999999988653 35
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++++||+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 151 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-------GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFG 151 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccc
Confidence 6899999999999998432 3578899999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCC-CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 236 LAKIGSDKAG-GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 236 ~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
++........ ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------- 215 (264)
T cd06653 152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---------------- 215 (264)
T ss_pred cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----------------
Confidence 9975432111 11112345788999999999888999999999999999999999999643211
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+............+......+.+++.+||+ +|..|||..+++.+
T Consensus 216 ~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 216 AAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11111111111223344455678999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=278.32 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=201.5
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+|.+.+.||.|+||.||++... ++..+++|++..... .....+..|+++++.++|+|++++.+.+... ..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999965 689999999875432 4456788899999999999999999987665 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++..... ....+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||.+....
T Consensus 81 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 81 ADGGDLSQKIKKQKK---EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154 (258)
T ss_pred cCCCcHHHHHHHhhc---cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecc
Confidence 999999999865421 125789999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
... .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||....... ......
T Consensus 155 ~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----------------~~~~~~ 216 (258)
T cd08215 155 STV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE----------------LALKIL 216 (258)
T ss_pred cCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH----------------HHHHHh
Confidence 432 12233567889999999998889999999999999999999999986543110 011111
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
... ....+......+.+++.+||+.+|++|||+.+++++
T Consensus 217 ~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 217 KGQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred cCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111 111222344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=280.49 Aligned_cols=249 Identities=24% Similarity=0.420 Sum_probs=196.2
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+|.+.+.||+|+||.||++... +|..+++|.+.... ....+.+.+|+.+++.++|+|++++++.+.+. ..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999965 68899999886431 23345778899999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC-cEEEecccccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKVSDFGLAKIG 240 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~ 240 (395)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++ .++|+|||.+...
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 81 CDGGDLMKRINRQR-----GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred CCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999999985432 23578999999999999999999998 999999999999998885 4699999998765
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.... .......|+..|+|||.+.+..++.++|+||||+++|||++|..||...... .. ....
T Consensus 153 ~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~----------~~~~ 214 (257)
T cd08225 153 NDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QL----------VLKI 214 (257)
T ss_pred cCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HH----------HHHH
Confidence 4322 1122345788999999998888999999999999999999999998643211 00 1111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...... ......+..+.+++.+||+.+|++|||+.+++.+
T Consensus 215 ~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 215 CQGYFA-PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred hcccCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111111 1112234568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=287.44 Aligned_cols=270 Identities=20% Similarity=0.256 Sum_probs=194.3
Q ss_pred CCCCCCeeeccCCeEEEEEEEc---CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKL 156 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~ 156 (395)
+|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+..|+.+++.++|||++++++++.+. ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778889999999999999964 47899999987632 33345678899999999999999999998765 356
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC----CCcEEEe
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK----NFHAKVS 232 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~----~~~~kl~ 232 (395)
+|+||+.+ +|.+++...... ....++...++.++.|++.||.|||+. +++||||||+||+++. ++.+||+
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQA--KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccC--CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 99999875 677766433211 123688999999999999999999998 9999999999999999 9999999
Q ss_pred ccccccccCCCCCC-ceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchh------h
Q 016117 233 DFGLAKIGSDKAGG-HVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL------V 304 (395)
Q Consensus 233 Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~------~ 304 (395)
|||++......... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........... .
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 99998865432221 11223457888999998876 4578999999999999999999999976543320000 0
Q ss_pred hhhhccccc-----------chhhhhhccccccCCCC---H--------HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 305 SWALPRLTD-----------REKILEIMDPALEGQYS---M--------KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 305 ~~~~~~~~~-----------~~~~~~~~d~~~~~~~~---~--------~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
......+.. ........+......++ . .....+.+++.+||+.+|++|||+.+++++
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000000 00000000000000111 0 223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=293.66 Aligned_cols=268 Identities=22% Similarity=0.314 Sum_probs=196.2
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC------ce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------RK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 155 (395)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ......+..|+.+++.++|+|++++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46799999999999999999985 478999999986432 23345678899999999999999999876543 35
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++++||+.+ +|.+++. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 84 ~lv~e~~~~-~l~~~~~--------~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 84 YIVQELMET-DLYKLIK--------TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred EEEehhccc-CHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccc
Confidence 799999864 7877773 23689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC-ceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc-
Q 016117 236 LAKIGSDKAGG-HVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT- 312 (395)
Q Consensus 236 ~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~- 312 (395)
++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ........+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~ 228 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGT 228 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCC
Confidence 98754332211 11223467889999998754 568899999999999999999999996432111 0000000000
Q ss_pred -cchhhhhhccccc---------cCCCC-----HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHHhh
Q 016117 313 -DREKILEIMDPAL---------EGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQS--LVPLV 366 (395)
Q Consensus 313 -~~~~~~~~~d~~~---------~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~--L~~~~ 366 (395)
.......+.+... ....+ ...+..+.+++.+||+.+|++|||+.+++++ +++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0011111111000 00000 1124568899999999999999999999986 44443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=308.98 Aligned_cols=265 Identities=25% Similarity=0.432 Sum_probs=208.1
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc----C----CcEEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS----N----GRKVAIKLMDQA-GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR 153 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 153 (395)
.++..+.+.||+|.||.|++|... . ...||||.++.. .....+.+..|+++|+.+ +|+|++.++|+|.+.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344556679999999999999843 1 346999998754 334567889999999998 699999999999885
Q ss_pred -ceEEEEEcccCCChhhhcccCC-CCCCC------C--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe
Q 016117 154 -RKLLVYDYMANGGLQEHLYPAN-GSNSV------A--SKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 223 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~-~~~~~------~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill 223 (395)
..++|+||+..|+|.++|...+ ..... . ..++....+.++.|||.|+.||++. +++||||.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEe
Confidence 5679999999999999998776 11111 1 2489999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeccccccccCCCCCCcee-eccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 016117 224 DKNFHAKVSDFGLAKIGSDKAGGHVS-TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEG 301 (395)
Q Consensus 224 ~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~ 301 (395)
+.+..+||+|||+++...+....... ....-+..|||||.+....|+.++||||||++||||++ |..||..-...
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--- 528 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--- 528 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH---
Confidence 99999999999999864443322211 11113556999999999999999999999999999999 88888541100
Q ss_pred hhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 302 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
..+.+.+.+.-+-..+..+..+++++++.||+.+|++||++.++.+.|+..+.
T Consensus 529 -------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 529 -------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred -------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 11122223323334455567789999999999999999999999999999765
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=284.88 Aligned_cols=265 Identities=21% Similarity=0.284 Sum_probs=194.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv 158 (395)
++|++.+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++++++|||++++++++... ..+++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999975 688999998864322 2233567899999999999999999987643 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
+||+. ++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~e~~~-~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~ 154 (293)
T cd07843 85 MEYVE-HDLKSLMETMK------QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR 154 (293)
T ss_pred ehhcC-cCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCcee
Confidence 99997 48988885432 3689999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh-h---------hh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV-S---------WA 307 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~-~---------~~ 307 (395)
...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+ . |.
T Consensus 155 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 155 EYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred eccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 654322 112234567889999988754 4689999999999999999999999754322111000 0 00
Q ss_pred h-cccc--cchhhhhhccccccCCCCHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 308 L-PRLT--DREKILEIMDPALEGQYSMK-EVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 308 ~-~~~~--~~~~~~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
. ..+. ............+...++.. ....+.+++.+||+.+|++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0000 00000000001111111111 25568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=281.70 Aligned_cols=264 Identities=23% Similarity=0.324 Sum_probs=195.3
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
+|++.+.||.|++|.||+|... +|..||+|.+..... .....+..|+++++.++|+|++++++++.+. ..++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 688999999875432 2345677899999999999999999988776 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.+ +|.+++.... ....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~-~l~~~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 81 DK-DLKKYMDTHG----VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred Cc-cHHHHHHhcC----CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 85 8888875432 124689999999999999999999998 999999999999999999999999999875432
Q ss_pred CCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh-hhhhcccccchhhhhh
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV-SWALPRLTDREKILEI 320 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 320 (395)
.. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||............ ....... ......+
T Consensus 153 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 228 (284)
T cd07836 153 PV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPT--ESTWPGI 228 (284)
T ss_pred Cc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC--hhhHHHH
Confidence 21 11123456788999998865 45788999999999999999999999754432111000 0000000 0000000
Q ss_pred cc-cccc-----------CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 MD-PALE-----------GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~d-~~~~-----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+ +... ....+..+..+.+++.+||+.+|.+||++.+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0000 01111234578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=285.11 Aligned_cols=269 Identities=22% Similarity=0.264 Sum_probs=193.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccC-CCcceeEEEEEecCc------
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLR-SPYLLALLGYCSDRR------ 154 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~------ 154 (395)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.+. |+|++++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999964 68999999876432 223356788999999995 699999999876543
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-CCcEEEec
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSD 233 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~D 233 (395)
.+++|||+.+ +|.+++...... ....+++..++.++.|++.||.|||+. +++||||+|+||+++. ++.++|+|
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG--PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence 5799999985 888888644321 134689999999999999999999998 9999999999999998 89999999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
||++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....................
T Consensus 155 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 232 (295)
T cd07837 155 LGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232 (295)
T ss_pred cccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999875432211 1122346788999998865 4578999999999999999999999975432110000000000000
Q ss_pred cc--hhhhhhcc----cc----ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 DR--EKILEIMD----PA----LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 ~~--~~~~~~~d----~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. .......+ +. .........+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 00000000 00 0000111234578899999999999999999999854
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=285.45 Aligned_cols=275 Identities=25% Similarity=0.288 Sum_probs=197.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLL 157 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~l 157 (395)
.++|++.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+.++++++|+|++++++++.+. ..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357889999999999999999964 689999998864322 1223456799999999999999999988654 3579
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
|+||+.+ +|.+++.... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 86 v~e~~~~-~l~~~l~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~ 155 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP------TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLA 155 (309)
T ss_pred EEecCCC-CHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcccee
Confidence 9999964 7888875322 4689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhh--------
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL-------- 308 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~-------- 308 (395)
........ ......++..|+|||.+.+ ..++.++||||||+++|||++|..||...+............
T Consensus 156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 156 RTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred eecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 76543221 1122345778999999875 567899999999999999999999997543321111000000
Q ss_pred cccccchhhhhh-ccccccCCC---CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 016117 309 PRLTDREKILEI-MDPALEGQY---SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 372 (395)
Q Consensus 309 ~~~~~~~~~~~~-~d~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~~ 372 (395)
+........... ......... .......+.+++.+||+.||++|||+.+++++ .++.....+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h--~~f~~~~~~ 299 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES--SYFKEKPLP 299 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC--hhhccCCCC
Confidence 000000000000 000000000 00124567889999999999999999999964 555544433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=278.59 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=199.3
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+|++.+.||+|+||.||++... +++.+++|.+.... ......+..|+++++.++|+||+++.+++.+. ..++++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999854 78899999987532 22345677899999999999999999877665 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++..... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 81 APFGDLSKAISKRKK---KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK 154 (256)
T ss_pred cCCCCHHHHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence 999999999865321 124689999999999999999999998 99999999999999999999999999997654
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.. . .....
T Consensus 155 ~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~--------------~~~~~ 213 (256)
T cd08530 155 KN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---D--------------LRYKV 213 (256)
T ss_pred cC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H--------------HHHHH
Confidence 43 122345788999999999989999999999999999999999999654321 0 00000
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
........+.....++.+++.+||+.+|++|||+.+++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 214 QRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1111112233456679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=281.49 Aligned_cols=258 Identities=23% Similarity=0.281 Sum_probs=189.0
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccC-CCcceeEEEEEecC---ceEEEEE
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLR-SPYLLALLGYCSDR---RKLLVYD 160 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~---~~~lv~e 160 (395)
|++.+.||+|+||.||++... +++.+|+|.+..... ........|+.++.++. |+|++++++++.+. ..++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567789999999999999954 688999998875322 22234456888888885 99999999988754 4679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+. |+|.+++.... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++. +.++|+|||++...
T Consensus 81 ~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 81 LMD-MNLYELIKGRK------RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGI 149 (282)
T ss_pred cCC-ccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccc
Confidence 996 58888874322 4689999999999999999999998 9999999999999999 99999999999765
Q ss_pred CCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc-chhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD-REKIL 318 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~ 318 (395)
..... .....++..|+|||.+.. ..++.++|||||||++|||++|..||...+..+. +......... .....
T Consensus 150 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 223 (282)
T cd07831 150 YSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVL 223 (282)
T ss_pred ccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHH
Confidence 33221 123457889999997654 5678899999999999999999999975443211 1111000000 00000
Q ss_pred hhccc------cccC-------CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDP------ALEG-------QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~------~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+.. .... ......+..+.+++.+||+.+|++|||+.+++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000 0000 0011335789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=280.65 Aligned_cols=241 Identities=27% Similarity=0.374 Sum_probs=183.3
Q ss_pred eeeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHh---ccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 92 VVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLG---RLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
.||+|+||.||++... +++.+|+|.+..... .....+..|..+++ ...|+|++.+.+++... ..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999964 689999998864321 11223344444433 34799999999988765 5679999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+|+|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 81 ~~~L~~~i~~-------~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~ 150 (279)
T cd05633 81 GGDLHYHLSQ-------HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150 (279)
T ss_pred CCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence 9999998843 23689999999999999999999998 9999999999999999999999999998644322
Q ss_pred CCCceeeccccccccccchhhc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
. .....|+..|+|||.+. +..++.++||||+||++|+|++|..||.......... +....
T Consensus 151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--------------~~~~~- 211 (279)
T cd05633 151 K----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------------IDRMT- 211 (279)
T ss_pred C----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH--------------HHHHh-
Confidence 1 12346899999999886 4568899999999999999999999997543211100 00000
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
.......+...+..+.+++..||+.||.+|| |+.+++++
T Consensus 212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 212 LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0011122333456789999999999999999 59999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=282.16 Aligned_cols=264 Identities=21% Similarity=0.261 Sum_probs=192.4
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
|++.+.||.|++|.||+|... +|..|++|++.... ......+.+|+++++.++|+|++++++++.+. ..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999964 79999999886432 22335678899999999999999999988776 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
. ++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~-~~l~~~~~~~~-----~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~ 151 (283)
T cd07835 81 D-LDLKKYMDSSP-----LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV 151 (283)
T ss_pred C-cCHHHHHhhCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence 5 68999885332 13689999999999999999999998 999999999999999999999999999875432
Q ss_pred CCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchh-hhhhhc-------cccc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL-VSWALP-------RLTD 313 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~-~~~~~~-------~~~~ 313 (395)
.. .......++..|+|||++.+. .++.++||||||+++|+|++|..||...+....... ...... ....
T Consensus 152 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 152 PV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred Cc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 21 111223467889999987654 578999999999999999999999975432110000 000000 0000
Q ss_pred chhhhhhcccc---ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 REKILEIMDPA---LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 ~~~~~~~~d~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.......+... .........+..+.+++.+||+.+|++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 0001111223578899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=279.70 Aligned_cols=243 Identities=26% Similarity=0.366 Sum_probs=189.3
Q ss_pred eeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCCh
Q 016117 93 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 167 (395)
Q Consensus 93 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L 167 (395)
||+|+||+||++... +|+.+++|.+.... ......+..|+++++.++|||++++++++... ..++++||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68999999886432 22344567899999999999999999988765 56799999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCc
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 247 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 247 (395)
.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--- 149 (277)
T cd05577 81 KYHIYNVG-----EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--- 149 (277)
T ss_pred HHHHHHcC-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---
Confidence 99986433 13689999999999999999999998 99999999999999999999999999987543311
Q ss_pred eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccC
Q 016117 248 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327 (395)
Q Consensus 248 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 327 (395)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... .+...... ...
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------------~~~~~~~~-~~~ 215 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-------------ELKRRTLE-MAV 215 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH-------------HHHhcccc-ccc
Confidence 1223457788999999988889999999999999999999999996543211100 00000000 011
Q ss_pred CCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHH
Q 016117 328 QYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQ 360 (395)
Q Consensus 328 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~ 360 (395)
..+...+..+.+++.+||+.+|++|| ++.+++.
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 12223356789999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=285.76 Aligned_cols=267 Identities=21% Similarity=0.263 Sum_probs=191.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC--------
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------- 153 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 153 (395)
++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++|||++++++++...
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999964 68999999886432 22234566799999999999999999987643
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
..++++||+.+ +|.+++... ...+++.+++.++.|++.||.|||++ +++|+||+|+||+++.++.+||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~------~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNK------NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhc------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEEC
Confidence 23799999964 787777432 23689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCC--ceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhc
Q 016117 233 DFGLAKIGSDKAGG--HVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 309 (395)
Q Consensus 233 Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~ 309 (395)
|||++......... .......++..|+|||.+.+. .++.++||||||+++|||++|..||...........+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999754332211 111234567889999988764 478899999999999999999999975443211111111000
Q ss_pred cccc----chhhhhhccc-cccCCC---------CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 310 RLTD----REKILEIMDP-ALEGQY---------SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 310 ~~~~----~~~~~~~~d~-~~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.... ........+. ...... ..-....+.+++.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000 0000000000 000000 00012457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=284.73 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=189.0
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccC-CCcceeEEEEEecC-ceEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+|...+.||+|+||.||++... +++.+|+|.+.... ......+..|+.++.++. |+||+++++++... ..++++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3455678999999999999964 68999999887432 233457788999999996 99999999987665 56789999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.. ++.++...... .....+++..+..++.|++.||+|||+.. +++||||||+||+++.++.++|+|||++....
T Consensus 85 ~~~-~l~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYE--VLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 764 55443311000 01246899999999999999999999632 89999999999999999999999999987543
Q ss_pred CCCCCceeeccccccccccchhhccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTG---HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
... ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ... .+.
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~----------~~~ 221 (288)
T cd06616 160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFD----------QLT 221 (288)
T ss_pred cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHH----------HHh
Confidence 321 11233578889999998765 689999999999999999999999964321 000 011
Q ss_pred hhc---cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIM---DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~---d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
... .+.+........+..+.+|+.+||+.+|++|||+.+|+.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 222 QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred hhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 1111112222345678999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=274.29 Aligned_cols=246 Identities=26% Similarity=0.444 Sum_probs=197.7
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+|++.+.||+|++|.||++... +++.+++|.+..... ...+.+..|++++++++|+|++++++++.+. ..+++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999865 678999999876543 3456788999999999999999999988766 55699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 150 (254)
T cd06627 81 AENGSLRQIIKKF-------GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN 150 (254)
T ss_pred CCCCcHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence 9999999998432 4689999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
..... .....++..|+|||.+.+..++.++||||+|+++|+|++|..||...... ...+.. ..
T Consensus 151 ~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~~~---------~~-- 213 (254)
T cd06627 151 DVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALFRI---------VQ-- 213 (254)
T ss_pred CCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHH---------hc--
Confidence 43221 23345788999999998888899999999999999999999998643211 000000 00
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
......+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 214 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 214 --DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred --cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0001112223456889999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=290.55 Aligned_cols=270 Identities=24% Similarity=0.320 Sum_probs=197.8
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC------c
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------R 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 154 (395)
.++|.+.+.||+|+||+||++.. .++..||+|.+... .......+..|+.+++.++|+|++++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35688899999999999999995 47899999988643 222345677899999999999999999977543 3
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++++||+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Df 152 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-------SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDF 152 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcC
Confidence 579999996 688888842 24689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhc----
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP---- 309 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~---- 309 (395)
|++....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.............
T Consensus 153 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 153 GLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred ccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9997643321 12233457889999998865 4688999999999999999999999965432110000000000
Q ss_pred ----ccccchhhhhhcc---ccccC---CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHHhhh
Q 016117 310 ----RLTDREKILEIMD---PALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS--LVPLVK 367 (395)
Q Consensus 310 ----~~~~~~~~~~~~d---~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~--L~~~~~ 367 (395)
.... ......+. ..... ......+..+.+++.+||+.+|++|||+.+++++ +..+..
T Consensus 231 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 231 EDLGFIRN-EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred HHhhhcCc-hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 0000 00000000 00000 0011234578899999999999999999999987 554433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=281.54 Aligned_cols=264 Identities=22% Similarity=0.286 Sum_probs=193.7
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEEEEE
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLVYD 160 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~e 160 (395)
|.+.+.||+|++|.||+|... +++.+++|.+.... ......+..|+++++.++|+|++++++++.+. ..++++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999965 58899999987652 33345688899999999999999999988765 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+++ +|.+++.... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus 81 ~~~~-~l~~~~~~~~------~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 81 YMDH-DLTGLLDSPE------VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred cccc-cHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 9974 8888885332 4689999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc--chhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD--REKI 317 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~ 317 (395)
..... .......++..|+|||.+.+ ..++.++||||||+++|||++|..||..................... ....
T Consensus 151 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 151 TKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred cCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 43321 11222346778999998765 46789999999999999999999999754422111000000000000 0000
Q ss_pred hh-----hc------cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 318 LE-----IM------DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 318 ~~-----~~------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. .. ...+.......++..+.+++.+||+.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 00 0000000011125578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=282.40 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=195.0
Q ss_pred CeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCChh
Q 016117 91 NVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQ 168 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~ 168 (395)
..||+|+||.||++.. .+++.+++|.+..........+.+|+.+++.++|+|++++++++... ..++++||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 4699999999999986 47899999988654444556788999999999999999999988766 567999999999999
Q ss_pred hhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCce
Q 016117 169 EHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHV 248 (395)
Q Consensus 169 ~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 248 (395)
+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ .
T Consensus 106 ~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~ 172 (292)
T cd06657 106 DIVTH--------TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 172 (292)
T ss_pred HHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--c
Confidence 98732 3578999999999999999999998 999999999999999999999999999875433221 1
Q ss_pred eeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCC
Q 016117 249 STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQ 328 (395)
Q Consensus 249 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 328 (395)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|..||........ .. .......+.+..
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~----------~~~~~~~~~~~~- 238 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MK----------MIRDNLPPKLKN- 238 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH----------HHHhhCCcccCC-
Confidence 2234578899999999888899999999999999999999999864322100 00 000111111110
Q ss_pred CCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 329 YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 329 ~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
....+..+.+++.+||+.+|.+||++.+++++ +++..
T Consensus 239 -~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~--~~~~~ 275 (292)
T cd06657 239 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAK 275 (292)
T ss_pred -cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC--hHHhc
Confidence 11223457889999999999999999999974 55443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=289.78 Aligned_cols=270 Identities=22% Similarity=0.317 Sum_probs=197.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEec-----CceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSD-----RRKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~ 156 (395)
.+|++.+.||+|+||.||+|... +|+.|++|++.... ......+..|+.+++.++||||+++++++.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888999999999999999954 68999999987532 2334567789999999999999999987643 2467
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+++||+. ++|.+++.. ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 85 lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 85 VVMDLME-SDLHHIIHS-------DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred EEEehhh-hhHHHHhcc-------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence 9999995 689888842 23589999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCC--ceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc--
Q 016117 237 AKIGSDKAGG--HVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL-- 311 (395)
Q Consensus 237 ~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~-- 311 (395)
+......... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 8754332211 11223468889999998865 468899999999999999999999997543321100000000000
Q ss_pred -----ccchhhhhhccccc-cCCCC-----HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 312 -----TDREKILEIMDPAL-EGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 312 -----~~~~~~~~~~d~~~-~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.....+....+... ....+ ...+..+.+++.+||+.+|++|||+.+++.+ .++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~--~~~~ 298 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH--PFLA 298 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC--hhhh
Confidence 00000111111000 00111 1235679999999999999999999999974 4444
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=289.55 Aligned_cols=267 Identities=23% Similarity=0.304 Sum_probs=195.3
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC---ce
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR---RK 155 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~---~~ 155 (395)
..++|++.+.||+|+||.||+|... +++.+++|.+... .......+..|+.+++++ +|+||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3457888899999999999999965 6889999987532 223345677899999999 999999999987543 46
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++|+||+. ++|.+++.. ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 85 ~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g 152 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA--------NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFG 152 (337)
T ss_pred EEEecccc-cCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeecc
Confidence 79999997 589888832 2578889999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCC---ceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 236 LAKIGSDKAGG---HVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 236 ~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
++......... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....+..............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99755432211 12233568889999998765 467889999999999999999999996543221110000000000
Q ss_pred cc-------chhhhhhcccccc------CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 312 TD-------REKILEIMDPALE------GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 312 ~~-------~~~~~~~~d~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. ......+++.... .......+..+.+++.+||+.+|++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00 0000011110000 00011134678999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=278.77 Aligned_cols=244 Identities=27% Similarity=0.438 Sum_probs=190.0
Q ss_pred eeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCCh
Q 016117 93 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 167 (395)
Q Consensus 93 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L 167 (395)
||+|+||.||++... +|+.+++|.+..... ...+.+.+|+++++.++|+|++++++.+..+ ..++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 589999999865432 3445788899999999999999999877666 56799999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCC--
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG-- 245 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 245 (395)
.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 150 (265)
T cd05579 81 ASLLENV-------GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN 150 (265)
T ss_pred HHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence 9998532 3689999999999999999999998 999999999999999999999999999875433211
Q ss_pred ----CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 246 ----GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 246 ----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
........++..|+|||.......+.++||||||+++|++++|..||....... ....+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----------------~~~~~~ 214 (265)
T cd05579 151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE----------------IFQNIL 214 (265)
T ss_pred cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHh
Confidence 112233457788999999988889999999999999999999999996443210 001111
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
............+..+.+++.+||+.+|.+|||+.++.+.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 215 NGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred cCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 10110000111256789999999999999999995554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=282.12 Aligned_cols=266 Identities=19% Similarity=0.274 Sum_probs=191.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|++.+.||+|.+|+||+|... +|+.|++|.+..... ...+.+.+|++++++++|+|++++++++.+. ..++|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999965 788999998864322 2335678899999999999999999998776 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-CCcEEEeccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSDFGLAKI 239 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~ 239 (395)
|+. ++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||+|+||+++. ++.+||+|||++..
T Consensus 82 ~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~ 152 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-----DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (294)
T ss_pred ccc-ccHHHHHHhCC-----CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence 996 57887774322 12467888999999999999999998 9999999999999985 56799999999975
Q ss_pred cCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh-hhhhcccccc---
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV-SWALPRLTDR--- 314 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~~~--- 314 (395)
..... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||....+.+..... ..........
T Consensus 153 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 153 FGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 43221 11123456788999998876 45789999999999999999999999754322111000 0000000000
Q ss_pred -hhhhhhcc--ccccC----CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 315 -EKILEIMD--PALEG----QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 315 -~~~~~~~d--~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+..... +.... ......+..+.+++.+|++.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 00000 0011223468899999999999999999999964
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=282.23 Aligned_cols=257 Identities=16% Similarity=0.190 Sum_probs=180.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcC----CcEEEEEEeccCCcccH-----------HHHHHHHHHHhccCCCcceeEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGKQGE-----------DEFKMEVELLGRLRSPYLLALLGY 149 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~~~ 149 (395)
++|.+.++||+|+||+||+|.+.+ +..+++|+......... .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578999999999999999999654 45667775432221111 011223345566789999999987
Q ss_pred EecCc-----eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC
Q 016117 150 CSDRR-----KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224 (395)
Q Consensus 150 ~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 224 (395)
+.... .+++++++. .++.+.+... ...++..+..++.|++.||+|||+. +++||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI-------KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh-------ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 65432 245666553 3555555221 2356788899999999999999998 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCC-----ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 016117 225 KNFHAKVSDFGLAKIGSDKAGG-----HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 299 (395)
Q Consensus 225 ~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~ 299 (395)
.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 9999999999999754322111 11123468999999999999999999999999999999999999997543211
Q ss_pred CchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 300 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
....... ......+...... ....+..+.+++..|++.+|++||++.++.+.|
T Consensus 241 --~~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 --NLIHAAK-----CDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred --HHHHHhH-----HHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111000 0011111111111 112245688999999999999999999999876
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=281.82 Aligned_cols=244 Identities=29% Similarity=0.393 Sum_probs=189.4
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
|+..+.||+|+||.||+|+.. ++..+++|.+.... ......+.+|+++++.++|+|++++.+++... ..++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 566678999999999999964 67889999886421 22234677899999999999999999988766 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+. |+|.+.+.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 97 ~~-~~l~~~~~~~~------~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 97 CL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred cC-CCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 96 68877764322 3588999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCCceeeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
.. ....++..|+|||.+. ...++.++|||||||++|+|++|..||....... ...
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----------------~~~ 224 (308)
T cd06634 167 PA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----------------ALY 224 (308)
T ss_pred Cc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH----------------HHH
Confidence 22 2345788899999874 3567889999999999999999999986432110 000
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
.+................+.+++.+||+.+|++||++.+++++-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 225 HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 00000001111223445688999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=293.52 Aligned_cols=270 Identities=24% Similarity=0.364 Sum_probs=202.4
Q ss_pred CCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-------ceEE
Q 016117 87 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------RKLL 157 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------~~~l 157 (395)
+...+.||+|+||.||+|+. .+|+.||||.++.. .....+....|+++|++++|+|||+++++-++. ..++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44457899999999999994 58999999998753 344566788899999999999999999876543 4679
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC--C--CCcEEEec
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD--K--NFHAKVSD 233 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~--~--~~~~kl~D 233 (395)
+||||.+|+|...|.... ....+++.+.+.++.+++.||.|||++ +|+||||||.||++- + ...-||+|
T Consensus 95 vmEyC~gGsL~~~L~~PE----N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPE----NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred EEeecCCCcHHHHhcCcc----cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence 999999999999996543 567899999999999999999999999 999999999999993 3 33479999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
||.|+...+.. ......||..|++||.... +.|+...|.|||||++|+++||..||...........+.|.... .
T Consensus 168 fG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t-k 243 (732)
T KOG4250|consen 168 FGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT-K 243 (732)
T ss_pred ccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc-c
Confidence 99999766544 5667889999999999984 88999999999999999999999999765443222112221100 0
Q ss_pred cchhhhhhccccc------------cCCCCHHHHHHHHHHHhhcCCCCCCCCC--CHHHHHHHHHHhhh
Q 016117 313 DREKILEIMDPAL------------EGQYSMKEVIQVAAIAAMCVQPEADYRP--LMADVVQSLVPLVK 367 (395)
Q Consensus 313 ~~~~~~~~~d~~~------------~~~~~~~~~~~l~~li~~cl~~~p~~RP--t~~~vl~~L~~~~~ 367 (395)
.+..+....++.. ....+......+-..+..+|..+|.+|= ...+.-..+..+++
T Consensus 244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 0000000011111 1122344455667778888888888887 55555555555544
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=281.76 Aligned_cols=267 Identities=23% Similarity=0.306 Sum_probs=194.2
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-----
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR----- 153 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 153 (395)
...++|++.+.||+|+||.||+|... +|+.|++|.+.... ......+..|+++++.++|||++++++++.+.
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567999999999999999999975 68899999986432 22335677899999999999999999987653
Q ss_pred ------ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC
Q 016117 154 ------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 227 (395)
Q Consensus 154 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~ 227 (395)
..++++||+.+ ++..++... ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~ 153 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG------LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKG 153 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 36799999976 677766432 24689999999999999999999999 999999999999999999
Q ss_pred cEEEeccccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhh
Q 016117 228 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 306 (395)
Q Consensus 228 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~ 306 (395)
.+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 154 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 154 QIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred cEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999999976543221 11122345778999998865 4578899999999999999999999975432111100000
Q ss_pred hh--------cccccchhhhhhccc------cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 307 AL--------PRLTDREKILEIMDP------ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 307 ~~--------~~~~~~~~~~~~~d~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. +........ ...+. ..... ....+..+.+++..||+.+|++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYF-NTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccc-cccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 000000000 00000 00000 00124578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=280.55 Aligned_cols=243 Identities=29% Similarity=0.414 Sum_probs=188.5
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
|...+.||+|+||+||+|+.. +++.+++|.+..... .....+..|+++++.++|+|++++++++.+. ..++++||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999964 688999999864322 2234677899999999999999999998776 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+. |+|.+++.... ..+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 103 ~~-~~l~~~l~~~~------~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~ 172 (313)
T cd06633 103 CL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS 172 (313)
T ss_pred CC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence 95 57777774322 3589999999999999999999998 99999999999999999999999999886432
Q ss_pred CCCCCceeeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
.. ....|+..|+|||++. ...++.++||||||+++|+|++|..||........ ...
T Consensus 173 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---~~~------------ 231 (313)
T cd06633 173 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYH------------ 231 (313)
T ss_pred CC------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHH------------
Confidence 21 2345788899999974 45688899999999999999999999865432110 000
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..............+..+.+++.+||+.+|.+||++.+++.+
T Consensus 232 -~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 232 -IAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -HHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000001111223458899999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=289.91 Aligned_cols=247 Identities=24% Similarity=0.402 Sum_probs=205.1
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
...+.|.+.+.||+|.|+.|.+|++. ++..||||.+.+..- ...+.+.+|+++|+.++|||||+++++.... ..++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 44577999999999999999999954 799999999976532 2335578899999999999999999998865 7789
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
||||+.+|.+.+++.... .+....+..++.|+.++++|||++ .|+|||||++|+|++.+.++||+|||++
T Consensus 133 V~eya~~ge~~~yl~~~g-------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS 202 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHG-------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFS 202 (596)
T ss_pred EEEeccCchhHHHHHhcc-------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccc
Confidence 999999999999996544 456688899999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccccccccchhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
..... .......+|++.|.|||++.+..| +++.|+||+|+++|.|++|..||+....
T Consensus 203 ~~~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------------------- 260 (596)
T KOG0586|consen 203 TFFDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------------------- 260 (596)
T ss_pred eeecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------------------
Confidence 87653 335567899999999999998776 5789999999999999999999985432
Q ss_pred hhhhccccccCCCC--HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.++-++.+.+.+. .-...+..+++++++-.+|.+|++++++.+.
T Consensus 261 -k~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 261 -KELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -ccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 2222222322222 2233456789999999999999999999865
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=279.51 Aligned_cols=263 Identities=23% Similarity=0.311 Sum_probs=195.4
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc--cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
|.+.+.||+|++|.||++... +++.+++|.+...... ....+..|+++++.++|+|++++++++.++ ..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999964 7889999988754322 345778899999999999999999987766 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.+ +|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~-~l~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 81 DT-DLYKLIKDRQ------RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGS 150 (283)
T ss_pred CC-CHHHHHHhhc------ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence 75 8888874322 4689999999999999999999999 999999999999999999999999999876544
Q ss_pred CCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhh--------hhccccc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW--------ALPRLTD 313 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~--------~~~~~~~ 313 (395)
.. .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....... .......
T Consensus 151 ~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 151 PV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred Cc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 32 112234577889999998876 789999999999999999999999965432111000000 0000000
Q ss_pred --chhhhhhccccc--cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 --REKILEIMDPAL--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 --~~~~~~~~d~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
........+... ........+..+.+++.+||+.+|.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000000000 001112345689999999999999999999999853
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=293.33 Aligned_cols=247 Identities=23% Similarity=0.408 Sum_probs=192.6
Q ss_pred CCeeeccCCeEEEEEEEc-CCcEEEEEEec--c--CCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-c--eEEEEEc
Q 016117 90 SNVVGHGGFGLVYRGVLS-NGRKVAIKLMD--Q--AGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R--KLLVYDY 161 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~--~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~--~~lv~e~ 161 (395)
..+||+|.|-+||+|.+. +|-.||=-.++ . ......+.|..|+.+|+.|+|+||++++..+.+. + ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 357999999999999964 56666533322 1 1233457899999999999999999999976654 3 4499999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-CCcEEEecccccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSDFGLAKIG 240 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~ 240 (395)
+..|+|..|+.+.+ .++...+..|+.||++||.|||++ .|+|+|||||-+||+|+. .|.|||+|+|+|+..
T Consensus 125 ~TSGtLr~Y~kk~~-------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ccCCcHHHHHHHhc-------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 99999999997654 688889999999999999999998 889999999999999975 589999999999976
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.... .....|||.|||||... ..|....||||||++++||+|+..||..-.. .-.+..-
T Consensus 197 r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n----------------~AQIYKK 255 (632)
T KOG0584|consen 197 RKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN----------------PAQIYKK 255 (632)
T ss_pred hccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC----------------HHHHHHH
Confidence 5443 23368999999999766 7899999999999999999999999963221 1111111
Q ss_pred ccccccCCCCHH----HHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 321 MDPALEGQYSMK----EVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 321 ~d~~~~~~~~~~----~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
+ ..+-.+.. ...++.+||.+|+.. .++|||+.|++. ..++..+.+
T Consensus 256 V---~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~--d~Ff~~d~g 304 (632)
T KOG0584|consen 256 V---TSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK--DPFFDEDGG 304 (632)
T ss_pred H---HcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh--Chhhccccc
Confidence 1 11111111 123688999999999 999999999995 366665533
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=286.82 Aligned_cols=271 Identities=24% Similarity=0.306 Sum_probs=200.6
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC------ceE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------RKL 156 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 156 (395)
+|.+.+.||.|++|.||++... ++..+++|.+.... ....+.+..|+++++.++|+||+++.+++... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999965 58999999887543 33446788899999999999999999987655 467
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
++++|+. ++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 81 lv~e~~~-~~l~~~l~~~-------~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~ 149 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-------QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGL 149 (330)
T ss_pred EEecchh-hhHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCc
Confidence 9999997 5788888422 3689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC-ceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc--
Q 016117 237 AKIGSDKAGG-HVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT-- 312 (395)
Q Consensus 237 ~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-- 312 (395)
+......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229 (330)
T ss_pred eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence 9865443210 112234578889999999887 889999999999999999999999975543211100000000000
Q ss_pred -----cchhhhhhccc-cccC-----CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHHhhh
Q 016117 313 -----DREKILEIMDP-ALEG-----QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS--LVPLVK 367 (395)
Q Consensus 313 -----~~~~~~~~~d~-~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~--L~~~~~ 367 (395)
........+.. .... ......+..+.+++.+||+.+|++|||+.+++.+ ++++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000000 0000 0111234578999999999999999999999975 454444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=285.89 Aligned_cols=265 Identities=22% Similarity=0.324 Sum_probs=193.3
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-------
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 153 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 153 (395)
.++|.+.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368888999999999999999964 68999999886431 22235678899999999999999999987543
Q ss_pred ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEec
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 233 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 233 (395)
+.+++++|+.. +|..++ ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|
T Consensus 94 ~~~lv~e~~~~-~l~~~~---------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM---------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred eEEEEeccccc-CHHHHH---------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEee
Confidence 34799999864 666654 13588999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||................ ...
T Consensus 161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~ 234 (342)
T cd07879 161 FGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT-GVP 234 (342)
T ss_pred CCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc-CCC
Confidence 9998754321 123456788999999876 468899999999999999999999997543211100000000 000
Q ss_pred cchhh--------hhhcc---ccccCCCC---HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHHhhh
Q 016117 313 DREKI--------LEIMD---PALEGQYS---MKEVIQVAAIAAMCVQPEADYRPLMADVVQS--LVPLVK 367 (395)
Q Consensus 313 ~~~~~--------~~~~d---~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~--L~~~~~ 367 (395)
..... ..... ........ ......+.+++.+||+.||++||++.+++.+ ++.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000 00000 00000000 1123468899999999999999999999965 555544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=280.96 Aligned_cols=244 Identities=28% Similarity=0.394 Sum_probs=199.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
+.|+.-++||+|+||.||-+.. .+|+.+|.|.+.+. .........+|-.+|..++.+.||.+--.++.. ..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 4577888999999999999984 47999999987643 233445667899999999999999996656554 678999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
..|+||+|.-+|+... ...+++..++.++.+|+.||.+||.. +|+.|||||+|||+|+.|+++|+|+|+|..
T Consensus 265 tlMNGGDLkfHiyn~g-----~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG-----NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EeecCCceeEEeeccC-----CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 9999999999997655 25799999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... .....+||.+|||||++.+..|+...|.|||||++|||+.|+.||...... .-.+
T Consensus 337 i~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-----------------vk~e 396 (591)
T KOG0986|consen 337 IPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-----------------VKRE 396 (591)
T ss_pred cCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-----------------hhHH
Confidence 65443 223347999999999999999999999999999999999999999643321 1111
Q ss_pred hccccc---cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 016117 320 IMDPAL---EGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 356 (395)
Q Consensus 320 ~~d~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 356 (395)
-+|... ...++...+++..+++...|+.||.+|.-.+
T Consensus 397 Evdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 397 EVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 112111 1255666677899999999999999997544
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=283.26 Aligned_cols=261 Identities=20% Similarity=0.248 Sum_probs=189.1
Q ss_pred Ceeecc--CCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHG--GFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
..||.| +||+||++... +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++..+ ..++++||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 89999999964 799999999864322 2345788899999999999999999998776 56699999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+.......
T Consensus 84 ~~l~~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~ 155 (328)
T cd08226 84 GSANSLLKTYF-----PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG 155 (328)
T ss_pred CCHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence 99999886432 23588999999999999999999998 99999999999999999999999998654321111
Q ss_pred CCc-----eeeccccccccccchhhccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc------
Q 016117 245 GGH-----VSTRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL------ 311 (395)
Q Consensus 245 ~~~-----~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~------ 311 (395)
... ......++..|+|||++.+. .++.++|||||||++|||++|..||........ .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~ 233 (328)
T cd08226 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDI 233 (328)
T ss_pred ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccc
Confidence 000 01112345679999998764 478999999999999999999999975432110 000000000
Q ss_pred -------------------------ccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 312 -------------------------TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 312 -------------------------~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..........+..+...........+.+|+.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000001111111222233456789999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=279.80 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=188.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|++.+.||+|+||.||+|... +++.+|+|.+..... .....+..|+.++... .|+|++++++++.+. ..++++|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 56788899999999999999976 489999999875322 2334566677766666 599999999998776 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+. ++|.+++.... ..+++..+..++.|++.||+|||+.. +++||||+|+||++++++.++|+|||++...
T Consensus 95 ~~~-~~l~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 95 LMS-TCLDKLLKRIQ------GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred ccC-cCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 985 46776664322 36899999999999999999999632 8999999999999999999999999998754
Q ss_pred CCCCCCceeeccccccccccchhhccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGH----LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
..... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .. .
T Consensus 166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~-------------~ 227 (296)
T cd06618 166 VDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FE-------------V 227 (296)
T ss_pred cCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HH-------------H
Confidence 33221 12234678899999987553 788999999999999999999999643211 00 0
Q ss_pred hhhhcccccc-CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALE-GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...++..... .......+..+.+++.+||+.+|++||++.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 228 LTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111100 00111234568999999999999999999999966
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=287.82 Aligned_cols=268 Identities=21% Similarity=0.296 Sum_probs=194.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC----------
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---------- 153 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------- 153 (395)
++|.+.+.||.|+||.||+|... +|..|++|.+........+.+.+|+++++.++|||++++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67888999999999999999964 6899999998765555566788999999999999999998765543
Q ss_pred -----ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC-CCC
Q 016117 154 -----RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-KNF 227 (395)
Q Consensus 154 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~ 227 (395)
..++++||+. ++|.+++. ...+++..+..++.|++.||.|||+. +++||||||+||+++ +++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE--------QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 3569999997 58888873 23588999999999999999999998 999999999999997 566
Q ss_pred cEEEeccccccccCCCCCCc-eeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhh
Q 016117 228 HAKVSDFGLAKIGSDKAGGH-VSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS 305 (395)
Q Consensus 228 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~ 305 (395)
.++|+|||++.......... ......++..|+|||.+.. ..++.++|||||||++|+|++|+.||....+........
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 78999999987543221111 1122357888999998754 568889999999999999999999997543211100000
Q ss_pred hhhcccccchhhhhh--------ccccccCCC-----CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 306 WALPRLTDREKILEI--------MDPALEGQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~--------~d~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
...+ .......... ......... ......++.+|+.+||+.+|.+|||+.+++.+ .+++
T Consensus 233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h--~~~~ 304 (342)
T cd07854 233 ESVP-VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH--PYMS 304 (342)
T ss_pred HhcC-CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC--Cccc
Confidence 0000 0000000000 000000000 01233568899999999999999999999964 5554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=272.07 Aligned_cols=247 Identities=21% Similarity=0.274 Sum_probs=187.1
Q ss_pred HHHHHhCCCCCCCee--eccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-
Q 016117 79 QLHSATGGFSKSNVV--GHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR- 153 (395)
Q Consensus 79 ~~~~~~~~~~~~~~l--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 153 (395)
+.....++|.+.+.+ |+|+||.||++.. .++..+++|.+........ |......+ +|+|++++++.+...
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 333445567777766 9999999999995 4788899999864322111 22222222 799999999988765
Q ss_pred ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC-cEEEe
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKVS 232 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~ 232 (395)
..++||||+++++|.+++... ..+++..+..++.|+++||.|||+. +++|+||+|+||+++.++ .++|+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE-------GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence 567999999999999999432 3689999999999999999999998 999999999999999988 99999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
|||++....... ...++..|+|||++.+..++.++||||||+++|+|++|..||....... .....+.
T Consensus 153 dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~----- 220 (267)
T PHA03390 153 DYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL----- 220 (267)
T ss_pred cCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH-----
Confidence 999987543221 2357889999999998899999999999999999999999997433211 0111110
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-HHHHHH
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-MADVVQ 360 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~~vl~ 360 (395)
....... ......+..+.+++.+||+.+|.+||+ ++++++
T Consensus 221 ------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 221 ------KRQQKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------HhhcccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0011000 111234567899999999999999996 688885
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=302.07 Aligned_cols=271 Identities=18% Similarity=0.205 Sum_probs=185.0
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEcC--CcEEEEE------------------EeccCCcccHHHHHHHHHHHhccCCCc
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLSN--GRKVAIK------------------LMDQAGKQGEDEFKMEVELLGRLRSPY 142 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~n 142 (395)
..++|.+.+.||+|+||+||++.... +...+.| .+. ........+.+|+.++++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 34689999999999999999987532 2222222 111 11223356788999999999999
Q ss_pred ceeEEEEEecC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCE
Q 016117 143 LLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNI 221 (395)
Q Consensus 143 iv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni 221 (395)
|+++++++.+. ..+++++++. ++|.+++...... .........+..++.|++.||.|||++ +|+||||||+||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NI 298 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFD--WKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENI 298 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhcccc--ccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 99999998776 5668888874 5777777533211 112344667888999999999999998 999999999999
Q ss_pred EeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC-
Q 016117 222 LLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE- 300 (395)
Q Consensus 222 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~- 300 (395)
|++.++.+||+|||++........ .......||..|+|||++.+..++.++|||||||++|||++|..++........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 999999999999999976543221 122335689999999999999999999999999999999998765432221111
Q ss_pred chhhhhhh------ccccc-chhhhhhcccccc----CCCC-----HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 301 GVLVSWAL------PRLTD-REKILEIMDPALE----GQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 301 ~~~~~~~~------~~~~~-~~~~~~~~d~~~~----~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+..... ..+.. .......++.... ...+ .....++.+++.+||+.||.+|||+.|++.+
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111000 00000 0011111110000 0000 0112457788999999999999999999964
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=274.32 Aligned_cols=260 Identities=24% Similarity=0.297 Sum_probs=191.3
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhcc---CCCcceeEEEEEecCc------
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRL---RSPYLLALLGYCSDRR------ 154 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~------ 154 (395)
|++.+.||+|+||.||+|... ++..+|+|++..... .....+..|+.+++++ +|+|++++++++.+..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999976 589999999874322 2234566687777665 5999999999987653
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++++||+. ++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~df 151 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP-----KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADF 151 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEecc
Confidence 669999997 47888875432 13589999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
|++....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........... ........
T Consensus 152 g~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~ 225 (287)
T cd07838 152 GLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDK---IFDVIGLP 225 (287)
T ss_pred CcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHH---HHHHcCCC
Confidence 9987653322 11223468889999999988999999999999999999999999875443211000 00000000
Q ss_pred hh---------hhhhcccccc---CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 315 EK---------ILEIMDPALE---GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 315 ~~---------~~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. ....+..... .....+....+.+++.+||+.+|.+||++.+++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 0000000000 11112334678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=279.58 Aligned_cols=248 Identities=27% Similarity=0.406 Sum_probs=197.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccC-CCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~~~lv 158 (395)
++|.+.+.||+|+||.||++... ++..+++|++... .....+.+..|.+++++++ |+||+++++++.+. ..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999965 7899999998642 1233456788999999998 99999999987665 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+.+++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++.
T Consensus 81 ~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~ 150 (280)
T cd05581 81 LEYAPNGELLQYIRKY-------GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAK 150 (280)
T ss_pred EcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCcccc
Confidence 9999999999999532 3699999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCCC------------------ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 016117 239 IGSDKAGG------------------HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE 300 (395)
Q Consensus 239 ~~~~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~ 300 (395)
........ .......++..|+|||......++.++||||||++++++++|..||......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-- 228 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-- 228 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--
Confidence 54432211 1122345788999999998888999999999999999999999999744310
Q ss_pred chhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH----HHHHH
Q 016117 301 GVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM----ADVVQ 360 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~~vl~ 360 (395)
. ......+ .....+...+..+.+++.+||+.+|++|||+ .+++.
T Consensus 229 -~-------------~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 -L-------------TFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -H-------------HHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 0011110 1112223335678999999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=273.20 Aligned_cols=241 Identities=24% Similarity=0.340 Sum_probs=182.9
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHH-hccCCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELL-GRLRSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..++ ...+|+|++++++++.++ ..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999964 689999999864322 1122334454443 445899999999988766 56799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-- 149 (260)
T cd05611 82 GDCASLIKTL-------GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-- 149 (260)
T ss_pred CCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc--
Confidence 9999998432 3588999999999999999999998 999999999999999999999999999875332
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...... ...... ..... .
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~---------~~~~~--~ 211 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVFDNI---------LSRRI--N 211 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---------Hhccc--C
Confidence 12345788899999998888899999999999999999999999643321 000000 00000 0
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.........+..+.+++.+||+.+|++|||+.++.+.
T Consensus 212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 0111112345678999999999999999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=279.56 Aligned_cols=260 Identities=18% Similarity=0.236 Sum_probs=186.2
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCCh
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 167 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L 167 (395)
+.+|.|+++.++++.. +++.||+|++... .....+.+..|+++++.++|+||+++++++.+. ..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3344444544444444 7899999998753 234456788999999999999999999988766 56799999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCC--
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG-- 245 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 245 (395)
.+++.... ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.++|+|||.+........
T Consensus 87 ~~~l~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 87 EDLLKTHF-----PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred HHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 99986432 23588999999999999999999999 999999999999999999999999998864432111
Q ss_pred ---Cceeeccccccccccchhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcc---ccc----
Q 016117 246 ---GHVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR---LTD---- 313 (395)
Q Consensus 246 ---~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~---~~~---- 313 (395)
........++..|+|||.+.. ..++.++||||||+++|||++|..||....... ......... ...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence 111122446778999999876 358899999999999999999999997533211 000000000 000
Q ss_pred ---chhhhh----hcccc----ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 ---REKILE----IMDPA----LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 ---~~~~~~----~~d~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...... ..++. ...........++.+|+.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 00000 0112223344678899999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=274.22 Aligned_cols=250 Identities=20% Similarity=0.326 Sum_probs=192.0
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC-----CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA-----GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
+|.+.+.||+|+||.||++... .+..+++|+++.. .......+..|+.+++.++|||++++++++.+. ..+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999864 3455666665431 122334566789999999999999999987665 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
+||+++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||+|+||++++ +.++|+|||++.
T Consensus 81 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~ 153 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH---TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSR 153 (260)
T ss_pred EEeCCCCCHHHHHHHHhh---cccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCcee
Confidence 999999999998864321 235689999999999999999999998 9999999999999975 569999999987
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... . ...
T Consensus 154 ~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~----------~~~ 215 (260)
T cd08222 154 LLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------S----------VVL 215 (260)
T ss_pred ecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------H----------HHH
Confidence 643322 1222345788899999998888899999999999999999999998633210 0 001
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+... .....+...+.++.+++.+||+.+|++||++.+++++
T Consensus 216 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 216 RIVEG-PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HHHcC-CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11111 1112233455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=263.25 Aligned_cols=244 Identities=26% Similarity=0.434 Sum_probs=187.8
Q ss_pred CCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 89 KSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 89 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
....||+|..|+||++... +|..+|||.+.... ....+.+.+.+.++..- ..|.||+.+|||..+ ..++.||.|..
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 3457999999999999954 68999999987543 33445677788777665 479999999998766 55678887754
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
.+..++... ..++++..+-++...+.+||.||-+.+ +|+|||+||+|||+|+.|++|+||||++-...+..
T Consensus 176 -C~ekLlkri------k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 176 -CAEKLLKRI------KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred -HHHHHHHHh------cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 344444322 246888888899999999999999776 99999999999999999999999999997654432
Q ss_pred CCceeeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 245 GGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
-.++..|.+.|||||.+. ...|+.++||||||++++||.||..||...+.. . ..+..++
T Consensus 247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--F-------------e~ltkvl 308 (391)
T KOG0983|consen 247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--F-------------EVLTKVL 308 (391)
T ss_pred ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--H-------------HHHHHHH
Confidence 234566889999999986 347889999999999999999999999764422 1 1122222
Q ss_pred c---ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 322 D---PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 322 d---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+ +.+.. ....+..+.+|+..||++|+.+||...+++++
T Consensus 309 n~ePP~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 309 NEEPPLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred hcCCCCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2 22211 12245679999999999999999999999865
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=283.55 Aligned_cols=270 Identities=22% Similarity=0.326 Sum_probs=196.8
Q ss_pred ecHHHHHHHhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEe
Q 016117 75 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCS 151 (395)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 151 (395)
....++....++|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34456677889999999999999999999985 478999999886432 223456778999999999999999999875
Q ss_pred cC-------ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC
Q 016117 152 DR-------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224 (395)
Q Consensus 152 ~~-------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 224 (395)
.. ..+++++++ +++|.+++. ...+++..+..++.|++.||+|||++ +++||||||+||+++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~ 154 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVK--------CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVN 154 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEc
Confidence 32 244666655 788888773 23589999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchh
Q 016117 225 KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL 303 (395)
Q Consensus 225 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~ 303 (395)
+++.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........
T Consensus 155 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (345)
T cd07877 155 EDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229 (345)
T ss_pred CCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999998754321 223457888999998866 5688899999999999999999999964332110000
Q ss_pred h-h-------hhhcccccc--hhhhhhccccccCCCC---HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 304 V-S-------WALPRLTDR--EKILEIMDPALEGQYS---MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 304 ~-~-------~~~~~~~~~--~~~~~~~d~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
. . ......... ......+.......+. ......+.+++.+|++.+|.+|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 0 000000000 0000000000000000 0123468899999999999999999999966
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=273.42 Aligned_cols=241 Identities=28% Similarity=0.388 Sum_probs=182.8
Q ss_pred eeeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHH---HHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 92 VVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVE---LLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
.||+|+||.||++... +++.||+|.+..... .....+..|.. .++...|||++.+.+++.+. ..++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999854 688999998864321 11222334433 44445799999999988766 5669999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+|+|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 g~~L~~~l~~-------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~ 150 (278)
T cd05606 81 GGDLHYHLSQ-------HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150 (278)
T ss_pred CCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence 9999988842 24689999999999999999999998 9999999999999999999999999998754322
Q ss_pred CCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
. .....|+..|+|||.+.++ .++.++||||+|+++|+|++|..||............ .......
T Consensus 151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-----------~~~~~~~ 215 (278)
T cd05606 151 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----------RMTLTMA 215 (278)
T ss_pred C----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-----------HHhhccC
Confidence 1 1234688999999998754 6899999999999999999999999754321110000 0000011
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
. ..+...+..+.+++.+|++.+|.+|| ++.+++++
T Consensus 216 ~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 216 V----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred C----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1 11222345789999999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=281.22 Aligned_cols=264 Identities=23% Similarity=0.322 Sum_probs=195.3
Q ss_pred HHHHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEec-C-c
Q 016117 80 LHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-R-R 154 (395)
Q Consensus 80 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~-~ 154 (395)
+...+++|++.+.||.|+||.||++... +++.+|+|.+... .....+.+..|+++++.++|||++++.+++.. . .
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446778999999999999999999854 7899999987532 22234577889999999999999999998764 3 5
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++++||+ +++|.+++. ...++...+..++.|++.||.|||+. +++|+||+|+||++++++.++|+||
T Consensus 85 ~~lv~e~~-~~~L~~~~~--------~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~df 152 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT--------SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDF 152 (328)
T ss_pred EEEEeehh-ccCHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcc
Confidence 67999998 568888873 23578888899999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhc----
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP---- 309 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~---- 309 (395)
|++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.................
T Consensus 153 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 227 (328)
T cd07856 153 GLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227 (328)
T ss_pred ccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 998753221 122356788999998765 5789999999999999999999999965432111000000000
Q ss_pred ----ccccchhhhhhc-cccccCCCCH-----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 310 ----RLTDREKILEIM-DPALEGQYSM-----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 310 ----~~~~~~~~~~~~-d~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...... ....+ .-......+. ..+..+.+++.+||+.+|++|||+.+++.+
T Consensus 228 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 228 DVINTICSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhccchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00000 0000111111 124578999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=281.66 Aligned_cols=271 Identities=20% Similarity=0.220 Sum_probs=192.8
Q ss_pred CCCC-CCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCccc--------------HHHHHHHHHHHhccCCCcceeEEE
Q 016117 85 GGFS-KSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG--------------EDEFKMEVELLGRLRSPYLLALLG 148 (395)
Q Consensus 85 ~~~~-~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~~ 148 (395)
++|. +.+.||+|+||+||+|... +++.||+|.+....... ...+.+|+++++.++|+|++++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 3467999999999999965 68999999886432211 124678999999999999999999
Q ss_pred EEecC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC
Q 016117 149 YCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 227 (395)
Q Consensus 149 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~ 227 (395)
++... ..++++||+. |+|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-------~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~ 156 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR-------KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKG 156 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCC
Confidence 88766 5669999996 689888842 23588999999999999999999998 999999999999999999
Q ss_pred cEEEeccccccccCCCC------------CCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCC
Q 016117 228 HAKVSDFGLAKIGSDKA------------GGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDV 294 (395)
Q Consensus 228 ~~kl~Dfg~~~~~~~~~------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~ 294 (395)
.++|+|||++....... .........++..|+|||.+.+. .++.++||||||+++|+|++|..||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999987543111 01111223467889999998764 468999999999999999999999975
Q ss_pred CCCCCCchhhhhhhcccccch--hhhh-----hccccccC---CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 295 NKPSGEGVLVSWALPRLTDRE--KILE-----IMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~--~~~~-----~~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
.........+........... .... -....... ......+..+.+++.+||+.+|++|||+.+++.+ .
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~--~ 314 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH--E 314 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC--c
Confidence 542211000000000000000 0000 00000000 0011224568899999999999999999999963 5
Q ss_pred hhhh
Q 016117 365 LVKY 368 (395)
Q Consensus 365 ~~~~ 368 (395)
+...
T Consensus 315 ~~~~ 318 (335)
T PTZ00024 315 YFKS 318 (335)
T ss_pred ccCC
Confidence 5543
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=264.32 Aligned_cols=255 Identities=23% Similarity=0.279 Sum_probs=199.7
Q ss_pred HhCCCCCC-CeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-----c
Q 016117 83 ATGGFSKS-NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-----R 154 (395)
Q Consensus 83 ~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-----~ 154 (395)
.+++|++. ++||-|-.|.|-.+..+ +|+.+|+|++... ...++|+++.-.. .|||||.+++++.+. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566654 68999999999998854 7999999998653 3456677765544 799999999988653 3
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC---CCcEEE
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKV 231 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl 231 (395)
.++|||.|+||.|.+.+...+ ...+++.++..|+.||+.|+.|||+. +|.||||||+|+|... |..+||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-----~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-----DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-----cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence 459999999999999996554 35799999999999999999999999 9999999999999954 567999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
+|||+|+..... ......+.|+.|.|||++....|+...|+||+|+++|-|++|.+||.........
T Consensus 206 tDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---------- 272 (400)
T KOG0604|consen 206 TDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------- 272 (400)
T ss_pred cccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC----------
Confidence 999999864432 2345678899999999999999999999999999999999999999865532111
Q ss_pred ccchhhhhhccccccCCCCH----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 312 TDREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
++.-..+..... .++. .-++...++|+.+|+.+|++|.|+.+++.+ .++...
T Consensus 273 --pgMk~rI~~gqy--~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h--pwi~~~ 328 (400)
T KOG0604|consen 273 --PGMKRRIRTGQY--EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH--PWINQY 328 (400)
T ss_pred --hhHHhHhhccCc--cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC--chhccc
Confidence 111112221111 2222 235678899999999999999999999975 555543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=282.20 Aligned_cols=267 Identities=22% Similarity=0.317 Sum_probs=195.2
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-----
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR----- 153 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 153 (395)
...++|++.+.||+|+||.||++.. .++..||+|++.... ......+..|+.+++.++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3467899999999999999999985 478999999885422 22234677899999999999999999987643
Q ss_pred --ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEE
Q 016117 154 --RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 231 (395)
Q Consensus 154 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl 231 (395)
..+++++|+ +++|.+++. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~--------~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK--------HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 236999998 778888873 23589999999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh-hh---
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV-SW--- 306 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~-~~--- 306 (395)
+|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||............ ..
T Consensus 160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07880 160 LDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT 234 (343)
T ss_pred eecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 999998754322 123456888999999876 45889999999999999999999999754321100000 00
Q ss_pred ----hhcccccchhhhhhcccc--cc-C---CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 307 ----ALPRLTDREKILEIMDPA--LE-G---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 307 ----~~~~~~~~~~~~~~~d~~--~~-~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
....+.. .......... .. . .........+.+++.+|++.||++|||+.+++.+ .+++.
T Consensus 235 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~--~~~~~ 303 (343)
T cd07880 235 PSKEFVQKLQS-EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH--PYFEE 303 (343)
T ss_pred CCHHHHHhhcc-hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC--ccHhh
Confidence 0000000 0000000000 00 0 0011223468899999999999999999999953 44443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=275.07 Aligned_cols=251 Identities=26% Similarity=0.370 Sum_probs=192.2
Q ss_pred CCCCCCeeeccCCeEEEEEEE----cCCcEEEEEEeccCC----cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ce
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~ 155 (395)
+|++.+.||+|+||.||++.. .+|..||+|++.... ....+.+..|+.+++.+ +|+||+++++++..+ ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 368899999986432 12335678899999999 589999999888766 45
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++++||+++++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+|||++.++.++|+|||
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 150 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-------ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG 150 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCc
Confidence 6999999999999998532 3588899999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
++........ .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||......... ...
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~------- 220 (290)
T cd05613 151 LSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEI------- 220 (290)
T ss_pred cceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHH-------
Confidence 9875433211 112235588899999998753 4678999999999999999999999643221110 000
Q ss_pred chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 314 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 314 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
...+.... ..++......+.+++.+||+.+|++|| ++.+++.+
T Consensus 221 ---~~~~~~~~--~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 221 ---SRRILKSE--PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---HHHhhccC--CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00111100 112223445688999999999999997 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=275.48 Aligned_cols=255 Identities=25% Similarity=0.336 Sum_probs=194.7
Q ss_pred CCCCCCeeeccCCeEEEEEEE----cCCcEEEEEEeccCC----cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ce
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~ 155 (395)
+|++.+.||+|++|.||++.. .+++.+|+|.+.... ....+.+..|+.++.++ +|+|++++++.+..+ ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367788999999999999884 257889999886431 12235677899999999 599999999887766 45
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++||||+.+|+|.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||
T Consensus 81 ~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg 150 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-------REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFG 150 (288)
T ss_pred EEEEecCCCCcHHHHHhh-------cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECc
Confidence 699999999999999843 23588999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH--LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
++........ .......++..|+|||.+.+.. .+.++||||||+++|||++|..||......... ..
T Consensus 151 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~-------- 219 (288)
T cd05583 151 LSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SE-------- 219 (288)
T ss_pred cccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HH--------
Confidence 9875433221 1122345788999999987654 788999999999999999999999643211100 00
Q ss_pred chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 314 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 314 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
....+.... ...+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 220 --~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 220 --ISRRILKSK--PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --HHHHHHccC--CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 000111110 112222345688999999999999999998887766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=281.00 Aligned_cols=268 Identities=24% Similarity=0.292 Sum_probs=191.2
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc--cHHHHHHHHHHHhccCCCcceeEEEEEecC-------
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 153 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 153 (395)
.++|++.+.||+|+||.||+|... +++.+++|.+...... ....+.+|+++++.++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999965 6899999988643221 234567899999999999999999876432
Q ss_pred --ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEE
Q 016117 154 --RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 231 (395)
Q Consensus 154 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl 231 (395)
..+++++|+.. +|...+... ...+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~------~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l 156 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP------SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKI 156 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 24799999865 677666432 24689999999999999999999998 9999999999999999999999
Q ss_pred eccccccccCCCCCC---------ceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 016117 232 SDFGLAKIGSDKAGG---------HVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 301 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~---------~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~ 301 (395)
+|||++......... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~ 236 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999754322111 11122356788999998765 45889999999999999999999999754432111
Q ss_pred hhhhhhhccccc-----chhhhhhccccccCCCC-------HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 302 VLVSWALPRLTD-----REKILEIMDPALEGQYS-------MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 302 ~~~~~~~~~~~~-----~~~~~~~~d~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
............ ...+....+.......+ ......+.+++.+||+.+|++|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 110000000000 00000000000000000 1122568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=275.21 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=194.3
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
|+..+.||+|.+|.||+|+.. +++.+++|.+.... ....+.+..|+.+++.++|+|++++++++.+. ..++++||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556778999999999999965 58999999987643 33345778899999999999999999988766 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
. ++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~-~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKRP------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 7 58999995432 3689999999999999999999999 999999999999999999999999999876443
Q ss_pred CCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhh--------hhccccc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW--------ALPRLTD 313 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~--------~~~~~~~ 313 (395)
... ......++..|+|||.+.+. .++.++||||||+++|||++|..||.............. .+.....
T Consensus 151 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 151 PLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred Ccc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 221 11223456789999998766 789999999999999999999999975442111000000 0000000
Q ss_pred chhhhhhccccccC---CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 REKILEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 ~~~~~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.......+...... .........+.+++.+||+.+|++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000000000 0011124579999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=273.36 Aligned_cols=263 Identities=23% Similarity=0.296 Sum_probs=192.3
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccC-CCcceeEEEEEecC-ceEEEEEcc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
|.+.+.||+|++|+||+|... +++.+++|.+..... .......+|+..+++++ |+|++++++++.++ ..+++|||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999975 578899998865322 22234456899999998 99999999987665 667999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
+|+|.+++.... ...+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||++.....
T Consensus 81 -~~~l~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDRK-----GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhcc-----cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 889999885432 24689999999999999999999998 999999999999999999999999999975443
Q ss_pred CCCCceeeccccccccccchhhc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc-----chh
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD-----REK 316 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~ 316 (395)
.. ......++..|+|||.+. ...++.++|+||||+++|||++|+.||..................... ...
T Consensus 152 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 152 RP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred CC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 22 112345788899999875 456789999999999999999999999654332111100000000000 000
Q ss_pred hhhhccccccC-------CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALEG-------QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....++..... .........+.+++.+||+.+|++|||+.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00001101000 0011114578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=266.29 Aligned_cols=239 Identities=26% Similarity=0.373 Sum_probs=193.9
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcc---cHHHHHHHHHHHhccCCCcceeEEEEE-ecCceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYC-SDRRKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~lv 158 (395)
-++|...++||+|.||.|.+++- .+|+.+|+|++++.--. ....-..|-++|+..+||.+..+---+ ...+.++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 35688899999999999999994 47999999999764322 233445689999999999998885544 44578899
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||..+|.|.-+|.. ...+++...+.+...|..||.|||++ +|+.||||.+|.|+|.+|.+||+|||+++
T Consensus 247 MeyanGGeLf~HLsr-------er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR-------ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred EEEccCceEeeehhh-------hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccch
Confidence 999999999998843 45788888999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
..-. .+......|||+.|+|||++....|+.+.|.|.+|+++|||++|+.||...+.. .+.
T Consensus 317 E~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-----------------kLF 377 (516)
T KOG0690|consen 317 EEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-----------------KLF 377 (516)
T ss_pred hccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-----------------HHH
Confidence 5332 234566799999999999999999999999999999999999999999865432 222
Q ss_pred hhc-cccccCCCCHHHHHHHHHHHhhcCCCCCCCCC
Q 016117 319 EIM-DPALEGQYSMKEVIQVAAIAAMCVQPEADYRP 353 (395)
Q Consensus 319 ~~~-d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 353 (395)
+++ -..+ .++.....+...|+...|.++|.+|.
T Consensus 378 eLIl~ed~--kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 378 ELILMEDL--KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HHHHhhhc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 221 1111 22333445677899999999999997
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=263.21 Aligned_cols=279 Identities=22% Similarity=0.279 Sum_probs=199.8
Q ss_pred CCCCCCeeeccCCeEEEEEEEcC-----CcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEec--CceE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLSN-----GRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSD--RRKL 156 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 156 (395)
.|+....||+|.||.||+|...+ ...+|+|.++.... .......+|+.+++.++|||++.+..++.+ ...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 58888999999999999996432 23689999875422 223466789999999999999999997755 3567
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC----CcEEEe
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN----FHAKVS 232 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~----~~~kl~ 232 (395)
++++|.+. +|...++-.+.. ....++...+..|+.||+.|+.|||++ =++||||||.||||..+ |.|||+
T Consensus 105 l~fdYAEh-DL~~II~fHr~~--~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRAS--KAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEehhhhh-hHHHHHHHhccc--hhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 99999977 788888766543 235899999999999999999999999 79999999999999776 999999
Q ss_pred ccccccccCCCCCCc-eeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc------hhh
Q 016117 233 DFGLAKIGSDKAGGH-VSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG------VLV 304 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~------~~~ 304 (395)
|||+++...+.-... .....+.|..|.|||.+.+. .|+.+.|||++||++.||++-.+-|...+..-.. ..+
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999765433221 23346679999999999875 7899999999999999999999888754332111 111
Q ss_pred hhhhcccc-----cchhhhhhccc------cccCCCC---HH--------HHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 305 SWALPRLT-----DREKILEIMDP------ALEGQYS---MK--------EVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 305 ~~~~~~~~-----~~~~~~~~~d~------~~~~~~~---~~--------~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
..+...+. ....+....+- .....+. .. .....++|+..+|+.||.+|.|+++.+++
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh- 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH- 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc-
Confidence 11110000 00001111100 0000000 00 01247889999999999999999999986
Q ss_pred HHhhhhcCCC
Q 016117 363 VPLVKYNRST 372 (395)
Q Consensus 363 ~~~~~~~~~~ 372 (395)
..+..+..+
T Consensus 338 -~yF~~d~lp 346 (438)
T KOG0666|consen 338 -PYFTEDPLP 346 (438)
T ss_pred -cccccCCCC
Confidence 444444433
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=278.27 Aligned_cols=269 Identities=20% Similarity=0.259 Sum_probs=190.2
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-C--CcEEEEEEeccCC--cccHHHHHHHHHHHhcc-CCCcceeEEEEEec---C--c
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-N--GRKVAIKLMDQAG--KQGEDEFKMEVELLGRL-RSPYLLALLGYCSD---R--R 154 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~---~--~ 154 (395)
+|++.+.||+|+||.||++... . +..+|+|.+.... ....+.+..|+++++++ +||||+++++++.. . .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999964 4 7789999886432 22245677899999999 59999999986432 1 3
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.+++++|+. ++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+||
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-------GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence 457777775 689888842 24689999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCC--Cceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh----
Q 016117 235 GLAKIGSDKAG--GHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA---- 307 (395)
Q Consensus 235 g~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~---- 307 (395)
|++........ ........|+..|+|||.+.+ ..++.++||||||+++|+|++|..||...............
T Consensus 150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (332)
T cd07857 150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP 229 (332)
T ss_pred CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence 99975432211 111223568899999998765 56899999999999999999999999754321100000000
Q ss_pred ----hcccccch--hhhhhccccccC---CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 308 ----LPRLTDRE--KILEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 308 ----~~~~~~~~--~~~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
........ ............ .........+.+++.+||+.+|++|||+.+++.+ +++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~--~~~~ 296 (332)
T cd07857 230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH--PYLA 296 (332)
T ss_pred CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC--hhhh
Confidence 00000000 000000000000 0001124578899999999999999999999854 4444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=310.88 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=196.5
Q ss_pred HhCCCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEecc--CCcccHHHHHHHHHHHhccCCCcceeEEEEEecCc-eEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQ--AGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLV 158 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv 158 (395)
.+-++.-..+||.|.||.||.|. ..+|+..|+|-+.- ........+.+|..++..++|||+|+.+|+-...+ .++.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 33456677899999999999999 55799999997652 22334456788999999999999999999987764 4599
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
||||.+|+|.+.+... ...++.....+..|++.|++|||++ +||||||||.||+++.+|.+|++|||.|.
T Consensus 1313 MEyC~~GsLa~ll~~g-------ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHG-------RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHhccCcHHHHHHhc-------chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeeccccee
Confidence 9999999999999433 2355666677889999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCC--ceeeccccccccccchhhccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 239 IGSDKAGG--HVSTRVLGTQGYVAPEYALTG---HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 239 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
........ .-.....||+.|||||++.+. ....++||||+||+..||+||+.||...+.. +.+.+.
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy~------ 1453 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMYH------ 1453 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHhH------
Confidence 66543211 112346799999999999864 4567899999999999999999999643321 111100
Q ss_pred chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+-..-..+.+...+..-.+|+.+||+.||..|-++.+++++
T Consensus 1454 -------V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 -------VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -------HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 00111123444466678899999999999999888877764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=282.16 Aligned_cols=259 Identities=24% Similarity=0.347 Sum_probs=193.0
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecCc-----
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR----- 154 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 154 (395)
..++|++.+.||+|++|.||+|... ++..||+|++... .......+..|+.+++.++|+|++++.+++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567889999999999999999965 6889999988642 1223356778999999999999999988665432
Q ss_pred --eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 155 --KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 155 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
.++++||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~ 160 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKIL 160 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEc
Confidence 57999988 6689888842 4689999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ........
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~i~~~~ 232 (343)
T cd07851 161 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ---LKRIMNLV 232 (343)
T ss_pred ccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhc
Confidence 99999754322 223457888999998865 4678999999999999999999999975432110 00000000
Q ss_pred c--c--------chhhhhhccccc---cCCC---CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 312 T--D--------REKILEIMDPAL---EGQY---SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 312 ~--~--------~~~~~~~~d~~~---~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
. . .......+.... ...+ ....+..+.+++.+||+.+|++|||+.+|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 0 000000000000 0000 01124578999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=265.40 Aligned_cols=235 Identities=28% Similarity=0.373 Sum_probs=187.8
Q ss_pred eeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCCh
Q 016117 93 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 167 (395)
Q Consensus 93 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L 167 (395)
||.|+||.||++... +++.+++|.+..... .....+..|+++++.++|+|++++++.+.++ ..+++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 589999999875422 2345788899999999999999999987766 56799999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCc
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGH 247 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 247 (395)
.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~ 148 (250)
T cd05123 81 FSHLSKE-------GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--S 148 (250)
T ss_pred HHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--C
Confidence 9999432 3589999999999999999999998 99999999999999999999999999987654322 1
Q ss_pred eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccC
Q 016117 248 VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327 (395)
Q Consensus 248 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 327 (395)
......++..|+|||...+...+.++|+||||+++|++++|..||...... . ....+.... .
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~-------------~~~~~~~~~--~ 210 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---E-------------IYEKILKDP--L 210 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---H-------------HHHHHhcCC--C
Confidence 123345788899999998888899999999999999999999999643310 0 011111111 1
Q ss_pred CCCHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 016117 328 QYSMKEVIQVAAIAAMCVQPEADYRPLMAD 357 (395)
Q Consensus 328 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~ 357 (395)
..+...+..+.+++.+||..+|++|||+.+
T Consensus 211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 211 RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 122223567889999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=298.97 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=180.6
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-------
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 153 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 153 (395)
-..+|+..++||+||||.||+++.+ +|+.||||++.-. +........+|+.+|++|+|||||+++....+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3456777889999999999999966 9999999998744 233345677899999999999999997321100
Q ss_pred --------------------------------------------------------------------------------
Q 016117 154 -------------------------------------------------------------------------------- 153 (395)
Q Consensus 154 -------------------------------------------------------------------------------- 153 (395)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------c----------eEEEEEcccCCChhhhcccCCCCCCCCCCC--CHHHHHHHHHHHHH
Q 016117 154 -----------------------R----------KLLVYDYMANGGLQEHLYPANGSNSVASKL--DWETRLRIALEAAK 198 (395)
Q Consensus 154 -----------------------~----------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l--~~~~~~~i~~~i~~ 198 (395)
+ .||-||||+...|.+++... .+ .....++++.+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N--------~~~~~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN--------HFNSQRDEAWRLFREILE 708 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc--------ccchhhHHHHHHHHHHHH
Confidence 0 12444555554444444221 12 35678999999999
Q ss_pred HHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC--------------C--CCCCceeeccccccccccch
Q 016117 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS--------------D--KAGGHVSTRVLGTQGYVAPE 262 (395)
Q Consensus 199 ~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~--------------~--~~~~~~~~~~~g~~~y~aPE 262 (395)
||+|+|++ +++||||||.||+++++..|||+|||+++... . .......+..+||.-|+|||
T Consensus 709 GLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 709 GLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 99999999 99999999999999999999999999997511 0 00111234577999999999
Q ss_pred hhccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCC--CCHHHHHHH
Q 016117 263 YALTG---HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQ--YSMKEVIQV 337 (395)
Q Consensus 263 ~~~~~---~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~--~~~~~~~~l 337 (395)
++.+. .|+.|+|+||||++|+||+. ||... +.....+..+.+..+..+ +..+....-
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---------------MERa~iL~~LR~g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS---------------MERASILTNLRKGSIPEPADFFDPEHPEE 847 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCch---------------HHHHHHHHhcccCCCCCCcccccccchHH
Confidence 99764 49999999999999999995 56421 111122333333333322 222333455
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHH
Q 016117 338 AAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 338 ~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
..+|.++++.||++|||+.|++.
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhh
Confidence 78999999999999999999985
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=299.59 Aligned_cols=261 Identities=25% Similarity=0.326 Sum_probs=206.2
Q ss_pred HHHHHHHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEec
Q 016117 77 FKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152 (395)
Q Consensus 77 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 152 (395)
..++.-..++|.+.++||+|+||.|..++.+ +++.||+|++++. ......-|..|-.+|..-+.+-|+.++-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4456666778999999999999999999964 6889999999763 34455678999999999899999999877776
Q ss_pred C-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEE
Q 016117 153 R-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 231 (395)
Q Consensus 153 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl 231 (395)
+ ..|+||+||+||+|..++... ..+++..++.++..|.-||.-||+. |+|||||||+|||+|.+|++||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~-------~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikL 216 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF-------DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKL 216 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc-------CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEee
Confidence 6 678999999999999999432 3699999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhc----c-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhh
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL----T-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 306 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~ 306 (395)
+|||.+-..... +.-.....+|||.|.+||++. + +.|+..+|.||+|+++|||+.|..||..++..+.+
T Consensus 217 ADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY----- 290 (1317)
T KOG0612|consen 217 ADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY----- 290 (1317)
T ss_pred ccchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH-----
Confidence 999998765533 233455678999999999986 3 57899999999999999999999999865432211
Q ss_pred hhcccccchhhhhhccccccCCCC--HHHHHHHHHHHhhcCCCCCCCCCC---HHHHHHHHHHhhh
Q 016117 307 ALPRLTDREKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPL---MADVVQSLVPLVK 367 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~d~~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPt---~~~vl~~L~~~~~ 367 (395)
..+++-.-.-.+| .+-+.+..+||...+ -+|+.|.. ++++-.| .++.
T Consensus 291 -----------~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H--pFF~ 342 (1317)
T KOG0612|consen 291 -----------GKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH--PFFE 342 (1317)
T ss_pred -----------HHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC--cccc
Confidence 1122211111222 234567788888877 46778888 7777754 4444
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=259.35 Aligned_cols=255 Identities=23% Similarity=0.347 Sum_probs=198.1
Q ss_pred CeeeccCCeEEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEEcccCCCh
Q 016117 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYDYMANGGL 167 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~g~L 167 (395)
+.||+|+|+.|-.++ +.+|..+|||++.+..........+|++++.+. .|+||+.+++||+++ +.|+|||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999988 779999999999877666677888999999998 699999999999888 56699999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC---cEEEeccccccccCCCC
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF---HAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~~~~~~ 244 (395)
.+++.+. ..+++.++.++.++|+.||.+||.. +|.||||||+|||..... -+|||||.+..-.....
T Consensus 164 LshI~~~-------~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 164 LSHIQKR-------KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred HHHHHHh-------hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCC
Confidence 9999543 5799999999999999999999999 999999999999996543 48999998875322111
Q ss_pred C-----Cceeeccccccccccchhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 245 G-----GHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 245 ~-----~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
. .......+|+..|||||++. ...|+.+.|.||||++||-|++|.+||......+-++-. .+. .+
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr----Ge~-Cr 308 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR----GEV-CR 308 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC----CCc-cH
Confidence 1 11123467889999999874 236889999999999999999999999876654322211 110 01
Q ss_pred hhhhhhccccccC--CCCHHH----HHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 315 EKILEIMDPALEG--QYSMKE----VIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 315 ~~~~~~~d~~~~~--~~~~~~----~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
.-...++.....+ .++.+. +.+..+++...+-.++.+|.++..++.
T Consensus 309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1122223333333 233332 457788999999999999999999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=279.99 Aligned_cols=243 Identities=23% Similarity=0.288 Sum_probs=194.5
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~ 159 (395)
.+..|.+...+|.|+|+.|-++.. .+++..++|++.... .+..+|..++... +|||++++.+++.++ +.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 356788888899999999999884 578899999997642 2234466565554 899999999999887 778999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe-CCCCcEEEecccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL-DKNFHAKVSDFGLAK 238 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill-~~~~~~kl~Dfg~~~ 238 (395)
|.+.++-+.+.+... ......+..|+.+|+.++.|||++ +++||||||+|||+ ++.++++|+|||.+.
T Consensus 396 e~l~g~ell~ri~~~--------~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK--------PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred hhccccHHHHHHHhc--------chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhh
Confidence 999999888888432 233377888999999999999998 99999999999999 689999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
..... ....+-|..|.|||++....|++++|+||||++||+|++|+.||.....+ .
T Consensus 465 ~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------------~ 520 (612)
T KOG0603|consen 465 ELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------------------I 520 (612)
T ss_pred hCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------------------H
Confidence 65443 23346788899999999999999999999999999999999999743211 1
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
++......+.++...+....+|+.+||+.+|.+||+|.++..+ .++
T Consensus 521 ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h--~w~ 566 (612)
T KOG0603|consen 521 EIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH--PWF 566 (612)
T ss_pred HHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC--cch
Confidence 1111112223334556778999999999999999999999864 444
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=236.11 Aligned_cols=263 Identities=22% Similarity=0.281 Sum_probs=194.0
Q ss_pred CCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecCce-EEEEEcc
Q 016117 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRK-LLVYDYM 162 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~lv~e~~ 162 (395)
|...++||+|.||+||+|+ ..+++.||+|.+.-. ++.-.....+|+-+++.++|.|||+++++...+.. -+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 4455789999999999999 457899999988643 22233567889999999999999999998877654 4999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.. +|..+.... ...++...++.++.|+++||.++|++ ++.|||+||+|.|++.+|++|++|||+++...-
T Consensus 84 dq-dlkkyfdsl------ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 84 DQ-DLKKYFDSL------NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred hH-HHHHHHHhc------CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 54 787777433 35689999999999999999999999 999999999999999999999999999986443
Q ss_pred CCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhccccc--chhhh
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTD--REKIL 318 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~ 318 (395)
.. ......+.|..|.+|.++.+. -|+...|+||-||++.|+.. |++.|...+..+....+-|......+ ...+.
T Consensus 154 pv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 154 PV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred ce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc
Confidence 22 223345678999999999876 58899999999999999988 66666544332222222222111111 11233
Q ss_pred hhccccccCCCC---------HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPALEGQYS---------MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+.|...-..++ +.....=++++...+.-+|..|.+++..+++
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 333333322222 1222345678888899999999999998864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=292.15 Aligned_cols=144 Identities=30% Similarity=0.485 Sum_probs=126.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||+||+|... +++.||+|++..... .....+..|+.+++.++|+||+++++++... ..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999965 689999999875322 2235678899999999999999999887765 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
||+.+++|.+++... ..+++..++.++.||+.||.|||.. +|+||||||+|||++.++.++|+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-------~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-------GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998532 3578899999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=281.40 Aligned_cols=261 Identities=25% Similarity=0.431 Sum_probs=212.0
Q ss_pred ecHHHHHHHhCCCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEe-
Q 016117 75 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCS- 151 (395)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~- 151 (395)
..+..+...++.|++.+.||.|.+|.||+++ .++++..|+|++... ....++...|.++++.. .|||++.++|++.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3445555567788999999999999999999 558999999998765 33456778899999988 6999999999774
Q ss_pred -----cCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC
Q 016117 152 -----DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN 226 (395)
Q Consensus 152 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~ 226 (395)
+++.|+|||||.+|+..++++... ...+.|..+..|+..++.|+.+||.+ .++|||||-.|||++.+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-----g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-----GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTEN 159 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-----ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEecc
Confidence 346889999999999999996554 46799999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccccccCCCCCCceeeccccccccccchhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 016117 227 FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 301 (395)
Q Consensus 227 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~ 301 (395)
+.|||+|||++........ ......||+.|||||++.. ..|+..+|+||||++..||..|.+|+..+.+.-..
T Consensus 160 ~~VKLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL 237 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL 237 (953)
T ss_pred CcEEEeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh
Confidence 9999999999976544332 2345679999999999863 34677899999999999999999999766542110
Q ss_pred hhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 302 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..-..+|.+.-.-+..-..++.+||..||.+|-+.||++.+++++
T Consensus 238 ---------------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 238 ---------------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---------------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111113333334455667889999999999999999999998853
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=257.88 Aligned_cols=220 Identities=21% Similarity=0.192 Sum_probs=172.5
Q ss_pred cCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCChhhhccc
Q 016117 96 GGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYP 173 (395)
Q Consensus 96 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~ 173 (395)
|.+|.||++... +++.+|+|.+.... .+..|...+....|||++++++++.+. ..+++|||+.+|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999964 78999999986542 233455555566799999999987766 56799999999999999853
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeeccc
Q 016117 174 ANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 253 (395)
Q Consensus 174 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 253 (395)
. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+....... ....
T Consensus 79 ~-------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~ 143 (237)
T cd05576 79 F-------LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEA 143 (237)
T ss_pred h-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCC
Confidence 2 3589999999999999999999998 99999999999999999999999999876543221 2234
Q ss_pred cccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHH
Q 016117 254 GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKE 333 (395)
Q Consensus 254 g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 333 (395)
++..|+|||...+..++.++||||+|+++|||++|..|+....... ..... ...+...
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------------~~~~~----~~~~~~~ 201 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------------NTHTT----LNIPEWV 201 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------------ccccc----cCCcccC
Confidence 5677999999988889999999999999999999998875321100 00000 0111223
Q ss_pred HHHHHHHHhhcCCCCCCCCCCHHH
Q 016117 334 VIQVAAIAAMCVQPEADYRPLMAD 357 (395)
Q Consensus 334 ~~~l~~li~~cl~~~p~~RPt~~~ 357 (395)
...+.+++.+||+.||++||++.+
T Consensus 202 ~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 202 SEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CHHHHHHHHHHccCCHHHhcCCCc
Confidence 456889999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=260.95 Aligned_cols=241 Identities=27% Similarity=0.391 Sum_probs=194.2
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~l 157 (395)
..+|.+..+||+|+||.|.+|..+ +.+.+|||++++..- .+.+--..|-++|+.. +-|.+++++.+++.- +.++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 346888999999999999999854 567899999875422 1222334577788766 567889998877654 7789
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
||||+.+|+|.-.+.+. ..+.+..+..++..||-||-+||++ +|+.||||.+||++|.+|.+||+|||++
T Consensus 428 VMEyvnGGDLMyhiQQ~-------GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQV-------GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred EEEEecCchhhhHHHHh-------cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 99999999999888543 4688888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...-- ........+||+.|+|||++..++|+.+.|.||||++||||+.|++||+.++.. ...
T Consensus 498 KEni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~----------------elF 559 (683)
T KOG0696|consen 498 KENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----------------ELF 559 (683)
T ss_pred ccccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHH
Confidence 75322 223455689999999999999999999999999999999999999999876532 222
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL 354 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 354 (395)
..+.+... .|+-..+.+...++...+.++|.+|.-
T Consensus 560 ~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 560 QAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence 23333322 455556677888999999999999964
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=260.07 Aligned_cols=275 Identities=20% Similarity=0.323 Sum_probs=200.6
Q ss_pred CCcceecHHHHHHHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCC--Cc----
Q 016117 70 NGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS--PY---- 142 (395)
Q Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~n---- 142 (395)
.|+-.+...+.. +++|.+...+|+|.||.|-.+... .+..||+|+++..... .+..+-|+++|.++.+ |+
T Consensus 76 dGH~v~~~gD~l--~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~r 152 (415)
T KOG0671|consen 76 DGHYVYQVGDIL--TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFR 152 (415)
T ss_pred CceEEEEecccc--ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceE
Confidence 344444444433 688999999999999999998854 5789999999865332 3455669999999932 32
Q ss_pred ceeEEEEEecC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCE
Q 016117 143 LLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNI 221 (395)
Q Consensus 143 iv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni 221 (395)
++.+.+|+.-. +.++|+|.+ +-++.++|...+ ..+++...++.|+.|+++++++||+. +++|-||||+||
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~-----y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENI 223 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENN-----YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENI 223 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCC-----ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheE
Confidence 56666677544 677999987 568999995432 45799999999999999999999999 999999999999
Q ss_pred EeCC--------------------CCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHH
Q 016117 222 LLDK--------------------NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVV 281 (395)
Q Consensus 222 ll~~--------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~ 281 (395)
|+.+ +..++++|||-|+...... ...+.|..|.|||++.+-.++.++||||+||+
T Consensus 224 Lfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCI 298 (415)
T KOG0671|consen 224 LFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCI 298 (415)
T ss_pred EEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeE
Confidence 9932 3458999999998644322 45667889999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCchhhhhhhccccc------------------------chhhhhhcccccc----CCCCHHH
Q 016117 282 LLELLTGRVPIDVNKPSGEGVLVSWALPRLTD------------------------REKILEIMDPALE----GQYSMKE 333 (395)
Q Consensus 282 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~d~~~~----~~~~~~~ 333 (395)
|+|+.+|...|..-+..+...+...+..++.. .+......+++.. -.....+
T Consensus 299 L~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e 378 (415)
T KOG0671|consen 299 LVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLE 378 (415)
T ss_pred EEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHH
Confidence 99999999999765432221122211111110 0001111111110 0112334
Q ss_pred HHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 334 VIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 334 ~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+|++|+.+||..||.+|+|+.|++.+
T Consensus 379 ~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 379 HVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HhHHHHHHHHHHccCccccccHHHHhcC
Confidence 5689999999999999999999999964
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=255.72 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=186.9
Q ss_pred CCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhcc-CCCcceeEEEE-EecCceEEEEEcccCC
Q 016117 90 SNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGY-CSDRRKLLVYDYMANG 165 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~lv~e~~~~g 165 (395)
...||.|+||+|++-.++ .|+..|||++..... ....++..|.+...+- +.||||+++|. |.++..|+.||.|.-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 457999999999998854 799999999985443 4556788888765554 78999999996 456688899999954
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCC
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 245 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 245 (395)
+|..+..... ......+++...-.|...+..||.||-... .|+|||+||+|||++..|.+||||||++..+.++.
T Consensus 148 SlDklYk~vy--~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si- 222 (361)
T KOG1006|consen 148 SLDKLYKRVY--SVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI- 222 (361)
T ss_pred hHHHHHHHHH--HHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH-
Confidence 5544332111 112356888888899999999999999765 89999999999999999999999999996543321
Q ss_pred Cceeeccccccccccchhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc--
Q 016117 246 GHVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM-- 321 (395)
Q Consensus 246 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 321 (395)
-.+...|...|||||.+.. ..|+.+|||||||++|||+.||+.|+..++.. . +.+..++
T Consensus 223 --AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv---------f------eql~~Vv~g 285 (361)
T KOG1006|consen 223 --AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV---------F------EQLCQVVIG 285 (361)
T ss_pred --HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH---------H------HHHHHHHcC
Confidence 1233457788999998863 35899999999999999999999999754321 0 1111111
Q ss_pred ccc-cc-CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 322 DPA-LE-GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 322 d~~-~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
|+. +. ..-..+....+..++..|+.+|-+.||+..++.++
T Consensus 286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111 11 11123356689999999999999999999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=250.83 Aligned_cols=235 Identities=28% Similarity=0.421 Sum_probs=188.6
Q ss_pred CCeEEEEEEEc-CCcEEEEEEeccCCccc-HHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCChhhhccc
Q 016117 97 GFGLVYRGVLS-NGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYP 173 (395)
Q Consensus 97 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~ 173 (395)
+||.||+|... +|+.+++|++....... .+.+..|++.+++++|+|++++++++... ..++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 58999999997654444 67899999999999999999999988765 66799999999999999853
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeeccc
Q 016117 174 ANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 253 (395)
Q Consensus 174 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 253 (395)
.. .+++..++.++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~ 147 (244)
T smart00220 81 RG-------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFV 147 (244)
T ss_pred cc-------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---cccccc
Confidence 22 288999999999999999999998 99999999999999999999999999998654432 223345
Q ss_pred cccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHH-
Q 016117 254 GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMK- 332 (395)
Q Consensus 254 g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~- 332 (395)
++..|++||.+.+..++.++||||||+++|+|++|..||...... ....+.+...........
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~ 211 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL----------------LELFKKIGKPKPPFPPPEW 211 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH----------------HHHHHHHhccCCCCccccc
Confidence 788899999999888999999999999999999999998652110 011111111110000000
Q ss_pred -HHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 333 -EVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 333 -~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
.+..+.+++.+||..+|++||++.++++
T Consensus 212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 212 KISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 4457899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=249.21 Aligned_cols=265 Identities=22% Similarity=0.302 Sum_probs=193.3
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEecc--CCcccHHHHHHHHHHHhccCCCcceeEEEEEecC---------c
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQ--AGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---------R 154 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------~ 154 (395)
|.-..+||+|.||.||+|+.+ +|+.||+|.+-. ..........+|+.+|..++|+|++.++..|... .
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444568999999999999954 678888885532 2222234567799999999999999999887431 2
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++|+.+|+. +|.-+|.. ....++..++.+++.++..||.|+|+. .|+|||+||.|+|++.++.+||+||
T Consensus 99 ~ylVf~~ceh-DLaGlLsn------~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSN------RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred eeeeHHHhhh-hHHHHhcC------ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence 5699999976 67777732 235799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCC--Cceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhh------
Q 016117 235 GLAKIGSDKAG--GHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS------ 305 (395)
Q Consensus 235 g~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~------ 305 (395)
|+++....... ....+..+.|..|.+||.+.+ +.|+++.|||+-||++.||++|.+-+...........++
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 99975433222 122344567999999998886 579999999999999999999999887665543322222
Q ss_pred --hhhcccccchhhhhhc-cccccCCCC--------HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 306 --WALPRLTDREKILEIM-DPALEGQYS--------MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 306 --~~~~~~~~~~~~~~~~-d~~~~~~~~--------~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..++...+-.....+- .|...+.+. .....+.++|+..++..||.+||++++++.+
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 1222222211111110 111111111 0112367889999999999999999999865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=261.05 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=193.9
Q ss_pred CCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccC---Cc----ccHHHHHHHHHHHhccCCCcceeEEEEEecC--ce
Q 016117 86 GFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA---GK----QGEDEFKMEVELLGRLRSPYLLALLGYCSDR--RK 155 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 155 (395)
+|-+.++||.|+|+.||+|. +...+.||+|+-... .. .-.+...+|..+.+.|.||.||++++|+.-+ ..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 57778899999999999999 557888999976421 11 1123456799999999999999999998633 56
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC---CCCcEEEe
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD---KNFHAKVS 232 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~ 232 (395)
+-|.|||++-+|.-||... ..+++.+++.|+.||+.||.||... +++|+|-||||.|||+- ..|.+||+
T Consensus 544 CTVLEYceGNDLDFYLKQh-------klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQH-------KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred eeeeeecCCCchhHHHHhh-------hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 7999999999999999543 4789999999999999999999988 88999999999999994 45889999
Q ss_pred ccccccccCCCCCC-----ceeeccccccccccchhhcc----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchh
Q 016117 233 DFGLAKIGSDKAGG-----HVSTRVLGTQGYVAPEYALT----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL 303 (395)
Q Consensus 233 Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~ 303 (395)
|||++......... .......||-+|++||++.- ...+.+.||||+|+++|.++.|+.||.......+
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--- 692 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--- 692 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH---
Confidence 99999877654433 22344679999999998763 3578899999999999999999999985432211
Q ss_pred hhhhhcccccchhhhhhcccccc-CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 304 VSWALPRLTDREKILEIMDPALE-GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
+. ....++...-. -+..+....+...||++||...-++|....++..
T Consensus 693 -------IL---qeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 -------IL---QENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred -------HH---hhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 00 00111111110 0111122346778999999999999998887764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=264.47 Aligned_cols=244 Identities=24% Similarity=0.400 Sum_probs=192.2
Q ss_pred CCeeeccCCeEEEEEEE-cCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecCc-eEEEEEcccCC
Q 016117 90 SNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANG 165 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e~~~~g 165 (395)
.++||+|.||+||-|++ ++|+.||||++.+- .......+++|+.+|+++.||.||.+...|+..+ .+.|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 47899999999999995 58999999998643 2345578999999999999999999999988775 45888887 55
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC---CCcEEEeccccccccCC
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~~~~~ 242 (395)
++.+.+... ....+++..-..++.||+.||.|||.+ +|+|+||||+|||+.+ ...+||||||.|+....
T Consensus 648 DMLEMILSs-----EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 648 DMLEMILSS-----EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred hHHHHHHHh-----hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 666666432 345788888889999999999999999 9999999999999954 46799999999998776
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.. .....+||+.|+|||++.++.|...-|+||.|+++|.-++|..||..++...+ ++++ ...+-
T Consensus 720 ks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd---------QIQN----AaFMy 783 (888)
T KOG4236|consen 720 KS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND---------QIQN----AAFMY 783 (888)
T ss_pred hh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH---------Hhhc----ccccc
Confidence 54 23357899999999999999999999999999999999999999975432110 0000 01111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+. ..=.+......+||...|+..-.+|-|.+..+.+
T Consensus 784 Pp---~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 784 PP---NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred CC---CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 10 0001234567889999999999999998877643
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=266.25 Aligned_cols=264 Identities=19% Similarity=0.280 Sum_probs=179.6
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEE-----------------cCCcEEEEEEeccCCcccHHHH--------------HHH
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVL-----------------SNGRKVAIKLMDQAGKQGEDEF--------------KME 131 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~e 131 (395)
..++|.+.++||+|+||+||+|.. ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999964 2356799999865432222233 346
Q ss_pred HHHHhccCCCcc-----eeEEEEEe---------cCceEEEEEcccCCChhhhcccCCCCC-----------------CC
Q 016117 132 VELLGRLRSPYL-----LALLGYCS---------DRRKLLVYDYMANGGLQEHLYPANGSN-----------------SV 180 (395)
Q Consensus 132 ~~~l~~l~h~ni-----v~l~~~~~---------~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------------~~ 180 (395)
+.++.+++|.++ +.++++|. ++..++||||+.+++|.++++...... ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766554 66677664 245789999999999999987532110 11
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeecccccccccc
Q 016117 181 ASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260 (395)
Q Consensus 181 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~a 260 (395)
...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 23467889999999999999999998 9999999999999999999999999998654322111 1112234789999
Q ss_pred chhhccCCC----------------------CccchhHHHHHHHHHHHhCCC-CCCCCCCCC------Cchhhhhhhccc
Q 016117 261 PEYALTGHL----------------------TTKSDVYSYGVVLLELLTGRV-PIDVNKPSG------EGVLVSWALPRL 311 (395)
Q Consensus 261 PE~~~~~~~----------------------~~~~DvwslG~~l~ell~g~~-pf~~~~~~~------~~~~~~~~~~~~ 311 (395)
||.+..... ..+.||||+||++|+|++|.. ||....... ......|..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--- 455 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--- 455 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh---
Confidence 998764321 124699999999999999875 664211100 000011100
Q ss_pred ccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCC---CCCCCHHHHHHH
Q 016117 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEA---DYRPLMADVVQS 361 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~~vl~~ 361 (395)
.......-...........+|+.++|..+| .+|+|+.|+++|
T Consensus 456 --------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 --------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000000001111234567889999999766 689999999965
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=275.46 Aligned_cols=270 Identities=19% Similarity=0.211 Sum_probs=168.7
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-C----CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEE-------E
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-N----GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY-------C 150 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-------~ 150 (395)
..++|.+.+.||+|+||.||+|.+. + +..||+|.+..... .+.+..+ .+....+.++..+... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4568999999999999999999965 4 68999998764321 1111111 1222222222222111 1
Q ss_pred ecCceEEEEEcccCCChhhhcccCCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCC
Q 016117 151 SDRRKLLVYDYMANGGLQEHLYPANGSN-------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK 217 (395)
Q Consensus 151 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk 217 (395)
.+...++++||+.+++|.+++....... ..........+..++.|++.||.|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 2336789999999999999886432100 0011122345678999999999999998 99999999
Q ss_pred CCCEEeCC-CCcEEEeccccccccCCCCCCceeeccccccccccchhhccC----------------------CCCccch
Q 016117 218 SSNILLDK-NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG----------------------HLTTKSD 274 (395)
Q Consensus 218 ~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~D 274 (395)
|+|||+++ ++.+||+|||++....... ........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 6899999999997543221 1223346789999999976432 2344669
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc-cchhhhhhccccccCC----C--CHHHHHHHHHHHhhcCCC
Q 016117 275 VYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT-DREKILEIMDPALEGQ----Y--SMKEVIQVAAIAAMCVQP 347 (395)
Q Consensus 275 vwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~~~~~----~--~~~~~~~l~~li~~cl~~ 347 (395)
||||||+||||+++..|+..... ..... ..... ..........+..... + .........+|+.+||+.
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~----~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLI----QFNRQ-LKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHH----HHHHH-HHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999997766532110 00000 00000 0000001111110000 0 000112355899999999
Q ss_pred CCCCCCCHHHHHHHHHHhhh
Q 016117 348 EADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 348 ~p~~RPt~~~vl~~L~~~~~ 367 (395)
||++|||+.+++++ .++.
T Consensus 437 dP~kR~ta~e~L~H--pff~ 454 (566)
T PLN03225 437 KGRQRISAKAALAH--PYFD 454 (566)
T ss_pred CcccCCCHHHHhCC--cCcC
Confidence 99999999999975 5554
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=240.72 Aligned_cols=247 Identities=24% Similarity=0.385 Sum_probs=195.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv 158 (395)
.+|.+.++||.|+|..|..++++ +.+.+|+|++++. ...+.+....|-.+..+. +||.+|.+..++..+ +.++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 36889999999999999999954 6788999988743 233445566787777776 799999999988776 66799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
.||+++|+|.-++. ....++++.++.+...|..||.|||+. +|+.||||.+|||+|..|.+||+|+|+++
T Consensus 330 ieyv~ggdlmfhmq-------rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQ-------RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEecCcceeeehh-------hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 99999999988874 345799999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC-Cchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG-EGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~ 317 (395)
..-. ........+||+.|.|||++.+..|+...|.|+||++++||+.|+.||+.-.... +.+..++. .
T Consensus 400 e~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl---------f 468 (593)
T KOG0695|consen 400 EGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL---------F 468 (593)
T ss_pred cCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH---------H
Confidence 5432 3345667899999999999999999999999999999999999999997422111 11111111 1
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL 354 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 354 (395)
+-++.+.++ .+...+.....+++..|++||.+|.-
T Consensus 469 qvilekqir--iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 469 QVILEKQIR--IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred HHHhhhccc--ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 112233332 23334455677889999999999863
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=252.03 Aligned_cols=205 Identities=27% Similarity=0.402 Sum_probs=171.6
Q ss_pred CCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
-|...+.||-|+||.|.++. ..+...+|+|.+++.+ .......+.|-.||+....+-||+|+--|.+. +.|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 46777889999999999998 4456779999887643 23345677899999999999999998877766 7889999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+++|++.++|.+. ..|.+..++.++..+..|+.+.|.. |+|||||||+|||||.+|.+||+|||+++-.
T Consensus 710 YIPGGDmMSLLIrm-------gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM-------GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred ccCCccHHHHHHHh-------ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccc
Confidence 99999999999654 3688899999999999999999999 9999999999999999999999999998521
Q ss_pred C---------CCCC-------------------------------CceeeccccccccccchhhccCCCCccchhHHHHH
Q 016117 241 S---------DKAG-------------------------------GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGV 280 (395)
Q Consensus 241 ~---------~~~~-------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~ 280 (395)
. .... .......+||+-|+|||++....|+..+|.||.|+
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 1 0000 00012346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCC
Q 016117 281 VLLELLTGRVPIDVNKPSGE 300 (395)
Q Consensus 281 ~l~ell~g~~pf~~~~~~~~ 300 (395)
+||||+.|+.||-.+.+.+.
T Consensus 860 il~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHHHHhhCCCCccCCCCCcc
Confidence 99999999999987776543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-33 Score=266.10 Aligned_cols=246 Identities=26% Similarity=0.393 Sum_probs=181.1
Q ss_pred CCCCCeeeccCCeE-EEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecCc-eEEEEEccc
Q 016117 87 FSKSNVVGHGGFGL-VYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLVYDYMA 163 (395)
Q Consensus 87 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~~ 163 (395)
|...+++|.|+.|+ ||+|.. +|+.||||++-.. ......+|+..|+.- +|||||++++.-.+.+ .|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44456799999987 699998 7899999987532 234567899999988 7999999998877775 45777877
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-----CCcEEEecccccc
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-----NFHAKVSDFGLAK 238 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfg~~~ 238 (395)
..+|.+++............ ...+....|+++||++||+. +|+||||||.||||+. ..+++|+|||+++
T Consensus 586 ~~sL~dlie~~~~d~~~~~~---i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSD---IDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred hhhHHHHHhccccchhhccc---ccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 56999999764111111111 34567889999999999998 9999999999999965 2578999999998
Q ss_pred ccCCCCCC-ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 239 IGSDKAGG-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTG-RVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 239 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
........ .......||-+|+|||++....-+.+.||||+||++|+.++| .+||...-..+ .+++.. ...
T Consensus 660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl~~-------~~~ 731 (903)
T KOG1027|consen 660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANILTG-------NYT 731 (903)
T ss_pred ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhhcC-------ccc
Confidence 76543322 223456799999999999998888899999999999999884 99997542110 000000 000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
+.. + ....++ +..+||.+|++.+|..||++.+|+.
T Consensus 732 L~~-----L--~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 LVH-----L--EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eee-----e--ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 000 0 001111 6788999999999999999999983
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=223.03 Aligned_cols=203 Identities=25% Similarity=0.411 Sum_probs=161.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCcceeEEEE-EecCceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRL-RSPYLLALLGY-CSDRRKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~lv~e 160 (395)
+.......||+|++|.|-+-++ .+|...|+|.+... +.+......+|+.+..+. ..|.+|.++|. +.+...++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 3344456799999999988874 58999999998754 233445677788876654 78999999995 45568889999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
.|.. +|..+-.+.- .....+++..+-+|+..+.+||.|||++. .++|||+||.|||++.+|++|+||||++-.+
T Consensus 126 ~M~t-Sldkfy~~v~---~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 126 LMDT-SLDKFYRKVL---KKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred Hhhh-hHHHHHHHHH---hcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9964 6665543222 12357899999999999999999999986 8999999999999999999999999999765
Q ss_pred CCCCCCceeeccccccccccchhhcc----CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALT----GHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~~l~ell~g~~pf~~~~ 296 (395)
.++.. .+...|...|||||.+.. ..|+.++||||||+++.||.+++.||....
T Consensus 200 ~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 200 VDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 54321 122457788999998763 478999999999999999999999997543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=255.86 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=197.7
Q ss_pred CCCCCCeeeccCCeEEEEEEEcCCc-EEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecCc-eEEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLSNGR-KVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 160 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 160 (395)
++.....||-|+||.|=++..++.. .+|+|++++. .....+....|-.+|...+.|.||+++-.|.+.. .|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3445567999999999998865433 4888988753 3344566778999999999999999999887774 569999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
-|-+|.|...|... ..|+..+...++..+.+|+.|||++ +|+.|||||+|.+++.+|-+||.|||.|+..
T Consensus 501 aClGGElWTiLrdR-------g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 501 ACLGGELWTILRDR-------GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhcCchhhhhhhhc-------CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHh
Confidence 99999999999544 4688889999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.... ..-.+|||+.|.|||++.++..+.+.|.||||+++|||++|.+||...++-...+++-..
T Consensus 571 ~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG------------- 634 (732)
T KOG0614|consen 571 GSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG------------- 634 (732)
T ss_pred ccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-------------
Confidence 5433 445689999999999999999999999999999999999999999876653222211100
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 361 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~vl~~ 361 (395)
+| .-.++........+++++.+..+|.+|.- ..+|-+|
T Consensus 635 id---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 635 ID---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hh---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 00 01223333345778999999999999986 5566554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=241.59 Aligned_cols=131 Identities=26% Similarity=0.413 Sum_probs=109.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-----C---CcceeEEEEEec---
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-----S---PYLLALLGYCSD--- 152 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~--- 152 (395)
++|-+.++||-|-|+|||++.+ .+.+.||+|+.+.+. .-.+....|+++|++++ | .+||+|+++|.-
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6788999999999999999995 467889999987653 23455677999999983 2 379999998853
Q ss_pred -C-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC
Q 016117 153 -R-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224 (395)
Q Consensus 153 -~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 224 (395)
+ +.++|+|++ +.+|..+|.... .+.++...+.+|+.||+.||.|||..| +|+|-||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~-----YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSN-----YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhC-----CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 2 467999988 668888886443 467999999999999999999999998 999999999999994
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=223.50 Aligned_cols=258 Identities=19% Similarity=0.316 Sum_probs=194.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCcceeEEEEEecC---ceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR---RKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~---~~~lv 158 (395)
.++|++.+++|.|.++.||.|. ..+++.++||++++. ..+.+.+|+.+|..|. ||||++++++..+. .+.++
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3568889999999999999999 567899999999854 3457889999999996 99999999988765 34599
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-CCcEEEeccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSDFGLA 237 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~ 237 (395)
+||..+.+...+. ..++...+...+.+++.||.|+|+. ||.|||+||.|+++|. .-.++|+|+|+|
T Consensus 114 FE~v~n~Dfk~ly----------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY----------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred hhhhccccHHHHh----------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence 9999998877766 5688889999999999999999999 9999999999999986 457999999999
Q ss_pred cccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhc-------
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP------- 309 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~------- 309 (395)
.+......- .-.+.+..|..||.+.. +.|+.+-|+|||||+|..|+..+.||-..... ...++..+..
T Consensus 181 EFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 181 EFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELY 256 (338)
T ss_pred hhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHH
Confidence 886654322 22345677899998864 56889999999999999999999998533221 1122211110
Q ss_pred ------ccccchhhhhhccccccCCC-------CHH-HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 310 ------RLTDREKILEIMDPALEGQY-------SMK-EVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 310 ------~~~~~~~~~~~~d~~~~~~~-------~~~-~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+.-......++..-.+... +.. ...+..+|+...|..|..+|||+.|.+.+
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00001111222211111100 011 12578899999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-33 Score=235.32 Aligned_cols=262 Identities=21% Similarity=0.316 Sum_probs=192.6
Q ss_pred CCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecCc------eEEEE
Q 016117 89 KSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR------KLLVY 159 (395)
Q Consensus 89 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~lv~ 159 (395)
..+-||-|+||.||...+. +|+.|++|.+... +-...+.+.+|+.+|..++|.|++..++.....+ .+.++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 4567999999999999854 7999999987643 2223456778999999999999999988776542 34566
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
|.| ..+|...+. ....++...+.-+.+||++||.|||+. +|.||||||.|.|+++|..+||||||+++.
T Consensus 137 ELm-QSDLHKIIV-------SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 137 ELM-QSDLHKIIV-------SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHH-Hhhhhheec-------cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence 666 346766663 335688888999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc------
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT------ 312 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------ 312 (395)
...... ..++..+-|..|.|||++.+ +.|+.+.||||.||++.|++..+..|...++.....++.....-..
T Consensus 206 ee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 544332 23445567889999999987 4799999999999999999999999987766543333221111000
Q ss_pred -cchhhhhhccccccCC---------CCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 313 -DREKILEIMDPALEGQ---------YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 313 -~~~~~~~~~d~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
.++-...++....+.. .......+...+...++..+|++|.+..+.+.++
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0111111222111110 0112233566788899999999999999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=220.62 Aligned_cols=209 Identities=36% Similarity=0.612 Sum_probs=179.1
Q ss_pred eeccCCeEEEEEEEc-CCcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCChhh
Q 016117 93 VGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQE 169 (395)
Q Consensus 93 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~ 169 (395)
||+|.+|.||++... +++.+++|++...... ....+.+|+..++.++|++++++++++... ..++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999975 4899999998764332 346788999999999999999999998775 6679999999999999
Q ss_pred hcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-CCcEEEeccccccccCCCCCCce
Q 016117 170 HLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSDFGLAKIGSDKAGGHV 248 (395)
Q Consensus 170 ~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~ 248 (395)
++.... ..+++..+..++.++++++.+||+. +++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~ 149 (215)
T cd00180 81 LLKENE------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--L 149 (215)
T ss_pred HHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--h
Confidence 985321 3688999999999999999999999 9999999999999999 89999999999976543321 1
Q ss_pred eeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccC
Q 016117 249 STRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327 (395)
Q Consensus 249 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 327 (395)
.....+...|++||..... .++.++|+|++|+++++|
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------ 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------ 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence 2234567889999998877 888999999999999999
Q ss_pred CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 328 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 328 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 358889999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=225.35 Aligned_cols=263 Identities=24% Similarity=0.323 Sum_probs=193.0
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-------ce
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------RK 155 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------~~ 155 (395)
+|.-...+|.|.- .|..+.+. .+++|++|.+... .....+...+|+.++..++|+|+++++.++... +.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555667888887 66666533 6899999976532 233445677899999999999999999988643 35
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++|||+|. .+|...+. -.++-.++..+..|++.|+.|||+. +|+||||||+||++..++.+||.|||
T Consensus 97 y~v~e~m~-~nl~~vi~---------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVIL---------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HHHHHhhh-hHHHHHHH---------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence 79999995 47877774 3477788999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhc------
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP------ 309 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~------ 309 (395)
+++..... -..+..+.+..|.|||++.+-.+....||||+||++.||++|+.-|.+....+....+.....
T Consensus 164 ~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 164 LARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred hhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 99853322 345667889999999999988899999999999999999999999975443332211111110
Q ss_pred --ccc--------cch-----hhhh-hccccccC--CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 310 --RLT--------DRE-----KILE-IMDPALEG--QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 310 --~~~--------~~~-----~~~~-~~d~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
++. ... ...+ +.|..+.. ..+.-....+.+++.+||-.||++|.++++++++ ..++
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H--PY~~ 314 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH--PYIK 314 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC--Ceee
Confidence 000 000 0011 11111111 1111234467889999999999999999999976 4444
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=239.60 Aligned_cols=196 Identities=22% Similarity=0.358 Sum_probs=163.7
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--------ccHHHHHHHHHHHhccC---CCcceeEEEEEe
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--------QGEDEFKMEVELLGRLR---SPYLLALLGYCS 151 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~l~~~~~ 151 (395)
..+|+..+.+|+|+||.|+++.++ +...|++|.+.+..- ...-..-.|+.+|+.++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346888999999999999999976 466789998864311 11112446999999997 999999999999
Q ss_pred cCce-EEEEEcc-cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcE
Q 016117 152 DRRK-LLVYDYM-ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 152 ~~~~-~lv~e~~-~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 229 (395)
++.. ++++|-. ++-+|.+++. ....+++.++..|+.|++.|+++||++ +|+|||||-+||.++.+|-+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE-------~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~ 709 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIE-------FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFV 709 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhh-------ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeE
Confidence 8855 4888876 4558999984 345799999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhccCCC-CccchhHHHHHHHHHHHhCCCCCC
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPID 293 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~ 293 (395)
||+|||-+...... .....+||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus 710 klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 710 KLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999998764332 2345789999999999999887 456899999999999999998885
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=216.82 Aligned_cols=198 Identities=32% Similarity=0.482 Sum_probs=168.4
Q ss_pred CCCCCeeeccCCeEEEEEEEcC-CcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
|.+.+.||+|++|+||++...+ ++.+++|.+...... ..+.+..|++.++.++|+|++++++++... ..++++|++.
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999764 899999999865444 567888999999999999999999988765 5679999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+++|.+++.... ..+++..+..++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+......
T Consensus 81 ~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKG------GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 999999985432 1178999999999999999999998 9999999999999999999999999998865443
Q ss_pred CCCceeeccccccccccchhh-ccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 016117 244 AGGHVSTRVLGTQGYVAPEYA-LTGHLTTKSDVYSYGVVLLELLTGRVPIDV 294 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~~l~ell~g~~pf~~ 294 (395)
... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 152 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 152 LAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 211 12234577889999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=236.05 Aligned_cols=201 Identities=26% Similarity=0.309 Sum_probs=164.7
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCC------CcceeEEEEE-ecCc
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS------PYLLALLGYC-SDRR 154 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~-~~~~ 154 (395)
..++|.+....|+|-|++|.+|... .|..||||++... +...+.=..|+++|++|+. -|+++++-.| ...+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 4467888889999999999999954 6889999999865 3334445679999999953 3677776644 5557
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC-CcEEEec
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSD 233 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~D 233 (395)
.|+|+|-+ ..+|.+.|...+. ...+....+..++.|+.-||..|-.. +++|.||||+||||+++ ..+||||
T Consensus 509 LClVFE~L-slNLRevLKKyG~----nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCD 580 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGR----NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCD 580 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCc----ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeecc
Confidence 88999976 5589999987763 35788899999999999999999988 99999999999999875 5689999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~ 296 (395)
||-|....... .+.+..+..|.|||++.+-+|+...|+||.||+||||.||+..|.+..
T Consensus 581 fGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 581 FGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred Ccccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 99997654332 223345667999999999999999999999999999999999997543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=212.31 Aligned_cols=248 Identities=18% Similarity=0.322 Sum_probs=177.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEE-EecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGY-CSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~-~~~lv~e 160 (395)
+.|.+.+.||+|.||.+-++.++ +.+.+++|-+... ....++|.+|..---.| .|.||+.-+++ ++.. -.++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45888899999999999999965 6788999988654 33456888887765555 58899988874 3333 4459999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe--CCCCcEEEecccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL--DKNFHAKVSDFGLAK 238 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill--~~~~~~kl~Dfg~~~ 238 (395)
|++.|+|.+-+. ...+-+....+++.|+++||.|+|+. +++|||||.+|||| .+..++||||||+.+
T Consensus 103 ~aP~gdL~snv~--------~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 103 FAPRGDLRSNVE--------AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred cCccchhhhhcC--------cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence 999999999883 34577888899999999999999999 99999999999999 345689999999987
Q ss_pred ccCCCCCCceeeccccccccccchhhccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTG-----HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
..+.. .....-+..|.+||..... ...+.+|||+||+++|.+++|+.|+..... .+.....|.. ...
T Consensus 172 k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~--w~~ 243 (378)
T KOG1345|consen 172 KVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQ--WLK 243 (378)
T ss_pred ccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHH--Hhc
Confidence 53322 1223345669999976532 235689999999999999999999973322 2222222221 000
Q ss_pred chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 016117 314 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVV 359 (395)
Q Consensus 314 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl 359 (395)
+. .+.+...+ ......+.++.++-+..+|++|=...++-
T Consensus 244 rk------~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 244 RK------NPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred cc------CccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHH
Confidence 00 01111111 11234577788899999999994444443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=240.21 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=198.0
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEe-cCceEEEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS-DRRKLLVYD 160 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~lv~e 160 (395)
...+|.....+|+|.||.||+++. .+++..|+|+++........-...|+-+++.-+||||+.++|-+. ....++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 345788889999999999999995 479999999998655555666778999999999999999999554 557889999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
||.+|+|++.-+. ...+++.++...++..++|++|||++ +=+|||||-.|||+++.|.+|++|||.+..+
T Consensus 93 ycgggslQdiy~~-------TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV-------TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred ecCCCcccceeee-------cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhh
Confidence 9999999998853 35789999999999999999999998 8899999999999999999999999998654
Q ss_pred CCCCCCceeeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
.... .......||+.|||||+.. .+.|...+|||++|+...|+-.-++|...-.+.....+ ..
T Consensus 163 tati--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L------------mT 228 (829)
T KOG0576|consen 163 TATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL------------MT 228 (829)
T ss_pred hhhh--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH------------hh
Confidence 3322 2234578999999999864 46788999999999999999887777532221110000 11
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
...+++.-.. -.......+.+|++.|+.++|.+|||++.++.
T Consensus 229 kS~~qpp~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 229 KSGFQPPTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccCCCCCccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1112221111 11233456889999999999999999988763
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=206.10 Aligned_cols=169 Identities=20% Similarity=0.202 Sum_probs=126.9
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|.+++... ...+++..++.++.|++.||.|||++ + ||+|||++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~ 63 (176)
T smart00750 1 VSLADILEVR------GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ 63 (176)
T ss_pred CcHHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc
Confidence 6888888532 24699999999999999999999988 5 999999999999999 99987644321
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
..|++.|+|||++.+..++.++|||||||++|||++|..||....... ....... .......
T Consensus 64 -------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~---------~~~~~~~ 125 (176)
T smart00750 64 -------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILL---------NGMPADD 125 (176)
T ss_pred -------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHH---------HHhccCC
Confidence 257899999999999999999999999999999999999996443211 0000000 0000000
Q ss_pred ccC-CCCHHHHH--HHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 325 LEG-QYSMKEVI--QVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 325 ~~~-~~~~~~~~--~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
... ........ .+.+++.+||+.+|.+|||+.++++++..+...
T Consensus 126 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 126 PRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred ccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 000 11112222 689999999999999999999999998877653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=219.15 Aligned_cols=267 Identities=24% Similarity=0.342 Sum_probs=193.7
Q ss_pred HHHHhCCCCCCCeeeccCCeEEEEEEEc----CCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-
Q 016117 80 LHSATGGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR- 153 (395)
Q Consensus 80 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 153 (395)
+....+.|...++||+|.|++||++.+. ..+.||+|.+...+. ...+..|+++|..+ .+.||+++.+++..+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445567899999999999999999853 467899998876433 34688899999999 689999999988766
Q ss_pred ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-CCcEEEe
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVS 232 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~ 232 (395)
...+|+||+++....++. ..++...+..++..++.||.++|.+ ||+||||||.|+|.+. .+.-.|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~----------~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLY----------RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred eeEEEecccCccCHHHHH----------hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEE
Confidence 567999999999999988 3577899999999999999999999 9999999999999975 5778999
Q ss_pred ccccccccCC----------------C-CC-------------------------CceeeccccccccccchhhccC-CC
Q 016117 233 DFGLAKIGSD----------------K-AG-------------------------GHVSTRVLGTQGYVAPEYALTG-HL 269 (395)
Q Consensus 233 Dfg~~~~~~~----------------~-~~-------------------------~~~~~~~~g~~~y~aPE~~~~~-~~ 269 (395)
|||++..... . .+ ........||++|.|||++... ..
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 9999861000 0 00 0001123499999999998864 57
Q ss_pred CccchhHHHHHHHHHHHhCCCCCCCCCCCCCc--hhh-----------hhhhcc--cccch---hhhh------hc--cc
Q 016117 270 TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG--VLV-----------SWALPR--LTDRE---KILE------IM--DP 323 (395)
Q Consensus 270 ~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~--~~~-----------~~~~~~--~~~~~---~~~~------~~--d~ 323 (395)
+++.||||.|+++.-+++++.||-......+. .++ ...... +..+. .+.+ -+ ..
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 88999999999999999999999644332211 000 000000 00000 0000 00 00
Q ss_pred ccc--------CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 324 ALE--------GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 324 ~~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
... .....-.+..+++|+.+|+..||.+|.|+++.+.+
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 001 01111223478999999999999999999999954
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=253.26 Aligned_cols=196 Identities=18% Similarity=0.230 Sum_probs=135.0
Q ss_pred ccCC-CcceeEEEEEe-------c-CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 016117 137 RLRS-PYLLALLGYCS-------D-RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207 (395)
Q Consensus 137 ~l~h-~niv~l~~~~~-------~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 207 (395)
.++| .||.++++++. . ...+.++||+ +++|.++|... ...+++..++.++.||++||.|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~al~~lH~~- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP------DRSVDAFECFHVFRQIVEIVNAAHSQ- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc------cccccHHHHHHHHHHHHHHHHHHHhC-
Confidence 3455 57777777661 1 2334677776 66999999532 24599999999999999999999998
Q ss_pred CCCceeCCCCCCCEEeCCC-------------------CcEEEeccccccccCCCCC--------------Cceeecccc
Q 016117 208 SPPVIHRDFKSSNILLDKN-------------------FHAKVSDFGLAKIGSDKAG--------------GHVSTRVLG 254 (395)
Q Consensus 208 ~~~i~H~dlk~~Nill~~~-------------------~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~g 254 (395)
+|+||||||+||||+.. +.+|++|||+++....... ........|
T Consensus 100 --gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 177 (793)
T PLN00181 100 --GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME 177 (793)
T ss_pred --CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence 99999999999999654 4455666666543110000 000112357
Q ss_pred ccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHH
Q 016117 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEV 334 (395)
Q Consensus 255 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 334 (395)
|+.|+|||++.+..++.++|||||||+||||++|..|+..... ... . .....+.+. .....
T Consensus 178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~----~-----~~~~~~~~~-----~~~~~ 238 (793)
T PLN00181 178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMS----S-----LRHRVLPPQ-----ILLNW 238 (793)
T ss_pred CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHH----H-----HHHhhcChh-----hhhcC
Confidence 8889999999999999999999999999999998887642110 000 0 000011111 01122
Q ss_pred HHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 335 IQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 335 ~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.....++.+||+.+|.+||||.+++++
T Consensus 239 ~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 239 PKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 345678899999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-28 Score=203.13 Aligned_cols=249 Identities=20% Similarity=0.358 Sum_probs=191.9
Q ss_pred CCCCeeeccCCeEEEEEEEcCCcEEEEEEecc--CCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 88 SKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQ--AGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 88 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
.+..+|.+...|..|+|+++ |..++.|++.- ......++|..|.-.|+.+.||||++++|.|... +..++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34457889999999999995 55566677653 2344457899999999999999999999999877 67799999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|...|+... ...++..++.+++.++|+|++|||+. .+-|.---|....+++|++.+.+|+- +-.++....
T Consensus 272 gslynvlhe~t-----~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfqe- 343 (448)
T KOG0195|consen 272 GSLYNVLHEQT-----SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQE- 343 (448)
T ss_pred hHHHHHHhcCc-----cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeeec-
Confidence 99999997654 34678889999999999999999998 33455557999999999998888741 111111111
Q ss_pred CCceeeccccccccccchhhccCCCC---ccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLT---TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
......+.|++||.+...+-+ .++|+|||++++||+.|...||....+-+-+..+.
T Consensus 344 -----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia---------------- 402 (448)
T KOG0195|consen 344 -----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA---------------- 402 (448)
T ss_pred -----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh----------------
Confidence 112246789999999876543 47999999999999999999998766543322221
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhh
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLV 366 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~ 366 (395)
-..++-..++..+..+.+|+.-|++.||.+||.+..|+-.|++++
T Consensus 403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 122333556666778999999999999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=200.74 Aligned_cols=168 Identities=20% Similarity=0.173 Sum_probs=128.9
Q ss_pred HHHHhCCCCCCCeeeccCCeEEEEEEEc--CCcEEEEEEeccC-----CcccHHHHHHHHHHHhccCCCcceeEEEEEec
Q 016117 80 LHSATGGFSKSNVVGHGGFGLVYRGVLS--NGRKVAIKLMDQA-----GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152 (395)
Q Consensus 80 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 152 (395)
.....++|.+.+.||+|+||+||+|.+. +++.+|||++... .......+.+|+++|++++|+|+++.+.. .
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--~ 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--T 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--c
Confidence 3445678999999999999999999864 5777899987532 11234568899999999999999864322 2
Q ss_pred CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC-CCCCEEeCCCCcEEE
Q 016117 153 RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDF-KSSNILLDKNFHAKV 231 (395)
Q Consensus 153 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-k~~Nill~~~~~~kl 231 (395)
+..++||||+++++|.... ... ...++.|++++|.|||++ +|+|||| ||+|||++.++.++|
T Consensus 91 ~~~~LVmE~~~G~~L~~~~-----------~~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR-----------PHG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred CCcEEEEEccCCCCHHHhC-----------ccc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEE
Confidence 4678999999999996321 000 145788999999999998 9999999 999999999999999
Q ss_pred eccccccccCCCCCCce------eeccccccccccchhhcc
Q 016117 232 SDFGLAKIGSDKAGGHV------STRVLGTQGYVAPEYALT 266 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~ 266 (395)
+|||+++.......... .....+++.|+|||.+..
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999986544322111 124567888999998864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-24 Score=196.14 Aligned_cols=262 Identities=23% Similarity=0.285 Sum_probs=193.6
Q ss_pred CCCCCCeeeccCCeEEEEEEEcCC--cEEEEEEeccCCcccHHHHHHHHHHHhccCC----CcceeEEEEEe-cC-ceEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLSNG--RKVAIKLMDQAGKQGEDEFKMEVELLGRLRS----PYLLALLGYCS-DR-RKLL 157 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~~-~~-~~~l 157 (395)
+|.+.+.||+|+||.||.+..... ..+|+|............+..|..++..+.. +++..++.... .. ..++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 5789998765433333367889999998863 57888888773 44 4568
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC-----CcEEEe
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-----FHAKVS 232 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-----~~~kl~ 232 (395)
||+.+ +.+|.++..... ...++..+.+.++.|++.+|.+||+. +++||||||.|+++... ..+.|.
T Consensus 99 VM~l~-G~sL~dl~~~~~-----~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-----PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred EEecc-CccHHHHHHhCC-----CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEE
Confidence 87765 779998774332 35799999999999999999999999 99999999999999754 469999
Q ss_pred cccccc--ccCCCCCC-----ce-eeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh
Q 016117 233 DFGLAK--IGSDKAGG-----HV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 304 (395)
Q Consensus 233 Dfg~~~--~~~~~~~~-----~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~ 304 (395)
|||+++ ........ .. .....||..|.++....+.+.+.+.|+||++.++.|++.|..|+..........
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~-- 247 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKS-- 247 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHH--
Confidence 999998 32222211 11 223569999999999999999999999999999999999999986443221111
Q ss_pred hhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 305 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
..................+..+.++...+-..+..++|....+...|++.....
T Consensus 248 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 248 -----------KFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred -----------HHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111111010100011122345666666666689999999999999998888865
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=183.47 Aligned_cols=259 Identities=20% Similarity=0.258 Sum_probs=196.5
Q ss_pred CCCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
-+|.+.++||+|.||.++.|+ +-++++||||.-... ....++..|...++.|. .++|...+-|-.++ ...+|+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368999999999999999999 568999999975543 33457888999999985 57888877666665 45688887
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC-----CcEEEecccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-----FHAKVSDFGL 236 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-----~~~kl~Dfg~ 236 (395)
+ +-+|.++..-. ...|+..++..++.|++.-+.|+|++ .+|.|||||+|+||..- ..+.|+|||+
T Consensus 106 L-GPSLEDLFD~C------gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 106 L-GPSLEDLFDLC------GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred h-CcCHHHHHHHh------cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 7 66777776332 35799999999999999999999999 99999999999999643 4589999999
Q ss_pred ccccCCCCCC-ce----eeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 237 AKIGSDKAGG-HV----STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 237 ~~~~~~~~~~-~~----~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
|+.+.+.... ++ .....||.+||+-.-..+++.+.+.|.-|||-++++.+-|..||..-.......
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~--------- 246 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE--------- 246 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH---------
Confidence 9876554332 22 234679999999999999999999999999999999999999998655432211
Q ss_pred ccchhhhhhcccccc---CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 312 TDREKILEIMDPALE---GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
..+.+=+.... .......+.++...+...-..+-++-|..+-+...+..+++.
T Consensus 247 ----kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 247 ----KYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred ----HHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 11111111111 111122345666777777777888889998888888777764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=179.44 Aligned_cols=261 Identities=22% Similarity=0.302 Sum_probs=194.8
Q ss_pred HhCCCCCCCeeeccCCeEEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCC-CcceeEEEEEecC-ceEEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~-~~~lv~ 159 (395)
..++|.+.+.||+|+||.+|.|. ..+|+.||||+-.... ....+..|..+++.+++ ..|..+..|..+. ...+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34679999999999999999999 6689999999865432 23467789999999976 4565565565555 346999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC---CCcEEEecccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSDFGL 236 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~ 236 (395)
+.. +.+|.+++.-. ...++..+++.++-|++.-+.|+|.+ +++||||||+|+|..- ...+.++|||+
T Consensus 91 dLL-GPsLEdLfnfC------~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC------SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ecc-CccHHHHHHHH------hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccc
Confidence 977 66888877432 35789999999999999999999999 9999999999999954 45689999999
Q ss_pred ccccCCCCCCc-----eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 237 AKIGSDKAGGH-----VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 237 ~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
++...+..... ......||.+|.+--...+...+.+.|+-|+|.+|.++.-|..||..-.+....
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~---------- 230 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK---------- 230 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH----------
Confidence 98654433221 123467999999988888888899999999999999999999999865443211
Q ss_pred ccchhhhhhcccccc---CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 312 TDREKILEIMDPALE---GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
...+.+.+..+. .......+.++.-.+..|-...-++-|...-+-+.+.-++..
T Consensus 231 ---QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 231 ---QKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred ---HHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 111122221111 111122345677888899988889999988887776665553
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=213.77 Aligned_cols=252 Identities=21% Similarity=0.253 Sum_probs=180.2
Q ss_pred CCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccH----HHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 89 KSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGE----DEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 89 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
..+++|.|.+|.++..... ..+.++.|..... ..... ..+..|+-+-..+.|+|++..+..+.+. ...-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999977776632 3343444432210 11111 1244577777778999997777655544 3334499
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|++. +|..++... ..+....+..+++|+..|+.|+|+. ++.|||+|++|++++.+|.+||+|||.+...
T Consensus 402 ~~~~-Dlf~~~~~~-------~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-------GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred cccH-HHHHHHhcc-------cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceee
Confidence 9999 999998432 3688889999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCC--ceeeccccccccccchhhccCCCCc-cchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 241 SDKAGG--HVSTRVLGTQGYVAPEYALTGHLTT-KSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 241 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~-~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...... ......+|+..|+|||++.+..|.+ ..||||.|+++..|++|+.||......+....-.....+.
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~------ 544 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQR------ 544 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccc------
Confidence 444333 4556688999999999999999876 5799999999999999999997655443221000000000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
.+. .-........+..-..++.++|+.+|.+|.|+++|++
T Consensus 545 -~~~--~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 545 -NIF--EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -ccc--cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000 0000111233456778999999999999999999985
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.4e-22 Score=182.79 Aligned_cols=260 Identities=28% Similarity=0.412 Sum_probs=193.7
Q ss_pred CCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcc---cHHHHHHHHHHHhccCCC-cceeEEEEEecCc-eEEEEEc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSP-YLLALLGYCSDRR-KLLVYDY 161 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~-~~lv~e~ 161 (395)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|..+++.+.|+ +++++.+++.... .++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999976 78899988754332 356788999999999988 7999999886665 4799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC-cEEEecccccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKVSDFGLAKIG 240 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~ 240 (395)
+.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+...
T Consensus 80 ~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 80 VDGGSLEDLLKKIGRK----GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred CCCCcHHHHHHhcccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 9999999766432210 3688999999999999999999999 899999999999999988 7999999999754
Q ss_pred CCCCCCc----eeeccccccccccchhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC-Cchhhhhhhcccc
Q 016117 241 SDKAGGH----VSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG-EGVLVSWALPRLT 312 (395)
Q Consensus 241 ~~~~~~~----~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~ 312 (395)
....... ......|+..|+|||.+.+ ..++...|+|++|++++++++|..||....... .............
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 4332211 2355779999999999987 578899999999999999999999976443210 0000000000000
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
. .................+.+++..|+..+|..|.++.+....
T Consensus 233 -~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 -P-----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -c-----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000001223567889999999999999999988865
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=176.15 Aligned_cols=170 Identities=16% Similarity=0.169 Sum_probs=132.3
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHH---------HHHHHHHHhccCCCcceeEEEEEec-
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDE---------FKMEVELLGRLRSPYLLALLGYCSD- 152 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~l~~~~~~- 152 (395)
..++|...++||.|+||.||+... ++..+|+|++.......... +.+|+..+.++.|++|..+..++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468899999999999999999766 67789999997543332222 5789999999999999999887542
Q ss_pred --------CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC
Q 016117 153 --------RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224 (395)
Q Consensus 153 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 224 (395)
...+++|||++|.+|.++. .++. ....+++.+|..+|+. +++|||++|.||+++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-----------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~ 169 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-----------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS 169 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-----------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence 2467999999999998874 1222 2456899999999999 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHH
Q 016117 225 KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELL 286 (395)
Q Consensus 225 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell 286 (395)
.++ ++|+|||........... ...+....+..++|+|+||+++..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 988 999999988654221110 11344556778999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=170.46 Aligned_cols=139 Identities=17% Similarity=0.206 Sum_probs=107.8
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcc--c-------H-----------------HHHHHHHHHHhccCCCcc
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ--G-------E-----------------DEFKMEVELLGRLRSPYL 143 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~ni 143 (395)
...||+|+||.||+|...+|+.||+|+++..... . . .....|++.+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4579999999999999878999999998653211 1 0 122349999999988776
Q ss_pred eeEEEEEecCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceeCCCCCCCEE
Q 016117 144 LALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL-HEHCSPPVIHRDFKSSNIL 222 (395)
Q Consensus 144 v~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~dlk~~Nil 222 (395)
.....+. ....++||||++++++...... ...++...+..++.|++.+|.|+ |+. +++||||||+|||
T Consensus 82 ~~p~~~~-~~~~~iVmE~i~g~~l~~~~~~-------~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIl 150 (190)
T cd05147 82 PCPEPIL-LKSHVLVMEFIGDDGWAAPRLK-------DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLL 150 (190)
T ss_pred CCCcEEE-ecCCEEEEEEeCCCCCcchhhh-------cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEE
Confidence 4333322 2344899999998876654321 23688899999999999999999 687 9999999999999
Q ss_pred eCCCCcEEEecccccccc
Q 016117 223 LDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 223 l~~~~~~kl~Dfg~~~~~ 240 (395)
++ ++.++|+|||++...
T Consensus 151 i~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EE-CCcEEEEEccccccC
Confidence 98 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-21 Score=163.51 Aligned_cols=140 Identities=16% Similarity=0.158 Sum_probs=110.1
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccCCccc--------------------------HHHHHHHHHHHhccCCCcc
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG--------------------------EDEFKMEVELLGRLRSPYL 143 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~ni 143 (395)
...||+|++|.||+|...+|+.||+|++....... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999997789999999987542110 1123568899999999987
Q ss_pred eeEEEEEecCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCCEE
Q 016117 144 LALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNIL 222 (395)
Q Consensus 144 v~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nil 222 (395)
.....+... ..++||||++++++...... ...++......++.|++.++.++|+ . +++||||||+||+
T Consensus 82 ~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~-------~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIl 150 (190)
T cd05145 82 PVPEPILLK-KNVLVMEFIGDDGSPAPRLK-------DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNIL 150 (190)
T ss_pred CCceEEEec-CCEEEEEEecCCCchhhhhh-------hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEE
Confidence 544443332 35899999998865443211 1346788899999999999999999 8 9999999999999
Q ss_pred eCCCCcEEEeccccccccC
Q 016117 223 LDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 223 l~~~~~~kl~Dfg~~~~~~ 241 (395)
++ ++.++|+|||++....
T Consensus 151 l~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EE-CCCEEEEEcccceecC
Confidence 98 8899999999997644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-22 Score=184.60 Aligned_cols=218 Identities=25% Similarity=0.378 Sum_probs=159.9
Q ss_pred HhccCCCcceeEEEEEecC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 016117 135 LGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIH 213 (395)
Q Consensus 135 l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H 213 (395)
|+.+.|.|+.+++|.+.++ ..+.|.+||..|+|.+.+... ...+++.....++++++.||+|||.. +-..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~------~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE------DIKLDYFFILSFIRDISKGLAYLHNS--PIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc------ccCccHHHHHHHHHHHHHHHHHHhcC--cceee
Confidence 4578999999999998877 566999999999999999642 35789999999999999999999976 23399
Q ss_pred CCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCC-------CCccchhHHHHHHHHHHH
Q 016117 214 RDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH-------LTTKSDVYSYGVVLLELL 286 (395)
Q Consensus 214 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~DvwslG~~l~ell 286 (395)
+.+++.|+++|....+||+|||+.................-..-|.|||.+.+.. .+.++||||||++++|++
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 9999999999999999999999987654211111111222345699999987631 466799999999999999
Q ss_pred hCCCCCCCCCCCCCc-hhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 287 TGRVPIDVNKPSGEG-VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 287 ~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
+.+.||......... ..+.... . .....+.|.+... .+...++..++..||..+|++||++..|-..++.+
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~----~--~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVK----K--GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred hccCccccccccCChHHHHHHHH----h--cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 999999764333221 1111110 0 0011111111110 13334789999999999999999999999888877
Q ss_pred hhh
Q 016117 366 VKY 368 (395)
Q Consensus 366 ~~~ 368 (395)
...
T Consensus 225 ~~~ 227 (484)
T KOG1023|consen 225 NKG 227 (484)
T ss_pred ccc
Confidence 764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=172.26 Aligned_cols=233 Identities=19% Similarity=0.303 Sum_probs=143.9
Q ss_pred CCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCC-----------CcceeEEE-----
Q 016117 89 KSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRS-----------PYLLALLG----- 148 (395)
Q Consensus 89 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-----------~niv~l~~----- 148 (395)
..+.||.|+++.||.+.+. +|+.+++|+..... ....+.+++|.-....+.+ .-++++--
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3568999999999999976 58999999875332 2234566666555544322 11222111
Q ss_pred ---EEecC---------ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC
Q 016117 149 ---YCSDR---------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDF 216 (395)
Q Consensus 149 ---~~~~~---------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl 216 (395)
+.... +.+++|+-+ .++|.+++............+....++.+..|+++.+++||+. |++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 11111 235667666 5677776532111111122344555677779999999999999 9999999
Q ss_pred CCCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccC--------CCCccchhHHHHHHHHHHHhC
Q 016117 217 KSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG--------HLTTKSDVYSYGVVLLELLTG 288 (395)
Q Consensus 217 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--------~~~~~~DvwslG~~l~ell~g 288 (395)
+|+|++++.+|.++|+||+....... .......+..|.+||..... .++.+.|.|+||+++|.|.+|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999987754322 11113345779999976432 468899999999999999999
Q ss_pred CCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCC
Q 016117 289 RVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYR 352 (395)
Q Consensus 289 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 352 (395)
..||+...+...... .+ ..+. +.++.+..||..+|+.||.+|
T Consensus 247 ~lPf~~~~~~~~~~~--------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW--------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG--------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc--------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999985533211100 11 1233 667789999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-22 Score=197.68 Aligned_cols=246 Identities=23% Similarity=0.282 Sum_probs=172.7
Q ss_pred CCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC-cccHHHHHHHHHH--HhccCCCcceeEEEEEecCc-eEEEEEc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG-KQGEDEFKMEVEL--LGRLRSPYLLALLGYCSDRR-KLLVYDY 161 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~-~~lv~e~ 161 (395)
++...+.||++.|=.|.+|++.+|. |+||++-+.. ....+.|.++++- ...++|||.+++.-+..... .++|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677889999999999999997877 9999886443 3334455544433 44469999999876654443 3466666
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc--
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI-- 239 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~-- 239 (395)
..+ +|.|.+. ...-+..-+...|+-|++.||..+|.. +|+|||||.+||||+.=.=+.|+||.-.+.
T Consensus 103 vkh-nLyDRlS-------TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 103 VKH-NLYDRLS-------TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTY 171 (1431)
T ss_pred Hhh-hhhhhhc-------cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCcc
Confidence 644 8888883 334466777888999999999999999 999999999999999988899999986643
Q ss_pred cCCCCCCcee---eccccccccccchhhccC----------C-CCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhh
Q 016117 240 GSDKAGGHVS---TRVLGTQGYVAPEYALTG----------H-LTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLV 304 (395)
Q Consensus 240 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~----------~-~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~ 304 (395)
...++..... .....-.+|.|||.+... . .+++-||||+||++.||++ |++||.... +.
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~ 245 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LL 245 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HH
Confidence 2222222211 112223469999987541 1 5678899999999999988 889886322 11
Q ss_pred hhhhcccccchh-hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 305 SWALPRLTDREK-ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 305 ~~~~~~~~~~~~-~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+......+.+. ++++-|. .++.++..|++.||++|.++++.++.
T Consensus 246 aYr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 111111111111 1112122 47889999999999999999999976
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-20 Score=158.35 Aligned_cols=189 Identities=20% Similarity=0.143 Sum_probs=140.6
Q ss_pred CCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcc----cHHHHHHHHHHHhccC-CCcceeEEEEEecCceEEEEEcc
Q 016117 88 SKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ----GEDEFKMEVELLGRLR-SPYLLALLGYCSDRRKLLVYDYM 162 (395)
Q Consensus 88 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~lv~e~~ 162 (395)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|+++. |+++.+++++ ...+++|+|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeee
Confidence 3467899999999997766 7788888877654221 1125788999999995 5789999886 4568999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC-CCCCEEeCCCCcEEEeccccccccC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDF-KSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl-k~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
.+.+|...+. . ....++.|++.+|.++|++ +++|||| ||.|||++.++.++|+|||++....
T Consensus 81 ~G~~L~~~~~-----------~---~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 81 AGAAMYQRPP-----------R---GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred cCccHHhhhh-----------h---hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9988865431 0 1134778999999999999 9999999 7999999999999999999998544
Q ss_pred CCCCC----c---e----eeccccccccccchhhccC-CCC-ccchhHHHHHHHHHHHhCCCCCCCCCC
Q 016117 242 DKAGG----H---V----STRVLGTQGYVAPEYALTG-HLT-TKSDVYSYGVVLLELLTGRVPIDVNKP 297 (395)
Q Consensus 242 ~~~~~----~---~----~~~~~g~~~y~aPE~~~~~-~~~-~~~DvwslG~~l~ell~g~~pf~~~~~ 297 (395)
..... . . ......++.|+.|+....- ..+ ...+.++-|+-+|.++|+..++..+.+
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 32210 0 0 1112357778888865432 233 567899999999999999998765543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=189.27 Aligned_cols=195 Identities=23% Similarity=0.294 Sum_probs=152.5
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccC---CCcceeEEEE-EecCceEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR---SPYLLALLGY-CSDRRKLLV 158 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~-~~~~~~~lv 158 (395)
....|.+.+.||+|+||+||+|...+|+.||+|+-++.+.- +|.-=.+++.+|+ -+.|..+... ...+.-++|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 33568888999999999999999888999999987765332 1222233444444 1222333222 223455799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC-------CCCcEEE
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-------KNFHAKV 231 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-------~~~~~kl 231 (395)
++|.+.|+|.+++. ..+.+++..+..++.|++..+.+||.. +||||||||+|+||. ++..++|
T Consensus 773 ~ey~~~Gtlld~~N-------~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN-------TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeccccccHHHhhc-------cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEE
Confidence 99999999999995 345799999999999999999999999 999999999999993 3456999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCC
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 290 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~ 290 (395)
+|||.+-.+.....+......++|-.+-.+|...|++++.++|.|.|+.+++.|+.|+.
T Consensus 843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999965443333345556678889999999999999999999999999999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-21 Score=183.15 Aligned_cols=231 Identities=25% Similarity=0.338 Sum_probs=179.9
Q ss_pred eeeccCCeEEEEEE----EcCCcEEEEEEeccCCcc--cHHHHHHHHHHHhccC-CCcceeEEEEEecC-ceEEEEEccc
Q 016117 92 VVGHGGFGLVYRGV----LSNGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 92 ~lg~G~~g~V~~~~----~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
.+|+|.||.|+++. ...|..+++|++.+.... .......|..++...+ ||.++++.-.+..+ ..+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999865 234677899988654221 1114456888888886 99999998877665 5669999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+|.|...+.. ...+++.........++-+++++|+. +++|+|+|++||+++.+|.+++.|||+++..-..
T Consensus 81 gg~lft~l~~-------~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~ 150 (612)
T KOG0603|consen 81 GGDLFTRLSK-------EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE 150 (612)
T ss_pred cchhhhcccc-------CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhh
Confidence 9999998843 34677888888889999999999999 9999999999999999999999999999864433
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
. ..|||..|||||++. ....++|.||||++++||++|..||.. .....++..
T Consensus 151 ~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------------------~~~~~Il~~ 202 (612)
T KOG0603|consen 151 K------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------------------DTMKRILKA 202 (612)
T ss_pred h------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------------------HHHHHHhhh
Confidence 2 128999999999988 667899999999999999999999974 112222221
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH--HHHHHHH
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM--ADVVQSL 362 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~~vl~~L 362 (395)
. -..+.+....+.+++..++..+|..|.-. ..+.++.
T Consensus 203 ~--~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 203 E--LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred c--cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 1 24566677788889999999999999866 3444433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=154.47 Aligned_cols=135 Identities=18% Similarity=0.263 Sum_probs=103.9
Q ss_pred CCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-----CCCcceeEEEEEecCc----eE-E
Q 016117 88 SKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-----RSPYLLALLGYCSDRR----KL-L 157 (395)
Q Consensus 88 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~----~~-l 157 (395)
+-.+.||+|+||.||. ...++.. +||++........+.+.+|+.+++.+ .||||++++|++.++. .+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3456899999999996 3224444 69988765444567889999999999 5799999999988763 23 7
Q ss_pred EEEc--ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCceeCCCCCCCEEeCC----CCcEE
Q 016117 158 VYDY--MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL-EFLHEHCSPPVIHRDFKSSNILLDK----NFHAK 230 (395)
Q Consensus 158 v~e~--~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~dlk~~Nill~~----~~~~k 230 (395)
|+|| +.+|+|.+++.. ..+++. ..++.|++.++ .|||++ +|+||||||+|||++. ++.++
T Consensus 83 I~e~~G~~~~tL~~~l~~--------~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ--------CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EecCCCCcchhHHHHHHc--------ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence 8999 557999999942 124444 35677888777 999999 9999999999999964 34899
Q ss_pred Eeccccc
Q 016117 231 VSDFGLA 237 (395)
Q Consensus 231 l~Dfg~~ 237 (395)
|+||+.+
T Consensus 150 LiDg~G~ 156 (210)
T PRK10345 150 VCDNIGE 156 (210)
T ss_pred EEECCCC
Confidence 9995443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=157.10 Aligned_cols=142 Identities=17% Similarity=0.200 Sum_probs=110.7
Q ss_pred CCCCCCeeeccCCeEEEEEE--EcCCcEEEEEEeccCCcc------------------------cHHHHHHHHHHHhccC
Q 016117 86 GFSKSNVVGHGGFGLVYRGV--LSNGRKVAIKLMDQAGKQ------------------------GEDEFKMEVELLGRLR 139 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 139 (395)
-|.+.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57888999999999999998 568999999988643210 0123567999999997
Q ss_pred CCc--ceeEEEEEecCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceeCCC
Q 016117 140 SPY--LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP-VIHRDF 216 (395)
Q Consensus 140 h~n--iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~dl 216 (395)
+.+ +..++++ ...++||||+.+++|...... ...+.......++.|++.++.+||++ + ++|+||
T Consensus 109 ~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Di 175 (237)
T smart00090 109 EAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLK-------DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDL 175 (237)
T ss_pred hcCCCCCeeeEe---cCceEEEEEecCCcccccccc-------cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCC
Confidence 533 3344432 345899999999888766521 12345566788999999999999999 8 999999
Q ss_pred CCCCEEeCCCCcEEEeccccccccC
Q 016117 217 KSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 217 k~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
||+||+++ ++.++|+|||.+....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999 8899999999987533
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-19 Score=159.61 Aligned_cols=197 Identities=21% Similarity=0.226 Sum_probs=136.1
Q ss_pred CCCcceeEEEEEecC----------------------------ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHH
Q 016117 139 RSPYLLALLGYCSDR----------------------------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 190 (395)
Q Consensus 139 ~h~niv~l~~~~~~~----------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~ 190 (395)
+|||||++.++|.+. ..|+||.-++ .+|.+++.. ...+.....
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~--------~~~s~r~~~ 344 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT--------RHRSYRTGR 344 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc--------CCCchHHHH
Confidence 599999998866431 1246665543 478888853 345667788
Q ss_pred HHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe--CCCC--cEEEeccccccccCCCCC----Cceeeccccccccccch
Q 016117 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL--DKNF--HAKVSDFGLAKIGSDKAG----GHVSTRVLGTQGYVAPE 262 (395)
Q Consensus 191 ~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill--~~~~--~~kl~Dfg~~~~~~~~~~----~~~~~~~~g~~~y~aPE 262 (395)
.++.|+++|+.|||.+ ++.|||+|.+|||+ |+|+ .+.|+|||++--...-.- ........|...-||||
T Consensus 345 ~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPE 421 (598)
T KOG4158|consen 345 VILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPE 421 (598)
T ss_pred HHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchh
Confidence 8999999999999999 99999999999999 4443 478999999853221100 01112345778899999
Q ss_pred hhccCC------CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHH
Q 016117 263 YALTGH------LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQ 336 (395)
Q Consensus 263 ~~~~~~------~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 336 (395)
+....+ .-.++|.|+.|.+.||++....||...... .+..+. .++ ..-...+...+..
T Consensus 422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-----------~L~~r~-Yqe----~qLPalp~~vpp~ 485 (598)
T KOG4158|consen 422 IATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-----------LLDTRT-YQE----SQLPALPSRVPPV 485 (598)
T ss_pred hhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-----------eechhh-hhh----hhCCCCcccCChH
Confidence 886432 235899999999999999999999853211 000000 001 1111233445567
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 337 VAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 337 l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
+.+++...|+.||++||+..-....|+
T Consensus 486 ~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 486 ARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHHhcCCccccCCccHHHhHHH
Confidence 889999999999999999877666554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.9e-20 Score=168.04 Aligned_cols=174 Identities=22% Similarity=0.348 Sum_probs=129.4
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++.|++|...+|.++|...+ .....++...+.++.|++.|+.| + +.+|+|+||.||+...+..+||.||
T Consensus 331 lyI~Mn~c~~~tledWl~rr~----~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRR----TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCC----cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhh
Confidence 468999999999999996544 34567888999999999999999 5 8999999999999999999999999
Q ss_pred ccccccCCCC----CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhc
Q 016117 235 GLAKIGSDKA----GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALP 309 (395)
Q Consensus 235 g~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~ 309 (395)
|+.+...... .....+...||..||+||.+.+..|+.++||||||++|+|++. =..+|+.
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er--------------- 465 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER--------------- 465 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---------------
Confidence 9998654433 1223455779999999999999999999999999999999997 2222211
Q ss_pred ccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 016117 310 RLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADV 358 (395)
Q Consensus 310 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~v 358 (395)
..-..++-|..+....-.+.+ .-+.|+.+++...|.+||++.+.
T Consensus 466 ----~~t~~d~r~g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 466 ----IATLTDIRDGIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred ----HHhhhhhhcCCCChHHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence 111111222222111111111 23569999999999999944433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-18 Score=146.74 Aligned_cols=145 Identities=20% Similarity=0.152 Sum_probs=111.6
Q ss_pred HHHHHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcc----------------------cHHHHHHHHHHH
Q 016117 78 KQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ----------------------GEDEFKMEVELL 135 (395)
Q Consensus 78 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l 135 (395)
+++......|.+.+.||+|+||.||++...+|+.+|||++...... ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444448888999999999999999888999999987542210 012356788888
Q ss_pred hccCCCc--ceeEEEEEecCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 016117 136 GRLRSPY--LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIH 213 (395)
Q Consensus 136 ~~l~h~n--iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H 213 (395)
..+.|++ +...++ ....+++|||+++++|.+... ......++.+++.++.++|+. +++|
T Consensus 88 ~~l~~~~i~v~~~~~---~~~~~lv~e~~~g~~L~~~~~-------------~~~~~~~~~~i~~~l~~lh~~---gi~H 148 (198)
T cd05144 88 KALYEEGFPVPKPID---WNRHAVVMEYIDGVELYRVRV-------------LEDPEEVLDEILEEIVKAYKH---GIIH 148 (198)
T ss_pred HHHHHcCCCCCceee---cCCceEEEEEeCCcchhhccc-------------cccHHHHHHHHHHHHHHHHHC---CCCc
Confidence 8887774 344433 345689999999999876541 023467889999999999998 9999
Q ss_pred CCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 214 RDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 214 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+||+|+||++++++.++|+|||++....
T Consensus 149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 149 GDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCCcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.3e-18 Score=146.83 Aligned_cols=133 Identities=22% Similarity=0.329 Sum_probs=109.3
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCcc--------cHHHHHHHHHHHhccCCCcceeEEEEEe-cCceEEEEEc
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ--------GEDEFKMEVELLGRLRSPYLLALLGYCS-DRRKLLVYDY 161 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~lv~e~ 161 (395)
+.||+|++|.||+|.. .|..+++|+....... ....+..|++++..+.|+++.....++. ....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 7788999986543221 1235678999999999998877666554 4467899999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
+++++|.+++... .. .+..++.+++.+|.++|+. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~----------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN----------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc----------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998321 12 7888999999999999999 999999999999999 78999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=142.36 Aligned_cols=129 Identities=24% Similarity=0.363 Sum_probs=102.6
Q ss_pred eeeccCCeEEEEEEEcCCcEEEEEEeccCCcc--------cHHHHHHHHHHHhccCCCcceeEEEEE-ecCceEEEEEcc
Q 016117 92 VVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ--------GEDEFKMEVELLGRLRSPYLLALLGYC-SDRRKLLVYDYM 162 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~lv~e~~ 162 (395)
.||+|+||.||+|.+ +|..+++|........ ....+..|++++..+.|+++.....++ .+...+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 6788999986532211 124567899999999888754443333 344668999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
++++|.+++.... . .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998873211 0 7899999999999998 999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=163.28 Aligned_cols=136 Identities=20% Similarity=0.288 Sum_probs=108.3
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEe-ccC-Cc------ccHHHHHHHHHHHhccCCCcceeEEEEEecC-c
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLM-DQA-GK------QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~-~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~ 154 (395)
...|...+.||+|+||+||++.+.... +++|+. ... .. ...+.+..|+++++.++|++++....++.+. .
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344566789999999999999875443 444432 211 11 1124678899999999999998877666543 6
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++||||+++++|.+++. ....++.+++.+|.|||+. +++||||||+|||+ +++.++|+||
T Consensus 411 ~~lv~E~~~g~~L~~~l~---------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE---------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CEEEEEecCCCcHHHHHH---------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeC
Confidence 789999999999999882 3567899999999999999 99999999999999 6789999999
Q ss_pred ccccc
Q 016117 235 GLAKI 239 (395)
Q Consensus 235 g~~~~ 239 (395)
|+++.
T Consensus 472 Gla~~ 476 (535)
T PRK09605 472 GLGKY 476 (535)
T ss_pred ccccc
Confidence 99875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-18 Score=170.91 Aligned_cols=214 Identities=23% Similarity=0.337 Sum_probs=142.4
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEc
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDY 161 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~ 161 (395)
...+|..+++|..|+||.||..+++ ..+.+|+|+-++. . -+++ ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~-l----ilRn---ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN-L----ILRN---ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccc-h----hhhc---cccccCCccee-----------------
Confidence 3457888999999999999999876 4567888543221 0 0010 22222333322
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
|+-...+... ..++. +++.+++|||+- +|+|||+||+|.+|+.-|.+|++|||+...+.
T Consensus 136 ---gDc~tllk~~-------g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 ---GDCATLLKNI-------GPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred ---chhhhhcccC-------CCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 3333333211 12322 227899999988 99999999999999999999999999986432
Q ss_pred CCC-------------CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCch-hhhhh
Q 016117 242 DKA-------------GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV-LVSWA 307 (395)
Q Consensus 242 ~~~-------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~-~~~~~ 307 (395)
... ........+||+.|.|||++..+.|+...|.|++|+++||.+-|..||..+.+.+-.. .+..
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd- 273 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD- 273 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh-
Confidence 111 0111234689999999999999999999999999999999999999998775432110 0000
Q ss_pred hcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 016117 308 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADV 358 (395)
Q Consensus 308 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~v 358 (395)
...+. +.....+.++.+++.+.|+.+|.+|---...
T Consensus 274 ---------~i~wp------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 274 ---------DIEWP------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred ---------hcccc------ccCcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence 00000 1122233467888999999999998744333
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.4e-16 Score=132.55 Aligned_cols=136 Identities=20% Similarity=0.216 Sum_probs=97.7
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccCCccc--HHH----------------------HHHHHHHHhccCCCc--c
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG--EDE----------------------FKMEVELLGRLRSPY--L 143 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~n--i 143 (395)
.+.||+|+||+||+|...+|+.||+|++....... ... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998789999999886532211 111 124555666654432 3
Q ss_pred eeEEEEEecCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCCEE
Q 016117 144 LALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNIL 222 (395)
Q Consensus 144 v~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nil 222 (395)
.+.+++ ...+++|||++++.+........ ... .....++.+++.++.++|. . +++|+||+|+||+
T Consensus 82 ~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~-------~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL---NRHVLVMEFIGGDGIPAPRLKDV-------RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNIL 147 (187)
T ss_pred CceEec---CCCEEEEEEeCCCCccChhhhhh-------hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEE
Confidence 344432 34689999999965432211100 011 5678899999999999998 7 9999999999999
Q ss_pred eCCCCcEEEecccccccc
Q 016117 223 LDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 223 l~~~~~~kl~Dfg~~~~~ 240 (395)
++ ++.++++|||.+...
T Consensus 148 i~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EE-CCcEEEEECcccccc
Confidence 99 899999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.2e-15 Score=123.30 Aligned_cols=134 Identities=21% Similarity=0.185 Sum_probs=109.9
Q ss_pred CCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCC--CcceeEEEEEecC-ceEEEEEcccCC
Q 016117 89 KSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS--PYLLALLGYCSDR-RKLLVYDYMANG 165 (395)
Q Consensus 89 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~-~~~lv~e~~~~g 165 (395)
+.+.||+|.++.||++...+ ..+++|....... ...+..|...++.++| .++++++++.... ..++++||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35689999999999999844 7899998865432 4578889999999976 4888888877654 577999999887
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
.+..+ +......++.+++++++++|.....+++|+|++|.||+++..+.++++|||.+..
T Consensus 79 ~~~~~--------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66543 4456677899999999999986334799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.9e-15 Score=132.97 Aligned_cols=134 Identities=22% Similarity=0.216 Sum_probs=103.1
Q ss_pred CCeee-ccCCeEEEEEEEcCCcEEEEEEeccCC-------------cccHHHHHHHHHHHhccCCCcc--eeEEEEEecC
Q 016117 90 SNVVG-HGGFGLVYRGVLSNGRKVAIKLMDQAG-------------KQGEDEFKMEVELLGRLRSPYL--LALLGYCSDR 153 (395)
Q Consensus 90 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~ 153 (395)
...|| .|+.|+||.+.. .+..+++|.+.... ......+.+|++++..+.|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 899999999988 47789999775311 1122457789999999998775 6667664332
Q ss_pred -----ceEEEEEcccC-CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC
Q 016117 154 -----RKLLVYDYMAN-GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 227 (395)
Q Consensus 154 -----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~ 227 (395)
..++|+|++++ .+|.+++.. ..++.. .+.+++.+|.+||+. +|+|+||||.|||++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--------~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--------APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG 179 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--------CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence 23499999997 688888732 124433 356899999999999 999999999999999989
Q ss_pred cEEEeccccccc
Q 016117 228 HAKVSDFGLAKI 239 (395)
Q Consensus 228 ~~kl~Dfg~~~~ 239 (395)
.++|+|||.+..
T Consensus 180 ~v~LIDfg~~~~ 191 (239)
T PRK01723 180 KFWLIDFDRGEL 191 (239)
T ss_pred CEEEEECCCccc
Confidence 999999998875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.2e-17 Score=162.41 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=185.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcC--CcEEEEEEeccCC--cccHHHHHHHHHHHhccC-CCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSN--GRKVAIKLMDQAG--KQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~~~lv 158 (395)
..|.+.+.||+|.|+.|-...... ...++.|.+.... .........|..+-+.+. |+|++.+++...+. ..++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456777789999999998877543 3445666554332 222233445777777776 99999999987776 45689
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCceeCCCCCCCEEeCCCC-cEEEecccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH-EHCSPPVIHRDFKSSNILLDKNF-HAKVSDFGL 236 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~ 236 (395)
.+|..++++.+.+... .....+....-..+.|+..++.|+| .. ++.|+|+||+|.+++.++ ..+++|||+
T Consensus 100 ~~~s~g~~~f~~i~~~-----~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-----DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred cCcccccccccccccC-----CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchh
Confidence 9999999998888311 1124566677789999999999999 77 999999999999999999 999999999
Q ss_pred ccccCC-CCCCceeecccc-ccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 237 AKIGSD-KAGGHVSTRVLG-TQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 237 ~~~~~~-~~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
+..... ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ....|.
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~------ 244 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWK------ 244 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeec------
Confidence 987776 444445556778 9999999998884 556789999999999999999999875443321 111111
Q ss_pred chhhhhhccccc--cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 314 REKILEIMDPAL--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 314 ~~~~~~~~d~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
...- .............+++..++..+|+.|.+.+++..
T Consensus 245 --------~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 245 --------SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --------ccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 1100 00111122335677889999999999999998873
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.9e-15 Score=131.91 Aligned_cols=204 Identities=20% Similarity=0.300 Sum_probs=140.9
Q ss_pred HHHhccCCCcceeEEEEEecC------ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 016117 133 ELLGRLRSPYLLALLGYCSDR------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206 (395)
Q Consensus 133 ~~l~~l~h~niv~l~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 206 (395)
.-|-++.|.|||+++.|..+. +..+++|||..|++..+|..... ....+....-.+|+-||.+||.|||+.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~---~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK---NQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH---hhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 344456799999999987653 34699999999999999976653 235677778889999999999999997
Q ss_pred CCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC---CCceeeccccccccccchhhccCCCCccchhHHHHHHHH
Q 016117 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA---GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLL 283 (395)
Q Consensus 207 ~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 283 (395)
.|.++|+++.-+.|++..++-+|++-- ......... ...-.....+.++|.+||.-.....+.++|||+||+...
T Consensus 196 -~PpiihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 196 -DPPIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred -CCccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 889999999999999999998888432 111111000 000112234678899999766667778999999999999
Q ss_pred HHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 284 ELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 284 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
||..|..--...... ..+.. .....+..+-++. -+.++..|++..|..||+|++++.+
T Consensus 274 emailEiq~tnseS~---~~~ee-----~ia~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 274 EMAILEIQSTNSESK---VEVEE-----NIANVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHHheeccCCCcce---eehhh-----hhhhheeeccCcc------------ccCcCcccccCCCCCCcchhhhhcC
Confidence 999877543221110 00000 0001111111111 2347789999999999999999854
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=2e-13 Score=130.51 Aligned_cols=140 Identities=19% Similarity=0.208 Sum_probs=98.2
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccH----------------------------------------HHHH
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGE----------------------------------------DEFK 129 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 129 (395)
.+-||+|++|.||+|++.+|+.||||+..+...... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 357999999999999999999999999864321100 0234
Q ss_pred HHHHHHhcc----CCCcceeEEEEEe--cCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHH-HHHH
Q 016117 130 MEVELLGRL----RSPYLLALLGYCS--DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK-GLEF 202 (395)
Q Consensus 130 ~e~~~l~~l----~h~niv~l~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~-~l~~ 202 (395)
.|...+.++ +|.+-+.+-.++. ....+++|||+++++|.+...... ...+ ...++.+++. .+..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~------~~~~---~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE------AGLD---RKALAENLARSFLNQ 272 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh------cCCC---HHHHHHHHHHHHHHH
Confidence 455555544 2333344433332 336789999999999988763211 1122 3445555555 4678
Q ss_pred HhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 203 LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+|.. +++|+|++|.||+++.++.++++|||++....
T Consensus 273 l~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8888 99999999999999999999999999987544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.7e-14 Score=131.01 Aligned_cols=248 Identities=21% Similarity=0.219 Sum_probs=172.3
Q ss_pred CCCCCCeeec--cCCeEEEEEEE--c-CCcEEEEEEecc--CCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecCceEE
Q 016117 86 GFSKSNVVGH--GGFGLVYRGVL--S-NGRKVAIKLMDQ--AGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRRKLL 157 (395)
Q Consensus 86 ~~~~~~~lg~--G~~g~V~~~~~--~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~l 157 (395)
.|.+.+.+|. |.+|.+|.+.. . ++..+|+|.-.. ........=.+|+...+.+ .|+|.++....+..+...+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566788999 99999999986 3 578889987332 1112222223466666666 5899999777776665554
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCceeCCCCCCCEEeCCC-CcEEEe
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK----GLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVS 232 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~ 232 (395)
+.....+.+|.++.+... .-++....+....+..+ |+.++|+. .++|-|+||.||+...+ ..++++
T Consensus 195 iqtE~~~~sl~~~~~~~~------~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 195 IQTELCGESLQSYCHTPC------NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred eeeccccchhHHhhhccc------ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence 444445688888886433 33666777777777777 99999998 99999999999999999 889999
Q ss_pred ccccccccCCCCCC---ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhc
Q 016117 233 DFGLAKIGSDKAGG---HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 309 (395)
Q Consensus 233 Dfg~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~ 309 (395)
|||+........-. ....+..|...|++||.+. .-++..+|+|++|.++.+-.+|..++....- ..|.
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~-- 336 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWS-- 336 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------CCcc--
Confidence 99998866544311 1122335778899999654 5678899999999999999998776543210 1111
Q ss_pred ccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 310 RLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 310 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
++. ..+ +..++.......+...+..+++.+|-.|++...+..
T Consensus 337 ~~r------~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 QLR------QGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc------ccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111 111 111222223345666999999999999999988874
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.8e-13 Score=110.56 Aligned_cols=131 Identities=18% Similarity=0.106 Sum_probs=96.2
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccCCChhhh
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANGGLQEH 170 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g~L~~~ 170 (395)
+.|+.|.++.||++.. .+..+++|+...... ....+..|+.+++.+.+.++++-+-.+.....++||||+++.++.+.
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTE 81 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCccccc
Confidence 4688999999999987 478899998764322 22346779999999876555543333334456899999999877543
Q ss_pred cccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 171 LYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC--SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 171 l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
. ......+.+++.+|+.||... ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 82 ~---------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 82 D---------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c---------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 1 011235678999999999882 11259999999999998 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.2e-12 Score=122.08 Aligned_cols=166 Identities=19% Similarity=0.271 Sum_probs=122.3
Q ss_pred EcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCChhhhcccCCCCCCCCCCC
Q 016117 106 LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKL 184 (395)
Q Consensus 106 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l 184 (395)
..++.+|.|...............+-++.|+.++||||++++...... ..|+|+|-+. .|..++. .+
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk----------~l 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK----------EL 101 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH----------Hh
Confidence 447888888887765554455677889999999999999999876654 6789999875 3556662 23
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhh
Q 016117 185 DWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264 (395)
Q Consensus 185 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~ 264 (395)
.......-+.||+.||.|||+.+ +++|++|..+.|+|++.|.-||++|.++........ .......-..|..|+.+
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEI 177 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhc
Confidence 35566677899999999999765 899999999999999999999999998754332221 11112222346667644
Q ss_pred ccCCCCccchhHHHHHHHHHHHhCC
Q 016117 265 LTGHLTTKSDVYSYGVVLLELLTGR 289 (395)
Q Consensus 265 ~~~~~~~~~DvwslG~~l~ell~g~ 289 (395)
.... ...|.|.|||+++|++.|.
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCcc
Confidence 3222 4569999999999999993
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=4e-11 Score=101.00 Aligned_cols=138 Identities=14% Similarity=0.160 Sum_probs=98.1
Q ss_pred CeeeccCCeEEEEEEEcC-------CcEEEEEEeccCC----------------------cccHHHHH----HHHHHHhc
Q 016117 91 NVVGHGGFGLVYRGVLSN-------GRKVAIKLMDQAG----------------------KQGEDEFK----MEVELLGR 137 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~e~~~l~~ 137 (395)
..||.|--+.||.|...+ +..+|+|+.+... ......+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 4789999863210 01122233 79999999
Q ss_pred cCC--CcceeEEEEEecCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceeC
Q 016117 138 LRS--PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL-HEHCSPPVIHR 214 (395)
Q Consensus 138 l~h--~niv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~ 214 (395)
+.. -++..++++ .+.++||||+.+..+..... ....++......+..+++.+|..| |.. +++||
T Consensus 83 l~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~L-------kd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKL-------KDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhh-------hccccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 854 455666654 56789999997754422111 011244456677889999999999 777 99999
Q ss_pred CCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 215 DFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 215 dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
||++.||+++ ++.+.|+|||.+....+
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999999996 46899999998875443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.7e-12 Score=122.56 Aligned_cols=146 Identities=15% Similarity=0.124 Sum_probs=94.6
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcC-CcEEEEEEeccCCcc----------------------------------cHH--
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQ----------------------------------GED-- 126 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~-- 126 (395)
...|.. +-||+|++|.||+|++.+ |+.||||+..+.... ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 689999999999999877 999999998643110 001
Q ss_pred ----HHHHHHHHHhcc----CCCcceeEEEEEec--CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHH
Q 016117 127 ----EFKMEVELLGRL----RSPYLLALLGYCSD--RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 196 (395)
Q Consensus 127 ----~~~~e~~~l~~l----~h~niv~l~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i 196 (395)
+|..|+..+.++ .+.+.+.+-.++.+ ...+++|||+.|+.+.+.-.-.. .......+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~-~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA-AGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 133344444444 24444554444433 46789999999999977421110 00001123333334444444
Q ss_pred HHHHHHHhcCCCCCceeCCCCCCCEEeCCCC----cEEEeccccccccC
Q 016117 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNF----HAKVSDFGLAKIGS 241 (395)
Q Consensus 197 ~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~Dfg~~~~~~ 241 (395)
. .. +++|+|++|.||+++.++ .+++.|||+.....
T Consensus 277 f-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 F-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3 34 999999999999999888 99999999987544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.4e-11 Score=110.48 Aligned_cols=220 Identities=15% Similarity=0.156 Sum_probs=154.3
Q ss_pred CCeEEEEEE-EcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEe-----cCceEEEEEcccC-CChhh
Q 016117 97 GFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS-----DRRKLLVYDYMAN-GGLQE 169 (395)
Q Consensus 97 ~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-----~~~~~lv~e~~~~-g~L~~ 169 (395)
.-.+.|++. ..+|..|++|++.....+.......-++.++++.|.|+|++..++. +...++||+|+++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 446789998 4589999999995433333333445678999999999999998765 2356799999986 57777
Q ss_pred hcccCCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 170 HLYPANGS--------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 170 ~l~~~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+-+..... .......++..+|.++.|+..||.++|+. |+..+-|.+.+||++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 65433221 12345678899999999999999999999 99999999999999999999999998877654
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
.... +| +. .-.+-|.-.||.++..|.||...-...+.. .+.
T Consensus 445 ~d~~--------------~~--le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~-------------------~~s- 485 (655)
T KOG3741|consen 445 EDPT--------------EP--LE---SQQQNDLRDLGLLLLALATGTENSNRTDST-------------------QSS- 485 (655)
T ss_pred CCCC--------------cc--hh---HHhhhhHHHHHHHHHHHhhcccccccccch-------------------HHH-
Confidence 4320 11 11 123679999999999999997542111000 000
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
-........+.++++++......++++ -+..+++.++
T Consensus 486 ---~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 486 ---HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred ---HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 001122334556778888888888876 6777776543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.8e-10 Score=100.63 Aligned_cols=141 Identities=22% Similarity=0.316 Sum_probs=107.7
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCC--CcceeEEEEEecC----ceEEEEEccc
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRS--PYLLALLGYCSDR----RKLLVYDYMA 163 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~----~~~lv~e~~~ 163 (395)
+.|+.|..+.+|++...+|+.+++|....... .....+..|.++++.+.+ .++.+++.+.... ..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999986678999998764322 134567889999999976 3456777776553 4579999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC------------------------------------ 207 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 207 (395)
+.++.+.+.. ..++......++.+++.+|..||+..
T Consensus 84 G~~l~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 84 GRVLRDRLLR--------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred CEecCCCCCC--------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 9888776521 24666777778888888888888431
Q ss_pred -----------------CCCceeCCCCCCCEEeCC--CCcEEEeccccccc
Q 016117 208 -----------------SPPVIHRDFKSSNILLDK--NFHAKVSDFGLAKI 239 (395)
Q Consensus 208 -----------------~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~ 239 (395)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 135799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=4.5e-10 Score=91.54 Aligned_cols=130 Identities=22% Similarity=0.335 Sum_probs=94.6
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCC---cc-----cHHHHHHHHHHHhccCCCcceeEEEE-EecCceEEEEEc
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG---KQ-----GEDEFKMEVELLGRLRSPYLLALLGY-CSDRRKLLVYDY 161 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~-----~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~~lv~e~ 161 (395)
..+++|+-+.+|.+.+ -|.++++|.-.+.. +. ....-.+|+.++..++--.|....=+ +...+..++|||
T Consensus 2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578999999999976 44557777432211 11 11344579999998865544333333 344467899999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
.++..|.+.+... ...++..+-.-+.-||.. +|+|+||.++|+++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~--------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999998422 245777788888899999 999999999999997664 99999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.2e-11 Score=115.22 Aligned_cols=247 Identities=19% Similarity=0.201 Sum_probs=169.3
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEE--cCCcEEEEEEeccCCcccHHHH--HHHHHHHhcc-CCCcceeEE-EEEecCce
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVL--SNGRKVAIKLMDQAGKQGEDEF--KMEVELLGRL-RSPYLLALL-GYCSDRRK 155 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~--~~e~~~l~~l-~h~niv~l~-~~~~~~~~ 155 (395)
....+|..+..||.|.|+.|+.... .++..|++|.+.+.......+. ..|+.+...+ .|.+++... +|....+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 3456788889999999999998774 3678899997765433322222 3455555555 466766654 46666677
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC-CcEEEecc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDF 234 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Df 234 (395)
++=-||+.++++...+. ....++...++++..|++.++.++|+. .++|+|++|+||++..+ +..+++||
T Consensus 342 ~ip~e~~~~~s~~l~~~-------~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~ 411 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV-------TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDF 411 (524)
T ss_pred cCchhhhcCcchhhhhH-------HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccc
Confidence 78889999998777661 234677888999999999999999988 99999999999999876 88899999
Q ss_pred ccccccCCCCCCceeeccccccccc--cchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYV--APEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
|+++....... .....-++. +|+......+-.++|++|||..+.+.++|..--.....
T Consensus 412 ~~~t~~~~~~~-----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------------- 471 (524)
T KOG0601|consen 412 GCWTRLAFSSG-----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------------- 471 (524)
T ss_pred ccccccceecc-----cccccccccccchhhccccccccccccccccccccccccCcccCccccc---------------
Confidence 99874221111 111222334 45545566788899999999999999988754321110
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
...+...... ..+. ...++..+...++..++..||.+.++..+.+.
T Consensus 472 ----~~~i~~~~~p-~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 472 ----SLTIRSGDTP-NLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ----ceeeeccccc-CCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 1111111010 1111 11456668888999999999999988765443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=9.6e-09 Score=93.59 Aligned_cols=268 Identities=18% Similarity=0.214 Sum_probs=157.7
Q ss_pred CCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEE------ecCc--eEEE
Q 016117 88 SKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYC------SDRR--KLLV 158 (395)
Q Consensus 88 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~------~~~~--~~lv 158 (395)
...+-||+|+-+.+|-.--- ...+.|++.........+ .+..|... .||-+-.-+.|- .++. .-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34677999999999874321 123557765433322222 23333333 555433312221 1122 2267
Q ss_pred EEcccCC-ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 159 YDYMANG-GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 159 ~e~~~~g-~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
|..+.+. ....++.... ..+.....+|...++.+..++.+.+-||.. |.+-||+.++|+||++++.+.|.|-.--
T Consensus 89 mP~v~g~~pI~~~y~p~t-RRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 89 MPKVSGKEPIHMIYSPAT-RRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred cccCCCccchhhhcCchh-hcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 7766553 2233332111 112345688999999999999999999999 9999999999999999999999885433
Q ss_pred cccCCCCCCceeeccccccccccchhhc-----cCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCCc---hhhhhhh
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTG-RVPIDVNKPSGEG---VLVSWAL 308 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g-~~pf~~~~~~~~~---~~~~~~~ 308 (395)
.... ........+|...|++||.-. +-.-+...|-|.||+++++++.| ++||..-...... ...+...
T Consensus 165 qi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 165 QINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred eecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 3221 122333466888999999754 23446788999999999998886 9999742211110 0001111
Q ss_pred cccccchhhhhhccccccCCCCHH-HHHHHHHHHhhcCCC--CCCCCCCHHHHHHHHHHhhhh
Q 016117 309 PRLTDREKILEIMDPALEGQYSMK-EVIQVAAIAAMCVQP--EADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~~~~~~~~~-~~~~l~~li~~cl~~--~p~~RPt~~~vl~~L~~~~~~ 368 (395)
..+....+...-+.+.. ...+.+ .+..+-.+..+|+.. ++.-|||++..+..|..+...
T Consensus 242 g~f~ya~~~~~g~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 242 GRFAYASDQRRGLKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred ceeeechhccCCCCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 11111111111111111 122222 123455566777765 367899999999888776653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-09 Score=88.56 Aligned_cols=142 Identities=21% Similarity=0.282 Sum_probs=100.1
Q ss_pred CCCeeeccCCeEEEEEEEcCCcEEEEEEec-cCCc-------ccHHHHHHHHHHHhccCCCcceeE-EEEEecCceEEEE
Q 016117 89 KSNVVGHGGFGLVYRGVLSNGRKVAIKLMD-QAGK-------QGEDEFKMEVELLGRLRSPYLLAL-LGYCSDRRKLLVY 159 (395)
Q Consensus 89 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~-~~~~-------~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~lv~ 159 (395)
...+|-+|+-+.|+++.+ .|+..+||.-. +.-. -......+|++.|.++.--.|.-. +-++......++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456899999999999998 67887777432 2111 112355679999988764444333 3344445778999
Q ss_pred EcccC-CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC---cEEEeccc
Q 016117 160 DYMAN-GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF---HAKVSDFG 235 (395)
Q Consensus 160 e~~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg 235 (395)
||.++ .++.+++..... ..........++..+-+.+.-||.+ +++||||..+||++..++ .+.++|||
T Consensus 90 E~~~g~~~vk~~i~~~~~-----~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfg 161 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME-----DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFG 161 (229)
T ss_pred EeccchhHHHHHHHHHcc-----CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeec
Confidence 99977 477888754431 1222223367888999999999999 999999999999996543 45899999
Q ss_pred cccc
Q 016117 236 LAKI 239 (395)
Q Consensus 236 ~~~~ 239 (395)
++..
T Consensus 162 ls~~ 165 (229)
T KOG3087|consen 162 LSSV 165 (229)
T ss_pred chhc
Confidence 9864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.8e-11 Score=119.77 Aligned_cols=249 Identities=23% Similarity=0.281 Sum_probs=162.3
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEec-CceE
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-RRKL 156 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 156 (395)
+..+.+.+.+-+-+|.++.++.+.-. .|...++|+.... .....+....+-.++-...+|-++....-+.. ....
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34456677777889999999887732 3433444433221 11111222222222222334444433322222 3566
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
++++|..+++|...|+... ..+..-.+..+..+..++.|||.. .+.|+|++|.|.+...++..+++|||.
T Consensus 881 L~~~~~~~~~~~Skl~~~~-------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG-------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGT 950 (1205)
T ss_pred hhhHHhccCCchhhhhcCC-------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccc
Confidence 9999999999999986543 344444555666788899999987 799999999999999999999999984
Q ss_pred ccccC------CC-------------------C----CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh
Q 016117 237 AKIGS------DK-------------------A----GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287 (395)
Q Consensus 237 ~~~~~------~~-------------------~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~ 287 (395)
..... .. . .........+|+.|.+||.+.+......+|.|+.|++++|.++
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence 32110 00 0 0011233568999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccC-CCCHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 016117 288 GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG-QYSMKEVIQVAAIAAMCVQPEADYRPLMA 356 (395)
Q Consensus 288 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 356 (395)
|.+||....++.. ...+....+.. ..+........+++...+..+|.+|-.+.
T Consensus 1031 g~pp~na~tpq~~----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQI----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCCCcchhhh----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999987655421 11222211111 22233445677788888899999998887
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.6e-09 Score=89.68 Aligned_cols=126 Identities=25% Similarity=0.318 Sum_probs=81.5
Q ss_pred EEEEEEEcCCcEEEEEEeccCC--------------c--------c----cHHHHHHHHHHHhccCCC--cceeEEEEEe
Q 016117 100 LVYRGVLSNGRKVAIKLMDQAG--------------K--------Q----GEDEFKMEVELLGRLRSP--YLLALLGYCS 151 (395)
Q Consensus 100 ~V~~~~~~~~~~vavK~~~~~~--------------~--------~----~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 151 (395)
.||.|...+|..+|+|+..... . . ......+|.+.|..+... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899998899999999863210 0 0 013456799999999765 45566544
Q ss_pred cCceEEEEEccc--CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCceeCCCCCCCEEeCCCCc
Q 016117 152 DRRKLLVYDYMA--NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF-LHEHCSPPVIHRDFKSSNILLDKNFH 228 (395)
Q Consensus 152 ~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~dlk~~Nill~~~~~ 228 (395)
.+.++||||+. +..+..+.. ..++......++.+++..+.. +|.. +++||||.+.||+++++ .
T Consensus 79 -~~~~ivME~I~~~G~~~~~l~~---------~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 79 -NRNVIVMEYIGEDGVPLPRLKD---------VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp -ETTEEEEE--EETTEEGGCHHH---------CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-C
T ss_pred -eCCEEEEEecCCCccchhhHHh---------ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-e
Confidence 25589999998 544444331 111133456677778775665 4677 99999999999999887 9
Q ss_pred EEEeccccccccC
Q 016117 229 AKVSDFGLAKIGS 241 (395)
Q Consensus 229 ~kl~Dfg~~~~~~ 241 (395)
+.|+|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.9e-08 Score=89.71 Aligned_cols=139 Identities=17% Similarity=0.105 Sum_probs=98.7
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCc-----------ccHHHHHHHHHHHhccCCCc--ceeEEEEEec-----
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK-----------QGEDEFKMEVELLGRLRSPY--LLALLGYCSD----- 152 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~----- 152 (395)
+.+-......|++..+ +|+.+.||....... .....+.+|...+..+...+ ...++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555555777666 778899997643221 11123678888888874333 3444555432
Q ss_pred -CceEEEEEcccCC-ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-----
Q 016117 153 -RRKLLVYDYMANG-GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK----- 225 (395)
Q Consensus 153 -~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~----- 225 (395)
...++|+|++++. +|.+++.... ....+......++.+++..+.-||.. +++|+|+++.|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-----~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-----TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence 2467999999886 7888873211 12345667788999999999999999 9999999999999975
Q ss_pred --CCcEEEecccccc
Q 016117 226 --NFHAKVSDFGLAK 238 (395)
Q Consensus 226 --~~~~kl~Dfg~~~ 238 (395)
+..+.++||+.+.
T Consensus 179 ~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 179 EEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCceEEEEECCccc
Confidence 5789999999875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.5e-08 Score=87.67 Aligned_cols=148 Identities=22% Similarity=0.191 Sum_probs=100.0
Q ss_pred cHHHHHHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC------------------c----ccHHHHHHHHH
Q 016117 76 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG------------------K----QGEDEFKMEVE 133 (395)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~----~~~~~~~~e~~ 133 (395)
.+..+.....-..+.+.||-|--+.||.|..++|.++|+|.-+... . .......+|.+
T Consensus 82 AL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~ 161 (304)
T COG0478 82 ALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFE 161 (304)
T ss_pred HHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHH
Confidence 3333333333355678999999999999999999999999532110 0 01134567899
Q ss_pred HHhccCCC--cceeEEEEEecCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 016117 134 LLGRLRSP--YLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 211 (395)
Q Consensus 134 ~l~~l~h~--niv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 211 (395)
.|..|... .+.+.+++ +...+|||+.++-.|...- ++......++..|+.-+.-+-.. |+
T Consensus 162 ~L~~L~~~G~~VP~P~~~---nRHaVvMe~ieG~eL~~~r------------~~~en~~~il~~il~~~~~~~~~---Gi 223 (304)
T COG0478 162 ALQRLYPEGVKVPKPIAW---NRHAVVMEYIEGVELYRLR------------LDVENPDEILDKILEEVRKAYRR---GI 223 (304)
T ss_pred HHHHhhhcCCCCCCcccc---ccceeeeehcccceeeccc------------CcccCHHHHHHHHHHHHHHHHHc---Cc
Confidence 99988654 55555433 4678999999885544332 12333334444455544444455 89
Q ss_pred eeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 212 IHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 212 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+|+|+++-||+++++|.+.++||-.+....
T Consensus 224 VHGDlSefNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 224 VHGDLSEFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred cccCCchheEEEecCCCEEEEeCcccccCC
Confidence 999999999999999999999997765433
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.3e-09 Score=105.03 Aligned_cols=150 Identities=21% Similarity=0.255 Sum_probs=102.4
Q ss_pred HHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCC-------ceeeccccccccccchhhcc
Q 016117 194 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG-------HVSTRVLGTQGYVAPEYALT 266 (395)
Q Consensus 194 ~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~ 266 (395)
.+++.|+.|+|... +++|++|.|++|.++.++..||+.|+.+......... ....-..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 34558999999764 8999999999999999999999999987543321110 01111223456999999999
Q ss_pred CCCCccchhHHHHHHHHHHHhCCCC-CCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcC
Q 016117 267 GHLTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCV 345 (395)
Q Consensus 267 ~~~~~~~DvwslG~~l~ell~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl 345 (395)
...+.++|+||+|+++|.+..|..+ +.......... .....+..-...++.+.+.++.+=+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--------------FSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhh--------------hhhcccccccccccccCcHHHHHHHHHHh
Confidence 8889999999999999999954444 43222111100 00111111112333455667888889999
Q ss_pred CCCCCCCCCHHHHH
Q 016117 346 QPEADYRPLMADVV 359 (395)
Q Consensus 346 ~~~p~~RPt~~~vl 359 (395)
..++.-||++..+.
T Consensus 250 ~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLL 263 (700)
T ss_pred cCCcccCcchhhhh
Confidence 99999999877765
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.3e-07 Score=76.36 Aligned_cols=139 Identities=19% Similarity=0.154 Sum_probs=101.6
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccC------CcccHHHHHHHHHHHhccCCC--cceeEEEEEe---cC---ce
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQA------GKQGEDEFKMEVELLGRLRSP--YLLALLGYCS---DR---RK 155 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~---~~---~~ 155 (395)
.-.-|.||-+-|++-.. +|..+-+|.-... -+.....|.+|...+.++..- .+.+++ ++. .. ..
T Consensus 23 ~pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA 100 (216)
T PRK09902 23 EPNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRA 100 (216)
T ss_pred CCCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEE
Confidence 33456789999999776 4557888876521 133567899999999998542 244444 332 11 35
Q ss_pred EEEEEcccC-CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc--EEEe
Q 016117 156 LLVYDYMAN-GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH--AKVS 232 (395)
Q Consensus 156 ~lv~e~~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--~kl~ 232 (395)
++|+|.+.+ -+|.+++.... ..+.+......++.+++..++-||+. ++.|+|+.+.||+++.++. ++++
T Consensus 101 ~LVTe~L~g~~~L~~~l~~~~-----~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lI 172 (216)
T PRK09902 101 LLVTEDMAGFISIADWYAQHA-----VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFL 172 (216)
T ss_pred EEEEEeCCCCccHHHHHhcCC-----cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEE
Confidence 699997764 57888873221 23567777889999999999999999 9999999999999986666 9999
Q ss_pred cccccc
Q 016117 233 DFGLAK 238 (395)
Q Consensus 233 Dfg~~~ 238 (395)
||.-++
T Consensus 173 DlEk~r 178 (216)
T PRK09902 173 DLEKSR 178 (216)
T ss_pred Ehhccc
Confidence 998665
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.2e-07 Score=79.07 Aligned_cols=104 Identities=25% Similarity=0.291 Sum_probs=80.1
Q ss_pred HHHHHHHHHHhccCC--CcceeEEEEEecC-----ceEEEEEcccCC-ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHH
Q 016117 126 DEFKMEVELLGRLRS--PYLLALLGYCSDR-----RKLLVYDYMANG-GLQEHLYPANGSNSVASKLDWETRLRIALEAA 197 (395)
Q Consensus 126 ~~~~~e~~~l~~l~h--~niv~l~~~~~~~-----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~ 197 (395)
....+|...+..+.. -.....+++.... ..++|+|++++. +|.+++.... ..+......++.+++
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-------~~~~~~~~~ll~~l~ 128 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-------QLDPSQRRELLRALA 128 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-------ccchhhHHHHHHHHH
Confidence 456778888777743 2345556655442 346999999874 7888884321 255667788999999
Q ss_pred HHHHHHhcCCCCCceeCCCCCCCEEeCCCC---cEEEeccccccc
Q 016117 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNF---HAKVSDFGLAKI 239 (395)
Q Consensus 198 ~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~ 239 (395)
..++-||.. +++|+|+++.|||++.+. .+.++||+-+..
T Consensus 129 ~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 129 RLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999 999999999999998887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3e-07 Score=88.88 Aligned_cols=140 Identities=16% Similarity=0.212 Sum_probs=92.5
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCccc------------------------------HH----------HHHH
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG------------------------------ED----------EFKM 130 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~ 130 (395)
+-|+.++-|.||+|++++|+.||||+..+.-... .+ ++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5689999999999999999999999874321100 01 1333
Q ss_pred HHHHHhcc----CCCcceeEEEEEe--cCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 016117 131 EVELLGRL----RSPYLLALLGYCS--DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204 (395)
Q Consensus 131 e~~~l~~l----~h~niv~l~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 204 (395)
|..-+.++ ++..-+.+=.++. .+..+++|||++|-.+.+...... ..++...+.....++.--.-+-|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~------~g~d~k~ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS------AGIDRKELAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh------cCCCHHHHHHHHHHHHHHHHHhc
Confidence 44444443 2233334444443 357899999999998888852221 23554444333333322222333
Q ss_pred cCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 205 ~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++|.|..|-||+++.++++.+.|||+.....
T Consensus 285 -----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 -----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred -----CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 89999999999999999999999999987544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.3e-06 Score=76.21 Aligned_cols=140 Identities=17% Similarity=0.190 Sum_probs=82.5
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCc--ceeEEEEEecCc-eEEEEEcccCCC-
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY--LLALLGYCSDRR-KLLVYDYMANGG- 166 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~-~~lv~e~~~~g~- 166 (395)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+.+..+.. ..++|++++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 46899999999983 35568889876532 3345688999999986443 466677766554 458999998863
Q ss_pred hhhhc---------------------ccCCCCCCCCCCCCH--HHHHHHHH-------HHHH-HHHHHhcC-CCCCceeC
Q 016117 167 LQEHL---------------------YPANGSNSVASKLDW--ETRLRIAL-------EAAK-GLEFLHEH-CSPPVIHR 214 (395)
Q Consensus 167 L~~~l---------------------~~~~~~~~~~~~l~~--~~~~~i~~-------~i~~-~l~~LH~~-~~~~i~H~ 214 (395)
+...+ |.... ....++. ......+. .+.. ...+|... ..+.++|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~---~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC---DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC---CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 21111 11100 0011110 00000000 0000 11222211 13367899
Q ss_pred CCCCCCEEeCCCCcEEEeccccccc
Q 016117 215 DFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 215 dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
|+.|.||++++++ +.++||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.4e-06 Score=73.51 Aligned_cols=154 Identities=18% Similarity=0.224 Sum_probs=101.1
Q ss_pred ecHHHHHHHhCCCCCCCe---eeccCCeEEEEEEEcCCcEEEEEEeccCCcc-------------------cH-----HH
Q 016117 75 FTFKQLHSATGGFSKSNV---VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ-------------------GE-----DE 127 (395)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~---lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------------~~-----~~ 127 (395)
.+.+.+.....+..+... |++|--+.||+|...++..+|+|++...... .. ..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 455566666666666555 4567778899999888999999987532111 11 12
Q ss_pred HHHHHHHHhccC--CCcceeEEEEEecCceEEEEEcccCCCh-hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 016117 128 FKMEVELLGRLR--SPYLLALLGYCSDRRKLLVYDYMANGGL-QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204 (395)
Q Consensus 128 ~~~e~~~l~~l~--h~niv~l~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 204 (395)
...|+.-|+++. +-.+.+.+++. +..++|||+..... .-.| ....+...+...+..++++.+.-|-
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~---~nVLvMEfIg~~g~pAP~L--------kDv~~e~~e~~~~~~~~v~~~~~l~ 183 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR---NNVLVMEFIGDDGLPAPRL--------KDVPLELEEAEGLYEDVVEYMRRLY 183 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec---CCeEEEEeccCCCCCCCCc--------ccCCcCchhHHHHHHHHHHHHHHHH
Confidence 345777777763 33334444433 34799999865421 1111 1122333356677788888888777
Q ss_pred cCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 205 ~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
... +++|+||+.-|||+. ++.+.|+|||.+....+
T Consensus 184 ~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 184 KEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred Hhc--CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 632 899999999999999 88999999998875443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.3e-06 Score=72.79 Aligned_cols=136 Identities=17% Similarity=0.200 Sum_probs=89.7
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHH---------HHHHHHhccC---CCcceeEEEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFK---------MEVELLGRLR---SPYLLALLGYC 150 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~---------~e~~~l~~l~---h~niv~l~~~~ 150 (395)
..++|...+++-.....-|.+-.. +|..+++|..........+.|. +.+..+..++ -.....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 446788888888877777766666 7789999987654433333322 2333333332 22233322222
Q ss_pred e------cCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC
Q 016117 151 S------DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224 (395)
Q Consensus 151 ~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 224 (395)
. ....+++|||++|..|.+.. .++. .+...+.+++.-||+. |+.|+|..|.|++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-----------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE-----------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVS 169 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch-----------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEE
Confidence 1 12345899999998887764 1222 2445677889999999 999999999999998
Q ss_pred CCCcEEEecccccc
Q 016117 225 KNFHAKVSDFGLAK 238 (395)
Q Consensus 225 ~~~~~kl~Dfg~~~ 238 (395)
.+ .++++||+..+
T Consensus 170 ~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 170 NN-GIRIIDTQGKR 182 (229)
T ss_pred CC-cEEEEECcccc
Confidence 65 49999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=8e-08 Score=92.02 Aligned_cols=244 Identities=14% Similarity=0.101 Sum_probs=155.3
Q ss_pred CCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCc-ceeEEEEEecC-ceEEEEEccc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY-LLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~-~~~lv~e~~~ 163 (395)
-+...+.+++|+++.+++.+....+....+.+... .....++++|.+.+||| .+..++-+..+ ..++.++++.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 34445668899999999988544444556655432 35566899999999999 44444433333 3458899988
Q ss_pred CC-ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 164 NG-GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 164 ~g-~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.+ +..... +.....+...+...+...-.++++++|+. .-+|+| ||+..+ +..+..||+....+..
T Consensus 318 ~~rs~~~~~------~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 318 TGRSSALEM------TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred CCccccccC------ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCc
Confidence 77 222222 11122344455666777788999999976 568888 777765 6889999998876554
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.. ......+++.|+|||+.....+....|+|++|.-..++.-|.+|-....... . ..........+.+
T Consensus 384 ~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~--~-------~~g~~p~s~~L~~ 451 (829)
T KOG0576|consen 384 TM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVL--P-------MIGNGPNSPMLTD 451 (829)
T ss_pred cc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcccc--C-------CCCCCCCccccch
Confidence 32 2334668999999999999999999999999988778888877754311100 0 0000000001111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
... ... ..-.++...|+...|..|+..-+.+ +.++++.
T Consensus 452 ~~a-w~~-----~~~~~~~~~~~~g~P~~pkv~mgac--fsKvfng 489 (829)
T KOG0576|consen 452 KSA-WSP-----VFHRDFPAPCLNGLPPTPKVHMGAC--FSKVFNG 489 (829)
T ss_pred hhh-cCc-----ccccCCcccccCCCCCCCcchhhHH--HHHHhcc
Confidence 000 000 0011366788999999999888777 4566654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.1e-05 Score=70.72 Aligned_cols=142 Identities=20% Similarity=0.219 Sum_probs=82.7
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC--cceeEEEEEecC----ceEEEEEcccC
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP--YLLALLGYCSDR----RKLLVYDYMAN 164 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~----~~~lv~e~~~~ 164 (395)
+.|+.|..+.||+....+ +.+++|..... .....+..|..+++.+... .+..++.++... ..+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999866 69999987643 3456778899999888533 345666644332 24699999999
Q ss_pred CChhh----------------h---cccCCCCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHH
Q 016117 165 GGLQE----------------H---LYPANGSNSVASKLDWET---------RLRI------------ALEAAK-GLEFL 203 (395)
Q Consensus 165 g~L~~----------------~---l~~~~~~~~~~~~l~~~~---------~~~i------------~~~i~~-~l~~L 203 (395)
..+.. . ++.... ....+.... .... ...+.. .+..+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPP---PFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHT---TCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccc---cccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 87777 1 111110 001111100 0000 011122 23333
Q ss_pred hcC----CCCCceeCCCCCCCEEeC-CCCcEEEecccccc
Q 016117 204 HEH----CSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAK 238 (395)
Q Consensus 204 H~~----~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~ 238 (395)
++. ....++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 321 234799999999999999 66667899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.28 E-value=5e-06 Score=70.16 Aligned_cols=103 Identities=26% Similarity=0.281 Sum_probs=82.0
Q ss_pred HHHHHHhccCC-CcceeEEEEEecCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 016117 130 MEVELLGRLRS-PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208 (395)
Q Consensus 130 ~e~~~l~~l~h-~niv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 208 (395)
.|.-+++.+++ +++.+++|.|. .+++.||...+++...-.. -.....-+|..+.+|+.++++.+.+|+....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG---~~~v~E~~~~~~~~~~~~~----l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG---RFYVVEYVGAGSLYGIYRP----LSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC---CEEEEEeecCccccccccc----cccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 47888888876 69999999994 4789999988766432100 0011257899999999999999999998655
Q ss_pred CCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 209 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
..+.-.|++++|+-+++++++|++|...+..
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 5688899999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.2e-05 Score=81.75 Aligned_cols=78 Identities=15% Similarity=0.284 Sum_probs=56.9
Q ss_pred CCeeeccCCeEEEEEEEcCC---cEEEEEEeccCC-cccHHHHHHHHHHHhccC-CCcc--eeEEEEEecC----ceEEE
Q 016117 90 SNVVGHGGFGLVYRGVLSNG---RKVAIKLMDQAG-KQGEDEFKMEVELLGRLR-SPYL--LALLGYCSDR----RKLLV 158 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~----~~~lv 158 (395)
.+.++.|.++.+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. ..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46788999999999876544 467888765432 123456888999999995 6654 7778887763 57899
Q ss_pred EEcccCCCh
Q 016117 159 YDYMANGGL 167 (395)
Q Consensus 159 ~e~~~~g~L 167 (395)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.8e-05 Score=68.97 Aligned_cols=140 Identities=21% Similarity=0.155 Sum_probs=82.7
Q ss_pred eeccCC-eEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCcceeEEEEEecC-ceEEEEEcccCCChhh
Q 016117 93 VGHGGF-GLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLVYDYMANGGLQE 169 (395)
Q Consensus 93 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~ 169 (395)
|..|.. ..||+.... +..+++|+..... ...+..|+++++.+. +--+.+++++.... ..++||++++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 778998764 4788999876542 335677999988884 33455666666544 5689999999877764
Q ss_pred hc-------------------ccCCCCCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHhc---
Q 016117 170 HL-------------------YPANGSNSVASKLDW--ETRLRIAL--------------------EAAKGLEFLHE--- 205 (395)
Q Consensus 170 ~l-------------------~~~~~~~~~~~~l~~--~~~~~i~~--------------------~i~~~l~~LH~--- 205 (395)
.. +.... ....+.. ........ .+...+..|-.
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 158 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPV---ADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP 158 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCc---ccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence 42 11110 0001110 00000000 01111222211
Q ss_pred -CCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 206 -HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 206 -~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
...+.++|+|+.|.||+++++..+.|+||+.+..
T Consensus 159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 1134699999999999999987788999987753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.4e-05 Score=77.18 Aligned_cols=142 Identities=18% Similarity=0.185 Sum_probs=92.7
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCccc-------------------------------HH------HHHHHHH
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG-------------------------------ED------EFKMEVE 133 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~e~~ 133 (395)
+-||..+.|.|++|++++|+.||||+-++.-+.. .+ +|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999864321110 01 1233333
Q ss_pred HHh----ccCCCc---ceeEEEEEe--cCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 016117 134 LLG----RLRSPY---LLALLGYCS--DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204 (395)
Q Consensus 134 ~l~----~l~h~n---iv~l~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 204 (395)
-.. .+.|-+ -|.+=.++. ....+++||||+|..+.+.-.-. ...++...+..-+.+...-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~------~~gi~~~~i~~~l~~~~~~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID------KRGISPHDILNKLVEAYLEQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH------HcCCCHHHHHHHHHHHHHHHHHhc
Confidence 222 234444 122333333 34778999999999887764322 234555555555555444444444
Q ss_pred cCCCCCceeCCCCCCCEEeCC----CCcEEEeccccccccCCC
Q 016117 205 EHCSPPVIHRDFKSSNILLDK----NFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 205 ~~~~~~i~H~dlk~~Nill~~----~~~~kl~Dfg~~~~~~~~ 243 (395)
|++|+|=.|-||+++. ++.+.+-|||+.......
T Consensus 321 -----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 -----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred -----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 8999999999999983 678999999998765443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.2e-05 Score=63.04 Aligned_cols=128 Identities=17% Similarity=0.238 Sum_probs=87.5
Q ss_pred CCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccCCChh
Q 016117 89 KSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANGGLQ 168 (395)
Q Consensus 89 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g~L~ 168 (395)
..+.|++|.+|.||++.+ .|..+|+|+-... .....+..|.++|..++-.++.+=+-++. ..++.|||..+-+|.
T Consensus 26 v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg--~~~i~me~i~G~~L~ 100 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW-RGGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG--EDFIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhcccccEEEEeec-cCceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec--hhhhhhhhhcCcchh
Confidence 356799999999999999 4568888876643 34567889999999988776655443332 224559999887877
Q ss_pred hhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCC-C-CCEEeCCCCcEEEeccccccc
Q 016117 169 EHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK-S-SNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 169 ~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk-~-~Nill~~~~~~kl~Dfg~~~~ 239 (395)
+.-.. .+ .+-...+++.---|... +|-|+.|. | .||++ .+..+.|+||.-|+.
T Consensus 101 ~~~~~----------~~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv-~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIG----------GD----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLV-NDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhc----------cc----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEe-cCCcEEEEEccchhh
Confidence 76521 12 22233444553344444 89999987 4 45555 444999999998874
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.9e-05 Score=68.58 Aligned_cols=139 Identities=13% Similarity=0.066 Sum_probs=79.4
Q ss_pred eeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcce-eEEEEEecCceEEEEEcccCCChhhh-
Q 016117 93 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLL-ALLGYCSDRRKLLVYDYMANGGLQEH- 170 (395)
Q Consensus 93 lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~lv~e~~~~g~L~~~- 170 (395)
+..|-.+.+|+... +++.+++|+.........-....|.++++.+....++ +++.+. ...+|++|+++..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~---~~~~v~e~i~G~~~~~~~ 79 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN---EHWLLVEWLEGEVITLDQ 79 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe---CCEEEEEeccCccccccc
Confidence 55677888998874 6778889976543222112356788999988654343 333332 24689999998665431
Q ss_pred ----------------cccCCCCCCCCCCCCHHH-HHHHHHHH---------HHHHHHHhcC-----CCCCceeCCCCCC
Q 016117 171 ----------------LYPANGSNSVASKLDWET-RLRIALEA---------AKGLEFLHEH-----CSPPVIHRDFKSS 219 (395)
Q Consensus 171 ----------------l~~~~~~~~~~~~l~~~~-~~~i~~~i---------~~~l~~LH~~-----~~~~i~H~dlk~~ 219 (395)
+|.... ....++... +.....++ ...+..+-.. ....++|+|+.|.
T Consensus 80 ~~~~~~~~~la~~l~~lH~~~~---~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 80 FVALDLLLELAALLHQLHSQPR---FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred ccCchhHHHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 122111 111222221 11111111 1112212111 1236899999999
Q ss_pred CEEeCCCCcEEEeccccccc
Q 016117 220 NILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 220 Nill~~~~~~kl~Dfg~~~~ 239 (395)
||++++++ +.++||+.+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00015 Score=61.54 Aligned_cols=127 Identities=18% Similarity=0.265 Sum_probs=86.5
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccCC----------------cccHHHHHHHHHHHhccC------CCcceeEE
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG----------------KQGEDEFKMEVELLGRLR------SPYLLALL 147 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~l~ 147 (395)
...||+|+.-.||. ++++....||+..... ....++..+|+.-+..+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999998886 4566678889887554 123456667777666665 78899999
Q ss_pred EEEecCc-eEEEEEcccC------CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCC
Q 016117 148 GYCSDRR-KLLVYDYMAN------GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSN 220 (395)
Q Consensus 148 ~~~~~~~-~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 220 (395)
|+..++. .-+|+|...+ -+|.+++.. ..++. .... .+-.-..||-++ .|+.+|++|.|
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--------~~~~~-~~~~---~L~~f~~~l~~~---~Iv~~dl~~~N 148 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE--------GGLTE-ELRQ---ALDEFKRYLLDH---HIVIRDLNPHN 148 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc--------CCccH-HHHH---HHHHHHHHHHHc---CCeecCCCccc
Confidence 9998874 4488887643 256677622 23444 3333 333445566666 89999999999
Q ss_pred EEeCCC---C-cEEEec
Q 016117 221 ILLDKN---F-HAKVSD 233 (395)
Q Consensus 221 ill~~~---~-~~kl~D 233 (395)
|++..+ . .+.|+|
T Consensus 149 Iv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 149 IVVQRRDSGEFRLVLID 165 (199)
T ss_pred EEEEecCCCceEEEEEe
Confidence 999432 2 566766
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.00 E-value=7.9e-05 Score=65.65 Aligned_cols=72 Identities=21% Similarity=0.262 Sum_probs=44.8
Q ss_pred CeeeccCCe-EEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC---cceeEEEEEecC----ceEEEEEcc
Q 016117 91 NVVGHGGFG-LVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP---YLLALLGYCSDR----RKLLVYDYM 162 (395)
Q Consensus 91 ~~lg~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~----~~~lv~e~~ 162 (395)
+.|+.|+.. .||+. +..+++|..... .....+..|.++++.+... .+..+++..... ..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457767665 48875 245777875432 2345788899999888532 233444433321 247899999
Q ss_pred cCCChh
Q 016117 163 ANGGLQ 168 (395)
Q Consensus 163 ~~g~L~ 168 (395)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00029 Score=64.29 Aligned_cols=75 Identities=9% Similarity=0.073 Sum_probs=55.5
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCC---CcceeEEEEEec----CceEEEEEcc
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS---PYLLALLGYCSD----RRKLLVYDYM 162 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~----~~~~lv~e~~ 162 (395)
.+-||.|..+.||+....++ .+++|..+. ......+..|.+.|+.+.. -.+.+++++|.. +..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 45799999999999986555 477777543 1133578889999998843 367788887753 3578999999
Q ss_pred cCCCh
Q 016117 163 ANGGL 167 (395)
Q Consensus 163 ~~g~L 167 (395)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.96 E-value=7.1e-05 Score=77.07 Aligned_cols=194 Identities=18% Similarity=0.200 Sum_probs=134.5
Q ss_pred HHHHHHHhccCCCcceeEEEEEecCc--e---EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 016117 129 KMEVELLGRLRSPYLLALLGYCSDRR--K---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203 (395)
Q Consensus 129 ~~e~~~l~~l~h~niv~l~~~~~~~~--~---~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L 203 (395)
..|++.+..+.|+|++.++.|..+.. . ....+++..-++...+. ....++..+.+.+..++..|+.|+
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-------~v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-------SVGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh-------hccccCHHHHHHHHHHHhhhHHHH
Confidence 34777888889999999998876542 1 14556777777777773 234688899999999999999999
Q ss_pred hcCCCCCceeCCCCCC---CEEeCCCCcEEEe--ccccccccCCCCCCceeeccccccccccchhhccCCCCc--cchhH
Q 016117 204 HEHCSPPVIHRDFKSS---NILLDKNFHAKVS--DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTT--KSDVY 276 (395)
Q Consensus 204 H~~~~~~i~H~dlk~~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~Dvw 276 (395)
|+. ...|.-+... +...+..+.+.++ ||+............ ....+..|.+||......++. ..|+|
T Consensus 303 h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 303 HSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred HHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHH
Confidence 988 5666655555 5555666777777 888776554433221 223455678888777666554 47999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 016117 277 SYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA 356 (395)
Q Consensus 277 slG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 356 (395)
++|.++..+..|..+-... .....+++.... . .+.+....|+..++++|++..
T Consensus 377 ~lgll~~~~~~~~~i~~~~-------------------~~~~~~l~~~~~-----~---~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKS-------------------AVPVSLLDVLST-----S---ELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHHHHHhhhhhcCcccccc-------------------cchhhhhccccc-----h---hhhhhhhhhcchhhhhccchh
Confidence 9999999999887653211 011111111111 1 467788999999999999999
Q ss_pred HHHHHH
Q 016117 357 DVVQSL 362 (395)
Q Consensus 357 ~vl~~L 362 (395)
+++.+.
T Consensus 430 ~ll~~~ 435 (1351)
T KOG1035|consen 430 ELLTHP 435 (1351)
T ss_pred hhhhch
Confidence 999763
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.0002 Score=63.09 Aligned_cols=74 Identities=12% Similarity=0.108 Sum_probs=48.3
Q ss_pred CeeeccCCeEEEEEEEcC--CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcce-eEEEEEecCceEEEEEcccCCCh
Q 016117 91 NVVGHGGFGLVYRGVLSN--GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLL-ALLGYCSDRRKLLVYDYMANGGL 167 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~lv~e~~~~g~L 167 (395)
+.|..|-...+|+....+ +..+++|+....... ......|+.+++.+...+++ ++++.+. ..+++||+++.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ---NGLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC---CcEEEEeeCCCcC
Confidence 457788889999998764 678999977543221 12334688888888544443 3333322 2479999988765
Q ss_pred h
Q 016117 168 Q 168 (395)
Q Consensus 168 ~ 168 (395)
.
T Consensus 80 ~ 80 (235)
T cd05157 80 E 80 (235)
T ss_pred C
Confidence 3
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00036 Score=65.77 Aligned_cols=75 Identities=19% Similarity=0.245 Sum_probs=52.2
Q ss_pred CeeeccCCeEEEEEEEcCC-cEEEEEEeccCC-------cccHHHHHHHHHHHhccC-C--CcceeEEEEEecCceEEEE
Q 016117 91 NVVGHGGFGLVYRGVLSNG-RKVAIKLMDQAG-------KQGEDEFKMEVELLGRLR-S--PYLLALLGYCSDRRKLLVY 159 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~lv~ 159 (395)
+.||.|.+..||++...+| +.++||.-.+.. ....+.+..|.+.|+.+. + .++.+++.+ .+...++||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~-D~~~~~lVM 110 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY-DEELAVTVM 110 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-CCCCCEEEE
Confidence 4689999999999998776 589999743211 123456677888888863 2 345555555 445578999
Q ss_pred EcccCCC
Q 016117 160 DYMANGG 166 (395)
Q Consensus 160 e~~~~g~ 166 (395)
||+++..
T Consensus 111 E~L~~~~ 117 (401)
T PRK09550 111 EDLSDHK 117 (401)
T ss_pred ecCCCcc
Confidence 9998643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00025 Score=59.75 Aligned_cols=124 Identities=27% Similarity=0.417 Sum_probs=86.5
Q ss_pred CCCCCCCeeeccCC-eEEEEEEEcCCcEEEEEEecc---CCc------------------ccHHHHHHHHHHHhccC---
Q 016117 85 GGFSKSNVVGHGGF-GLVYRGVLSNGRKVAIKLMDQ---AGK------------------QGEDEFKMEVELLGRLR--- 139 (395)
Q Consensus 85 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~--- 139 (395)
.+++..+.||.|.- |.||++.. +|+.+|+|++.. ... .-...|..|.+.+.+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999999 778999999321 000 11235778888888875
Q ss_pred CCcc--eeEEEEEecC-------------------ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHH
Q 016117 140 SPYL--LALLGYCSDR-------------------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 198 (395)
Q Consensus 140 h~ni--v~l~~~~~~~-------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~ 198 (395)
+.++ ++++||..=. ...||.||.+... .+.. .-+.++.+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~----~~~~~~~~ 175 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQI----RDIPQMLR 175 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccch----hHHHHHHH
Confidence 3455 8999986211 0125666554322 1222 23456777
Q ss_pred HHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 199 ~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
-|..+|.. +|+-+|+++.|.. .-+|+|||.+
T Consensus 176 dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 176 DLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 78889998 9999999999975 3478899854
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.001 Score=61.43 Aligned_cols=144 Identities=15% Similarity=0.165 Sum_probs=77.0
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCc--ceeEEEE-------EecCceEEEEEc
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY--LLALLGY-------CSDRRKLLVYDY 161 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-------~~~~~~~lv~e~ 161 (395)
+.|+.|....+|+....+| .+++|+... ...+....|..++..|...+ +.+.+.. ...+..+++++|
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566777789999887555 688898762 12334445666666653222 2333321 123456799999
Q ss_pred ccCCChhh-----------h---cccCCCCCC----CCCCCCH-HHHHH------------HHHH-HHHHHHHHhcC---
Q 016117 162 MANGGLQE-----------H---LYPANGSNS----VASKLDW-ETRLR------------IALE-AAKGLEFLHEH--- 206 (395)
Q Consensus 162 ~~~g~L~~-----------~---l~~~~~~~~----~~~~l~~-~~~~~------------i~~~-i~~~l~~LH~~--- 206 (395)
++|..+.. . +|....... ....+.| ..... ...+ +...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 98875421 1 111111100 0011112 11111 1111 11122333211
Q ss_pred -CCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 207 -CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 207 -~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
...+++|+|+.|.||+++.+...-|+||+.+.
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23489999999999999876656899999875
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00052 Score=62.69 Aligned_cols=146 Identities=19% Similarity=0.162 Sum_probs=84.1
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCc--ceeEEEE-------EecCceEEEEE
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY--LLALLGY-------CSDRRKLLVYD 160 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~-------~~~~~~~lv~e 160 (395)
.+.|..|....+|+.... +..+++|+... ........|++++..+.+.+ +.+++.. ..++..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 345777877899998764 45788898764 23345667888888875432 3444331 11234578999
Q ss_pred cccCCChhhh--------------cccCCCCC----CCCCCCCHHHHH----------HHHHHHHHHHHHHhc----CCC
Q 016117 161 YMANGGLQEH--------------LYPANGSN----SVASKLDWETRL----------RIALEAAKGLEFLHE----HCS 208 (395)
Q Consensus 161 ~~~~g~L~~~--------------l~~~~~~~----~~~~~l~~~~~~----------~i~~~i~~~l~~LH~----~~~ 208 (395)
+++|..+... +|...... .......|.... .....+...+.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9988765320 11111000 000111221110 011112334444443 112
Q ss_pred CCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 209 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
.+++|+|+.|.||+++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999987788999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.001 Score=61.09 Aligned_cols=146 Identities=16% Similarity=0.175 Sum_probs=81.7
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCc--ceeEEEEE-------ecCceEEEEE
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY--LLALLGYC-------SDRRKLLVYD 160 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~-------~~~~~~lv~e 160 (395)
.+.++.|....+|+....+| .+++|+..... ..+....|.+++..|.... +.+++... .++..+++++
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 34577777789999876444 67888775421 2345566777777774322 33443311 1234679999
Q ss_pred cccCCChhhh--------------cccCCCCCCC---C--CCCCHHHHH------------HHHHHHHHHHHHHhc----
Q 016117 161 YMANGGLQEH--------------LYPANGSNSV---A--SKLDWETRL------------RIALEAAKGLEFLHE---- 205 (395)
Q Consensus 161 ~~~~g~L~~~--------------l~~~~~~~~~---~--~~l~~~~~~------------~i~~~i~~~l~~LH~---- 205 (395)
|++|..+... +|........ . ..-.|.... .....+...+.++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9988554211 1211110000 0 001111110 001123334555532
Q ss_pred CCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 206 ~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123489999999999999988877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00071 Score=62.00 Aligned_cols=145 Identities=22% Similarity=0.225 Sum_probs=82.8
Q ss_pred CeeeccCCeEEEEEEEcC-------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcce-eEEEEEecCceEEEEEcc
Q 016117 91 NVVGHGGFGLVYRGVLSN-------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLL-ALLGYCSDRRKLLVYDYM 162 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~lv~e~~ 162 (395)
+.|..|-...+|+....+ ++.+++|+...... .......|.+++..+....+. ++++++.+ ..|++|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~---~~v~e~i 79 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN---GRIEEFI 79 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC---Cchhhee
Confidence 346667777899888654 57899999765322 223456788888888543333 44444432 3578998
Q ss_pred cCCChhhh-----------------cccCCCCC-C-CCCCC--CHHHHHH--------------------------HHHH
Q 016117 163 ANGGLQEH-----------------LYPANGSN-S-VASKL--DWETRLR--------------------------IALE 195 (395)
Q Consensus 163 ~~g~L~~~-----------------l~~~~~~~-~-~~~~l--~~~~~~~--------------------------i~~~ 195 (395)
+|..+... +|...... . ..... -+..+.. +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88766432 11111110 0 00011 1111111 1112
Q ss_pred HHHHHHHHhc------CCCCCceeCCCCCCCEEeCCC----CcEEEeccccccc
Q 016117 196 AAKGLEFLHE------HCSPPVIHRDFKSSNILLDKN----FHAKVSDFGLAKI 239 (395)
Q Consensus 196 i~~~l~~LH~------~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~~ 239 (395)
+..-+.++-. .....++|+|+.+.||+++++ +.+.++||..+..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2222334432 124478999999999999885 8899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00086 Score=61.22 Aligned_cols=139 Identities=17% Similarity=0.204 Sum_probs=94.7
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccCC---------------------c-ccH----HHHHHHHHHHhccCCCcc
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG---------------------K-QGE----DEFKMEVELLGRLRSPYL 143 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---------------------~-~~~----~~~~~e~~~l~~l~h~ni 143 (395)
...|..|--+.||.+.-.+|..+|||+++... . ... -....|+.-|++|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34678888999999998899999999864210 0 001 123357777777765443
Q ss_pred eeEEEEEecCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe
Q 016117 144 LALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 223 (395)
Q Consensus 144 v~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill 223 (395)
. +-.-..-...++||+++.......-. .....++...+..+-.|++.-|.-|...| ++||.||+--|+|+
T Consensus 229 P-~PePIlLk~hVLVM~FlGrdgw~aPk-------LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 229 P-CPEPILLKNHVLVMEFLGRDGWAAPK-------LKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred C-CCCceeeecceEeeeeccCCCCcCcc-------cccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 2 11111223557999998643322211 12235667778888888999898888887 89999999999999
Q ss_pred CCCCcEEEeccccccc
Q 016117 224 DKNFHAKVSDFGLAKI 239 (395)
Q Consensus 224 ~~~~~~kl~Dfg~~~~ 239 (395)
.+|.+.|+|.+.+..
T Consensus 299 -hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 -HDGKLYIIDVSQSVE 313 (520)
T ss_pred -ECCEEEEEEcccccc
Confidence 557899999887754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0026 Score=57.33 Aligned_cols=31 Identities=29% Similarity=0.579 Sum_probs=25.9
Q ss_pred CceeCCCCCCCEEeCCCCc-EEEecccccccc
Q 016117 210 PVIHRDFKSSNILLDKNFH-AKVSDFGLAKIG 240 (395)
Q Consensus 210 ~i~H~dlk~~Nill~~~~~-~kl~Dfg~~~~~ 240 (395)
.++|+|+.+.||++++++. .-|.||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 5899999999999987555 569999988753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0045 Score=56.40 Aligned_cols=138 Identities=20% Similarity=0.303 Sum_probs=82.4
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEecc--CCcccHHHHHHHHHHHhccCC--CcceeEEEEEecC---ceEEEEEccc
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQ--AGKQGEDEFKMEVELLGRLRS--PYLLALLGYCSDR---RKLLVYDYMA 163 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~---~~~lv~e~~~ 163 (395)
+.+..|.-..+|..... +++++++ ... ..........+|+.+++.+.- --+...+++|.++ ..++||+|+.
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 33433433445555543 7888888 332 122233455678888887743 2334445666554 3579999998
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHH-HHHHHHHHHHhc-------------------------------------
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIA-LEAAKGLEFLHE------------------------------------- 205 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~-~~i~~~l~~LH~------------------------------------- 205 (395)
+..+.+.+.... . . .+++ ..++..|+-||+
T Consensus 109 Ge~~~~~~~~~~--------~--~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~ 176 (321)
T COG3173 109 GEVVWSALPPES--------L--G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR 176 (321)
T ss_pred ceeccCcCCccc--------c--h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence 865444432110 0 0 1111 244444444442
Q ss_pred -------------CC-----CCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 206 -------------HC-----SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 206 -------------~~-----~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
+. .+.++|||+.+.|++++.+.-+=+.||+++.....
T Consensus 177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 21 24789999999999999988899999999986544
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0053 Score=56.81 Aligned_cols=80 Identities=20% Similarity=0.192 Sum_probs=51.6
Q ss_pred eeeccCCeEEEEEEEcCC-cEEEEEEeccC------C-cccHHHHHHHHHHHhccC--CCcceeEEEEEecCceEEEEEc
Q 016117 92 VVGHGGFGLVYRGVLSNG-RKVAIKLMDQA------G-KQGEDEFKMEVELLGRLR--SPYLLALLGYCSDRRKLLVYDY 161 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~lv~e~ 161 (395)
.||.|...-||++...+| +.++||.-.+. + +-..+...-|.+.|+... -|..++-+-++..+...++||+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd 81 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED 81 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence 479999999999997654 68999964311 1 222344556778887653 3555555555566677799999
Q ss_pred ccCC-Chhhhc
Q 016117 162 MANG-GLQEHL 171 (395)
Q Consensus 162 ~~~g-~L~~~l 171 (395)
++.. .|.+.|
T Consensus 82 L~~~~ilR~~L 92 (370)
T TIGR01767 82 LSHHKIARKGL 92 (370)
T ss_pred CccchHHHHHH
Confidence 8653 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0046 Score=57.67 Aligned_cols=143 Identities=16% Similarity=0.175 Sum_probs=81.2
Q ss_pred eeeccCCeEEEEEEEcC-----CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcce-eEEEEEecCceEEEEEcccCC
Q 016117 92 VVGHGGFGLVYRGVLSN-----GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLL-ALLGYCSDRRKLLVYDYMANG 165 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~lv~e~~~~g 165 (395)
.|..|-...+|+....+ ++.+++|+......... +...|..+++.+...++. ++++.+..+ .+.+|+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g---~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG---RVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc---eEEEeeCCC
Confidence 45567788899987532 36899998765433222 236688888888654443 445555433 578888766
Q ss_pred Chhhh-----------------cccCCCCCCCCCCCCHHHHHHHHHHH-----------------HHHHHHH----hc-C
Q 016117 166 GLQEH-----------------LYPANGSNSVASKLDWETRLRIALEA-----------------AKGLEFL----HE-H 206 (395)
Q Consensus 166 ~L~~~-----------------l~~~~~~~~~~~~l~~~~~~~i~~~i-----------------~~~l~~L----H~-~ 206 (395)
+|... +|...... ......+..+..+..++ ...+..| .. .
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~-~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPG-PKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCC-CCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 65321 12211110 01112233333333221 1111122 21 1
Q ss_pred CCCCceeCCCCCCCEEeCC-CCcEEEeccccccc
Q 016117 207 CSPPVIHRDFKSSNILLDK-NFHAKVSDFGLAKI 239 (395)
Q Consensus 207 ~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~ 239 (395)
....++|+|+++.||++++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1236899999999999976 47899999988753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0058 Score=55.21 Aligned_cols=72 Identities=21% Similarity=0.321 Sum_probs=45.5
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccC---CCcceeEEEEEecC-ceEEEEEcccCC
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR---SPYLLALLGYCSDR-RKLLVYDYMANG 165 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~-~~~lv~e~~~~g 165 (395)
.+.++.|....+|+.. .+++.+.+|+-.. .....|..|.+-|+.|. --.+.+++++.... ..++++||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999987 5788899998762 22346888988888883 34567777776543 568999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.00078 Score=60.49 Aligned_cols=147 Identities=19% Similarity=0.139 Sum_probs=95.5
Q ss_pred eecHHHHHHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC------------------ccc----HHHHHHH
Q 016117 74 VFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG------------------KQG----EDEFKME 131 (395)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~~~----~~~~~~e 131 (395)
.+.++.+..-..-+++.+.||-|--+-||.+...+|++.++|.-.... ..+ .-...+|
T Consensus 81 yLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kE 160 (465)
T KOG2268|consen 81 YLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKE 160 (465)
T ss_pred HHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHH
Confidence 334444443333577889999999999999999999999999531100 001 1123457
Q ss_pred HHHHhccC-CC-cceeEEEEEecCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 016117 132 VELLGRLR-SP-YLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209 (395)
Q Consensus 132 ~~~l~~l~-h~-niv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 209 (395)
...|+.|. |- -+.+.+ ...+.++||+++.+-.|...-+ ..+..+ +...+..-+--|-.+
T Consensus 161 fafmkaL~e~gfpVPkpi---D~~RH~Vvmelv~g~Pl~~v~~----------v~d~~~---ly~~lm~~Iv~la~~--- 221 (465)
T KOG2268|consen 161 FAFMKALYERGFPVPKPI---DHNRHCVVMELVDGYPLRQVRH----------VEDPPT---LYDDLMGLIVRLANH--- 221 (465)
T ss_pred HHHHHHHHHcCCCCCCcc---cccceeeHHHhhcccceeeeee----------cCChHH---HHHHHHHHHHHHHHc---
Confidence 77777773 22 122222 3346789999988877655432 122233 333344444555556
Q ss_pred CceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 210 PVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 210 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
|++|+|..-=||++++++.++++||-....
T Consensus 222 GlIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 222 GLIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred CceecccchheeEEecCCCEEEeechHhhc
Confidence 999999999999999999999999976543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.08 E-value=8.5e-05 Score=78.46 Aligned_cols=159 Identities=14% Similarity=0.036 Sum_probs=113.0
Q ss_pred HHHHHHhccCCCcceeEEEEEecC---ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 016117 130 MEVELLGRLRSPYLLALLGYCSDR---RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206 (395)
Q Consensus 130 ~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~ 206 (395)
.|..-++...|+++.....-..+. +.+.+++|+..|.+.+.+.+.... ...++..-+.....+......-+|+.
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee---~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEE---SPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcccc---CCcchhchHHHHHHHHHhccchhhhc
Confidence 344455556788776655433322 456899999999999998655432 23344444444444445566666654
Q ss_pred C--CCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHH
Q 016117 207 C--SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLE 284 (395)
Q Consensus 207 ~--~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~e 284 (395)
. +.--+|+++|+.|.++..+.+++++++|+.+...+.. .......+++.|++|+..+.-.++.++|+|..|+.+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 3 2246899999999999999999999999998322211 12334567888999999988889999999999999999
Q ss_pred HHhCCCCCC
Q 016117 285 LLTGRVPID 293 (395)
Q Consensus 285 ll~g~~pf~ 293 (395)
..-|..+|-
T Consensus 1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred HhcccHHHH
Confidence 999988873
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.015 Score=54.79 Aligned_cols=80 Identities=19% Similarity=0.188 Sum_probs=51.3
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccC----Cc---ccHHHHHHHHHHHhccC---CCcceeEEEEEecCceEEEE
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQA----GK---QGEDEFKMEVELLGRLR---SPYLLALLGYCSDRRKLLVY 159 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~lv~ 159 (395)
.+.||.|....||+... .+..++||.-... .. .....-..|.+.|+.+. ..++.+++.++. +..+++|
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-d~~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-TMALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-CCCEEEE
Confidence 45789999999999886 4557999975421 11 12223344567776653 246777887776 4467889
Q ss_pred EcccC--CChhhhc
Q 016117 160 DYMAN--GGLQEHL 171 (395)
Q Consensus 160 e~~~~--g~L~~~l 171 (395)
|++++ ..+.+.+
T Consensus 115 E~L~~~~~ilr~~L 128 (418)
T PLN02756 115 RYLEPPHIILRKGL 128 (418)
T ss_pred eecCCcceehhhhh
Confidence 99976 3444444
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.012 Score=50.22 Aligned_cols=151 Identities=18% Similarity=0.116 Sum_probs=87.0
Q ss_pred cCCeEEEEEEEcCCcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCcceeEEEEEecCceE-EEEEcccCCChhhhccc
Q 016117 96 GGFGLVYRGVLSNGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYP 173 (395)
Q Consensus 96 G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-lv~e~~~~g~L~~~l~~ 173 (395)
++.++.-.++.+-|. ..+|.+...... ....|..+.++++++. .|+++..- +...+ ++.|+|....
T Consensus 73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------- 140 (308)
T PF07387_consen 73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------- 140 (308)
T ss_pred CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------
Confidence 444555555443333 344444432222 4456778888888764 45666522 23334 8888874321
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeeccc
Q 016117 174 ANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 253 (395)
Q Consensus 174 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 253 (395)
.... -.+.. =+.+|.-.|+. +.+.+|||..|+||+-|..|.+||.|-+..-. .. .
T Consensus 141 ---------i~~~---N~i~a-gi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~~----V----- 195 (308)
T PF07387_consen 141 ---------INFS---NFITA-GIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--NQ----V----- 195 (308)
T ss_pred ---------cchh---HHHHH-hHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--he----e-----
Confidence 0111 11111 14677788865 55899999999999999999999999775431 00 0
Q ss_pred cccccccchhhccCCCCccchhHHHHHHHHHHHhCC
Q 016117 254 GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR 289 (395)
Q Consensus 254 g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~ 289 (395)
-|.-- .....+.++.+-+|=.-++++....
T Consensus 196 ---~~vN~---~Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 196 ---NMVNI---EYESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred ---eEEee---eccccChHHHHHHHHHHHHHHHHHH
Confidence 01110 1123456777777777777776643
|
The function of this family is unknown. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.022 Score=52.84 Aligned_cols=143 Identities=14% Similarity=0.184 Sum_probs=78.7
Q ss_pred eeeccCCeEEEEEEEcC----CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcce-eEEEEEecCceEEEEEcccCCC
Q 016117 92 VVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLL-ALLGYCSDRRKLLVYDYMANGG 166 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~lv~e~~~~g~ 166 (395)
.|..|-...+|+....+ +..|++|+....... .-+...|..+++.+...++. ++++++..+ ++.+|+++..
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G---~i~~fi~g~~ 96 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG---MIQSFINART 96 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc---EeehhhcCCC
Confidence 45557778888886533 247999987654322 22335688888888655553 455554322 4888887655
Q ss_pred hhhh-----------------cccCCCCCCCCCCCCHHHHHHHHHHH----------------------HHHHH----HH
Q 016117 167 LQEH-----------------LYPANGSNSVASKLDWETRLRIALEA----------------------AKGLE----FL 203 (395)
Q Consensus 167 L~~~-----------------l~~~~~~~~~~~~l~~~~~~~i~~~i----------------------~~~l~----~L 203 (395)
|... +|...... ....-.+..+..+..++ ..-+. .+
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~-~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPG-SKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCC-CCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 4221 12211100 00111233332222221 11111 11
Q ss_pred hcC-CCCCceeCCCCCCCEEeCC-CCcEEEeccccccc
Q 016117 204 HEH-CSPPVIHRDFKSSNILLDK-NFHAKVSDFGLAKI 239 (395)
Q Consensus 204 H~~-~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~ 239 (395)
... ...-++|+|+.+.||++++ ++.++++||..+..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111 1124799999999999974 57899999998753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.018 Score=54.03 Aligned_cols=75 Identities=16% Similarity=0.243 Sum_probs=50.9
Q ss_pred CCeeeccCCeEEEEEEEcC-CcEEEEEEecc---CC---cccHHHHHHHHHHHhccC--CCcceeEEEEEecCceEEEEE
Q 016117 90 SNVVGHGGFGLVYRGVLSN-GRKVAIKLMDQ---AG---KQGEDEFKMEVELLGRLR--SPYLLALLGYCSDRRKLLVYD 160 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~---~~---~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~lv~e 160 (395)
.+.||.|.-.-||++...+ ++.|+||.-.. .. +-..++..-|.+.|+... -|..++-+-++......+|||
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~~~vME 113 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMNCCVME 113 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHhhHHHH
Confidence 3578999999999999743 67899995431 11 223455666888888763 355566555555566679999
Q ss_pred cccC
Q 016117 161 YMAN 164 (395)
Q Consensus 161 ~~~~ 164 (395)
+++.
T Consensus 114 dL~~ 117 (409)
T PRK12396 114 DLSD 117 (409)
T ss_pred hCcc
Confidence 9854
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.039 Score=50.66 Aligned_cols=29 Identities=31% Similarity=0.431 Sum_probs=25.4
Q ss_pred CCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 209 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
.+++|||+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.18 Score=46.64 Aligned_cols=71 Identities=15% Similarity=0.154 Sum_probs=44.3
Q ss_pred ccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC--cceeEE---E--EE-ecCceEEEEEcccCCC
Q 016117 95 HGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP--YLLALL---G--YC-SDRRKLLVYDYMANGG 166 (395)
Q Consensus 95 ~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~---~--~~-~~~~~~lv~e~~~~g~ 166 (395)
.+.-..||+....++..+++|+.... ......+..|.+.+..+... .++... | +. .++..+.++++++|..
T Consensus 35 ~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 35 NSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 34567789998878889999987643 23455677788888777321 122211 1 11 1334567889887754
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.017 Score=49.77 Aligned_cols=30 Identities=33% Similarity=0.490 Sum_probs=21.5
Q ss_pred CceeCCCCCCCEEe-CCCCcEEEeccccccc
Q 016117 210 PVIHRDFKSSNILL-DKNFHAKVSDFGLAKI 239 (395)
Q Consensus 210 ~i~H~dlk~~Nill-~~~~~~kl~Dfg~~~~ 239 (395)
.++|+|+.+.||++ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 68999999999999 8899999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.0086 Score=57.22 Aligned_cols=46 Identities=17% Similarity=0.235 Sum_probs=35.8
Q ss_pred HHHHHHHHHHhccCCCcceeEEEEEecC--ceEEEEEcccCCChhhhcc
Q 016117 126 DEFKMEVELLGRLRSPYLLALLGYCSDR--RKLLVYDYMANGGLQEHLY 172 (395)
Q Consensus 126 ~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~lv~e~~~~g~L~~~l~ 172 (395)
........+++.+.|+|+...+.+.... +..+|+|++ +.+|.+.+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~ 74 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK 74 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence 4566778899999999999999887655 345788877 558888874
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.16 Score=47.95 Aligned_cols=74 Identities=14% Similarity=0.203 Sum_probs=44.0
Q ss_pred CeeeccCCeEEEEEEEcCC--cE-----EEEEEeccCCcccHHHHHHHHHHHhccCCCcceeE-EEEEecCceEEEEEcc
Q 016117 91 NVVGHGGFGLVYRGVLSNG--RK-----VAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL-LGYCSDRRKLLVYDYM 162 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~lv~e~~ 162 (395)
+.|..|-...+|++...++ .. |.++..... ....-+-..|+++++.+...++.+- ++.+. ..+++||+
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~---~g~l~efI 131 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG---DFTIQEWV 131 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecC---CEEEEEEe
Confidence 3555688889999875433 22 444443222 1111223568999999976655444 44443 25899999
Q ss_pred cCCChh
Q 016117 163 ANGGLQ 168 (395)
Q Consensus 163 ~~g~L~ 168 (395)
++.+|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 887654
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.12 Score=47.54 Aligned_cols=32 Identities=19% Similarity=0.264 Sum_probs=28.3
Q ss_pred CCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 208 ~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
..+++|+|+.+.|+|++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999999999999988764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.68 E-value=0.27 Score=45.44 Aligned_cols=143 Identities=20% Similarity=0.270 Sum_probs=81.8
Q ss_pred eeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCc---cee---EEEE---EecC--ceEEEEE
Q 016117 92 VVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY---LLA---LLGY---CSDR--RKLLVYD 160 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n---iv~---l~~~---~~~~--~~~lv~e 160 (395)
.|.+ .-..+|+....+|+. ++|+.... ....+...|+..+..+.-.. .++ +-|- .... ..+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556788888866666 88988764 34556777888888873221 122 2121 1123 4568999
Q ss_pred cccCCChhh-h--------------cccCCCCC-----CCCCCCCHHH-------------HHHHHHHHHHHHHHHhcC-
Q 016117 161 YMANGGLQE-H--------------LYPANGSN-----SVASKLDWET-------------RLRIALEAAKGLEFLHEH- 206 (395)
Q Consensus 161 ~~~~g~L~~-~--------------l~~~~~~~-----~~~~~l~~~~-------------~~~i~~~i~~~l~~LH~~- 206 (395)
|++|..+.. . ||...+.. .......|.. ......++...+..+.+.
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999887773 1 11111110 0111223320 011223344444444432
Q ss_pred ---C-CCC--ceeCCCCCCCEEeCCCCc-EEEecccccc
Q 016117 207 ---C-SPP--VIHRDFKSSNILLDKNFH-AKVSDFGLAK 238 (395)
Q Consensus 207 ---~-~~~--i~H~dlk~~Nill~~~~~-~kl~Dfg~~~ 238 (395)
. ..+ +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 113 899999999999998875 8899999765
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.086 Score=48.56 Aligned_cols=55 Identities=25% Similarity=0.379 Sum_probs=49.0
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 182 SKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 182 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
..-.+.++..++.+.+..++-+.... ++=|||+.-.|||++ .|++-|+||-+++.
T Consensus 316 k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 316 KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 34678899999999999888888765 889999999999999 99999999999984
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.16 Score=54.36 Aligned_cols=144 Identities=23% Similarity=0.292 Sum_probs=77.9
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-------CCcceeEEE-----EEe--cC--c
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-------SPYLLALLG-----YCS--DR--R 154 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-------h~niv~l~~-----~~~--~~--~ 154 (395)
+.|+ |..-.+|+....+|..+++|+.+... .......|...+..|. -|.+++-.. ... ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 3453 45677899888788899999987642 2234444556666552 122232211 111 12 2
Q ss_pred eEEEEEcccCCChhhhc-----------------cc----CCCCCCCCCCCCHH-----------------HHHHHHHHH
Q 016117 155 KLLVYDYMANGGLQEHL-----------------YP----ANGSNSVASKLDWE-----------------TRLRIALEA 196 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l-----------------~~----~~~~~~~~~~l~~~-----------------~~~~i~~~i 196 (395)
.+.+++|.++..+.+.. +. ... ......+.|. ..+.++.++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~-p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~ 186 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMH-PGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF 186 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCC-CCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence 35789999987775511 00 000 0001112221 112222233
Q ss_pred HHHHH-----HHhcCCCCCceeCCCCCCCEEeCCCC--cEE-Eeccccccc
Q 016117 197 AKGLE-----FLHEHCSPPVIHRDFKSSNILLDKNF--HAK-VSDFGLAKI 239 (395)
Q Consensus 197 ~~~l~-----~LH~~~~~~i~H~dlk~~Nill~~~~--~~k-l~Dfg~~~~ 239 (395)
..... .+.+. ..+++|+|+.+.|||++.+. ++. |+|||-+..
T Consensus 187 ~~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 187 LARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 22221 12222 33799999999999998875 454 999997753
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.33 Score=41.89 Aligned_cols=74 Identities=19% Similarity=0.242 Sum_probs=47.8
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccC---CCcceeEEEEEecC-ceEEEEEcccCCC
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR---SPYLLALLGYCSDR-RKLLVYDYMANGG 166 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~-~~~lv~e~~~~g~ 166 (395)
+.+.-|.--..|.... +..++.+|+-. ......|..|+.-|..|. .-++.+++.+-.+. ..++|++|.+.|.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3455555555565554 55678888643 223456777877776664 34566666665444 6789999999876
Q ss_pred hh
Q 016117 167 LQ 168 (395)
Q Consensus 167 L~ 168 (395)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 65
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=94.39 E-value=0.027 Score=33.59 Aligned_cols=12 Identities=42% Similarity=0.780 Sum_probs=4.8
Q ss_pred HHHHHHHHhhhh
Q 016117 30 LVAFSYYCYIRN 41 (395)
Q Consensus 30 ~~~~~~~~~~r~ 41 (395)
++++++++++|+
T Consensus 28 l~~~l~~~~rR~ 39 (40)
T PF08693_consen 28 LGAFLFFWYRRK 39 (40)
T ss_pred HHHHhheEEecc
Confidence 333434444443
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 395 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-57 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-55 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-52 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-38 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-30 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-24 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-24 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-24 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-24 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-23 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-23 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-23 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-22 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-22 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-22 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-20 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-16 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-15 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 457 bits (1178), Expect = e-162
Identities = 119/291 (40%), Positives = 170/291 (58%), Gaps = 8/291 (2%)
Query: 73 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEV 132
L AT F ++GHG FG VY+GVL +G KVA+K QG +EF+ E+
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 133 ELLGRLRSPYLLALLGYCSDRRK-LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR 191
E L R P+L++L+G+C +R + +L+Y YM NG L+ HLY GS+ + WE RL
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY---GSDLPTMSMSWEQRLE 143
Query: 192 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR 251
I + AA+GL +LH +IHRD KS NILLD+NF K++DFG++K G++ H+ST
Sbjct: 144 ICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200
Query: 252 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311
V GT GY+ PEY + G LT KSDVYS+GVVL E+L R I + P L WA+
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
+ ++ +I+DP L + + + + A C+ ++ RP M DV+ L
Sbjct: 261 NNG-QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 439 bits (1131), Expect = e-155
Identities = 124/295 (42%), Positives = 181/295 (61%), Gaps = 9/295 (3%)
Query: 72 LQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG-EDEFKM 130
L+ F+ ++L A+ FS N++G GGFG VY+G L++G VA+K + + QG E +F+
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 131 EVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETR 189
EVE++ LL L G+C +LLVY YMANG + L LDW R
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR---ERPESQPPLDWPKR 133
Query: 190 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS 249
RIAL +A+GL +LH+HC P +IHRD K++NILLD+ F A V DFGLAK+ K HV+
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVT 192
Query: 250 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE--GVLVSWA 307
T V GT G++APEY TG + K+DV+ YGV+LLEL+TG+ D+ + + + +L+ W
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 308 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
L ++ K+ ++D L+G Y +EV Q+ +A +C Q RP M++VV+ L
Sbjct: 253 KGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 435 bits (1121), Expect = e-154
Identities = 109/318 (34%), Positives = 174/318 (54%), Gaps = 24/318 (7%)
Query: 60 ESGKLEVTTDNGLQVFTFKQLHSATGGFSK------SNVVGHGGFGLVYRGVLSNGRKVA 113
E+ LEV+ F+F +L + T F + N +G GGFG+VY+G + N VA
Sbjct: 1 ENKSLEVSDTR-FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVA 58
Query: 114 IK----LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYDYMANGGLQ 168
+K ++D ++ + +F E++++ + + L+ LLG+ SD LVY YM NG L
Sbjct: 59 VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118
Query: 169 EHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 228
+ L +G+ L W R +IA AA G+ FLHE+ IHRD KS+NILLD+ F
Sbjct: 119 DRLSCLDGT----PPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFT 171
Query: 229 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTG 288
AK+SDFGLA+ A +++R++GT Y+APE L G +T KSD+YS+GVVLLE++TG
Sbjct: 172 AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITG 230
Query: 289 RVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPE 348
+D ++ +L+ + + I + +D + V + ++A+ C+ +
Sbjct: 231 LPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEK 287
Query: 349 ADYRPLMADVVQSLVPLV 366
+ RP + V Q L +
Sbjct: 288 KNKRPDIKKVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 8e-84
Identities = 73/328 (22%), Positives = 121/328 (36%), Gaps = 33/328 (10%)
Query: 62 GKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG 121
G +G+ + L+ + V G FG V++ L VA+K+
Sbjct: 2 GHHHHHHSSGVD-LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD 59
Query: 122 KQGEDEFKMEVELLGRLRSPYLLALLGYC-----SDRRKLLVYDYMANGGLQEHLYPANG 176
KQ + + EV L ++ +L +G D L+ + G L + L
Sbjct: 60 KQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---- 114
Query: 177 SNSVASKLDWETRLRIALEAAKGLEFLHEH-------CSPPVIHRDFKSSNILLDKNFHA 229
A+ + W IA A+GL +LHE P + HRD KS N+LL N A
Sbjct: 115 ----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170
Query: 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTT-----KSDVYSYGVVLLE 284
++DFGLA + +GT+ Y+APE + D+Y+ G+VL E
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 285 LLTGRVPIDVNKPSGEGVLVS--WALPRLTDREKI--LEIMDPALEGQYSMKEVI-QVAA 339
L + D P L D +++ + P L + + +
Sbjct: 231 LASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290
Query: 340 IAAMCVQPEADYRPLMADVVQSLVPLVK 367
C +A+ R V + + + +
Sbjct: 291 TIEECWDHDAEARLSAGCVGERITQMQR 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-67
Identities = 90/292 (30%), Positives = 143/292 (48%), Gaps = 29/292 (9%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLLALLG 148
+G G FG V+R +G VA+K++ + +EF EV ++ RLR P ++ +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 149 YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
+ L +V +Y++ G L L+ + +LD RL +A + AKG+ +LH +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH----KSGAREQLDERRRLSMAYDVAKGMNYLH-NR 156
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 267
+PP++HR+ KS N+L+DK + KV DFGL+++ + S GT ++APE
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDE 214
Query: 268 HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327
KSDVYS+GV+L EL T + P P+ V A+ R +I ++P +
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----VVAAVGFKCKRLEIPRNLNPQV-- 268
Query: 328 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSP 379
AAI C E RP A ++ L PL+K + P + S
Sbjct: 269 ----------AAIIEGCWTNEPWKRPSFATIMDLLRPLIK--SAVPPPNRSD 308
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-66
Identities = 70/295 (23%), Positives = 126/295 (42%), Gaps = 33/295 (11%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
VVG G FG+V + + VAIK ++ + F +E+ L R+ P ++ L G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 151 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
+ + LV +Y G L L+ + L+ ++G+ +LH
Sbjct: 71 LN--PVCLVMEYAEGGSLYNVLH----GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 210 PVIHRDFKSSNILLDKNF-HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 268
+IHRD K N+LL K+ DFG A T G+ ++APE +
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSN 179
Query: 269 LTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327
+ K DV+S+G++L E++T R P ++ P+ + WA+ R +++ + +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPA---FRIMWAVHN-GTRPPLIKNLPKPI-- 233
Query: 328 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSPSFH 382
+ ++ C + RP M ++V+ + L++Y + P H
Sbjct: 234 ----ESLMT------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQH 278
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 3e-66
Identities = 68/349 (19%), Positives = 115/349 (32%), Gaps = 59/349 (16%)
Query: 75 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVE- 133
+ ++G G +G VY+G L + R VA+K+ F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNI 58
Query: 134 -LLGRLRSPYLLALLGYC------SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDW 186
+ + + + LLV +Y NG L ++L DW
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--------LHTSDW 110
Query: 187 ETRLRIALEAAKGLEFLHE------HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI- 239
+ R+A +GL +LH H P + HRD S N+L+ + +SDFGL+
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 240 -----GSDKAGGHVSTRVLGTQGYVAPEYA-------LTGHLTTKSDVYSYGVVLLELLT 287
+ + +GT Y+APE + D+Y+ G++ E+
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 288 GRVPIDVNKPSGEGVL----VSWALPRLTD----------REKILEIMDPALEGQYSMKE 333
+ + E + P D R K E S+KE
Sbjct: 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE 290
Query: 334 VIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSPSFH 382
I+ C +A+ R + + L+ +S + H
Sbjct: 291 TIE------DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHH 333
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 4e-62
Identities = 77/287 (26%), Positives = 127/287 (44%), Gaps = 42/287 (14%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED-------EFKMEVELLGRLRSPY 142
+G GGFGLV++G + + VAIK + +GE EF+ EV ++ L P
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 143 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
++ L G + +V +++ G L L + W +LR+ L+ A G+E+
Sbjct: 85 IVKLYGLMHNP-PRMVMEFVPCGDLYHRLLDKAH------PIKWSVKLRLMLDIALGIEY 137
Query: 203 LHEHCSPPVIHRDFKSSNILLDK-----NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
+ + +PP++HRD +S NI L AKV+DFGL++ + +LG
Sbjct: 138 MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQ 191
Query: 258 YVAPEYALTGHL--TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315
++APE T K+D YS+ ++L +LTG P D + + R
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG--KIKFINMIREEGLRP 249
Query: 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
I E P L + VI+ +C + RP + +V+ L
Sbjct: 250 TIPEDCPPRL------RNVIE------LCWSGDPKKRPHFSYIVKEL 284
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-60
Identities = 71/283 (25%), Positives = 133/283 (46%), Gaps = 34/283 (12%)
Query: 93 VGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGE--DEFKMEVELLGRLRSPYLLALLGYC 150
+G G FG VY+G VA+K+++ + FK EV +L + R +L +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 151 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 210
+ + +V + L HL+ + K + + + IA + A+G+++LH +
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHLHASET------KFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 211 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE---YALTG 267
+IHRD KS+NI L ++ K+ DFGLA S +G H ++ G+ ++APE +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 268 HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI---MDPA 324
+ +SDVY++G+VL EL+TG++P + + + R + + ++
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367
+ + A C++ + D RP ++ + L +
Sbjct: 258 M------------KRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-60
Identities = 71/311 (22%), Positives = 110/311 (35%), Gaps = 48/311 (15%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGE--DEFKMEVELLGRLRSPYLLALLG 148
++G G FG VY G +VAI+L+D + FK EV + R ++ +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 149 YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
C L ++ L + A LD +IA E KG+ +LH
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAK------IVLDVNKTRQIAQEIVKGMGYLH--- 147
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS---TRVLGTQGYVAPE-- 262
+ ++H+D KS N+ D ++DFGL I G G ++APE
Sbjct: 148 AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 263 -------YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315
+ SDV++ G + EL P +P+ + W +
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEA---IIWQMGTGMKPN 262
Query: 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKI 375
M + + I C E + RP ++ L L K NR
Sbjct: 263 LSQIGMGKEI------------SDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR---- 306
Query: 376 SSSPSFHASRS 386
S P H +S
Sbjct: 307 LSHPG-HFWKS 316
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 8e-60
Identities = 57/281 (20%), Positives = 106/281 (37%), Gaps = 40/281 (14%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLLALLG 148
+ G +++G G + +K++ + +F E L P +L +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 149 YCSD---RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 205
C L+ +M G L L+ +D ++ AL+ A+G+ FLH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-----VVDQSQAVKFALDMARGMAFLH- 128
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 265
P + S ++++D++ A++S + S + +VAPE AL
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAPE-AL 180
Query: 266 TG----HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321
+D++S+ V+L EL+T VP G+ V+ R T I +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT----IPPGI 236
Query: 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
P + + + +C+ + RP +V L
Sbjct: 237 SPHV------------SKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-59
Identities = 77/285 (27%), Positives = 120/285 (42%), Gaps = 42/285 (14%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLM----DQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
++G GGFG VYR G +VA+K D+ Q + + E +L L+ P ++AL
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 147 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 205
G C L LV ++ G L L ++ + + A++ A+G+ +LH+
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSG--------KRIPPDILVNWAVQIARGMNYLHD 123
Query: 206 HCSPPVIHRDFKSSNILLDKNFH--------AKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
P+IHRD KSSNIL+ + K++DFGLA+ + G
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAA-GAYA 179
Query: 258 YVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317
++APE + SDV+SYGV+L ELLTG VP V++ + I
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR-GIDGLA---VAYGVAMNKLALPI 235
Query: 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
A + C P+ RP +++ L
Sbjct: 236 PSTCPEPF------------AKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 3e-55
Identities = 72/310 (23%), Positives = 118/310 (38%), Gaps = 54/310 (17%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVE--LLGRLRSPYLLALLG 148
+G G +G V+ G G KVA+K+ E + E E +R +L +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 149 YCSDRRKL-----LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
L+ DY NG L ++L ++ LD ++ L++A + GL L
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK--------STTLDAKSMLKLAYSSVSGLCHL 150
Query: 204 HE-----HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI--GSDKAGGHVSTRVLGTQ 256
H P + HRD KS NIL+ KN ++D GLA +GT+
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 257 GYVAPEYALTGHL-------TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 309
Y+ PE L L +D+YS+G++L E+ V + + + LP
Sbjct: 211 RYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE--------YQLP 261
Query: 310 --RLTDREKILEIMD---------PALEGQYSMKEVI-QVAAIAAMCVQPEADYRPLMAD 357
L + E M P+ ++S E + Q+ + C R
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 358 VVQSLVPLVK 367
V ++L + +
Sbjct: 322 VKKTLAKMSE 331
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 5e-55
Identities = 63/291 (21%), Positives = 111/291 (38%), Gaps = 38/291 (13%)
Query: 91 NVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 149
V+G G FG + G + +K + + ++ + F EV+++ L P +L +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
++L + +Y+ G L+ + + + W R+ A + A G+ +LH
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDS------QYPWSQRVSFAKDIASGMAYLHSM-- 127
Query: 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD------------KAGGHVSTRVLGTQ 256
+IHRD S N L+ +N + V+DFGLA++ D K V+G
Sbjct: 128 -NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 257 GYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316
++APE K DV+S+G+VL E++ P ++ R
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV---RGFLDRY 243
Query: 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367
P+ I C + + RP + L L
Sbjct: 244 CPPNCPPSF------------FPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-54
Identities = 72/307 (23%), Positives = 116/307 (37%), Gaps = 52/307 (16%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVEL--LGRLRSPYLLALLG 148
VG G +G V+RG G VA+K+ + E + E EL LR +L +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 149 YCSDRRKL-----LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
R L+ Y G L ++L + LD + LRI L A GL L
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ--------LTTLDTVSCLRIVLSIASGLAHL 121
Query: 204 HE-----HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI--GSDKAGGHVSTRVLGTQ 256
H P + HRD KS NIL+ KN ++D GLA + S + +GT+
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 257 GYVAPE------YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP- 309
Y+APE + D++++G+VL E+ V G++ + P
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS--------NGIVEDYKPPF 233
Query: 310 -RLTDREKILEIMD---------PALEGQYSMKEVI-QVAAIAAMCVQPEADYRPLMADV 358
+ + E M P + ++ + +A + C R +
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 359 VQSLVPL 365
++L +
Sbjct: 294 KKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-52
Identities = 72/310 (23%), Positives = 119/310 (38%), Gaps = 54/310 (17%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVE--LLGRLRSPYLLALLG 148
+G G FG V+RG G +VA+K+ + E + E E LR +L +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 149 YCSDRRKL-----LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
+ LV DY +G L ++L + E +++AL A GL L
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN--------RYTVTVEGMIKLALSTASGLAHL 155
Query: 204 HE-----HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI--GSDKAGGHVSTRVLGTQ 256
H P + HRD KS NIL+ KN ++D GLA + +GT+
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 257 GYVAPEYALTGHL-------TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 309
Y+APE L + ++D+Y+ G+V E+ +++ LP
Sbjct: 216 RYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY--------QLP 266
Query: 310 --RLTDREKILEIMD---------PALEGQYSMKEVIQ-VAAIAAMCVQPEADYRPLMAD 357
L + +E M P + ++ E ++ +A I C R
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326
Query: 358 VVQSLVPLVK 367
+ ++L L +
Sbjct: 327 IKKTLSQLSQ 336
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-40
Identities = 67/289 (23%), Positives = 122/289 (42%), Gaps = 46/289 (15%)
Query: 94 GHGGFGLVYRGVL-SNGRKVAIKLM-DQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS 151
G G FG V+ G L ++ VA+K + + +F E +L + P ++ L+G C+
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182
Query: 152 DRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 210
++ +V + + G L + ++L +T L++ +AA G+E+L
Sbjct: 183 QKQPIYIVMELVQGGDFLTFL------RTEGARLRVKTLLQMVGDAAAGMEYLESK---C 233
Query: 211 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY----VAPEYALT 266
IHRD + N L+ + K+SDFG+++ +D V G + APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEAD----GVYAASGGLRQVPVKWTAPEALNY 289
Query: 267 GHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 325
G +++SDV+S+G++L E + G P P L++++ +
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASP----------------YPNLSNQQTREFVEK--- 330
Query: 326 EGQYSMKE----VIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370
G + V + C E RP + + Q L + K +R
Sbjct: 331 -G-GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 8e-39
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 21/207 (10%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G FG V+ G + KVA+K + + G D F E L+ +L+ L+ L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 151 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 210
+ ++ +YM NG L + L +G KL L +A + A+G+ F+ E
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKTPSGI-----KLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 211 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYAL 265
IHRD +++NIL+ K++DFGLA++ D + G + + APE
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK------WTAPEAIN 183
Query: 266 TGHLTTKSDVYSYGVVLLELLT-GRVP 291
G T KSDV+S+G++L E++T GR+P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIP 210
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-38
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G FG V+ + KVA+K M + G + F E ++ L+ L+ L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 151 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 210
+ ++ ++MA G L + L GS KL + + + A+G+ F+ +
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIAEGMAFIEQRN--- 304
Query: 211 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---APEYALTG 267
IHRD +++NIL+ + K++DFGLA++ D T G + + APE G
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEAINFG 360
Query: 268 HLTTKSDVYSYGVVLLELLT-GRVP 291
T KSDV+S+G++L+E++T GR+P
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIP 385
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G FG+V G VAIK++ + G EDEF E +++ L L+ L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 151 SDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
+ +R ++ +YMANG L +L + + + L + + + +E+L
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL------REMRHRFQTQQLLEMCKDVCEAMEYLESKQ-- 140
Query: 210 PVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYA 264
+HRD + N L++ KVSDFGL++ D G R + PE
Sbjct: 141 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVL 193
Query: 265 LTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+ ++KSD++++GV++ E+ + G++P
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 60/220 (27%), Positives = 93/220 (42%), Gaps = 23/220 (10%)
Query: 82 SATGGFSKSN-VVGHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGR 137
S G F K + +G G F VY+G+ +VA + + K FK E E+L
Sbjct: 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 81
Query: 138 LRSPYLLALLGYCSDRRKL-----LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI 192
L+ P ++ K LV + M +G L+ + +
Sbjct: 82 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFK------VMKIKVLRSW 134
Query: 193 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAGGHVSTR 251
+ KGL+FLH +PP+IHRD K NI + K+ D GLA + +
Sbjct: 135 CRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKA 189
Query: 252 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
V+GT ++APE + DVY++G+ +LE+ T P
Sbjct: 190 VIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYP 228
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G FG V+ G + +VAIK + + G + F E +++ +LR L+ L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 151 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 210
S+ +V +YM+ G L + L G +L + +A + A G+ ++
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMAAQIASGMAYVERMN--- 300
Query: 211 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYAL 265
+HRD +++NIL+ +N KV+DFGLA++ D + G + + APE AL
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAAL 354
Query: 266 TGHLTTKSDVYSYGVVLLELLT-GRVP 291
G T KSDV+S+G++L EL T GRVP
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVP 381
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 23/208 (11%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G FGLV+ G N KVAIK + + G E++F E E++ +L P L+ L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 151 SDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
++ LV ++M +G L ++L + ET L + L+ +G+ +L E C
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL------RTQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 124
Query: 210 PVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYA 264
VIHRD + N L+ +N KVSDFG+ + D G + + +PE
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK------WASPEVF 177
Query: 265 LTGHLTTKSDVYSYGVVLLELLT-GRVP 291
++KSDV+S+GV++ E+ + G++P
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRK-----VAIK-LMDQAGKQGEDEFKMEVELLGRLRS 140
F K V+G G FG VY+G+ + VAIK L + + E E ++ + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 141 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
P++ LLG C L+ M G L +++ + L+W ++ AKG+
Sbjct: 77 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD-----KAGGHVSTRVLG 254
+L + ++HRD + N+L+ H K++DFGLAK +G++ GG V +
Sbjct: 131 NYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK--- 184
Query: 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
++A E L T +SDV+SYGV + EL+T G P
Sbjct: 185 ---WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 21/207 (10%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G FG V+ G + +VAIK + + G + F E +++ +LR L+ L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 151 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 210
S+ +V +YM+ G L + L G +L + +A + A G+ ++
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMAAQIASGMAYVERMN--- 383
Query: 211 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYAL 265
+HRD +++NIL+ +N KV+DFGLA++ D + G + + APE AL
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAAL 437
Query: 266 TGHLTTKSDVYSYGVVLLELLT-GRVP 291
G T KSDV+S+G++L EL T GRVP
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVP 464
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-37
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRK-----VAIK-LMDQAGKQGEDEFKMEVELLGRLRS 140
K V+G G FG V++GV + V IK + D++G+Q + +G L
Sbjct: 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 141 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
+++ LLG C LV Y+ G L +H+ G+ L+W ++ AKG+
Sbjct: 75 AHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGM 128
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD-----KAGGHVSTRVLG 254
+L EH ++HR+ + N+LL +V+DFG+A + D + +
Sbjct: 129 YYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK--- 182
Query: 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
++A E G T +SDV+SYGV + EL+T G P
Sbjct: 183 ---WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 92 VVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS 151
+G G FG+V G VA+K++ + G EDEF E + + +L P L+ G CS
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 152 DRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 210
+V +Y++NG L +L S L+ L + + +G+ FL H
Sbjct: 74 KEYPIYIVTEYISNGCLLNYL------RSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--- 124
Query: 211 VIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEYAL 265
IHRD + N L+D++ KVSDFG+ + D G + + APE
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK------WSAPEVFH 178
Query: 266 TGHLTTKSDVYSYGVVLLELLT-GRVP 291
++KSDV+++G+++ E+ + G++P
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG--EDEFKMEVELLGRLRSPYLLALLG 148
+G G FG V G G KVA+K + K F E ++ +LR L+ LLG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 149 YCSDRRKLL--VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
+ + L V +YMA G L ++L S L + L+ +L+ + +E+L +
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-----VLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPEYAL 265
+HRD + N+L+ ++ AKVSDFGL K S + G + + + APE
Sbjct: 137 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 187
Query: 266 TGHLTTKSDVYSYGVVLLELLT-GRVP 291
+TKSDV+S+G++L E+ + GRVP
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 6e-36
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 40/218 (18%)
Query: 92 VVGHGGFGLVYRGVLSNGR----KVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
++G G FG VY GV +N + VA+K +++F E ++ L P+++ L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 147 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
+G + ++ + G L +L + L T + +L+ K + +L
Sbjct: 79 IGIIEEEPTWIIMELYPYGELGHYL------ERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV------- 259
+HRD NIL+ K+ DFGL+ R + + Y
Sbjct: 133 N---CVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKASVTRL 176
Query: 260 -----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+PE TT SDV+ + V + E+L+ G+ P
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-35
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 91 NVVGHGGFGLVYRGVLSNGR-KVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 149
+ +G G +G VY GV VA+K + + +EF E ++ ++ P L+ LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
C+ ++ ++M G L ++L N ++ L +A + + +E+L +
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLEKKN- 131
Query: 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEY 263
IHRD + N L+ +N KV+DFGL+++ + AG + + APE
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPES 183
Query: 264 ALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+ KSDV+++GV+L E+ T G P
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQG--EDEFKMEVELLGRLRSPYLLALLG 148
+G G FG V G G KVA+K + K F E ++ +LR L+ LLG
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 149 YCSDRRKLL--VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
+ + L V +YMA G L ++L S L + L+ +L+ + +E+L +
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-----VLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPEYAL 265
+HRD + N+L+ ++ AKVSDFGL K S + G + + + APE
Sbjct: 309 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 359
Query: 266 TGHLTTKSDVYSYGVVLLELLT-GRVP 291
+TKSDV+S+G++L E+ + GRVP
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-35
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 92 VVGHGGFGLVYRGVLSNGR-----KVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
V+G G FG VY+G+L VAIK L ++ +F E ++G+ ++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 146 LLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L G S + +++ +YM NG L + L +G + + + A G+++L
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDG------EFSVLQLVGMLRGIAAGMKYLA 164
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---AP 261
+HRD + NIL++ N KVSDFGL+++ D +T G + + AP
Sbjct: 165 NMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKIPIRWTAP 219
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
E T+ SDV+S+G+V+ E++T G P
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 94 GHGGFGLVYRGVLSNGRK---VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 149
G G FG V +GV +K VAIK L K +E E +++ +L +PY++ L+G
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 150 CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
C +LV + G L + L ++ + + + G+++L E
Sbjct: 79 CQAEALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYLEEKN-- 130
Query: 210 PVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD------KAGGHVSTRVLGTQGYVAPE 262
+HRD + N+LL +AK+SDFGL+K +G+D ++ G + + APE
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK------WYAPE 183
Query: 263 YALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+++SDV+SYGV + E L+ G+ P
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 65/310 (20%), Positives = 115/310 (37%), Gaps = 47/310 (15%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---EVELLGRLRSPY 142
F +G G F VYR L +G VA+K + E++LL +L P
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 143 LLALLGYCSDRRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
++ + +L + + G L + + T + ++ LE
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMI---KHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+H V+HRD K +N+ + K+ D GL + S K + V GT Y++P
Sbjct: 151 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLV-GTPYYMSP 205
Query: 262 E------YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315
E Y KSD++S G +L E+ + P +K + + +
Sbjct: 206 ERIHENGY------NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-----------K 248
Query: 316 KILE-IMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 372
KI + P YS +++++ MC+ P+ + RP + V V + +
Sbjct: 249 KIEQCDYPPLPSDHYSEELRQLVN------MCINPDPEKRPDVTYVYD--VAKRMHACTA 300
Query: 373 PKISSSPSFH 382
+ H
Sbjct: 301 SSLEHHHHHH 310
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 92 VVGHGGFGLVYRGVLSNGR---KVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
+G G FG V +G + VA+K++ + +DE E ++ +L +PY++ +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 147 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
+G C +LV + G L ++L + + + + + + G+++L E
Sbjct: 84 IGICEAESWMLVMEMAELGPLNKYL-------QQNRHVKDKNIIELVHQVSMGMKYLEES 136
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---APEY 263
+HRD + N+LL +AK+SDFGL+K + + + V APE
Sbjct: 137 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT--HGKWPVKWYAPEC 191
Query: 264 ALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
++KSDV+S+GV++ E + G+ P
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-35
Identities = 60/287 (20%), Positives = 107/287 (37%), Gaps = 41/287 (14%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G GGF V L +G A+K + +Q +E + E ++ P +L L+ YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 151 SDRRK-----LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 205
R L+ + G L + + L + L + L +GLE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEI---ERLKDKGNFLTEDQILWLLLGICRGLEAIH- 151
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-------GTQGY 258
+ HRD K +NILL + D G G L T Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 259 VAPE-YALTGH--LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315
APE +++ H + ++DV+S G VL ++ G P D+ G+ V +
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----------- 258
Query: 316 KILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360
+ + ++S + +++ + + RP + ++
Sbjct: 259 AVQNQLSIPQSPRHSSALWQLLN------SMMTVDPHQRPHIPLLLS 299
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-35
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 91 NVVGHGGFGLVYRGVL-----SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLL 144
+G G FG V + G +VA+K L ++G + K E+E+L L ++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 145 ALLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
G C++ L+ +++ +G L+E+L P N + K++ + +L+ A++ KG++
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKN-----KINLKQQLKYAVQICKGMD 140
Query: 202 FLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYV 259
+L +HRD + N+L++ K+ DFGL K I +DK V V
Sbjct: 141 YLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD---DRDSPV 193
Query: 260 ---APEYALTGHLTTKSDVYSYGVVLLELLT 287
APE + SDV+S+GV L ELLT
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-35
Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 91 NVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+ +G G FG V + G VA+K + +G + +F+ E+++L L S +++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 146 LLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
G + LV +Y+ +G L++ L + + +LD L + + KG+E+
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRA-----RLDASRLLLYSSQICKGMEY 142
Query: 203 LHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDK------AGGHVSTRVLG 254
L C +HRD + NIL++ H K++DFGLAK + DK G
Sbjct: 143 LGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF--- 195
Query: 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+ APE + +SDV+S+GVVL EL T
Sbjct: 196 ---WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRK-----VAIK-LMDQAGKQGEDEFKMEVELLGRLRS 140
F K V+G G FG VY+G+ + VAIK L + + E E ++ + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 141 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
P++ LLG C L+ M G L +++ + L+W ++ AKG+
Sbjct: 77 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD-----KAGGHVSTRVLG 254
+L + ++HRD + N+L+ H K++DFGLAK +G++ GG V +
Sbjct: 131 NYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK--- 184
Query: 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
++A E L T +SDV+SYGV + EL+T G P
Sbjct: 185 ---WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-35
Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 91 NVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 149
+ +G G +G VY GV VA+K + + +EF E ++ ++ P L+ LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
C+ ++ ++M G L ++L N ++ L +A + + +E+L +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLEKKN- 338
Query: 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAPEY 263
IHR+ + N L+ +N KV+DFGL+++ + AG + + APE
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPES 390
Query: 264 ALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+ KSDV+++GV+L E+ T G P
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSP 419
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 53/211 (25%), Positives = 84/211 (39%), Gaps = 22/211 (10%)
Query: 92 VVGHGGFGLVYRGVL----SNGRKVAIKLM---DQAGKQGEDEFKMEVELLGRLRSPYLL 144
+G G FG+V RG VA+K + + + D+F EV + L L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 145 ALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L G +V + G L + L G + + + A++ A+G+ +L
Sbjct: 85 RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEGMGYLE 138
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---AP 261
IHRD + N+LL K+ DFGL + +V + AP
Sbjct: 139 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAP 193
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
E T + SD + +GV L E+ T G+ P
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 91 NVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+G G FG V + G VA+K + + ++ +F+ E+E+L L+ ++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 146 LLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
G C + L+ +Y+ G L+++L + ++D L+ + KG+E+
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKE-----RIDHIKLLQYTSQICKGMEY 129
Query: 203 LHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYV- 259
L IHRD + NIL++ K+ DFGL K + DK V + +
Sbjct: 130 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE---PGESPIF 182
Query: 260 --APEYALTGHLTTKSDVYSYGVVLLELLT 287
APE + SDV+S+GVVL EL T
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 63/213 (29%), Positives = 89/213 (41%), Gaps = 33/213 (15%)
Query: 91 NVVGHGGFGLVYRGVLSN-----GRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLL 144
+G G FG V G VA+K L AG Q +K E+++L L +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 145 ALLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
G C D LV +Y+ G L+++L + L A + +G+
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLP--------RHSIGLAQLLLFAQQICEGMA 148
Query: 202 FLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYV 259
+LH H IHRD + N+LLD + K+ DFGLAK + V G
Sbjct: 149 YLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED-----GDS 199
Query: 260 -----APEYALTGHLTTKSDVYSYGVVLLELLT 287
APE SDV+S+GV L ELLT
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 92 VVGHGGFGLVYRGVLSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
+G G FG V++G+ + VAIK + ++F E + + P+++ L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 147 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
+G ++ ++ + G L+ L S +AS + + A + + L +L
Sbjct: 82 IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY------AYQLSTALAYLESK 135
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAP 261
+HRD + N+L+ N K+ DFGL++ D + G + + ++AP
Sbjct: 136 R---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAP 186
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
E T+ SDV+ +GV + E+L G P
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-34
Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 41/226 (18%)
Query: 91 NVVGHGGFGLVYRGVLSNGRK------VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYL 143
+G G FG+VY GV K VAIK + + A + EF E ++ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 144 LALLGYCSDRRKLL-VYDYMANGGLQEHL---YPANGSNSVASKLDWETRLRIALEAAKG 199
+ LLG S + L + + M G L+ +L PA +N V + +++A E A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY- 258
+ +L+ + +HRD + N ++ ++F K+ DFG+ R + Y
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT-------------RDIYETDYY 194
Query: 259 ------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
++PE G TT SDV+S+GVVL E+ T P
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 27/212 (12%)
Query: 92 VVGHGGFGLVYRGVLSNGRK---VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLALL 147
+G G FG V +GV +K VAIK L K +E E +++ +L +PY++ L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 148 GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
G C +LV + G L + L ++ + + + G+++L E
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD------KAGGHVSTRVLGTQGYVA 260
+HR+ + N+LL +AK+SDFGL+K +G+D ++ G + + A
Sbjct: 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK------WYA 507
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
PE +++SDV+SYGV + E L+ G+ P
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 91 NVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+G G FG V + G VA+K + + ++ +F+ E+E+L L+ ++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 146 LLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
G C + L+ +Y+ G L+++L + ++D L+ + KG+E+
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKE-----RIDHIKLLQYTSQICKGMEY 160
Query: 203 LHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYV- 259
L IHRD + NIL++ K+ DFGL K + DK V + +
Sbjct: 161 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE---PGESPIF 213
Query: 260 --APEYALTGHLTTKSDVYSYGVVLLELLT 287
APE + SDV+S+GVVL EL T
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-34
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 91 NVVGHGGFGLVYRGVLSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
VVG G FG V G L K VAIK L ++ +F E ++G+ P ++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 146 LLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L G + + ++V +YM NG L L + + + + A G+++L
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA------QFTVIQLVGMLRGIASGMKYLS 164
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---AP 261
+ +HRD + NIL++ N KVSDFGL ++ D +TR G + + +P
Sbjct: 165 DMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSP 219
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
E T+ SDV+SYG+VL E+++ G P
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-34
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 46/228 (20%)
Query: 94 GHGGFGLVYRGVLSNGRK------VAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALL 147
G G FG V+ N VA+K + +F+ E ELL L+ +++
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83
Query: 148 GYCSDRR-KLLVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLRIALEAA 197
G C D ++V++YM +G L + L +L L IA + A
Sbjct: 84 GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 143
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
G+ +L +HRD + N L+ N K+ DFG++ R + +
Sbjct: 144 SGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS-------------RDVYSTD 187
Query: 258 Y-------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
Y + PE + TT+SDV+S+GV+L E+ T G+ P
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-34
Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 40/231 (17%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
F + V+G G FG V + + R AIK + ++ EV LL L Y++
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 146 LLG-YCSDRRKL-------------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR 191
+ R + + +Y NG L + ++ N + R
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN------LNQQRDEYWR 120
Query: 192 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD--------- 242
+ + + L ++H +IHRD K NI +D++ + K+ DFGLAK
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 243 ----KAGGHVSTRVLGTQGYVAPE-YALTGHLTTKSDVYSYGVVLLELLTG 288
+ ++++ + GT YVA E TGH K D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-34
Identities = 65/324 (20%), Positives = 121/324 (37%), Gaps = 54/324 (16%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---EVELLGRLRSPY 142
+ + +G G FG +GR+ IK ++ + E + EV +L ++ P
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN-ISRMSSKEREESRREVAVLANMKHPN 84
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
++ + L +V DY G L + + G + L ++ L+
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV-----LFQEDQILDWFVQICLALK 139
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+H+ ++HRD KS NI L K+ ++ DFG+A++ + + ++ +GT Y++P
Sbjct: 140 HVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLN--STVELARACIGTPYYLSP 194
Query: 262 E------YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315
E Y KSD+++ G VL EL T + + LV
Sbjct: 195 EICENKPY------NNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVL---------- 235
Query: 316 KILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRP-----LMADVVQSLVPLVKY 368
KI+ P + YS ++ ++ + RP L + +
Sbjct: 236 KIISGSFPPVSLHYSYDLRSLVS------QLFKRNPRDRPSVNSILEKGFIAKRIEKFLS 289
Query: 369 NRSTPKISSSPSFHASRSPAFPDK 392
+ + +F S P K
Sbjct: 290 PQLIAEEFCLKTFSKFGSQPIPAK 313
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-34
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 91 NVVGHGGFGLVYRGVL----SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
++G G G V G L VAIK L ++ +F E ++G+ P ++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 146 LLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L G + R ++V +YM NG L L +G + + + G+ +L
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG------QFTIMQLVGMLRGVGAGMRYLS 168
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV---AP 261
+ +HRD + N+L+D N KVSDFGL+++ D +T G + + AP
Sbjct: 169 DLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT--GGKIPIRWTAP 223
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
E ++ SDV+S+GVV+ E+L G P
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 49/233 (21%)
Query: 91 NVVGHGGFGLVYRGVLSNGRK------VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYL 143
+G FG VY+G L VAIK L D+A +EF+ E L RL+ P +
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 144 LALLGYCSDRR-KLLVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLRIA 193
+ LLG + + +++ Y ++G L E L + +V S L+ + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 194 LEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRV 252
+ A G+E+L H +H+D + N+L+ + K+SD GL R
Sbjct: 135 AQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLF-------------RE 177
Query: 253 LGTQGY-------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+ Y +APE + G + SD++SYGVVL E+ + G P
Sbjct: 178 VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 49/220 (22%), Positives = 87/220 (39%), Gaps = 26/220 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLR--SPY 142
+S +G GG V++ + + AIK ++ +A Q D ++ E+ L +L+ S
Sbjct: 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 143 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
++ L Y + + + N L L +D R + +
Sbjct: 71 IIRLYDYEITDQYIYMVMECGNIDLNSWLK-KKK------SIDPWERKSYWKNMLEAVHT 123
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
+H+H ++H D K +N L+ K+ DFG+A V +GT Y+ PE
Sbjct: 124 IHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 263 -----------YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
++ KSDV+S G +L + G+ P
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQG-EDEFKMEVELLGRLRSPYLLALLGY 149
G G FG VY + +A+K++ Q K G E + + EVE+ LR P +L L GY
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
D ++ L+ +Y G + L SK D + E A L + H
Sbjct: 78 FHDATRVYLILEYAPLGTVYREL-------QKLSKFDEQRTATYITELANALSYCHSKR- 129
Query: 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 268
VIHRD K N+LL K++DFG + A T + GT Y+ PE
Sbjct: 130 --VIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 269 LTTKSDVYSYGVVLLELLTGRVPID 293
K D++S GV+ E L G+ P +
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFE 208
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-33
Identities = 64/216 (29%), Positives = 95/216 (43%), Gaps = 29/216 (13%)
Query: 91 NVVGHGGFGLVYRGVLSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
V+G G FG VY G L + A+K L +F E ++ P +L+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 146 LLGYCSDRRK--LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
LLG C L+V YM +G L+ + + + + L+ AKG+++L
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI------RNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 204 HE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD---KAGGHVSTR--VLGTQ 256
+HRD + N +LD+ F KV+DFGLA+ + + V
Sbjct: 145 ASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM- 199
Query: 257 GYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
A E T TTKSDV+S+GV+L EL+T G P
Sbjct: 200 ---ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 45/230 (19%)
Query: 91 NVVGHGGFGLVYRGVLSNGRK------VAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLL 144
+G G FG V+ N VA+K + +A + +F+ E ELL L+ +++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 145 ALLGYCSDRR-KLLVYDYMANGGLQEHL--------YPANGSNSVASKLDWETRLRIALE 195
G C++ R L+V++YM +G L L A G + L L +A +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGT 255
A G+ +L +HRD + N L+ + K+ DFG++ R + +
Sbjct: 167 VAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMS-------------RDIYS 210
Query: 256 QGY-------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
Y + PE L TT+SDV+S+GVVL E+ T G+ P
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-----FKMEVELLGRLRSPYLLAL 146
+G GG V+ L + R VA+K++ D F+ E + L P ++A+
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRA--DLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 147 LGYCSDRRKLLVYDYMA----NGG-LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
Y+ +G L++ ++ G + + + + +A + L
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEG------PMTPKRAIEVIADACQALN 130
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST-RVLGTQGYVA 260
F H++ +IHRD K +NI++ KV DFG+A+ +D T V+GT Y++
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
PE A + +SDVYS G VL E+LTG P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 60/275 (21%), Positives = 99/275 (36%), Gaps = 44/275 (16%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKMEVELLGRL-RSPY 142
F + + +GHG +G V++ +GR A+K + G + EV ++ + P
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
+ L + L L + LQ+H S L + L
Sbjct: 119 CVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGAS------LPEAQVWGYLRDTLLALA 171
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
LH ++H D K +NI L K+ DFGL G V G Y+AP
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAP 225
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE-I 320
E L G T +DV+S G+ +LE+ P G +++ +
Sbjct: 226 E-LLQGSYGTAADVFSLGLTILEVACNMEL-----PHG-----------GEGWQQLRQGY 268
Query: 321 MDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRP 353
+ P S ++ V+ M ++P+ R
Sbjct: 269 LPPEFTAGLSSELRSVLV------MMLEPDPKLRA 297
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-33
Identities = 50/221 (22%), Positives = 89/221 (40%), Gaps = 28/221 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLR--SPY 142
+S +G GG V++ + + AIK ++ +A Q D ++ E+ L +L+ S
Sbjct: 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
++ L Y + + +V + N L L +D R + +
Sbjct: 90 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKK------SIDPWERKSYWKNMLEAVH 141
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+H+H ++H D K +N L+ K+ DFG+A V +GT Y+ P
Sbjct: 142 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 262 E-----------YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
E ++ KSDV+S G +L + G+ P
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-33
Identities = 67/218 (30%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 91 NVVGHGGFGLVYRGVLSNGR----KVAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
V+G G FG+VY G + + AIK L Q + F E L+ L P +LA
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 146 LLGYCSDRR--KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
L+G ++ YM +G L + + + N L + L+ A+G+E+L
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDL-----ISFGLQVARGMEYL 140
Query: 204 HE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK--------IGSDKAGGHVSTRVLG 254
E +HRD + N +LD++F KV+DFGLA+ + +
Sbjct: 141 AEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK--- 193
Query: 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+ A E T TTKSDV+S+GV+L ELLT G P
Sbjct: 194 ---WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-33
Identities = 57/214 (26%), Positives = 86/214 (40%), Gaps = 36/214 (16%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-----FKMEVELLGRLRSPYLLAL 146
+G GG VY KVAIK + E E F+ EV +L +++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQLSHQNIVS- 75
Query: 147 LGYCSDRRKLLVYDYMANGGLQ----EHLYPANGSN-----SVASKLDWETRLRIALEAA 197
+ D E++ G L +T + +
Sbjct: 76 -----------MIDVDEEDDCYYLVMEYI---EGPTLSEYIESHGPLSVDTAINFTNQIL 121
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
G++ H+ ++HRD K NIL+D N K+ DFG+AK S+ + + VLGT
Sbjct: 122 DGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQ 177
Query: 258 YVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
Y +PE A +D+YS G+VL E+L G P
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-33
Identities = 46/220 (20%), Positives = 90/220 (40%), Gaps = 30/220 (13%)
Query: 94 GHGGFGLVYRGVLSNGRKVAIKLMD-----------------QAGKQGEDEFKMEVELLG 136
G F + + + A+K + + K D+FK E++++
Sbjct: 40 NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 137 RLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR-IAL 194
+++ Y L G ++ ++ ++Y+YM N + + + + ++ I
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 195 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLG 254
++H + + HRD K SNIL+DKN K+SDFG ++ D + G
Sbjct: 159 SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD---KKIKGSR-G 212
Query: 255 TQGYVAPEYALTGHLTT---KSDVYSYGVVLLELLTGRVP 291
T ++ PE + + K D++S G+ L + VP
Sbjct: 213 TYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 92 VVGHGGFGLVYRGVLSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
+G G FG V++G+ + VAIK + ++F E + + P+++ L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 147 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
+G ++ ++ + G L+ L LD + + A + + L +L
Sbjct: 457 IGVITENPVWIIMELCTLGELRSFLQVRKF------SLDLASLILYAYQLSTALAYLESK 510
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-----KAGGHVSTRVLGTQGYVAP 261
+HRD + N+L+ N K+ DFGL++ D + G + + ++AP
Sbjct: 511 R---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAP 561
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
E T+ SDV+ +GV + E+L G P
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 48/220 (21%), Positives = 86/220 (39%), Gaps = 26/220 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLR--SPY 142
+S +G GG V++ + + AIK ++ +A Q D ++ E+ L +L+ S
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 143 LLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
++ L Y + + + N L L +D R + +
Sbjct: 118 IIRLYDYEITDQYIYMVMECGNIDLNSWLK-KKK------SIDPWERKSYWKNMLEAVHT 170
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
+H+H ++H D K +N L+ K+ DFG+A V +G Y+ PE
Sbjct: 171 IHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 263 -----------YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
++ KSDV+S G +L + G+ P
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-32
Identities = 71/220 (32%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 91 NVVGHGGFGLVYRGVLSNG---RKVAIKLM-DQAGKQGEDEFKMEVELLGRLRS-PYLLA 145
+V+G G FG V + + AIK M + A K +F E+E+L +L P ++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLRIALE 195
LLG C R L L +Y +G L + L +NS AS L + L A +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD---KAGGHVSTRV 252
A+G+++L + IHRD + NIL+ +N+ AK++DFGL++ K G + R
Sbjct: 151 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 206
Query: 253 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
++A E TT SDV+SYGV+L E+++ G P
Sbjct: 207 -----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 55/227 (24%), Positives = 97/227 (42%), Gaps = 43/227 (18%)
Query: 91 NVVGHGGFGLVYRGVLSNGR----KVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLL 144
++G G FG V G L KVA+K M D + ++ +EF E + P ++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 145 ALLGYCSDR------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 198
LLG C + + +++ +M G L +L + + + +T L+ ++ A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL-YSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
G+E+L +HRD + N +L + V+DFGL+ + + + Y
Sbjct: 159 GMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLS-------------KKIYSGDY 202
Query: 259 -------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+A E T+KSDV+++GV + E+ T G P
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 29/220 (13%)
Query: 91 NVVGHGGFGLVYRGVLSNGRK------VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYL 143
+GHG FG VY G +S VA+K L + +Q E +F ME ++ + +
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 144 LALLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
+ +G + ++ + MA G L+ L S S L L +A + A G ++
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 203 LHE-HCSPPVIHRDFKSSNILLDK---NFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQG 257
L E H IHRD + N LL AK+ DFG+A+ I S G
Sbjct: 156 LEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA------SYYRKGGCA 205
Query: 258 YV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+ PE + G T+K+D +S+GV+L E+ + G +P
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 66/318 (20%), Positives = 117/318 (36%), Gaps = 74/318 (23%)
Query: 94 GHGGFGLVYRGVLSNGR--------KVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
G G F +++GV +V +K++D+A + + F ++ +L +L+
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVL 76
Query: 146 LLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
G C +LV +++ G L +L ++ KL+ A + A + FL
Sbjct: 77 NYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV------AKQLAAAMHFLE 130
Query: 205 EHCSPPVIHRDFKSSNILLDK--------NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 256
E+ +IH + + NILL + K+SD G++ VL
Sbjct: 131 ENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKD 175
Query: 257 GY------VAPEYALTG-HLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWAL 308
V PE +L +D +S+G L E+ + G P L
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP----------------L 219
Query: 309 PRLTDREKILEIMD----PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364
L + K+ D PA + ++A + C+ E D+RP +++ L
Sbjct: 220 SALDSQRKLQFYEDRHQLPAPKAA-------ELANLINNCMDYEPDHRPSFRAIIRDLNS 272
Query: 365 LVKYNRSTPKISSSPSFH 382
L P+ S H
Sbjct: 273 LF-TPDLVPRGSHHHHHH 289
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 59/215 (27%), Positives = 88/215 (40%), Gaps = 36/215 (16%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-----FKMEVELLGRLRSPYLLA 145
+VG GG G VY R VA+KLM + D + E GRL+ P+++
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSET--LSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 146 LLGYCSDRRKLLVYDYMANGGLQEHLYPA----NGSN-----SVASKLDWETRLRIALEA 196
++D+ G + LY NG + L + I +
Sbjct: 99 ------------IHDF---GEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQI 143
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 256
L+ H HRD K NIL+ + A + DFG+A +D+ + +GT
Sbjct: 144 GSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTL 199
Query: 257 GYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
Y+APE H T ++D+Y+ VL E LTG P
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 89 KSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALL 147
V+G G +G+VY G LSN ++AIK + + + E+ L L+ ++ L
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 148 GYCSDRRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLR-IALEAAKGLEFLHE 205
G S+ + ++ + + G L L G D E + + +GL++LH+
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK-----DNEQTIGFYTKQILEGLKYLHD 140
Query: 206 HCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE-- 262
+ ++HRD K N+L++ + K+SDFG +K + + GT Y+APE
Sbjct: 141 NQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEII 195
Query: 263 -YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
G+ +D++S G ++E+ TG+ P
Sbjct: 196 DKGPRGY-GKAADIWSLGCTIIEMATGKPP 224
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 54/229 (23%), Positives = 93/229 (40%), Gaps = 46/229 (20%)
Query: 91 NVVGHGGFGLVYRGVLSNG----RKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLL 144
++G G FG V L KVA+K++ D +EF E + P++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 145 ALLGYCSDR-------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 197
L+G +++ +M +G L L A+ L +T +R ++ A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL-ASRIGENPFNLPLQTLVRFMVDIA 147
Query: 198 KGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 256
G+E+L + IHRD + N +L ++ V+DFGL+ R + +
Sbjct: 148 CGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLS-------------RKIYSG 190
Query: 257 GY-------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
Y +A E T SDV+++GV + E++T G+ P
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-32
Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 91 NVVGHGGFGLVYRGVLSNGRK----VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
V+G G FG VY G L + A+K L +F E ++ P +L+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 146 LLGYCSDRRK--LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
LLG C L+V YM +G L+ + + + + L+ AKG++FL
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN------PTVKDLIGFGLQVAKGMKFL 208
Query: 204 HE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV--- 259
+HRD + N +LD+ F KV+DFGLA+ DK V + T +
Sbjct: 209 ASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVK 261
Query: 260 --APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
A E T TTKSDV+S+GV+L EL+T G P
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 60/228 (26%), Positives = 93/228 (40%), Gaps = 37/228 (16%)
Query: 91 NVVGHGGFGLVYRGVLSN------GRKVAIKLM-DQAGKQGEDEFKMEVELLGRLRS-PY 142
+G G FG V R VA+K++ + A E+++L +
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 143 LLALLGYCSDRRK--LLVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLR 191
++ LLG C+ +++ ++ G L +L Y + L E +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 192 IALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVS 249
+ + AKG+EFL C IHRD + NILL + K+ DFGLA I D
Sbjct: 153 YSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLARDIYKD------P 202
Query: 250 TRVLGTQGYV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
V + APE T +SDV+S+GV+L E+ + G P
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 91 NVVGHGGFGLVYRGVLSNGRK------VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYL 143
+GHG FG VY G +S VA+K L + +Q E +F ME ++ + +
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 144 LALLGYCSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
+ +G + ++ + MA G L+ L S S L L +A + A G ++
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 203 LHE-HCSPPVIHRDFKSSNILLDK---NFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQG 257
L E H IHRD + N LL AK+ DFG+A+ I G
Sbjct: 197 LEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA------GYYRKGGCA 246
Query: 258 YV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+ PE + G T+K+D +S+GV+L E+ + G +P
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 52/236 (22%)
Query: 91 NVVGHGGFGLVYRGVLSNGRK--------VAIKLM-DQAGKQGEDEFKMEVELLGRLRS- 140
+G G FG V K VA+K++ D A ++ + E+E++ +
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 141 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRL 190
++ LLG C+ L ++ +Y + G L+E+L Y + + ++ ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 191 RIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS 249
+ A+G+E+L C IHRD + N+L+ +N K++DFGLA
Sbjct: 161 SCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLA------------ 204
Query: 250 TRVLGTQGY-------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
R + Y +APE T +SDV+S+GV++ E+ T G P
Sbjct: 205 -RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQG-EDEFKMEVELLGRLRSPYLLALL 147
+G G FG VY N +A+K++ Q K+G E + + E+E+ LR P +L +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 148 GYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
Y DR+++ L+ ++ G L + L + D + E A L + HE
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL-------QKHGRFDEQRSATFMEELADALHYCHER 133
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL----GTQGYVAPE 262
VIHRD K N+L+ K++DFG + H + GT Y+ PE
Sbjct: 134 K---VIHRDIKPENLLMGYKGELKIADFGWSV--------HAPSLRRRTMCGTLDYLPPE 182
Query: 263 YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
K D++ GV+ E L G P
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 61/299 (20%), Positives = 118/299 (39%), Gaps = 65/299 (21%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
F + ++G GGFG V++ +G+ IK + ++ + EV+ L +L ++
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVH 68
Query: 146 LLGY--------------CSDRRKLLVY---DYMANGGLQEHLYPANGSNSVASKLDWET 188
G S + ++ ++ G L++ + G KLD
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-----KLDKVL 123
Query: 189 RLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI--GSDKAGG 246
L + + KG++++H +I+RD K SNI L K+ DFGL K
Sbjct: 124 ALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-- 178
Query: 247 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVS 305
TR GT Y++PE + + D+Y+ G++L ELL + +K
Sbjct: 179 ---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--------- 226
Query: 306 WALPRLTDREKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
++ D + + K ++Q + + + RP ++++++L
Sbjct: 227 ----------FFTDLRDGIISDIFDKKEKTLLQ------KLLSKKPEDRPNTSEILRTL 269
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 67/321 (20%), Positives = 115/321 (35%), Gaps = 54/321 (16%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLALLGY 149
V+ GGF VY + +GR+ A+K + ++ EV + +L P ++
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 150 CSDRRK--------LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
S ++ L+ + G L E L L +T L+I + + ++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG----PLSCDTVLKIFYQTCRAVQ 150
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-------- 253
+H PP+IHRD K N+LL K+ DFG A S S +
Sbjct: 151 HMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 254 --GTQGYVAPE-YALTGHL--TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 308
T Y PE L + K D+++ G +L L + P + L
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE-----DGAKL----- 259
Query: 309 PRLTDREKIL--EIMDPALEGQYS-MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365
+I+ + P + QY+ +I+ +Q + R +A+VV L +
Sbjct: 260 -------RIVNGKYSIPPHDTQYTVFHSLIR------AMLQVNPEERLSIAEVVHQLQEI 306
Query: 366 VKYNRSTPKISSSPSFHASRS 386
PK + +
Sbjct: 307 AAARNVNPKSPITELLEQNGG 327
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 38/287 (13%), Positives = 76/287 (26%), Gaps = 44/287 (15%)
Query: 45 KRLNTPKRVDREEKGESGKLEVTTDNGLQVFTFKQLHSATGG----FSKSNVVGHGGFGL 100
R+ E +S + + + ++ S G + V+G
Sbjct: 34 NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYA 93
Query: 101 VYRGV-LSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGRLRS---------------- 140
G + + + + K EV L LR
Sbjct: 94 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153
Query: 141 ---------PYLLALLGYCSDRRKLLVYDYM--ANGGLQEHLYPANGSNSVASKLDWETR 189
++ + D L + LQ +S L R
Sbjct: 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 213
Query: 190 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS 249
L++ L+ + L LH + ++H + +I+LD+ ++ F A
Sbjct: 214 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVS-PI 269
Query: 250 TRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVP 291
R A +T D ++ G+ + + +P
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-31
Identities = 30/302 (9%), Positives = 67/302 (22%), Gaps = 45/302 (14%)
Query: 37 CYIRNKVSKRLNTPKRVDREEKGE-SGKLEVTTDNGLQVFTFKQLHSATGGFSKS----N 91
++R+ + + E E + +E T + S +
Sbjct: 9 SFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVE 68
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGRLRSPYLLALL 147
+ G +V+ + A+K+ + E RL
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 148 GYC------------------------SDRRKLLVYDYM--ANGGLQEHLYPANGSNSVA 181
D M A+ L+ +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 182 SKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241
+ + + L ++H F N+ + + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL---- 241
Query: 242 DKAGGHVSTRVLGTQGYVAPEYALTGHL--TTKSDVYSYGVVLLELLTGRVPIDVNKPSG 299
G Y E+ T + + G+ + + +P + P
Sbjct: 242 -WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 300 EG 301
+G
Sbjct: 301 KG 302
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-31
Identities = 64/233 (27%), Positives = 86/233 (36%), Gaps = 52/233 (22%)
Query: 94 GHGGFGLVYRGVLSNGRK------VAIK-LMDQAGKQGEDEFKMEVELLGRLRS-PYLLA 145
G G FG V K VA+K L A + E+++L L + ++
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 146 LLGYCSDRRKLLV-YDYMANGGLQEHL-----------YPANGSNSVASKLDWETRLRIA 193
LLG C+ LV +Y G L L LD E L +
Sbjct: 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151
Query: 194 LEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRV 252
+ AKG+ FL +C IHRD + NILL K+ DFGLA R
Sbjct: 152 YQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLA-------------RD 194
Query: 253 LGTQGY-------------VAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+ +APE T +SDV+SYG+ L EL + G P
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 7e-31
Identities = 44/253 (17%), Positives = 79/253 (31%), Gaps = 31/253 (12%)
Query: 91 NVVGHGGFGLVYRGV------LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS---P 141
+++G G F VY N +K +K+ A EF + +L+ RL+
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLKPSMQH 127
Query: 142 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
+ + LV + + G L + + + + A+ +
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE--KVMPQGLVISFAMRMLYMI 185
Query: 201 EFLHEHCSPPVIHRDFKSSNILL-----------DKNFHAKVSDFGLAKIGSDKAGGHVS 249
E +H+ +IH D K N +L D + + D G + G +
Sbjct: 186 EQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 250 TRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 309
T T G+ E + D + + +L G + V GE
Sbjct: 243 TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT-YMKVKNEGGECKPEG-LFR 300
Query: 310 RLTDREKILEIMD 322
RL + E
Sbjct: 301 RLPHLDMWNEFFH 313
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 70/289 (24%), Positives = 115/289 (39%), Gaps = 42/289 (14%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM--EVELLGRLRSPYLLALLG 148
+G G +G + S+G+ + K +D ++ + EV LL L+ P ++
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 149 YCSDRRKLLVY---DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 205
DR +Y +Y G L + LD E LR+ + L+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 206 HCSPP--VIHRDFKSSNILLDKNFHAKVSDFGLAKI---GSDKAGGHVSTRVLGTQGYVA 260
V+HRD K +N+ LD + K+ DFGLA+I + A T V GT Y++
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA----KTFV-GTPYYMS 184
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320
PE KSD++S G +L EL P L KI E
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----------QKELA--GKIREG 231
Query: 321 MDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367
+ +YS + E+I + + +RP + +++++ PL+
Sbjct: 232 KFRRIPYRYSDELNEIIT------RMLNLKDYHRPSVEEILEN--PLIL 272
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 66/206 (32%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQG-EDEFKMEVELLGRLRSPYLLALLGY 149
G G F VYR + G +VAIK++D K G + EV++ +L+ P +L L Y
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
D + LV + NG + +L S + E R + G+ +LH H
Sbjct: 80 FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-----ENEAR-HFMHQIITGMLYLHSHG- 132
Query: 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH 268
++HRD SN+LL +N + K++DFGLA T + GT Y++PE T
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYT-LCGTPNYISPE-IATRS 187
Query: 269 L-TTKSDVYSYGVVLLELLTGRVPID 293
+SDV+S G + LL GR P D
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFD 213
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 25/213 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+ VG G FG V+R G + A+K + E E+ L SP ++
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPRIVP 114
Query: 146 LLGYCSDRRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLR-IALEAAKGLEFL 203
L G + + ++ + + G L + + L E R +A +GLE+L
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMG-------CLP-EDRALYYLGQALEGLEYL 166
Query: 204 HEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAK-IGSDKAGGHVSTR--VLGTQGYV 259
H ++H D K+ N+LL + A + DFG A + D G + T + GT+ ++
Sbjct: 167 HTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223
Query: 260 APE-YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
APE K D++S ++L +L G P
Sbjct: 224 APEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHP 255
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 38/226 (16%)
Query: 94 GHGGFGLVYRGVLSNGRK--------VAIKLM-DQAGKQGEDEFKMEVELLGRLRS-PYL 143
G G FG V K VA+K++ D A ++ + E+E++ + +
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 144 LALLGYCSDRRKL-LVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLRIA 193
+ LLG C+ L ++ +Y + G L+E+L Y + + ++ ++ +
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 194 LEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTR 251
+ A+G+E+L C IHRD + N+L+ +N K++DFGLA I +
Sbjct: 210 YQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNI------DYY 259
Query: 252 VLGTQGYV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
T G + APE T +SDV+S+GV++ E+ T G P
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 57/231 (24%), Positives = 101/231 (43%), Gaps = 43/231 (18%)
Query: 94 GHGGFGLVYRGVLSNGRK------VAIKLM-DQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
G G FG V + + + VA+K++ + A + E +L ++ P+++ L
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL 91
Query: 147 LGYCSDRR-KLLVYDYMANGGLQEHL-----------------YPANGSNSVASKLDWET 188
G CS LL+ +Y G L+ L ++ + L
Sbjct: 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151
Query: 189 RLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGG 246
+ A + ++G+++L E +HRD + NIL+ + K+SDFGL+ + +
Sbjct: 152 LISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGLSRDVYEE---- 203
Query: 247 HVSTRVLGTQGYV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+ V +QG + A E TT+SDV+S+GV+L E++T G P
Sbjct: 204 --DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-30
Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 94 GHGGFGLVYRGVL--------SNGRKVAIKLM-DQAGKQGEDEFKMEVELLGRLRS-PYL 143
G G FG V + KVA+K++ A ++ + E+E++ + +
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137
Query: 144 LALLGYCSDRRKL-LVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLRIA 193
+ LLG C+ L ++ +Y + G L+E+L Y N S++ +L + + A
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197
Query: 194 LEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTR 251
+ A+G+E+L C IHRD + N+L+ ++ K++DFGLA I
Sbjct: 198 YQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHI------DYY 247
Query: 252 VLGTQGYV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
T G + APE T +SDV+S+GV+L E+ T G P
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 45/213 (21%), Positives = 75/213 (35%), Gaps = 37/213 (17%)
Query: 92 VVGHGGFGLVYRGV--LSNGRKVAIKLMDQAGKQGEDE-FKMEVELLGRLRSPYLLALLG 148
+ HGG G +Y + NGR V +K + +G E + L + P ++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ--- 143
Query: 149 YCSDRRKLLVYDYMANGGLQEHLYP------ANGSN---SVASKLDWETRLRIALEAAKG 199
+++++ + G + S KL + LE
Sbjct: 144 ---------IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPA 194
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGY 258
L +LH +++ D K NI+L + K+ D G I S + GT G+
Sbjct: 195 LSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-------LYGTPGF 243
Query: 259 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
APE T +D+Y+ G L L
Sbjct: 244 QAPEIV-RTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-30
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 25/209 (11%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQG-EDEFKMEVELLGRLRSPYLLALLGY 149
G GGF + A K++ K ++ ME+ + L +++ G+
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASK--LDWETRLRIALEAAKGLEFLHEH 206
D + +V + L E K + E R + G ++LH +
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELH--------KRRKALTEPEAR-YYLRQIVLGCQYLHRN 160
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTRVLGTQGYVAPEYAL 265
VIHRD K N+ L+++ K+ DFGLA K+ D G + GT Y+APE L
Sbjct: 161 R---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPE-VL 213
Query: 266 TGHL-TTKSDVYSYGVVLLELLTGRVPID 293
+ + + DV+S G ++ LL G+ P +
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 34/225 (15%)
Query: 91 NVVGHGGFGLVYRGVL------SNGRKVAIK-LMDQAGKQGEDEFKMEVELLGRLRS-PY 142
+G G FG V KVA+K L A ++ E++++ L
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 143 LLALLGYCSDRRKLLV-YDYMANGGLQEHL-------YPANGSNSVASKLDWETRLRIAL 194
++ LLG C+ +LV +Y G L L S L +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 195 EAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTRV 252
+ A+G+ FL +C IHRD + N+LL AK+ DFGLA I +D S +
Sbjct: 172 QVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMND------SNYI 221
Query: 253 LGTQGYV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+ + APE T +SDV+SYG++L E+ + G P
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 1e-29
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 23/208 (11%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQG-EDEFKMEVELLGRLRSPYLLALLGY 149
G GGF + A K++ K ++ ME+ + L +++ G+
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLD-WETRLRIALEAAKGLEFLHEHC 207
D + +V + L E L E R + G ++LH +
Sbjct: 84 FEDNDFVFVVLELCRRRSLLELH-------KRRKALTEPEAR-YYLRQIVLGCQYLHRNR 135
Query: 208 SPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGGHVSTRVLGTQGYVAPEYALT 266
VIHRD K N+ L+++ K+ DFGLA K+ D G + GT Y+APE L+
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD---GERKKVLCGTPNYIAPE-VLS 188
Query: 267 GHL-TTKSDVYSYGVVLLELLTGRVPID 293
+ + DV+S G ++ LL G+ P +
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 64/308 (20%), Positives = 112/308 (36%), Gaps = 67/308 (21%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLL 144
F +G GGFG+V+ + AIK + ++ ++ EV+ L +L P ++
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 145 ALLGYCSD----------RRKLLVY---DYMANGGLQEHLYPANGSNSVASKLDWETRLR 191
+ K+ +Y L++ + + + L
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI----EERERSVCLH 122
Query: 192 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI----------GS 241
I L+ A+ +EFLH ++HRD K SNI + KV DFGL +
Sbjct: 123 IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 301
T +GT+ Y++PE + K D++S G++L ELL
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------------- 225
Query: 302 VLVSWALPRLTDREKILEIMD------PALEGQYS--MKEVIQVAAIAAMCVQPEADYRP 353
P T E++ + D P L Q ++Q + P RP
Sbjct: 226 -------PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ------DMLSPSPMERP 272
Query: 354 LMADVVQS 361
+++++
Sbjct: 273 EAINIIEN 280
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 22/224 (9%)
Query: 84 TGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSP 141
G + +G GGFG V R + G +VAIK Q + + + +E++++ +L P
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 142 YLLALL-------GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL 194
+++ + LL +Y G L+++L L +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN----QFENCCGLKEGPIRTLLS 128
Query: 195 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA---KVSDFGLAKIGSDKAGGHVSTR 251
+ + L +LHE+ +IHRD K NI+L K+ D G AK G + T
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ---GELCTE 182
Query: 252 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVN 295
+GT Y+APE T D +S+G + E +TG P N
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 94 GHGGFGLVYRGVLSNGRK------VAIK-LMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
G G FG V++ VA+K L ++A + +F+ E L+ +P ++ L
Sbjct: 56 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKL 115
Query: 147 LGYCSDRR-KLLVYDYMANGGLQEHL-----------------YPANGSNSVASKLDWET 188
LG C+ + L+++YMA G L E L A S+ L
Sbjct: 116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 175
Query: 189 RLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGG 246
+L IA + A G+ +L E +HRD + N L+ +N K++DFGL+ I S
Sbjct: 176 QLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGLSRNIYSA---- 227
Query: 247 HVSTRVLGTQGYV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
+ PE TT+SDV++YGVVL E+ + G P
Sbjct: 228 --DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-29
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 43/231 (18%)
Query: 94 GHGGFGLVYRGVLSNGRK------VAIKLM-DQAGKQGEDEFKMEVELLGRLRS-PYLLA 145
G G FG V K VA+K++ ++A + E++++ +L S ++
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113
Query: 146 LLGYCSDRRKLLV-YDYMANGGLQEHL----------------YPANGSNSVASKLDWET 188
LLG C+ + + ++Y G L +L + L +E
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173
Query: 189 RLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA-KIGSDKAGG 246
L A + AKG+EFL C +HRD + N+L+ K+ DFGLA I SD
Sbjct: 174 LLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLARDIMSD---- 225
Query: 247 HVSTRVLGTQGYV-----APEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
S V+ + APE G T KSDV+SYG++L E+ + G P
Sbjct: 226 --SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-29
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 87 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEF---KMEVELLGRLRSPY 142
F ++G G F V + R+ AIK++++ E++ E +++ RL P+
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGL 200
+ L D KL Y NG L +++ D ET R E L
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-------SFD-ETCTRFYTAEIVSAL 143
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260
E+LH +IHRD K NILL+++ H +++DFG AK+ S ++ + +GT YV+
Sbjct: 144 EYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 261 PEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
PE LT KS D+++ G ++ +L+ G P
Sbjct: 201 PE-LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 63/250 (25%), Positives = 101/250 (40%), Gaps = 29/250 (11%)
Query: 55 REEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSK----SNVVGHGGFGLVYRGV-LSNG 109
SG+ + LQ + S G S+ +G G +G V
Sbjct: 3 HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTH 62
Query: 110 RKVAIKLMDQAGKQGEDE--FKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGG 166
+ AIK++ + EV +L L P ++ L + D+R LV + G
Sbjct: 63 VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122
Query: 167 LQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL- 223
L + + + A+ + ++ L + +LH+H ++HRD K N+LL
Sbjct: 123 LFDEII-HRMKFNEVDAAVI-----IKQVLSG---VTYLHKHN---IVHRDLKPENLLLE 170
Query: 224 --DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVV 281
+K+ K+ DFGL+ + + LGT Y+APE L K DV+S GV+
Sbjct: 171 SKEKDALIKIVDFGLSAVFEN---QKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
Query: 282 LLELLTGRVP 291
L LL G P
Sbjct: 227 LFILLAGYPP 236
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 27/222 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLL 144
+ S+++G G V+RG G AIK+ + + D E E+L +L ++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 145 ALLGY---CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
L + R K+L+ ++ G L L S A L L + + G+
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLE----EPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 202 FLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
L E+ ++HR+ K NI+ D K++DFG A+ D + GT+
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--DEQFVSLY-GTEE 180
Query: 258 YVAPE--------YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
Y+ P+ D++S GV TG +P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 27/222 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLL 144
+ S+++G G V+RG G AIK+ + + D E E+L +L ++
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 145 ALLGY---CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
L + R K+L+ ++ G L L S A L L + + G+
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLE----EPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 202 FLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
L E+ ++HR+ K NI+ D K++DFG A+ D + GT+
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLYGTEE 180
Query: 258 YVAPE--------YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
Y+ P+ D++S GV TG +P
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+++ +G G G VY + ++ G++VAI+ M+ + ++ E+ ++ ++P ++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L +L +V +Y+A G L + + + +D + E + LEFLH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLH 133
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
+ VIHRD KS NILL + K++DFG + + + ++GT ++APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV 188
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVP 291
K D++S G++ +E++ G P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-28
Identities = 39/299 (13%), Positives = 85/299 (28%), Gaps = 55/299 (18%)
Query: 39 IRNKVSKRLNTPKRVDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKS----NVVG 94
+ ++ R+ E +S + + + ++ S G ++ V+G
Sbjct: 23 VIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLG 82
Query: 95 HGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGRLR----------- 139
G + + + + K EV L LR
Sbjct: 83 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142
Query: 140 --------------SPYLLALLGYCSDRRKLLVYDYM--ANGGLQEHLYPANGSNSVASK 183
++ + D L + LQ +S
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202
Query: 184 LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243
L RL++ L+ + L LH + ++H + +I+LD+ ++ F +
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR 259
Query: 244 AGGHVSTRVLGTQGYVAPEYALT-----------GHLTTKSDVYSYGVVLLELLTGRVP 291
++G+ PE +T D ++ G+V+ + +P
Sbjct: 260 ------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 19/213 (8%)
Query: 87 FSKSNVVGHGGFGLVYRG-VLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPY 142
F V+G GGFG V+ + + G+ A K +++ ++G +E ++L ++ S +
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 143 LLALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKG 199
+++L Y + LV M G ++ H+Y + N E R + G
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ----EPRAIFYTAQIVSG 301
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
LE LH+ +I+RD K N+LLD + + ++SD GLA GT G++
Sbjct: 302 LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGYA-GTPGFM 356
Query: 260 APEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
APE L G S D ++ GV L E++ R P
Sbjct: 357 APE-LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 56/227 (24%), Positives = 86/227 (37%), Gaps = 33/227 (14%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLA 145
++G+G G V GR VA+K M D ME++LL P ++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNVIR 73
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
+ R L + + N LQ+ + N S+ + + + A G+ LH
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 205 EHCSPPVIHRDFKSSNILLD-------------KNFHAKVSDFGLAKI---GSDKAGGHV 248
+IHRD K NIL+ +N +SDFGL K G ++
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 249 STRVLGTQGYVAPE-------YALTGHLTTKSDVYSYGVVLLELLTG 288
+ GT G+ APE LT D++S G V +L+
Sbjct: 190 NNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 24/216 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLA 145
F +V+GHG G + + + R VA+K + + EV+LL P ++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL---PECFSFADREVQLLRESDEHPNVIR 82
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
DR+ + + A LQE++ + ++ + + + GL LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE------PITLLQQTTSGLAHLH 135
Query: 205 EHCSPPVIHRDFKSSNILL-----DKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGY 258
++HRD K NIL+ A +SDFGL K + + + V GT+G+
Sbjct: 136 SLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 259 VAPEY---ALTGHLTTKSDVYSYGVVLLELLTGRVP 291
+APE + T D++S G V +++
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLAL 146
V+G G FG V G++ A+K++ + K ++ EV+LL +L P ++ L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 147 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLEFL 203
+ D+ LV + G L + + + S A+++ +R L + ++
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEII-SRKRFSEVDAARI-----IRQVLSG---ITYM 142
Query: 204 HEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260
H++ ++HRD K N+LL K+ + ++ DFGL+ +GT Y+A
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTAYYIA 196
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
PE L G K DV+S GV+L LL+G P
Sbjct: 197 PE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+G G G+V +GR+VA+K+MD +Q + EV ++ + ++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
+ +L ++ +++ G L + + +L+ E + + L +LH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQ--------VRLNEEQIATVCEAVLQALAYLH 158
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTR--VLGTQGYVAP 261
+ VIHRD KS +ILL + K+SDFG A+I D R ++GT ++AP
Sbjct: 159 ---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-----PKRKSLVGTPYWMAP 210
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
E T+ D++S G++++E++ G P
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 77/284 (27%), Positives = 124/284 (43%), Gaps = 61/284 (21%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLL 144
F+K +G G FG V++G+ + VAIK++D + E ++ + E+ +L + SPY+
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 145 ALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
G Y D + ++ +Y+ G + L P LD I E KGL++L
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEP--------GPLDETQIATILREILKGLDYL 135
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H IHRD K++N+LL ++ K++DFG+A +D + +GT ++APE
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEV 190
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVP------------IDVNKPSGEGVLVSWALPRL 311
+K+D++S G+ +EL G P I N P
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------- 236
Query: 312 TDREKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRP 353
P LEG YS +KE + C+ E +RP
Sbjct: 237 -----------PTLEGNYSKPLKEFV------EACLNKEPSFRP 263
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLL 144
+ V+G G +V KVAIK ++ Q DE E++ + + P ++
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 145 ALLGYCS--DRRKL-LVYDYMANGGLQEHL-YPANGSNSVASKLDWETRLRIALEAAKGL 200
+ Y S + +L LV ++ G + + + + + LD T I E +GL
Sbjct: 77 SY--YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL-AKIGSDKAGGHVSTR--VLGTQG 257
E+LH++ IHRD K+ NILL ++ +++DFG+ A + + R +GT
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 258 YVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVP 291
++APE K+D++S+G+ +EL TG P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIK-------------LMDQAGKQGEDEFKMEVELLG 136
+G G +G V + + AIK ++ ++ +E E+ LL
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 137 RLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIA 193
L P ++ L D++ LV ++ G L E + A+ + ++
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII-NRHKFDECDAANI-----MKQI 155
Query: 194 LEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVST 250
L + +LH+H ++HRD K NILL + + K+ DFGL+ S +
Sbjct: 156 LSG---ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK---DYKLR 206
Query: 251 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
LGT Y+APE L K DV+S GV++ LL G P
Sbjct: 207 DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 22/213 (10%)
Query: 87 FSKSNVVGHGGFGLVYRG-VLSNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPY 142
F + V+G GGFG V V + G+ A K +++ ++GE E ++L ++ S +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 143 LLALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKG 199
+++L Y + LV M G L+ H+Y + + E R A E G
Sbjct: 246 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFP----EARAVFYAAEICCG 298
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
LE LH +++RD K NILLD + H ++SD GLA + G + RV GT GY+
Sbjct: 299 LEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGYM 352
Query: 260 APEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
APE + T S D ++ G +L E++ G+ P
Sbjct: 353 APE-VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-27
Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 35/218 (16%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIKLMD----QAGKQGEDEFKMEVELLGRLRSPYLLAL-- 146
G G +G V + + A+K++ + GE K E++LL RLR ++ L
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 147 -LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK------- 198
L ++ +V +Y G+QE L +SV K R + +A
Sbjct: 74 VLYNEEKQKMYMVMEY-CVCGMQEML------DSVPEK-----RFPVC-QAHGYFCQLID 120
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
GLE+LH ++H+D K N+LL K+S G+A+ A G+ +
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 259 VAPEYALTGHLT---TKSDVYSYGVVLLELLTGRVPID 293
PE G T K D++S GV L + TG P +
Sbjct: 178 QPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 42/220 (19%), Positives = 82/220 (37%), Gaps = 25/220 (11%)
Query: 87 FSKSNVVGHG--GFGLVYRGV-LSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRSP 141
+ V+G G V G V ++ ++ + + E+ + P
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 142 YLLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL-EAAKG 199
++ + +D +V +MA G ++ + ++ E + L K
Sbjct: 87 NIVPYRATFIADNELWVVTSFMAYGSAKDLI-----CTHFMDGMN-ELAIAYILQGVLKA 140
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG----LAKIGSDKAGGHVSTRVL-G 254
L+++H +HR K+S+IL+ + +S + G + H +
Sbjct: 141 LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 255 TQGYVAPE---YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
+++PE L G+ KSD+YS G+ EL G VP
Sbjct: 198 VLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVP 236
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 67/215 (31%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---EVELLGRLRSPY 142
FS +GHG FG VY + N VAIK M +GKQ ++++ EV L +LR P
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 143 LLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
+ G Y + LV +Y G + L L + A +GL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK------PLQEVEIAAVTHGALQGLA 168
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR--VLGTQGYV 259
+LH H +IHRD K+ NILL + K+ DFG A ++ +GT ++
Sbjct: 169 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWM 217
Query: 260 APEYALT---GHLTTKSDVYSYGVVLLELLTGRVP 291
APE L G K DV+S G+ +EL + P
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE--FKMEVELLGRLRSPYLLALL 147
++G G FG V + ++ A+K++++A + +D EVELL +L P ++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 148 GYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLEFLH 204
D +V + G L + + S A+++ ++ + ++H
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARI-----IKQVFSG---ITYMH 138
Query: 205 EHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+H ++HRD K NILL +K+ K+ DFGL+ +GT Y+AP
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAP 192
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
E L G K DV+S GV+L LL+G P
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 15/207 (7%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
F +G G +G VY+ + G+ VAIK + + E E+ ++ + SP+++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
G L +V +Y G + + + N L + I KGLE+LH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK------TLTEDEIATILQSTLKGLEYLH 142
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
IHRD K+ NILL+ HAK++DFG+A +D + V+GT ++APE
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVP 291
+D++S G+ +E+ G+ P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 55/267 (20%), Positives = 108/267 (40%), Gaps = 32/267 (11%)
Query: 39 IRNKVSKRLNTPKRVDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSK----SNVVG 94
+R + K + + + + ++ + + + + G +G
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELG 60
Query: 95 HGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR 153
G FG+V+R V + GR K ++ + K E+ ++ +L P L+ L D+
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 154 RKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
++ L+ ++++ G L +++ S + +R A E GL+ +HEH
Sbjct: 121 YEMVLILEFLSGGELFDRIAAEDYKM----SEAEVINY-----MRQACE---GLKHMHEH 168
Query: 207 CSPPVIHRDFKSSNILL--DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
++H D K NI+ K K+ DFGLA + + T + APE
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIV 222
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVP 291
+ +D+++ GV+ LL+G P
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 48/212 (22%), Positives = 95/212 (44%), Gaps = 18/212 (8%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+ +G G FG VY+ G A K+++ ++ +++ +E+E+L PY++
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 146 LLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
LLG Y D + ++ ++ G + + + L + + + L FLH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR------GLTEPQIQVVCRQMLEALNFLH 134
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
+IHRD K+ N+L+ +++DFG++ S +GT ++APE
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVV 189
Query: 265 LTGHLT-----TKSDVYSYGVVLLELLTGRVP 291
+ + K+D++S G+ L+E+ P
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 73/216 (33%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 87 FSKSNVVGHGGFGLVYRG-VLSNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRS-- 140
FS ++G GGFG VY G+ A+K +D+ KQGE E +L + +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 141 -PYLLALLGYC-SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEA 196
P+++ + Y KL + D M G L HL +G S E +R A E
Sbjct: 251 CPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFS-------EADMRFYAAEI 301
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 256
GLE +H V++RD K +NILLD++ H ++SD GLA S V GT
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK---KKPHASV-GTH 354
Query: 257 GYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
GY+APE G S D +S G +L +LL G P
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 53/296 (17%), Positives = 98/296 (33%), Gaps = 65/296 (21%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRL-RSPY 142
F + +G G FG V++ V +G AIK AG E EV L + +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 143 LLALLGYCSDRRKLLVY-DYMANGGLQEHLYPANGSNSVASKLDWETRLR-IALEAAKGL 200
++ ++ +L+ +Y G L + + S E L+ + L+ +GL
Sbjct: 73 VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK----EAELKDLLLQVGRGL 128
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKN-------------------FHAKVSDFGLAKIGS 241
++H ++H D K SNI + + K+ D G S
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 242 DKAGGHVSTRVLGTQGYVAPE--YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 299
G ++A E HL K+D+++ + ++
Sbjct: 186 S-----PQVEE-GDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGAEPLPRNGDQ-- 236
Query: 300 EGVLVSWALPRLTDREKILEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRP 353
W +I + P + S E++ + + P+ + RP
Sbjct: 237 ------WH--------EIRQGRLPRIPQVLSQEFTELL------KVMIHPDPERRP 272
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 6e-26
Identities = 58/246 (23%), Positives = 88/246 (35%), Gaps = 49/246 (19%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMD-----QAGKQGEDEFKMEVELLGRLRSPYLLA 145
+G G +G+V + AIK+M+ Q + + K EV L+ +L P +
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL---------- 194
L D + + LV + G L + L ++ +D
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 195 ----------------EAAK-------GLEFLHEHCSPPVIHRDFKSSNILL--DKNFHA 229
+ L +LH + HRD K N L +K+F
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209
Query: 230 KVSDFGLAKI--GSDKAGGHVSTRVLGTQGYVAPE--YALTGHLTTKSDVYSYGVVLLEL 285
K+ DFGL+K + + T GT +VAPE K D +S GV+L L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 286 LTGRVP 291
L G VP
Sbjct: 270 LMGAVP 275
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 68/303 (22%), Positives = 119/303 (39%), Gaps = 42/303 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRLRSPY 142
F K + +G G G+V++ +G +A KL+ + E+++L SPY
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNSPY 92
Query: 143 LLALLG-YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL-RIALEAAKGL 200
++ G + SD + ++M G L + + G E L ++++ KGL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP-------EQILGKVSIAVIKGL 144
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD-KAGGHVSTRVLGTQGYV 259
+L E ++HRD K SNIL++ K+ DFG++ D A V GT+ Y+
Sbjct: 145 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYM 197
Query: 260 APEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319
+PE H + +SD++S G+ L+E+ GR PI ++ +
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSP 379
++ M +P L+ +V P + P S
Sbjct: 258 RTPGRPLNKFGMD------------SRPPMAIFELLDYIVNEPPPKL------PSGVFSL 299
Query: 380 SFH 382
F
Sbjct: 300 EFQ 302
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE--FKMEVELLGRLRSPYLLALLG 148
++G G FG V + ++ A+K++++A + +D EVELL +L P ++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 149 YCSDRRKL-LVYDYMANGGL-----QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
D +V + G L + + S A+++ ++ + +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRF----SEHDAARI-----IKQVFSG---ITY 136
Query: 203 LHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
+H+H ++HRD K NILL +K+ K+ DFGL+ +GT Y+
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYI 190
Query: 260 APEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
APE L G K DV+S GV+L LL+G P
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 55/224 (24%), Positives = 93/224 (41%), Gaps = 43/224 (19%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMD---------QAGKQGEDEFKMEVELLGRLRS- 140
++G G +V R + ++ A+K++D + ++ + EV++L ++
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 141 PYLLALLGYCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIA 193
P ++ L LV+D M G L + L S K+ +R
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL-----SEKETRKI-----MRAL 133
Query: 194 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 253
LE + LH+ ++HRD K NILLD + + K++DFG + G V
Sbjct: 134 LEV---ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVC 184
Query: 254 GTQGYVAPE------YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
GT Y+APE + D++S GV++ LL G P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 31/211 (14%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
V+G G F V+ G+ A+K + ++ + + E+ +L +++ ++ L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 151 SDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
LV ++ G L + + AS + ++ L A +++L
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVY-----TEKDASLV-----IQQVLSA---VKYL 122
Query: 204 HEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260
HE+ ++HRD K N+L ++N ++DFGL+K+ + + + GT GYVA
Sbjct: 123 HENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVA 175
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
PE + D +S GV+ LL G P
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-25
Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 23/207 (11%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G +G V V + A K + + + D FK E+E++ L P ++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 151 SDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLEFLHEHC 207
D + LV + G L E + A+++ ++ L A + + H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERV-VHKRVFRESDAARI-----MKDVLSA---VAYCHKL- 125
Query: 208 SPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
V HRD K N L + K+ DFGLA G + +GT YV+P+
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKVGTPYYVSPQ-V 179
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVP 291
L G + D +S GV++ LL G P
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 73/278 (26%), Positives = 118/278 (42%), Gaps = 44/278 (15%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRL-RSPYLLAL 146
+G G +G V + V +G+ +A+K + E E K M+++++ R PY++
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 147 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRL-RIALEAAKGLEFLH 204
G + + M+ + Y S + + E L +I L K L L
Sbjct: 87 YGALFREGDCWICMELMS-TSF-DKFYKYVYS-VLDDVIP-EEILGKITLATVKALNHLK 142
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE-- 262
E+ +IHRD K SNILLD++ + K+ DFG++ D TR G + Y+APE
Sbjct: 143 ENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERI 197
Query: 263 --YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL---VSWALPRLTDREKI 317
A +SDV+S G+ L EL TGR P + L V P+L++ E
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-QLTQVVKGDPPQLSNSE-- 254
Query: 318 LEIMDPALEGQYS--MKEVIQVAAIAAMCVQPEADYRP 353
E ++S + +C+ + RP
Sbjct: 255 --------EREFSPSFINFV------NLCLTKDESKRP 278
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-25
Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 25/219 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLL 144
F +VG+G +G VY+G + G+ AIK+MD G E+E K E+ +L + +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84
Query: 145 ALLG------YCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 197
G +L LV ++ G + + + G+ L E I E
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-----TLKEEWIAYICREIL 139
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
+GL LH+H VIHRD K N+LL +N K+ DFG++ G + +GT
Sbjct: 140 RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPY 194
Query: 258 YVAPEYALTGHLT-----TKSDVYSYGVVLLELLTGRVP 291
++APE KSD++S G+ +E+ G P
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMD-QAGKQGEDEFKMEVELLGRLRSPYLLALLGY 149
+G G FG V+ S+G + IK ++ + ++ + E+E+L L P ++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
D + +V + G L E + A S+ ++ + A L + H
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA---LAYFHSQ-- 143
Query: 209 PPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 265
V+H+D K NIL + K+ DFGLA++ ST GT Y+APE
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS---DEHSTNAAGTALYMAPE-VF 198
Query: 266 TGHLTTKSDVYSYGVVLLELLTGRVP 291
+T K D++S GVV+ LLTG +P
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 56/262 (21%), Positives = 107/262 (40%), Gaps = 24/262 (9%)
Query: 40 RNKVSKRLNTPKRVDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSK----SNVVGH 95
+ + ++ ++ R + S + + + + + + +G
Sbjct: 108 KRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGT 167
Query: 96 GGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR 154
G FG+V+R + G A K + + ++ + E++ + LR P L+ L D
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227
Query: 155 KL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLEFLHEHCSPPV 211
++ ++Y++M+ G L E + + S A + +R + GL +HE+
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQVCK---GLCHMHEN---NY 276
Query: 212 IHRDFKSSNILL-DKNFHA-KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL 269
+H D K NI+ K + K+ DFGL V GT + APE A +
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTT-GTAEFAAPEVAEGKPV 333
Query: 270 TTKSDVYSYGVVLLELLTGRVP 291
+D++S GV+ LL+G P
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSP 355
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 59/251 (23%), Positives = 102/251 (40%), Gaps = 40/251 (15%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLALLGY 149
+G G F + + V + + A+K++ K+ E + E+ L P ++ L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANG--SNSVASKLDWETRLRIALEAAKGLEFLHEH 206
D+ LV + + G L E + S + AS + +R + A + +H+
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIK-KKKHFSETEASYI-----MRKLVSA---VSHMHDV 125
Query: 207 CSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
V+HRD K N+L + N K+ DFG A++ T Y APE
Sbjct: 126 G---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLHYAAPE- 179
Query: 264 ALTGHLTTKS-DVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322
L + +S D++S GV+L +L+G+VP + R +EIM
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPF-------------QSHDRSLTCTSAVEIMK 226
Query: 323 PALEGQYSMKE 333
+G +S +
Sbjct: 227 KIKKGDFSFEG 237
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 30/212 (14%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLLALLGYCS 151
G G +G V V VA+K++D + K E+ + L ++ G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 152 DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK-------GLEFL 203
+ L +Y + G L + + P + +A + G+ +L
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDI-------------GMPEP-DAQRFFHQLMAGVVYL 121
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H + HRD K N+LLD+ + K+SDFGLA + + ++ GT YVAPE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE- 177
Query: 264 ALTGHL--TTKSDVYSYGVVLLELLTGRVPID 293
L DV+S G+VL +L G +P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 92 VVGHGGFGLVY--RGVLSNGRKVAIKLMDQAGKQGEDEF---KMEVELLGRLRSPYLLAL 146
+G G FG V + + A+K M++ +E E++++ L P+L+ L
Sbjct: 22 AIGKGSFGKVCIVQKN-DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 147 LGYCS--DRRKL-LVYDYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEAAKGLEF 202
+ S D + +V D + G L+ HL +L I E L++
Sbjct: 81 --WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV-------KLFIC-ELVMALDY 130
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
L +IHRD K NILLD++ H ++DF +A + T + GT+ Y+APE
Sbjct: 131 LQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMAGTKPYMAPE 184
Query: 263 ----YALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
G+ + + D +S GV ELL GR P
Sbjct: 185 MFSSRKGAGY--SFAVDWWSLGVTAYELLRGRRP 216
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 63/274 (22%), Positives = 109/274 (39%), Gaps = 42/274 (15%)
Query: 41 NKVSKRLNTPKRVDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGL 100
+ K D + KG + ++ + + +V+G G +
Sbjct: 50 QSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSV 109
Query: 101 VYRGV-LSNGRKVAIKLMD--------QAGKQGEDEFKMEVELLGRLRS-PYLLALLGYC 150
V R V + G + A+K+M+ + ++ + + E +L ++ P+++ L+
Sbjct: 110 VRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169
Query: 151 SDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
+ LV+D M G L + L S + +R LEA + FL
Sbjct: 170 ESSSFMFLVFDLMRKGELFDYLTEKVAL-----SEKETRSI-----MRSLLEA---VSFL 216
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE- 262
H + ++HRD K NILLD N ++SDFG + G + GT GY+APE
Sbjct: 217 HANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP---GEKLRELCGTPGYLAPEI 270
Query: 263 -----YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
+ D+++ GV+L LL G P
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 50/212 (23%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
SK+ ++G G FG V++ + G K+A K++ G + ++E K E+ ++ +L L+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 146 LLGYCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAAK 198
L + + LV +Y+ G L + + + ++ E
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL----TELDTILF-----MKQICE--- 198
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILL-DKNFHA-KVSDFGLAKIGSDKAGGHVSTRVLGTQ 256
G+ +H+ ++H D K NIL +++ K+ DFGLA+ GT
Sbjct: 199 GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---REKLKVNFGTP 252
Query: 257 GYVAPEYALTGHLTTKSDVYSYGVVLLELLTG 288
++APE ++ +D++S GV+ LL+G
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 6e-24
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE--FKMEVELLGRLRSPYLLALLG 148
+G G F +V R V + G + A K+++ D + E + +L+ P ++ L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 149 YCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
+ LV+D + G L +E S + AS ++ LE+ +
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFY-----SEADASHC-----IQQILES---IA 119
Query: 202 FLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
+ H + ++HR+ K N+LL K K++DFGLA +D GT GY
Sbjct: 120 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGY 173
Query: 259 VAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVP 291
++PE L + D+++ GV+L LL G P
Sbjct: 174 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 27/218 (12%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFK---MEVELLGRL-RSPYLLAL 146
+G G G V++ G +A+K M ++G ++E K M+++++ + PY++
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN--KEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 147 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRL-RIALEAAKGLEFLH 204
G + + + M ++ G E L ++ + K L +L
Sbjct: 90 FGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIP-------ERILGKMTVAIVKALYYLK 141
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE-- 262
E VIHRD K SNILLD+ K+ DFG++ D R G Y+APE
Sbjct: 142 EKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERI 196
Query: 263 ---YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKP 297
++DV+S G+ L+EL TG+ P K
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 30/221 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKV-AIKLMDQAG--KQGEDE-FKMEVELLGRLRSPY 142
F V+G G F V + +V A+K+M++ K+GE F+ E ++L +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 143 LLALLGYCS--DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAK 198
+ L + + D L LV +Y G L L ++ R E
Sbjct: 123 ITQL--HFAFQDENYLYLVMEYYVGGDLLTLLS------KFGERIP-AEMARFYLAEIVM 173
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GTQG 257
++ +H +HRD K NILLD+ H +++DFG +A G V + V GT
Sbjct: 174 AIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKL--RADGTVRSLVAVGTPD 228
Query: 258 YVAPEYALTGHLTTKSDVY-------SYGVVLLELLTGRVP 291
Y++PE + Y + GV E+ G+ P
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRLRSP 141
F + +G G FG V +G A+K++D+ KQ E E +L + P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIE-HTLNEKRILQAVNFP 101
Query: 142 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKG 199
+L+ L D L +V +Y+A G + HL + E R A +
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-------RFS-EPHARFYAAQIVLT 153
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GTQGY 258
E+LH +I+RD K N+L+D+ + +V+DFG AK + T L GT
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEA 204
Query: 259 VAPEYALT-GHLTTKS-DVYSYGVVLLELLTGRVP 291
+APE L+ G+ K+ D ++ GV++ E+ G P
Sbjct: 205 LAPEIILSKGY--NKAVDWWALGVLIYEMAAGYPP 237
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 36/219 (16%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQA---GKQGEDE--FKMEVELLGRLRSPYLLA 145
V+G G F +V R + G++ A+K++D A G K E + L+ P+++
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 146 LLGYCSDRRKL-LVYDYMANG---------GLQEHLYPANGSNSVASKLDWETRLRIALE 195
LL S L +V+++M +Y S +VAS +R LE
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY----SEAVASHY-----MRQILE 141
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRV 252
A L + H++ +IHRD K +LL + + K+ FG+A + G V+
Sbjct: 142 A---LRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--SGLVAGGR 193
Query: 253 LGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
+GT ++APE DV+ GV+L LL+G +P
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 9e-24
Identities = 56/212 (26%), Positives = 88/212 (41%), Gaps = 30/212 (14%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-FKMEVELLGRLRSPYLLALLGYCS 151
G G +G V V VA+K++D E K E+ + L ++ G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 152 DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK-------GLEFL 203
+ L +Y + G L + + P + +A + G+ +L
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDI-------------GMPEP-DAQRFFHQLMAGVVYL 121
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H + HRD K N+LLD+ + K+SDFGLA + + ++ GT YVAPE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE- 177
Query: 264 ALTGHL--TTKSDVYSYGVVLLELLTGRVPID 293
L DV+S G+VL +L G +P D
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 32/221 (14%)
Query: 87 FSKSNVVGHGGFGLVY--RGVLSNGRKVAIKLMDQAG--KQGEDE-FKMEVELLGRLRSP 141
F V+G G FG V + + + A+K++++ K+ E F+ E ++L S
Sbjct: 76 FEILKVIGRGAFGEVAVVKLK-NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 142 YLLALLGYCS--DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAA 197
++ L + + D L LV DY G L L +L E R E
Sbjct: 135 WITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFED------RLP-EEMARFYLAEMV 185
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
++ +H+ +HRD K NIL+D N H +++DFG + S V GT
Sbjct: 186 IAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPD 241
Query: 258 YVAPE------YALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
Y++PE + D +S GV + E+L G P
Sbjct: 242 YISPEILQAMEGGKGRY--GPECDWWSLGVCMYEMLYGETP 280
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 59/262 (22%), Positives = 106/262 (40%), Gaps = 39/262 (14%)
Query: 89 KSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLAL 146
+ +V+G G V + L ++ A+K++++ EVE+L + + +L L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 147 LGYCSDRRKL-LVYDYMANGGLQEHLYPANG--SNSVASKLDWETRLRIALEAAKGLEFL 203
+ + + + LV++ M G + H++ + AS + ++ A L+FL
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEASVV-----VQDVASA---LDFL 127
Query: 204 HEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKI------GSDKAGGHVSTRVLG 254
H + HRD K NIL ++ K+ DF L S + + T G
Sbjct: 128 HNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-G 183
Query: 255 TQGYVAPEYALTGHLTT------KSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 308
+ Y+APE + + D++S GV+L LL+G P S G A
Sbjct: 184 SAEYMAPE-VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 309 PRLTDREKILEIMDPALEGQYS 330
P + + + EG+Y
Sbjct: 243 PACQN-----MLFESIQEGKYE 259
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 40/216 (18%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM--EVELLGRLRSPYLLALLGYC 150
G G F V + GR+VAIK++D+ K+ EV ++ L P ++ L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 151 SDRRKL-LV---------YDY-MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 199
+ L L+ +DY +A+G ++E E R +
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----------------EAR-SKFRQIVSA 126
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
+++ H+ ++HRD K+ N+LLD + + K++DFG + + GG + G Y
Sbjct: 127 VQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC-GAPPYA 180
Query: 260 APEYALTGHLTT--KSDVYSYGVVLLELLTGRVPID 293
APE G + DV+S GV+L L++G +P D
Sbjct: 181 APE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 57/254 (22%), Positives = 98/254 (38%), Gaps = 49/254 (19%)
Query: 68 TDNGLQVFTFKQLHSA-----TGGFSK----SNVVGHGGFGLVYRGV-LSNGRKVAIK-- 115
+ + +VF F L S +G G G V +KVAI+
Sbjct: 109 SLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 168
Query: 116 ----LMDQAGKQGEDE--FKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANGGL-- 167
+ ++ + + E+E+L +L P ++ + + +V + M G L
Sbjct: 169 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFD 228
Query: 168 ----QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 223
+ L + L A +++LHE+ +IHRD K N+LL
Sbjct: 229 KVVGNKRL-----KEATCKLY-----FYQMLLA---VQYLHENG---IIHRDLKPENVLL 272
Query: 224 ---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE---YALTGHLTTKSDVYS 277
+++ K++DFG +KI + + + GT Y+APE T D +S
Sbjct: 273 SSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS 329
Query: 278 YGVVLLELLTGRVP 291
GV+L L+G P
Sbjct: 330 LGVILFICLSGYPP 343
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFK---MEVE-LLGRLRSPYLLA 145
+G G +G+V + + +G+ +A+K + E K M+++ + + P+ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN--SQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRL-RIALEAAKGLEFL 203
G + + + M + L + E L +IA+ K LE L
Sbjct: 71 FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP----EDILGKIAVSIVKALEHL 125
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE- 262
H S VIHRD K SN+L++ K+ DFG++ D G + Y+APE
Sbjct: 126 HSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCKPYMAPER 180
Query: 263 ---YALTGHLTTKSDVYSYGVVLLELLTGRVPID 293
+ KSD++S G+ ++EL R P D
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-23
Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 35/214 (16%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIKLMD-QAGKQGEDEFKM--EVELLGRLRSPYLLALLGY 149
G G FG V G G KVA+K+++ Q + + K+ E++ L R P+++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK-------GLE 201
S +V +Y++ G L +++ +G R+ EA + ++
Sbjct: 80 ISTPTDFFMVMEYVSGGELFDYIC-KHG------------RVEEM-EARRLFQQILSAVD 125
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+ H H V+HRD K N+LLD + +AK++DFGL+ + SD G + T G+ Y AP
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSC-GSPNYAAP 179
Query: 262 EYALTGHL--TTKSDVYSYGVVLLELLTGRVPID 293
E ++G L + D++S GV+L LL G +P D
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 34/214 (15%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE--FKMEVELLGRLRSPYLLALLG 148
+G G F +V R V + G + A K+++ D + E + +L+ P ++ L
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 149 YCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
+ LV+D + G L +E S + AS ++ LE+ +
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFY-----SEADASHC-----IQQILES---IA 142
Query: 202 FLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
+ H + ++HR+ K N+LL K K++DFGLA +D GT GY
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGTPGY 196
Query: 259 VAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVP 291
++PE L + D+++ GV+L LL G P
Sbjct: 197 LSPE-VLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 29/214 (13%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKMEVELLGRLRS--PYLL 144
G GGFG VY G+ +S+ VAIK + D MEV LL ++ S ++
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111
Query: 145 ALLGYCSDRRKL-LVYDYMANGG-LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
LL + L+ + L + + G L E + + +
Sbjct: 112 RLLDWFERPDSFVLILERPEPVQDLFDFIT-ERG------ALQEELARSFFWQVLEAVRH 164
Query: 203 LHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
H V+HRD K NIL+D N K+ DFG + D + GT+ Y P
Sbjct: 165 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFD-GTRVYSPP 217
Query: 262 EYALTGHL--TTKSDVYSYGVVLLELLTGRVPID 293
E+ + H + V+S G++L +++ G +P +
Sbjct: 218 EW-IRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 4e-23
Identities = 71/218 (32%), Positives = 104/218 (47%), Gaps = 36/218 (16%)
Query: 87 FSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRL 138
F +G G FG V+ L NGR A+K++ + KQ E E +L +
Sbjct: 8 FQILRTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVE-HTNDERLMLSIV 63
Query: 139 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEA 196
P+++ + G D +++ ++ DY+ G L L + N VA + A E
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-------KFYAA-EV 115
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GT 255
LE+LH +I+RD K NILLDKN H K++DFG AK D T L GT
Sbjct: 116 CLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGT 166
Query: 256 QGYVAPEYALT-GHLTTKS-DVYSYGVVLLELLTGRVP 291
Y+APE T + KS D +S+G+++ E+L G P
Sbjct: 167 PDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTP 202
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-23
Identities = 52/216 (24%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKMEVELLGRLRS----PY 142
G GGFG V+ G L++ +VAIK ++ + +EV LL ++ + P
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 143 LLALLGYCSDRRKL-LVYDYMANGG-LQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
++ LL + + LV + L +++ G L + +
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYIT-EKG------PLGEGPSRCFFGQVVAAI 152
Query: 201 EFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
+ H V+HRD K NIL+D + AK+ DFG + D + GT+ Y
Sbjct: 153 QHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDFD-GTRVYS 205
Query: 260 APEYALTGHL--TTKSDVYSYGVVLLELLTGRVPID 293
PE+ ++ H + V+S G++L +++ G +P +
Sbjct: 206 PPEW-ISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 6e-23
Identities = 51/264 (19%), Positives = 91/264 (34%), Gaps = 53/264 (20%)
Query: 117 MDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPAN 175
+ D +++ + + + L S + L + L++ +
Sbjct: 97 WPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156
Query: 176 GSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235
+ L I ++ A+ +EFLH ++HRD K SNI + KV DFG
Sbjct: 157 SLED----REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFG 209
Query: 236 LAKI----------GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLEL 285
L + T +GT+ Y++PE + + K D++S G++L EL
Sbjct: 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269
Query: 286 LTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD------PALEGQYS--MKEVIQV 337
L T E++ I D P L Q ++Q
Sbjct: 270 LY---------------------SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQ- 307
Query: 338 AAIAAMCVQPEADYRPLMADVVQS 361
+ P RP D++++
Sbjct: 308 -----DMLSPSPTERPEATDIIEN 326
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 6e-23
Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 35/214 (16%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEF---KMEVELLGRLRSPYLLALLGY 149
G G FG V G G KVA+K++++ + D + E++ L R P+++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK-------GLE 201
S + +V +Y++ G L +++ NG RL E+ + G++
Sbjct: 85 ISTPSDIFMVMEYVSGGELFDYIC-KNG------------RLDEK-ESRRLFQQILSGVD 130
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+ H H V+HRD K N+LLD + +AK++DFGL+ + SD G + T G+ Y AP
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSC-GSPNYAAP 184
Query: 262 EYALTGHL--TTKSDVYSYGVVLLELLTGRVPID 293
E ++G L + D++S GV+L LL G +P D
Sbjct: 185 E-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 33/214 (15%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE--FKMEVELLGRLRSPYLLALLG 148
+G G F +V R V + G++ A +++ D + E + L+ P ++ L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 149 YCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
S+ L++D + G L +E+ S + AS ++ LEA +
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYY-----SEADASHC-----IQQILEA---VL 124
Query: 202 FLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
H+ V+HR+ K N+LL K K++DFGLA + GT GY
Sbjct: 125 HCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGY 179
Query: 259 VAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVP 291
++PE L D+++ GV+L LL G P
Sbjct: 180 LSPE-VLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 6e-23
Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 40/221 (18%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDE--FKMEVELLGRLRSPY 142
+G G G V +KVAIK + ++ + + E+E+L +L P
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 143 LLALLGYCSDRRKLLVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEA 196
++ + + +V + M G L + L + L A
Sbjct: 77 IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRL-----KEATCKLY-----FYQMLLA 126
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 253
+++LHE+ +IHRD K N+LL +++ K++DFG +KI + + +
Sbjct: 127 ---VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLC 177
Query: 254 GTQGYVAPE---YALTGHLTTKSDVYSYGVVLLELLTGRVP 291
GT Y+APE T D +S GV+L L+G P
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 9e-23
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 29/212 (13%)
Query: 92 VVGHGGFGLVY----RGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLA 145
V+G G FG V+ + A+K++ +A + KME ++L + P+++
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 146 LLGYCS--DRRKL-LVYDYMANGG-LQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGL 200
L + + KL L+ D++ GG L L S E ++ E A L
Sbjct: 91 L--HYAFQTEGKLYLILDFL-RGGDLFTRL-------SKEVMFT-EEDVKFYLAELALAL 139
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260
+ LH +I+RD K NILLD+ H K++DFGL+K D + GT Y+A
Sbjct: 140 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMA 194
Query: 261 PEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
PE + T+S D +S+GV++ E+LTG +P
Sbjct: 195 PE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 62/216 (28%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 87 FSKSNVVGHGGFGLVY--RGVLSNGRKVAIKLMDQAG--KQGEDE-FKMEVELLGRLRSP 141
+ V+G G FG V R S + A+KL+ + K+ + F E +++ SP
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHK-STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 142 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
+++ L D R L +V +YM G L + + A R A E L
Sbjct: 130 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-------RFYTA-EVVLAL 181
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL-GTQGYV 259
+ +H IHRD K N+LLDK+ H K++DFG + + G V GT Y+
Sbjct: 182 DAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE--GMVRCDTAVGTPDYI 236
Query: 260 APEYALTGHLT---TKS-DVYSYGVVLLELLTGRVP 291
+PE + + D +S GV L E+L G P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 50/217 (23%), Positives = 84/217 (38%), Gaps = 35/217 (16%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQGEDEFKM------EVELLGRLRSPYLL 144
G G FG V+ V ++V +K + + + E E+ +L R+ ++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 145 ALLGYCSDRRKL-LVYDYMANGG-----LQEHLYPANGSNSVASKLDWETRLRIALEAAK 198
+L ++ LV + +G + H +LD I +
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-----------PRLDEPLASYIFRQLVS 141
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
+ +L +IHRD K NI++ ++F K+ DFG A G T GT Y
Sbjct: 142 AVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFYTFC-GTIEY 195
Query: 259 VAPEYALTGHLTT--KSDVYSYGVVLLELLTGRVPID 293
APE L G+ + +++S GV L L+ P
Sbjct: 196 CAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 21/206 (10%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G FG+V+R V S+ + K + G + K E+ +L R +L L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 151 SDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLEFLHEHC 207
+L +++++++ + E + + + + E L+FLH H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVCE---ALQFLHSH- 121
Query: 208 SPPVIHRDFKSSNILL--DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 265
+ H D + NI+ ++ K+ +FG A+ G + Y APE
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQ 176
Query: 266 TGHLTTKSDVYSYGVVLLELLTGRVP 291
++T +D++S G ++ LL+G P
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMD------QAGKQGEDEFKMEVELLGRLRSPYLL 144
+G G F +V + S G + A K + +E + EV +L ++ ++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 145 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLE 201
L +R + L+ + ++ G L + L S S A+ ++ L+ G+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSF-----IKQILD---GVN 129
Query: 202 FLHEHCSPPVIHRDFKSSNILL-DKNFHA---KVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
+LH + H D K NI+L DKN K+ DFGLA D G + GT
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPE 183
Query: 258 YVAPEYALTGHLTTKSDVYSYGVVLLELLTG 288
+VAPE L ++D++S GV+ LL+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 66/275 (24%), Positives = 113/275 (41%), Gaps = 58/275 (21%)
Query: 77 FKQLHSATGGFSK----SNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKME 131
+QLH + F+ +G G + + R + + + A+K++D++ + +E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---- 65
Query: 132 VELLGRLRS-PYLLALLGYCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASK 183
+E+L R P ++ L D + + +V + M G L Q+ S AS
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF-----SEREASA 120
Query: 184 LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL-DKNFHA---KVSDFGLAKI 239
+ L + +E+LH V+HRD K SNIL D++ + ++ DFG AK
Sbjct: 121 V-----LFTITKT---VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169
Query: 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVPIDVNKPS 298
+A + T +VAPE L + D++S GV+L +LTG P
Sbjct: 170 L--RAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPF------ 220
Query: 299 GEGVLVSWALPRLTDREKILEIMDPALEGQYSMKE 333
P T EI+ G++S+
Sbjct: 221 -------ANGPDDTPE----EILARIGSGKFSLSG 244
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 54/245 (22%), Positives = 100/245 (40%), Gaps = 30/245 (12%)
Query: 55 REEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVA 113
L + F + T +G G F +V + + S G++ A
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTS-----KELGRGKFAVVRQCISKSTGQEYA 58
Query: 114 IKLMD--QAGKQGEDEFKMEVELLGRLRS-PYLLALLGYCSDRRKL-LVYDYMANGGLQE 169
K + + G+ E E+ +L +S P ++ L + ++ L+ +Y A G +
Sbjct: 59 AKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFS 118
Query: 170 HLYPANG---SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL--- 223
P S + +L ++ LE G+ +LH++ ++H D K NILL
Sbjct: 119 LCLPELAEMVSENDVIRL-----IKQILE---GVYYLHQNN---IVHLDLKPQNILLSSI 167
Query: 224 DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLL 283
K+ DFG+++ + + GT Y+APE +TT +D+++ G++
Sbjct: 168 YPLGDIKIVDFGMSRK--IGHACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAY 224
Query: 284 ELLTG 288
LLT
Sbjct: 225 MLLTH 229
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G +VYR + A+K++ + + + E+ +L RL P ++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 151 SDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
++ LV + + G L + + S A+ ++ LEA + +L
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYY-----SERDAADA-----VKQILEA---VAYL 164
Query: 204 HEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260
HE+ ++HRD K N+L + K++DFGL+KI + V GT GY A
Sbjct: 165 HENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPGYCA 218
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
PE + D++S G++ LL G P
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-22
Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE------DEFKMEVELLGRLRSPYLL 144
+G G F +V + G++ A K + + +E + EV +L +R P ++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 145 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLE 201
L ++ + L+ + ++ G L + L S + A++ L+ L+ G+
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQF-----LKQILD---GVH 122
Query: 202 FLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
+LH + H D K NI+L N K+ DFG+A +AG GT
Sbjct: 123 YLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNIF-GTPE 176
Query: 258 YVAPEYALTGHLTTKSDVYSYGVVLLELLTG 288
+VAPE L ++D++S GV+ LL+G
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-22
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIKLMD-QAGKQGEDEFKM--EVELLGRLRSPYLLALLGY 149
G G FG V +KVA+K + Q K+ + ++ E+ L LR P+++ L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK-------GLE 201
+ + +V +Y A G L +++ R+ E + +E
Sbjct: 78 ITTPTDIVMVIEY-AGGELFDYIV-EKK------------RMTED-EGRRFFQQIICAIE 122
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+ H H ++HRD K N+LLD N + K++DFGL+ I +D G + T G+ Y AP
Sbjct: 123 YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--GNFLKTSC-GSPNYAAP 176
Query: 262 EYALTGHL--TTKSDVYSYGVVLLELLTGRVPID 293
E + G L + DV+S G+VL +L GR+P D
Sbjct: 177 E-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 70/259 (27%), Positives = 107/259 (41%), Gaps = 22/259 (8%)
Query: 41 NKVSKRLNTPKRVDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGL 100
V+ L + + + S + + F ++G G FG
Sbjct: 104 QTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGK 163
Query: 101 VYRGVL-SNGRKVAIKLMDQAGKQGEDEF---KMEVELLGRLRSPYLLALLGYC--SDRR 154
V + GR A+K++ + +DE E +L R P+L AL Y + R
Sbjct: 164 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDR 222
Query: 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLHEHCSPPVIH 213
V +Y G L HL S E R R E L++LH + V++
Sbjct: 223 LCFVMEYANGGELFFHL-------SRERVFS-EDRARFYGAEIVSALDYLHSEKN--VVY 272
Query: 214 RDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKS 273
RD K N++LDK+ H K++DFGL K G G GT Y+APE L + ++
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCGTPEYLAPE-VLEDNDYGRA 329
Query: 274 -DVYSYGVVLLELLTGRVP 291
D + GVV+ E++ GR+P
Sbjct: 330 VDWWGLGVVMYEMMCGRLP 348
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-22
Identities = 67/208 (32%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 92 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEF---KMEVELLGRLRSPYLLALL 147
++G G FG V + GR A+K++ + +DE E +L R P+L AL
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 148 GYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFLH 204
Y + R V +Y G L HL S E R R E LE+LH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHL-------SRERVFT-EERARFYGAEIVSALEYLH 122
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
V++RD K N++LDK+ H K++DFGL K G G GT Y+APE
Sbjct: 123 SR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPE-V 176
Query: 265 LTGHLTTKS-DVYSYGVVLLELLTGRVP 291
L + ++ D + GVV+ E++ GR+P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-22
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKMEVELLGRLRSPYLL 144
+G G F +V + S G + A K +E + EV +L ++ P ++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 145 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS--VASKLDWETRLRIALEAAKGLE 201
L +R + L+ + ++ G L + L S S A+ ++ L+ G+
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSF-----IKQILD---GVN 129
Query: 202 FLHEHCSPPVIHRDFKSSNILL-DKNFHA---KVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
+LH + H D K NI+L DKN K+ DFGLA D G + GT
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPE 183
Query: 258 YVAPEYALTGHLTTKSDVYSYGVVLLELLTG 288
+VAPE L ++D++S GV+ LL+G
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 54/234 (23%), Positives = 96/234 (41%), Gaps = 48/234 (20%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKM---------------- 130
G G +G+V ++ A+K L+ QAG +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 131 ----EVELLGRLRSPYLLAL---LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASK 183
E+ +L +L P ++ L L ++ +V++ + G + E P
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--VPTLK------P 133
Query: 184 LDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243
L + + KG+E+LH +IHRD K SN+L+ ++ H K++DFG++
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKG 189
Query: 244 AGGHVSTRVLGTQGYVAPEYALTGHLT----TKSDVYSYGVVLLELLTGRVPID 293
+ +S V GT ++APE +L+ DV++ GV L + G+ P
Sbjct: 190 SDALLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 92 VVGHGGFGLVY----RGVLSNGRKVAIKLMDQA---GKQGEDEF-KMEVELLGRLRSPYL 143
V+G GG+G V+ + G+ A+K++ +A + K E +L ++ P++
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 144 LALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGL 200
+ L+ Y + + L+ +Y++ G L L E E + L
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQL-------EREGIFM-EDTACFYLAEISMAL 134
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260
LH+ +I+RD K NI+L+ H K++DFGL K G V+ GT Y+A
Sbjct: 135 GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DGTVTHTFCGTIEYMA 189
Query: 261 PEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
PE L ++ D +S G ++ ++LTG P
Sbjct: 190 PE-ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 49/225 (21%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLLA 145
++ V+G+G FG+V++ L +VAIK + Q + FK E++++ ++ P ++
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVD 96
Query: 146 LL------GYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA- 197
L G D L LV +Y+ E +Y A +L+ +
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYV-----PETVYRA---------SRHYAKLKQTMPMLL 142
Query: 198 ---------KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-KVSDFGLAK--IGSDKAG 245
+ L ++H + HRD K N+LLD K+ DFG AK I +
Sbjct: 143 IKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV 199
Query: 246 GHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGR 289
++ +R Y APE + TT D++S G V+ EL+ G+
Sbjct: 200 SYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 53/213 (24%), Positives = 81/213 (38%), Gaps = 35/213 (16%)
Query: 94 GHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152
G G FG+ VA+K +++ G ++ + E+ LR P ++
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 153 RRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK-------GLEFLH 204
L ++ +Y + G L E + G R EA G+ + H
Sbjct: 88 PTHLAIIMEYASGGELYERIC-NAG------------RFSED-EARFFFQQLLSGVSYCH 133
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHA--KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
+ HRD K N LLD + K+ DFG +K + V GT Y+APE
Sbjct: 134 SMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HSQPKSTV-GTPAYIAPE 187
Query: 263 YALTGHL--TTKSDVYSYGVVLLELLTGRVPID 293
L +DV+S GV L +L G P +
Sbjct: 188 -VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 37/218 (16%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIK------LMDQAGKQGEDEFKMEVELLGRLRSPYLL 144
+G G F +V + S G + A K ++ + EV +L ++ P ++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 145 ALLGYCSDRRKL-LVYDYMANGGL------QEHLYPANGSNSVASKLDWETRLRIALEAA 197
L ++ + L+ + +A G L +E L + A++ L+ L
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEKESL-----TEEEATEF-----LKQILNG- 126
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFGLAKIGSDKAGGHVSTRVL 253
+ +LH + H D K NI+L K+ DFGLA G+ +
Sbjct: 127 --VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKNIF 178
Query: 254 GTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
GT +VAPE L ++D++S GV+ LL+G P
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 9e-21
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 47/227 (20%)
Query: 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLL 144
++ + V+G+G FG+VY+ L +G VAIK + Q + FK E++++ +L ++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110
Query: 145 ALLG--YCSDRRKL-----LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 197
L Y S +K LV DY+ E +Y ++ + + +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRV-------ARHYSRAKQTLPVIYV 158
Query: 198 K--------GLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-KVSDFGLAK--IGSDKAGG 246
K L ++H + HRD K N+LLD + K+ DFG AK + +
Sbjct: 159 KLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 247 HVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPI 292
++ +R Y APE T+ DV+S G VL ELL G+ PI
Sbjct: 216 YICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 9e-21
Identities = 60/213 (28%), Positives = 89/213 (41%), Gaps = 32/213 (15%)
Query: 92 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVE--------LLGRLRSPY 142
V+G G FG V A+K++ K+ +VE L + P+
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKIL----KKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 143 LLALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKG 199
L L C + R V +Y+ G L H+ + E A E A G
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGRFK-EPHAVFYAAEIAIG 454
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
L FL +I+RD K N++LD H K++DFG+ K G + GT Y+
Sbjct: 455 LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DGVTTKTFCGTPDYI 509
Query: 260 APEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
APE + KS D +++GV+L E+L G+ P
Sbjct: 510 APE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 92 VVGHGGFGLVY----RGVLSNGRKVAIKLMDQAGKQGEDEF----KMEVELLGRL-RSPY 142
V+G G +G V+ G+ A+K++ +A + + + E ++L + +SP+
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 143 LLALLGYCS--DRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAK 198
L+ L + + KL L+ DY+ G L HL S + E ++I E
Sbjct: 121 LVTL--HYAFQTETKLHLILDYINGGELFTHL-------SQRERFT-EHEVQIYVGEIVL 170
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
LE LH+ +I+RD K NILLD N H ++DFGL+K GT Y
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEY 226
Query: 259 VAPE---YALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
+AP+ +GH K+ D +S GV++ ELLTG P
Sbjct: 227 MAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 32/213 (15%)
Query: 92 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVE--------LLGRLRSPY 142
++G G FG V+ + AIK + K+ +VE L P+
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 143 LLALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKG 199
L + + V +Y+ G L H+ + K D +R A E G
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCH-------KFD-LSRATFYAAEIILG 130
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
L+FLH +++RD K NILLDK+ H K++DFG+ K G + GT Y+
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYI 185
Query: 260 APEYALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
APE L G S D +S+GV+L E+L G+ P
Sbjct: 186 APE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 5e-20
Identities = 63/277 (22%), Positives = 96/277 (34%), Gaps = 85/277 (30%)
Query: 91 NVVGHGGFGLVYRGVL------SNGRKVAIKLM-DQAGKQGEDEFKMEVELLGRLRS-PY 142
+G G FG V + R VA+K++ + A E+++L +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 143 LLALLGYCSDRRKLL-------------------------------------VYDYMANG 165
++ LLG C+ L Y
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 166 GLQEHLYPANGSNSVASKLDWETR------------------------LRIALEAAKGLE 201
L+ L S S AS E + + + + AKG+E
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSD-----KAGGHVSTRVLGT 255
FL S IHRD + NILL + K+ DFGLA+ I D K + +
Sbjct: 208 FL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK---- 260
Query: 256 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVP 291
++APE T +SDV+S+GV+L E+ + G P
Sbjct: 261 --WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 56/236 (23%), Positives = 94/236 (39%), Gaps = 40/236 (16%)
Query: 75 FTFKQLHSATGGFSK-----SNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEF 128
F+ + V+G G G V G+K A+KL+ + K
Sbjct: 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----A 68
Query: 129 KMEVELLGRLRS-PYLLALLGYCSDRRK-----LLVYDYMANGGLQEHLYPANGSNS--- 179
+ EV+ + P+++ +L + L++ + M G L + G +
Sbjct: 69 RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ-ERGDQAFTE 127
Query: 180 -VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFG 235
A+++ +R A ++FLH H + HRD K N+L +K+ K++DFG
Sbjct: 128 REAAEI-----MRDIGTA---IQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176
Query: 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
AK + + T T YVAPE D++S GV++ LL G P
Sbjct: 177 FAKETTQ---NALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 7e-20
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 92 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK-MEVE---LLGRLRSPYLLAL 146
V+G G + V L R A+K++ + +++ ++ E P+L+ L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 147 LGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFL 203
C ++ R V +Y+ G L H+ KL E R + E + L +L
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQ-------RKLP-EEHARFYSAEISLALNYL 126
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
HE +I+RD K N+LLD H K++D+G+ K G G ++ GT Y+APE
Sbjct: 127 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPE- 180
Query: 264 ALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
L G S D ++ GV++ E++ GR P
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 8e-20
Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 92 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK-MEVE---LLGRLRSPYLLAL 146
V+G G FG V + G A+K++ + +D+ + E L P+L L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 147 LGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFL 203
C + R V +++ G L H+ + + D E R R A E L FL
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQ-------KSRRFD-EARARFYAAEIISALMFL 140
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H+ +I+RD K N+LLD H K++DFG+ K G G + GT Y+APE
Sbjct: 141 HDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFCGTPDYIAPE- 194
Query: 264 ALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
L L + D ++ GV+L E+L G P
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 92 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK-MEVE---LLGRLRSPYLLAL 146
V+G G FG V A+K++ + +D+ + VE L + P+L L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 147 LGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFL 203
C + R V +Y+ G L H+ + E A E A GL FL
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGRFK-EPHAVFYAAEIAIGLFFL 137
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
+I+RD K N++LD H K++DFG+ K G + GT Y+APE
Sbjct: 138 QSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--DGVTTKTFCGTPDYIAPE- 191
Query: 264 ALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
+ KS D +++GV+L E+L G+ P
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 92 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK-MEVE---LLGRLRSPYLLAL 146
V+G G FG V + A+K++ + + E K + E LL ++ P+L+ L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 147 LGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFL 203
+ + + V DY+ G L HL E R R A E A L +L
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHL-------QRERCFL-EPRARFYAAEIASALGYL 155
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H +++RD K NILLD H ++DFGL K + ++ GT Y+APE
Sbjct: 156 HSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNSTTSTFCGTPEYLAPE- 209
Query: 264 ALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
L ++ D + G VL E+L G P
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 92 VVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFK-MEVE---LLGRLRSPYLLAL 146
V+G G + V L R A++++ + +++ ++ E P+L+ L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 147 LGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI-ALEAAKGLEFL 203
C ++ R V +Y+ G L H+ KL E R + E + L +L
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQ-------RKLP-EEHARFYSAEISLALNYL 169
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
HE +I+RD K N+LLD H K++D+G+ K G G ++ GT Y+APE
Sbjct: 170 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPE- 223
Query: 264 ALTGHLTTKS-DVYSYGVVLLELLTGRVP 291
L G S D ++ GV++ E++ GR P
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGRL 138
+ +VG G +G+V + GR VAIK L +D+ K E++LL +L
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-----DDKMVKKIAMREIKLLKQL 81
Query: 139 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 197
R L+ LL C +++ LV++++ + + + L + LD++ + +
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL------ELFPNGLDYQVVQKYLFQII 134
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG---HVSTRVLG 254
G+ F H H +IHRD K NIL+ ++ K+ DFG A+ + V+TR
Sbjct: 135 NGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR--- 188
Query: 255 TQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGR 289
Y APE + DV++ G ++ E+ G
Sbjct: 189 --WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-18
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGRL 138
+ K +G G +G V++ VA+K +D +DE E+ LL L
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-----DDEGVPSSALREICLLKEL 58
Query: 139 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 197
+ ++ L +KL LV+++ + L+++ +S LD E +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYF------DSCNGDLDPEIVKSFLFQLL 111
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
KGL F H V+HRD K N+L+++N K+++FGLA+ S V+ T
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVV-TLW 166
Query: 258 YVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPI 292
Y P+ +T D++S G + EL P+
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 42/229 (18%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGRL 138
+ K +G G FG V++ G+KVA+K LM+ E E F + E+++L L
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-----EKEGFPITALREIKILQLL 73
Query: 139 RSPYLLALLGYCSDRRKL---------LVYDYMAN--GGLQEHLYPANGSNSVASKLDWE 187
+ ++ L+ C + LV+D+ + GL ++ K
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---------LVKFTLS 124
Query: 188 TRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK---IGSDKA 244
R+ GL ++H + ++HRD K++N+L+ ++ K++DFGLA+ + +
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 245 GGHVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPI 292
+ RV+ T Y PE L D++ G ++ E+ T PI
Sbjct: 182 PNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PI 228
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 27/215 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKM----EVELLGRLR 139
F + +G+G + VY+G+ + G VA+K +D E+ E+ L+ L+
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-----EEGTPSTAIREISLMKELK 61
Query: 140 SPYLLALLGYCSDRRKL-LVYDYMAN--GGLQEHLYPANGSNSVASKLDWETRLRIALEA 196
++ L KL LV+++M N + + L+ +
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSR----TVGNTPRGLELNLVKYFQWQL 117
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 256
+GL F HE+ ++HRD K N+L++K K+ DFGLA+ S+ V+ T
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-NTFSSEVV-TL 172
Query: 257 GYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGR 289
Y AP+ L G +T D++S G +L E++TG+
Sbjct: 173 WYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGRL 138
+ K +G G +G+V++ G+ VAIK L + +D K E+ +L +L
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-----DDPVIKKIALREIRMLKQL 59
Query: 139 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 197
+ P L+ LL +R+L LV++Y + + L + + I +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYC-DHTVLHEL------DRYQRGVPEHLVKSITWQTL 112
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG---HVSTRVLG 254
+ + F H+H IHRD K NIL+ K+ K+ DFG A++ + + V+TR
Sbjct: 113 QAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR--- 166
Query: 255 TQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGR 289
Y +PE L G DV++ G V ELL+G
Sbjct: 167 --WYRSPE-LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 55/229 (24%), Positives = 85/229 (37%), Gaps = 45/229 (19%)
Query: 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIK--LMDQAGKQGEDEFKMEVELLGRLRSPYL 143
F + G G FG V G G VAIK + D + E ++ L L P +
Sbjct: 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE---LQIMQDLAVLHHPNI 81
Query: 144 LALLG--YCSDRRKL------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALE 195
+ L Y R +V +Y+ + L+ + + ++
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRC-------CRNYYRRQVAPPPI 129
Query: 196 AAK--------GLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-KVSDFGLAKI-GSDKAG 245
K + LH S V HRD K N+L+++ K+ DFG AK +
Sbjct: 130 LIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 246 GH-VSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPI 292
+ +R Y APE H TT D++S G + E++ G PI
Sbjct: 189 VAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGRLR 139
+ K VG G +G+VY+ S GR VA+K +D EDE E+ LL L
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA-----EDEGIPSTAIREISLLKELH 77
Query: 140 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 198
P +++L+ R L LV+++M L++ L + + L + +
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVL------DENKTGLQDSQIKIYLYQLLR 130
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
G+ H+H ++HRD K N+L++ + K++DFGLA+ + V+ T Y
Sbjct: 131 GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHEVV-TLWY 185
Query: 259 VAPEYALTG--HLTTKSDVYSYGVVLLELLTGR 289
AP+ L G +T D++S G + E++TG+
Sbjct: 186 RAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 4e-18
Identities = 36/207 (17%), Positives = 58/207 (28%), Gaps = 50/207 (24%)
Query: 92 VVGHGGFGLVYRG---VLSNGRKVAIKLMDQAGKQGED---EFKMEVELLGRLRSPYLLA 145
G ++ L R+VA+ +D G +D E L R+ P +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 146 LLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
+L R L+V +++ G LQE + +R A + H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA---------DTSPSPVGAIRAMQSLAAAADAAH 146
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
V S + + + G V VL +
Sbjct: 147 RA---GVALSIDHPSRVRVSID-------------------GDV---VLAYPATMPDA-- 179
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVP 291
+ D+ G L LL R P
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWP 201
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 7e-18
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 24/213 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKM----EVELLGRLR 139
+ K + +G G F VY+ + + VAIK + + +D E++LL L
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHR-SEAKDGINRTALREIKLLQELS 70
Query: 140 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 198
P ++ LL + + LV+D+M L+ + + L L +
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFM-ETDLEVII------KDNSLVLTPSHIKAYMLMTLQ 123
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
GLE+LH+H ++HRD K +N+LLD+N K++DFGLAK + +V+ T+ Y
Sbjct: 124 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVV-TRWY 178
Query: 259 VAPEYALTG--HLTTKSDVYSYGVVLLELLTGR 289
APE L G D+++ G +L ELL
Sbjct: 179 RAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 1e-17
Identities = 50/213 (23%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGRLR 139
+ +G G +G+VY+ + G A+K +++ EDE E+ +L L+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK-----EDEGIPSTTIREISILKELK 58
Query: 140 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 198
++ L +++L LV++++ + L++ L + L+ T L+
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLL------DVCEGGLESVTAKSFLLQLLN 111
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
G+ + H+ V+HRD K N+L+++ K++DFGLA+ + ++ T Y
Sbjct: 112 GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI-PVRKYTHEIV-TLWY 166
Query: 259 VAPEYALTG--HLTTKSDVYSYGVVLLELLTGR 289
AP+ L G +T D++S G + E++ G
Sbjct: 167 RAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 87 FSKSNVVGHGGFGLVYRG-VLSNGRKVAIK--LMDQAGKQGEDEFKM----EVELLGRLR 139
+ K + +G G + VY+G VA+K ++ E+ EV LL L+
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-----EEGAPCTAIREVSLLKDLK 58
Query: 140 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 198
++ L + L LV++Y+ + L+++L + + ++ + +
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL------DDCGNIINMHNVKLFLFQLLR 111
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
GL + H V+HRD K N+L+++ K++DFGLA+ S + V+ T Y
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEVV-TLWY 166
Query: 259 VAPEYAL-TGHLTTKSDVYSYGVVLLELLTGR 289
P+ L + +T+ D++ G + E+ TGR
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 47/228 (20%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKM----EVELLGRLR 139
+ +G G +G VY+ +G VA+K + G + EV LL RL
Sbjct: 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG-GGGGGGLPISTVREVALLRRLE 69
Query: 140 S---PYLLALL-----GYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 190
+ P ++ L+ K+ LV++++ + + + LD
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV------DQ--------DLRTYLDKAPPP 115
Query: 191 RIALEAAK--------GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI-GS 241
+ E K GL+FLH +C ++HRD K NIL+ K++DFGLA+I
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSY 172
Query: 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR 289
A ++ V+ T Y APE L T D++S G + E+ +
Sbjct: 173 QMA---LTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 56/262 (21%), Positives = 100/262 (38%), Gaps = 39/262 (14%)
Query: 44 SKRLNTPKRVDREEKGESGKLEVTTDNGLQVFTFKQLHSATGGFSKSNVVGHGGFGLVYR 103
+ P + + + V + ++ + T V+G G G V +
Sbjct: 26 PALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTS-----QVLGLGINGKVLQ 80
Query: 104 GV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLALLGYCSDRRK-----L 156
K A+K++ + + EVEL R P+++ ++ + L
Sbjct: 81 IFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135
Query: 157 LVYDYMANGGLQEHLYPANGSNS----VASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 212
+V + + G L + G + AS++ ++ EA +++LH +
Sbjct: 136 IVMECLDGGELFSRIQ-DRGDQAFTEREASEI-----MKSIGEA---IQYLHSIN---IA 183
Query: 213 HRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL 269
HRD K N+L N K++DFG AK + ++T T YVAPE
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTTPC-YTPYYVAPEVLGPEKY 240
Query: 270 TTKSDVYSYGVVLLELLTGRVP 291
D++S GV++ LL G P
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPP 262
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 52/244 (21%), Positives = 92/244 (37%), Gaps = 54/244 (22%)
Query: 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKM-EVELLGRLRSPYLL 144
+S +G G FG+V +G++ A+K + Q + +K E++++ L ++
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNII 63
Query: 145 ALLGY----CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALE----- 195
L+ Y + K N ++ N SV L + +E
Sbjct: 64 KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 196 --------------------------AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229
+ + F+H S + HRD K N+L++ +
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNT 180
Query: 230 -KVSDFGLAKI--GSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLEL 285
K+ DFG AK S+ + ++ +R Y APE L T D++S G V EL
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 286 LTGR 289
+ G+
Sbjct: 236 ILGK 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM--EVELLGRLRSPYLLALL 147
VG G +G V + +G KVAIK + + + + E+ LL ++ ++ LL
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 148 GYCSDRRKL-------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
+ L LV +M + + K E + + KGL
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFM----------QTDLQKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260
+++H S V+HRD K N+ ++++ K+ DFGLA+ + G+V TR Y A
Sbjct: 140 KYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRA 191
Query: 261 PEYALTGHLTTKS-DVYSYGVVLLELLTGRV 290
PE L+ ++ D++S G ++ E+LTG+
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 44/219 (20%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---------EVELLGRLRS 140
+G G G+V R VAIK + + F+ E+ L+ +
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNH 120
Query: 141 PYLLALL-------GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIA 193
+++LL + LV + M AN + +LD E +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM----------DANLCQVIQMELDHERMSYLL 170
Query: 194 LEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG--GHVSTR 251
+ G++ LH S +IHRD K SNI++ + K+ DFGLA+ +V TR
Sbjct: 171 YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 227
Query: 252 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 290
Y APE L D++S G ++ E++ ++
Sbjct: 228 Y-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 55/237 (23%), Positives = 84/237 (35%), Gaps = 41/237 (17%)
Query: 77 FKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDE--FKM---- 130
+LH+ ++ + G +G V GV S G VAIK + G
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 131 -----EVELLGRLRSPYLLALL------GYCSDRRKLLVYDYMANGGLQEHLYPANGSNS 179
E+ LL P +L L + + LV + M + +
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM----------RTDLAQV 123
Query: 180 VASKLDWETRLRIAL---EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236
+ + + I GL LH V+HRD NILL N + DF L
Sbjct: 124 IHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNL 180
Query: 237 AKIGSDKAG--GHVSTRVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRV 290
A+ + A +V+ R Y APE + TK D++S G V+ E+ +
Sbjct: 181 AREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 30/216 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM--EVELLGRLRSPYL 143
+ +G G G+V R VAIK + + + + E+ L+ + +
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 144 LALLGYCSDRRKL-------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 196
+ LL + ++ L +V + M AN + +LD E + +
Sbjct: 87 IGLLNVFTPQKSLEEFQDVYIVMELM----------DANLCQVIQMELDHERMSYLLYQM 136
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA--GGHVSTRVLG 254
G++ LH S +IHRD K SNI++ + K+ DFGLA+ +V TR
Sbjct: 137 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-- 191
Query: 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 290
Y APE L D++S G ++ E++ G V
Sbjct: 192 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 41/224 (18%)
Query: 93 VGHGGFGLVYRGV---LSNGRKVAIKLMDQAGKQGEDEFKM----EVELLGRLRSPYLLA 145
VG G +G VY+ + + A+K + M E+ LL L+ P +++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALK------QIEGTGISMSACREIALLRELKHPNVIS 82
Query: 146 LLGYCSDR--RKL-LVYDYMANGGLQEH-------LYPANGSNSVASKLDWETRLRIALE 195
L RK+ L++DY EH + A+ +N +L + +
Sbjct: 83 LQKVFLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA----KVSDFGLAKIGSD--KAGGHVS 249
G+ +LH + V+HRD K +NIL+ K++D G A++ + K +
Sbjct: 137 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 250 TRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPI 292
V+ T Y APE L H T D+++ G + ELLT PI
Sbjct: 194 PVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 235
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
KGL ++H + +IHRD K N+ ++++ K+ DFGLA+ + G+V TR
Sbjct: 139 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 258 YVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRV 290
Y APE L T++ D++S G ++ E++TG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 5e-16
Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 53/230 (23%)
Query: 87 FSKSNVVGHGGFGLVYRG--VLSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGR 137
+ +G G +G V++ + + GR VA+K + +E + EV +L
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-----GEEGMPLSTIREVAVLRH 67
Query: 138 LRS---PYLLALLGYCSDRRKL------LVYDYMANGGLQEHLYPANGSNSVASKLDWET 188
L + P ++ L C+ R LV++++ + + + LD
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQ--------DLTTYLDKVP 113
Query: 189 RLRIALEAAK--------GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI- 239
+ E K GL+FLH H V+HRD K NIL+ + K++DFGLA+I
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR 289
A +++ V+ T Y APE L T D++S G + E+ +
Sbjct: 171 SFQMA---LTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 44/209 (21%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS----PYLLALL 147
+G G + V+ + ++N KV +K++ K+ + K E+++L LR L ++
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIV 100
Query: 148 GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC 207
R LV++++ N + LY + + E K L++ H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFK-QLYQTLTDYDIRFYM---------YEILKALDYCHSMG 150
Query: 208 SPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAG--GHVSTRVLGTQGYVAPEYA 264
++HRD K N+++D ++ ++ D+GLA+ V++R + PE
Sbjct: 151 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELL 202
Query: 265 LTGHLTTKS-DVYSYGVVLLELLTGRVPI 292
+ + S D++S G +L ++ + P
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 36/94 (38%), Positives = 58/94 (61%), Gaps = 9/94 (9%)
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
+GL+++H S +IHRD K SN+ ++++ K+ DFGLA+ +D+ G+V+TR
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 258 YVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRV 290
Y APE L ++ D++S G ++ ELLTGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 9e-16
Identities = 49/220 (22%), Positives = 85/220 (38%), Gaps = 37/220 (16%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDE-FKM----EVELLGRL 138
+ + +G G +G VY+ + VAIK ++ E+E EV LL L
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-----EEEGVPGTAIREVSLLKEL 90
Query: 139 RSPYLLALLGYCSDRRKL-LVYDYMAN--GGLQEHLYPANGSNSVASKLDWETRLRIALE 195
+ ++ L +L L+++Y N + + + S +
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRV-IKS---------FLYQ 140
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-----KVSDFGLAKIGSDKAGGHVST 250
G+ F H +HRD K N+LL + + K+ DFGLA+ +
Sbjct: 141 LINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-TH 196
Query: 251 RVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGR 289
++ T Y PE L + H +T D++S + E+L
Sbjct: 197 EII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 15/100 (15%)
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG------GHVSTR 251
+GL+++H S V+HRD K SN+LL+ K+ DFGLA++ +V+TR
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 252 VLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRV 290
Y APE L TKS D++S G +L E+L+ R
Sbjct: 196 -----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 51/218 (23%), Positives = 85/218 (38%), Gaps = 37/218 (16%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKL--MDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 149
+G G FG+++ G L N ++VAIK Q DE++ L G + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAG---CTGIPNVYYF 74
Query: 150 CSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
+ +LV D + G E L + K +T A + ++ +HE
Sbjct: 75 GQEGLHNVLVIDLL--GPSLEDLL-----DLCGRKFSVKTVAMAAKQMLARVQSIHEKS- 126
Query: 209 PPVIHRDFKSSNILLDKNFHAK-----VSDFGLAKIGSDKAGG-HVSTR----VLGTQGY 258
+++RD K N L+ + V DFG+ K D H+ R + GT
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT--- 181
Query: 259 VAPEYA-LTGHLTT----KSDVYSYGVVLLELLTGRVP 291
Y + HL + D+ + G V + L G +P
Sbjct: 182 --ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 12/102 (11%)
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ- 256
+ ++ LH VIHRD K SN+L++ N KV DFGLA+I + A + +
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 257 -GYV------APEYALTGHLTTKS-DVYSYGVVLLELLTGRV 290
+V APE LT +++ DV+S G +L EL R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-14
Identities = 49/218 (22%), Positives = 84/218 (38%), Gaps = 37/218 (16%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKL--MDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 149
+G G FG + G L VAIKL M Q E++ +L + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS---GDGIPQVYYF 73
Query: 150 CSDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
+ +V + + G E L+ + +T L IA++ +E++H
Sbjct: 74 GPCGKYNAMVLELL--GPSLEDLF-----DLCDRTFSLKTVLMIAIQLISRMEYVHSKN- 125
Query: 209 PPVIHRDFKSSNILLDKNFHAKVS-----DFGLAKIGSDKAGG-HVSTR----VLGTQGY 258
+I+RD K N L+ + + DF LAK D H+ R + GT
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT--- 180
Query: 259 VAPEYA-LTGHL----TTKSDVYSYGVVLLELLTGRVP 291
Y + HL + + D+ + G + + L G +P
Sbjct: 181 --ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-14
Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 25/211 (11%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYC 150
+G G FG +Y G ++ G +VAIKL K + +E ++ ++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 151 SDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
++ ++V + + G E L+ N + K +T L +A + +E++H
Sbjct: 75 AEGDYNVMVMELL--GPSLEDLF-----NFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 210 PVIHRDFKSSNILLDKNFHAK---VSDFGLAKIGSDKAGG-HVSTR----VLGTQGYVAP 261
IHRD K N L+ + DFGLAK D H+ R + GT Y A
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-AS 183
Query: 262 EYALTGH-LTTKSDVYSYGVVLLELLTGRVP 291
G + + D+ S G VL+ G +P
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 52/246 (21%), Positives = 90/246 (36%), Gaps = 73/246 (29%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM--EVELLGRLRSPYLLALL- 147
++G G +G VY + + VAIK +++ + D ++ E+ +L RL+S Y++ L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 148 -----GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWET------RLRIALEA 196
+V + ++ + I L
Sbjct: 93 LIIPDDLLKFDELYIVLEIA------------------------DSDLKKLFKTPIFLTE 128
Query: 197 A----------KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 246
G F+H +IHRD K +N LL+++ KV DFGLA+ + +
Sbjct: 129 EHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 247 HVSTRVLGTQ--------------GYV------APEYALTGHLTTKS-DVYSYGVVLLEL 285
++ + + +V APE L TKS D++S G + EL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 286 LTGRVP 291
L
Sbjct: 246 LNMLQS 251
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYC 150
+G G FG +Y G + +VAIKL + K + E ++ L+ + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 151 SDRR-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
+ +LV D + G E L+ N + KL +T L +A + +EF+H
Sbjct: 73 VEGDYNVLVMDLL--GPSLEDLF-----NFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 210 PVIHRDFKSSNILLDKNFHAK---VSDFGLAKIGSDKAGG-HVSTR----VLGTQGYVAP 261
+HRD K N L+ A + DFGLAK D + H+ R + GT Y A
Sbjct: 124 -FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-AS 181
Query: 262 EYALTGH-LTTKSDVYSYGVVLLELLTGRVP 291
G + + D+ S G VL+ L G +P
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 29/101 (28%), Positives = 54/101 (53%), Gaps = 16/101 (15%)
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAG------GHVST 250
+GL+++H S V+HRD K +N+ ++ ++ K+ DFGLA+I + T
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 251 RVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRV 290
+ Y +P L+ + TK+ D+++ G + E+LTG+
Sbjct: 188 K-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 47/226 (20%), Positives = 85/226 (37%), Gaps = 45/226 (19%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G F V+ + N VA+K++ + K + + E++LL R+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVND---ADNTKED 81
Query: 151 SDRRKLLV--YDY-MANGGLQEHL-----------------YPANGSNSVASKLDWETRL 190
S ++ D+ G H+ Y G + K
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK------- 134
Query: 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD------KNFHAKVSDFGLAKIGSDKA 244
+I+ + GL+++H C +IH D K N+L++ K++D G A +
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 290
+ TR Y +PE L +D++S ++ EL+TG
Sbjct: 193 TNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 48/271 (17%), Positives = 86/271 (31%), Gaps = 92/271 (33%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKM---------EVELLG 136
+ +++G G +G V R VAIK + F+ E+ +L
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILN 107
Query: 137 RLRSPYLLALL------GYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 190
RL +++ +L +V + ++
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA------------------------DSDF 143
Query: 191 ------RIALEAA----------KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234
+ L G++++H S ++HRD K +N L++++ KV DF
Sbjct: 144 KKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDF 200
Query: 235 GLAKIGSDKAGGHVSTRVLGTQ-------------------GYV------APEYALTGHL 269
GLA+ G+ + + G+V APE L
Sbjct: 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN 260
Query: 270 TTKS-DVYSYGVVLLELLTGRVPIDVNKPSG 299
T++ DV+S G + ELL
Sbjct: 261 YTEAIDVWSIGCIFAELLNMIKENVAYHADR 291
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 48/233 (20%), Positives = 86/233 (36%), Gaps = 49/233 (21%)
Query: 93 VGHGGFGLVYRGV------LSNGRKVAIKLMDQAGKQGEDEFKM-----EVELLGRLRSP 141
+G GGFG +Y + + +K+ E K + E + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 142 YLLALLG-----------YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRL 190
L LG + ++ D G + +Y AN + +T L
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAK-----RFSRKTVL 155
Query: 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV--SDFGLAKIGSDKAGG-H 247
+++L LE++HEH +H D K+SN+LL+ +V D+GLA +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 248 VSTR----VLGTQGYVAPEYA-LTGHL----TTKSDVYSYGVVLLELLTGRVP 291
+ GT E+ + H + + D+ G +++ LTG +P
Sbjct: 213 YAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 35/113 (30%), Positives = 53/113 (46%), Gaps = 23/113 (20%)
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ- 256
K +++LH S ++HRD K SNILL+ H KV+DFGL++ + + + +
Sbjct: 120 KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 257 ------------GYV------APEYALTGHLTTKS-DVYSYGVVLLELLTGRV 290
YV APE L TK D++S G +L E+L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 47/217 (21%), Positives = 82/217 (37%), Gaps = 61/217 (28%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLALLGY 149
V+G G G V + K A+K++ + + EVEL R P+++ ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 150 CSDRRK-----LLVYDYMANGGL-------QEHLYPANGSNSVASKLDWETRLRIALEAA 197
+ L+V + + G L + + + AS++ ++ EA
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF----TEREASEI-----MKSIGEA- 129
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLG 254
+++LH + HRD K N+L N K++DFG AK G
Sbjct: 130 --IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------TTG 172
Query: 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
+ Y D++S GV++ LL G P
Sbjct: 173 -EKY-----------DKSCDMWSLGVIMYILLCGYPP 197
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 48/233 (20%), Positives = 90/233 (38%), Gaps = 49/233 (21%)
Query: 93 VGHGGFGLVYRGV---------LSNGRKVAIKLMDQAGKQ-GEDEF------KMEVELLG 136
G++Y +K ++KL + G+ E F ++V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 137 RLRSPYLLAL-----LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR 191
+L S LLA+ G D+ + LV + G + + + ++ + + L+
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER----SVLQ 163
Query: 192 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV--SDFGLAKIGSDKAGGHVS 249
+A LEFLHE+ +H + + NI +D ++V + +G A +G HV+
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP-SGKHVA 219
Query: 250 TR------VLGTQGYVAPEYA-LTGHL----TTKSDVYSYGVVLLELLTGRVP 291
G E+ + H + +SD+ S G +L+ L G +P
Sbjct: 220 YVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 9e-12
Identities = 51/232 (21%), Positives = 86/232 (37%), Gaps = 50/232 (21%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVA---IKLMDQAGKQGEDEFKMEVELLG-----RLRSPYL 143
+G GGFGL+Y + K A +K+ Q E K + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 144 LALLG-----------YCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI 192
L LG + + +V + + G + + NG T L++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG------TFKKSTVLQL 156
Query: 193 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV--SDFGLAKIGSDKAGGHV-- 248
+ LE++HE+ +H D K++N+LL +V +D+GL+ G H
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP-NGNHKQY 212
Query: 249 ---STRVL-GTQGYVAPEYA-LTGHL----TTKSDVYSYGVVLLELLTGRVP 291
+ GT E+ L H + +SDV G +L L G++P
Sbjct: 213 QENPRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 3e-11
Identities = 40/258 (15%), Positives = 69/258 (26%), Gaps = 56/258 (21%)
Query: 73 QVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLM---DQAGKQGE---- 125
F T + +G G FG V++ + + VAIK++ G
Sbjct: 9 GPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKT 66
Query: 126 -DEFKMEVELLGRL---------RSPYLLALLGYCSDRRK-----LLVYDYMANGGLQEH 170
+E E+ + L R+ + L + L +D+ + +
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 171 LYPANGSNS------------------VASKLDWETRLRIALEAAKGLEFLHEHCSPPVI 212
P + T I + L
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FE 184
Query: 213 HRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG-------HVSTRVLGTQGYV-----A 260
HRD N+LL K K+ K + + G + +R+ V
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244
Query: 261 PEYALTGHLTTKSDVYSY 278
E TG + D+Y
Sbjct: 245 DEDLFTGDGDYQFDIYRL 262
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 43/220 (19%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLM-------DQAGKQGEDEFKMEVELLGRLRSP- 141
+++G G FG V + VAIK++ +QA ++EV LL +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA--------QIEVRLLELMNKHD 111
Query: 142 -----YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYP---ANGSNSVASKLDWETRLRI 192
Y++ L + R L LV++ L +LY V+ L TR +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEM-----LSYNLYDLLRNTNFRGVSLNL---TR-KF 162
Query: 193 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILL--DKNFHAKVSDFGLAKIGSDKAGGHVST 250
A + L FL +IH D K NILL K K+ DFG + + ++ +
Sbjct: 163 AQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS 221
Query: 251 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 290
R Y +PE L D++S G +L+E+ TG
Sbjct: 222 RF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 49/277 (17%), Positives = 85/277 (30%), Gaps = 89/277 (32%)
Query: 93 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS--------PYL 143
+G G F V+ + + VA+K++ A E E+ LL +R+ +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 144 LALLGY-----------CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRI 192
+ LL C +V++ + HL ++ L +I
Sbjct: 104 VQLLDDFKISGVNGTHIC------MVFEVL-----GHHLLKWIIKSNYQ-GLPLPCVKKI 151
Query: 193 ALEAAKGLEFLHEHCSPPVIHRDFKSSNILL----------------------------- 223
+ +GL++LH C +IH D K NILL
Sbjct: 152 IQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 224 --------------------DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
+ K++D G A + TR Y + E
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEV 264
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE 300
+ T +D++S + EL TG + +
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 52/224 (23%), Positives = 87/224 (38%), Gaps = 55/224 (24%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLM-------DQAGKQGEDEFKMEVELLGRLR---- 139
V+G G FG V + + VA+K++ QA E+ +L LR
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA--------AEEIRILEHLRKQDK 155
Query: 140 --SPYLLALLGYCSDRRKL-LV--------YDYMANGGLQEHLYPANGSNSVASKLDWET 188
+ ++ +L + R + + Y+ + Q G + +
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQ-------GFSLPLVR----- 203
Query: 189 RLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA--KVSDFGLAKIGSDKAGG 246
+ A + L+ LH++ +IH D K NILL + + KV DFG + +
Sbjct: 204 --KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT 258
Query: 247 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 290
++ +R Y APE L D++S G +L ELLTG
Sbjct: 259 YIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 3e-06
Identities = 52/355 (14%), Positives = 110/355 (30%), Gaps = 107/355 (30%)
Query: 36 YCYIRNKVSKRLNTPKRVDREEKGESGKLEVTTDNGLQVFT---------FKQLHSATGG 86
Y ++ + + P + R + +L N QVF + +L A
Sbjct: 91 YKFLMSPIKTEQRQPSMMTRMYIEQRDRLY----NDNQVFAKYNVSRLQPYLKLRQALLE 146
Query: 87 FSKS-NVVGHG--GFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL 143
+ NV+ G G G + + A+ + Q + +FK+ +
Sbjct: 147 LRPAKNVLIDGVLGSG---KTWV------ALDVCLSYKVQCKMDFKI-----------FW 186
Query: 144 LALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG-LEF 202
L L C+ +L + + L N S+ D + +++ + + + L
Sbjct: 187 LN-LKNCNSPETVLE--------MLQKLLYQIDPNW-TSRSDHSSNIKLRIHSIQAELRR 236
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSD-FGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
L + + +++ ++L +AK + F L S ++L
Sbjct: 237 L-------LKSKPYENCLLVLLNVQNAKAWNAFNL------------SCKIL-------- 269
Query: 262 EYALTGHLTTK-SDVYSYGVVLLELLTGRVPID-----VNKPSGEGVLVSWA------LP 309
LTT+ V L T + +D + + +L+ + LP
Sbjct: 270 -------LTTRFKQVTD---FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP 319
Query: 310 RLTDREKILEI-M-------DPALEGQYSMKEVIQVAAIAAMCV--QPEADYRPL 354
R + + A + ++ I + A+YR +
Sbjct: 320 REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 49/240 (20%), Positives = 81/240 (33%), Gaps = 69/240 (28%)
Query: 92 VVGHGGFGLVYRGV--LSNGRKVAIKLM-------DQAGKQGEDEFKMEVELLGRLRSPY 142
+G G FG V + +VA+K++ + A ++E+ +L +++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA--------RLEINVLKKIKE-- 75
Query: 143 LLALLGYCSDRRKLLV--YDY--------MANGGLQEHLY---PANGSNSVASKLDWETR 189
+ + L V D+ +A L ++ + N R
Sbjct: 76 ------KDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPH---VR 126
Query: 190 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-------------------K 230
+A + L FLHE+ + H D K NIL + +
Sbjct: 127 -HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182
Query: 231 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV 290
V+DFG A + V+TR Y PE L DV+S G +L E G
Sbjct: 183 VADFGSATFDHEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 54/244 (22%), Positives = 86/244 (35%), Gaps = 77/244 (31%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLM-------DQAGKQGEDEFKMEVELLGRLRS--- 140
+G G FG V + N + A+K++ A K+E ++L ++++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA--------KIEADILKKIQNDDI 93
Query: 141 --PYLLALLGY-------C--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETR 189
++ G C + +Y+ + N N + +
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR----------NNYNGFHIED---IK 140
Query: 190 LRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA-------------------- 229
+E K L +L + + H D K NILLD +
Sbjct: 141 -LYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 230 -----KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLE 284
K+ DFG A SD G ++TR Y APE L SD++S+G VL E
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPEVILNLGWDVSSDMWSFGCVLAE 251
Query: 285 LLTG 288
L TG
Sbjct: 252 LYTG 255
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 54/240 (22%), Positives = 85/240 (35%), Gaps = 73/240 (30%)
Query: 92 VVGHGGFGLVYRGV--LSNGRKVAIKLM-------DQAGKQGEDEFKMEVELLGRLRSP- 141
+G G FG V + + GR VA+K++ + A + E+++L L +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA--------RSEIQVLEHLNTTD 72
Query: 142 ----YLLALLGYCSDRRK-------LL---VYDYMANGGLQEHLYPANGSNSVASKLDWE 187
+ + + LL YD++ NG
Sbjct: 73 PNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKE----------NGFLPFRLDH--- 119
Query: 188 TRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA------------------ 229
R ++A + K + FLH + + H D K NIL ++ +
Sbjct: 120 IR-KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 230 -KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTG 288
KV DFG A + VSTR Y APE L + DV+S G +L+E G
Sbjct: 176 IKVVDFGSATYDDEHHSTLVSTRH-----YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 395 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.01 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.83 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.62 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.56 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.4 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.39 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.28 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.27 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.09 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.79 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.74 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.7 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.5 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.44 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.41 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.4 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.37 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.16 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.13 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.98 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.87 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.83 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.62 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 94.89 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.85 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.5 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.26 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.58 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 87.48 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 83.08 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 82.7 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-60 Score=430.83 Aligned_cols=265 Identities=26% Similarity=0.373 Sum_probs=214.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
++|.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.++ ..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45778899999999999999864 4778999999876666677899999999999999999999999876 6779
Q ss_pred EEEcccCCChhhhcccCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEE
Q 016117 158 VYDYMANGGLQEHLYPANG------SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 231 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl 231 (395)
|||||++|+|.++|..... .......++|.+++.++.|++.||+|||++ +|+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 9999999999999975421 112335799999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcc
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPR 310 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 310 (395)
+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||...+.. ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~------- 239 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EV------- 239 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HH-------
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH-------
Confidence 99999986543332223334568999999999999999999999999999999999 99999754321 11
Q ss_pred cccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 311 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
...+... .....+..++.++.+|+.+||+.||++|||+.+|++.|+++.+..
T Consensus 240 ------~~~i~~~-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 240 ------IECITQG-RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp ------HHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ------HHHHHcC-CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1111111 111223345567999999999999999999999999999988754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=431.43 Aligned_cols=264 Identities=27% Similarity=0.391 Sum_probs=207.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
.+|.+.+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+. ..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35677789999999999999864 4788999999876666678899999999999999999999999876 5779
Q ss_pred EEEcccCCChhhhcccCCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcE
Q 016117 158 VYDYMANGGLQEHLYPANGS--------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 229 (395)
|||||++|+|.++++..... ......++|.+++.++.|++.||+|||++ +|+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 99999999999999765421 11235699999999999999999999998 99999999999999999999
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhh
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~ 308 (395)
||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||...... ...
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~---- 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAI---- 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHH----
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHH----
Confidence 9999999986544433333445679999999999999999999999999999999999 99999754311 111
Q ss_pred cccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 309 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
..+.. ......+..++.++.+|+.+||+.||++||||.||+++|+.+.+.
T Consensus 271 ---------~~i~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 ---------DCITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp ---------HHHHH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---------HHHHc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11111 011122334456789999999999999999999999999999874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=424.45 Aligned_cols=261 Identities=29% Similarity=0.484 Sum_probs=205.6
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~ 161 (395)
.+++.+.+.||+|+||+||+|++.+ .||||+++... ....+.|.+|++++++++|||||++++++.+++.++||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy 112 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQW 112 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEc
Confidence 3567888999999999999998743 59999987432 3345689999999999999999999999988888999999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
|++|+|.++|+... ..+++.++..++.|+|.||+|||++ +|+||||||+|||+++++.+||+|||+|+...
T Consensus 113 ~~gGsL~~~l~~~~------~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 113 CEGSSLYKHLHVQE------TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp CSSCBHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred CCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 99999999996433 4699999999999999999999998 99999999999999999999999999998655
Q ss_pred CCCCCceeeccccccccccchhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...........+||+.|||||++.+ ..|+.++|||||||+||||+||+.||...... ..+.... ..
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~~~~~~~--------~~ 252 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---DQIIFMV--------GR 252 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHHH--------HT
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---HHHHHHH--------hc
Confidence 4333334455789999999999864 46899999999999999999999999754321 1111000 00
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
....+.+ ...+.+++..+.+|+.+||+.||++||||.+|+++|+.+..
T Consensus 253 ~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 253 GYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp TCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred CCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1111111 12233455678999999999999999999999999988764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=426.23 Aligned_cols=262 Identities=26% Similarity=0.386 Sum_probs=211.2
Q ss_pred CCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
++++.+.||+|+||+||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+. ..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3556788999999999999863 46789999997543 33457899999999999999999999999876 5779
Q ss_pred EEEcccCCChhhhcccCCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc
Q 016117 158 VYDYMANGGLQEHLYPANGSN---------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 228 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~ 228 (395)
|||||++|+|.++|....... .....+++..++.++.|||.||+|||++ +|+||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 999999999999996543211 1235699999999999999999999999 9999999999999999999
Q ss_pred EEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhh
Q 016117 229 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWA 307 (395)
Q Consensus 229 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~ 307 (395)
+||+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |..||...... ...
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~--- 257 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVV--- 257 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHH---
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHH---
Confidence 99999999986544333333445679999999999999999999999999999999998 89999754311 111
Q ss_pred hcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 308 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 308 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
..+........+.+++..+.+|+.+||+.||++||||.+|+++|+.+.+
T Consensus 258 -----------~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 258 -----------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp -----------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred -----------HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 1111111122344556779999999999999999999999999987643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-57 Score=419.27 Aligned_cols=273 Identities=23% Similarity=0.337 Sum_probs=218.1
Q ss_pred HHHHHHhCCCCCCCeeeccCCeEEEEEEEcC------CcEEEEEEeccCCc-ccHHHHHHHHHHHhccCC-CcceeEEEE
Q 016117 78 KQLHSATGGFSKSNVVGHGGFGLVYRGVLSN------GRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRS-PYLLALLGY 149 (395)
Q Consensus 78 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~l~~~ 149 (395)
.+.+...++|++.+.||+|+||+||+|.+.. ++.||||++..... ...+.|.+|+++|++++| ||||+++|+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 3444556789999999999999999998642 36799999975433 334678999999999966 899999999
Q ss_pred EecC--ceEEEEEcccCCChhhhcccCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 016117 150 CSDR--RKLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKS 218 (395)
Q Consensus 150 ~~~~--~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~ 218 (395)
|.+. ..++|||||++|+|.++|...... ......+++..++.++.|||.||+|||++ +|+||||||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~ 213 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAA 213 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCc
Confidence 8653 468999999999999999754321 11234689999999999999999999999 999999999
Q ss_pred CCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 016117 219 SNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKP 297 (395)
Q Consensus 219 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~ 297 (395)
+|||+++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |..||.....
T Consensus 214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654443334455779999999999999999999999999999999998 9999975432
Q ss_pred CCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 298 SGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.. .+...+........+...+.++.+++.+||+.||++|||+.+|+++|+++++.+
T Consensus 294 ~~----------------~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 294 DE----------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp SH----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HH----------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 11 111111111111223334567899999999999999999999999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-57 Score=412.65 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=208.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
..|++.+.||+|+||+||+|... +|+.||||++........+.+.+|+++|+.++|||||++++++.++ ..++|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45889999999999999999975 7999999999765555566788999999999999999999998776 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 154 ~gg~L~~~l~~--------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 154 EGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp TTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 99999999842 3599999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|..||...+... ... .+..-..
T Consensus 223 ~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~----------~i~~~~~ 287 (346)
T 4fih_A 223 EV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK----------MIRDNLP 287 (346)
T ss_dssp SS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH----------HHHHSSC
T ss_pred CC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH----------HHHcCCC
Confidence 32 23345789999999999999999999999999999999999999997543211 000 0111111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
+.+ ......+.++.+|+.+||+.||++|||+.|++++ .++..
T Consensus 288 ~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H--p~~~~ 329 (346)
T 4fih_A 288 PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAK 329 (346)
T ss_dssp CCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGG
T ss_pred CCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--HhhcC
Confidence 111 1112334578899999999999999999999975 55543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-57 Score=415.00 Aligned_cols=250 Identities=21% Similarity=0.389 Sum_probs=199.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.++ ..++|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999964 79999999997542 23356788999999999999999999998776 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
||++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 104 y~~gg~L~~~i~~~~-----~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK-----GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp CCTTCBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred CCCCCcHHHHHHHcC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceee
Confidence 999999999996433 23578999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
... .......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. .....+
T Consensus 176 ~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----------------~~~~~i 237 (350)
T 4b9d_A 176 NST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK----------------NLVLKI 237 (350)
T ss_dssp CHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------HHHHHH
T ss_pred cCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----------------HHHHHH
Confidence 321 11234467999999999999999999999999999999999999999754311 011111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...... ..+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 238 ISGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HcCCCC-CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111110 1222334578999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-56 Score=406.94 Aligned_cols=254 Identities=21% Similarity=0.236 Sum_probs=204.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
+.|.+.++||+|+||+||+|++. +|+.||||+++.... ..+|+.+++.++|||||++++++.++ ..++||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45777889999999999999965 699999999975422 24699999999999999999998876 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC-cEEEeccccccccC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKVSDFGLAKIGS 241 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~~~~ 241 (395)
++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++...
T Consensus 133 ~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 133 EGGSLGQLIKQM-------GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp TTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred CCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 999999999532 4699999999999999999999999 999999999999999987 69999999998654
Q ss_pred CCCCCc---eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 242 DKAGGH---VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 242 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+..
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------------ 270 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------------ 270 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------------
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------------
Confidence 332111 12346799999999999999999999999999999999999999976543221111100
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.+......+...+..+.+|+.+||+.||++|||+.|++++|...+..
T Consensus 271 ---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 271 ---EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp ---SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 00000112233456788999999999999999999999999998875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-57 Score=407.00 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=206.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||+|+.. +|+.||+|++... .....+.+.+|+++|++++|||||++++++.+. ..++||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999964 7999999999642 234456789999999999999999999999877 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 112 Ey~~gG~L~~~i~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~ 181 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKV 181 (311)
T ss_dssp CCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence 999999999999532 4699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.............+||+.|||||++.+..|+.++||||+||++|||++|..||...+.. . ....
T Consensus 182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~-------------~~~~ 245 (311)
T 4aw0_A 182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---L-------------IFAK 245 (311)
T ss_dssp CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H-------------HHHH
T ss_pred cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---H-------------HHHH
Confidence 65444444455678999999999999999999999999999999999999999754311 0 1111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
+..... .++...+.++.+|+.+||+.||++|||+.|++.
T Consensus 246 i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 246 IIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred HHcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 111111 112223456889999999999999999998753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=402.97 Aligned_cols=271 Identities=24% Similarity=0.331 Sum_probs=200.5
Q ss_pred CCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHH--HHHHHHhccCCCcceeEEEEEecC-----ceEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFK--MEVELLGRLRSPYLLALLGYCSDR-----RKLLV 158 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~l~~~~~~~-----~~~lv 158 (395)
+|.+.+.||+|+||+||+|++ +|+.||||++... ..+.+. .|+..+.+++|||||+++++|.+. ..++|
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 467788999999999999998 6899999999653 223333 455566778999999999998754 35799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceeCCCCCCCEEeCCCCcEEEec
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH-----CSPPVIHRDFKSSNILLDKNFHAKVSD 233 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~dlk~~Nill~~~~~~kl~D 233 (395)
|||+++|+|.+++.. ..+++..+.+++.|++.||+|||++ ..++|+||||||+|||++.++++||+|
T Consensus 80 ~Ey~~~gsL~~~l~~--------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred ecCCCCCcHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 999999999999953 3589999999999999999999975 245899999999999999999999999
Q ss_pred cccccccCCCCCC--ceeeccccccccccchhhccC------CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhh
Q 016117 234 FGLAKIGSDKAGG--HVSTRVLGTQGYVAPEYALTG------HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS 305 (395)
Q Consensus 234 fg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~ 305 (395)
||+++........ ......+||+.|||||++.+. .++.++|||||||+||||+||..||......... ...
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p-~~~ 230 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYD 230 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTT
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc-chh
Confidence 9999865443221 112345799999999999764 3677999999999999999999887643321110 000
Q ss_pred hhhcccccchhhhhhccccccCCC-----CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 306 WALPRLTDREKILEIMDPALEGQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~d~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
..............+.+..++... +.+....+.+|+.+||+.||++||||.+|++.|+++.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 000000000111111222222111 2355678999999999999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=397.99 Aligned_cols=246 Identities=26% Similarity=0.435 Sum_probs=193.4
Q ss_pred CCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEec-----CceEEEE
Q 016117 88 SKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-----RRKLLVY 159 (395)
Q Consensus 88 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~lv~ 159 (395)
.+.+.||+|+||+||+|.+. ++..||+|.+... .....+.|.+|++++++++|||||++++++.+ ...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45568999999999999965 6889999998643 23344678999999999999999999998854 1357999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC-CCCcEEEecccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAK 238 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~ 238 (395)
|||++|+|.+++... ..+++..+..++.|++.||+|||++ .++|+||||||+|||++ .++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 999999999999532 4699999999999999999999998 22399999999999997 48999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||...... ..+.... ..
T Consensus 181 ~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~i----~~----- 244 (290)
T 3fpq_A 181 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRV----TS----- 244 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHH----TT-----
T ss_pred eCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHHH----Hc-----
Confidence 53322 2345789999999998865 6999999999999999999999999643211 0000000 00
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
......+... .+.++.+|+.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 245 GVKPASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TCCCGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000011111 22358899999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=414.04 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=209.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
+.|++.+.||+|+||+||+|... +|+.||||++........+.+.+|+.+|+.++|||||++++++.++ ..++|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46999999999999999999965 7999999999766555667789999999999999999999988776 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|.....
T Consensus 231 ~gG~L~~~i~~--------~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 231 EGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp TTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred CCCcHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 99999999842 3599999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|..||....... ... .+.....
T Consensus 300 ~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~----------~i~~~~~ 364 (423)
T 4fie_A 300 EV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK----------MIRDNLP 364 (423)
T ss_dssp SC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH----------HHHHSCC
T ss_pred CC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH----------HHHcCCC
Confidence 32 23345789999999999999999999999999999999999999997543211 000 0111111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
+.+ ......+.++.+|+.+||+.||++|||+.|++++ .++..
T Consensus 365 ~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H--p~~~~ 406 (423)
T 4fie_A 365 PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH--PFLAK 406 (423)
T ss_dssp CCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC--GGGGG
T ss_pred CCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC--HHhcC
Confidence 111 1112234568899999999999999999999975 55543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=390.77 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=190.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||+|.. .+|+.||+|++.... ....+.+.+|+++++.++|||||++++++.+. ..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999995 479999999986432 23356789999999999999999999998877 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+ +|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 93 Ey~-~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 161 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-------DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNI 161 (275)
T ss_dssp ECC-CEEHHHHHHHS-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred eCC-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCee
Confidence 999 68999998543 4699999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
..... .....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+.. .. ..
T Consensus 162 ~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~-------------~~ 222 (275)
T 3hyh_A 162 MTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VL-------------FK 222 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH-------------HH
T ss_pred cCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HH-------------HH
Confidence 54322 2345689999999999998876 57999999999999999999999753211 00 01
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.+..... ..+...+.++.+|+.+||+.||++|||+.|++++ .+++
T Consensus 223 ~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h--pw~k 267 (275)
T 3hyh_A 223 NISNGVY--TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD--DWFK 267 (275)
T ss_dssp HHHHTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC--HHHH
T ss_pred HHHcCCC--CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC--cccc
Confidence 1111111 1122234568899999999999999999999975 4554
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=396.70 Aligned_cols=247 Identities=26% Similarity=0.372 Sum_probs=193.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc----CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
++|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|++++++++|||||++++++.++ ..++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999852 47899999986432 22234678899999999999999999998776 5679
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
||||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 104 vmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla 173 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS 173 (304)
T ss_dssp EECCCTTCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred EEEcCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccc
Confidence 99999999999999532 4699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
+...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. ...
T Consensus 174 ~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----------------~~~ 235 (304)
T 3ubd_A 174 KESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK----------------ETM 235 (304)
T ss_dssp EC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHH
T ss_pred eeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH----------------HHH
Confidence 8543322 2234578999999999999999999999999999999999999999754321 011
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH-----HHHHHH
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM-----ADVVQS 361 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~~vl~~ 361 (395)
..+....+ ..+...+.++.+|+.+||+.||++|||+ +|++++
T Consensus 236 ~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 236 TMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp HHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred HHHHcCCC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 11111111 1222334568899999999999999995 566653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=386.31 Aligned_cols=247 Identities=23% Similarity=0.386 Sum_probs=186.8
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecCc---------
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR--------- 154 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------- 154 (395)
+|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 5888999999999999999965 789999999875433 33467889999999999999999999875432
Q ss_pred ----eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEE
Q 016117 155 ----KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 230 (395)
Q Consensus 155 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k 230 (395)
.+++|||+.+|+|.+++.... .....++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRC----TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCC----SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcC----CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence 479999999999999996543 223466788999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCC----------ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 016117 231 VSDFGLAKIGSDKAGG----------HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE 300 (395)
Q Consensus 231 l~Dfg~~~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~ 300 (395)
|+|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---- 231 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---- 231 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----
Confidence 9999999865432211 11234579999999999999999999999999999999996 774211
Q ss_pred chhhhhhhcccccchhhhhhccccccCCCC---HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 301 GVLVSWALPRLTDREKILEIMDPALEGQYS---MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
... ..+..+.+ ...+ ......+.+|+.+||+.||++|||+.|++++
T Consensus 232 -~~~----------~~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 232 -ERV----------RTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp -HHH----------HHHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHH----------HHHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 00111111 1122 2233457789999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=371.75 Aligned_cols=288 Identities=41% Similarity=0.714 Sum_probs=241.3
Q ss_pred eecHHHHHHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC
Q 016117 74 VFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR 153 (395)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 153 (395)
.+++.++...+++|.+.+.||+|+||+||+|...+|+.||+|++........+.+.+|+.+++.++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34555666678899999999999999999999888999999998876666677899999999999999999999998766
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
..++||||+.+|+|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~ 181 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDL---PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT 181 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCC---CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEEC
T ss_pred CeEEEEEEcCCCCcHHHHHhccCC---CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEe
Confidence 67799999999999999965432 234699999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
|||++................||+.|+|||++.+..++.++||||||+++|||++|+.||....+........|.... .
T Consensus 182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~ 260 (321)
T 2qkw_B 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-H 260 (321)
T ss_dssp CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH-H
T ss_pred ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc-c
Confidence 999998654333333334456899999999999999999999999999999999999999876655544444443221 1
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
........+++.+......+.+..+.+++.+||+.||++|||+.+++++|+.+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 22344556666666777888999999999999999999999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=380.94 Aligned_cols=272 Identities=22% Similarity=0.304 Sum_probs=202.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEec-------Cc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSD-------RR 154 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------~~ 154 (395)
++|++.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|+++|+.++|||||++++++.. +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 46999999999999999999964 799999999975422 234567889999999999999999998753 35
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++|||||. |+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 134 ~~ivmE~~~-g~L~~~i~~-------~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DF 202 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS-------SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDF 202 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS-------SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEeCCC-CCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeec
Confidence 689999995 689999953 34799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCC--CCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 235 GLAKIGSDKA--GGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 235 g~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
|+++...... ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||...+.......+.......
T Consensus 203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282 (398)
T ss_dssp TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998653321 12234457899999999998875 56999999999999999999999997544221111110000000
Q ss_pred cc-------chhhhhhccccc-cCCCCH-----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 312 TD-------REKILEIMDPAL-EGQYSM-----KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 312 ~~-------~~~~~~~~d~~~-~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.. .......+.... ....+. ..+.++.+|+.+||+.||++|||+.|++++ .++...
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H--p~f~~~ 351 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH--PFLAKY 351 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS--GGGTTT
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC--HhhCcC
Confidence 00 000000000000 001111 123468899999999999999999999975 565543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=374.27 Aligned_cols=199 Identities=25% Similarity=0.362 Sum_probs=167.8
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc----CCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ce
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~ 155 (395)
...+.|++.+.||+|+||+||+|+.+ +++.||+|.+... .....+.+|+++|+.+ +||||+++++++.+. ..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 44578999999999999999999853 4678999998654 2345678899999998 699999999988776 56
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC-CcEEEecc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDF 234 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Df 234 (395)
++||||+++|+|.+++ ..+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+||
T Consensus 96 ~lvmE~~~g~~L~~~~----------~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 96 VIAMPYLEHESFLDIL----------NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp EEEEECCCCCCHHHHH----------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEeCCCcccHHHHH----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 6999999999999998 2589999999999999999999999 99999999999999876 89999999
Q ss_pred ccccccCCCCC--------------------------CceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHh
Q 016117 235 GLAKIGSDKAG--------------------------GHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLT 287 (395)
Q Consensus 235 g~~~~~~~~~~--------------------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~ 287 (395)
|+|+....... .......+||+.|+|||++.+. .|+.++||||+||++|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 99975432211 0112345799999999999875 58999999999999999999
Q ss_pred CCCCCCCC
Q 016117 288 GRVPIDVN 295 (395)
Q Consensus 288 g~~pf~~~ 295 (395)
|+.||...
T Consensus 243 G~~Pf~~~ 250 (361)
T 4f9c_A 243 GRYPFYKA 250 (361)
T ss_dssp TCSSSSCC
T ss_pred CCCCCCCC
Confidence 99999643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=391.22 Aligned_cols=249 Identities=21% Similarity=0.334 Sum_probs=205.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
++|++.+.||+|+||+||+|... +|+.||+|++........+.+.+|+.+|+.++|||||++++++.+. ..+++||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57999999999999999999965 7999999999766555667888999999999999999999999877 566999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC--CcEEEecccccccc
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN--FHAKVSDFGLAKIG 240 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~--~~~kl~Dfg~~~~~ 240 (395)
.+|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+++..
T Consensus 237 ~gg~L~~~i~~~~------~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 237 SGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp CCCBHHHHHTCTT------SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred CCCcHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 9999999985332 4689999999999999999999999 99999999999999854 89999999999875
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||....... . ...+
T Consensus 308 ~~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~-------------~~~i 368 (573)
T 3uto_A 308 DPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---T-------------LRNV 368 (573)
T ss_dssp CTT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---H-------------HHHH
T ss_pred cCC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---H-------------HHHH
Confidence 433 23445689999999999999999999999999999999999999997543210 0 1111
Q ss_pred ccc--cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 MDP--ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~d~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
... .+........+.++.+|+.+||+.||.+|||+.|+++|
T Consensus 369 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 369 KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 100 01111111223568899999999999999999999974
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=363.58 Aligned_cols=291 Identities=42% Similarity=0.724 Sum_probs=239.6
Q ss_pred cceecHHHHHHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEE
Q 016117 72 LQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYC 150 (395)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~ 150 (395)
...+++.++....++|++.+.||+|+||+||+|...+|+.||+|++..... .....+.+|+++++.++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456888999999999999999999999999999988899999999875422 2233688999999999999999999998
Q ss_pred ecC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcE
Q 016117 151 SDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 151 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 229 (395)
.+. ..++||||+.+|+|.+++..... ....+++..+..++.|++.||.|||+++.++++||||||+|||++.++.+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPE---SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCST---TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 766 67799999999999999975542 23469999999999999999999999866689999999999999999999
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC--CCCchhhhhh
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKP--SGEGVLVSWA 307 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~--~~~~~~~~~~ 307 (395)
||+|||++....... ........||+.|+|||++.+..++.++||||||+++|+|++|..||..... ........|.
T Consensus 174 kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 174 VVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 999999998654332 2233445699999999999988999999999999999999999999963211 1122233333
Q ss_pred hcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 308 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 308 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
. ..........+.+..+......+.+..+.+++.+||+.||.+|||+.+|+++|+...-
T Consensus 253 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 253 K-GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp T-TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred H-HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 2 2223345566677777778888999999999999999999999999999999986433
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=384.75 Aligned_cols=248 Identities=28% Similarity=0.381 Sum_probs=197.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHH---HHHHHhccCCCcceeEEEEEecC-ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKM---EVELLGRLRSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~-~~~ 156 (395)
++|.+.++||+|+||+||+|+.. +|+.||+|++.... ......+.+ ++.+++.++|||||++++++.+. ..+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 46999999999999999999965 79999999986421 222233333 46677778999999999998877 567
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+||||+++|+|.++|... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+
T Consensus 269 lVmEy~~GGdL~~~l~~~-------~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp EEECCCCSCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccce
Confidence 999999999999999543 4699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
|....... ....+||+.|||||++.+ ..|+.++|||||||++|||++|..||..........+
T Consensus 339 A~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i------------ 402 (689)
T 3v5w_A 339 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI------------ 402 (689)
T ss_dssp CEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH------------
T ss_pred eeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH------------
Confidence 98654332 345689999999999974 5799999999999999999999999975432211100
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 361 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~vl~~ 361 (395)
...+..... .++...+.++.+|+.+||+.||.+|++ +.||++|
T Consensus 403 -~~~i~~~~~--~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 403 -DRMTLTMAV--ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -HHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -HHhhcCCCC--CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 011111111 122233456889999999999999998 6888764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=352.17 Aligned_cols=263 Identities=31% Similarity=0.472 Sum_probs=202.4
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
...++|++.+.||+|+||+||+|.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+. ..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3456788999999999999999987 688999999875432 2345788999999999999999999998776 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP--VIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
|||+.+|+|.+++.... ....+++..++.++.|++.||+|||++ + ++||||||+|||++.++.+||+|||+
T Consensus 113 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSG----AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp EECCTTCBHHHHHHSTT----HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred EecCCCCcHHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999996432 123489999999999999999999998 7 99999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
+....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .
T Consensus 186 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~----------------~ 247 (309)
T 3p86_A 186 SRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ----------------V 247 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH----------------H
T ss_pred Cccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------H
Confidence 97543221 12234568999999999999999999999999999999999999997543210 0
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
...+.........+...+..+.+|+.+||+.+|.+|||+.++++.|+.+++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 248 VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 001100111112223344568899999999999999999999999999998643
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=356.13 Aligned_cols=274 Identities=22% Similarity=0.283 Sum_probs=209.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCc-----eEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-----KLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~lv~ 159 (395)
++|++.+.||+|+||+||+|... ++.||+|++.... .....+..|+.++++++||||+++++++.+.. .++||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 46888999999999999999974 8999999996542 23345566888999999999999999987642 57999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-------CCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH-------CSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
||+++|+|.+++.. ..+++..++.++.|++.||.|||+. .+++++||||||+|||++.++.+||+
T Consensus 102 e~~~~g~L~~~l~~--------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 102 AFHEKGSLSDFLKA--------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp ECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 99999999999943 3589999999999999999999975 13379999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-----HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 307 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~ 307 (395)
|||++................||+.|+|||++.+. .++.++|||||||++|||++|+.||...............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999765543333333446789999999999863 4556889999999999999999999765443222221111
Q ss_pred hcccccchhhhhhccccccCCC-----CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 308 LPRLTDREKILEIMDPALEGQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 308 ~~~~~~~~~~~~~~d~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
...................... ....+..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1110101111111111111111 124556799999999999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=341.96 Aligned_cols=285 Identities=35% Similarity=0.586 Sum_probs=229.2
Q ss_pred CcceecHHHHHHHhCCCCCC------CeeeccCCeEEEEEEEcCCcEEEEEEeccCC----cccHHHHHHHHHHHhccCC
Q 016117 71 GLQVFTFKQLHSATGGFSKS------NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRLRS 140 (395)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h 140 (395)
....|.+.++..++++|... +.||+|+||+||+|.. +++.||+|++.... ....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 35678999999999998877 8999999999999987 68899999986432 2335678899999999999
Q ss_pred CcceeEEEEEecC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCC
Q 016117 141 PYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSS 219 (395)
Q Consensus 141 ~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~ 219 (395)
|||+++++++.+. ..+++|||+++|+|.+++.... ....+++..++.++.|++.||.|||++ +++||||||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~ 162 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD----GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSA 162 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG----GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc----CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHH
Confidence 9999999998776 6789999999999999986432 224689999999999999999999999 9999999999
Q ss_pred CEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 016117 220 NILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSG 299 (395)
Q Consensus 220 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~ 299 (395)
||+++.++.+||+|||++................|++.|+|||.+.+ .++.++||||||+++|+|++|..||.......
T Consensus 163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999999999986554333333344678999999998865 57899999999999999999999997654332
Q ss_pred CchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 300 EGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.... +..........+...+++.+. ..+...+..+.+++.+||+.+|.+|||+.+++++|+++..
T Consensus 242 ~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 242 LLLD--IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp BTTH--HHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHH--HHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1111 111011112233444444442 4567778899999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=359.36 Aligned_cols=265 Identities=21% Similarity=0.371 Sum_probs=211.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc--------CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR- 153 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 153 (395)
++|.+.+.||+|+||+||+|... ++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 56888899999999999999852 35679999997542 23346788999999999 899999999998776
Q ss_pred ceEEEEEcccCCChhhhcccCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 224 (395)
..++||||+.+|+|.+++...... ......+++..++.++.|++.||.|||++ +|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEEC
Confidence 678999999999999999764321 11234689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchh
Q 016117 225 KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVL 303 (395)
Q Consensus 225 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~ 303 (395)
.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---- 313 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 313 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence 999999999999986544332222334457889999999999999999999999999999999 999997533110
Q ss_pred hhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 304 VSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
+...+........+...+..+.+++.+||+.+|++|||+.++++.|++++...
T Consensus 314 -------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 314 -------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp -------------HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 00111111111223334557899999999999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=357.60 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=205.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCc----EEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGR----KVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv 158 (395)
++|++.+.||+|+||+||+|.+. +++ +||+|.+... .....+.+.+|+.++++++||||+++++++.+...+++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v 94 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 45888899999999999999964 444 3588877543 23455789999999999999999999999999888899
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
++|+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 95 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EECCTTCBHHHHHHHST------TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 99999999999996543 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...............+|..|+|||++.+..++.++||||||+++|||++ |..||...... .+
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~~ 228 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EI 228 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------GH
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-----------------HH
Confidence 7654433333334557889999999999999999999999999999999 99999754321 11
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
...+........+...+..+.+++.+||+.+|++|||+.+++++|+++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 229 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 111111111222333455789999999999999999999999999998874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=351.37 Aligned_cols=261 Identities=24% Similarity=0.373 Sum_probs=210.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
++|.+.+.||+|+||+||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++.++ ..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 46788899999999999999975 6899999998766666677899999999999999999999998776 566999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.+|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 90 KGGTLRGIIKSMD------SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp TTCBHHHHHHHCC------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred CCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 9999999996532 4689999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCc------------eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcc
Q 016117 243 KAGGH------------VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 310 (395)
Q Consensus 243 ~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~ 310 (395)
..... ......||+.|+|||++.+..++.++||||||+++|||++|..||....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-------- 232 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-------- 232 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS--------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH--------
Confidence 22111 1114568999999999999999999999999999999999999986543321110
Q ss_pred cccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 311 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
........+... +...+..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 233 ---~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 233 ---GLNVRGFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ---SBCHHHHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---hhhhhccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 001111111111 1122345889999999999999999999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=351.76 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=207.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc----CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
++|.+.+.||+|+||+||+|.+. .+..||+|++... .....+.+.+|+.+++.++||||+++++++.+. ..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46888899999999999999974 3456999999754 233456789999999999999999999999876 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+.+|+|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 129 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD------GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred eeCCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999995432 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCc-eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 239 IGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 239 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
......... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... .
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----------------~ 262 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----------------D 262 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----------------H
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----------------H
Confidence 654432211 2223446778999999999999999999999999999999 99999643311 0
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
....+........+...+..+.+++.+||+.||++|||+.+|++.|+.+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 263 VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1111111111122333456789999999999999999999999999999985
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=347.46 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=205.2
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
.++|++.+.||+|+||+||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.+. ..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35799999999999999999995 57899999999766556677889999999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+|+|.+++.. ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 99 ~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 99 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp CTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 999999999943 3589999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
.... ......||+.|+|||++.+..++.++||||||+++|||++|..||....+...... +..
T Consensus 168 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-------------~~~-- 230 (297)
T 3fxz_A 168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-------------IAT-- 230 (297)
T ss_dssp STTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------HHH--
T ss_pred Cccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHh--
Confidence 3321 23345799999999999999999999999999999999999999965432100000 000
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
........+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 231 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000111122334568899999999999999999999974
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=363.28 Aligned_cols=260 Identities=24% Similarity=0.369 Sum_probs=207.8
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.++|.+.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+. ..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356788899999999999999976 789999999875422 2234678899999999999999999999876 5779999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 193 ~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp CCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 999999999995322 3589999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.............++..|+|||++.+..++.++||||||+++|||++ |..||...... ....
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-----------------~~~~ 326 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-----------------QTRE 326 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-----------------HHHH
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHH
Confidence 32211111111235678999999998899999999999999999998 99999653311 1111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.+........+...+..+.+++.+||+.||++|||+.+|++.|+++.+..
T Consensus 327 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 327 FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 11111111222334557889999999999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=352.82 Aligned_cols=258 Identities=25% Similarity=0.410 Sum_probs=205.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcE----EEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRK----VAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv 158 (395)
++|++.+.||+|+||+||+|.+. +++. |++|.+.... ......+.+|+.+++.++||||+++++++.+...++|
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v 92 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLV 92 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEE
Confidence 46888899999999999999964 4443 7888875432 2333467789999999999999999999988888999
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
+||+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 93 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHR------GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EECCTTCBSHHHHHSSG------GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEeCCCCCHHHHHHHcc------ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccc
Confidence 99999999999996432 4688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...............++..|+|||++.+..++.++||||||+++|+|++ |..||........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------------- 226 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV----------------- 226 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-----------------
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-----------------
Confidence 7655443334445668889999999999999999999999999999999 9999975432211
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
...+........+...+..+.+++.+||+.||.+|||+.+++++|+++...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 227 PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011111111111112233578899999999999999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=358.08 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=198.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc----CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
++|++.+.||+|+||+||+|... ++..||+|.+.... ....+.|.+|+.++++++||||+++++++.+. ..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 47899999999999999999864 56789999987542 33456789999999999999999999999876 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 125 ~e~~~~~sL~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD------AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 99999999999996432 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCc-eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 239 IGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 239 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
......... ......++..|+|||++.+..++.++||||||+++|||++ |..||...... .
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-----------------~ 258 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----------------D 258 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-----------------H
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----------------H
Confidence 654332111 1112335678999999999999999999999999999998 99999643311 1
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
+...+........+...+..+.+++.+||+.+|++|||+.+|++.|++++..
T Consensus 259 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 259 VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1111111111222334456789999999999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=339.86 Aligned_cols=256 Identities=29% Similarity=0.455 Sum_probs=208.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
++|++.+.||+|+||+||+|...+++.||+|++... ....+.+.+|++++++++||||+++++++.+. ..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 467888999999999999999988999999999764 33456789999999999999999999999876 5679999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 89 ~~~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 89 HGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp TCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCcHHHHHHhcC------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999995432 4689999999999999999999999 9999999999999999999999999999754322
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
. ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... . ....+..
T Consensus 160 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~-------------~~~~~~~ 222 (269)
T 4hcu_A 160 Q-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---E-------------VVEDIST 222 (269)
T ss_dssp H-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---H-------------HHHHHHT
T ss_pred c-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---H-------------HHHHHhc
Confidence 1 111223446778999999999999999999999999999999 99999753311 0 0001110
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
......+...+..+.+++.+||+.+|++|||+.+++++|+++.+.
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 223 -GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 011111222345688999999999999999999999999999873
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=357.03 Aligned_cols=276 Identities=23% Similarity=0.337 Sum_probs=216.8
Q ss_pred ecHHHHHHHhCCCCCCCeeeccCCeEEEEEEE------cCCcEEEEEEeccCCc-ccHHHHHHHHHHHhcc-CCCcceeE
Q 016117 75 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLAL 146 (395)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l 146 (395)
+...+.+...++|.+.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34445555677899999999999999999984 2457899999975432 3345788999999999 78999999
Q ss_pred EEEEecC--ceEEEEEcccCCChhhhcccCCCCC----------------------------------------------
Q 016117 147 LGYCSDR--RKLLVYDYMANGGLQEHLYPANGSN---------------------------------------------- 178 (395)
Q Consensus 147 ~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------- 178 (395)
++++.+. ..+++|||+.+|+|.+++.......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 9998765 3679999999999999997653210
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCC
Q 016117 179 -------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 245 (395)
Q Consensus 179 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 245 (395)
.....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 0022389999999999999999999999 999999999999999999999999999986544433
Q ss_pred CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 246 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
........||+.|+|||++.+..++.++||||||+++|||++ |..||....... .....+...
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~~~~~~~~ 312 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----------------EFCRRLKEG 312 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----------------HHHHHHHHT
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH----------------HHHHHHHcC
Confidence 334445678899999999999999999999999999999998 999997543221 011111111
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.....+...+..+.+++..||+.||++|||+.+++++|+++++.+
T Consensus 313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 111122223456889999999999999999999999999998753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=358.45 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=211.2
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~ 155 (395)
.++|++.+.||+|+||+||+|.+. ++..||+|++... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 356888999999999999999843 4678999998643 233445788999999999999999999998776 56
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC---cEEEe
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF---HAKVS 232 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~ 232 (395)
++||||+.+|+|.+++............+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 899999999999999976654444446799999999999999999999999 999999999999998554 59999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------------- 293 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------------- 293 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------------
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------------
Confidence 9999975432222222334567899999999999999999999999999999998 99999754311
Q ss_pred ccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.+...+........+...+..+.+|+.+||+.+|++|||+.+|+++|+.+...
T Consensus 294 ----~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 294 ----EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 01111111111112223345688999999999999999999999999998875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=338.20 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=208.4
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
.++|++.+.||+|+||+||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++.+. ..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 35688889999999999999999888899999997643 3456789999999999999999999999876 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++++|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 86 ~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 86 SNGCLLNYLRSHG------KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp TTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred CCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 9999999995432 3589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ....+.
T Consensus 157 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------------~~~~~~ 219 (268)
T 3sxs_A 157 DQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE----------------VVLKVS 219 (268)
T ss_dssp TCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH----------------HHHHHH
T ss_pred hhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH----------------HHHHHH
Confidence 321 12223446778999999999899999999999999999999 999996433110 000000
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
. ......+...+..+.+++.+||+.+|++|||+.+++++|+++.+++
T Consensus 220 ~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 220 Q-GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp T-TCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred c-CCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 0 0001111122346889999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=353.04 Aligned_cols=269 Identities=22% Similarity=0.364 Sum_probs=214.7
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc--------CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEec
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSD 152 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 152 (395)
..++|.+.+.||+|+||+||+|... .+..||+|++.... ....+.+.+|+++++.+ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467888999999999999999852 23579999997543 23346788999999999 99999999999987
Q ss_pred C-ceEEEEEcccCCChhhhcccCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEE
Q 016117 153 R-RKLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNIL 222 (395)
Q Consensus 153 ~-~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nil 222 (395)
. ..++||||+.+|+|.+++...... ......+++..++.++.|++.||.|||++ +++||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 6 577999999999999999765421 11234699999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 016117 223 LDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEG 301 (395)
Q Consensus 223 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~ 301 (395)
++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--- 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999986554333233344567889999999999999999999999999999999 99999643311
Q ss_pred hhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 302 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
.+...+........+...+..+.+|+.+||+.+|++|||+.+|+++|++++.....
T Consensus 301 --------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 301 --------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp --------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred --------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11111111111122223345789999999999999999999999999999986544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=347.39 Aligned_cols=251 Identities=20% Similarity=0.356 Sum_probs=204.4
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
.++|++.+.||+|+||.||+|.+ .+|+.||+|++... .....+.+.+|+++++.++||||+++++++.+. ..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46799999999999999999997 58999999998653 223445688999999999999999999999876 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 94 e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 163 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-------GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNE 163 (328)
T ss_dssp CCCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred ECCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence 999999999999543 3689999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLT-TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...... ....
T Consensus 164 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------------~~~~ 224 (328)
T 3fe3_A 164 FTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK----------------ELRE 224 (328)
T ss_dssp GSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHH
T ss_pred cCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH----------------HHHH
Confidence 54322 23456799999999999988765 7999999999999999999999754311 0011
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.+..... ..+...+.++.+|+.+||+.||.+|||+.+++++ .++.
T Consensus 225 ~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h--~~~~ 269 (328)
T 3fe3_A 225 RVLRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD--RWIN 269 (328)
T ss_dssp HHHHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC--TTTT
T ss_pred HHHhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC--Hhhc
Confidence 1111111 1122234568899999999999999999999975 4444
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=345.26 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=200.2
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.++|++.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.++ ..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367899999999999999999965 789999999864322 2335688899999999999999999999877 4569999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+|+|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 86 ~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 86 YCSGGELFDRIEP-------DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp CCTTEEGGGGSBT-------TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeecccee
Confidence 9999999999943 24699999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCCceeeccccccccccchhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.............||+.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+.
T Consensus 156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~------------ 222 (323)
T 3tki_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK------------ 222 (323)
T ss_dssp EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH------------
T ss_pred ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh------------
Confidence 43322223345679999999999987765 7789999999999999999999975432211 111110
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
............+..+.+|+.+||+.||++|||+.|++++
T Consensus 223 --~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 223 --EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0000000011223467899999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=364.44 Aligned_cols=259 Identities=24% Similarity=0.390 Sum_probs=211.7
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcc
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYM 162 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~ 162 (395)
..++|.+.+.||+|+||+||+|.+.++..||||++.... ...+.|.+|+.++++++||||+++++++.+...++||||+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~ 264 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFM 264 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeec
Confidence 445688889999999999999999888999999997643 4567899999999999999999999999877889999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.+|+|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 265 ~~g~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 265 AKGSLLDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp TTCBHHHHHHSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred CCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 9999999995322 13588999999999999999999999 999999999999999999999999999986432
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
.. ........++..|+|||++....++.++||||||+++|||++ |..||...... ... ..+
T Consensus 337 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~--------------~~i 398 (454)
T 1qcf_A 337 NE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVI--------------RAL 398 (454)
T ss_dssp HH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH--------------HHH
T ss_pred Cc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHH--------------HHH
Confidence 11 011122346778999999999999999999999999999999 99999643311 000 011
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
........+...+..+.+|+.+||+.||++|||+.+|++.|+++...
T Consensus 399 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 399 ERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11111122233456789999999999999999999999999998874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=339.51 Aligned_cols=258 Identities=25% Similarity=0.407 Sum_probs=206.7
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
.++|++.+.||+|+||+||++.+.++..||+|++.... ...+.+.+|+++++.++||||+++++++.+. ..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 34688889999999999999999888899999997643 3456789999999999999999999999876 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.+++|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 102 ~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 102 ANGCLLNYLREM------RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp TTCBHHHHHHCG------GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CCCcHHHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 999999999542 24699999999999999999999999 999999999999999999999999999975432
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
.. ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ..... +
T Consensus 173 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~----------------~~~~~-~ 234 (283)
T 3gen_A 173 DE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----------------ETAEH-I 234 (283)
T ss_dssp HH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----------------HHHHH-H
T ss_pred cc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh----------------HHHHH-H
Confidence 21 111122346778999999999999999999999999999998 99999753311 00001 1
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
........+...+..+.+++.+||+.+|++|||+.+++++|+++++.+
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 235 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 111111112222456889999999999999999999999999998763
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=348.64 Aligned_cols=258 Identities=28% Similarity=0.424 Sum_probs=203.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCc----EEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGR----KVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv 158 (395)
++|++.+.||+|+||+||+|.+. +++ +|++|.+... .....+.+.+|+.+++.++||||+++++++.+...+++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v 94 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 94 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEE
Confidence 56888999999999999999964 444 3577777543 34456789999999999999999999999999888999
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
++|+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ECCCSSCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 99999999999996543 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...............+|+.|+|||++.+..++.++||||||+++|||++ |..||....... +
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----------------~ 228 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-----------------I 228 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-----------------H
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----------------H
Confidence 6544333333334556888999999999999999999999999999999 999997543211 1
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
...+........+...+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 229 SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 111111111122333445789999999999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=346.03 Aligned_cols=265 Identities=22% Similarity=0.329 Sum_probs=196.8
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEcC-Cc---EEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecCc-e
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLSN-GR---KVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-K 155 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~ 155 (395)
..++|++.+.||+|+||+||+|.... ++ .||+|++... .....+.+.+|++++++++||||+++++++.... .
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34679999999999999999999643 32 7999998754 3344578899999999999999999999987652 2
Q ss_pred ------EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcE
Q 016117 156 ------LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 156 ------~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 229 (395)
++++||+.+|+|.+++...... .....+++..++.++.|++.||.|||++ +++||||||+|||++.++.+
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIG-ENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhcc-ccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 7999999999999998643311 1123689999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhh
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~ 308 (395)
||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------- 247 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--------- 247 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---------
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---------
Confidence 9999999976544332222334456788999999999999999999999999999999 999997543211
Q ss_pred cccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 309 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
....+... .....+...+..+.+++.+||+.||++|||+.++++.|++++..
T Consensus 248 -------~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 248 -------IYNYLIGG-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp -------HHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------HHHHHhcC-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00111110 01112223445789999999999999999999999999999985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=341.51 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=210.6
Q ss_pred ceecHHHHHHHhCC----------CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC
Q 016117 73 QVFTFKQLHSATGG----------FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP 141 (395)
Q Consensus 73 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ 141 (395)
..++++++..+++. |...+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34677777776654 666778999999999999976 7999999999876666677899999999999999
Q ss_pred cceeEEEEEecC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCC
Q 016117 142 YLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSN 220 (395)
Q Consensus 142 niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~N 220 (395)
||+++++++... ..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+|
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N 171 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--------VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDS 171 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHH
Confidence 999999988766 56799999999999999842 3589999999999999999999999 99999999999
Q ss_pred EEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 016117 221 ILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGE 300 (395)
Q Consensus 221 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~ 300 (395)
||++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|..||......
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-- 247 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-- 247 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--
T ss_pred EEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 9999999999999999976543221 223457999999999999999999999999999999999999999754311
Q ss_pred chhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 301 GVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.... .+.....+.+ ......+..+.+++.+||+.||++|||+.+++++
T Consensus 248 -~~~~----------~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 -QAMK----------RLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -HHHH----------HHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HHHH----------HHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0111111111 1111234568899999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=361.37 Aligned_cols=261 Identities=26% Similarity=0.410 Sum_probs=208.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEccc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMA 163 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~ 163 (395)
.++|++.+.||+|+||.||+|.+.++..||+|++.... ...+.|.+|+.++++++||||+++++++.++..++||||+.
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhc
Confidence 45678889999999999999999888889999997643 34578999999999999999999999998888899999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+|+|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 262 ~gsL~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 262 KGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp TCBHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999995321 23589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.. .......++..|+|||++.+..++.++||||||+++|||++ |..||...... . +...+.
T Consensus 334 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~--------------~~~~i~ 395 (452)
T 1fmk_A 334 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---E--------------VLDQVE 395 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H--------------HHHHHH
T ss_pred ce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---H--------------HHHHHH
Confidence 11 11223446788999999999999999999999999999999 99999643311 0 001111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
.......+...+..+.+++.+||+.||++|||+.+|++.|+++......
T Consensus 396 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 396 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 1111122334456789999999999999999999999999999875433
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=342.30 Aligned_cols=268 Identities=25% Similarity=0.378 Sum_probs=213.8
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE------cCCcEEEEEEeccCCc-ccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-c
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-R 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 154 (395)
.++|.+.+.||+|+||+||+|.+ .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+. .
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35688889999999999999985 2467899999975433 3346788999999999 999999999998766 6
Q ss_pred eEEEEEcccCCChhhhcccCCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSN-----------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 223 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill 223 (395)
.++||||+++|+|.+++....... .....+++..++.++.|++.||.|||++ +++||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 779999999999999997654210 1123589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCch
Q 016117 224 DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGV 302 (395)
Q Consensus 224 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~ 302 (395)
+.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 255 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--- 255 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh---
Confidence 9999999999999986654443333344567889999999999999999999999999999999 999997543211
Q ss_pred hhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 303 LVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
.....+........+...+..+.+++.+||+.||.+|||+.+++++|++++....
T Consensus 256 -------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 256 -------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp -------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred -------------HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 1111111111111122334578999999999999999999999999999998643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=344.43 Aligned_cols=265 Identities=23% Similarity=0.383 Sum_probs=211.1
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE------cCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~ 155 (395)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+. ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45688889999999999999985 245789999987542 33346788999999999999999999998766 67
Q ss_pred EEEEEcccCCChhhhcccCCCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 016117 156 LLVYDYMANGGLQEHLYPANGSN-----------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKS 218 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~ 218 (395)
++||||+.+|+|.+++....... .....+++..++.++.|++.||.|||++ +++||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 79999999999999997643210 0123589999999999999999999999 999999999
Q ss_pred CCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 016117 219 SNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKP 297 (395)
Q Consensus 219 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~ 297 (395)
+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986544332222333457788999999999999999999999999999999 9999975432
Q ss_pred CCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 298 SGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.. +...+........+...+..+.+++.+||+.||++|||+.+++++|++++.+
T Consensus 259 ~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 ER-----------------LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GG-----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HH-----------------HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 11 1111111111122223445789999999999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=345.36 Aligned_cols=271 Identities=23% Similarity=0.328 Sum_probs=207.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-----cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~ 156 (395)
++|++.+.||+|+||+||++++ .+++.||+|++........+.+.+|+++++.++||||+++++++... ..+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 4688889999999999999984 36889999999876555567889999999999999999999998543 468
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+
T Consensus 90 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred EEEEeCCCCCHHHHHHhcc------cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 9999999999999996432 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC-ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc-
Q 016117 237 AKIGSDKAGG-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR- 314 (395)
Q Consensus 237 ~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 314 (395)
+......... .......++..|+|||.+.+..++.++||||||+++|||++|..||...... ............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQM 236 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccch
Confidence 9865433211 1222345677899999999999999999999999999999999998632110 000000000000
Q ss_pred --hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 315 --EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 315 --~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
......+........+...+..+.+++.+||+.||++|||+.++++.|+++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 237 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 011111111112223334556799999999999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=347.74 Aligned_cols=269 Identities=23% Similarity=0.371 Sum_probs=209.6
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEE------cCCcEEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR- 153 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 153 (395)
..++|.+.+.||+|+||+||+|.. .++..||+|++... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 446788999999999999999996 24568999998753 233446788999999999 899999999998776
Q ss_pred ceEEEEEcccCCChhhhcccCCCCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCC
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSN----------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK 217 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk 217 (395)
..++||||+++|+|.+++....... .....+++..++.++.|++.||.|||++ +++|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 6779999999999999997544211 0123489999999999999999999999 99999999
Q ss_pred CCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 016117 218 SSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNK 296 (395)
Q Consensus 218 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~ 296 (395)
|+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986554433333444567889999999999999999999999999999998 999997543
Q ss_pred CCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 297 PSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
... .....+........+...+..+.+|+.+||+.||.+|||+.+++++|+.++....
T Consensus 280 ~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 280 VDA----------------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp CSH----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cHH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 211 1111111111112222335678999999999999999999999999999988643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=338.92 Aligned_cols=261 Identities=28% Similarity=0.513 Sum_probs=197.4
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~ 161 (395)
.++|++.+.||+|+||+||+|... ..+|+|++.... ....+.+.+|+.+++.++||||+++++++.....++||||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~ 100 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 100 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEe
Confidence 467999999999999999999864 359999987543 2334678899999999999999999999888888999999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+++|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 101 ~~~~~L~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 101 CEGSSLYHHLHAS------ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp CCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred cCCCcHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999533 24689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCceeeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
............||+.|+|||++. +..++.++||||||+++|+|++|..||....... ...... ..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~---------~~ 240 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMV---------GR 240 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHH---------HH
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHh---------cc
Confidence 333233334467899999999986 5678889999999999999999999997533210 000000 00
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
....+.+ .......+..+.+|+.+||+.+|++|||+.++++.|+++.+
T Consensus 241 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 241 GSLSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TSCCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cccCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0011111 11222344678999999999999999999999999999875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=338.40 Aligned_cols=259 Identities=21% Similarity=0.326 Sum_probs=199.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcC----CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv 158 (395)
.++|++.+.||+|+||+||+|.... +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv 93 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 93 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEE
Confidence 3568888999999999999998643 4579999987532 2334678899999999999999999999988888999
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 94 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 99999999999995432 3589999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
....... .......+++.|+|||++.+..++.++||||||+++|||++ |..||....... ..
T Consensus 165 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~------------- 227 (281)
T 1mp8_A 165 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI------------- 227 (281)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH-------------
T ss_pred ccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HH-------------
Confidence 6543221 11223456788999999999999999999999999999997 999997543211 11
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
..+... .....+...+..+.+++.+||+.||++|||+.++++.|+++++.+
T Consensus 228 ~~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 228 GRIENG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHcC-CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111110 011122234467889999999999999999999999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=343.76 Aligned_cols=281 Identities=27% Similarity=0.414 Sum_probs=203.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcC-----CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSN-----GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
++|++.+.||+|+||+||+|.... +..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456778899999999999998642 2469999987542 23345788999999999999999999999876 5679
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
||||+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 124 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp EEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcc
Confidence 999999999999996432 4689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCc-eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 238 KIGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 238 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
.......... ......++..|+|||++.+..++.++||||||+++|||++ |..||...... .
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~------------- 258 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---E------------- 258 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---H-------------
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---H-------------
Confidence 8654322111 1122345778999999999999999999999999999999 99999643210 0
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCCCCCCcccCCCCCCCCCCC
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSPSFHASRSPAFPDKVG 394 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (395)
....+.+ ......+...+..+.+++.+||+.+|++|||+.++++.|++++...... ..-..+.+..+...|+++|
T Consensus 259 ~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~---~~~~~~~p~~~~~~p~~sg 333 (333)
T 1mqb_A 259 VMKAIND-GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL---KTLADFDPRVSIRLPSTSG 333 (333)
T ss_dssp HHHHHHT-TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG---GSBCCC-------------
T ss_pred HHHHHHC-CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh---hhhcCCCccchhhCCCCCC
Confidence 0111111 1111122234567899999999999999999999999999998853321 2233455566667777766
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=337.75 Aligned_cols=263 Identities=24% Similarity=0.372 Sum_probs=204.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||++... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+. ..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 57889999999999999999964 789999998854322 2345788999999999999999999999877 466999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++++|.+++... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 91 e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 91 EYIEGPTLSEYIESH-------GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp ECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred eCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 999999999999532 3689999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
...... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||...... ........ .
T Consensus 161 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~------~ 227 (294)
T 4eqm_A 161 LSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQ------D 227 (294)
T ss_dssp C--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHS------S
T ss_pred cccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhh------c
Confidence 543221 1223456899999999999999999999999999999999999999754311 00000000 0
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHHHhhhhcCC
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-LMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~~vl~~L~~~~~~~~~ 371 (395)
.. +..........+..+.+++.+||+.||.+|| ++.++.+.|+.++..++.
T Consensus 228 ~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 228 SV-PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp CC-CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred cC-CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 00 0000011122345688999999999999999 999999999998886543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=346.73 Aligned_cols=268 Identities=24% Similarity=0.381 Sum_probs=210.4
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR- 153 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~- 153 (395)
...++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 123 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence 34578999999999999999999974 34889999997543 23346788999999999999999999998776
Q ss_pred ceEEEEEcccCCChhhhcccCCCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCC
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSN-----------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDF 216 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dl 216 (395)
..++||||+++|+|.+++....... .....+++..++.++.|++.||.|||++ +++||||
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dl 200 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 200 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 6779999999999999997543110 0125799999999999999999999999 9999999
Q ss_pred CCCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 016117 217 KSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVN 295 (395)
Q Consensus 217 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~ 295 (395)
||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999999975433222222334567889999999999999999999999999999999 99999643
Q ss_pred CCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 296 KPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
... . ....+.+... ...+...+..+.+++.+||+.+|++|||+.+++++|+++....
T Consensus 281 ~~~---~-------------~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 281 AHE---E-------------VIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp CHH---H-------------HHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred ChH---H-------------HHHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 211 0 0111111111 1122233457899999999999999999999999999998753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=335.08 Aligned_cols=261 Identities=26% Similarity=0.412 Sum_probs=211.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEccc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMA 163 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~ 163 (395)
.++|++.+.||+|+||+||+|...++..||+|.+... ....+.+.+|+++++.++||||+++++++.++..+++|||+.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCC
Confidence 3568888999999999999999888889999999754 334678899999999999999999999998888899999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+++|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+|||++......
T Consensus 91 ~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 91 NGSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp TCBHHHHTTSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCHHHHHhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999994321 13689999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
. ........++..|+|||.+.+..++.++||||||+++|||++ |..||...... ... ..+.
T Consensus 163 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~-------------~~~~- 224 (279)
T 1qpc_A 163 E-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVI-------------QNLE- 224 (279)
T ss_dssp C-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH-------------HHHH-
T ss_pred c-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHH-------------HHHh-
Confidence 2 111223446788999999998899999999999999999999 99999643211 000 0000
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
.......+...+..+.+++.+||+.+|++|||+.++++.|++++.....
T Consensus 225 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred cccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 0011111223345789999999999999999999999999999886433
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=336.93 Aligned_cols=260 Identities=26% Similarity=0.393 Sum_probs=199.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhc--cCCCcceeEEEEEecC-----ceE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGR--LRSPYLLALLGYCSDR-----RKL 156 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~-----~~~ 156 (395)
.++|++.+.||+|+||+||+|.. +++.||+|++... ....+..|.+++.. ++||||+++++++.+. ..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 35789999999999999999998 7899999998643 34556667777776 7999999999986432 357
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCceeCCCCCCCEEeCCCCc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH--------EHCSPPVIHRDFKSSNILLDKNFH 228 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlk~~Nill~~~~~ 228 (395)
+||||+++|+|.+++. ...+++..++.++.|++.||+||| +. +++||||||+|||++.++.
T Consensus 83 lv~e~~~~g~L~~~l~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ--------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEECCCTTCBHHHHHT--------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred EehhhccCCCHHHHHh--------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence 9999999999999993 236899999999999999999999 77 9999999999999999999
Q ss_pred EEEeccccccccCCCCCCc--eeeccccccccccchhhccC------CCCccchhHHHHHHHHHHHhC----------CC
Q 016117 229 AKVSDFGLAKIGSDKAGGH--VSTRVLGTQGYVAPEYALTG------HLTTKSDVYSYGVVLLELLTG----------RV 290 (395)
Q Consensus 229 ~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~~l~ell~g----------~~ 290 (395)
+||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||++| ..
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 9999999997654332211 12234789999999999876 445799999999999999999 77
Q ss_pred CCCCCCCCCCchhhhhhhcccccchhhhhhccccc-cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 291 PIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL-EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 291 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
||....+.......... . .......+.+ ....+...+..+.+|+.+||+.||++|||+.+|++.|+++
T Consensus 232 pf~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRK--V-----VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTTTSCSSCCHHHHHH--H-----HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccCCCCcchhhhhH--H-----HhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 77543322211100000 0 0000001111 1112234677899999999999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=355.38 Aligned_cols=252 Identities=28% Similarity=0.411 Sum_probs=206.2
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC--ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~lv~e~ 161 (395)
.++|++.+.||+|+||.||+|.+ .|+.||||+++... ..+.|.+|+.++++++||||+++++++.+. ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 35688889999999999999998 47899999997643 456899999999999999999999997655 57799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+|+|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++...
T Consensus 269 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 269 MAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CTTCBHHHHHHHHC-----TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 99999999996532 13478999999999999999999999 99999999999999999999999999998543
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
... ....++..|+|||++.+..++.++||||||+++|||++ |..||........ .. .
T Consensus 341 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~-------------~- 398 (450)
T 1k9a_A 341 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP-------------R- 398 (450)
T ss_dssp -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HH-------------H-
T ss_pred ccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH-------------H-
Confidence 221 12356889999999999999999999999999999998 9999975432210 00 0
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
+........+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 399 i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 399 VEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 001111122333456789999999999999999999999999998864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=332.60 Aligned_cols=253 Identities=30% Similarity=0.487 Sum_probs=194.8
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC----cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
.++|++.+.||+|+||+||+|.+ .++.+|+|++.... ....+.+.+|+++++.++||||+++++++.+. ..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35788899999999999999998 58999999986432 22346788999999999999999999998876 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC--------CCcEE
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK--------NFHAK 230 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--------~~~~k 230 (395)
|||+.+++|.+++. ...+++..++.++.|++.||.|||++...+++||||||+||+++. ++.+|
T Consensus 85 ~e~~~~~~L~~~~~--------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVLS--------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHHT--------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 99999999999983 246899999999999999999999981112999999999999986 77899
Q ss_pred EeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcc
Q 016117 231 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 310 (395)
Q Consensus 231 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~ 310 (395)
|+|||++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 157 l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------------ 220 (271)
T 3dtc_A 157 ITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------------ 220 (271)
T ss_dssp ECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------------
T ss_pred EccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------------
Confidence 99999997544322 22356899999999999999999999999999999999999999743211
Q ss_pred cccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 311 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
...............+...+..+.+++.+||+.+|++|||+.+++++|+++
T Consensus 221 ----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 221 ----AVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----HHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 011111111111222333446789999999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=336.58 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=200.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccC
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMAN 164 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~ 164 (395)
++|++.+.||+|+||+||++.. .++.||+|.+... ...+.+.+|++++++++||||+++++++.+ ..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN-PVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-TTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CcEEEEEcCCC
Confidence 4578889999999999999998 5788999998643 345678999999999999999999998874 47899999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc-EEEeccccccccCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH-AKVSDFGLAKIGSDK 243 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-~kl~Dfg~~~~~~~~ 243 (395)
|+|.+++.... ....+++..++.++.|++.||.|||+....+++||||||+||+++.++. +||+|||++......
T Consensus 84 ~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 84 GSLYNVLHGAE----PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CBHHHHHHCSS----SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCHHHHHhccC----CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 99999996433 2235789999999999999999999932128999999999999988876 799999999754322
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....+.. .....+
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~---------~~~~~~ 223 (307)
T 2eva_A 160 -----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AFRIMWAV---------HNGTRP 223 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--HHHHHHHH---------HTTCCC
T ss_pred -----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--HHHHHHHH---------hcCCCC
Confidence 12345899999999999999999999999999999999999999743221 00011100 000011
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
......+..+.+++.+||+.||++|||+.++++.|+++.+....
T Consensus 224 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 224 ----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ----CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ----CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 11122345688999999999999999999999999999886544
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=341.93 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=202.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||++... +|+.||+|++... .......+..|+.+++.++||||+++++++.+. ..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56888999999999999999965 6899999998643 233456788999999999999999999998876 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 85 E~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 85 EYANGGELFFHLSR-------ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp ECCTTCBHHHHHHH-------HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred eCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 99999999999853 24689999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... . ....
T Consensus 155 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~-------------~~~~ 216 (337)
T 1o6l_A 155 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---R-------------LFEL 216 (337)
T ss_dssp SCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H-------------HHHH
T ss_pred cccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---H-------------HHHH
Confidence 33221 2234567999999999999999999999999999999999999999743211 0 0111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
+....+ .++...+.++.+|+.+||+.||++|| ++.+++++
T Consensus 217 i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 217 ILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHcCCC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 111111 12223345788999999999999999 89999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=343.14 Aligned_cols=247 Identities=22% Similarity=0.345 Sum_probs=201.4
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc------cHHHHHHHHHHHhccCCCcceeEEEEEecC-ce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ------GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~ 155 (395)
.+.|.+.+.||+|+||+||++... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356888999999999999999965 6899999998754221 346789999999999999999999999877 56
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC----cEEE
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF----HAKV 231 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl 231 (395)
++||||+.+|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ-------KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp EEEEECCCSCBHHHHHTT-------CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred EEEEEcCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEE
Confidence 799999999999999943 24689999999999999999999999 999999999999998876 7999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .
T Consensus 161 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~--------- 225 (361)
T 2yab_A 161 IDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---E--------- 225 (361)
T ss_dssp CCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---H---------
T ss_pred EecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---H---------
Confidence 9999998654322 233467999999999999999999999999999999999999999754311 0
Q ss_pred ccchhhhhhccccccCCCCH----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 312 TDREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....+..... .++. ..+..+.+|+.+||+.||++|||+.+++++
T Consensus 226 ----~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 226 ----TLANITAVSY--DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp ----HHHHHHTTCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----HHHHHHhcCC--CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111111000 1111 123468899999999999999999999853
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=342.07 Aligned_cols=268 Identities=21% Similarity=0.369 Sum_probs=210.3
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc--------CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR 153 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 153 (395)
.++|++.+.||+|+||+||+|... ++..||+|++.... ....+.+.+|+++++.+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 357888999999999999999863 46789999997543 23346788999999999 899999999998776
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSN---------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL 223 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill 223 (395)
..++||||+.+|+|.+++....... .....+++..++.++.|++.||.|||++ +++||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 5679999999999999997543211 1123589999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCch
Q 016117 224 DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGV 302 (395)
Q Consensus 224 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~ 302 (395)
+.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...... .
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---H
Confidence 9999999999999986554332222333456788999999998899999999999999999999 99999643211 0
Q ss_pred hhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 303 LVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
+...+........+...+..+.+++.+||+.+|.+|||+.++++.|++++.....
T Consensus 268 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 268 --------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp --------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred --------------HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 0000100111112223345789999999999999999999999999999986554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=333.35 Aligned_cols=261 Identities=25% Similarity=0.381 Sum_probs=210.1
Q ss_pred CCCCCCC-eeeccCCeEEEEEEEc---CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEE
Q 016117 85 GGFSKSN-VVGHGGFGLVYRGVLS---NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVY 159 (395)
Q Consensus 85 ~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~ 159 (395)
++|.+.+ .||+|+||.||+|... ++..||+|++.... ....+.+.+|+++++.++||||+++++++..+..++||
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~ 88 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 88 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEE
Confidence 3455555 8999999999999853 57889999997643 33456788999999999999999999999877889999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+++|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.++|+|||++..
T Consensus 89 e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 89 EMAGGGPLHKFLVGK------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp ECCTTEEHHHHHTTC------TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EeCCCCCHHHHHHhC------CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence 999999999999532 24689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCc-eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 240 GSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 240 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~------------ 224 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMA------------ 224 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHH------------
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHH------------
Confidence 54332211 1223446889999999998899999999999999999998 99999754321 1110
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
.+........+...+..+.+++..||+.+|++|||+.+++++|+++......
T Consensus 225 --~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 225 --FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp --HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred --HHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 0101111122233456799999999999999999999999999999986544
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=361.60 Aligned_cols=258 Identities=24% Similarity=0.405 Sum_probs=211.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
..+|++.+.||+|+||.||+|.+. ++..||+|.+... ....+.|.+|+.++++++||||++++++|.+. ..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 356778899999999999999976 4889999999764 33467899999999999999999999999876 67799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 298 ~~~g~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 298 MTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp CTTCBHHHHHHHSC-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cCCCCHHHHHHhcC-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 99999999996543 24589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
... ........++..|+|||++.+..++.++||||||+++|||++ |..||...... .+.+.
T Consensus 370 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-----------------~~~~~ 431 (495)
T 1opk_A 370 GDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYEL 431 (495)
T ss_dssp TCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHHH
T ss_pred CCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHH
Confidence 321 111223446778999999999999999999999999999999 99999754321 11111
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
+........+...+..+.+|+.+||+.||++|||+.+|++.|+.++..
T Consensus 432 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 432 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 111122222334456789999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=337.40 Aligned_cols=265 Identities=21% Similarity=0.276 Sum_probs=198.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|++.+.||+|+||+||+|...+|+.||+|++.... ......+.+|+++++.++||||+++++++.+. ..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 5788899999999999999999889999999987432 22346788999999999999999999999876 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+ +|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 101 MEK-DLKKVLDENK------TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp CSE-EHHHHHHTCT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred CCC-CHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 984 7888875432 4589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc-----ch
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD-----RE 315 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~ 315 (395)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..................... ..
T Consensus 171 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 171 IPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp SCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred CCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 322 12234568999999999876 56899999999999999999999999765433221111100000000 00
Q ss_pred hhhhhcccccc--CCC-----CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 316 KILEIMDPALE--GQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 316 ~~~~~~d~~~~--~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
......+.... ... ......++.+|+.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00000000000 000 11123468899999999999999999999974
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=333.18 Aligned_cols=252 Identities=29% Similarity=0.488 Sum_probs=202.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCccc-------HHHHHHHHHHHhccCCCcceeEEEEEecCceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG-------EDEFKMEVELLGRLRSPYLLALLGYCSDRRKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 156 (395)
++|++.+.||+|+||+||+|... +++.||+|++....... .+.+.+|+.+++.++||||+++++++.+.. +
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~ 97 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-R 97 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-E
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-e
Confidence 57888899999999999999964 78999999986432221 167889999999999999999999987655 7
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCCEEeCCCCc-----E
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP--VIHRDFKSSNILLDKNFH-----A 229 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nill~~~~~-----~ 229 (395)
++|||+.+|+|.+++.... ..+++..++.++.|++.||.|||++ + ++||||||+|||++.++. +
T Consensus 98 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKA------HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp EEEECCTTCBHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred EEEEecCCCCHHHHHhccc------CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence 9999999999999885432 4699999999999999999999998 7 999999999999988776 9
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhc--cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL--TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 307 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~ 307 (395)
||+|||++..... ......||+.|+|||++. ...++.++||||||+++|+|++|..||.........
T Consensus 169 kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~------ 237 (287)
T 4f0f_A 169 KVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK------ 237 (287)
T ss_dssp EECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH------
T ss_pred EeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH------
Confidence 9999999974332 234467899999999984 456789999999999999999999999754322100
Q ss_pred hcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 308 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 308 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
..............+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 238 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 238 --------FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp --------HHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred --------HHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 01111111112222334456789999999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=335.47 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=193.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--------------------------ccHHHHHHHHHHHhc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--------------------------QGEDEFKMEVELLGR 137 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~ 137 (395)
++|++.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+++++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 57889999999999999999964 688999999864321 112468889999999
Q ss_pred cCCCcceeEEEEEec---CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeC
Q 016117 138 LRSPYLLALLGYCSD---RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHR 214 (395)
Q Consensus 138 l~h~niv~l~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~ 214 (395)
++||||+++++++.+ ...++||||+++++|.+++. ...+++..++.++.|++.||.|||++ +++||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~ 161 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--------LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHR 161 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHHC---Ceecc
Confidence 999999999999875 24679999999999988762 24699999999999999999999999 99999
Q ss_pred CCCCCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCC---CCccchhHHHHHHHHHHHhCCCC
Q 016117 215 DFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH---LTTKSDVYSYGVVLLELLTGRVP 291 (395)
Q Consensus 215 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~~l~ell~g~~p 291 (395)
||||+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..|
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 999999999999999999999998654322 2233467999999999988665 37789999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 292 IDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 292 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
|...... ... ..+.............+..+.+++.+||+.||++|||+.+++++
T Consensus 240 f~~~~~~---~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 240 FMDERIM---CLH-------------SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SCCSSHH---HHH-------------HHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCccHH---HHH-------------HHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 9643210 000 00000111101111233568899999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=334.00 Aligned_cols=273 Identities=19% Similarity=0.267 Sum_probs=210.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~ 159 (395)
++|.+.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+. ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46888899999999999999975 58999999997532 33456788999999999999999999988754 457999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe----CCCCcEEEeccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFG 235 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg 235 (395)
||+++++|.+++.... ....+++..++.++.|++.||.|||++ +++||||||+|||+ +.++.+||+|||
T Consensus 89 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPS----NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp ECCTTCBHHHHHHSGG----GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred eCCCCCCHHHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 9999999999996433 123499999999999999999999999 99999999999999 888889999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhc--------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCch-hhhh
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYAL--------TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV-LVSW 306 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~-~~~~ 306 (395)
++....... ......||+.|+|||++. +..++.++|||||||++|||++|..||.......... ....
T Consensus 162 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 162 AARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred CceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 998654432 223456899999999986 5778999999999999999999999997543322111 1110
Q ss_pred hhcccc-c-chhhhhhc--------cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 307 ALPRLT-D-REKILEIM--------DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 307 ~~~~~~-~-~~~~~~~~--------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
...... . ........ +-......+......+.+++.+||+.||++|||+.|++++..+-..
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 000000 0 00000000 0111224567788899999999999999999999999998875543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=346.82 Aligned_cols=276 Identities=25% Similarity=0.363 Sum_probs=210.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-----cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEec--C-ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD--R-RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~-~~~ 156 (395)
++|++.+.||+|+||.||++.+ .+++.||+|++........+.+.+|+++++.++||||+++++++.. . ..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4688889999999999999984 3688999999987655566778999999999999999999998753 2 466
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR------ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEeecCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence 9999999999999995432 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCc-eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhh-cccccc
Q 016117 237 AKIGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL-PRLTDR 314 (395)
Q Consensus 237 ~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~ 314 (395)
+.......... ......++..|+|||++.+..++.++||||||+++|+|++|..||...... ....... ......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE---FLRMMGCERDVPAL 250 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHCC----CCHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch---hhhhcccccccccH
Confidence 98654332211 122345788899999999999999999999999999999999998632210 0000000 000001
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCCC
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRST 372 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~~ 372 (395)
......+........+...+..+.+|+.+||+.||++|||+.+++++|+.+.......
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 1122222222222334445667999999999999999999999999999998875543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=339.13 Aligned_cols=247 Identities=20% Similarity=0.305 Sum_probs=202.2
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
.++|.+.+.||+|+||+||++... +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+. ..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467889999999999999999965 6889999998754 33455788999999999999999999998776 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC--CCcEEEeccccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK--NFHAKVSDFGLAKI 239 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~ 239 (395)
+++|+|.+++... ...+++..++.++.|++.||.|||++ +++||||||+|||++. ++.+||+|||++..
T Consensus 83 ~~g~~L~~~l~~~------~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 83 ISGLDIFERINTS------AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp CCCCBHHHHHTSS------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred CCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 9999999999532 23689999999999999999999999 9999999999999987 78999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....
T Consensus 154 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----------------~~~~~ 214 (321)
T 1tki_A 154 LKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----------------QIIEN 214 (321)
T ss_dssp CCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHH
T ss_pred CCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH----------------HHHHH
Confidence 54322 334567899999999999888999999999999999999999999753311 01111
Q ss_pred hccccccCCCCH----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+..... ..+. ..+.++.+|+.+||+.||.+|||+.+++++
T Consensus 215 i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 215 IMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHcCCC--CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111 1111 123568899999999999999999999974
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=333.55 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=205.9
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcC----CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv 158 (395)
.++|.+.+.||+|+||+||+|...+ +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.++..+++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v 90 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWII 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEE
Confidence 3568888999999999999998543 3469999987542 3345678899999999999999999999988888999
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+.+++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 91 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 91 MELYPYGELGHYLERNK------NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence 99999999999995432 4589999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
....... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... ...
T Consensus 162 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~------------ 225 (281)
T 3cc6_A 162 YIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIG------------ 225 (281)
T ss_dssp CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHH------------
T ss_pred ccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHH------------
Confidence 6543221 11223456788999999999999999999999999999998 999996433211 000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.+........+...+..+.+++.+||+.+|++|||+.+++++|+++...+
T Consensus 226 --~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 226 --VLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp --HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 00000001112223456889999999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=330.01 Aligned_cols=256 Identities=29% Similarity=0.451 Sum_probs=207.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
++|++.+.||+|+||.||++...+++.||+|++.... ...+.+.+|+++++.++||||+++++++.+. ..+++|||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 4678889999999999999999888999999997643 3456889999999999999999999998776 6779999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 87 ~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 87 HGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp TCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCcHHHHHhhCc------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999996432 3589999999999999999999999 9999999999999999999999999999754321
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
. ........++..|+|||++.+..++.++||||||+++|+|++ |..||...... .. ...+..
T Consensus 158 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~-------------~~~i~~ 220 (267)
T 3t9t_A 158 Q-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EV-------------VEDIST 220 (267)
T ss_dssp H-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH-------------HHHHHT
T ss_pred c-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HH-------------HHHHhc
Confidence 1 011123446778999999999999999999999999999999 89999753211 00 001100
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
......+...+..+.+++.+||+.+|++|||+.+++++|+++.+.
T Consensus 221 -~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 221 -GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 000111122345688999999999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=339.20 Aligned_cols=275 Identities=23% Similarity=0.331 Sum_probs=215.4
Q ss_pred HHHHHHHhCCCCCCCeeeccCCeEEEEEEE------cCCcEEEEEEeccCCc-ccHHHHHHHHHHHhcc-CCCcceeEEE
Q 016117 77 FKQLHSATGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLG 148 (395)
Q Consensus 77 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~ 148 (395)
........++|.+.+.||+|+||+||+|.. .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 334444567899999999999999999984 2468899999975432 2345788999999999 7899999999
Q ss_pred EEecC--ceEEEEEcccCCChhhhcccCCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCC
Q 016117 149 YCSDR--RKLLVYDYMANGGLQEHLYPANGSN---------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK 217 (395)
Q Consensus 149 ~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk 217 (395)
++... ..++++||+.+|+|.+++....... .....+++..++.++.|++.||.|||++ +++|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCc
Confidence 98764 3679999999999999996544210 0122388999999999999999999999 99999999
Q ss_pred CCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 016117 218 SSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNK 296 (395)
Q Consensus 218 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~ 296 (395)
|+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999986554433333444567889999999999999999999999999999998 999996543
Q ss_pred CCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 297 PSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
... ... ..+........+...+..+.+++.+||+.||.+|||+.+++++|++++..+.
T Consensus 256 ~~~--~~~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 256 IDE--EFC--------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CSH--HHH--------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hhH--HHH--------------HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 211 000 0000000111122234568899999999999999999999999999988643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=335.91 Aligned_cols=262 Identities=18% Similarity=0.201 Sum_probs=207.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|.+.+.||+|+||+||+|.. .+|+.||+|++..... .+.+..|+.+++.+ +||||+++++++.+. ..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5788899999999999999996 5789999999875432 23578899999999 999999999998876 45799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc-----EEEecccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH-----AKVSDFGL 236 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfg~ 236 (395)
+ +++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++. +||+|||+
T Consensus 87 ~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 87 L-GPSLEDLFDLCD------RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp C-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred C-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 9 999999996432 4699999999999999999999999 9999999999999999887 99999999
Q ss_pred ccccCCCCCCc-----eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 237 AKIGSDKAGGH-----VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 237 ~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
+.......... ......||+.|+|||++.+..++.++||||||+++|||++|..||.................
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~-- 234 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD-- 234 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH--
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh--
Confidence 98654332211 12356799999999999999999999999999999999999999976543221111110000
Q ss_pred ccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.........+... .+ .+.+++..||+.+|.+||++.+|.+.|+++.+..
T Consensus 235 ----~~~~~~~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 235 ----TKRATPIEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp ----HHHHSCHHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----hhccCCHHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0000000000011 12 7899999999999999999999999999998864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=362.35 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=202.4
Q ss_pred eeeccCCeEEEEEEEc---CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccCCCh
Q 016117 92 VVGHGGFGLVYRGVLS---NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANGGL 167 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g~L 167 (395)
.||+|+||.||+|.+. ++..||||+++... ....+.+.+|+++++.++||||+++++++.++..++||||+.+|+|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L 422 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL 422 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence 7999999999999864 46679999997643 3456789999999999999999999999998888999999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCC-
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG- 246 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 246 (395)
.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 423 ~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 423 HKFLVGK------REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHTTC------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 9999543 24689999999999999999999999 9999999999999999999999999999865432211
Q ss_pred ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccc
Q 016117 247 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 325 (395)
Q Consensus 247 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 325 (395)
.......+++.|+|||++.+..++.++|||||||++|||++ |..||....... +...+....
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-----------------~~~~i~~~~ 556 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-----------------VMAFIEQGK 556 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-----------------HHHHHHTTC
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----------------HHHHHHcCC
Confidence 11122345688999999999999999999999999999998 999997543211 111111111
Q ss_pred cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 326 EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 326 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
....+...+..+.+|+..||+.+|++|||+.+|++.|+.+....
T Consensus 557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 11223345567999999999999999999999999999988753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=344.61 Aligned_cols=249 Identities=24% Similarity=0.386 Sum_probs=197.8
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~ 156 (395)
..++|++.+.||+|+||+||+|+.. +|+.||+|++... .....+.+..|..+++.+ +||||+++++++.+. ..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3468999999999999999999965 6899999998743 223445678899999988 799999999999877 566
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+||||+.+|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 101 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~ 170 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-------RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGM 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccc
Confidence 999999999999999532 4699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
+...... .......+||+.|+|||++.+..++.++|||||||++|||++|..||...+.. ..
T Consensus 171 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----------------~~ 232 (353)
T 3txo_A 171 CKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED----------------DL 232 (353)
T ss_dssp CBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HH
T ss_pred eeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH----------------HH
Confidence 9753322 12334567999999999999989999999999999999999999999754321 11
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH------HHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM------ADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~~vl~~ 361 (395)
...+..... .++...+..+.+|+.+||+.||++||++ .+++++
T Consensus 233 ~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 233 FEAILNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred HHHHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 111111111 1222234568899999999999999998 777753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=363.11 Aligned_cols=259 Identities=27% Similarity=0.412 Sum_probs=210.8
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEccc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMA 163 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~ 163 (395)
.++|++.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+++|++++|+||+++++++.++..++||||+.
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~ 344 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 344 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhc
Confidence 45677888999999999999999888889999997643 34578999999999999999999999998888899999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 345 ~gsL~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 345 KGSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp TEEHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred CCcHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999995321 23589999999999999999999999 9999999999999999999999999999754321
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
. ........++..|+|||++.+..++.++||||||+++|||++ |..||...... . +...+.
T Consensus 417 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~--------------~~~~i~ 478 (535)
T 2h8h_A 417 E-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---E--------------VLDQVE 478 (535)
T ss_dssp H-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---H--------------HHHHHH
T ss_pred c-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---H--------------HHHHHH
Confidence 1 001122346778999999999999999999999999999999 99999643211 0 001111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.......+...+..+.+|+.+||+.||++|||+.+|++.|+.++...
T Consensus 479 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 479 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 11111222334567899999999999999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=328.11 Aligned_cols=251 Identities=20% Similarity=0.329 Sum_probs=202.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~ 159 (395)
++|.+.+.||+|+||+||+|.+ +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+. ..+++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 4688899999999999999998 58999999997543 23345788999999999999999999998764 467999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP--VIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
||+++|+|.+++.... ...+++..++.++.|++.||.|||++ + ++||||||+||+++.++.++|+|||+.
T Consensus 89 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT-----NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp ECCTTCBHHHHHHSCS-----SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred cccCCCcHHHHHhhcc-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccce
Confidence 9999999999996432 23589999999999999999999998 7 999999999999999999999999887
Q ss_pred cccCCCCCCceeeccccccccccchhhccCCCCc---cchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTT---KSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
..... ....||+.|+|||.+.+..++. ++||||||+++|||++|..||......
T Consensus 161 ~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---------------- 217 (271)
T 3kmu_A 161 FSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM---------------- 217 (271)
T ss_dssp CTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH----------------
T ss_pred eeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH----------------
Confidence 54222 2245789999999998765544 799999999999999999999643211
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
...............+...+..+.+++..||+.||++|||+.++++.|+++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 218 EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 01111111111112233345578999999999999999999999999999865
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=331.53 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=212.2
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
..++|++.+.||+|+||+||+|.+. ++..||+|.+... ....+.+.+|+++++.++||||+++++++.+. ..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 3456888899999999999999976 5889999999754 34457889999999999999999999999876 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 90 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp CCTTEEHHHHHHHCC-----TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred cCCCCcHHHHHHhcc-----cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999999999996533 24689999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 162 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-----------------~~~~ 223 (288)
T 3kfa_A 162 TGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QVYE 223 (288)
T ss_dssp CSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----------------GHHH
T ss_pred cCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHH
Confidence 4332 222333556788999999999999999999999999999999 99999654321 1111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.+........+...+..+.+++.+||+.||.+|||+.++++.|++++..
T Consensus 224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 224 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111122233446789999999999999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=335.52 Aligned_cols=267 Identities=22% Similarity=0.319 Sum_probs=200.0
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc----CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecCc-
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR- 154 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~- 154 (395)
...++|.+.+.||+|+||+||+|... ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34457888899999999999999854 34589999987542 233467889999999999999999999987642
Q ss_pred -----eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcE
Q 016117 155 -----KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 155 -----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 229 (395)
.++++||+.+|+|.+++...... .....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLE-TGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBT-TSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhh-cCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence 37999999999999998543211 1235699999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhh
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~ 308 (395)
||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~---- 259 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MY---- 259 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH----
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HH----
Confidence 9999999976543322222233457889999999999999999999999999999999 889986543211 00
Q ss_pred cccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 309 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
..+... .....+...+..+.+++.+||+.+|.+|||+.+++++|+++++..
T Consensus 260 ---------~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 260 ---------DYLLHG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ---------HHHHTT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ---------HHHHcC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 011110 011122233457899999999999999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=336.22 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=200.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK------QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~ 156 (395)
+.|.+.+.||+|+||+||++... +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 45888999999999999999975 689999999864322 2356789999999999999999999998876 567
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC----cEEEe
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF----HAKVS 232 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~ 232 (395)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+|||++.++ .+||+
T Consensus 91 lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE-------KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEECCCSCBHHHHHTT-------SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEcCCCCCHHHHHHh-------cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 99999999999999943 24689999999999999999999999 999999999999998887 89999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .....
T Consensus 161 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~----- 229 (326)
T 2y0a_A 161 DFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANV----- 229 (326)
T ss_dssp CCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH-----
T ss_pred ECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHH-----
Confidence 999998654322 2234569999999999999999999999999999999999999996432110 00000
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. .............+..+.+|+.+||+.||++|||+.+++++
T Consensus 230 -----~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 230 -----SA-VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -----HH-TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----Hh-cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 00000000001123468899999999999999999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=342.31 Aligned_cols=252 Identities=21% Similarity=0.321 Sum_probs=203.4
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
.+.|.+.+.||+|+||+||+|... +|+.+|+|++..........+.+|+.+++.++||||+++++++.+. ..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357899999999999999999965 6899999999765444556788999999999999999999998876 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC--CCcEEEeccccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK--NFHAKVSDFGLAKI 239 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~ 239 (395)
+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++. ++.+||+|||++..
T Consensus 130 ~~gg~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 130 LSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp CCCCBHHHHTTCTT------CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred CCCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999999995322 3689999999999999999999999 9999999999999974 57899999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... ...... ..
T Consensus 201 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i----------~~ 264 (387)
T 1kob_A 201 LNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNV----------KR 264 (387)
T ss_dssp CCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHH----------HH
T ss_pred cCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHH----------Hh
Confidence 54332 233457999999999999999999999999999999999999999754311 000000 00
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.............+..+.+|+.+||+.||++|||+.+++++
T Consensus 265 -~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 265 -CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00001111112234568899999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=344.27 Aligned_cols=257 Identities=25% Similarity=0.382 Sum_probs=199.4
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~l 157 (395)
.++|++.++||+|+||+||+++.. +++.||+|++.... ....+.+..|..++.++ +||||+++++++.+. ..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 356889999999999999999965 68899999987532 22234577899999887 899999999998877 5679
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
||||+.+|+|..++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 131 V~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla 200 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMC 200 (396)
T ss_dssp EEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEcCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeeccee
Confidence 99999999999998532 4699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
+..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||............ ......
T Consensus 201 ~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~-------~~~~~~ 271 (396)
T 4dc2_A 201 KEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-------TEDYLF 271 (396)
T ss_dssp BCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C-------CHHHHH
T ss_pred eecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh-------hHHHHH
Confidence 753222 12344578999999999999999999999999999999999999999643322110000 000001
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH------HHHHHH
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM------ADVVQS 361 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~~vl~~ 361 (395)
..+....+ .++...+.++.+|+.+||+.||.+||++ .+|+++
T Consensus 272 ~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 272 QVILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp HHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred HHHhcccc--CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 11111111 2222344578899999999999999996 566543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=338.21 Aligned_cols=265 Identities=24% Similarity=0.360 Sum_probs=206.7
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE------cCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~ 155 (395)
.++|.+.+.||+|+||.||+|.+ .++..||+|.+... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45799999999999999999983 25778999998643 233456788999999999999999999998876 56
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC---CCcEEEe
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVS 232 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~ 232 (395)
++||||+++|+|.+++............+++..++.++.|++.||.|||++ +++||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 899999999999999976654434445699999999999999999999999 9999999999999984 4569999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~------ 256 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLE------ 256 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHH------
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHH------
Confidence 9999975443332223334567889999999999999999999999999999998 99998643211 0000
Q ss_pred ccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.+........+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 257 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 257 --------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp --------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 0000001111223345688999999999999999999999999998875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=334.99 Aligned_cols=283 Identities=20% Similarity=0.306 Sum_probs=192.3
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.++|++.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999964 68999999987443 23346788999999999999999999999876 5669999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+. |+|.+++...... .....+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVG-NTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp CCC-CBHHHHHHHHHSS-SCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred ecC-CCHHHHHHhcccc-ccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 998 6999988543211 1224689999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhc--------cc
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP--------RL 311 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~--------~~ 311 (395)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+..... ..
T Consensus 159 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 159 GIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp TSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred CCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 4322 12234568999999999876 4689999999999999999999999975432111000000000 00
Q ss_pred cc------------chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCCCCCCCCCC
Q 016117 312 TD------------REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSP 379 (395)
Q Consensus 312 ~~------------~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~~~~~~~~~ 379 (395)
.. .......+.+.... ..+..+.+|+.+||+.||++|||+.+++++ .++......+.+..|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h--p~f~~~~~~~~~~~~~ 310 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALHH--PWFAEYYHHASMGGSR 310 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTTS--GGGGGGCC--------
T ss_pred hhhhhcccccccccchhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhCC--hhhhcccchhhccccc
Confidence 00 00000111111111 123468999999999999999999999975 5565544444444333
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=332.02 Aligned_cols=265 Identities=18% Similarity=0.209 Sum_probs=209.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.++|.+.+.||+|+||+||+|.. .+|+.||+|++.... ..+.+.+|+.+++.+ +|+|++++++++.+. ..++++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35688999999999999999996 578999999986432 234578899999999 799999999998776 5669999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc-----EEEeccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH-----AKVSDFG 235 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~-----~kl~Dfg 235 (395)
|+ +++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++. +||+|||
T Consensus 87 ~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp CC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ec-CCCHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 99 999999996432 3589999999999999999999998 9999999999999987776 9999999
Q ss_pred cccccCCCCCC-----ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcc
Q 016117 236 LAKIGSDKAGG-----HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 310 (395)
Q Consensus 236 ~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~ 310 (395)
++......... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~- 235 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE- 235 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH-
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh-
Confidence 99865543221 122346799999999999999999999999999999999999999976543222111111000
Q ss_pred cccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 311 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
.......+.+.. ..+..+.+++.+||+.+|++|||+.+|++.|+++.+...
T Consensus 236 -----~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 236 -----KKQSTPLRELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp -----HHHHSCHHHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -----hccCccHHHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 000000000011 223578999999999999999999999999999998644
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=341.28 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=195.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCC--CcceeEEEEEecCc-eEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRS--PYLLALLGYCSDRR-KLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~-~~lv~ 159 (395)
++|++.+.||+|+||+||++...+++.||+|++.... ....+.+.+|+.+++.++| +||+++++++.+.. .++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 4688899999999999999998889999999986432 2334678899999999976 99999999998774 56899
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
| +.+++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ ++.+||+|||++..
T Consensus 89 e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp C-CCSEEHHHHHHHS-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred e-CCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccc
Confidence 9 6788999999543 4689999999999999999999999 999999999999996 67899999999986
Q ss_pred cCCCCCCceeeccccccccccchhhcc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALT-----------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~ 308 (395)
..............||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------- 226 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---------- 226 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----------
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----------
Confidence 544333333345679999999999865 67889999999999999999999999642210
Q ss_pred cccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 309 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
......++++......+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 227 -----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 227 -----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -----HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 112223333333223333334568899999999999999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=341.99 Aligned_cols=252 Identities=20% Similarity=0.306 Sum_probs=192.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
.++|.+.+.||+|+||+||++... +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+. ..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 357899999999999999999975 78999999997543 3345788999999999999999999998876 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc--EEEeccccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH--AKVSDFGLAKI 239 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~~ 239 (395)
+.+|+|.+++... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++. +||+|||+++.
T Consensus 98 ~~~~~L~~~l~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 98 ASGGELYERICNA-------GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp CCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred CCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 9999999998532 4699999999999999999999999 9999999999999987765 99999999874
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCcc-chhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTK-SDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
.... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........... .+.
T Consensus 168 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------------~~~ 232 (361)
T 3uc3_A 168 SVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK------------TIQ 232 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH------------HHH
T ss_pred cccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH------------HHH
Confidence 3221 12234569999999999988887665 8999999999999999999975443221111 111
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+.............+..+.+|+.+||+.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 233 RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1111111111111223568899999999999999999999976
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=331.44 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=206.0
Q ss_pred CCCCCCC-eeeccCCeEEEEEEE---cCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEE
Q 016117 85 GGFSKSN-VVGHGGFGLVYRGVL---SNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 158 (395)
Q Consensus 85 ~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv 158 (395)
++|.+.+ .||+|+||+||+|.+ .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++..+..++|
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv 95 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLV 95 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEE
Confidence 4567766 899999999999964 2468899999875422 235678899999999999999999999987788999
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
+||+.+++|.+++... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 96 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EECCTTEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEeCCCCCHHHHHHhC-------cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 9999999999999542 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCc-eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 239 IGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 239 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------------~ 228 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----------------E 228 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------H
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----------------H
Confidence 654332211 1122346788999999998889999999999999999999 99999754311 0
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
+...+........+...+..+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 229 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 111111111112223345678999999999999999999999999999988643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=330.04 Aligned_cols=265 Identities=19% Similarity=0.301 Sum_probs=196.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|++.+.||+|+||+||+|...+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688899999999999999999889999999986432 22346788999999999999999999998876 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.+ +|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 151 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (288)
T ss_dssp CSE-EHHHHHHTST------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred cCC-CHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence 975 8988885432 4689999999999999999999999 99999999999999999999999999997643
Q ss_pred CCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc--cchhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT--DREKIL 318 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~ 318 (395)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.................... ......
T Consensus 152 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 152 IPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp C-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 221 12234568999999999876 4589999999999999999999999975432110000000000000 000000
Q ss_pred h--hcccccc-------CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 E--IMDPALE-------GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~--~~d~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
. .+++... .......+..+.+|+.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 0011100 01111234568899999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=334.33 Aligned_cols=244 Identities=27% Similarity=0.405 Sum_probs=201.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||+++.. +|+.||+|++... .....+.+.+|..+++.++||||+++++++.+. ..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46888999999999999999965 7899999998643 123456778899999999999999999999877 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+|+|.+++... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 86 e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~ 155 (318)
T 1fot_A 86 DYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY 155 (318)
T ss_dssp CCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCccee
Confidence 999999999999532 4689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .....
T Consensus 156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------------~~~~~ 214 (318)
T 1fot_A 156 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----------------KTYEK 214 (318)
T ss_dssp CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHH
T ss_pred cCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----------------HHHHH
Confidence 4432 23467999999999999999999999999999999999999999753311 11111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
+....+ .++...+.++.+++.+||+.||++|| ++++++++
T Consensus 215 i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 215 ILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 111111 12223345788999999999999999 89999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=347.65 Aligned_cols=250 Identities=21% Similarity=0.296 Sum_probs=199.8
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
.++|.+.+.||+|+||+||++... +|+.+|+|++..... ...+.+.+|+.+++.++||||+++++++.+. ..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 456899999999999999999964 789999999875432 2345688999999999999999999999877 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC---CCCcEEEecccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD---KNFHAKVSDFGL 236 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~ 236 (395)
||+.+|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 90 E~~~gg~L~~~i~~~-------~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 90 DLVTGGELFEDIVAR-------EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp CCCBCCBHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 999999999998543 4689999999999999999999999 999999999999998 568899999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 160 a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~------------- 221 (444)
T 3soa_A 160 AIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RL------------- 221 (444)
T ss_dssp CBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH-------------
T ss_pred eEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HH-------------
Confidence 97654332 2233467999999999999999999999999999999999999999654311 00
Q ss_pred hhhhccccc--cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPAL--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+..... ........+..+.+|+.+||+.||++|||+.+++++
T Consensus 222 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 222 YQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 001110000 001111234568899999999999999999999974
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=340.26 Aligned_cols=246 Identities=23% Similarity=0.356 Sum_probs=199.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
.++|.+.+.||+|+||+||+|.. .+++.||+|++... .......+.+|+.+++.++||||+++++++.+. ..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36789999999999999999996 57899999998642 122345788999999999999999999999877 56699
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+ +|+|.+++... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 88 ~E~~-~g~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~ 156 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-------KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSN 156 (336)
T ss_dssp ECCC-CEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred EECC-CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccce
Confidence 9999 78999988533 4699999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...... .....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||..........
T Consensus 157 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------------- 218 (336)
T 3h4j_B 157 IMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------------- 218 (336)
T ss_dssp TTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---------------
T ss_pred eccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---------------
Confidence 644322 2334579999999999988776 689999999999999999999997543221100
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+... ....+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 219 -~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 219 -KVNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -HHHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 00000 001122234568899999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=339.86 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=200.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
.++|.+.+.||+|+||.||++... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999965 68999999997542 23345788999999999999999999998877 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC---CcEEEecccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN---FHAKVSDFGL 236 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg~ 236 (395)
||+.+|+|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 108 e~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 108 DLVTGGELFEDIVA-------REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp CCCCSCBHHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred ecCCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 99999999999853 24689999999999999999999999 99999999999999765 4599999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
+....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......
T Consensus 178 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i~-------- 243 (362)
T 2bdw_A 178 AIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIK-------- 243 (362)
T ss_dssp CBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH--------
T ss_pred ceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH--------
Confidence 97654322 223467999999999999999999999999999999999999999754311 0000000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....+ .........+..+.+|+.+||+.||++|||+.+++++
T Consensus 244 -~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 244 -AGAYD--YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -HTCCC--CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -hCCCC--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 0000001224568899999999999999999998864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=334.82 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=200.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CC-------cEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ce
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NG-------RKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~ 155 (395)
++|.+.+.||+|+||+||+|... ++ ..||+|++........+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 46888899999999999999854 33 57999999776666678899999999999999999999998776 67
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc-------
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH------- 228 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~------- 228 (395)
++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK------NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred EEEEECCCCCCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 79999999999999996432 3489999999999999999999999 9999999999999988887
Q ss_pred -EEEeccccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhh
Q 016117 229 -AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 306 (395)
Q Consensus 229 -~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~ 306 (395)
+||+|||++..... .....+++.|+|||++.+ ..++.++||||||+++|||++|..|+...... ......
T Consensus 159 ~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~~~~~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQF 230 (289)
T ss_dssp EEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHH
T ss_pred eeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--HHHHHH
Confidence 99999999864322 123457889999999987 67899999999999999999965554322110 000000
Q ss_pred hhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 307 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
. .. ... .+...+..+.+++.+||+.||++|||+.+++++|++++..
T Consensus 231 ~----------~~--~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 231 Y----------ED--RHQ----LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp H----------HT--TCC----CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred h----------hc--cCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 0 00 000 1111123588999999999999999999999999999883
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=334.85 Aligned_cols=269 Identities=22% Similarity=0.364 Sum_probs=206.3
Q ss_pred CCCCCCeeeccCCeEEEEEEE-----cCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKL 156 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~ 156 (395)
.|++.+.||+|+||.||+|.+ .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 477889999999999999984 36889999998743 234457889999999999999999999998764 357
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
++|||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||+
T Consensus 102 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNK------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence 9999999999999995432 4589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCC-ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc--cc
Q 016117 237 AKIGSDKAGG-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL--TD 313 (395)
Q Consensus 237 ~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~ 313 (395)
+......... .......+|..|+|||++.+..++.++||||||+++|+|++|..|+..... .......+.. ..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMT 248 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccC
Confidence 9865443221 122345678889999999999999999999999999999999998642210 0000000000 00
Q ss_pred chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 314 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 314 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.......+........+...+..+.+++.+||+.||.+|||+.++++.|+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 011111111111222333445679999999999999999999999999998864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=341.28 Aligned_cols=260 Identities=28% Similarity=0.423 Sum_probs=195.3
Q ss_pred CCCCCCeeeccCCeEEEEEEEc--CC--cEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC--ceEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS--NG--RKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--RKLLV 158 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~lv 158 (395)
.|.+.+.||+|+||+||+|.+. ++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3566789999999999999853 22 368999886532 33456789999999999999999999987543 56899
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 170 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 240 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 240 (373)
T ss_dssp EECCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EECCCCCCHHHHHhhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccc
Confidence 99999999999995432 4588999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCC--ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 239 IGSDKAGG--HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 239 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
........ .......+++.|+|||++.+..++.++||||||+++|||++ |.+||........ ....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~~-------- 309 (373)
T 3c1x_A 241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYL-------- 309 (373)
T ss_dssp -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHHH--------
T ss_pred cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHHH--------
Confidence 54332211 11233457788999999999999999999999999999999 6777764432211 0000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
... .....+...+..+.+++.+||+.+|++|||+.++++.|++++.....
T Consensus 310 -----~~~-~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 310 -----LQG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp -----HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred -----HcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 000 00011222345689999999999999999999999999999986443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=338.49 Aligned_cols=270 Identities=25% Similarity=0.386 Sum_probs=210.8
Q ss_pred HHHHHhCCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEe
Q 016117 79 QLHSATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCS 151 (395)
Q Consensus 79 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 151 (395)
+.....++|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33345567899999999999999999854 367899999875432 33456889999999999999999999987
Q ss_pred cC-ceEEEEEcccCCChhhhcccCCCC---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC
Q 016117 152 DR-RKLLVYDYMANGGLQEHLYPANGS---NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 227 (395)
Q Consensus 152 ~~-~~~lv~e~~~~g~L~~~l~~~~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~ 227 (395)
+. ..++||||+.+|+|.+++...... ......+++..++.++.|++.||.|||++ +++||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence 76 577999999999999998643210 11124578999999999999999999999 999999999999999999
Q ss_pred cEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhh
Q 016117 228 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSW 306 (395)
Q Consensus 228 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~ 306 (395)
.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...... ..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~--- 249 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QV--- 249 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HH---
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HH---
Confidence 999999999975443222222233456888999999999999999999999999999999 89998643211 00
Q ss_pred hhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 307 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
...+..... ...+...+..+.+++.+||+.||++|||+.+++++|++++..
T Consensus 250 ----------~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 250 ----------LRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp ----------HHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ----------HHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 011111111 111223345688999999999999999999999999988764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=362.38 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=201.8
Q ss_pred CeeeccCCeEEEEEEEc---CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccCC
Q 016117 91 NVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANG 165 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g 165 (395)
+.||+|+||+||+|.+. .++.||||+++... ....+.+.+|++++++++||||+++++++.++..++||||+.+|
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g 454 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 454 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence 47999999999999753 46789999997532 23357899999999999999999999999888888999999999
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCC
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 245 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 245 (395)
+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 455 ~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 455 PLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 999999532 4689999999999999999999999 999999999999999999999999999986543321
Q ss_pred C-ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 246 G-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 246 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
. .......+|..|+|||++.+..++.++||||||+++|||++ |..||...... .+...+..
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----------------~~~~~i~~ 587 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----------------EVTAMLEK 587 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------HHHHHHHT
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHc
Confidence 1 12223456788999999999999999999999999999998 99999754321 11111111
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
......+...+.++.+|+..||+.||++|||+.+|++.|+++...
T Consensus 588 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 588 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 112223334556799999999999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=337.01 Aligned_cols=272 Identities=26% Similarity=0.344 Sum_probs=209.7
Q ss_pred CCCCCeeeccCCeEEEEEEEc-----CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEE
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-----NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLL 157 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~l 157 (395)
|++.+.||+|+||+||++.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+. ..++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 378899999999999988642 68899999997543 23356788999999999999999999998763 4579
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 113 v~e~~~~~~L~~~l~~--------~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR--------HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp EECCCTTCBHHHHGGG--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEecccCCcHHHHHhh--------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccc
Confidence 9999999999999943 3489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC-ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 238 KIGSDKAGG-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 238 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
......... .......++..|+|||++.+..++.++||||||+++|+|++|..||....... .....+.. .......
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~-~~~~~~~ 259 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQ-GQMTVLR 259 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCC-HHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccc-cchhHHH
Confidence 875443221 12233557888999999999999999999999999999999999986321100 00000000 0000111
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
....+........+...+..+.+|+.+||+.||++|||+.++++.|+++.+....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 2222222222333444556799999999999999999999999999999886443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=336.46 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=196.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecCc--------
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-------- 154 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------- 154 (395)
++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46888999999999999999976 79999999987433 334567899999999999999999999875431
Q ss_pred --------------------------------------------------eEEEEEcccCCChhhhcccCCCCCCCCCCC
Q 016117 155 --------------------------------------------------KLLVYDYMANGGLQEHLYPANGSNSVASKL 184 (395)
Q Consensus 155 --------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l 184 (395)
.+++|||+.+|+|.+++.... .....
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~ 161 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC----SLEDR 161 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC----SGGGS
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc----Cccch
Confidence 579999999999999996543 23456
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCC----------ceeecccc
Q 016117 185 DWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG----------HVSTRVLG 254 (395)
Q Consensus 185 ~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~g 254 (395)
++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++......... .......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 7788999999999999999999 9999999999999999999999999999865543211 11233569
Q ss_pred ccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHH
Q 016117 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEV 334 (395)
Q Consensus 255 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 334 (395)
|+.|+|||++.+..++.++||||||+++|||++|..|+... ............ ........
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------------------~~~~~~~~~~~~-~~~~~~~~ 299 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------------------VRIITDVRNLKF-PLLFTQKY 299 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------------------HHHHHHHHTTCC-CHHHHHHC
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------------------HHHHHHhhccCC-CcccccCC
Confidence 99999999999999999999999999999999987664210 000001111100 01112334
Q ss_pred HHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 335 IQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 335 ~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+.+++.+||+.||++|||+.+++++
T Consensus 300 ~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 300 PQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 567899999999999999999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=340.63 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=200.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||.||++... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+. ..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46888999999999999999965 6889999998642 233456788999999999999999999999876 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+|+|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 95 e~~~gg~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ-------NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp CCCTTEEHHHHHHT-------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeee
Confidence 99999999999953 24699999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||..............
T Consensus 165 ~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---------- 231 (384)
T 4fr4_A 165 LPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---------- 231 (384)
T ss_dssp CCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH----------
T ss_pred ccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH----------
Confidence 54322 2345679999999999874 4589999999999999999999999975433221111111
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-HHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-MADVVQ 360 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~~vl~ 360 (395)
+... ...++...+..+.+|+.+||+.||.+||+ +.++.+
T Consensus 232 ---~~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 232 ---FETT--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---HHHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---Hhhc--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0000 01222233457899999999999999998 677664
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=342.22 Aligned_cols=270 Identities=19% Similarity=0.236 Sum_probs=205.1
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcC------CcEEEEEEeccCCcccH-----------HHHHHHHHHHhccCCCcceeE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSN------GRKVAIKLMDQAGKQGE-----------DEFKMEVELLGRLRSPYLLAL 146 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l 146 (395)
.++|.+.+.||+|+||+||+|.+.. ++.||+|++........ ..+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578899999999999999999754 47899999875432111 123345566777889999999
Q ss_pred EEEEecC-----ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCE
Q 016117 147 LGYCSDR-----RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNI 221 (395)
Q Consensus 147 ~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Ni 221 (395)
++++... ..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Ni 183 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA------KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNL 183 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHE
Confidence 9987653 257999999 999999996432 4699999999999999999999999 999999999999
Q ss_pred EeC--CCCcEEEeccccccccCCCCCC-----ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 016117 222 LLD--KNFHAKVSDFGLAKIGSDKAGG-----HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDV 294 (395)
Q Consensus 222 ll~--~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~ 294 (395)
|++ .++.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 998 8899999999999764322111 111335599999999999999999999999999999999999999974
Q ss_pred CCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 295 NKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
.... ........ ......+..++++.+... ..+..+.+++..||+.+|++||++.+|++.|++++....
T Consensus 264 ~~~~--~~~~~~~~--~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 264 NLKD--PKYVRDSK--IRYRENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp GTTC--HHHHHHHH--HHHHHCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cccC--HHHHHHHH--HHhhhhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 3221 11111111 011123334444443211 123568899999999999999999999999999998643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=338.47 Aligned_cols=269 Identities=23% Similarity=0.366 Sum_probs=211.4
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEcC-C-----cEEEEEEeccCCc-ccHHHHHHHHHHHhcc-CCCcceeEEEEEecC
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLSN-G-----RKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR 153 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 153 (395)
...++|.+.+.||+|+||+||+|.... + ..||+|.+..... ...+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345789999999999999999999642 2 4799999975432 3346788999999999 899999999998776
Q ss_pred -ceEEEEEcccCCChhhhcccCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGS-------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK 225 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~ 225 (395)
..++||||+++|+|.+++...... ......+++..++.++.|++.||.|||++ +++||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECC
Confidence 677999999999999998643210 00124689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhh
Q 016117 226 NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLV 304 (395)
Q Consensus 226 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~ 304 (395)
++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----- 274 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS----- 274 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-----
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-----
Confidence 99999999999986544333333344567889999999999999999999999999999998 999997543211
Q ss_pred hhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 305 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.....+........+...+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 275 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 275 -----------KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp -----------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 111111111111112223457889999999999999999999999999988753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=328.97 Aligned_cols=259 Identities=28% Similarity=0.411 Sum_probs=201.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcC----CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC--ceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--RKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~l 157 (395)
.+|.+.+.||+|+||+||+|...+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++.+. ..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457788999999999999998642 2358999887533 23446788999999999999999999986543 5679
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
+|||+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 105 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a 175 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 175 (298)
T ss_dssp EEECCTTCBHHHHHHCTT------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred EEeCCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccc
Confidence 999999999999995432 4689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC--CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 238 KIGSDKAG--GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 238 ~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
........ ........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||........ ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~-------- 244 (298)
T 3f66_A 176 RDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVY-------- 244 (298)
T ss_dssp CCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHH--------
T ss_pred ccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHH--------
Confidence 75443221 111233457788999999999999999999999999999999 5556544332110 000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
+... .....+...+..+.+++.+||+.+|++|||+.++++.|++++...
T Consensus 245 -----~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 245 -----LLQG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -----HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -----HhcC-CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0000 000111122356899999999999999999999999999999853
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=337.27 Aligned_cols=262 Identities=23% Similarity=0.302 Sum_probs=190.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCcceeEEEEEe--------cC-
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCS--------DR- 153 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~--------~~- 153 (395)
.+|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.+++++. ||||+++++++. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 46888999999999999999964 78999999987655555677889999999996 999999999883 22
Q ss_pred ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCCEEeCCCCcEEE
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP--VIHRDFKSSNILLDKNFHAKV 231 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nill~~~~~~kl 231 (395)
..++++||+. |+|.+++.... ....+++..++.++.|++.||.|||++ + ++||||||+|||++.++.+||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKME----SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHH----TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred eEEEEEEecC-CCHHHHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 2568999985 79999885422 124699999999999999999999998 7 999999999999999999999
Q ss_pred eccccccccCCCCCCc----------eeeccccccccccchhh---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 016117 232 SDFGLAKIGSDKAGGH----------VSTRVLGTQGYVAPEYA---LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPS 298 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~---~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~ 298 (395)
+|||++.......... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 9999998654322111 11134589999999998 5667899999999999999999999999643221
Q ss_pred CCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCCCCC
Q 016117 299 GEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPK 374 (395)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~~~~ 374 (395)
. +................+.+|+.+||+.||++|||+.+++++|+.+.......+.
T Consensus 260 ~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~ 315 (337)
T 3ll6_A 260 R--------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315 (337)
T ss_dssp --------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTT
T ss_pred H--------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCC
Confidence 0 0000000001111123478899999999999999999999999999986554443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=334.94 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=194.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCcceeEEEEEecC-c----e
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R----K 155 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~----~ 155 (395)
++|++.+.||+|+||+||++.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++... . .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 5788999999999999999996 5789999999975432 2235688999999999999999999987654 2 3
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||
T Consensus 92 ~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred EEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 7999999999999999532 3689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC-ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 236 LAKIGSDKAGG-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 236 ~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~----~---------- 227 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS----V---------- 227 (311)
T ss_dssp CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----H----------
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH----H----------
Confidence 99765433211 12234568999999999999999999999999999999999999997543210 0
Q ss_pred hhhhhhccccc--cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHH-HHHHHhhhh
Q 016117 315 EKILEIMDPAL--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVV-QSLVPLVKY 368 (395)
Q Consensus 315 ~~~~~~~d~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl-~~L~~~~~~ 368 (395)
......... ........+.++.+++.+||+.||++||++.+++ +.|.++...
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 228 --AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp --HHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred --HHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 000000000 0000011235688999999999999999766655 555555443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=337.72 Aligned_cols=249 Identities=21% Similarity=0.323 Sum_probs=198.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC-----CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA-----GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
+.|++.+.||+|+||+||+|... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46899999999999999999964 6899999998532 122457889999999999999999999988776 5679
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc---EEEecc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH---AKVSDF 234 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Df 234 (395)
||||+.+|+|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+|||++.++. +||+||
T Consensus 104 v~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRAD---AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEECCSSCBHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEeCCCCCCHHHHHHHhcc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999988854321 123589999999999999999999999 9999999999999986654 999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
|++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..
T Consensus 178 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~----------- 240 (351)
T 3c0i_A 178 GVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RL----------- 240 (351)
T ss_dssp TTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HH-----------
T ss_pred cceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HH-----------
Confidence 9998654322 223345799999999999999999999999999999999999999964310 00
Q ss_pred hhhhhhccccccCCCCH----HHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 315 EKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
...+..... .... ..+..+.+|+.+||+.||++|||+.++++
T Consensus 241 --~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 241 --FEGIIKGKY--KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --HHHHHHTCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHHcCCC--CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001110000 0111 12356889999999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=339.07 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=200.7
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ce
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~ 155 (395)
...++|.+.+.||+|+||+||+|+.. +|+.||+|++.... ....+.+..|..++..+ +||||+++++++.+. ..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999975 68999999987431 23455677899999887 999999999998876 56
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeECh
Confidence 7999999999999999532 4689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
++....... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+.. .
T Consensus 164 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~------------- 225 (345)
T 1xjd_A 164 MCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---E------------- 225 (345)
T ss_dssp TCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H-------------
T ss_pred hhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---H-------------
Confidence 997533221 2234567999999999999999999999999999999999999999754311 0
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHH-HHHH
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA-DVVQ 360 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-~vl~ 360 (395)
....+.... ..++...+..+.+|+.+||+.||++||++. ++++
T Consensus 226 ~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 226 LFHSIRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHhCC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 011111110 012222345688999999999999999998 6654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=326.15 Aligned_cols=260 Identities=27% Similarity=0.369 Sum_probs=202.7
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CC---cEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC-c-eEEEE
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NG---RKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R-KLLVY 159 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~-~~lv~ 159 (395)
|...+.||+|+||+||+|.+. ++ ..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+. . .++++
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 455688999999999999853 22 3799999875433 3446788999999999999999999998755 3 47999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 103 e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQ------RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp CCCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred ecccCCCHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 9999999999996432 4689999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCC--CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 240 GSDKA--GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 240 ~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
..... .........+++.|+|||.+.+..++.++||||||+++|+|++|..|+...... . ..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~--------------~~ 237 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--F--------------DL 237 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--G--------------GH
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--H--------------HH
Confidence 43321 111223356788999999999999999999999999999999966554322211 0 01
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
...+........+...+..+.+++.+||+.||.+|||+.++++.|+++++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 238 THFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred HHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 111111111112222345789999999999999999999999999999986443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=342.43 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=195.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHHHhccC--CCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLR--SPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~-~~~lv~ 159 (395)
..|.+.+.||+|+||+||++...+++.||+|++.... ....+.+.+|+.+++.++ ||||+++++++... ..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 3588899999999999999998789999999986432 234467889999999996 59999999998776 456999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
| +.+++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++ ++.+||+|||++..
T Consensus 136 E-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~ 203 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ 203 (390)
T ss_dssp E-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred e-cCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence 9 6788999999543 3688999999999999999999999 999999999999995 58999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhcc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALT-----------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~ 308 (395)
..............||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---------- 273 (390)
T 2zmd_A 204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---------- 273 (390)
T ss_dssp C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----------
T ss_pred ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----------
Confidence 544332223345679999999999865 36889999999999999999999999643210
Q ss_pred cccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 309 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+..++++......+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 274 -----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 274 -----ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -----HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 011222233222222222224568899999999999999999999865
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=334.15 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=191.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEE----cCCcEEEEEEeccCC----cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ce
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~ 155 (395)
++|++.+.||+|+||.||+++. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+. ..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5688899999999999999996 478999999987532 22345677899999999999999999998776 66
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++||||+.+|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE-------GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred EEEEeCCCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCC
Confidence 7999999999999999532 4688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .
T Consensus 167 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------~ 228 (327)
T 3a62_A 167 LCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK----------------K 228 (327)
T ss_dssp CC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----------------H
T ss_pred cccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH----------------H
Confidence 987533221 1233467999999999999999999999999999999999999999754311 0
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
....+..... ..+...+..+.+++.+||+.||++|| ++.+++++
T Consensus 229 ~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 229 TIDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHHHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHHHHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1111111111 12223345788999999999999999 77788764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=331.39 Aligned_cols=263 Identities=26% Similarity=0.383 Sum_probs=207.3
Q ss_pred HHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhc--cCCCcceeEEEEEecC-----
Q 016117 81 HSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGR--LRSPYLLALLGYCSDR----- 153 (395)
Q Consensus 81 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----- 153 (395)
....++|.+.+.||+|+||+||+|.. +|+.||+|++... ....+..|.+++.. ++||||+++++++...
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44556899999999999999999998 6899999998643 34567789998887 7999999999998765
Q ss_pred ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCceeCCCCCCCEEeCC
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH--------EHCSPPVIHRDFKSSNILLDK 225 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~dlk~~Nill~~ 225 (395)
..++||||+.+|+|.+++.. ..+++..++.++.|++.||.||| +. +++||||||+|||++.
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK 182 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred eeEEEEeecCCCcHHHHHhc--------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence 46799999999999999943 35899999999999999999999 77 9999999999999999
Q ss_pred CCcEEEeccccccccCCCCCCc--eeeccccccccccchhhccCC------CCccchhHHHHHHHHHHHhC---------
Q 016117 226 NFHAKVSDFGLAKIGSDKAGGH--VSTRVLGTQGYVAPEYALTGH------LTTKSDVYSYGVVLLELLTG--------- 288 (395)
Q Consensus 226 ~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~------~~~~~DvwslG~~l~ell~g--------- 288 (395)
++.+||+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 9999999999997654432211 123456899999999988653 33689999999999999999
Q ss_pred -CCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCC-----CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 289 -RVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 289 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
..||.......... .. ....+....+.... +.+....+.+++.+||+.||++|||+.+|+++|
T Consensus 263 ~~~p~~~~~~~~~~~-~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L 331 (342)
T 1b6c_B 263 YQLPYYDLVPSDPSV-EE----------MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331 (342)
T ss_dssp CCCTTTTTSCSSCCH-HH----------HHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccCccccCcCcccH-HH----------HHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 67775443221110 00 01111111111111 235667899999999999999999999999999
Q ss_pred HHhhhhc
Q 016117 363 VPLVKYN 369 (395)
Q Consensus 363 ~~~~~~~ 369 (395)
+++.+..
T Consensus 332 ~~i~~~~ 338 (342)
T 1b6c_B 332 SQLSQQE 338 (342)
T ss_dssp HHHHHTT
T ss_pred HHHHHHh
Confidence 9998864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=349.82 Aligned_cols=260 Identities=23% Similarity=0.297 Sum_probs=205.1
Q ss_pred cHHHHHHHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEe
Q 016117 76 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCS 151 (395)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 151 (395)
.+.++....++|++.++||+|+||+||+|+.. +++.||+|++.... ......+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34455556788999999999999999999976 57899999986421 122234788999999999999999999998
Q ss_pred cC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEE
Q 016117 152 DR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 230 (395)
Q Consensus 152 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k 230 (395)
+. ..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~------~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vk 215 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE------DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIR 215 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEE
Confidence 77 5679999999999999996432 4699999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCceeeccccccccccchhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhh
Q 016117 231 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS 305 (395)
Q Consensus 231 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~ 305 (395)
|+|||++....... .......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+...
T Consensus 216 L~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------ 288 (437)
T 4aw2_A 216 LADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------ 288 (437)
T ss_dssp ECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------
T ss_pred EcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------
Confidence 99999997654322 12233467999999999987 4678999999999999999999999997543211
Q ss_pred hhhcccccchhhhhhcccccc---CCCCHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 016117 306 WALPRLTDREKILEIMDPALE---GQYSMKEVIQVAAIAAMCVQPEADY--RPLMADVVQS 361 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~~vl~~ 361 (395)
....++..... .......+.++.+|+.+||+.+|++ ||+++|++++
T Consensus 289 ----------~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 289 ----------TYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ----------HHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ----------HHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11111110000 0001123456889999999998888 9999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=327.59 Aligned_cols=263 Identities=20% Similarity=0.245 Sum_probs=196.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.++ ..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888999999999999999975 68999999987432 23346788999999999999999999998776 5669999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+ +|.+++... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~-~l~~~~~~~------~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC------NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp CCSE-EHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCCC-CHHHHHHhC------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9975 566655432 24699999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCceeeccccccccccchhhccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc-----cc
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGH-LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT-----DR 314 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~ 314 (395)
.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ........... ..
T Consensus 152 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 152 GIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp CSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTC
T ss_pred CCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhh
Confidence 4322 2233456899999999998765 8999999999999999999888864322110 00100000000 00
Q ss_pred hhhhhhcccc---------ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 315 EKILEIMDPA---------LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 315 ~~~~~~~d~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.......+.. .........+..+.+|+.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000000 0001112344578899999999999999999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=334.89 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=199.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv 158 (395)
++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+..|..+++++ +||||+++++++.+. ..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46888899999999999999975 68899999997542 22345678899999987 899999999998876 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+.+|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 89 ~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158 (345)
T ss_dssp ECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred EeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccc
Confidence 9999999999999532 4689999999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||............ .......
T Consensus 159 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-------~~~~~~~ 229 (345)
T 3a8x_A 159 EGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-------TEDYLFQ 229 (345)
T ss_dssp CSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------------CHHHHHH
T ss_pred cccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc-------cHHHHHH
Confidence 533221 2234567999999999999999999999999999999999999999643221110000 0000011
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH------HHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM------ADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~~vl~~ 361 (395)
.+..... ..+...+..+.+|+.+||+.||.+||++ .+++++
T Consensus 230 ~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 230 VILEKQI--RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HHHcCCC--CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1111111 1222344578899999999999999996 566643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=335.92 Aligned_cols=249 Identities=21% Similarity=0.330 Sum_probs=186.8
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
..++|.+.+.||+|+||+||+|... +++.||+|++.... ..+.+.+|+++++.++||||+++++++.+. ..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3467899999999999999999976 58899999987542 345678899999999999999999999876 5669999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC---CCcEEEeccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSDFGLA 237 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~ 237 (395)
|+.+|+|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+|||++. ++.+||+|||++
T Consensus 129 ~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 129 LVTGGELFDRIVE-------KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp CCCSCBHHHHHTT-------CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred eCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 9999999999953 24589999999999999999999999 9999999999999975 899999999999
Q ss_pred cccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
....... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... .. .
T Consensus 199 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~-------------~ 260 (349)
T 2w4o_A 199 KIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FM-------------F 260 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HH-------------H
T ss_pred cccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HH-------------H
Confidence 7643321 2234568999999999999999999999999999999999999996433210 00 0
Q ss_pred hhhcccc--ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 318 LEIMDPA--LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 318 ~~~~d~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+.... .........+..+.+|+.+||+.||++|||+.+++++
T Consensus 261 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 261 RRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111110 0111112334578899999999999999999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=347.74 Aligned_cols=256 Identities=22% Similarity=0.300 Sum_probs=203.6
Q ss_pred HHHHHHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC
Q 016117 78 KQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR 153 (395)
Q Consensus 78 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 153 (395)
.++....++|.+.+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|..+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344455678999999999999999999975 6889999998642 122234578899999999999999999999877
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~--------~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred CEEEEEEeCCCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEe
Confidence 46699999999999999843 3589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhh
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH----LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~ 308 (395)
|||++....... .......+||+.|+|||++.+.. ++.++|||||||++|||++|..||...+..
T Consensus 211 DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---------- 279 (410)
T 3v8s_A 211 DFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---------- 279 (410)
T ss_dssp CCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH----------
T ss_pred ccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh----------
Confidence 999997654322 11233567999999999998765 788999999999999999999999754321
Q ss_pred cccccchhhhhhcccc--ccCCCCHHHHHHHHHHHhhcCCCCCCC--CCCHHHHHHH
Q 016117 309 PRLTDREKILEIMDPA--LEGQYSMKEVIQVAAIAAMCVQPEADY--RPLMADVVQS 361 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~--~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~~vl~~ 361 (395)
.....++... +........+..+.+|+.+||+.+|.+ ||++.||+++
T Consensus 280 ------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 280 ------GTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ------HHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ------hHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1111111110 000111123456889999999999988 9999999976
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=330.95 Aligned_cols=268 Identities=22% Similarity=0.315 Sum_probs=198.7
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35688999999999999999996 478999999987532 23346788999999999999999999988766 56699
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+.+++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 111 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKK---QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp EECCCSCBHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred EecCCCCCHHHHHHHhcc---cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 999999999999854221 124689999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....... .... .
T Consensus 185 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~-------------~ 248 (310)
T 2wqm_A 185 FFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLC-------------K 248 (310)
T ss_dssp ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHH-------------H
T ss_pred eecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHH-------------H
Confidence 544322 12234568999999999999999999999999999999999999996432210 0000 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCCCC
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTP 373 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~~~ 373 (395)
.+.............+..+.+++.+||+.||++|||+.++++.|+++......++
T Consensus 249 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 249 KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp HHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred HhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 0000000001112234568899999999999999999999999999999766543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=336.68 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=201.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||.||++... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+. ..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46888899999999999999975 6899999998643 123456788899999999999999999998876 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 121 e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp ECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccccccee
Confidence 999999999999532 3589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .....
T Consensus 191 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----------------~~~~~ 249 (350)
T 1rdq_E 191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----------------QIYEK 249 (350)
T ss_dssp CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHH
T ss_pred ccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH----------------HHHHH
Confidence 5432 23457999999999999999999999999999999999999999754311 01111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~vl~~ 361 (395)
+....+ .++...+..+.+++.+||+.||.+||+ +.+|+++
T Consensus 250 i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 250 IVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 111111 122233457899999999999999998 8888864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=326.54 Aligned_cols=252 Identities=28% Similarity=0.412 Sum_probs=199.1
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC--ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~lv~e~ 161 (395)
.++|++.+.||+|+||+||++.. +|+.||+|++... ...+.+.+|+.+++.++||||+++++++.+. ..++++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 35688899999999999999987 5889999998753 2456789999999999999999999987544 56899999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++....
T Consensus 97 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CTTEEHHHHHHHHH-----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred CCCCCHHHHHHhcc-----cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 99999999995321 12388999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... .. ..
T Consensus 169 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~--------------~~ 226 (278)
T 1byg_A 169 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV--------------PR 226 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH--------------HH
T ss_pred ccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH--------------HH
Confidence 221 22357888999999999999999999999999999998 999996432110 00 00
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
+........+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 227 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 111111122223345789999999999999999999999999998774
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=339.45 Aligned_cols=274 Identities=19% Similarity=0.263 Sum_probs=212.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv~ 159 (395)
++|.+.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+. ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46888899999999999999975 58999999997532 33456788999999999999999999998754 457999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe----CCCCcEEEeccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSDFG 235 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~Dfg 235 (395)
||+.+|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||
T Consensus 89 e~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPS----NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCCTTEEHHHHTTSGG----GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred ecCCCCCHHHHHHhhh----cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 9999999999996432 123499999999999999999999999 99999999999999 788889999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhcc--------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCch-hhhh
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALT--------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV-LVSW 306 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~-~~~~ 306 (395)
++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.......... ....
T Consensus 162 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 162 AARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp GCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred CceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 998654322 2234568999999999875 567789999999999999999999997543322111 1111
Q ss_pred hhcccc--cchhhhhhc--------cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 307 ALPRLT--DREKILEIM--------DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 307 ~~~~~~--~~~~~~~~~--------d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
...... ......... +.......+......+.+++.+||+.||++|||+.++++.++++++.
T Consensus 239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 100000 000000000 01112244577888999999999999999999999999999998875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=345.70 Aligned_cols=246 Identities=27% Similarity=0.436 Sum_probs=201.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++.+. ..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 56888999999999999999975 79999999986431 22346788999999999999999999998876 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 96 E~~~gg~L~~~l~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 96 EYVSGGELFDYICK-------NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp ECCSSEEHHHHTTS-------SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 99999999999953 24699999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ....
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----------------~~~~ 226 (476)
T 2y94_A 166 MSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP----------------TLFK 226 (476)
T ss_dssp CCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH----------------HHHH
T ss_pred ccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH----------------HHHH
Confidence 54322 2334679999999999988765 68999999999999999999999754321 0111
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+.+... ..+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 227 ~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 227 KICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp HHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1111111 1111223468899999999999999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=336.19 Aligned_cols=249 Identities=25% Similarity=0.367 Sum_probs=201.2
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~ 156 (395)
..++|.+.+.||+|+||+||++... +|+.||+|++... .....+.+..|..++..+ +||||+++++++.+. ..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3467999999999999999999976 5789999998743 223456778899999988 899999999998876 567
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 98 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~ 167 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 167 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence 999999999999999532 3689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
+....... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... ..
T Consensus 168 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----------------~~ 229 (353)
T 2i0e_A 168 CKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----------------EL 229 (353)
T ss_dssp CBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HH
T ss_pred ccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH----------------HH
Confidence 97533221 2234567999999999999999999999999999999999999999754311 11
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~vl~~ 361 (395)
...+....+ .++...+.++.+|+.+||+.||.+||+ +.+++++
T Consensus 230 ~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 230 FQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred HHHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111111111 122234457889999999999999995 5777754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=339.79 Aligned_cols=244 Identities=22% Similarity=0.350 Sum_probs=193.2
Q ss_pred CCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcccCCCh
Q 016117 90 SNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMANGGL 167 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~~g~L 167 (395)
.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.+. ..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999964 6899999999876555667899999999999999999999999876 56799999999999
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe--CCCCcEEEeccccccccCCCCC
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL--DKNFHAKVSDFGLAKIGSDKAG 245 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill--~~~~~~kl~Dfg~~~~~~~~~~ 245 (395)
.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++.......
T Consensus 174 ~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 174 FDRIIDES------YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp HHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred HHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 99885432 4689999999999999999999999 99999999999999 677899999999998654332
Q ss_pred CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccc
Q 016117 246 GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 325 (395)
Q Consensus 246 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 325 (395)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... . ....++....
T Consensus 244 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~-------------~~~~i~~~~~ 305 (373)
T 2x4f_A 244 --KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---E-------------TLNNILACRW 305 (373)
T ss_dssp --BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---H-------------HHHHHHHTCC
T ss_pred --ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---H-------------HHHHHHhccC
Confidence 223456999999999999999999999999999999999999999754311 0 0111111000
Q ss_pred --cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 326 --EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 326 --~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 306 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 306 DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000011224568899999999999999999999973
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=332.03 Aligned_cols=244 Identities=20% Similarity=0.259 Sum_probs=188.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.++||+|+||+||+|... +|+.||||++..... .....+..|+..+..+ +||||+++++++.++ ..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 46899999999999999999976 799999999865322 2223444566555555 999999999999876 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 137 e~~-~~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG------ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp ECC-CCBHHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred ecc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 999 678998885432 4699999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... ......||+.|+|||++.+ .++.++||||||+++|||++|..||.... ....
T Consensus 207 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-------------------~~~~ 263 (311)
T 3p1a_A 207 LGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-------------------GWQQ 263 (311)
T ss_dssp CC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-------------------HHHH
T ss_pred cccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-------------------HHHH
Confidence 54322 2234568999999998876 78999999999999999999977664211 0011
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+.............+..+.+|+.+||+.||++|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 264 LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111111000111123578999999999999999999999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=338.97 Aligned_cols=270 Identities=17% Similarity=0.236 Sum_probs=200.5
Q ss_pred hCCCCCCCeeecc--CCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 84 TGGFSKSNVVGHG--GFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 84 ~~~~~~~~~lg~G--~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
.++|++.+.||+| +||+||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3568899999999 99999999975 79999999987532 23345778899999999999999999998776 5679
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
||||+.+|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||.+
T Consensus 104 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF-----MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp EEECCTTCBHHHHHHHTC-----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEccCCCCHHHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 999999999999996542 24589999999999999999999999 9999999999999999999999999988
Q ss_pred cccCCCC-----CCceeeccccccccccchhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh-hhhhc
Q 016117 238 KIGSDKA-----GGHVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV-SWALP 309 (395)
Q Consensus 238 ~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~-~~~~~ 309 (395)
....... .........||+.|+|||++.+ ..++.++|||||||++|||++|..||............ ....+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 6432111 0111223468899999999987 67899999999999999999999999754432211000 00000
Q ss_pred ccccc------------------hhhhhhcc---c------cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 310 RLTDR------------------EKILEIMD---P------ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 310 ~~~~~------------------~~~~~~~d---~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..... ......+. + ..........+..+.+|+.+||+.||++|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00000 00000000 0 00001122234578999999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=323.00 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=201.1
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 456889999999999999999975 78999999986432 33456788999999999999999999998876 4569999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+++|.+++.. ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 86 ~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 86 YCSGGELFDRIEP-------DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp CCTTEEGGGGSBT-------TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecCCCcHHHHHhh-------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 9999999999843 24689999999999999999999999 9999999999999999999999999999764
Q ss_pred CCCCCCceeeccccccccccchhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.............|++.|+|||.+.+..+ +.++||||||+++|+|++|..||........ ....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~------------ 222 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK------------ 222 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH------------
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh------------
Confidence 33222222334568999999999987665 7789999999999999999999975432211 111111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
............+..+.+++.+||+.||++|||+.+++++
T Consensus 223 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 223 --EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp --TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0000000011223468899999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=326.48 Aligned_cols=266 Identities=21% Similarity=0.292 Sum_probs=204.3
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEE-ecC-ceEEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC-SDR-RKLLVY 159 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~-~~~lv~ 159 (395)
..++|++.+.||+|+||+||+|.. .+++.||+|++..... ...+..|+++++.++|++++..+.++ .+. ..+++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 346899999999999999999996 5789999998764322 23578899999999998888777765 333 457999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe---CCCCcEEEecccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGL 236 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~ 236 (395)
||+ +++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||+ +.++.+||+|||+
T Consensus 85 e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp ECC-CCBHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred Ecc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 999 999999985432 4599999999999999999999999 99999999999999 7889999999999
Q ss_pred ccccCCCCCCc-----eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 237 AKIGSDKAGGH-----VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 237 ~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
+.......... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..................
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 233 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK- 233 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH-
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc-
Confidence 98654432211 223467899999999999999999999999999999999999999765433222111111000
Q ss_pred ccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
......+..... .+..+.+++.+||+.+|++|||+.++++.|++++....
T Consensus 234 -----~~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 234 -----KMSTPIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -----HHHSCHHHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----cccchhhhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 000000000111 13568999999999999999999999999999998654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=320.67 Aligned_cols=266 Identities=21% Similarity=0.287 Sum_probs=207.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEe-cC-ceEEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS-DR-RKLLVYD 160 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~-~~~lv~e 160 (395)
.++|++.+.||+|+||+||+|.. .+|+.||+|++..... .+.+..|+.+++.++|++++..+.++. +. ..+++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46789999999999999999996 5799999999875432 246889999999999988777777653 33 4579999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC---CCCcEEEeccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD---KNFHAKVSDFGLA 237 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~ 237 (395)
|+ +++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++ .++.+||+|||++
T Consensus 86 ~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp CC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred ec-CCCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 99 999999995332 4699999999999999999999999 999999999999994 8899999999999
Q ss_pred cccCCCCCCc-----eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 238 KIGSDKAGGH-----VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 238 ~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
.......... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-- 233 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-- 233 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH--
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc--
Confidence 8655433211 123457899999999999999999999999999999999999999865433222111111000
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
......+.+... .+..+.+++.+||+.||++|||+.++++.|+++......
T Consensus 234 ----~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 234 ----KMSTPIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ----HHHSCHHHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ----ccCCchHHHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 000000001111 234688999999999999999999999999999987543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=334.70 Aligned_cols=266 Identities=22% Similarity=0.290 Sum_probs=204.9
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEec-----CceEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD-----RRKLL 157 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~l 157 (395)
.++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+++++.++||||+++++++.. ...++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35688999999999999999996 5789999999876555566788999999999999999999998862 24679
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
|+||+.+|+|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 108 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKD---KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEECCTTCBHHHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEeCCCCcHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 9999999999999865321 134689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCc-------eeeccccccccccchhhccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh
Q 016117 238 KIGSDKAGGH-------VSTRVLGTQGYVAPEYALTGH---LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 307 (395)
Q Consensus 238 ~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~ 307 (395)
.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.........
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------ 255 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS------ 255 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC------
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch------
Confidence 7533211100 011245789999999987554 688999999999999999999998531110000
Q ss_pred hcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 308 LPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 308 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
.................+..+.+++.+||+.||.+|||+.+++++|+++....+
T Consensus 256 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 256 ---------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp ---------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred ---------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 000000011111122234578999999999999999999999999999876433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=331.42 Aligned_cols=263 Identities=29% Similarity=0.446 Sum_probs=204.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEE--EEEEeccC-CcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKV--AIKLMDQA-GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~v--avK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv 158 (395)
++|.+.+.||+|+||.||+|... ++..+ ++|.+... .....+.+.+|+++++++ +||||+++++++.+. ..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56888999999999999999954 56644 99988643 233445788999999999 999999999998776 56699
Q ss_pred EEcccCCChhhhcccCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcE
Q 016117 159 YDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 229 (395)
|||+++|+|.+++...... ......+++..++.++.|++.||.|||++ +++||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 9999999999999654200 01234799999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhh
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~ 308 (395)
||+|||++....... ......+++.|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 182 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---------- 248 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------- 248 (327)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------
T ss_pred EEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH----------
Confidence 999999987422111 1123456788999999998889999999999999999998 99999654311
Q ss_pred cccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 309 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
.....+........+...+..+.+++.+||+.+|++|||+.+++++|++++....
T Consensus 249 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 249 -------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp -------HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred -------HHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0001111111112222334578999999999999999999999999999998644
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=327.09 Aligned_cols=267 Identities=25% Similarity=0.283 Sum_probs=196.7
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC-----cccHHHHHHHHHHHhccC---CCcceeEEEEEecC
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG-----KQGEDEFKMEVELLGRLR---SPYLLALLGYCSDR 153 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 153 (395)
..++|++.+.||+|+||+||+|.. .+++.||+|++.... ......+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 356899999999999999999995 578999999986322 122346677888777765 99999999998754
Q ss_pred c------eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC
Q 016117 154 R------KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 227 (395)
Q Consensus 154 ~------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~ 227 (395)
. .++++||+. |+|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+|||++.++
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-----PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG 157 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTS
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence 2 469999997 59999986443 23489999999999999999999999 999999999999999999
Q ss_pred cEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh
Q 016117 228 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 307 (395)
Q Consensus 228 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~ 307 (395)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...
T Consensus 158 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 158 TVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp CEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred CEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999997654322 234467899999999999999999999999999999999999999754321111000000
Q ss_pred hcccccch-----h-hhhhccccccC---CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 308 LPRLTDRE-----K-ILEIMDPALEG---QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 308 ~~~~~~~~-----~-~~~~~d~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
........ . ....+.+.... ....+.+..+.+|+.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000000 0 00000000000 0001223578899999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=324.69 Aligned_cols=255 Identities=20% Similarity=0.326 Sum_probs=204.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecCc-eEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 159 (395)
++|.+.+.||+|+||+||++... +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.. .+++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 46788899999999999999975 58899999986432 233467888999999999999999999998774 56999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+++|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 95 e~~~~~~L~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 95 ELCRRRSLLELHKR-------RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp ECCTTCBHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 99999999998843 24689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ....
T Consensus 165 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----------------~~~~ 226 (294)
T 2rku_A 165 VEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----------------TYLR 226 (294)
T ss_dssp CCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHH
T ss_pred cccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHH
Confidence 54322 12234568999999999999899999999999999999999999997533110 0001
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
+..... ..+...+..+.+++.+||+.||++|||+.+++++ .++.....
T Consensus 227 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~--~~~~~~~~ 274 (294)
T 2rku_A 227 IKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLND--EFFTSGYI 274 (294)
T ss_dssp HHTTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS--HHHHTSCC
T ss_pred HhhccC--CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC--hheecCCc
Confidence 111100 1112233568899999999999999999999975 44554433
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=344.82 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=193.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-------
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 153 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 153 (395)
.++|++.+.||+|+||+||+|... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999964 6899999998753 233456788999999999999999999998643
Q ss_pred ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEec
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 233 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 233 (395)
..++||||+.++ |.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~---------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~D 207 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 207 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred eEEEEEeCCCCC-HHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEE
Confidence 347999999764 666662 2489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh------
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA------ 307 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~------ 307 (395)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+...
T Consensus 208 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 208 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284 (464)
T ss_dssp CCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred EEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9999865432 1234567999999999999999999999999999999999999999754321110000000
Q ss_pred --hcccc-------------cchhhhhhccccccCCCC---HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 308 --LPRLT-------------DREKILEIMDPALEGQYS---MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 308 --~~~~~-------------~~~~~~~~~d~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..... ........+...+..... .....++.+|+.+||+.||++|||+.|++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 000000111000000001 1125678999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=334.03 Aligned_cols=264 Identities=25% Similarity=0.290 Sum_probs=199.8
Q ss_pred HHHHHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC-----CcccHHHHHHHHHHHhccCCCcceeEEEEEec
Q 016117 79 QLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA-----GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152 (395)
Q Consensus 79 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 152 (395)
++....++|.+.+.||+|+||+||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34455678999999999999999999964 6889999998642 23445688999999999999999999999987
Q ss_pred Cc-eEEEEEcccCCChhhhcccCCCCC---------------------------------CCCCCCCHHHHHHHHHHHHH
Q 016117 153 RR-KLLVYDYMANGGLQEHLYPANGSN---------------------------------SVASKLDWETRLRIALEAAK 198 (395)
Q Consensus 153 ~~-~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------~~~~~l~~~~~~~i~~~i~~ 198 (395)
.. .++||||+++|+|.+++....... .....+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 74 669999999999999985321100 00123467788999999999
Q ss_pred HHHHHhcCCCCCceeCCCCCCCEEeCCCC--cEEEeccccccccCCCCCC--ceeeccccccccccchhhcc--CCCCcc
Q 016117 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNF--HAKVSDFGLAKIGSDKAGG--HVSTRVLGTQGYVAPEYALT--GHLTTK 272 (395)
Q Consensus 199 ~l~~LH~~~~~~i~H~dlk~~Nill~~~~--~~kl~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~~ 272 (395)
||+|||++ +++||||||+|||++.++ .+||+|||++......... .......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998776 8999999999864332211 12344678999999999875 678999
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccC--CCCHHHHHHHHHHHhhcCCCCCC
Q 016117 273 SDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG--QYSMKEVIQVAAIAAMCVQPEAD 350 (395)
Q Consensus 273 ~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~l~~li~~cl~~~p~ 350 (395)
+||||||+++|||++|..||...... .....+....... ......+..+.+|+.+||+.||.
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 320 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA----------------DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH----------------HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChh
Confidence 99999999999999999999644311 1111111111110 00111245688999999999999
Q ss_pred CCCCHHHHHHH
Q 016117 351 YRPLMADVVQS 361 (395)
Q Consensus 351 ~RPt~~~vl~~ 361 (395)
+|||+.+++++
T Consensus 321 ~Rps~~~~l~h 331 (345)
T 3hko_A 321 ERFDAMRALQH 331 (345)
T ss_dssp TSCCHHHHHHS
T ss_pred HCCCHHHHhcC
Confidence 99999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=339.51 Aligned_cols=275 Identities=23% Similarity=0.301 Sum_probs=205.7
Q ss_pred cceecHHHHHHHhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-----CCccee
Q 016117 72 LQVFTFKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-----SPYLLA 145 (395)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~ 145 (395)
...+.+++.....++|.+.+.||+|+||+||+|.. .+++.||+|++... ....+.+..|+++++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34455555555668899999999999999999996 47899999999743 334456778999999986 999999
Q ss_pred EEEEEecC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC
Q 016117 146 LLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224 (395)
Q Consensus 146 l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 224 (395)
+++++... ..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 171 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-----YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLD 171 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEES
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEc
Confidence 99988766 567999999 999999996543 23589999999999999999999999 999999999999997
Q ss_pred C-------------------------CCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHH
Q 016117 225 K-------------------------NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYG 279 (395)
Q Consensus 225 ~-------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG 279 (395)
. ++.+||+|||++...... .....||+.|+|||++.+..++.++||||||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 246 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHH
Confidence 5 789999999999864332 2345689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccch-------hhhhhcc------ccccCCCC---------------H
Q 016117 280 VVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE-------KILEIMD------PALEGQYS---------------M 331 (395)
Q Consensus 280 ~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~d------~~~~~~~~---------------~ 331 (395)
|++|+|++|+.||....................... .....++ ........ .
T Consensus 247 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred HHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence 999999999999975432211111110000000000 0000000 00000000 0
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 332 KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 332 ~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.....+.+|+.+||+.||++|||+.|++++
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred chHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 012567899999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=339.88 Aligned_cols=250 Identities=21% Similarity=0.349 Sum_probs=192.7
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--------cccHHHHHHHHHHHhccCCCcceeEEEEEec
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--------KQGEDEFKMEVELLGRLRSPYLLALLGYCSD 152 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 152 (395)
...++|.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45678999999999999999999964 68999999986431 1112247889999999999999999999988
Q ss_pred CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC---CcE
Q 016117 153 RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN---FHA 229 (395)
Q Consensus 153 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~ 229 (395)
+..++||||+.+|+|.+++.. ...+++..++.++.|++.||+|||++ +++||||||+|||++.+ +.+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG-------NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS-------SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCE
T ss_pred CceEEEEEcCCCCcHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceE
Confidence 888999999999999999853 24689999999999999999999999 99999999999999654 459
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhh
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 306 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~ 306 (395)
||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ....
T Consensus 282 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~ 356 (419)
T 3i6u_A 282 KITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ 356 (419)
T ss_dssp EECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHH
T ss_pred EEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHH
Confidence 999999998654322 2334679999999999863 5788899999999999999999999975432111 0000
Q ss_pred hhcccccchhhhhhccccccCCCCH----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 307 ALPRLTDREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~d~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
. ..... .... ..+..+.+|+.+||+.||++|||+.+++++
T Consensus 357 i-------------~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 I-------------TSGKY--NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp H-------------HTTCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H-------------hcCCC--CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 00000 0111 123568899999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=327.25 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=195.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc--cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|++.+.||+|+||+||+|... +|+.||+|++...... ..+.+.+|+.++++++||||+++++++.+. ..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999999999999975 5899999988654322 245678899999999999999999998876 5669999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 83 ~~~~~~l~~~~~~-------~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 83 YCDHTVLHELDRY-------QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL 152 (311)
T ss_dssp CCSEEHHHHHHHT-------SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eCCCchHHHHHhh-------hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence 9999999988743 24689999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc-------
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT------- 312 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------- 312 (395)
.... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||....................
T Consensus 153 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 153 TGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp C--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence 4322 12234568999999999876 6789999999999999999999999975432211111111000000
Q ss_pred -cchhhhhhccccccCCCC-----HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 -DREKILEIMDPALEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 -~~~~~~~~~d~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..........+......+ ...+..+.+|+.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000000000 1223468899999999999999999999975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=326.43 Aligned_cols=264 Identities=26% Similarity=0.384 Sum_probs=200.5
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhcc--CCCcceeEEEEEecC-----c
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL--RSPYLLALLGYCSDR-----R 154 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~-----~ 154 (395)
...++|++.+.||+|+||.||+|... ++.||+|++... ....+..|.+++..+ +||||+++++++.+. .
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34467999999999999999999984 899999998643 234455566666654 999999999988654 4
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCceeCCCCCCCEEeCCCCcE
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC-----SPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~dlk~~Nill~~~~~~ 229 (395)
.++||||+.+|+|.+++.. ..+++..++.++.|++.||.|||++. .++++||||||+|||++.++.+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS--------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred eEEEEeccCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 5799999999999999943 35899999999999999999999651 2379999999999999999999
Q ss_pred EEeccccccccCCCCCCc--eeeccccccccccchhhccCCCCcc------chhHHHHHHHHHHHhC----------CCC
Q 016117 230 KVSDFGLAKIGSDKAGGH--VSTRVLGTQGYVAPEYALTGHLTTK------SDVYSYGVVLLELLTG----------RVP 291 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~------~DvwslG~~l~ell~g----------~~p 291 (395)
||+|||++.......... ......||+.|+|||++.+..++.+ +|||||||++|||++| ..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999997544322211 1224578999999999988766665 9999999999999999 445
Q ss_pred CCCCCCCCCchhhhhhhcccccchhhhh-hccccccCCC-----CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 292 IDVNKPSGEGVLVSWALPRLTDREKILE-IMDPALEGQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 292 f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~d~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
|....+..... ..... .......... ..+.+..+.+++.+||+.||++|||+.+|+++|+++
T Consensus 262 ~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 262 YHDLVPSDPSY------------EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTTTSCSSCCH------------HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhhcCCCCch------------hhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 44322211110 00111 1111111112 226678899999999999999999999999999999
Q ss_pred hhhc
Q 016117 366 VKYN 369 (395)
Q Consensus 366 ~~~~ 369 (395)
.+..
T Consensus 330 ~~~~ 333 (337)
T 3mdy_A 330 SESQ 333 (337)
T ss_dssp HHTT
T ss_pred Hhhc
Confidence 8853
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=322.18 Aligned_cols=246 Identities=23% Similarity=0.311 Sum_probs=200.8
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
.++|++.+.||+|+||+||+|... ++..+|+|.+........+.+.+|+++++.++||||+++++++.+. ..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 346888999999999999999965 5779999999766556678899999999999999999999999877 46699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe---CCCCcEEEecccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAK 238 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~ 238 (395)
+.+++|.+++... ..+++..++.++.|++.||.|||++ +++||||||+||++ +.++.++|+|||++.
T Consensus 88 ~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 88 CTGGELFERVVHK-------RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp CCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred cCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 9999999988532 4589999999999999999999999 99999999999999 788999999999997
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||...... ....
T Consensus 158 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~~ 217 (277)
T 3f3z_A 158 RFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS----------------EVML 217 (277)
T ss_dssp ECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HHHH
T ss_pred eccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH----------------HHHH
Confidence 654322 22345689999999988754 899999999999999999999999753311 0011
Q ss_pred hhccccccCCCCH----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+..... ..+. ..+..+.+++.+||+.||++|||+.+++++
T Consensus 218 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 218 KIREGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHhCCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111100 1111 124578899999999999999999999964
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=348.27 Aligned_cols=248 Identities=25% Similarity=0.357 Sum_probs=192.1
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
.++|++.+.||+|+||.||+|... +|+.||+|++... .......+..|+.+++.++||||+++++++.+. ..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 356889999999999999999964 7899999998742 233345677899999999999999999998776 56699
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||++
T Consensus 227 ~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a 296 (446)
T 4ejn_A 227 MEYANGGELFFHLSR-------ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLC 296 (446)
T ss_dssp ECCCSSCBHHHHHHH-------HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred EeeCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCc
Confidence 999999999999853 2468999999999999999999998 7 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
....... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... . ..
T Consensus 297 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~-------------~~ 358 (446)
T 4ejn_A 297 KEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---K-------------LF 358 (446)
T ss_dssp CTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H-------------HH
T ss_pred eeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---H-------------HH
Confidence 7533221 2234567999999999999999999999999999999999999999654311 0 01
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
..+..... .++...+..+.+|+.+||+.||.+|| |+.+++++
T Consensus 359 ~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 359 ELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp HHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHHHhCCC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11111111 12222345688999999999999999 99999964
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=328.50 Aligned_cols=259 Identities=23% Similarity=0.317 Sum_probs=198.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc--CCc--EEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS--NGR--KVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~l 157 (395)
++|++.+.||+|+||+||+|.+. +++ .||+|++... .....+.+.+|+++++.++||||+++++++.+...++
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 97 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCcee
Confidence 46888899999999999999853 333 6899988643 2334567889999999999999999999999888899
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
++||+.+++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eEecccCCCHHHHHHhcc------CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccc
Confidence 999999999999995432 4589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCc-eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 238 KIGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 238 ~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||...... .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~------------- 232 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---Q------------- 232 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---H-------------
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---H-------------
Confidence 8654433211 1223457788999999998889999999999999999999 99999654311 0
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
....+.........+...+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 233 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 11111111111112223446789999999999999999999999999988764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=331.26 Aligned_cols=271 Identities=23% Similarity=0.319 Sum_probs=210.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-----cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-----SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~ 156 (395)
++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+++++.++||||+++++++... ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4588889999999999999984 36889999999876555667899999999999999999999988654 467
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+|+||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+
T Consensus 121 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp EEECCCTTCBHHHHHHHST------TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred EEEECCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 9999999999999996432 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCc-eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc--
Q 016117 237 AKIGSDKAGGH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD-- 313 (395)
Q Consensus 237 ~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 313 (395)
+.......... ......++..|+|||.+.+..++.++||||||+++|||++|..||..... ............
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQM 267 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhh
Confidence 98654432211 11234567789999999988899999999999999999999998753210 000000000000
Q ss_pred -chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 314 -REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 314 -~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
...+.+.+........+...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0011111111111122334456799999999999999999999999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=335.04 Aligned_cols=245 Identities=30% Similarity=0.395 Sum_probs=195.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcc---cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
+.|+..+.||+|+||+||+|.. .+|+.||+|++...... ..+.+.+|+++++.++||||+++++++.+. ..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3488889999999999999996 57899999998754322 235688999999999999999999998766 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+. |+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 134 e~~~-g~l~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp ECCS-EEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred ecCC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 9997 68888874322 4689999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCceeeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
.... ....||+.|+|||++. ...++.++|||||||++|||++|..||...... . .
T Consensus 204 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~----------~ 261 (348)
T 1u5q_A 204 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------S----------A 261 (348)
T ss_dssp SSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------H----------H
T ss_pred cCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------H----------H
Confidence 4322 2356899999999985 567899999999999999999999999643211 0 0
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+.............+..+.+|+.+||+.||++|||+.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 262 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 001110000001111234568899999999999999999999865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=330.18 Aligned_cols=275 Identities=22% Similarity=0.353 Sum_probs=199.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHH--HhccCCCcceeEEEEEec-----C-ce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVEL--LGRLRSPYLLALLGYCSD-----R-RK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~-----~-~~ 155 (395)
.++|++.+.||+|+||+||+|+. +++.||+|++... ....+..|.++ +..++||||+++++++.. . ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 35788899999999999999987 7899999998643 23445555555 445899999999975432 1 34
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCceeCCCCCCCEEeCCCCcE
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC------SPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~dlk~~Nill~~~~~~ 229 (395)
++||||+++|+|.+++.. ...++..++.++.|++.||.|||+.. .++++||||||+|||++.++.+
T Consensus 88 ~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL--------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred EEEEecCCCCcHHHHHhh--------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 699999999999999943 24588999999999999999999762 2289999999999999999999
Q ss_pred EEeccccccccCCCCC------Cceeeccccccccccchhhcc-------CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 016117 230 KVSDFGLAKIGSDKAG------GHVSTRVLGTQGYVAPEYALT-------GHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~g~~pf~~~~ 296 (395)
||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999976543211 112234569999999999986 356678999999999999999987775433
Q ss_pred CCCCchhh-hhhhcccccchhhhhhc-----cccccC--CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 297 PSGEGVLV-SWALPRLTDREKILEIM-----DPALEG--QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 297 ~~~~~~~~-~~~~~~~~~~~~~~~~~-----d~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
........ ................. .+.+.. ......+..+.+|+.+||+.||++|||+.++++.|++++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 22211100 00000000000111111 111111 11234566899999999999999999999999999999986
Q ss_pred cC
Q 016117 369 NR 370 (395)
Q Consensus 369 ~~ 370 (395)
..
T Consensus 320 ~~ 321 (336)
T 3g2f_A 320 WE 321 (336)
T ss_dssp CC
T ss_pred HH
Confidence 44
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=321.61 Aligned_cols=252 Identities=28% Similarity=0.413 Sum_probs=200.4
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
.++|++.+.||+|+||+||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+. ..+++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 356888999999999999999965 57799999985421 22346788999999999999999999999877 46699
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 88 ~e~~~~~~l~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~ 157 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV 157 (279)
T ss_dssp ECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred EecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccc
Confidence 9999999999998532 4689999999999999999999998 99999999999999999999999999886
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
..... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ...
T Consensus 158 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~ 217 (279)
T 3fdn_A 158 HAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----------------TYK 217 (279)
T ss_dssp CC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHH
T ss_pred cCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH----------------HHH
Confidence 43322 1234568999999999999999999999999999999999999997432110 000
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.+... ....+...+..+.+|+.+||+.||.+|||+.+++++ .++...
T Consensus 218 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h--~~~~~~ 264 (279)
T 3fdn_A 218 RISRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH--PWITAN 264 (279)
T ss_dssp HHHHT--CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC--HHHHHH
T ss_pred HHHhC--CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC--ccccCC
Confidence 00000 011122234568899999999999999999999986 555543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=327.70 Aligned_cols=246 Identities=22% Similarity=0.332 Sum_probs=200.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK------QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~ 156 (395)
++|.+.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45888999999999999999975 689999999865322 1356789999999999999999999998877 567
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC----cEEEe
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF----HAKVS 232 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~ 232 (395)
+||||+.+++|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+||+++.++ .+||+
T Consensus 92 lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ-------KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEECCCCSCBHHHHHHT-------CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEcCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEc
Confidence 99999999999999953 24689999999999999999999999 999999999999999887 79999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .
T Consensus 162 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~---------- 225 (321)
T 2a2a_A 162 DFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---E---------- 225 (321)
T ss_dssp CCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---H----------
T ss_pred cCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---H----------
Confidence 999998654322 223456899999999999999999999999999999999999999643211 0
Q ss_pred cchhhhhhccccccCCCCH----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 DREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....+..... ..+. ..+..+.+|+.+||+.||++|||+.+++++
T Consensus 226 ---~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 226 ---TLANITSVSY--DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---HHHHHHTTCC--CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---HHHHHHhccc--ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0001100000 1111 123468899999999999999999999964
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=343.16 Aligned_cols=259 Identities=22% Similarity=0.269 Sum_probs=203.2
Q ss_pred cHHHHHHHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEe
Q 016117 76 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCS 151 (395)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 151 (395)
.+++.....++|++.+.||+|+||+||+++.. +|+.||+|++.... ....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455556678999999999999999999975 79999999986421 122345788999999999999999999998
Q ss_pred cC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEE
Q 016117 152 DR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 230 (395)
Q Consensus 152 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k 230 (395)
+. ..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG------ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEE
Confidence 77 4669999999999999995432 3689999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCceeeccccccccccchhhc-------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchh
Q 016117 231 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-------TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVL 303 (395)
Q Consensus 231 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~ 303 (395)
|+|||++....... .......+||+.|+|||++. ...++.++|||||||++|||++|+.||...+...
T Consensus 203 L~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---- 277 (412)
T 2vd5_A 203 LADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---- 277 (412)
T ss_dssp ECCCTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----
T ss_pred EeechhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH----
Confidence 99999998654322 11223467999999999987 3568999999999999999999999997543210
Q ss_pred hhhhhcccccchhhhhhcccc--cc-CCCCHHHHHHHHHHHhhcCCCCCCCC---CCHHHHHHH
Q 016117 304 VSWALPRLTDREKILEIMDPA--LE-GQYSMKEVIQVAAIAAMCVQPEADYR---PLMADVVQS 361 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~d~~--~~-~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~~vl~~ 361 (395)
....++... +. .......+.++.+|+.+||+ +|.+| |++++++++
T Consensus 278 ------------~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 278 ------------TYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp ------------HHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred ------------HHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 011111100 00 00112234578899999999 99998 589999865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=324.21 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=202.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEec-----------
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD----------- 152 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----------- 152 (395)
++|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|+++++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 46888999999999999999975 79999999987543 356789999999999999999998753
Q ss_pred ------CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC
Q 016117 153 ------RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN 226 (395)
Q Consensus 153 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~ 226 (395)
...+++|||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR-----GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 13579999999999999996432 24689999999999999999999999 99999999999999999
Q ss_pred CcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhh
Q 016117 227 FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 306 (395)
Q Consensus 227 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~ 306 (395)
+.+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..|+....
T Consensus 159 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------- 225 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------- 225 (284)
T ss_dssp TEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH----------
T ss_pred CCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH----------
Confidence 999999999998654432 1234568999999999999999999999999999999999998863110
Q ss_pred hhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 307 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.....+.+..+... .+..+.+++.+||+.||.+|||+.+++++|+.+.+..
T Consensus 226 --------~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 226 --------KFFTDLRDGIISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp --------HHHHHHHTTCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred --------HHHHHhhccccccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 00111111112222 2345789999999999999999999999999988753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=333.63 Aligned_cols=265 Identities=19% Similarity=0.229 Sum_probs=194.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc----CCcEEEEEEeccCCcc-----------cHHHHHHHHHHHhccCCCcceeEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAGKQ-----------GEDEFKMEVELLGRLRSPYLLALLGY 149 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~~ 149 (395)
++|.+.+.||+|+||+||+|... ++..+|+|++...... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56888999999999999999975 5788999998754321 11345678888999999999999998
Q ss_pred Eec----C-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC
Q 016117 150 CSD----R-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224 (395)
Q Consensus 150 ~~~----~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 224 (395)
+.+ . ..++||||+ +++|.+++... ..+++..++.++.|++.||.|||++ +++||||||+|||++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN-------GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG-------GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence 865 3 467999999 99999999532 3799999999999999999999999 999999999999998
Q ss_pred CCC--cEEEeccccccccCCCCC-----CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Q 016117 225 KNF--HAKVSDFGLAKIGSDKAG-----GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKP 297 (395)
Q Consensus 225 ~~~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~ 297 (395)
.++ .+||+|||++........ ........||+.|+|||++.+..++.++||||||+++|||++|..||.....
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 877 999999999976532211 1112345789999999999999999999999999999999999999963221
Q ss_pred CCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 298 SGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
... ......... .......+..... ....+..+.+++.+||+.||++|||+.+|++.|+++.-
T Consensus 266 ~~~--~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 266 DPV--AVQTAKTNL--LDELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp CHH--HHHHHHHHH--HHTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred ccH--HHHHHHHhh--cccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 110 000000000 0000000000000 00233468999999999999999999999999988654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=321.22 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=180.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ..++++
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 5688899999999999999996 478999999986431 22346788999999999999999999999877 456999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 161 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV------KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQ 161 (278)
T ss_dssp ECCTTEEHHHHHHTCS------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence 9999999999995432 4689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
...... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... ..
T Consensus 162 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------------~~ 223 (278)
T 3cok_A 162 LKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL----------------NK 223 (278)
T ss_dssp CC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------
T ss_pred ccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------------HH
Confidence 543221 123356899999999999889999999999999999999999999754322110 00
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+..... ..+...+..+.+++.+||+.||++|||+.+++++
T Consensus 224 ~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 224 VVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Hhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 000000 1112234568899999999999999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=321.12 Aligned_cols=251 Identities=20% Similarity=0.309 Sum_probs=200.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
.++|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467899999999999999999965 68999999986532 23346788899999999999999999999877 456999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc---EEEecccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH---AKVSDFGL 236 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~ 236 (395)
||+.+++|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++. +||+|||+
T Consensus 85 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp CCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred ecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 999999999988532 4689999999999999999999999 9999999999999976655 99999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
+....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ......
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~~~~--------- 219 (284)
T 3kk8_A 155 AIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQI--------- 219 (284)
T ss_dssp CEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---------
T ss_pred eEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHHHHH---------
Confidence 97654322 223456899999999999999999999999999999999999999653311 000000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...... .........+..+.+++.+||+.||++|||+.+++++
T Consensus 220 ~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 220 KAGAYD--YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHTCCC--CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred Hhcccc--CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 0001111234568899999999999999999999975
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=329.90 Aligned_cols=252 Identities=20% Similarity=0.292 Sum_probs=178.7
Q ss_pred CCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCcceeEEEEEecC-ceEEEEEcccCCC
Q 016117 90 SNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLVYDYMANGG 166 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~~~~g~ 166 (395)
.+.||+|+||+||++... +++.||+|++... ....+.+|+.+++.+. ||||+++++++.+. ..++||||+.+|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999975 6899999998643 3457788999999996 99999999999877 5679999999999
Q ss_pred hhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC---cEEEeccccccccCCC
Q 016117 167 LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF---HAKVSDFGLAKIGSDK 243 (395)
Q Consensus 167 L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~---~~kl~Dfg~~~~~~~~ 243 (395)
|.+++... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++ .+||+|||++......
T Consensus 93 L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 93 LFERIKKK-------KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 99999542 4699999999999999999999999 999999999999997655 8999999999864432
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
. .......||+.|+|||++.+..++.++||||||+++|+|++|..||............. .....+...
T Consensus 163 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---------~~~~~i~~~ 231 (325)
T 3kn6_A 163 N--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV---------EIMKKIKKG 231 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH---------HHHHHHTTT
T ss_pred C--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH---------HHHHHHHcC
Confidence 2 22334568999999999999999999999999999999999999997544321111000 011111111
Q ss_pred cccCCC--CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 324 ALEGQY--SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 324 ~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
...... ....+..+.+|+.+||+.||++|||+.+++++ .++.
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h--~w~~ 275 (325)
T 3kn6_A 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN--EWLQ 275 (325)
T ss_dssp CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC--GGGC
T ss_pred CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC--hhhc
Confidence 111000 01234578999999999999999999999864 4444
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=332.15 Aligned_cols=258 Identities=16% Similarity=0.171 Sum_probs=206.9
Q ss_pred HhCCCCCCCeeeccCCeEEEEEE------EcCCcEEEEEEeccCCcccHHHHHHHHHHHhccC---CCcceeEEEEEecC
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGV------LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR---SPYLLALLGYCSDR 153 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 153 (395)
..++|.+.+.||+|+||+||+|. ..+++.||+|++... ...++..|.++++.++ |+|++.+++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34678889999999999999994 447889999999754 3456777888888876 89999999988765
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-------
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK------- 225 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~------- 225 (395)
..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNT--PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTS--TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 678999999999999999643211 235699999999999999999999998 9999999999999998
Q ss_pred ----CCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 016117 226 ----NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 301 (395)
Q Consensus 226 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~ 301 (395)
++.+||+|||++...............+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--- 291 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--- 291 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC---
Confidence 8999999999997654333334455678999999999999999999999999999999999999998533211
Q ss_pred hhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCC-CCHHHHHHHHHHhhhhcC
Q 016117 302 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYR-PLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~~vl~~L~~~~~~~~ 370 (395)
... +...+... .....+.+++..|++.+|.+| |++.++.+.|++++....
T Consensus 292 ------------~~~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 292 ------------ECK----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp ------------EEE----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ------------cee----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 000 11111111 124457789999999999998 688999999999988643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=336.24 Aligned_cols=266 Identities=22% Similarity=0.305 Sum_probs=189.5
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccC-CCcceeEEEEEecC---ce
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR---RK 155 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~---~~ 155 (395)
..++|++.+.||+|+||+||+|... +|+.||+|++... .......+.+|+.+++.+. ||||+++++++... ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999964 7899999998643 2334456778999999997 99999999998643 46
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++||||+. |+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 87 ~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--------NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEecccC-cCHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 89999997 689988842 3689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC-------------------CCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 016117 236 LAKIGSDKA-------------------GGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVN 295 (395)
Q Consensus 236 ~~~~~~~~~-------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~ 295 (395)
+++...... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 997643211 1112334679999999999986 67899999999999999999999999754
Q ss_pred CCCCCchhhhhhhcccccchhhhh------------hc------cccccCC------------CCHHHHHHHHHHHhhcC
Q 016117 296 KPSGEGVLVSWALPRLTDREKILE------------IM------DPALEGQ------------YSMKEVIQVAAIAAMCV 345 (395)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~------d~~~~~~------------~~~~~~~~l~~li~~cl 345 (395)
+.......+...... .....+.. +. ....... .....+.++.+|+.+||
T Consensus 235 ~~~~~~~~i~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 235 STMNQLERIIGVIDF-PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp SHHHHHHHHHHHHCC-CCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred CHHHHHHHHHHhcCC-CCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 321111000000000 00000000 00 0000000 00012346889999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 016117 346 QPEADYRPLMADVVQS 361 (395)
Q Consensus 346 ~~~p~~RPt~~~vl~~ 361 (395)
+.||++|||+.|++++
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999976
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=336.44 Aligned_cols=243 Identities=26% Similarity=0.346 Sum_probs=188.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHH-HhccCCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVEL-LGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
++|.+.+.||+|+||+||+++.. +++.||+|++.... ......+..|..+ ++.++||||+++++++.+. ..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 56889999999999999999975 68899999997542 2223455667666 5678999999999998876 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+.+|+|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 118 ~E~~~gg~L~~~l~~-------~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 118 LDYINGGELFYHLQR-------ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp EECCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred EeCCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 999999999999953 24689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+.. ....
T Consensus 188 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----------------~~~~ 249 (373)
T 2r5t_A 188 ENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----------------EMYD 249 (373)
T ss_dssp GGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH----------------HHHH
T ss_pred ccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----------------HHHH
Confidence 533222 2234567999999999999999999999999999999999999999743211 1111
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMAD 357 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~ 357 (395)
.++...+ .++...+..+.+|+.+||+.||.+||++.+
T Consensus 250 ~i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 250 NILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred HHHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1111111 112223456889999999999999999853
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=334.80 Aligned_cols=250 Identities=22% Similarity=0.287 Sum_probs=188.9
Q ss_pred CCCCCC-CeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhc-cCCCcceeEEEEEec----C-ceE
Q 016117 85 GGFSKS-NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGR-LRSPYLLALLGYCSD----R-RKL 156 (395)
Q Consensus 85 ~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~-~~~ 156 (395)
++|.+. +.||+|+||+||++... +|+.||+|++... ..+.+|++++.+ .+||||+++++++.. . ..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 356555 68999999999999965 6899999998632 356778888754 589999999998764 2 467
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC---CCcEEEec
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSD 233 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~D 233 (395)
+||||+.+|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+|
T Consensus 136 lv~E~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEECCCSEEHHHHHHCC--------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 9999999999999996432 24699999999999999999999999 9999999999999987 78999999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCch-hhhhhhcccc
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV-LVSWALPRLT 312 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~ 312 (395)
||++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......... ......
T Consensus 208 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---- 280 (400)
T 1nxk_A 208 FGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---- 280 (400)
T ss_dssp CTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----
T ss_pred cccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----
Confidence 99998644321 2335678999999999999999999999999999999999999997654322110 000000
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+ .+........+.++.+|+.+||+.||++|||+.+++++
T Consensus 281 -----~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 281 -----MGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -----HTCC--CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----cCcc--cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 00000011234568899999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=328.67 Aligned_cols=247 Identities=21% Similarity=0.337 Sum_probs=200.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+. ..+++|
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 56888899999999999999975 57899999986432 23446788899999999999999999999877 466999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+++|.+++... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..
T Consensus 121 e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 121 ELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp CCCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 999999999988532 4689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ....
T Consensus 191 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----------------~~~~ 252 (335)
T 2owb_A 191 VEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----------------TYLR 252 (335)
T ss_dssp CCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHH
T ss_pred cccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH----------------HHHH
Confidence 54322 12234568999999999999999999999999999999999999996432110 0000
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+..... ..+......+.+|+.+||+.||++|||+.+++++
T Consensus 253 ~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 253 IKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HhcCCC--CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 1112233468899999999999999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=342.88 Aligned_cols=245 Identities=17% Similarity=0.205 Sum_probs=189.3
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC---CcccHHHHHHHHH---HHhccCCCcceeEE-------EE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVE---LLGRLRSPYLLALL-------GY 149 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~---~l~~l~h~niv~l~-------~~ 149 (395)
.++|.+.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35688889999999999999995 57999999998732 2334577889994 55556899999998 66
Q ss_pred EecC------------------ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 016117 150 CSDR------------------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPV 211 (395)
Q Consensus 150 ~~~~------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 211 (395)
+.+. ..+++|||+ +|+|.+++............+++..++.++.|++.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 5544 267999999 6899999964321111123455688899999999999999999 99
Q ss_pred eeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccC-----------CCCccchhHHHHH
Q 016117 212 IHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-----------HLTTKSDVYSYGV 280 (395)
Q Consensus 212 ~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DvwslG~ 280 (395)
+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985322 2344567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 281 VLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 281 ~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
++|||++|+.||......... ..+.... ... +..+.+|+.+||+.||++|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~----------------~~~~~~~--~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGS----------------EWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCS----------------GGGGSSC--CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccch----------------hhhhhhc--cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999754322111 0111100 122 346889999999999999999999996
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=328.69 Aligned_cols=262 Identities=20% Similarity=0.329 Sum_probs=202.8
Q ss_pred ecHHHHHHHhCCCCCC-CeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhcc-CCCcceeEEEE
Q 016117 75 FTFKQLHSATGGFSKS-NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRL-RSPYLLALLGY 149 (395)
Q Consensus 75 ~~~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 149 (395)
..++..+...+.|.+. +.||+|+||+||+|... +++.||+|++... .......+.+|+.+++.+ .||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344445556678877 88999999999999965 6899999998743 233456888999999999 56999999999
Q ss_pred EecC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC---
Q 016117 150 CSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK--- 225 (395)
Q Consensus 150 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--- 225 (395)
+.+. ..++||||+.+|+|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+|||++.
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~ 169 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPEL-----AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYP 169 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTT
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCC
Confidence 9877 5669999999999999985332 35699999999999999999999999 9999999999999987
Q ss_pred CCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhh
Q 016117 226 NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS 305 (395)
Q Consensus 226 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~ 305 (395)
++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ..
T Consensus 170 ~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~ 243 (327)
T 3lm5_A 170 LGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---YL 243 (327)
T ss_dssp BCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH
T ss_pred CCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HH
Confidence 7899999999998654322 12345689999999999999999999999999999999999999965331100 00
Q ss_pred hhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 306 WALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+... ............+..+.+++.+||+.||++|||+.+++++
T Consensus 244 ----------~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 244 ----------NISQV-NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ----------HHHHT-CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ----------HHHhc-ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00000 0011111112234568899999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=327.20 Aligned_cols=264 Identities=22% Similarity=0.288 Sum_probs=196.4
Q ss_pred CCCCCC-CeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKS-NVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e 160 (395)
+.|.+. +.||+|+||+||+|.. .+++.||+|++........+.+.+|++++.++ +||||+++++++.+. ..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 457774 7899999999999995 47899999999766556677889999999985 799999999998776 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc---EEEeccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH---AKVSDFGLA 237 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl~Dfg~~ 237 (395)
|+++|+|.+++... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++. +||+|||++
T Consensus 92 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-------RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp CCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred cCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 99999999999542 4689999999999999999999999 9999999999999988776 999999998
Q ss_pred cccCCCCC-----Cceeeccccccccccchhhcc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh
Q 016117 238 KIGSDKAG-----GHVSTRVLGTQGYVAPEYALT-----GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA 307 (395)
Q Consensus 238 ~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~ 307 (395)
........ ........||+.|+|||++.+ ..++.++|||||||++|||++|..||...............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 75432111 111223568999999999875 56889999999999999999999999765443211110000
Q ss_pred hcccccchhhhhhccccccCCCCH----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 308 LPRLTDREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 308 ~~~~~~~~~~~~~~d~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.... .......+..... ..+. ..+..+.+|+.+||+.||++|||+.+++++
T Consensus 242 ~~~~-~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 242 CPAC-QNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CHHH-HHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhH-HHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000 0000111111111 1111 123578899999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=346.97 Aligned_cols=253 Identities=26% Similarity=0.381 Sum_probs=204.4
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
.++|.+.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++.+. ..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888999999999999999975 7999999998642 233456788999999999999999999998876 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 263 mEy~~gg~L~~~l~~~~-----~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~ 334 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-----QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV 334 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEcCCCCcHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccce
Confidence 99999999999986432 23589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||........... +.
T Consensus 335 ~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~-------------i~ 398 (576)
T 2acx_A 335 HVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-------------VE 398 (576)
T ss_dssp ECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH-------------HH
T ss_pred ecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH-------------HH
Confidence 654322 23345799999999999998999999999999999999999999976443211111 11
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
..+.. ....++...+.++.+|+.+||+.||.+|| ++.||+++
T Consensus 399 ~~i~~-~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 399 RLVKE-VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred HHhhc-ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11100 01122223345789999999999999999 78888865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=325.03 Aligned_cols=261 Identities=23% Similarity=0.294 Sum_probs=197.3
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc---cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
..++|.+.+.||+|+||.||++... +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999965 7889999998754222 236788999999999999999999998766 5679
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
++||+++++|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++
T Consensus 112 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~ 181 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-------GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIA 181 (309)
T ss_dssp EEECCCCEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred EEEecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccC
Confidence 99999999999999532 3689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
........ .......|++.|+|||.+.+..++.++||||||+++|+|++|..||...... .... .+
T Consensus 182 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~---------~~ 247 (309)
T 2h34_A 182 SATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMGA---------HI 247 (309)
T ss_dssp ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHHH---------HH
T ss_pred cccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHHH---------Hh
Confidence 76443221 1223456899999999999999999999999999999999999999743211 0000 00
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHHHhhhhc
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-LMADVVQSLVPLVKYN 369 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~~vl~~L~~~~~~~ 369 (395)
...... ........+..+.+++.+||+.||++|| |++++++.|++++...
T Consensus 248 ~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 248 NQAIPR--PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp HSCCCC--GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred ccCCCC--ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 000000 0011222334688999999999999999 9999999999988853
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=323.34 Aligned_cols=248 Identities=28% Similarity=0.484 Sum_probs=201.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
+.|.+.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 45888899999999999999964 68999999987543 34457889999999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 102 ~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 102 LGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp CTTEEHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred CCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecC
Confidence 999999999842 4689999999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
... .......|++.|+|||++.+..++.++||||||+++|+|++|..||...... .... .+....
T Consensus 171 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----------~~~~~~ 235 (303)
T 3a7i_A 171 DTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVLF----------LIPKNN 235 (303)
T ss_dssp TTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH----------HHHHSC
T ss_pred ccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHHH----------HhhcCC
Confidence 322 1223456899999999999999999999999999999999999999643211 0000 000001
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
.+.+.. ..+..+.+++.+||+.||++|||+.+++++.
T Consensus 236 ~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 236 PPTLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CCCCCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CCCCcc----ccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 111112 2334688999999999999999999999753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=330.60 Aligned_cols=241 Identities=21% Similarity=0.336 Sum_probs=197.2
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCc--------ccHHHHHHHHHHHhccCCCcceeEEEEEecCc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK--------QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 154 (395)
.++|.+.+.||+|+||+||+|.. .+++.||+|++..... ...+.+..|+.+++.++||||+++++++.+..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 45799999999999999999995 4789999999875421 12235677999999999999999999998774
Q ss_pred -eEEEEEcccCC-ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 155 -KLLVYDYMANG-GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 155 -~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
.++||||+..| +|.+++... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH-------PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEe
Confidence 56999999777 999998532 3699999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
|||++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 173 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------- 235 (335)
T 3dls_A 173 DFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------- 235 (335)
T ss_dssp CCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------
T ss_pred ecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------
Confidence 999998654332 2234568999999999988776 7899999999999999999999963210
Q ss_pred ccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....... .+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 236 ----~~~~~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ----TVEAAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----GTTTCCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----HHhhccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 011123468899999999999999999999985
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=324.35 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=200.6
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEec---CceEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSD---RRKLL 157 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---~~~~l 157 (395)
.++|++.+.||+|+||+||++... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 457888999999999999999975 78999999987532 2334678899999999999999999998743 35679
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceeCCCCCCCEEeCCCCcEEEe
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP-----VIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~dlk~~Nill~~~~~~kl~ 232 (395)
||||+++++|.+++..... ....+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.+||+
T Consensus 85 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~ 158 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK---ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLG 158 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEEC
T ss_pred EEeCCCCCCHHHHHHhhcc---cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence 9999999999999964321 123589999999999999999999998 7 9999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ...
T Consensus 159 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~-------- 225 (279)
T 2w5a_A 159 DFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA-------- 225 (279)
T ss_dssp CCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH--------
T ss_pred cCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHH--------
Confidence 999997644321 1123356899999999999999999999999999999999999999754210 000
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHH
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVP 364 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~ 364 (395)
..+..... ...+...+..+.+++.+||+.||++|||+.++++++..
T Consensus 226 -----~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 226 -----GKIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -----HHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----HHHhhccc-ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 01111000 11222334578999999999999999999999976543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=322.96 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=194.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|.+.+.||+|+||+||++... ++..+|+|++.... ....+.+.+|+++++.++||||+++++++.+. ..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45888899999999999999964 68899999987543 33457889999999999999999999999876 56699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe---CCCCcEEEecccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAK 238 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~ 238 (395)
+.+|+|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+||++ +.++.+||+|||++.
T Consensus 102 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 102 CEGGELLERIVSAQA---RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CSCCBHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred CCCCcHHHHHHhhhh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999854321 124689999999999999999999999 99999999999999 456889999999997
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... ......|++.|+|||++. ..++.++||||||+++|+|++|..||....... .....
T Consensus 176 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~~~~~----------- 237 (285)
T 3is5_A 176 LFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---VQQKA----------- 237 (285)
T ss_dssp C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH-----------
T ss_pred ecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---HHhhh-----------
Confidence 544322 233456899999999876 568999999999999999999999997543110 00000
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....+..... ....+..+.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 238 TYKEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp HHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccCCcccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 00123468899999999999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=329.41 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=196.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.++|++.+.||+|+||.||++... +|+.||+|++...... ..+|++++.++ +||||+++++++.+. ..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 356899999999999999999975 6899999999754332 34688888887 799999999999877 4569999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC----CcEEEecccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN----FHAKVSDFGL 236 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~ 236 (395)
|+.+|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||+.++ +.+||+|||+
T Consensus 97 ~~~gg~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 97 LMKGGELLDKILRQ-------KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp CCCSCBHHHHHHTC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred CCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 99999999999532 4689999999999999999999999 99999999999998443 3599999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
+....... ......+||+.|+|||++.+..++.++|||||||++|||++|..||................
T Consensus 167 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~-------- 236 (342)
T 2qr7_A 167 AKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG-------- 236 (342)
T ss_dssp CEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH--------
T ss_pred cccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc--------
Confidence 98654332 12334678999999999988889999999999999999999999997532211111111000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. ...+........+..+.+|+.+||+.||++|||+.+++++
T Consensus 237 -~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 237 -SG--KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp -HC--CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -cC--CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0011111122334578899999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=326.39 Aligned_cols=270 Identities=21% Similarity=0.305 Sum_probs=193.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCccc-HHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|.+.+.||+|+||+||+|... +++.||+|++....... ...+.+|+.+++.++||||+++++++.+. ..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888999999999999999975 78999999986432211 12345699999999999999999998776 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+. |+|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 82 ~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG------NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CS-EEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred cc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 97 58988886432 4689999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhc--------ccc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP--------RLT 312 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~--------~~~ 312 (395)
... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+..... ...
T Consensus 152 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 152 IPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred CCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence 222 12234568999999999876 5789999999999999999999999975432111100000000 000
Q ss_pred cchhhhhhccccccCC----CCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 313 DREKILEIMDPALEGQ----YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
........-.+..... .....+..+.+|+.+||+.||++|||+.|++++ .++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~ 287 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH--PFFLS 287 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS--GGGGG
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC--hhhhh
Confidence 0000000000000000 001123568899999999999999999999974 44443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=317.08 Aligned_cols=251 Identities=23% Similarity=0.313 Sum_probs=199.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC----cccHHHHHHHHHHHhccCCCcceeEEEEEec--C-ce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG----KQGEDEFKMEVELLGRLRSPYLLALLGYCSD--R-RK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~-~~ 155 (395)
.++|.+.+.||+|+||.||++... +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+ . ..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999964 68899999987432 2345678999999999999999999998843 2 56
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++||||+.++ |.+++.... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg 154 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP-----EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALG 154 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST-----TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEehhccCC-HHHHHHhCc-----ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccc
Confidence 7999999877 777765432 24689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGH--LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
++................|++.|+|||++.+.. ++.++||||||+++|+|++|..||...... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----------- 220 (305)
T 2wtk_C 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---K----------- 220 (305)
T ss_dssp TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---H-----------
T ss_pred cccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---H-----------
Confidence 998755433333344566899999999988654 377999999999999999999999753210 0
Q ss_pred chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....+..... ..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 221 --~~~~i~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 221 --LFENIGKGSY--AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --HHHHHHHCCC--CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --HHHHHhcCCC--CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000100000 1122234568899999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=319.97 Aligned_cols=245 Identities=24% Similarity=0.412 Sum_probs=192.8
Q ss_pred CCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEec----C-ceEEE
Q 016117 87 FSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD----R-RKLLV 158 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~-~~~lv 158 (395)
|.+.+.||+|+||+||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.. . ..++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 566778999999999999964 6889999998643 23345678899999999999999999998754 2 35799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceeCCCCCCCEEeC-CCCcEEEeccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP--VIHRDFKSSNILLD-KNFHAKVSDFG 235 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~dlk~~Nill~-~~~~~kl~Dfg 235 (395)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+. + ++|+||||+|||++ .++.+||+|||
T Consensus 108 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEecCCCCHHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 9999999999999532 4689999999999999999999998 7 99999999999997 78999999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
++...... ......|++.|+|||++. ..++.++||||||+++|+|++|..||...... .....
T Consensus 178 ~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~---------- 240 (290)
T 1t4h_A 178 LATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYR---------- 240 (290)
T ss_dssp GGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHH----------
T ss_pred Cccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH--HHHHH----------
Confidence 99754332 223456899999999876 45899999999999999999999999643211 00000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+.........+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 241 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 241 ---RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0000000000111112468899999999999999999999964
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=333.47 Aligned_cols=266 Identities=18% Similarity=0.247 Sum_probs=203.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcC---------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCccee----------
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSN---------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA---------- 145 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------- 145 (395)
++|.+.+.||+|+||+||+|.... ++.||+|++... +.+.+|++++++++|||+++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578889999999999999999753 789999998753 35788999999999999987
Q ss_pred -----EEEEEec--CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 016117 146 -----LLGYCSD--RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKS 218 (395)
Q Consensus 146 -----l~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~ 218 (395)
+++++.. ...++||||+ +++|.+++.... ...+++..++.++.|++.||.|||++ +++||||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp 187 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-----KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA 187 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence 5666654 4567999999 999999996431 24699999999999999999999999 999999999
Q ss_pred CCEEeCCCC--cEEEeccccccccCCCCCC-----ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCC
Q 016117 219 SNILLDKNF--HAKVSDFGLAKIGSDKAGG-----HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291 (395)
Q Consensus 219 ~Nill~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p 291 (395)
+|||++.++ .+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|||++|..|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 9999999999754322111 112335789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 292 IDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 292 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
|........ ....... .. ......+.+.... ....+..+.+|+.+||+.||++|||+.++++.|+++++....
T Consensus 268 f~~~~~~~~-~~~~~~~-~~--~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 268 WTNCLPNTE-DIMKQKQ-KF--VDKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp TGGGTTCHH-HHHHHHH-HH--HHSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cccCCcCHH-HHHHHHH-hc--cCChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 975432110 0000000 00 0000001111000 011235689999999999999999999999999999987553
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=342.51 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=203.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||+||+++.. +|+.||+|++.... ....+.+..|+.+++.++||||+++++++.+. ..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999975 69999999986431 23456788899999999999999999998876 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 265 E~~~gg~L~~~l~~~~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDE---DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp CCCTTCBHHHHHHTSST---TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EeccCCCHHHHHHHhhc---ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 99999999999865431 234699999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||........... ....
T Consensus 339 ~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~------------~~~~ 404 (543)
T 3c4z_A 339 LKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE------------LKQR 404 (543)
T ss_dssp CCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH------------HHHH
T ss_pred ccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH------------HHHH
Confidence 54332 122345799999999999999999999999999999999999999976532211110 0111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH-----HHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM-----ADVVQ 360 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~~vl~ 360 (395)
+..... .++...+..+.+|+.+||+.||++||++ .+|++
T Consensus 405 i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 405 VLEQAV--TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHCCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred Hhhccc--CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 111111 2223345678899999999999999975 56664
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=319.70 Aligned_cols=256 Identities=24% Similarity=0.370 Sum_probs=197.8
Q ss_pred CCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
+|....+||+|+||+||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.+. ..++++||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 355556899999999999996 46889999999866555567899999999999999999999998776 5669999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-CCcEEEeccccccccCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl~Dfg~~~~~~~ 242 (395)
+++|.+++..... ...+++..+..++.|++.||.|||++ +++|+||||+||+++. ++.+||+|||++.....
T Consensus 103 ~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 103 GGSLSALLRSKWG----PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEHHHHHHHTTC----CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCHHHHHHhhcc----CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999965431 23567899999999999999999999 9999999999999987 89999999999976543
Q ss_pred CCCCceeeccccccccccchhhccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGH--LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.. .......|++.|+|||++.+.. ++.++||||||+++|+|++|..||....... .. ....
T Consensus 176 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~-----------~~~~ 238 (295)
T 2clq_A 176 IN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AA-----------MFKV 238 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HH-----------HHHH
T ss_pred CC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HH-----------HHhh
Confidence 22 1123456899999999987643 8899999999999999999999996322110 00 0000
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.........+...+..+.+++.+||+.||++|||+.+++++ .++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~--~~~~ 283 (295)
T 2clq_A 239 GMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD--EFLK 283 (295)
T ss_dssp HHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS--GGGC
T ss_pred ccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC--hhhh
Confidence 00001112222344578899999999999999999999864 4444
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=353.52 Aligned_cols=260 Identities=21% Similarity=0.323 Sum_probs=206.7
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEcC----CcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLL 157 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~l 157 (395)
..++|.+.+.||+|+||+||+|.+.. +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.++..++
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~l 467 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWI 467 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEE
Confidence 34668888999999999999998642 4579999987532 233467889999999999999999999998888899
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
||||+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++
T Consensus 468 v~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK------FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EEECCTTCBHHHHHHHTT------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred EEEcCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence 999999999999996432 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||...... ...
T Consensus 539 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~------------ 602 (656)
T 2j0j_A 539 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI------------ 602 (656)
T ss_dssp CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH------------
T ss_pred eecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHH------------
Confidence 86543221 12223456789999999999999999999999999999997 99999743311 000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
..+.. ......+...+..+.+++.+||+.||++|||+.++++.|+++++.+
T Consensus 603 -~~i~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 603 -GRIEN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp -HHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHHc-CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 01100 0011122334467899999999999999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=319.48 Aligned_cols=252 Identities=20% Similarity=0.334 Sum_probs=199.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc------ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK------QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~ 156 (395)
++|++.+.||+|+||+||++... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 45888999999999999999976 689999999864321 2357889999999999999999999998876 567
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC----cEEEe
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF----HAKVS 232 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~ 232 (395)
++|||+++++|.+++.. ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++ .+||+
T Consensus 85 lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE-------KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp EEEECCCSCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEeecCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEE
Confidence 99999999999999953 24689999999999999999999999 999999999999998877 89999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... .
T Consensus 155 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~--------- 219 (283)
T 3bhy_A 155 DFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---T--------- 219 (283)
T ss_dssp CCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---------
T ss_pred ecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---H---------
Confidence 999997654322 1234568999999999999999999999999999999999999997533110 0
Q ss_pred cchhhhhhccccccCCCCH----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHHhhh
Q 016117 313 DREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS--LVPLVK 367 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~--L~~~~~ 367 (395)
...+.... ...+. ..+..+.+++.+||+.||++|||+.+++++ ++.+..
T Consensus 220 ----~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 274 (283)
T 3bhy_A 220 ----LTNISAVN--YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274 (283)
T ss_dssp ----HHHHHTTC--CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred ----HHHhHhcc--cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence 00000000 00111 123468899999999999999999999973 455444
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=323.51 Aligned_cols=248 Identities=21% Similarity=0.343 Sum_probs=198.7
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
.++|.+.+.||+|+||+||++... +|+.||+|++........+.+.+|+.+++.++||||+++++++.+. ..+++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 346888999999999999999975 7899999999865444456788999999999999999999998877 45699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe---CCCCcEEEecccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLAK 238 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~~ 238 (395)
+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||++ +.++.++|+|||++.
T Consensus 88 ~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 88 VSGGELFDRILER-------GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp CCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred CCCccHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 9999999998532 3689999999999999999999999 99999999999999 788999999999987
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ... .
T Consensus 158 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~-------------~ 217 (304)
T 2jam_A 158 MEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLF-------------E 217 (304)
T ss_dssp CCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH-------------H
T ss_pred ecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH-------------H
Confidence 53321 223456899999999999999999999999999999999999999643211 000 0
Q ss_pred hhcccc--ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPA--LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+.... .........+..+.+++.+||+.||++|||+.+++++
T Consensus 218 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 218 KIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111000 0111112334578999999999999999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=318.93 Aligned_cols=245 Identities=25% Similarity=0.386 Sum_probs=200.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++.+. ..++++
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999975 6789999998642 123346788999999999999999999999876 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 94 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp CCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 999999999999532 3589999999999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... .....|++.|+|||++.+..++.++||||||+++|+|++|..||...... .....
T Consensus 164 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------------~~~~~ 223 (284)
T 2vgo_A 164 APSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT----------------ETHRR 223 (284)
T ss_dssp CSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHH
T ss_pred Ccccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh----------------HHHHH
Confidence 43321 23456899999999999999999999999999999999999999743211 00111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+..... ..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 224 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 224 IVNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHTTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred Hhcccc--CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 111111 1222234568899999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=319.05 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=195.3
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--------ccHHHHHHHHHHHhccCCCcceeEEEEEecCc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--------QGEDEFKMEVELLGRLRSPYLLALLGYCSDRR 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 154 (395)
.++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 356899999999999999999965 688999999864321 12235788999999999999999999998888
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc---EEE
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH---AKV 231 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl 231 (395)
.++||||+.+++|.+++.. ...+++..++.++.|++.||.|||++ +++||||||+|||++.++. +||
T Consensus 89 ~~lv~e~~~~~~L~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVG-------NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp EEEEEECCTTEETHHHHST-------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEE
T ss_pred eEEEEecCCCCcHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEE
Confidence 8999999999999999853 24689999999999999999999999 9999999999999987654 999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhh
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~ 308 (395)
+|||++...... .......||+.|+|||++. ...++.++||||||+++|+|++|..||........ ......
T Consensus 159 ~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~ 233 (322)
T 2ycf_A 159 TDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 233 (322)
T ss_dssp CCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH
T ss_pred ccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH
Confidence 999999865332 1223456899999999974 46788999999999999999999999975432211 110000
Q ss_pred cccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 309 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
.... . ..+.... ..+..+.+|+.+||+.||++|||+.++++
T Consensus 234 ~~~~------~-~~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKY------N-FIPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCC------C-CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCcc------c-cCchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0000 0 0000001 12356889999999999999999999984
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.81 Aligned_cols=264 Identities=23% Similarity=0.305 Sum_probs=203.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCc-ceeEEEEEecC-ceEEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY-LLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~-~~~lv~e 160 (395)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... ...+..|+++++.++|++ +..+..++.+. ..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 36799999999999999999996 5789999998865432 235788999999998755 44444455544 5579999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe---CCCCcEEEeccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGLA 237 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~~ 237 (395)
|+ +++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~-g~sL~~ll~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp CC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred CC-CCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 99 999999996432 4699999999999999999999999 99999999999999 58899999999999
Q ss_pred cccCCCCCCc-----eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 238 KIGSDKAGGH-----VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 238 ~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
.......... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~--- 230 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE--- 230 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH---
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh---
Confidence 8655433211 12256799999999999999999999999999999999999999976543221111111100
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
......+. .+... .+.++.+|+..||+.+|++||++.+|++.|++++...
T Consensus 231 --~~~~~~~~-~l~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 231 --KKVATSIE-ALCRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp --HHHHSCHH-HHHTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --ccccccHH-HHhcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 00000000 00111 2356899999999999999999999999999997743
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=340.08 Aligned_cols=193 Identities=24% Similarity=0.353 Sum_probs=151.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC------ce
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------RK 155 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 155 (395)
++|.+.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 67999999999999999999965 78999999986532 23346788999999999999999999998432 46
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++||||+ +|+|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 133 ~lv~e~~-~~~L~~~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFG 201 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT-------PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG 201 (458)
T ss_dssp EEEECCC-SEEHHHHHHS-------SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEecc-ccchhhhccc-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccc
Confidence 7999987 5789998843 24699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC-------------------------ceeeccccccccccchhh-ccCCCCccchhHHHHHHHHHHHhC
Q 016117 236 LAKIGSDKAGG-------------------------HVSTRVLGTQGYVAPEYA-LTGHLTTKSDVYSYGVVLLELLTG 288 (395)
Q Consensus 236 ~~~~~~~~~~~-------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~~l~ell~g 288 (395)
+++........ ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 99865422111 123345789999999986 466799999999999999999993
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=327.53 Aligned_cols=271 Identities=23% Similarity=0.271 Sum_probs=195.9
Q ss_pred HHHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc-----cHHHHHHHHHHHhccCCCcceeEEEEEecC-
Q 016117 81 HSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ-----GEDEFKMEVELLGRLRSPYLLALLGYCSDR- 153 (395)
Q Consensus 81 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~- 153 (395)
....++|.+.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344578999999999999999999964 6899999998643211 124678899999999999999999998766
Q ss_pred ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEec
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 233 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 233 (395)
..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~D 155 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLAD 155 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred ceEEEEEcCCC-CHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEe
Confidence 67799999986 8888885332 4588899999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
||++....... .......||+.|+|||++.+. .++.++|||||||++|||++|..||....... ..........
T Consensus 156 fg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~ 230 (346)
T 1ua2_A 156 FGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLG 230 (346)
T ss_dssp CGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHC
T ss_pred cccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcC
Confidence 99998654322 223345789999999998764 58999999999999999999999987543211 0000000000
Q ss_pred c--c---hhhhhhcccc---ccCCCC-----HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 313 D--R---EKILEIMDPA---LEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 313 ~--~---~~~~~~~d~~---~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
. . .......+.. .....+ ...+..+.+|+.+||+.||++|||+.|++++ .++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--~~f~~ 297 (346)
T 1ua2_A 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSN 297 (346)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTS
T ss_pred CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC--hhhhc
Confidence 0 0 0000000000 000111 1223578999999999999999999999975 55543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=333.79 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=199.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|.+.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 46888999999999999999975 78999999987542 33346788999999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++... ..+++..+..++.|++.||.|||+.. +++||||||+|||++.++.+||+|||++....
T Consensus 113 ~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 113 MDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999532 36899999999999999999999831 79999999999999999999999999986542
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhh----------------
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS---------------- 305 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~---------------- 305 (395)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 184 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 184 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred cc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 21 1233568999999999999999999999999999999999999997543211000000
Q ss_pred ------hhhccccc----chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 306 ------WALPRLTD----REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 306 ------~~~~~~~~----~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
........ ......+.............+..+.+|+.+||+.||++|||+.+++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000 000111111111111111234578999999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=328.25 Aligned_cols=265 Identities=24% Similarity=0.392 Sum_probs=196.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc--cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+. ..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46888999999999999999975 5899999988644322 245677899999999999999999999877 4679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 105 ~~~~~~l~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 105 FVDHTILDDLELF-------PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp CCSEEHHHHHHHS-------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred cCCcchHHHHHhh-------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 9999999888642 24689999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcc--------c
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR--------L 311 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~--------~ 311 (395)
.... .......|++.|+|||++.+. .++.++||||||+++|+|++|..||.................. .
T Consensus 175 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 175 AAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 3322 122345689999999999875 7899999999999999999999999754321111000000000 0
Q ss_pred ccchhhhhhccccccCCCC-----HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 312 TDREKILEIMDPALEGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...........+.+....+ ...+..+.+|+.+||+.||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000001111111111111 1234678999999999999999999999964
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=323.01 Aligned_cols=251 Identities=21% Similarity=0.392 Sum_probs=196.2
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
.++|++.+.||+|+||.||+|... +++.+|+|++........+.+..|+++++.++||||+++++++.+. ..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 357888999999999999999975 5899999999876666678899999999999999999999988766 67799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++....
T Consensus 98 ~~~~~l~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 98 CPGGAVDAIMLELD------RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp CTTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred CCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999885432 4589999999999999999999999 99999999999999999999999999875321
Q ss_pred CCCCCceeeccccccccccchhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
... .......|++.|+|||++. +..++.++||||||+++|+|++|..||....... .
T Consensus 169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~------------- 230 (302)
T 2j7t_A 169 KTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---V------------- 230 (302)
T ss_dssp HHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H-------------
T ss_pred ccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H-------------
Confidence 110 1112346899999999983 6678999999999999999999999997533110 0
Q ss_pred hhhhcccc-ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPA-LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+.... .....+...+..+.+++.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 231 LLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000000 0001112234568899999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=328.42 Aligned_cols=267 Identities=19% Similarity=0.259 Sum_probs=189.3
Q ss_pred HHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 82 SATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 82 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
...++|.+.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+. ..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34567999999999999999999954 789999999864422 2234677899999999999999999998776 5669
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe-----CCCCcEEEe
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL-----DKNFHAKVS 232 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill-----~~~~~~kl~ 232 (395)
||||+. |+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+
T Consensus 111 v~e~~~-~~L~~~~~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKN-------PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp EEECCS-EEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred EEecCC-CCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEEC
Confidence 999997 5999998543 3589999999999999999999999 99999999999999 455669999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
|||++....... .......||+.|+|||++.+. .++.++|||||||++|||++|..||...................
T Consensus 180 Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 180 DFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP 257 (329)
T ss_dssp CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 999997654322 122345679999999999874 58999999999999999999999997543211100000000000
Q ss_pred cc--chhh---hhhcc--ccccCCC-----CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 312 TD--REKI---LEIMD--PALEGQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 312 ~~--~~~~---~~~~d--~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. .... ..... +...... ......++.+|+.+||+.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00 0000 00000 0000000 00123578899999999999999999999964
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=325.31 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=200.4
Q ss_pred HHHHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc--------cHHHHHHHHHHHhcc-CCCcceeEEEE
Q 016117 80 LHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ--------GEDEFKMEVELLGRL-RSPYLLALLGY 149 (395)
Q Consensus 80 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~l~~~ 149 (395)
.....++|.+.+.||+|+||.||+|... +|+.||||++...... ..+.+..|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445567999999999999999999975 7999999998754311 134677899999999 89999999999
Q ss_pred EecC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc
Q 016117 150 CSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 228 (395)
Q Consensus 150 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~ 228 (395)
+... ..++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||||+|||++.++.
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE-------KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 8776 56799999999999999953 24689999999999999999999999 9999999999999999999
Q ss_pred EEEeccccccccCCCCCCceeeccccccccccchhhcc------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCch
Q 016117 229 AKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV 302 (395)
Q Consensus 229 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~ 302 (395)
++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .
T Consensus 239 ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~ 312 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---L 312 (365)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---H
T ss_pred EEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---H
Confidence 9999999997654332 2234678999999999863 35788999999999999999999999643211 0
Q ss_pred hhhhhhcccccchhhhhhccccccCCCCH----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 303 LVSWALPRLTDREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. ..+..... .... ..+..+.+++.+||+.||++|||+.+++++
T Consensus 313 ~~-------------~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 ML-------------RMIMEGQY--QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HH-------------HHHHHTCC--CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HH-------------HHHHhCCC--CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00 00100000 0011 123468899999999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=326.26 Aligned_cols=258 Identities=21% Similarity=0.277 Sum_probs=189.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-------c
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------R 154 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------~ 154 (395)
++|.+.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 57899999999999999999964 68999999987532 23345688899999999999999999998654 3
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++||||+.+ +|.+++. ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+||
T Consensus 105 ~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp EEEEEECCSE-EHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEcCCC-CHHHHHh---------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence 5799999974 7888773 3488999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc-
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD- 313 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~- 313 (395)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.... ..........
T Consensus 172 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~ 245 (371)
T 2xrw_A 172 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTP 245 (371)
T ss_dssp CC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHC-CCCC
T ss_pred eccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCC
Confidence 9997643321 22345789999999999999999999999999999999999999975432110 0000000000
Q ss_pred -----------------------chhhhhhccccccCCC---CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 -----------------------REKILEIMDPALEGQY---SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 -----------------------~~~~~~~~d~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.......+........ ....+..+.+|+.+||+.||++|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000011100000000 12235689999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=342.83 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=200.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||+||++... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+. ..++|+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46888999999999999999975 78999999986432 34567889999999999999999999999877 466999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe---CCCCcEEEecccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL---DKNFHAKVSDFGL 236 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill---~~~~~~kl~Dfg~ 236 (395)
||+.+|+|.+++... ..+++..++.++.|++.||.|||++ +++||||||+|||+ +.++.+||+|||+
T Consensus 106 e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 106 EVYTGGELFDEIISR-------KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp CCCCSCBHHHHHHTC-------SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred ecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 999999999998532 4689999999999999999999999 99999999999999 5678999999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
+....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ...
T Consensus 176 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~------------ 236 (484)
T 3nyv_A 176 STHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DIL------------ 236 (484)
T ss_dssp HHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH------------
T ss_pred eEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHH------------
Confidence 98654332 2334579999999999876 6899999999999999999999999754321 001
Q ss_pred hhhhccccccC--CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALEG--QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+....... ......+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 237 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 237 -KKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -HHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 1111100000 0011234568899999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=319.04 Aligned_cols=246 Identities=20% Similarity=0.290 Sum_probs=194.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv 158 (395)
.++|++.+.||+|+||+||+|... +++.||+|++... .......+.+|+..+..+ +||||+++++++.+. ..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 356888999999999999999975 7999999998753 233456778899999998 999999999998766 56699
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC------------
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN------------ 226 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~------------ 226 (395)
|||+++++|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYR---IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EECCTTCBHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred EEecCCCcHHHHHHhhcc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence 999999999999954321 124689999999999999999999999 99999999999999844
Q ss_pred -------CcEEEeccccccccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCC
Q 016117 227 -------FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPS 298 (395)
Q Consensus 227 -------~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~ 298 (395)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|+|++|..|+....
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-- 235 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-- 235 (289)
T ss_dssp ------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--
T ss_pred ccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--
Confidence 479999999998654322 23489999999999866 56789999999999999999988764221
Q ss_pred CCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 299 GEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
. ...+..... ...+...+..+.+++.+||+.||++|||+.+++++
T Consensus 236 ----~-------------~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 ----Q-------------WHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ----H-------------HHHHHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----H-------------HHHHHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0 001111100 11122234568899999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=325.38 Aligned_cols=274 Identities=21% Similarity=0.272 Sum_probs=201.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC--------
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------- 153 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 153 (395)
++|++.+.||+|+||+||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788999999999999999997 478999999886432 22345778899999999999999999988653
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
..++||||+.+ +|.+.+.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence 35799999975 7777774332 4599999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCC--Cceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhc
Q 016117 233 DFGLAKIGSDKAG--GHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 309 (395)
Q Consensus 233 Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~ 309 (395)
|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.....
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 246 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG 246 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999976542221 122334568999999999876 5689999999999999999999999975432211111110000
Q ss_pred cccc----ch---hhhhhccccccCCCCHH-------HHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 310 RLTD----RE---KILEIMDPALEGQYSMK-------EVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 310 ~~~~----~~---~~~~~~d~~~~~~~~~~-------~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
.... .. .....+........... ....+.+|+.+||+.||++|||+.|++++ .++....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~f~~~~ 319 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH--DFFWSDP 319 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGGSSS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC--CCcCCCC
Confidence 0000 00 00000000000011111 12458899999999999999999999985 5665433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=327.05 Aligned_cols=274 Identities=20% Similarity=0.238 Sum_probs=199.0
Q ss_pred ecHHHHHHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcc-----------cHHHHHHHHHHHhccCCCcc
Q 016117 75 FTFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ-----------GEDEFKMEVELLGRLRSPYL 143 (395)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~ni 143 (395)
....++....++|.+.+.||+|+||.||+|...+|+.||+|++...... ..+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 4466788889999999999999999999999888999999988642211 12678899999999999999
Q ss_pred eeEEEEEecC------ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCC
Q 016117 144 LALLGYCSDR------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK 217 (395)
Q Consensus 144 v~l~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk 217 (395)
+++++++... ..++||||+. |+|.+++.... ..+++..+..++.|++.||.|||++ +++|||||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 161 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR------IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLH 161 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCC
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCC
Confidence 9999987431 3579999998 68888885332 4689999999999999999999999 99999999
Q ss_pred CCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 016117 218 SSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296 (395)
Q Consensus 218 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~ 296 (395)
|+|||++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999997533222 2234568999999999887 678999999999999999999999997543
Q ss_pred CCCCchhhhhhhcccc-------cchhhhhhccccccC-------CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 297 PSGEGVLVSWALPRLT-------DREKILEIMDPALEG-------QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 297 ~~~~~~~~~~~~~~~~-------~~~~~~~~~d~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
................ ........+...... ......+..+.+|+.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 2111000000000000 000001111111100 0011223568899999999999999999999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=329.77 Aligned_cols=264 Identities=23% Similarity=0.318 Sum_probs=195.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-------
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 153 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 153 (395)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 357889999999999999999964 79999999986432 22345788999999999999999999998754
Q ss_pred ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEec
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 233 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 233 (395)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 171 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 171 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred eEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEe
Confidence 248999999 8899999843 3589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhh----
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL---- 308 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~---- 308 (395)
||+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.......+....
T Consensus 172 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 172 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246 (367)
T ss_dssp CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999864432 234568999999999887 689999999999999999999999997543211100000000
Q ss_pred ----cccccchhhhhhcc-------ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 309 ----PRLTDREKILEIMD-------PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 309 ----~~~~~~~~~~~~~d-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
..... ......+. ..+. ......+..+.+|+.+||+.||++|||+.+++++ .++..
T Consensus 247 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h--p~f~~ 313 (367)
T 1cm8_A 247 AEFVQRLQS-DEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH--PYFES 313 (367)
T ss_dssp HHHHHTCSC-HHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGTT
T ss_pred HHHHHHhhh-HHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC--hHHHh
Confidence 00000 00000000 0000 1112234568899999999999999999999975 44443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=320.20 Aligned_cols=256 Identities=17% Similarity=0.280 Sum_probs=197.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCcceeEEEEEec--C-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSD--R-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~-~~~lv~ 159 (395)
++|++.+.||+|+||+||+|.. .+++.||+|++... ..+.+.+|+.+++.++ ||||+++++++.+ . ..+++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5688999999999999999986 47899999998743 3567889999999997 9999999999886 3 467999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC-cEEEecccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKVSDFGLAK 238 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~~~ 238 (395)
||+.+++|.+++ ..+++..++.++.|++.||.|||++ +++||||||+|||++.++ .+||+|||++.
T Consensus 113 e~~~~~~l~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 113 EHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp ECCCCCCHHHHG----------GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eccCchhHHHHH----------HhCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 999999999998 2488999999999999999999999 999999999999998766 89999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc----
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD---- 313 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---- 313 (395)
...... ......++..|+|||++.+ ..++.++|||||||++|+|++|..||....... ............
T Consensus 180 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 180 FYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLY 254 (330)
T ss_dssp ECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHH
T ss_pred EcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhh
Confidence 654332 2234568899999999887 678999999999999999999999995432210 000000000000
Q ss_pred ----------chhhhhhcc--------ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 ----------REKILEIMD--------PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 ----------~~~~~~~~d--------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
......... ...........+..+.+|+.+||+.||++|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 000111111234678999999999999999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=326.46 Aligned_cols=258 Identities=28% Similarity=0.433 Sum_probs=196.9
Q ss_pred HHHHHHHhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEec--
Q 016117 77 FKQLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSD-- 152 (395)
Q Consensus 77 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-- 152 (395)
+.++....++|++.+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 334445667899999999999999999996 478999999987542 3456788999999999 89999999998864
Q ss_pred -----CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC
Q 016117 153 -----RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 227 (395)
Q Consensus 153 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~ 227 (395)
...++||||+.+|+|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG-----GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCC
Confidence 35679999999999999996432 24689999999999999999999999 999999999999999999
Q ss_pred cEEEeccccccccCCCCCCceeeccccccccccchhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCch
Q 016117 228 HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV 302 (395)
Q Consensus 228 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~ 302 (395)
.+||+|||++....... .......|++.|+|||++. +..++.++||||||+++|+|++|..||.......
T Consensus 167 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--- 241 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--- 241 (326)
T ss_dssp CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---
T ss_pred CEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---
Confidence 99999999987643321 1123456899999999987 5678999999999999999999999996433110
Q ss_pred hhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 303 LVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
... .+.....+.+ .....+..+.+++.+||+.||.+|||+.+++++
T Consensus 242 ~~~----------~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 242 ALF----------LIPRNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHH----------HHHHSCCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHH----------HhhcCccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 0000000111 111223568899999999999999999999964
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=314.96 Aligned_cols=246 Identities=26% Similarity=0.422 Sum_probs=191.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+. ..++++
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57888999999999999999975 7899999998643 223456788999999999999999999998876 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+++|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 91 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 91 EYVSGGELFDYICKH-------GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM 160 (276)
T ss_dssp ECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred eccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccc
Confidence 999999999999532 3589999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCceeeccccccccccchhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
..... ......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...... ... .
T Consensus 161 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~-------------~ 221 (276)
T 2h6d_A 161 MSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLF-------------K 221 (276)
T ss_dssp CCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH-------------H
T ss_pred cCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHH-------------H
Confidence 54322 2234568999999999987765 68999999999999999999999643210 000 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+..... ..+...+..+.+++.+||+.||++|||+.+++++
T Consensus 222 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 222 KIRGGVF--YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HhhcCcc--cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000 1112234568899999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=325.65 Aligned_cols=268 Identities=19% Similarity=0.255 Sum_probs=200.8
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcc---c--------------HHHHHHHHHHHhccCCCcceeE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ---G--------------EDEFKMEVELLGRLRSPYLLAL 146 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~--------------~~~~~~e~~~l~~l~h~niv~l 146 (395)
.++|.+.+.||+|+||.||+|.. +|+.||+|++...... . .+.+.+|+.+++.++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35789999999999999999999 9999999998643111 1 1788999999999999999999
Q ss_pred EEEEecC-ceEEEEEcccCCChhhhcccCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCCEEe
Q 016117 147 LGYCSDR-RKLLVYDYMANGGLQEHLYPANG-SNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILL 223 (395)
Q Consensus 147 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill 223 (395)
++++.+. ..++||||+++|+|.+++..... .......+++..++.++.|++.||.|||+ . +++|+||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9998877 56699999999999999321100 01113579999999999999999999998 8 99999999999999
Q ss_pred CCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccC-CCCc-cchhHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 016117 224 DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTT-KSDVYSYGVVLLELLTGRVPIDVNKPSGEG 301 (395)
Q Consensus 224 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~DvwslG~~l~ell~g~~pf~~~~~~~~~ 301 (395)
+.++.++|+|||++...... ......|+..|+|||++.+. .++. ++||||||+++|+|++|..||...... .
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~ 259 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--V 259 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--H
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--H
Confidence 99999999999999865432 23446789999999999877 6666 999999999999999999999754431 1
Q ss_pred hhhhhhhcc-cccchhhhhhcccccc---CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 302 VLVSWALPR-LTDREKILEIMDPALE---GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 302 ~~~~~~~~~-~~~~~~~~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
......... ............+... .......+..+.+|+.+||+.||.+|||+.+++++
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111000 0000000000000000 00012234578999999999999999999999963
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=329.89 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=198.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEE----cCCcEEEEEEeccCC----cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-c
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-R 154 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 154 (395)
++|.+.+.||+|+||+||++.. .+++.||+|++.... ....+.+..|+++++.+ +||||+++++++.+. .
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5789999999999999999997 378999999986432 12334567799999999 699999999988766 5
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++||||+.+|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCS
T ss_pred EEEEeecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeC
Confidence 67999999999999999532 3689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhcc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
|++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||............
T Consensus 204 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~-------- 274 (355)
T 1vzo_A 204 GLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------- 274 (355)
T ss_dssp SEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--------
T ss_pred CCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--------
Confidence 9997543221 112334679999999999985 35789999999999999999999999754322111100
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHHH
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQSL 362 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~L 362 (395)
...+... ...++...+..+.+|+.+||+.||.+|| |+.+++++.
T Consensus 275 ----~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 275 ----SRRILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----HHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----HHHHhcc--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0011100 1122233445688999999999999999 999998763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=339.66 Aligned_cols=247 Identities=23% Similarity=0.353 Sum_probs=197.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|.+.+.||+|+||+||++... +++.||+|++... .......+.+|++++++++||||+++++++.+. ..++|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 46899999999999999999975 7899999998632 233457889999999999999999999999877 5569999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC---CCCcEEEeccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD---KNFHAKVSDFGLA 237 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~ 237 (395)
|+.+|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 102 ~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 102 LYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp CCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred cCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 99999999988533 4689999999999999999999999 999999999999995 4567999999999
Q ss_pred cccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ...
T Consensus 172 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~------------- 231 (486)
T 3mwu_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DIL------------- 231 (486)
T ss_dssp TTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH-------------
T ss_pred eECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH-------------
Confidence 7654322 2334579999999999876 5899999999999999999999999754321 000
Q ss_pred hhhcccccc--CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 318 LEIMDPALE--GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 318 ~~~~d~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+...... .......+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 232 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred HHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011000000 00011224568899999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=325.65 Aligned_cols=257 Identities=22% Similarity=0.334 Sum_probs=195.8
Q ss_pred HHHHHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHHHhccC--CCcceeEEEEEecC
Q 016117 78 KQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLR--SPYLLALLGYCSDR 153 (395)
Q Consensus 78 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~ 153 (395)
+.+....++|++.+.||+|+||.||++...+++.||+|++.... ....+.+.+|+.+++.++ |+||+++++++.+.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 33334456789999999999999999998889999999986432 234467889999999997 59999999998877
Q ss_pred c-eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 154 R-KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 154 ~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
. .+++|| +.+++|.+++... ..+++..++.++.|++.||.|||++ +++||||||+|||+++ +.+||+
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~ 168 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLI 168 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEEC
T ss_pred CEEEEEEe-cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEe
Confidence 4 558888 6788999999542 3689999999999999999999999 9999999999999964 899999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhcc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-----------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 301 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~ 301 (395)
|||++................|++.|+|||.+.+ ..++.++||||||+++|+|++|..||......
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--- 245 (313)
T 3cek_A 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--- 245 (313)
T ss_dssp CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---
T ss_pred eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---
Confidence 9999986544332222334568999999999875 46888999999999999999999999643210
Q ss_pred hhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 302 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
........++......+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 246 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 246 ------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------------HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 011122222222222222234578899999999999999999999975
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=333.78 Aligned_cols=199 Identities=27% Similarity=0.379 Sum_probs=164.4
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC------c
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------R 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 154 (395)
.++|.+.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 357999999999999999999965 68899999997532 23346788999999999999999999998654 4
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++||||+. |+|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 105 ~~lv~e~~~-~~L~~~~~~-------~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DF 173 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT-------PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDF 173 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS-------SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEecCC-cCHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccC
Confidence 679999986 599999853 24699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCC--------------------ceeeccccccccccchhh-ccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 016117 235 GLAKIGSDKAGG--------------------HVSTRVLGTQGYVAPEYA-LTGHLTTKSDVYSYGVVLLELLTGRVPID 293 (395)
Q Consensus 235 g~~~~~~~~~~~--------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~~l~ell~g~~pf~ 293 (395)
|+++........ ......+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 999865432211 123456799999999986 56679999999999999999998666654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=339.19 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=193.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
+.|.+.+.||+|+||+||+|... ++..+|+|++.... ......+.+|+.+++.++||||+++++++.+. ..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46889999999999999999975 78899999987532 33456788999999999999999999999877 5669999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC---CCcEEEeccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSDFGLA 237 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~ 237 (395)
|+.+|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 117 ~~~~g~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 117 CYKGGELFDEIIHR-------MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp CCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred cCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 99999999988532 4689999999999999999999999 9999999999999976 455999999999
Q ss_pred cccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||....... ..
T Consensus 187 ~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~------------- 246 (494)
T 3lij_A 187 AVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---IL------------- 246 (494)
T ss_dssp EECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH-------------
T ss_pred eECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HH-------------
Confidence 8654332 233457999999999886 568999999999999999999999997543210 00
Q ss_pred hhhcccccc--CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 318 LEIMDPALE--GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 318 ~~~~d~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+...... .......+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 247 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 247 RKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred HHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 000000000 00001123468899999999999999999999965
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=332.48 Aligned_cols=251 Identities=11% Similarity=0.049 Sum_probs=178.9
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc---ccHHHHHHHHHHHhcc--CCCcceeEE-------EEEec
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---QGEDEFKMEVELLGRL--RSPYLLALL-------GYCSD 152 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~~~ 152 (395)
+|.+.+.||+|+||+||+|.+. +|+.||+|++..... ...+.+.+|+.+++.+ +|||+++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4778899999999999999965 789999999986432 2345667785545444 699988755 33322
Q ss_pred ------------------CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHH------HHHHHHHHHHHHHHhcCCC
Q 016117 153 ------------------RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETR------LRIALEAAKGLEFLHEHCS 208 (395)
Q Consensus 153 ------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~ 208 (395)
...++||||+. |+|.+++.... ..+.+..+ ..++.|++.||+|||++
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-- 213 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD------FVYVFRGDEGILALHILTAQLIRLAANLQSK-- 213 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH------HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc------cccchhhhhhhhhHHHHHHHHHHHHHHHHHC--
Confidence 12579999999 89999996532 23444455 67889999999999999
Q ss_pred CCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhcc--CCCCccchhHHHHHHHHHHH
Q 016117 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELL 286 (395)
Q Consensus 209 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell 286 (395)
+|+||||||+|||++.++.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 214 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 214 -GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp -TEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred -CCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 999999999999999999999999999986432 1224557799999999987 68999999999999999999
Q ss_pred hCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 287 TGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 287 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
+|+.||....+........ ...................+..+.+|+.+||+.||++|||+.++++
T Consensus 288 tg~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGSWKR---------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HSSCSTTBCCTTCTTCCCB---------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hCCCCCCCcCcccccchhh---------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999998654321110000 0000000111111111133457889999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=338.83 Aligned_cols=247 Identities=25% Similarity=0.364 Sum_probs=196.8
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-------------ccHHHHHHHHHHHhccCCCcceeEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-------------QGEDEFKMEVELLGRLRSPYLLALLG 148 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~~ 148 (395)
..++|.+.+.||+|+||+||+|... +++.+|+|++..... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3467999999999999999999965 688999999864321 23467889999999999999999999
Q ss_pred EEecC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC
Q 016117 149 YCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF 227 (395)
Q Consensus 149 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~ 227 (395)
++.+. ..++||||+.+|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~ 183 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-------HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKN 183 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTT
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCC
Confidence 99877 466999999999999998532 4699999999999999999999999 999999999999998775
Q ss_pred ---cEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh
Q 016117 228 ---HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 304 (395)
Q Consensus 228 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~ 304 (395)
.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||...... .
T Consensus 184 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~-- 254 (504)
T 3q5i_A 184 SLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---D-- 254 (504)
T ss_dssp CCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H--
T ss_pred CCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---H--
Confidence 69999999998654332 233457999999999887 46899999999999999999999999754321 0
Q ss_pred hhhhcccccchhhhhhccccccCCCCH----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 305 SWALPRLTDREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~d~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....+..... ..+. ..+..+.+|+.+||+.||.+|||+.+++++
T Consensus 255 -----------~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 255 -----------IIKKVEKGKY--YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp -----------HHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----------HHHHHHcCCC--CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0111111100 0111 123568899999999999999999999975
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=318.94 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=196.2
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
..++|++.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+. ..+++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4467899999999999999999975 58999999987532 346788999999999999999999988766 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 105 ~~~~~~L~~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 105 YCGAGSVSDIIRLR------NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp CCTTEEHHHHHHHH------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 99999999998532 24689999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ... .....
T Consensus 176 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~----------~~~~~ 240 (314)
T 3com_A 176 TDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR---AIF----------MIPTN 240 (314)
T ss_dssp BTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH----------HHHHS
T ss_pred hhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH---HHH----------HHhcC
Confidence 4322 12234568999999999999999999999999999999999999996432110 000 00000
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+.. ..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 241 PPPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CCCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000 1112234568899999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=351.05 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=202.6
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~ 156 (395)
..++|.+.+.||+|+||+||+|... +++.||+|++... .....+.+..|..++..+ +||||+.+++++.+. ..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467899999999999999999965 6889999998742 223445678899999987 799999999998876 566
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 419 lV~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGl 488 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 488 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred EEEeCcCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecce
Confidence 999999999999999543 4699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
+....... ......+||+.|+|||++.+..++.++||||||+++|||++|..||...+.. ..
T Consensus 489 a~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~----------------~~ 550 (674)
T 3pfq_A 489 CKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----------------EL 550 (674)
T ss_dssp CEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------------HH
T ss_pred eeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH----------------HH
Confidence 98533222 2234568999999999999999999999999999999999999999754321 11
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCH-----HHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM-----ADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~~vl~~ 361 (395)
...++...+ .++...+.++.+|+.+||+.||++||++ .+|+++
T Consensus 551 ~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 551 FQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp HHHHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred HHHHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 122222211 2233345678999999999999999998 677653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=319.59 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=196.4
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEE--cCCcEEEEEEeccCC--cccHHHHHHHHHHHhcc---CCCcceeEEEEEe----
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVL--SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRL---RSPYLLALLGYCS---- 151 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~---- 151 (395)
..++|++.+.||+|+||+||+|.. .+|+.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346799999999999999999997 368899999886432 12223566777777766 8999999999886
Q ss_pred -cC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcE
Q 016117 152 -DR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 152 -~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 229 (395)
.. ..++++||+. |+|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP-----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC-----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCE
Confidence 22 4569999998 69999986543 23589999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhc
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 309 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~ 309 (395)
||+|||++...... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....... .......
T Consensus 160 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~ 233 (326)
T 1blx_A 160 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILD 233 (326)
T ss_dssp EECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHH
T ss_pred EEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHH
Confidence 99999999754321 12234568999999999999999999999999999999999999997543211 0000000
Q ss_pred ccc--cchhh-------hhhcc---ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 310 RLT--DREKI-------LEIMD---PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 310 ~~~--~~~~~-------~~~~d---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
... ..... ...+. ...........+..+.+|+.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00000 00000 000001112234568899999999999999999999964
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=332.50 Aligned_cols=266 Identities=20% Similarity=0.263 Sum_probs=193.3
Q ss_pred HHHhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC------
Q 016117 81 HSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------ 153 (395)
Q Consensus 81 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 153 (395)
+...++|++.+.||+|+||+||+|.. .+|+.||+|++...... ..+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999996 47899999988654222 23699999999999999999987432
Q ss_pred ---------------------------------ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 016117 154 ---------------------------------RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200 (395)
Q Consensus 154 ---------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l 200 (395)
..++||||++ |+|.+.+..... ....+++..+..++.|++.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR---SGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHH
Confidence 1569999998 587777653211 224699999999999999999
Q ss_pred HHHhcCCCCCceeCCCCCCCEEeC-CCCcEEEeccccccccCCCCCCceeeccccccccccchhhccC-CCCccchhHHH
Q 016117 201 EFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSY 278 (395)
Q Consensus 201 ~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvwsl 278 (395)
.|||++ +|+||||||+|||++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++||||+
T Consensus 155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 999998 999999999999997 68999999999998654332 22345689999999998865 58999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh-------h-----ccccccCCCCHHHHHHHHHHHhhcCC
Q 016117 279 GVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE-------I-----MDPALEGQYSMKEVIQVAAIAAMCVQ 346 (395)
Q Consensus 279 G~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~-----~d~~~~~~~~~~~~~~l~~li~~cl~ 346 (395)
||++|||++|+.||...........+........ ...+.. . .........+...+..+.+|+.+||+
T Consensus 229 G~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT-KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC-HHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-HHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 9999999999999975432111100000000000 000000 0 00000001122234568999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 016117 347 PEADYRPLMADVVQS 361 (395)
Q Consensus 347 ~~p~~RPt~~~vl~~ 361 (395)
.||++|||+.|++++
T Consensus 308 ~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 308 YEPDLRINPYEAMAH 322 (383)
T ss_dssp SSGGGSCCHHHHHTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999953
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=323.93 Aligned_cols=270 Identities=21% Similarity=0.284 Sum_probs=200.9
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecC------ce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDR------RK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 155 (395)
.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457899999999999999999965 688999999975332 2346788999999999999999999998643 46
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++++||+. |+|.+++.. ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||
T Consensus 106 ~iv~e~~~-~~L~~~l~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp EEEEECCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEcccC-cCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence 79999997 589998842 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCC-ceeeccccccccccchhhc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 236 LAKIGSDKAGG-HVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 236 ~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
++......... .......||+.|+|||++. +..++.++|||||||++|+|++|..||...........+........
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~- 252 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS- 252 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC-
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC-
Confidence 99865432211 1123457899999999875 45589999999999999999999999975543221111100000000
Q ss_pred chhh--------hhhccccc-cCCCC-----HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 314 REKI--------LEIMDPAL-EGQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 314 ~~~~--------~~~~d~~~-~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.... ........ ....+ ...+..+.+|+.+||+.||++|||+.+++++ .++..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h--p~~~~ 319 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH--PYLEQ 319 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS--GGGTT
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC--cchhh
Confidence 0000 00000000 00111 1123568899999999999999999999975 55543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=325.13 Aligned_cols=264 Identities=25% Similarity=0.380 Sum_probs=196.9
Q ss_pred HHHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceE
Q 016117 80 LHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 80 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~ 156 (395)
.....++|++.+.||+|+||+||+|...+ .+|+|++.... ....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 33445789999999999999999999754 49999886432 22334577899999999999999999998876 567
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+++||+.+++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++ ++.++|+|||+
T Consensus 106 iv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAK------IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp EECBCCCSEEHHHHTTSSC------CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred EEeecccCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 9999999999999995432 4689999999999999999999999 999999999999998 67999999999
Q ss_pred ccccCCCC---CCceeeccccccccccchhhcc---------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh
Q 016117 237 AKIGSDKA---GGHVSTRVLGTQGYVAPEYALT---------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 304 (395)
Q Consensus 237 ~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~ 304 (395)
+....... .........|++.|+|||++.+ ..++.++||||||+++|||++|..||...... . .
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~-~ 251 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---A-I 251 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---H-H
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H-H
Confidence 87543211 1112233458999999999874 45788999999999999999999999743311 0 0
Q ss_pred hhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 305 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
.+ .+.....+... ....+..+.+++.+||+.||++|||+.++++.|+++.+..+.
T Consensus 252 ~~---------~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 252 IW---------QMGTGMKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp HH---------HHHTTCCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred HH---------HhccCCCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 00 00000111111 111233588999999999999999999999999999986443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=326.64 Aligned_cols=264 Identities=21% Similarity=0.285 Sum_probs=200.3
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccC--------CCcceeEEEEEe---
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR--------SPYLLALLGYCS--- 151 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~--- 151 (395)
.++|.+.+.||+|+||+||+|... +++.||+|++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 367999999999999999999964 6889999999753 334567888999999985 788999999876
Q ss_pred -cC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC--
Q 016117 152 -DR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-- 227 (395)
Q Consensus 152 -~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-- 227 (395)
+. ..++||||+ +++|.+++.... ...+++..++.++.|++.||.|||+++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN-----YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc-----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 33 467999999 666766664332 246899999999999999999999853 799999999999998775
Q ss_pred -----------------------------------------------cEEEeccccccccCCCCCCceeecccccccccc
Q 016117 228 -----------------------------------------------HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260 (395)
Q Consensus 228 -----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~a 260 (395)
.+||+|||++...... .....||+.|+|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~a 261 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCC
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccC
Confidence 7999999999865432 233468999999
Q ss_pred chhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhh---hhc---cc---------------ccchhhhh
Q 016117 261 PEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW---ALP---RL---------------TDREKILE 319 (395)
Q Consensus 261 PE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~---~~~---~~---------------~~~~~~~~ 319 (395)
||++.+..++.++|||||||++|||++|..||.............. ... .. ........
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 9999999999999999999999999999999976544322111000 000 00 00000000
Q ss_pred hcccc---------ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPA---------LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+.+.. .....+......+.+|+.+||+.||++|||+.+++++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00000 0113456777889999999999999999999999964
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=318.93 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=183.8
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcc--cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ--GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
.++|++.+.||+|+||+||++.. .+|+.||+|++...... ..+.+.++...++.++||||+++++++.+. ..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 45788899999999999999996 47899999998754222 223344455568888999999999998776 677999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+. |+|.+++..... ....+++..++.++.|++.||.|||++. +++||||||+||+++.++.+||+|||++..
T Consensus 86 e~~~-~~l~~~l~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVID---KGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp ECCS-EEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred ehhc-cchHHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9997 588777743211 1246999999999999999999999842 899999999999999999999999999976
Q ss_pred cCCCCCCceeeccccccccccchhh----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYA----LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
..... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||...... ..
T Consensus 160 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~ 221 (290)
T 3fme_A 160 LVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP---------------FQ 221 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH---------------HH
T ss_pred ccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch---------------HH
Confidence 54322 22234689999999996 4567899999999999999999999999643211 00
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..................+..+.+++.+||+.||++|||+.+++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 222 QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1111111111111112234568999999999999999999999973
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=329.93 Aligned_cols=198 Identities=24% Similarity=0.337 Sum_probs=168.7
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhcc------CCCcceeEEEEEecC-ce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRL------RSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~-~~ 155 (395)
..+|++.+.||+|+||+||+|... +++.||+|++... ....+.+..|+.+++.+ +|+||+.+++++... ..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 356899999999999999999865 6899999999753 33345677888888887 567999999998766 56
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc--EEEec
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH--AKVSD 233 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~--~kl~D 233 (395)
+++|||+. ++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+|
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK-----FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECC
T ss_pred EEEEeccC-CCHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEee
Confidence 69999996 68999886543 23589999999999999999999999 9999999999999999887 99999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~ 296 (395)
||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 246 FG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 246 FGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999754332 234578999999999999999999999999999999999999997543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=323.00 Aligned_cols=268 Identities=23% Similarity=0.362 Sum_probs=184.2
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
..++|.+.+.||+|+||+||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++... ..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 356899999999999999999995 478999999886432 23345788899999999999999999988766 677999
Q ss_pred EcccCCChhhhcccCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 160 DYMANGGLQEHLYPANGS-NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
||+++++|.+++...... ......+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999998542110 11234689999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCC---Cceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 239 IGSDKAG---GHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 239 ~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
....... ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||........ ........ ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~-~~ 245 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LMLTLQND-PP 245 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHHTSS-CC
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HHHHhccC-CC
Confidence 5433211 112234568999999999875 5789999999999999999999999975432110 00000000 00
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.......+...... .+..+.+++.+||+.||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 246 SLETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CTTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000111111112 23468899999999999999999999964
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=313.81 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=199.2
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc---------ccHHHHHHHHHHHhccC-CCcceeEEEEEe
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK---------QGEDEFKMEVELLGRLR-SPYLLALLGYCS 151 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 151 (395)
..++|.+.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4568999999999999999999975 689999999864321 12356778999999995 999999999998
Q ss_pred cC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEE
Q 016117 152 DR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 230 (395)
Q Consensus 152 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k 230 (395)
+. ..++||||+.+++|.+++.. ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 164 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE-------KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIK 164 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred cCCeEEEEEeccCCCcHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEE
Confidence 76 46699999999999999953 24689999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCceeeccccccccccchhhc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh
Q 016117 231 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL------TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 304 (395)
Q Consensus 231 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~ 304 (395)
|+|||++....... ......+++.|+|||++. ...++.++||||||+++|+|++|..||...... ..
T Consensus 165 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~- 237 (298)
T 1phk_A 165 LTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LM- 237 (298)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH-
T ss_pred EecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HH-
Confidence 99999997654322 223456899999999885 456889999999999999999999999643211 00
Q ss_pred hhhhcccccchhhhhhccccc--cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 305 SWALPRLTDREKILEIMDPAL--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~d~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+..... ........+..+.+++.+||+.||++|||+.+++++
T Consensus 238 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 238 ------------LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp ------------HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ------------HHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 000111000 001112234578999999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=317.43 Aligned_cols=262 Identities=19% Similarity=0.310 Sum_probs=199.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEE--cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCc------ceeEEEEEecC-ce
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL--SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY------LLALLGYCSDR-RK 155 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~-~~ 155 (395)
++|++.+.||+|+||+||+|.. .+++.||+|++... ....+.+.+|+.+++.++|+| ++++++++.+. ..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5788999999999999999986 36889999999753 334567888999999987654 99999988766 56
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC----------
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---------- 225 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---------- 225 (395)
++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENG-----FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred EEEEcCC-CCCHHHHHHhcC-----CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 7999999 889999986433 23688999999999999999999999 9999999999999987
Q ss_pred ---------CCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 016117 226 ---------NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296 (395)
Q Consensus 226 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~ 296 (395)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|..||....
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 678999999999864332 234568999999999999999999999999999999999999997543
Q ss_pred CCCCchhhhhhhcccccc-------------------------hhhhhhccccc-cCCCCHHHHHHHHHHHhhcCCCCCC
Q 016117 297 PSGEGVLVSWALPRLTDR-------------------------EKILEIMDPAL-EGQYSMKEVIQVAAIAAMCVQPEAD 350 (395)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~d~~~-~~~~~~~~~~~l~~li~~cl~~~p~ 350 (395)
.................. ........+.. ........+..+.+|+.+||+.||.
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 221111111000000000 00000000000 0112334567899999999999999
Q ss_pred CCCCHHHHHHH
Q 016117 351 YRPLMADVVQS 361 (395)
Q Consensus 351 ~RPt~~~vl~~ 361 (395)
+|||+.|++++
T Consensus 319 ~Rpt~~ell~h 329 (339)
T 1z57_A 319 KRITLREALKH 329 (339)
T ss_dssp TSCCHHHHTTS
T ss_pred cccCHHHHhcC
Confidence 99999999965
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=330.99 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=190.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-c------eEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R------KLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~------~~l 157 (395)
.+|++.+.||+|+||+||+|+...+..+|+|.+...... ..+|+++++.++||||+++++++... . .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 458889999999999999999877777999987543222 23599999999999999999988432 1 569
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC-CCCcEEEecccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGL 236 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~ 236 (395)
||||+.++.+........ ....+++..++.++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 116 v~e~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAK----LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEECCSEEHHHHHHHHHH----TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EeeccCccHHHHHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 999998754433321111 134689999999999999999999999 999999999999998 799999999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
+....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+....... ...
T Consensus 189 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p-~~~ 264 (394)
T 4e7w_A 189 AKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP-SRE 264 (394)
T ss_dssp CEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC-CHH
T ss_pred cccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC-CHH
Confidence 98653322 22345689999999998765 58999999999999999999999997543211100000000000 000
Q ss_pred hhhh----hcccccc--------CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 316 KILE----IMDPALE--------GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 316 ~~~~----~~d~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+.. .....+. ..+....+.++.+|+.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000 0000000 00111234578999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=325.67 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=183.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-------c
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------R 154 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------~ 154 (395)
++|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 6799999999999999999995 478999999986532 23346778999999999999999999988642 4
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+||
T Consensus 109 ~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CEEEEECC-CEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred EEEEeccc-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence 57999998 6899888842 4689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhh-----
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL----- 308 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~----- 308 (395)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+....
T Consensus 177 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 177 GLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred ccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999764322 234578999999999887 678999999999999999999999997543211100000000
Q ss_pred ---cccccchhhhhhcccccc-CCCCH-----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 309 ---PRLTDREKILEIMDPALE-GQYSM-----KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 309 ---~~~~~~~~~~~~~d~~~~-~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.... .......+..... ...+. ..+..+.+|+.+||+.||++|||+.+++++ .++..
T Consensus 252 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h--p~~~~ 317 (367)
T 2fst_X 252 ELLKKIS-SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQ 317 (367)
T ss_dssp HHHTTCC-CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTT
T ss_pred HHHHHhh-hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC--hhhhh
Confidence 0000 0000001000000 01111 123568899999999999999999999975 44543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=316.58 Aligned_cols=268 Identities=21% Similarity=0.313 Sum_probs=193.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEec-----------
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD----------- 152 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----------- 152 (395)
++|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 57888999999999999999976 589999999876655556788999999999999999999998732
Q ss_pred ----CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC-CCC
Q 016117 153 ----RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-KNF 227 (395)
Q Consensus 153 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~ 227 (395)
...++||||+. |+|.+++.. ..+++..++.++.|++.||+|||++ +++||||||+||+++ +++
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ--------GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred ccccCceeEEeeccC-CCHHHHhhc--------CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 24579999997 699999832 3589999999999999999999999 999999999999996 677
Q ss_pred cEEEeccccccccCCCCC-Cceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhh
Q 016117 228 HAKVSDFGLAKIGSDKAG-GHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS 305 (395)
Q Consensus 228 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~ 305 (395)
.+||+|||++........ ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999986533211 112233457899999998875 678999999999999999999999997543211100000
Q ss_pred hhhcccccchhhhhhcc-------cccc-CCCC-----HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 306 WALPRLTDREKILEIMD-------PALE-GQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~d-------~~~~-~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
...+.. ......++.. .... ...+ ...+..+.+|+.+||+.||++|||+.+++++ .++.
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~~~ 310 (320)
T 2i6l_A 239 ESIPVV-HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH--PYMS 310 (320)
T ss_dssp HHSCCC-CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS--HHHH
T ss_pred HhcCCC-chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC--cccc
Confidence 000000 0000000000 0000 0000 1224578999999999999999999999974 4444
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=322.89 Aligned_cols=271 Identities=20% Similarity=0.278 Sum_probs=198.4
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEec------Cce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSD------RRK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 155 (395)
.++|.+.+.||+|+||+||+|... +|+.||+|++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 357888999999999999999975 68999999997432 2334567889999999999999999998764 356
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
++++||+. |+|.+++.. ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||
T Consensus 90 ~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST--------QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp EEEECCCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEeccC-ccHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecc
Confidence 79999997 689998843 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCCc--------eeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhh
Q 016117 236 LAKIGSDKAGGH--------VSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 306 (395)
Q Consensus 236 ~~~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~ 306 (395)
++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 998654322111 1223568999999998764 6789999999999999999999999975431110000000
Q ss_pred hhcccc--------cchhhhhhcccccc-CCC-----CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 307 ALPRLT--------DREKILEIMDPALE-GQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 307 ~~~~~~--------~~~~~~~~~d~~~~-~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
...... ......+.+..... ... ....+..+.+|+.+||+.||++|||+.+++++ .++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~~~~ 311 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH--PYLQT 311 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC--ccccc
Confidence 000000 00000010000000 000 01234568899999999999999999999974 45543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=321.38 Aligned_cols=275 Identities=21% Similarity=0.258 Sum_probs=190.6
Q ss_pred HHHHHHhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-c-
Q 016117 78 KQLHSATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R- 154 (395)
Q Consensus 78 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~- 154 (395)
.......++|.+.+.||+|+||+||+|... +|+.||+|++.... .....+..++..++.++||||+++++++... .
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667789999999999999999999974 68999999886542 2234566788888999999999999988542 1
Q ss_pred ------eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCceeCCCCCCCEEeCC-
Q 016117 155 ------KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH--EHCSPPVIHRDFKSSNILLDK- 225 (395)
Q Consensus 155 ------~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~dlk~~Nill~~- 225 (395)
.++||||+.+ +|...+.... .....+++..+..++.|++.||.||| +. +++||||||+|||++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYY---RRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHH---TTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred cccceeEEEEeecccc-cHHHHHHHHh---hcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence 5699999986 4444332211 12346889999999999999999999 77 9999999999999986
Q ss_pred CCcEEEeccccccccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh
Q 016117 226 NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 304 (395)
Q Consensus 226 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~ 304 (395)
++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||........ .
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~ 241 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ---L 241 (360)
T ss_dssp TTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H
T ss_pred CCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH---H
Confidence 8999999999998654332 22345689999999998765 489999999999999999999999975432111 1
Q ss_pred hhhhccccc-chhhhhhccc----------------cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 305 SWALPRLTD-REKILEIMDP----------------ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 305 ~~~~~~~~~-~~~~~~~~d~----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
......... .......+++ ..........+..+.+|+.+||+.||.+|||+.+++++ .++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h--p~f~ 319 (360)
T 3e3p_A 242 HEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH--PYFD 319 (360)
T ss_dssp HHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS--GGGG
T ss_pred HHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC--cccc
Confidence 100000000 0000000000 00011122245679999999999999999999999975 5554
Q ss_pred h
Q 016117 368 Y 368 (395)
Q Consensus 368 ~ 368 (395)
.
T Consensus 320 ~ 320 (360)
T 3e3p_A 320 E 320 (360)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=314.33 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=190.6
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEec----------
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD---------- 152 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------- 152 (395)
.++|++.+.||+|+||+||+|... +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 356888999999999999999964 7899999998643 3345678899999999999999999998753
Q ss_pred ----CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc
Q 016117 153 ----RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH 228 (395)
Q Consensus 153 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~ 228 (395)
...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN------LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC------GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc------cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 24579999999999999996432 3578899999999999999999999 9999999999999999999
Q ss_pred EEEeccccccccCCCCC------------CceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 016117 229 AKVSDFGLAKIGSDKAG------------GHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVN 295 (395)
Q Consensus 229 ~kl~Dfg~~~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~ 295 (395)
+||+|||++........ ........|++.|+|||++.+. .++.++||||||+++|+|++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 99999999976432210 1122345689999999999864 78999999999999999998 55311
Q ss_pred CCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 296 KPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
. ..... . ..+.. ....+....+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 232 ~-----~~~~~-~------~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 M-----ERVNI-L------KKLRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp H-----HHHHH-H------HHHHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h-----hHHHH-H------Hhccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0 00000 0 00000 11112223334445668899999999999999999999964
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=320.99 Aligned_cols=266 Identities=20% Similarity=0.329 Sum_probs=199.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-----------CCcceeEEEEEec
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-----------SPYLLALLGYCSD 152 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~ 152 (395)
++|.+.+.||+|+||+||+|.. .+++.||+|++... ....+.+.+|+.++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5788999999999999999996 47899999999743 334467788999999886 8899999998764
Q ss_pred C-----ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC---
Q 016117 153 R-----RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD--- 224 (395)
Q Consensus 153 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~--- 224 (395)
. ..+++|||+ +++|.+++.... ...+++..++.++.|++.||.|||+++ +++||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYE-----HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhh-----ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence 3 356999999 899999996543 235899999999999999999999853 799999999999994
Q ss_pred ---CCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc
Q 016117 225 ---KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 301 (395)
Q Consensus 225 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~ 301 (395)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|..||.........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4558999999999765432 22346899999999999999999999999999999999999999755432111
Q ss_pred hh---hhhhhcccc------------------cch-----------hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCC
Q 016117 302 VL---VSWALPRLT------------------DRE-----------KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEA 349 (395)
Q Consensus 302 ~~---~~~~~~~~~------------------~~~-----------~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p 349 (395)
.. .......+. ... .....+.. ....+...+..+.+|+.+||+.||
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSST
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhccCc
Confidence 00 000000000 000 00000000 113456778899999999999999
Q ss_pred CCCCCHHHHHHHHHHhhhh
Q 016117 350 DYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 350 ~~RPt~~~vl~~L~~~~~~ 368 (395)
++|||+.+++++ .++..
T Consensus 323 ~~Rpt~~ell~h--p~f~~ 339 (373)
T 1q8y_A 323 RKRADAGGLVNH--PWLKD 339 (373)
T ss_dssp TTCBCHHHHHTC--GGGTT
T ss_pred cccCCHHHHhhC--hhhhc
Confidence 999999999974 45543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=320.30 Aligned_cols=263 Identities=23% Similarity=0.328 Sum_probs=195.6
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecCc------
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR------ 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 154 (395)
.++|.+.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 357889999999999999999965 68999999997532 223467889999999999999999999987653
Q ss_pred -eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEec
Q 016117 155 -KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSD 233 (395)
Q Consensus 155 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~D 233 (395)
.++||||+. ++|.+++. ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|
T Consensus 121 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~D 187 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG---------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD 187 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECS
T ss_pred eEEEEEcccc-ccHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEe
Confidence 289999997 68888872 3489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh-----
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA----- 307 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~----- 307 (395)
||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...............
T Consensus 188 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 262 (371)
T 4exu_A 188 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 262 (371)
T ss_dssp TTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 9999754322 234568999999999887 68899999999999999999999999754321100000000
Q ss_pred ---hcccccchhhhhhccccc---cCC---CCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 308 ---LPRLTDREKILEIMDPAL---EGQ---YSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 308 ---~~~~~~~~~~~~~~d~~~---~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
..... ............ ... .....+..+.+|+.+||+.||++|||+.+++++ .++.
T Consensus 263 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h--p~f~ 328 (371)
T 4exu_A 263 TEFVQKLN-DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH--PFFE 328 (371)
T ss_dssp HHHHTTCS-CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS--GGGT
T ss_pred HHHHHHhh-hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC--cccc
Confidence 00000 000000000000 000 001224578999999999999999999999975 4444
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=330.67 Aligned_cols=260 Identities=24% Similarity=0.322 Sum_probs=190.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-------ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------~~~ 156 (395)
.+|++.+.||+|+||+||+|.+. +|+.||||++..... .+.+|+++++.++||||+++++++... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35888899999999999999975 689999998865322 234699999999999999999987431 145
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC-CcEEEeccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFG 235 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg 235 (395)
+||||+.+ +|.+.+.... .....+++..++.++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 130 lv~e~~~~-~l~~~~~~~~---~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYS---RAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEECCCE-EHHHHHHHHH---HTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eehhcccc-cHHHHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence 89999986 5655553211 1124689999999999999999999998 99999999999999855 678999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc-
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD- 313 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~- 313 (395)
+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.. ....+..
T Consensus 203 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~-i~~~lg~p 276 (420)
T 1j1b_A 203 SAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVE-IIKVLGTP 276 (420)
T ss_dssp TCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCSC
T ss_pred hhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCC
Confidence 998654322 22345789999999998765 799999999999999999999999975432111 100 0000000
Q ss_pred -chhhhhh-------ccccccC-----CCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 -REKILEI-------MDPALEG-----QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 -~~~~~~~-------~d~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+..+ ..+.+.. .+....+.++.+|+.+||+.||.+|||+.|++++
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0000000 0000000 0111234578999999999999999999999964
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=327.65 Aligned_cols=253 Identities=23% Similarity=0.279 Sum_probs=184.1
Q ss_pred CCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEEEcccC
Q 016117 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVYDYMAN 164 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~e~~~~ 164 (395)
|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++.+. ..++||||+.
T Consensus 17 ~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp EEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 4456789999999998777778999999998643 245678899999986 899999999998876 4569999995
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC-------------CcEEE
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-------------FHAKV 231 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-------------~~~kl 231 (395)
|+|.+++.............++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 699999965442211111224445678999999999999999 99999999999999654 58999
Q ss_pred eccccccccCCCCCCc--eeeccccccccccchhhcc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCc
Q 016117 232 SDFGLAKIGSDKAGGH--VSTRVLGTQGYVAPEYALT-------GHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEG 301 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~ 301 (395)
+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.......
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-- 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-- 247 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence 9999998654432111 1234579999999999975 678999999999999999999 999996432110
Q ss_pred hhhhhhhcccccchhhhhhcc-ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 302 VLVSWALPRLTDREKILEIMD-PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~d-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
.. ....... +..........+.++.+++.+||+.||.+|||+.++++
T Consensus 248 --~~----------i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 --SN----------IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp --HH----------HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HH----------HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00 0111111 11112224456778999999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=317.40 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=193.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecCc-------
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR------- 154 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------- 154 (395)
++|.+.+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 56888899999999999999964 68999999987532 223457888999999999999999999987652
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.+++|||+. ++|.+++. ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+||
T Consensus 104 ~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 170 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG---------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 170 (353)
T ss_dssp CEEEEECCS-EEGGGTTT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECST
T ss_pred EEEEecccc-CCHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeec
Confidence 389999997 68888772 3489999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh------
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA------ 307 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~------ 307 (395)
|++...... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|..||...............
T Consensus 171 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 171 GLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 245 (353)
T ss_dssp TCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCH
T ss_pred ccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999754322 233568999999999887 67899999999999999999999999754321100000000
Q ss_pred --hcccccchhhhhhc---ccccc---CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 308 --LPRLTDREKILEIM---DPALE---GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 308 --~~~~~~~~~~~~~~---d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...... ......+ ..... .......+..+.+|+.+||+.||++|||+.+++++
T Consensus 246 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLND-KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSC-HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhh-HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 0000000 00000 01122345678999999999999999999999964
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.22 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=197.6
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
..++|++.+.||+|+||+||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+. ..+++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3457999999999999999999975 7899999998643 234567889999999999999999999998876 56699
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC---CcEEEeccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN---FHAKVSDFG 235 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~---~~~kl~Dfg 235 (395)
+||+.+++|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.+ +.+||+|||
T Consensus 100 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 100 GELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp ECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccC
Confidence 9999999999988532 3689999999999999999999999 99999999999999764 479999999
Q ss_pred cccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 236 LAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
++....... ......+++.|+|||.+.+ .++.++||||||+++|+|++|..||...... ....
T Consensus 170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~---------- 232 (287)
T 2wei_A 170 LSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DILK---------- 232 (287)
T ss_dssp GGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----------
T ss_pred cceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHHH----------
Confidence 997654322 1223458899999998875 4899999999999999999999999754311 0000
Q ss_pred hhhhhccccccCCC--CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 316 KILEIMDPALEGQY--SMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 316 ~~~~~~d~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.+......... ....+..+.+++.+||+.+|++|||+.+++++
T Consensus 233 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 233 ---RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ---HHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---HHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00000000000 01223568899999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=323.22 Aligned_cols=276 Identities=21% Similarity=0.282 Sum_probs=183.7
Q ss_pred CCC-CCeeeccCCeEEEEEEEc---CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEec--C-ceEEEE
Q 016117 87 FSK-SNVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD--R-RKLLVY 159 (395)
Q Consensus 87 ~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~-~~~lv~ 159 (395)
|.+ .++||+|+||+||+|... +++.||+|++.... ....+.+|+.+++.++||||+++++++.. . ..++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 554 458999999999999965 57889999997542 23468889999999999999999998843 3 567999
Q ss_pred EcccCCChhhhcccCCC--CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe----CCCCcEEEec
Q 016117 160 DYMANGGLQEHLYPANG--SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL----DKNFHAKVSD 233 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~--~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----~~~~~~kl~D 233 (395)
||+. |+|.+++..... .......+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9986 578777743211 011223599999999999999999999999 99999999999999 7789999999
Q ss_pred cccccccCCCCC-CceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc------hhhh
Q 016117 234 FGLAKIGSDKAG-GHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG------VLVS 305 (395)
Q Consensus 234 fg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~------~~~~ 305 (395)
||++........ ........||+.|+|||++.+. .++.++|||||||++|||++|..||......... ....
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 999986543211 1223346789999999999874 5899999999999999999999999754432100 0000
Q ss_pred hhhcc--------------cccchhhhhhccccccCCCCH---------HHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 016117 306 WALPR--------------LTDREKILEIMDPALEGQYSM---------KEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362 (395)
Q Consensus 306 ~~~~~--------------~~~~~~~~~~~d~~~~~~~~~---------~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L 362 (395)
..... ..........+.......... .....+.+|+.+||+.||.+|||+.|++++
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h- 334 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD- 334 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS-
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC-
Confidence 00000 000000000000000000000 013467899999999999999999999985
Q ss_pred HHhhhhcC
Q 016117 363 VPLVKYNR 370 (395)
Q Consensus 363 ~~~~~~~~ 370 (395)
.++....
T Consensus 335 -p~f~~~~ 341 (405)
T 3rgf_A 335 -PYFLEDP 341 (405)
T ss_dssp -GGGTSSS
T ss_pred -hhhccCC
Confidence 6665433
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=316.30 Aligned_cols=201 Identities=25% Similarity=0.326 Sum_probs=167.5
Q ss_pred HhCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CC-----cceeEEEEEecC-c
Q 016117 83 ATGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SP-----YLLALLGYCSDR-R 154 (395)
Q Consensus 83 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~-~ 154 (395)
..++|.+.+.||+|+||+||+|... +++.||+|++... ....+.+..|+.+++.++ |+ +++.+++++... .
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3568999999999999999999965 6889999999743 333456777888888885 44 499999988765 5
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC--CCCcEEEe
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD--KNFHAKVS 232 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~~~kl~ 232 (395)
.++||||+. |+|.+++.... ...+++..++.++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTN-----FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTT-----TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred eEEEEecCC-CCHHHHHhhcC-----cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 679999996 59999986543 23589999999999999999999953 22899999999999994 57889999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNK 296 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~ 296 (395)
|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 204 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 204 DFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999865432 234568999999999999999999999999999999999999997543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=314.01 Aligned_cols=263 Identities=21% Similarity=0.308 Sum_probs=196.8
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CC-cEEEEEEeccCCcccHHHHHHHHHHHhccCCCc------ceeEEEEEecC-c
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NG-RKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY------LLALLGYCSDR-R 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~-~ 154 (395)
.++|.+.+.||+|+||+||+|... ++ +.||+|++... ....+.+..|+.+++.++|++ ++.+.+++... .
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 367899999999999999999964 34 68999999753 334567888999999998766 88899988765 5
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEe-----------
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILL----------- 223 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill----------- 223 (395)
.++||||+ +++|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~-----~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN-----FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECC
T ss_pred EEEEEecc-CCChHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccc
Confidence 67999999 667777775432 23689999999999999999999998 99999999999999
Q ss_pred --------CCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 016117 224 --------DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVN 295 (395)
Q Consensus 224 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~ 295 (395)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|..||...
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 56789999999999864332 23456899999999999999999999999999999999999999754
Q ss_pred CCCCCchhhhhhhcccccc-------------------------hhhhhhcccc-ccCCCCHHHHHHHHHHHhhcCCCCC
Q 016117 296 KPSGEGVLVSWALPRLTDR-------------------------EKILEIMDPA-LEGQYSMKEVIQVAAIAAMCVQPEA 349 (395)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~d~~-~~~~~~~~~~~~l~~li~~cl~~~p 349 (395)
................... ........+. ............+.+|+.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 3211111010000000000 0000000000 0011223445689999999999999
Q ss_pred CCCCCHHHHHHH
Q 016117 350 DYRPLMADVVQS 361 (395)
Q Consensus 350 ~~RPt~~~vl~~ 361 (395)
++|||+.+++++
T Consensus 323 ~~Rpt~~e~l~h 334 (355)
T 2eu9_A 323 AQRITLAEALLH 334 (355)
T ss_dssp TTSCCHHHHTTS
T ss_pred hhCcCHHHHhcC
Confidence 999999999964
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=313.80 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=170.8
Q ss_pred hCCCCCC-CeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEec----C-ceE
Q 016117 84 TGGFSKS-NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSD----R-RKL 156 (395)
Q Consensus 84 ~~~~~~~-~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~-~~~ 156 (395)
.++|.+. ++||+|+||+||+|... +|+.||+|++... .....+....++.++||||+++++++.. . ..+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 3568874 46999999999999976 6899999998643 1222223344566799999999998864 2 357
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC---CCcEEEec
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSD 233 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~D 233 (395)
+||||+.+|+|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+|||++. ++.+||+|
T Consensus 103 lv~e~~~gg~L~~~l~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG-----DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEECCTTEEHHHHHHTC------CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEeccCCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 9999999999999996432 24699999999999999999999999 9999999999999976 45599999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
||++...... ......+|+.|+|||++.+..++.++||||||+++|+|++|..||............. ...
T Consensus 175 fg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~-- 245 (336)
T 3fhr_A 175 FGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRI-- 245 (336)
T ss_dssp CTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred cccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhh--
Confidence 9999754432 1234568999999999988889999999999999999999999997543221100000 000
Q ss_pred chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. . ............+..+.+|+.+||+.||++|||+.+++++
T Consensus 246 --~~-~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 246 --RL-G--QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --hc-c--ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0 0000111112234568899999999999999999999974
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=312.14 Aligned_cols=257 Identities=23% Similarity=0.372 Sum_probs=174.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-ccHHHHHHHHH-HHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-QGEDEFKMEVE-LLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|.+.+.||+|+||.||+|... +|+.||+|++..... .....+..|.. +++.++||||+++++++.+. ..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 67888999999999999999975 789999999875422 22344555655 77778999999999998776 5669999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+ +|.+++..... .....+++..+..++.|++.||.|||+.. +++||||||+|||++.++.+||+|||++...
T Consensus 102 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 102 LMST-SFDKFYKYVYS--VLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCSE-EHHHHHHHHHH--TTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred ecCC-ChHHHHHHHHh--hhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9985 77777642110 01346899999999999999999999842 7999999999999999999999999999764
Q ss_pred CCCCCCceeeccccccccccchhh----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYA----LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
.... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||......... .. ...
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~-~~~---- 243 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----LT-QVV---- 243 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C-CCC----
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----HH-HHh----
Confidence 4322 12234689999999998 4567899999999999999999999999753221000 00 000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....+.+........+..+.+|+.+||+.||++|||+.+++++
T Consensus 244 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 244 --KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp --CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000111111111234568999999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=311.72 Aligned_cols=244 Identities=23% Similarity=0.421 Sum_probs=189.5
Q ss_pred HHHHhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcc------cHHHHHHHHHHHhcc----CCCcceeEEE
Q 016117 80 LHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ------GEDEFKMEVELLGRL----RSPYLLALLG 148 (395)
Q Consensus 80 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~l~~ 148 (395)
.....++|.+.+.||+|+||.||+|.. .+++.||+|++...... ....+..|+.++.++ +|+||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 344567899999999999999999985 47889999998654221 122455689999988 8999999999
Q ss_pred EEecC-ceEEEEEc-ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC-C
Q 016117 149 YCSDR-RKLLVYDY-MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-K 225 (395)
Q Consensus 149 ~~~~~-~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~ 225 (395)
++.+. ..++++|+ +.+++|.+++... ..+++..++.++.|++.||.|||++ +++||||||+||+++ .
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK-------GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLR 175 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETT
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCC
Confidence 98765 56799999 7899999999542 3589999999999999999999999 999999999999998 8
Q ss_pred CCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh
Q 016117 226 NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLT-TKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV 304 (395)
Q Consensus 226 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~ 304 (395)
++.+||+|||++....... .....|+..|+|||++.+..+. .++||||||+++|+|++|+.||.....
T Consensus 176 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------- 244 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------- 244 (312)
T ss_dssp TTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred CCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------
Confidence 8999999999998654322 2345689999999999877664 589999999999999999999963210
Q ss_pred hhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 305 SWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 305 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+..... ..+...+..+.+++.+||+.+|++|||+.+++++
T Consensus 245 ---------------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ---------------ILEAEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ---------------HHHTCC--CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------------Hhhhcc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 1112234568899999999999999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=310.58 Aligned_cols=245 Identities=23% Similarity=0.367 Sum_probs=195.0
Q ss_pred HHHHHhCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcc------cHHHHHHHHHHHhccC--CCcceeEEEE
Q 016117 79 QLHSATGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ------GEDEFKMEVELLGRLR--SPYLLALLGY 149 (395)
Q Consensus 79 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~ 149 (395)
+.....++|.+.+.||+|+||+||+|.. .+++.||+|++...... ..+.+..|+.+++.++ |+|+++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3344567899999999999999999995 47899999998653221 1235667999999996 5999999999
Q ss_pred EecC-ceEEEEEcccC-CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC-CC
Q 016117 150 CSDR-RKLLVYDYMAN-GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-KN 226 (395)
Q Consensus 150 ~~~~-~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~ 226 (395)
+.+. ..++++|++.+ ++|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+|||++ ++
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR 186 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCC
Confidence 9876 45699999976 899999853 24689999999999999999999999 999999999999998 78
Q ss_pred CcEEEeccccccccCCCCCCceeeccccccccccchhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhh
Q 016117 227 FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS 305 (395)
Q Consensus 227 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~ 305 (395)
+.+||+|||++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|..||.....
T Consensus 187 ~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------- 254 (320)
T 3a99_A 187 GELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------- 254 (320)
T ss_dssp TEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred CCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------
Confidence 99999999999865432 2234568999999999987765 6789999999999999999999963210
Q ss_pred hhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 306 WALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
. .... ...... .+..+.+|+.+||+.||++|||+.+++++
T Consensus 255 ~----------~~~~--~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 I----------IRGQ--VFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp H----------HHCC--CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred h----------hccc--cccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000 001112 23468899999999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=318.54 Aligned_cols=246 Identities=24% Similarity=0.324 Sum_probs=181.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEecCc-eEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDRR-KLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~lv~e~~ 162 (395)
.+|.+.+.||+|+||+||.....+|+.||||++...... .+.+|+.+++.+ +||||+++++++.+.. .++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 357778899999999977655668999999998654322 356799999999 8999999999988774 56999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-----CCcEEEeccccc
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-----NFHAKVSDFGLA 237 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfg~~ 237 (395)
. |+|.+++..... .+....++.++.|++.||.|||++ +|+||||||+|||++. ...+||+|||++
T Consensus 101 ~-g~L~~~l~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 101 A-ATLQEYVEQKDF------AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp S-EEHHHHHHSSSC------CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred C-CCHHHHHHhcCC------CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 6 699999965432 234445678999999999999999 9999999999999953 346889999999
Q ss_pred cccCCCCCC-ceeeccccccccccchhhc---cCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccc
Q 016117 238 KIGSDKAGG-HVSTRVLGTQGYVAPEYAL---TGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 238 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
......... .......||+.|+|||++. ...++.++|||||||++|||++ |..||...... ...
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~~~------- 239 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----QAN------- 239 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----HHH-------
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----HHH-------
Confidence 865432211 1233467999999999997 4567889999999999999999 99998533210 000
Q ss_pred cchhhhhhcccc-cc-CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 313 DREKILEIMDPA-LE-GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 313 ~~~~~~~~~d~~-~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
...... .. ..........+.+|+.+||+.||.+|||+.++++
T Consensus 240 ------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 240 ------ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ------HHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------HHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000000 00 0112234556889999999999999999999994
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=333.99 Aligned_cols=240 Identities=23% Similarity=0.380 Sum_probs=192.4
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc--CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-c-----
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS--NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-R----- 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~----- 154 (395)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.... ......+..|+.++++++||||+++++++... .
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 68999999986432 23345788999999999999999999998754 2
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++||||+++++|.+++. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.+ .+||+||
T Consensus 159 ~~lv~E~~~g~~L~~~~~---------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKG---------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp EEEEEECCCCEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCC
T ss_pred eEEEEEeCCCCcHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEec
Confidence 589999999999988773 2689999999999999999999999 99999999999999886 9999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
|++...... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.......
T Consensus 226 G~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~--------------- 283 (681)
T 2pzi_A 226 GAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG--------------- 283 (681)
T ss_dssp TTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------
T ss_pred ccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------
Confidence 999865432 3456899999999987654 889999999999999999998876321100
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-HHHHHHHHHHhhh
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-MADVVQSLVPLVK 367 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~~vl~~L~~~~~ 367 (395)
+ ............+.+|+.+||+.||++||+ ++++.+.|..++.
T Consensus 284 -----~----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 284 -----L----PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp -----C----CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred -----c----cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0 000011122356889999999999999994 6667777776654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=305.93 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=174.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc-c-HHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ-G-EDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|++.+.||+|+||.||+|... +|+.||+|++...... . .+.+.++..+++.++||||+++++++.+. ..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 56888899999999999999975 7899999998754322 1 23344455678888999999999998876 5669999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
|+ ++.+..+.... ...+++..++.++.|++.||.|||+ + +++|+||||+||+++.++.+||+|||++..
T Consensus 105 ~~-~~~~~~l~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM------QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp CC-SEEHHHHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred cc-CCcHHHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 99 44454444221 2468999999999999999999998 5 899999999999999999999999999975
Q ss_pred cCCCCCCceeeccccccccccchhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
..... ......+++.|+|||++. ...++.++||||||+++|+|++|..||...... ...
T Consensus 175 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~----------- 238 (318)
T 2dyl_A 175 LVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEV----------- 238 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHH-----------
T ss_pred ccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHH-----------
Confidence 43322 223456899999999984 457889999999999999999999999743211 000
Q ss_pred hhhhhhccccc-cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 315 EKILEIMDPAL-EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 315 ~~~~~~~d~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+..... ........+..+.+++.+||+.||.+|||+.+++++
T Consensus 239 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 239 --LTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --HHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --HHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011110000 000011233568899999999999999999999964
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=328.97 Aligned_cols=270 Identities=23% Similarity=0.342 Sum_probs=202.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEec------C-c
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD------R-R 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~-~ 154 (395)
.++|.+.+.||+|+||+||+|.. .+|+.||+|++... .....+.+.+|+++++.++||||+++++++.. . .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999996 46899999998753 23345678899999999999999999998754 2 4
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCc---EEE
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFH---AKV 231 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~---~kl 231 (395)
.++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++. +||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~----~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE----NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS----CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred EEEEEEeCCCCCHHHHHHhcc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEE
Confidence 679999999999999996543 123588999999999999999999999 9999999999999987665 999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
+|||++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||..... ...|....
T Consensus 166 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i- 236 (676)
T 3qa8_A 166 IDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKV- 236 (676)
T ss_dssp CSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTC-
T ss_pred ccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhh-
Confidence 9999998654332 22346789999999999999999999999999999999999999964311 11111000
Q ss_pred ccchhhhhh----------ccc--cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHH-----HHHHHHHhhhhc
Q 016117 312 TDREKILEI----------MDP--ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMAD-----VVQSLVPLVKYN 369 (395)
Q Consensus 312 ~~~~~~~~~----------~d~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~-----vl~~L~~~~~~~ 369 (395)
......... +.. ..........+..+.+++.+||+.||++|||+.+ ..+.++.++...
T Consensus 237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 000000000 000 0112334456778999999999999999999988 456677776643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=296.43 Aligned_cols=233 Identities=16% Similarity=0.121 Sum_probs=180.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc---cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+. ..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57899999999999999999975 5899999999754332 236788999999999999999999998776 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+++|.+++.. .....++..++.|++.||.|||++ +++||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~---------~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT---------SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp ECCCEEEHHHHHTT---------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred EecCCCCHHHHHhc---------CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----
Confidence 99999999999831 235567889999999999999999 99999999999999999999997443
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
|++ .++.++|||||||++|||++|+.||............ .......
T Consensus 175 ------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~~----- 221 (286)
T 3uqc_A 175 ------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTAGQ----- 221 (286)
T ss_dssp ------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCTTSC-----
T ss_pred ------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHhccC-----
Confidence 333 3688999999999999999999999865432211000 0000000
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
... ........+..+.+++.+||+.||++| |+.++++.|+++.....
T Consensus 222 -~~~--~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 222 -PIE--PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp -BCC--HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred -CCC--hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 000 000011223468899999999999999 99999999999887543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=317.15 Aligned_cols=243 Identities=16% Similarity=0.198 Sum_probs=176.9
Q ss_pred CCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCC-Ccc----------ee-----
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRS-PYL----------LA----- 145 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~ni----------v~----- 145 (395)
.|...+.||+|+||+||+|.+ .+|+.||||++..... ...+.+.+|+.+++.++| +|. +.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 466778999999999999995 4799999999874322 235678899999999977 221 11
Q ss_pred ------EEEEEec------CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCcee
Q 016117 146 ------LLGYCSD------RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIH 213 (395)
Q Consensus 146 ------l~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H 213 (395)
+..++.. ...+++|++ .+++|.+++............+++..++.++.|++.||+|||++ +|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 1111111 123455554 46899988842211111234688889999999999999999999 9999
Q ss_pred CCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhh----------ccCCCCccchhHHHHHHHH
Q 016117 214 RDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA----------LTGHLTTKSDVYSYGVVLL 283 (395)
Q Consensus 214 ~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~DvwslG~~l~ 283 (395)
|||||+|||++.++.+||+|||++...... ....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999999999999998753322 334567 999999999 5556888999999999999
Q ss_pred HHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 016117 284 ELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360 (395)
Q Consensus 284 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~ 360 (395)
||++|+.||........ ...++... ... +..+.+|+.+||+.||++|||+.++++
T Consensus 309 elltg~~Pf~~~~~~~~----------------~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG----------------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHSSCCCCTTGGGSC----------------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCCCCcchhhh----------------HHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999975432110 11111111 122 256899999999999999999877753
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=289.34 Aligned_cols=226 Identities=21% Similarity=0.310 Sum_probs=174.7
Q ss_pred CCCCCC-CeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHH-hccCCCcceeEEEEEec----C-ceE
Q 016117 85 GGFSKS-NVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELL-GRLRSPYLLALLGYCSD----R-RKL 156 (395)
Q Consensus 85 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~-~~~ 156 (395)
++|.+. +.||+|+||.||++.. .+++.||+|++... ..+.+|++++ +..+||||+++++++.. . ..+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456665 7799999999999996 47899999998642 4567788888 55699999999998865 3 467
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC---CCcEEEec
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSD 233 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~D 233 (395)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+|||++. ++.+||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEECCCCSCBHHHHHHHCT-----TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEeecCCCcHHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 9999999999999996533 23689999999999999999999999 9999999999999998 78999999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
||++.... +..++.++|||||||++|||++|..||.......... ...
T Consensus 164 fg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------~~~- 211 (299)
T 3m2w_A 164 FGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMK- 211 (299)
T ss_dssp CTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------CSC-
T ss_pred cccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------HHH-
Confidence 99986432 1346779999999999999999999997543221000 000
Q ss_pred chhhhhhccccccCCCC----HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 REKILEIMDPALEGQYS----MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 ~~~~~~~~d~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+.... ...+ ...+..+.+|+.+||+.||++|||+.+++++
T Consensus 212 ----~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 212 ----TRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ----CSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000 0111 1124578999999999999999999999974
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=293.19 Aligned_cols=241 Identities=17% Similarity=0.194 Sum_probs=183.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC--------cccHHHHHHHHHHHhccC---------CCcceeEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--------KQGEDEFKMEVELLGRLR---------SPYLLALL 147 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~l~ 147 (395)
++|++.+.||+|+||+||+|+. +|+.||+|++.... ....+.+.+|+.+++.++ |||++++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4688899999999999999998 78999999987542 223367889999999886 88888887
Q ss_pred EEEe-------------------------------cCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHH
Q 016117 148 GYCS-------------------------------DRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 196 (395)
Q Consensus 148 ~~~~-------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i 196 (395)
+++. ....++||||+.+|++.+.+.. ..+++..++.++.|+
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--------~~~~~~~~~~i~~qi 170 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--------KLSSLATAKSILHQL 170 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--------TCCCHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--------cCCCHHHHHHHHHHH
Confidence 7642 4567899999999987777732 358999999999999
Q ss_pred HHHHHHHh-cCCCCCceeCCCCCCCEEeCCCC--------------------cEEEeccccccccCCCCCCceeeccccc
Q 016117 197 AKGLEFLH-EHCSPPVIHRDFKSSNILLDKNF--------------------HAKVSDFGLAKIGSDKAGGHVSTRVLGT 255 (395)
Q Consensus 197 ~~~l~~LH-~~~~~~i~H~dlk~~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~ 255 (395)
+.||.||| ++ +|+||||||+|||++.++ .+||+|||+++..... ...||
T Consensus 171 ~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt 240 (336)
T 2vuw_A 171 TASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFC 240 (336)
T ss_dssp HHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECC
T ss_pred HHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEe
Confidence 99999999 88 999999999999999887 8999999999865432 34799
Q ss_pred cccccchhhccCCCCccchhHHHHHH-HHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh-hccccccCCCCHHH
Q 016117 256 QGYVAPEYALTGHLTTKSDVYSYGVV-LLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE-IMDPALEGQYSMKE 333 (395)
Q Consensus 256 ~~y~aPE~~~~~~~~~~~DvwslG~~-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~d~~~~~~~~~~~ 333 (395)
+.|+|||++.+.. +.++||||+|++ .+++++|..||... .|.. ... ...... ..............
T Consensus 241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~ 308 (336)
T 2vuw_A 241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLH-YLT-DKMLKQMTFKTKCNTPAMKQI 308 (336)
T ss_dssp CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHH-HHH-HHHHHTCCCSSCCCSHHHHHH
T ss_pred ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhh-HHH-HhhhhhhccCcccchhhhhhc
Confidence 9999999998766 889999998777 77788899988420 0000 000 000000 00111111122356
Q ss_pred HHHHHHHHhhcCCCCCCCCCCHHHHH-HH
Q 016117 334 VIQVAAIAAMCVQPEADYRPLMADVV-QS 361 (395)
Q Consensus 334 ~~~l~~li~~cl~~~p~~RPt~~~vl-~~ 361 (395)
+.++.+|+.+||+.| |+.|++ ++
T Consensus 309 s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 309 KRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred CHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 778999999999976 999988 53
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-31 Score=263.98 Aligned_cols=183 Identities=17% Similarity=0.114 Sum_probs=126.4
Q ss_pred eeccCCeEEEEEE-EcCCcEEEEEEeccCC----------cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEEE
Q 016117 93 VGHGGFGLVYRGV-LSNGRKVAIKLMDQAG----------KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 93 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv~ 159 (395)
.+.|++|.+..++ ..-|+.+++|++.... ....++|.+|+++|+++ .|+||+++++++.++ ..|+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5566666665554 3358889999986431 12335789999999999 799999999999887 677999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||++|++|.++|... ..++.. +|+.||+.||+|+|++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 322 Eyv~G~~L~d~i~~~-------~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG-------EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp ECCCSEEHHHHHHTT-------CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred ecCCCCcHHHHHHhC-------CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCee
Confidence 999999999999543 345543 5889999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCC
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~p 291 (395)
..... ......+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 389 ~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 389 TPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 54322 22345679999999999876 467789999999998887665544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=233.20 Aligned_cols=184 Identities=21% Similarity=0.207 Sum_probs=140.9
Q ss_pred CCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcc--------cHHHHHHHHHHHhccCCCcceeEEEEE-ecCceEEE
Q 016117 88 SKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ--------GEDEFKMEVELLGRLRSPYLLALLGYC-SDRRKLLV 158 (395)
Q Consensus 88 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~lv 158 (395)
...+.||+|+||+||++.. .++.+++|........ ..+.+.+|++++++++||||+++..++ ...+.++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999954 6788999976532211 124578999999999999999544443 34467899
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+++++|.+++.. +..++.|++.||.|||++ +|+||||||+|||++. .+||+|||+++
T Consensus 418 mE~~~ggsL~~~l~~---------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~ 477 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGK 477 (540)
T ss_dssp EECCCSEEHHHHSTT---------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred EECCCCCCHHHHHHH---------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCE
Confidence 999999999999942 467999999999999999 9999999999999998 99999999998
Q ss_pred ccCCCCCCc-----eeeccccccccccchhhcc--CCCCccchhHHHHHHHHHHHhCCCCC
Q 016117 239 IGSDKAGGH-----VSTRVLGTQGYVAPEYALT--GHLTTKSDVYSYGVVLLELLTGRVPI 292 (395)
Q Consensus 239 ~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~~l~ell~g~~pf 292 (395)
......... ......||+.|+|||++.. ..|+...|+|+..+-..+.+.++.+|
T Consensus 478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 754321111 1134679999999999986 56888899999999998888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=201.40 Aligned_cols=155 Identities=12% Similarity=0.066 Sum_probs=124.0
Q ss_pred cHHHHHHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCc------------------ccHHHHHHHHHHHhc
Q 016117 76 TFKQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK------------------QGEDEFKMEVELLGR 137 (395)
Q Consensus 76 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~ 137 (395)
.+..+......|.+.+.||+|+||.||+|...+|+.||+|++..... .....+.+|+.+++.
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 34455555566778899999999999999997799999999864321 124568899999999
Q ss_pred cCCCcceeEEEEEecCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCC
Q 016117 138 LRSPYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK 217 (395)
Q Consensus 138 l~h~niv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk 217 (395)
++ | +++.+++..+..++||||+++|+|.+ +.. .....++.|++.||.|||++ +++|||||
T Consensus 161 l~--~-~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~-------------~~~~~i~~qi~~~l~~lH~~---giiHrDlk 220 (282)
T 1zar_A 161 LQ--G-LAVPKVYAWEGNAVLMELIDAKELYR-VRV-------------ENPDEVLDMILEEVAKFYHR---GIVHGDLS 220 (282)
T ss_dssp TT--T-SSSCCEEEEETTEEEEECCCCEEGGG-CCC-------------SCHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred cc--C-CCcCeEEeccceEEEEEecCCCcHHH-cch-------------hhHHHHHHHHHHHHHHHHHC---CCEeCCCC
Confidence 99 4 66666666667799999999999998 511 12346999999999999999 99999999
Q ss_pred CCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhcc
Q 016117 218 SSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 266 (395)
Q Consensus 218 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 266 (395)
|+|||++ ++.+||+|||++.. +..++|||.+..
T Consensus 221 p~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 221 QYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp TTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred HHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 9999999 99999999999863 233789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.4e-21 Score=171.39 Aligned_cols=137 Identities=18% Similarity=0.133 Sum_probs=106.1
Q ss_pred CCCCCCeeeccCCeEEEEEEE-cCCcE--EEEEEeccCCcc------------------------cHHHHHHHHHHHhcc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVL-SNGRK--VAIKLMDQAGKQ------------------------GEDEFKMEVELLGRL 138 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l 138 (395)
-|.+.+.||+|+||.||+|.. .+|+. ||||++...... ....+..|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 366788999999999999997 68989 999987543111 013578899999999
Q ss_pred CCCcc--eeEEEEEecCceEEEEEcccC-C----ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCC
Q 016117 139 RSPYL--LALLGYCSDRRKLLVYDYMAN-G----GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH-EHCSPP 210 (395)
Q Consensus 139 ~h~ni--v~l~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ 210 (395)
.|+++ ..++.+ ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| +. +
T Consensus 128 ~~~~i~~p~~~~~---~~~~lVmE~~g~~g~~~~~L~~~~~~----------~~~~~~~~i~~qi~~~l~~lH~~~---g 191 (258)
T 1zth_A 128 KEAGVSVPQPYTY---MKNVLLMEFIGEDELPAPTLVELGRE----------LKELDVEGIFNDVVENVKRLYQEA---E 191 (258)
T ss_dssp HHTTCCCCCEEEE---ETTEEEEECCEETTEECCBHHHHGGG----------GGGSCHHHHHHHHHHHHHHHHHTS---C
T ss_pred HhCCCCCCeEEEc---CCCEEEEEecCCCCCccccHHHHhhc----------cChHHHHHHHHHHHHHHHHHHHHC---C
Confidence 88764 334432 366899999942 4 56555421 224467789999999999999 88 9
Q ss_pred ceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 211 VIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 211 i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
++||||||+|||++. .++|+|||++...
T Consensus 192 ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999988 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=8.7e-18 Score=155.37 Aligned_cols=146 Identities=13% Similarity=0.100 Sum_probs=103.9
Q ss_pred HHHHHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCc--------------ccHHH--------HHHHHHHH
Q 016117 78 KQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGK--------------QGEDE--------FKMEVELL 135 (395)
Q Consensus 78 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~e~~~l 135 (395)
..+.....-|++.+.||+|+||.||+|...+|+.||||+++.... ..... ...|...|
T Consensus 88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL 167 (397)
T 4gyi_A 88 HTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM 167 (397)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 344444445899999999999999999988999999998753210 00111 12456666
Q ss_pred hccCCCcceeEEEEEecCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCC
Q 016117 136 GRLRSPYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRD 215 (395)
Q Consensus 136 ~~l~h~niv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~d 215 (395)
.++.+.++... ..+.....++||||+.+++|..+.. . .....++.|++.+|.|||+. +++|||
T Consensus 168 ~rL~~~gv~vp-~p~~~~~~~LVME~i~G~~L~~l~~-----------~--~~~~~l~~qll~~l~~lH~~---gIVHrD 230 (397)
T 4gyi_A 168 KALYEEGFPVP-EPIAQSRHTIVMSLVDALPMRQVSS-----------V--PDPASLYADLIALILRLAKH---GLIHGD 230 (397)
T ss_dssp HHHHHTTCSCC-CEEEEETTEEEEECCSCEEGGGCCC-----------C--SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred HHHHhcCCCCC-eeeeccCceEEEEecCCccHhhhcc-----------c--HHHHHHHHHHHHHHHHHHHC---CCcCCC
Confidence 66644433211 1112234579999999988876541 1 12356789999999999998 999999
Q ss_pred CCCCCEEeCCCC----------cEEEecccccccc
Q 016117 216 FKSSNILLDKNF----------HAKVSDFGLAKIG 240 (395)
Q Consensus 216 lk~~Nill~~~~----------~~kl~Dfg~~~~~ 240 (395)
|||.|||+++++ .+.|+||+-+...
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999998776 3899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=1.5e-12 Score=115.67 Aligned_cols=145 Identities=14% Similarity=0.074 Sum_probs=110.5
Q ss_pred HHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCcceeEEEEEecC-ceEEE
Q 016117 81 HSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 81 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~~~lv 158 (395)
....+.|++...++.|+.+.||++.. +++.+++|+...........+..|+.+++.+. +.++.++++++.+. ..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 34456788888888899999999985 46899999987532122345888999999984 66788888887665 56799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC------------------------------- 207 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------- 207 (395)
|||++|.+|.+.+.. ......++.+++.+|+.||+..
T Consensus 89 ~e~i~G~~l~~~~~~------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 89 MSEADGVLCSEEYED------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EECCSSEEHHHHCCT------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred EEecCCeehhhccCC------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 999999998876411 1123467889999999999820
Q ss_pred -------------------------CCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 208 -------------------------SPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 208 -------------------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0358999999999999876666799998775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.5e-11 Score=108.94 Aligned_cols=136 Identities=18% Similarity=0.122 Sum_probs=97.7
Q ss_pred CCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCc--ceeEEEEEecC-ceEEEEEcc
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY--LLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~-~~~lv~e~~ 162 (395)
.+.+..+.+.|..+.||+....+|+.+++|+.... ....+..|+.+++.+.+.+ +.+++++..++ ..+++|||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34443333456669999998777888999997643 2245778999999986544 45578877654 578999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC----------------------------------- 207 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 207 (395)
++.+|. .. ..+ ...++.+++..|+.||+..
T Consensus 98 ~G~~l~--~~----------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 98 PGQDLL--SS----------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp SSEETT--TS----------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred CCcccC--cC----------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 998884 21 111 1256778888888888652
Q ss_pred --------------------CCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 208 --------------------SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 208 --------------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
...++|+|++|.||+++++..+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=3.3e-10 Score=105.33 Aligned_cols=141 Identities=13% Similarity=0.245 Sum_probs=105.6
Q ss_pred CCCeeeccCCeEEEEEEEcCCcEEEEEEec--cCC-cccHHHHHHHHHHHhccC--CCcceeEEEEEecC----ceEEEE
Q 016117 89 KSNVVGHGGFGLVYRGVLSNGRKVAIKLMD--QAG-KQGEDEFKMEVELLGRLR--SPYLLALLGYCSDR----RKLLVY 159 (395)
Q Consensus 89 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~----~~~lv~ 159 (395)
..+.|+.|.++.||+.... +..+++|+.. ... ......+..|..+++.+. +.++.+++.++.+. ..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999998874 4678888775 321 122346778999999986 45678888888765 378999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC-------------------------------- 207 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------- 207 (395)
||+++..+.+.. ...++......++.+++..|+.||+..
T Consensus 121 e~v~G~~l~~~~---------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 121 EFVSGRVLWDQS---------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp ECCCCBCCCCTT---------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred EecCCeecCCCc---------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 999998875432 134678888999999999999999731
Q ss_pred -----------------------CCCceeCCCCCCCEEeCCCCc--EEEeccccccc
Q 016117 208 -----------------------SPPVIHRDFKSSNILLDKNFH--AKVSDFGLAKI 239 (395)
Q Consensus 208 -----------------------~~~i~H~dlk~~Nill~~~~~--~kl~Dfg~~~~ 239 (395)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 146999999999999987753 68999998875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.01 E-value=1.6e-10 Score=104.81 Aligned_cols=182 Identities=21% Similarity=0.254 Sum_probs=120.6
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCc--ceeEEEEEecCc----eEEEEEcc
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPY--LLALLGYCSDRR----KLLVYDYM 162 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~----~~lv~e~~ 162 (395)
.+.++.|....||+.. ..+++|+.... .....+..|.++++.+. +.. +..++.+..... .++||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999853 56889986432 23467888999998883 332 344454443332 36899999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC----------------------------------- 207 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 207 (395)
++.+|.+... ..++..++..++.+++..++.||+..
T Consensus 99 ~G~~l~~~~~---------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 99 KGVPLTPLLL---------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp CCEECCHHHH---------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred CCeECCcccc---------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 9988865431 24667777888888888888888621
Q ss_pred --------------------CCCceeCCCCCCCEEeCC--CCcEEEeccccccccCCCCCCceeecccccccc---ccch
Q 016117 208 --------------------SPPVIHRDFKSSNILLDK--NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY---VAPE 262 (395)
Q Consensus 208 --------------------~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y---~aPE 262 (395)
.+.++|+|++|.||++++ +..+.|+||+.+....... .......+ ..|+
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDEEYGME 243 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTTSCCHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhccccCHH
Confidence 135799999999999988 5568899999987543211 00000011 1222
Q ss_pred hhc----c-CCC---------CccchhHHHHHHHHHHHhCCCCC
Q 016117 263 YAL----T-GHL---------TTKSDVYSYGVVLLELLTGRVPI 292 (395)
Q Consensus 263 ~~~----~-~~~---------~~~~DvwslG~~l~ell~g~~pf 292 (395)
... . +.. ....+.|++|.++|.+.+|..+|
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 0 111 12358999999999999998775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=7.4e-07 Score=80.59 Aligned_cols=134 Identities=22% Similarity=0.250 Sum_probs=93.0
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC---cceeEEEEEe--cCceEEEEEcccCC
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP---YLLALLGYCS--DRRKLLVYDYMANG 165 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~--~~~~~lv~e~~~~g 165 (395)
+.++.|....||+. |..+++|+-.. ......+..|.++|+.+.+. .+..++.++. ++..+++|+++++.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 56888999999987 56788888532 22345788999999999652 3556666664 33578999999998
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC-------------------------------------- 207 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------- 207 (395)
++.+... ..++......++.+++..|+.||+..
T Consensus 99 ~l~~~~~---------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 99 ILGEDGM---------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp ECHHHHH---------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ECchhhh---------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 8876321 12344455555555555555555431
Q ss_pred -------------------CCCceeCCCCCCCEEeCC---CCc-EEEeccccccc
Q 016117 208 -------------------SPPVIHRDFKSSNILLDK---NFH-AKVSDFGLAKI 239 (395)
Q Consensus 208 -------------------~~~i~H~dlk~~Nill~~---~~~-~kl~Dfg~~~~ 239 (395)
.+.++|+|+.+.||+++. ++. +.|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 225699999999999987 455 58999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=6e-07 Score=79.60 Aligned_cols=134 Identities=19% Similarity=0.114 Sum_probs=93.5
Q ss_pred eeeccCCe-EEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCcceeEEEEEecC-ceEEEEEcccCCCh
Q 016117 92 VVGHGGFG-LVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RKLLVYDYMANGGL 167 (395)
Q Consensus 92 ~lg~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~~~lv~e~~~~g~L 167 (395)
.+..|..| .||+.... ++..+++|+-... ....+..|...|+.+. +-.+.++++++.+. ..++||+++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34555554 68987754 5678999986532 3456788999998884 33466778887665 67899999999887
Q ss_pred hhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------
Q 016117 168 QEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC---------------------------------------- 207 (395)
Q Consensus 168 ~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 207 (395)
.+.... .......+..+++..|+.||...
T Consensus 108 ~~~~~~-----------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 108 FQVLEE-----------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp HHHHHH-----------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred cccccC-----------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 765421 11223445666777777777431
Q ss_pred ---------------CCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 208 ---------------SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 208 ---------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999877778999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=9.5e-07 Score=81.68 Aligned_cols=79 Identities=9% Similarity=-0.012 Sum_probs=55.2
Q ss_pred Cee-eccCCeEEEEEEEc-------CCcEEEEEEeccCC---cccHHHHHHHHHHHhccCC---CcceeEEEEEecC---
Q 016117 91 NVV-GHGGFGLVYRGVLS-------NGRKVAIKLMDQAG---KQGEDEFKMEVELLGRLRS---PYLLALLGYCSDR--- 153 (395)
Q Consensus 91 ~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~--- 153 (395)
+.| +.|....+|+.... +++.+++|+..... ......+..|..+++.+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999988754 26789999865432 1012356778888888842 3567788877654
Q ss_pred -ceEEEEEcccCCChhh
Q 016117 154 -RKLLVYDYMANGGLQE 169 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~ 169 (395)
..+++|||+++..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 3689999999877654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.28 E-value=3.1e-06 Score=75.79 Aligned_cols=78 Identities=17% Similarity=0.217 Sum_probs=56.9
Q ss_pred CCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCC---cceeEEEEEecCceEEEEEccc
Q 016117 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSP---YLLALLGYCSDRRKLLVYDYMA 163 (395)
Q Consensus 87 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~lv~e~~~ 163 (395)
..-.+.+|.|..+.||+....+|+.+++|+...........|..|...|+.+... .+.+++++ +..+++|||+.
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---~~~~lv~e~l~ 93 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW---DDRTLAMEWVD 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---ETTEEEEECCC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec---cCceEEEEeec
Confidence 3445679999999999999999999999987654444445678899999988432 23444443 34578999988
Q ss_pred CCCh
Q 016117 164 NGGL 167 (395)
Q Consensus 164 ~g~L 167 (395)
.+..
T Consensus 94 ~~~~ 97 (288)
T 3f7w_A 94 ERPP 97 (288)
T ss_dssp CCCC
T ss_pred ccCC
Confidence 7653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=5.2e-06 Score=77.89 Aligned_cols=75 Identities=19% Similarity=0.204 Sum_probs=49.4
Q ss_pred CCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCc-------ccHHHHHHHHHHHhccCC--Ccce-eEEEEEecCceEEE
Q 016117 90 SNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGK-------QGEDEFKMEVELLGRLRS--PYLL-ALLGYCSDRRKLLV 158 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~niv-~l~~~~~~~~~~lv 158 (395)
.+.||.|..+.||++... +++.+++|....... ...+.+..|.++++.+.. +..+ +++.+ .....++|
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d~~~~~lv 113 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTV 113 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-cCCccEEE
Confidence 357899999999999753 568899997653211 123456778999888742 3333 45543 44567899
Q ss_pred EEcccCC
Q 016117 159 YDYMANG 165 (395)
Q Consensus 159 ~e~~~~g 165 (395)
||++.+.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.09 E-value=3.3e-05 Score=70.65 Aligned_cols=142 Identities=18% Similarity=0.253 Sum_probs=78.6
Q ss_pred eeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCC--CcceeEEE------E-EecCceEEEEEcc
Q 016117 92 VVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS--PYLLALLG------Y-CSDRRKLLVYDYM 162 (395)
Q Consensus 92 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~-~~~~~~~lv~e~~ 162 (395)
.|+.|..+.+|+....+| .+++|+.... ...+..|..+++.+.. -.+.+++. + ...+..+++++|+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 455677889999987554 5899988652 2344456666665531 12233332 1 1244567999999
Q ss_pred cCCChh--------------hhcccCCCCC--C-----CCCCCCHHHH-------------------------------H
Q 016117 163 ANGGLQ--------------EHLYPANGSN--S-----VASKLDWETR-------------------------------L 190 (395)
Q Consensus 163 ~~g~L~--------------~~l~~~~~~~--~-----~~~~l~~~~~-------------------------------~ 190 (395)
++..+. ..+|...... . ....-.|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986543 1122111000 0 0011123211 1
Q ss_pred HHHHHHHHHHHHHhc----------CCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 191 RIALEAAKGLEFLHE----------HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 191 ~i~~~i~~~l~~LH~----------~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
.+..++..++.+|++ .....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666653 013489999999999999888899999999775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00019 Score=64.71 Aligned_cols=141 Identities=14% Similarity=0.194 Sum_probs=90.0
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccC---CCcceeEEEEEecC-ceEEEEEcccCC
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR---SPYLLALLGYCSDR-RKLLVYDYMANG 165 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~-~~~lv~e~~~~g 165 (395)
.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.+. ...+.+++.++... ..+++|||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 35689999999999886 5678899987542 3557888999998884 35677888877654 678999999987
Q ss_pred Chhh-----------hcccCCCCCC---------------CCCCCCHHHHH---HHHH----------------HHHHH-
Q 016117 166 GLQE-----------HLYPANGSNS---------------VASKLDWETRL---RIAL----------------EAAKG- 199 (395)
Q Consensus 166 ~L~~-----------~l~~~~~~~~---------------~~~~l~~~~~~---~i~~----------------~i~~~- 199 (395)
.+.. .||....... ..-.-+|.... ++.. .+...
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 2333221000 00012454321 1111 11111
Q ss_pred HHHHhc-CCCCCceeCCCCCCCEEeCCCCcEEEeccc
Q 016117 200 LEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFG 235 (395)
Q Consensus 200 l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg 235 (395)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223432 2245899999999999998887 8888874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00016 Score=64.93 Aligned_cols=71 Identities=11% Similarity=0.059 Sum_probs=44.5
Q ss_pred CCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcc-eeEEEEEecCceEEEEEcc-cCCCh
Q 016117 90 SNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYDYM-ANGGL 167 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~~-~~g~L 167 (395)
.+.|+.|....+|+. +.+++|+........ .....|..+++.+...++ .++++++ ....+++++|+ ++.++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~-~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD-PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC-TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE-CCCCEEEEeecCCCccC
Confidence 567999999999998 568889876432111 123458888877743333 3555443 33457899999 55444
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00021 Score=67.44 Aligned_cols=76 Identities=16% Similarity=0.158 Sum_probs=46.5
Q ss_pred CceeCCCCCCCEEeCCCCcEEEeccccccccCCCCCCceeeccc--cccccccchhhccCC---CCccchhHHHHHHHHH
Q 016117 210 PVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVL--GTQGYVAPEYALTGH---LTTKSDVYSYGVVLLE 284 (395)
Q Consensus 210 ~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~---~~~~~DvwslG~~l~e 284 (395)
.++|||+++.||+++.++ +.++||+.+....... ... ... -...|.+|+...... .....++.+....+|+
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~--Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF--DIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH--HHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH--HHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 899999999999998876 9999999887543211 000 000 012356665443111 1123455677778887
Q ss_pred HHhCC
Q 016117 285 LLTGR 289 (395)
Q Consensus 285 ll~g~ 289 (395)
.+.+.
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00048 Score=62.29 Aligned_cols=160 Identities=14% Similarity=0.142 Sum_probs=85.0
Q ss_pred cHHHHHHHhCCCCCC-----CeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCc--ceeEEE
Q 016117 76 TFKQLHSATGGFSKS-----NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY--LLALLG 148 (395)
Q Consensus 76 ~~~~~~~~~~~~~~~-----~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~ 148 (395)
+.+++...-..|.+. +.|+.|....+|+....+| .+++|+..... ..+.+..|..+++.+...+ +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 344455444555542 3466788899999987555 68899886521 1234566788877774222 222221
Q ss_pred E-------EecCceEEEEEcccCCChhh--------------hcccCCCCCC-CC-CC---CCHHHHHH-----------
Q 016117 149 Y-------CSDRRKLLVYDYMANGGLQE--------------HLYPANGSNS-VA-SK---LDWETRLR----------- 191 (395)
Q Consensus 149 ~-------~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~~~-~~-~~---l~~~~~~~----------- 191 (395)
. ...+..+++++|+++..+.. .+|....... .. .. ..|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 12345678999998865421 1221110000 00 00 11222110
Q ss_pred -HHHHHHHHHHHHhcC----CCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 192 -IALEAAKGLEFLHEH----CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 192 -i~~~i~~~l~~LH~~----~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
+...+...+.+++.. ....++|+|+.+.||+++.+..+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133445555422 12379999999999999887666899998765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00041 Score=64.22 Aligned_cols=143 Identities=20% Similarity=0.205 Sum_probs=84.1
Q ss_pred CeeeccCCeEEEEEEEc--------CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCc-ceeEEEEEecCceEEEEEc
Q 016117 91 NVVGHGGFGLVYRGVLS--------NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY-LLALLGYCSDRRKLLVYDY 161 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~lv~e~ 161 (395)
+.|..|-...+|+.... +++.+++|+.... ........+|..+++.+...+ ..++++++.+ .+|+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~---g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE---GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT---EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC---ccEEEE
Confidence 46777888889998864 2478999986432 223456678999998884322 3556666654 289999
Q ss_pred ccCCChhhh-----------------cccCCCCCCCCCCC--CHHHHHHHHHHHHH-------------------HHHHH
Q 016117 162 MANGGLQEH-----------------LYPANGSNSVASKL--DWETRLRIALEAAK-------------------GLEFL 203 (395)
Q Consensus 162 ~~~g~L~~~-----------------l~~~~~~~~~~~~l--~~~~~~~i~~~i~~-------------------~l~~L 203 (395)
+++.+|... ||..... ..... -+.++.++..++.. .+..|
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~--~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMP--FTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCS--SCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCC--CCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 988655321 1211111 11122 24555555544422 22333
Q ss_pred h----cC-CCCCceeCCCCCCCEEeCCC----CcEEEeccccccc
Q 016117 204 H----EH-CSPPVIHRDFKSSNILLDKN----FHAKVSDFGLAKI 239 (395)
Q Consensus 204 H----~~-~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~~ 239 (395)
. .. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 21 12368999999999999876 7899999998763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00044 Score=57.90 Aligned_cols=99 Identities=15% Similarity=0.133 Sum_probs=63.9
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
-+|.+.|...+ .+++++++|.++.|.+.+|.-+-... .-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~------~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------ 97 (229)
T 2yle_A 33 LSLEEILRLYN------QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------ 97 (229)
T ss_dssp EEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------
T ss_pred ccHHHHHHHcC------CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------
Confidence 36888886544 68999999999999999987762210 111233456899999999988753 1110
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT 287 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~ 287 (395)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0122367888653 345678899999999999886
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00044 Score=65.36 Aligned_cols=72 Identities=19% Similarity=0.220 Sum_probs=49.6
Q ss_pred CeeeccCCeEEEEEEEcC--------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcc-eeEEEEEecCceEEEEEc
Q 016117 91 NVVGHGGFGLVYRGVLSN--------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYDY 161 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~ 161 (395)
+.|+.|....+|+....+ ++.+++|+.... .....+..|..+++.+...++ .++++.+.+ .++++|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG---GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC---CEEEEE
Confidence 467888889999998753 578999988432 112455679999988854344 566666543 388999
Q ss_pred ccCCCh
Q 016117 162 MANGGL 167 (395)
Q Consensus 162 ~~~g~L 167 (395)
+++.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 976444
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0012 Score=59.96 Aligned_cols=143 Identities=20% Similarity=0.141 Sum_probs=72.5
Q ss_pred eeeccCCeE-EEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCC--CcceeEEEEEecCceEEEEEcccCCChh
Q 016117 92 VVGHGGFGL-VYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS--PYLLALLGYCSDRRKLLVYDYMANGGLQ 168 (395)
Q Consensus 92 ~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~lv~e~~~~g~L~ 168 (395)
.|+.|.... +|+....+|..+++|....... ..+..|+.+++.+.. -.+.+++.+..+ ..+++||++.+..+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~-~g~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA-RGLLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT-TTEEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC-CCEEEEeeCCCcchH
Confidence 455554444 5676654467788876543221 234456777776642 234566666433 347899998776654
Q ss_pred hhccc---------------------CCCCCCCCCCCCHHHHH-------H-------------HHHHHHHHHHHHh---
Q 016117 169 EHLYP---------------------ANGSNSVASKLDWETRL-------R-------------IALEAAKGLEFLH--- 204 (395)
Q Consensus 169 ~~l~~---------------------~~~~~~~~~~l~~~~~~-------~-------------i~~~i~~~l~~LH--- 204 (395)
+.+.. .... ....++..... . ....+...+..+.
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTP--ELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCC--CCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCc--cCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 43321 1100 00112211100 0 0001112222221
Q ss_pred cCCCCCceeCCCCCCCEEeCCC----CcEEEecccccccc
Q 016117 205 EHCSPPVIHRDFKSSNILLDKN----FHAKVSDFGLAKIG 240 (395)
Q Consensus 205 ~~~~~~i~H~dlk~~Nill~~~----~~~kl~Dfg~~~~~ 240 (395)
......++|||+.+.||+++.+ +.+.|+||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1113379999999999999874 68999999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0029 Score=60.17 Aligned_cols=73 Identities=11% Similarity=0.078 Sum_probs=47.2
Q ss_pred CeeeccCCeEEEEEEEcC-CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcc-eeEEEEEecCceEEEEEcccCCCh
Q 016117 91 NVVGHGGFGLVYRGVLSN-GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYDYMANGGL 167 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~~~~g~L 167 (395)
+.|+.|-...+|+....+ +..+++|+......... +...|..+++.+...++ .++++++. + .++++|+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~-G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N-GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T-EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C-eEEEEeeCCccC
Confidence 467788889999998754 57899998754322111 12568888988865544 45666663 2 359999987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0055 Score=55.35 Aligned_cols=145 Identities=12% Similarity=0.092 Sum_probs=80.6
Q ss_pred CeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCc--ceeEEEE------EecCceEEEEEcc
Q 016117 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY--LLALLGY------CSDRRKLLVYDYM 162 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~------~~~~~~~lv~e~~ 162 (395)
..++ |....||+....+|+.+++|...... .....+..|..+++.+.... +.+++.. ..++..+++++++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 78889999877677789999986431 23456777888888774222 3333332 1133456899999
Q ss_pred cCCChhh--------------hcccCCC--CCCCCCCCCHHHH----------------------HHHHHHHHHHHHHHh
Q 016117 163 ANGGLQE--------------HLYPANG--SNSVASKLDWETR----------------------LRIALEAAKGLEFLH 204 (395)
Q Consensus 163 ~~g~L~~--------------~l~~~~~--~~~~~~~l~~~~~----------------------~~i~~~i~~~l~~LH 204 (395)
++..+.. .+|.... ........++... ...+..++..+.-+-
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8754321 0111100 0000112222211 111112222222221
Q ss_pred c-CCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 205 E-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 205 ~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
. .....++|||+++.||+++ + .+.++||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 1123689999999999998 4 899999988764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0014 Score=60.64 Aligned_cols=73 Identities=11% Similarity=0.076 Sum_probs=43.8
Q ss_pred CeeeccCCeEEEEEEEcC---------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcc-eeEEEEEecCceEEEEE
Q 016117 91 NVVGHGGFGLVYRGVLSN---------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYD 160 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e 160 (395)
+.|+.|....+|+....+ ++.+++|+....... ......|..+++.+...++ .++++.. ..+++++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~---~~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF---NGGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE---TTEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec---CCcEEEE
Confidence 457788888999988654 268899987543211 1123568888888754343 4555543 2378999
Q ss_pred cccCCCh
Q 016117 161 YMANGGL 167 (395)
Q Consensus 161 ~~~~g~L 167 (395)
|+++..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0035 Score=57.15 Aligned_cols=31 Identities=16% Similarity=0.276 Sum_probs=27.6
Q ss_pred CCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 209 ~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3799999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.62 E-value=0.03 Score=52.53 Aligned_cols=144 Identities=13% Similarity=0.159 Sum_probs=84.1
Q ss_pred CeeeccCCeEEEEEEEcC--------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCc-ceeEEEEEecCceEEEEEc
Q 016117 91 NVVGHGGFGLVYRGVLSN--------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPY-LLALLGYCSDRRKLLVYDY 161 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~lv~e~ 161 (395)
+.+..|-...+|+....+ ++.+++|+........ -+..+|..+++.+...+ ..++++.+ ..++|++|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~---~~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF---PEGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE---TTEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc---CCCEEEEE
Confidence 467778889999998753 6789999865432211 12356888888874333 34455433 23789999
Q ss_pred ccCCChhhh-----------------cccCCC-----CCC-CCCCCCHHHHHHHHHHHH-------------------HH
Q 016117 162 MANGGLQEH-----------------LYPANG-----SNS-VASKLDWETRLRIALEAA-------------------KG 199 (395)
Q Consensus 162 ~~~g~L~~~-----------------l~~~~~-----~~~-~~~~l~~~~~~~i~~~i~-------------------~~ 199 (395)
+++..|..- +|.... ... ...+..+.++..+..++- ..
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 998664221 111000 000 111123455444443321 22
Q ss_pred HHHHhc---------------------CCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 200 LEFLHE---------------------HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 200 l~~LH~---------------------~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
+.+|.+ .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 333321 11236899999999999 7788999999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.89 E-value=0.015 Score=34.83 Aligned_cols=28 Identities=14% Similarity=0.014 Sum_probs=10.7
Q ss_pred EEEehHHHHHHHHHHHHHHHHHHhhhhc
Q 016117 15 LVVIVVVASLALASLLVAFSYYCYIRNK 42 (395)
Q Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~r~~ 42 (395)
.+++.++..+++++++++..+++++||+
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 3333333333333333333333334433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.85 E-value=0.047 Score=50.82 Aligned_cols=30 Identities=27% Similarity=0.386 Sum_probs=25.5
Q ss_pred CceeCCCCCCCEEe------CCCCcEEEeccccccc
Q 016117 210 PVIHRDFKSSNILL------DKNFHAKVSDFGLAKI 239 (395)
Q Consensus 210 ~i~H~dlk~~Nill------~~~~~~kl~Dfg~~~~ 239 (395)
.++|+|+.+.||++ +++..+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999998864
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.50 E-value=0.017 Score=34.52 Aligned_cols=19 Identities=11% Similarity=-0.073 Sum_probs=7.2
Q ss_pred HHHHHHHHHHHHHHhhhhc
Q 016117 24 LALASLLVAFSYYCYIRNK 42 (395)
Q Consensus 24 ~~~~~~~~~~~~~~~~r~~ 42 (395)
++++++++...+++++||+
T Consensus 20 v~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 20 LFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhhhhh
Confidence 3333333333333334433
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.26 E-value=0.38 Score=40.10 Aligned_cols=115 Identities=13% Similarity=0.172 Sum_probs=77.3
Q ss_pred CCCcceeEEEEEecCceE-EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCC
Q 016117 139 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFK 217 (395)
Q Consensus 139 ~h~niv~l~~~~~~~~~~-lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk 217 (395)
.||+.+.. .+..+.+.+ +.|+.-. +..++- .-..++...+++++.+++....++++. +|--|.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~--------~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~ 106 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD--------NIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLA 106 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG--------GGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH--------HHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEe
Confidence 67888866 344444433 4444333 222222 124688899999999999888766644 899999
Q ss_pred CCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 016117 218 SSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 293 (395)
Q Consensus 218 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~ 293 (395)
|+|++++.++.+++.-.|+.... +|. ..+...=.-.+=|++..+++++..|.
T Consensus 107 P~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 107 PDELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999999877764322 221 12223334467789999999998884
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.58 E-value=0.71 Score=38.59 Aligned_cols=114 Identities=11% Similarity=0.119 Sum_probs=74.6
Q ss_pred CCCcceeEEEEEecC-ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCceeCCC
Q 016117 139 RSPYLLALLGYCSDR-RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE-FLHEHCSPPVIHRDF 216 (395)
Q Consensus 139 ~h~niv~l~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~i~H~dl 216 (395)
.||++ . ..+-.++ ...+.+..-+++.-...+ ..++...+++++.+++.... +++ .-+|--|
T Consensus 48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i----------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l 110 (219)
T 4ano_A 48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAI----------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIV 110 (219)
T ss_dssp SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHH----------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCC
T ss_pred cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHH----------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEE
Confidence 57777 2 2333333 334555554343333333 36788999999999888776 555 4588999
Q ss_pred CCCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 016117 217 KSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPID 293 (395)
Q Consensus 217 k~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~ 293 (395)
.|+|++++.++.+++.-.|+-.. ++|. ..+..-=.-++=|++..++.++..|.
T Consensus 111 ~P~NL~f~~~~~p~i~hRGi~~~-------------------lpP~-----e~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 111 CPENLMFNRALEPFFLHVGVKES-------------------LPPD-----EWDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CGGGEEECTTCCEEESCCEETTT-------------------BSSC-----SCCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eCceEEEeCCCcEEEEEcCCccc-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999999987776432 2222 11222223467788888998888774
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=87.48 E-value=0.24 Score=28.63 Aligned_cols=18 Identities=28% Similarity=0.209 Sum_probs=7.6
Q ss_pred HHHHHHHHHHHHHHHhhh
Q 016117 23 SLALASLLVAFSYYCYIR 40 (395)
Q Consensus 23 ~~~~~~~~~~~~~~~~~r 40 (395)
+++.+++++++.+|+++|
T Consensus 20 ~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 20 LLLGAALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHeec
Confidence 333333444444444443
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.08 E-value=0.94 Score=28.29 Aligned_cols=30 Identities=20% Similarity=0.202 Sum_probs=15.8
Q ss_pred ceeEEEehHHHHHHHHHHHHHHHHHHhhhh
Q 016117 12 RVALVVIVVVASLALASLLVAFSYYCYIRN 41 (395)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~ 41 (395)
+++++++.+++.++++++++++++-|-..+
T Consensus 11 p~wiIi~svl~GLllL~li~~~LwK~GFFk 40 (54)
T 2knc_A 11 PIWWVLVGVLGGLLLLTILVLAMWKVGFFK 40 (54)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 444555555555555555666665554333
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.70 E-value=0.61 Score=29.02 Aligned_cols=30 Identities=17% Similarity=0.157 Sum_probs=15.8
Q ss_pred ceeEEEehHHHHHHHHHHHHHHHHHHhhhh
Q 016117 12 RVALVVIVVVASLALASLLVAFSYYCYIRN 41 (395)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~ 41 (395)
+++++++.+++.++++++++++++-|-..+
T Consensus 8 p~WiIi~svl~GLLLL~Lii~~LwK~GFFK 37 (54)
T 2l8s_A 8 PLWVILLSAFAGLLLLMLLILALWKIGFFK 37 (54)
T ss_dssp CTHHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 444555555555555555666665554433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 395 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-72 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-55 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 1e-72
Identities = 80/293 (27%), Positives = 134/293 (45%), Gaps = 31/293 (10%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLL 144
+ +G G FG VY+G VA+K++ Q FK EV +L + R +L
Sbjct: 10 ITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 145 ALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
+GY + + +V + L HL+ K + + IA + A+G+++LH
Sbjct: 68 LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET------KFEMIKLIDIARQTAQGMDYLH 121
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
+IHRD KS+NI L ++ K+ DFGLA + S +G H ++ G+ ++APE
Sbjct: 122 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 265 LT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321
+ +SDVY++G+VL EL+TG++P + + + D K+
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPK 374
A+ + A C++ + D RPL ++ S+ L RS PK
Sbjct: 239 PKAM------------KRLMAECLKKKRDERPLFPQILASIELLA---RSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-65
Identities = 69/276 (25%), Positives = 115/276 (41%), Gaps = 26/276 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
+G G FG V+ G + KVA+K + Q G D F E L+ +L+ L+ L
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 147 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
+ ++ +YM NG L + L +G KL L +A + A+G+ F+ E
Sbjct: 74 YAVVTQEPIYIITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEER 128
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 266
IHRD +++NIL+ K++DFGLA++ D + APE
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINY 184
Query: 267 GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALE 326
G T KSDV+S+G++L E++T + E + R+ + E
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE------- 237
Query: 327 GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
++ + +C + + RP + L
Sbjct: 238 ---------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (508), Expect = 5e-62
Identities = 72/312 (23%), Positives = 129/312 (41%), Gaps = 45/312 (14%)
Query: 75 FTFKQLHSATGGFSKS---------NVVGHGGFGLVYRGVL----SNGRKVAIKLMD-QA 120
FTF+ + A F+K V+G G FG V G L VAIK +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 121 GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS 179
++ +F E ++G+ P ++ L G + + ++ ++M NG L L +G +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 180 VASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239
+ + A G+++L + +HRD + NIL++ N KVSDFGL++
Sbjct: 127 ------VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 240 GSDKAGGHVSTRVLGTQG---YVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVN 295
D T LG + + APE T+ SDV+SYG+V+ E+++ G P
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 296 KPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLM 355
+ ++ ++ M + + C Q + ++RP
Sbjct: 238 TN-----------------QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 356 ADVVQSLVPLVK 367
+V +L +++
Sbjct: 281 GQIVNTLDKMIR 292
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 5e-62
Identities = 74/282 (26%), Positives = 125/282 (44%), Gaps = 28/282 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
+ +G G FGLV+ G N KVAIK + + G E++F E E++ +L P L+ L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 147 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 205
G C ++ + LV+++M +G L ++L G ET L + L+ +G+
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF------AAETLLGMCLDVCEGM---AY 116
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 265
VIHRD + N L+ +N KVSDFG+ + D ST + +PE
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFS 175
Query: 266 TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPAL 325
++KSDV+S+GV++ E+ + N+ + E + D + P L
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL 226
Query: 326 EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367
V I C + + RP + +++ L + +
Sbjct: 227 AST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-61
Identities = 65/279 (23%), Positives = 119/279 (42%), Gaps = 30/279 (10%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
+ +G G FG+V G VAIK++ + G EDEF E +++ L L+ L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 147 LGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE 205
G C+ +R + ++ +YMANG L +L + + L + + + +E+L
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRH------RFQTQQLLEMCKDVCEAMEYLES 118
Query: 206 HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYAL 265
+HRD + N L++ KVSDFGL++ D S + PE +
Sbjct: 119 KQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLM 174
Query: 266 TGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324
++KSD++++GV++ E+ + G++P + + E +
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------------SETAEHIAQG 217
Query: 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363
L +V I C +AD RP ++ +++
Sbjct: 218 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 4e-61
Identities = 56/210 (26%), Positives = 105/210 (50%), Gaps = 16/210 (7%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLL 144
F K + +G G G+V++ +G +A KL+ K ++ E+++L SPY++
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 145 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
G ++ + ++M G L + L A ++ + ++++ KGL +L
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVSIAVIKGLTYL 120
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
E ++HRD K SNIL++ K+ DFG++ D ++ +GT+ Y++PE
Sbjct: 121 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPER 174
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVPID 293
H + +SD++S G+ L+E+ GR PI
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 7e-61
Identities = 66/299 (22%), Positives = 119/299 (39%), Gaps = 34/299 (11%)
Query: 92 VVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCS 151
+G G FG V+RG G +VA+K+ ++ + E+ LR +L + +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 152 DRRK-----LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
LV DY +G L ++L + E +++AL A GL LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN--------RYTVTVEGMIKLALSTASGLAHLHME 119
Query: 207 C-----SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI--GSDKAGGHVSTRVLGTQGYV 259
P + HRD KS NIL+ KN ++D GLA + +GT+ Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 260 APEYALT------GHLTTKSDVYSYGVVLLELLTGRVPIDVNK----PSGEGVLVSWALP 309
APE ++D+Y+ G+V E+ +++ P + V ++
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 310 RLTDREKILEIMDPALEGQYSMKEVIQ-VAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367
+ + + + P + ++ E ++ +A I C R + ++L L +
Sbjct: 240 EM-RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-60
Identities = 66/281 (23%), Positives = 113/281 (40%), Gaps = 26/281 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
+G G FG V+ G + +VAIK + G + F E +++ +LR L+ L
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 147 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
S+ +V +YM+ G L + L G + +A + A G+ ++
Sbjct: 78 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYL-----RLPQLVDMAAQIASGMAYVERM 132
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 266
+HRD +++NIL+ +N KV+DFGLA++ D + APE AL
Sbjct: 133 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALY 188
Query: 267 GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALE 326
G T KSDV+S+G++L EL T ++L+ ++
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGM----------------VNREVLDQVERGYR 232
Query: 327 GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367
+ + + C + E + RP + L
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-60
Identities = 68/299 (22%), Positives = 125/299 (41%), Gaps = 33/299 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNG-----RKVAIKLMDQAGKQGE-DEFKMEVELLGRLRS 140
++ V+G G FG VY+G+L VAIK + + + +F E ++G+
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 141 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKG 199
++ L G S + + ++ +YM NG L + L +G + + + A G
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG------EFSVLQLVGMLRGIAAG 122
Query: 200 LEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGY 258
+ + +HRD + NIL++ N KVSDFGL++ + D + ++ +
Sbjct: 123 M---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 259 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318
APE T+ SDV+S+G+V+ E++T + E ++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------VM 223
Query: 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISS 377
+ ++ M + + C Q E RP AD+V L L++ S ++
Sbjct: 224 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (494), Expect = 3e-60
Identities = 63/291 (21%), Positives = 124/291 (42%), Gaps = 28/291 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+ + +G G +G VY GV VA+K + + + E EF E ++ ++ P L+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 77
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
LLG C+ ++ ++M G L ++L N ++ L +A + + +E+L
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLE 132
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
+ IHRD + N L+ +N KV+DFGL+++ + + APE
Sbjct: 133 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESL 188
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324
+ KSDV+++GV+L E+ T + D ++ E+++
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQVYELLEKD 232
Query: 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKI 375
+ +V + C Q RP A++ Q+ + + + + ++
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 283
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-58
Identities = 75/282 (26%), Positives = 122/282 (43%), Gaps = 34/282 (12%)
Query: 90 SNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLL 144
+ V+G G FG VY G L + A+K +++ GE +F E ++ P +L
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 145 ALLGYC--SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
+LLG C S+ L+V YM +G L+ + + + L+ AKG+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH------NPTVKDLIGFGLQVAKGM-- 143
Query: 203 LHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI--GSDKAGGHVSTRVLGTQGYVA 260
S +HRD + N +LD+ F KV+DFGLA+ + H T ++A
Sbjct: 144 -KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320
E T TTKSDV+S+GV+L EL+T P + + + + RL E +
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD- 261
Query: 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
+ + C P+A+ RP +++V +
Sbjct: 262 ---------------PLYEVMLKCWHPKAEMRPSFSELVSRI 288
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-58
Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 33/307 (10%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGR----KVAIKLMDQAG-KQGEDEFKMEVELLGRLRS 140
F K V+G G FG VY+G+ + G VAIK + +A + E E ++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 141 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
P++ LLG C L+ M G L +++ + + L ++ AKG+
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIG------SQYLLNWCVQIAKGM 124
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260
+L + ++HRD + N+L+ H K++DFGLAK+ + + + ++A
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319
E L T +SDV+SYGV + EL+T G P D +I
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------------SEISS 224
Query: 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSP 379
I++ I V I C +AD RP +++ + + + I
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE 284
Query: 380 SFHASRS 386
H
Sbjct: 285 RMHLPSP 291
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 9e-58
Identities = 65/275 (23%), Positives = 123/275 (44%), Gaps = 32/275 (11%)
Query: 94 GHGGFGLVYRGVL---SNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLLALLGY 149
G G FG V +GV VAIK++ Q ++ + +E E +++ +L +PY++ L+G
Sbjct: 18 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 77
Query: 150 CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
C +LV + G L + L ++ + + + G+++L E
Sbjct: 78 CQAEALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYLEEK--- 128
Query: 210 PVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPEYALTGH 268
+HRD + N+LL +AK+SDFGL+K +G+D + + + APE
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 269 LTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327
+++SDV+SYGV + E L+ G+ P K +++ ++
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----------------PEVMAFIEQGKRM 231
Query: 328 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
+ + ++ A+ + C + + RP V Q +
Sbjct: 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-57
Identities = 67/278 (24%), Positives = 110/278 (39%), Gaps = 34/278 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLAL 146
+G G FG V G G KVA+K + F E ++ +LR L+ L
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 65
Query: 147 LGYCSDRRK--LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
LG + + +V +YMA G L ++L S L + L+ +L+ + +E+L
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-----VLGGDCLLKFSLDVCEAMEYLE 120
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
+ +HRD + N+L+ ++ AKVSDFGL K S + APE
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEAL 172
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324
+TKSDV+S+G++L E+ + P + V ++ +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------------PRVEKGYKMD 220
Query: 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
V + C +A RP + + L
Sbjct: 221 APDGCPP----AVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-57
Identities = 66/279 (23%), Positives = 113/279 (40%), Gaps = 37/279 (13%)
Query: 91 NVVGHGGFGLVYRGVL-SNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRSPYLLALL 147
+G G F VY+G+ +VA + + K FK E E+L L+ P ++
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 148 GYCSDRRK-----LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEF 202
K +LV + M +G L+ +L + + + KGL+F
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-------VMKIKVLRSWCRQILKGLQF 127
Query: 203 LHEHCSPPVIHRDFKSSNILL-DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
LH PP+IHRD K NI + K+ D GLA + + V+GT ++AP
Sbjct: 128 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAP 182
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321
E DVY++G+ +LE+ T P + + + ++ +
Sbjct: 183 EM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY------------RRVTSGV 229
Query: 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360
PA + ++ EV + I C++ D R + D++
Sbjct: 230 KPASFDKVAIPEVKE---IIEGCIRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 4e-57
Identities = 67/297 (22%), Positives = 116/297 (39%), Gaps = 45/297 (15%)
Query: 92 VVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRS-PYL 143
V+G G FG V +VA+K++ + E + E++++ +L S +
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 144 LALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNS----------------VASKLDW 186
+ LLG C+ + L+++Y G L +L S + L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 187 ETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 246
E L A + AKG+EFL +HRD + N+L+ K+ DFGLA+ +
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 247 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVS 305
V ++APE G T KSDV+SYG++L E+ + G P
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-------------- 266
Query: 306 WALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
P + +++ + ++ I C ++ RP ++ L
Sbjct: 267 --YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 5e-57
Identities = 64/282 (22%), Positives = 110/282 (39%), Gaps = 30/282 (10%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMD--QAGKQGEDEFKMEVELLGRLRSPYL 143
+ +G G +G + S+G+ + K +D + + EV LL L+ P +
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 144 LALLGYCSDRRK---LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
+ DR +V +Y G L + LD E LR+ + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ---YLDEEFVLRVMTQLTLAL 122
Query: 201 EFLHEH--CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
+ H V+HRD K +N+ LD + K+ DFGLA+I + + +GT Y
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYY 180
Query: 259 VAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318
++PE KSD++S G +L EL P A + KI
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-------------AFSQKELAGKIR 227
Query: 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360
E + +YS ++ I + + +RP + ++++
Sbjct: 228 EGKFRRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 8e-57
Identities = 67/296 (22%), Positives = 106/296 (35%), Gaps = 38/296 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRL- 138
S +G G FG V VA+K++ + E + E+++L L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 139 RSPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVAS-----------KLDW 186
++ LLG C+ ++ +Y G L L S + LD
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 187 ETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGG 246
E L + + AKG+ FL IHRD + NILL K+ DFGLA+ + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 247 HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 306
V ++APE T +SDV+SYG+ L EL +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------------- 248
Query: 307 ALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
P + K +++ ++ I C + RP +VQ +
Sbjct: 249 --PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (472), Expect = 9e-57
Identities = 66/301 (21%), Positives = 117/301 (38%), Gaps = 44/301 (14%)
Query: 87 FSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMD-QAGKQGEDEFKMEVELLGRLR 139
+G G FG V++ VA+K++ +A + +F+ E L+
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74
Query: 140 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLY-----------------PANGSNSVA 181
+P ++ LLG C+ + + L+++YMA G L E L A S+
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 182 SKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241
L +L IA + A G+ +L E +HRD + N L+ +N K++DFGL++
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG 301
++ PE TT+SDV++YGVVL E+ + +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY-------- 243
Query: 302 VLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361
+ E I + D + +++ + +C RP + +
Sbjct: 244 -------YGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295
Query: 362 L 362
L
Sbjct: 296 L 296
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 9e-57
Identities = 61/281 (21%), Positives = 118/281 (41%), Gaps = 34/281 (12%)
Query: 89 KSNVVGHGGFGLVYRGVLSN---GRKVAIKLMDQAGKQGE--DEFKMEVELLGRLRSPYL 143
+ +G G FG V +G + VA+K++ DE E ++ +L +PY+
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 144 LALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
+ ++G C +LV + G L ++L + + + + + + G+++L
Sbjct: 71 VRMIGICEAESWMLVMEMAELGPLNKYLQQNR-------HVKDKNIIELVHQVSMGMKYL 123
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPE 262
E +HRD + N+LL +AK+SDFGL+K + +D+ T + APE
Sbjct: 124 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 263 YALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321
++KSDV+S+GV++ E + G+ P K ++ ++
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----------------SEVTAML 223
Query: 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
+ ++ + +C + + RP A V L
Sbjct: 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 1e-56
Identities = 76/302 (25%), Positives = 113/302 (37%), Gaps = 42/302 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED---EFKMEVELLGRLRSPY 142
FS +GHG FG VY + N VAIK M +GKQ + + EV L +LR P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
+ G LV +Y L + A +GL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-------PLQEVEIAAVTHGALQGLA 129
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+LH H +IHRD K+ NILL + K+ DFG A I + + +GT ++AP
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAP 180
Query: 262 EYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318
E L G K DV+S G+ +EL + P+ + + ++ I
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-------------FNMNAMSALYHIA 227
Query: 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSS 378
+ PAL+ + + C+Q RP +++ V R I
Sbjct: 228 QNESPALQSGHWSEYFRN---FVDSCLQKIPQDRPTSEVLLKH--RFVLRERPPTVIMDL 282
Query: 379 PS 380
Sbjct: 283 IQ 284
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-55
Identities = 76/313 (24%), Positives = 130/313 (41%), Gaps = 37/313 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNG---RKVAIKLMDQ-AGKQGEDEFKMEVELLGRL-RSP 141
+V+G G FG V + + AIK M + A K +F E+E+L +L P
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 142 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLY---------PANGSNSVASKLDWETRLR 191
++ LLG C R L L +Y +G L + L +NS AS L + L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 192 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR 251
A + A+G+++L IHRD + NIL+ +N+ AK++DFGL++ T
Sbjct: 132 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTM 185
Query: 252 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311
++A E TT SDV+SYGV+L E+++
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP----------------YCG 229
Query: 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371
++ E + + + +V + C + + RP A ++ SL +++ ++
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
Query: 372 TPKISSSPSFHAS 384
+ F +
Sbjct: 290 YVNTTLYEKFTYA 302
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 8e-55
Identities = 66/281 (23%), Positives = 110/281 (39%), Gaps = 41/281 (14%)
Query: 87 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPY 142
F +G G FG VY + +A+K++ +A E + + EVE+ LR P
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
+L L GY D ++ L+ +Y G + L + K D + E A L
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELANALS 120
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+ H VIHRD K N+LL K++DFG + A T + GT Y+ P
Sbjct: 121 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP 173
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321
E K D++S GV+ E L G+ P + N E
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------------------ETY 213
Query: 322 DPALEGQYSMKEVI--QVAAIAAMCVQPEADYRPLMADVVQ 360
+++ + + + + ++ RP++ +V++
Sbjct: 214 KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 7e-54
Identities = 58/290 (20%), Positives = 110/290 (37%), Gaps = 35/290 (12%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY 149
+G G FG VY+ A K++D ++ +++ +E+++L P ++ LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 150 CSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCS 208
L ++ ++ A G + + L + + L +LH++
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER------PLTESQIQVVCKQTLDALNYLHDN-- 129
Query: 209 PPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT-- 266
+IHRD K+ NIL + K++DFG++ + +GT ++APE +
Sbjct: 130 -KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCET 186
Query: 267 ---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323
K+DV+S G+ L+E+ P L + KI + P
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHH-------------ELNPMRVLLKIAKSEPP 233
Query: 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTP 373
L C++ D R + ++Q P V + + P
Sbjct: 234 TLAQPSRWSS--NFKDFLKKCLEKNVDARWTTSQLLQH--PFVTVDSNKP 279
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-53
Identities = 58/280 (20%), Positives = 98/280 (35%), Gaps = 32/280 (11%)
Query: 91 NVVGHGGFGLVYRGVL----SNGRKVAIKLMDQ---AGKQGEDEFKMEVELLGRLRSPYL 143
+G G FG+V RG VA+K + + + D+F EV + L L
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 144 LALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
+ L G +V + G L + L G T R A++ A+G+ +L
Sbjct: 74 IRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQG------HFLLGTLSRYAVQVAEGMGYL 127
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQGYVAPE 262
IHRD + N+LL K+ DFGL + + + + + APE
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 263 YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322
T + SD + +GV L E+ T + + + + + +R E
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKEGERLPRPEDCP 241
Query: 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
+ + C + + RP + L
Sbjct: 242 QDI------------YNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 4e-53
Identities = 65/299 (21%), Positives = 133/299 (44%), Gaps = 38/299 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+++ +G G G VY + ++ G++VAI+ M+ + ++ E+ ++ ++P ++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L +L +V +Y+A G L + + + +D + E + LEFLH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLH 133
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
+ VIHRD KS NILL + K++DFG + ++GT ++APE
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVV 188
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVP-IDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323
K D++S G++ +E++ G P ++ N ++ + P L + EK+
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA---- 244
Query: 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS----TPKISSS 378
++ + C+ + + R +++Q +K + TP I+++
Sbjct: 245 ------IFRDFLN------RCLDMDVEKRGSAKELLQH--QFLKIAKPLSSLTPLIAAA 289
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 5e-53
Identities = 60/278 (21%), Positives = 108/278 (38%), Gaps = 29/278 (10%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLL 144
+ +G G +G V V VA+K++D + K E+ + L ++
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 145 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
G+ + L +Y + G L + + P G + R + G+ +L
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-------MPEPDAQRFFHQLMAGVVYL 119
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H + HRD K N+LLD+ + K+SDFGLA + + ++ GT YVAPE
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 264 ALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322
DV+S G+VL +L G +P D S + +D ++ ++
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ---------EYSDWKEKKTYLN 227
Query: 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360
P + + ++ + R + D+ +
Sbjct: 228 PWKKIDSAPLALLH------KILVENPSARITIPDIKK 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-52
Identities = 69/287 (24%), Positives = 125/287 (43%), Gaps = 30/287 (10%)
Query: 87 FSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGKQGE-DEFKMEVELLGRLR 139
+ S +G G FG+VY GV +VAIK +++A E EF E ++
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81
Query: 140 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLY---PANGSNSVASKLDWETRLRIALE 195
+++ LLG S + ++ + M G L+ +L PA +N V + +++A E
Sbjct: 82 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141
Query: 196 AAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGT 255
A G+ +L+ + +HRD + N ++ ++F K+ DFG+ + + + L
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 256 QGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315
+++PE G TT SDV+S+GVVL E+ T + + + R
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVMEG 251
Query: 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
+L+ D + + + MC Q RP +++ S+
Sbjct: 252 GLLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-52
Identities = 53/285 (18%), Positives = 111/285 (38%), Gaps = 31/285 (10%)
Query: 92 VVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGKQGE-DEFKMEVELLGRLRSPYLLAL 146
+G G FG V++G+ + VAIK ++F E + + P+++ L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 147 LGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH 206
+G ++ ++ + G L+ L S LD + + A + + L +L
Sbjct: 74 IGVITENPVWIIMELCTLGELRSFLQVRKYS------LDLASLILYAYQLSTALAYLESK 127
Query: 207 CSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT 266
+HRD + N+L+ N K+ DFGL++ D + +++ ++APE
Sbjct: 128 R---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINF 183
Query: 267 GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALE 326
T+ SDV+ +GV + E+L V + + + +I +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI------------GRIENGERLPMP 231
Query: 327 GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371
+ ++ C + RP ++ L +++ ++
Sbjct: 232 PNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-50
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED---EFKMEVELLGRLRSPY 142
F ++G G F V L+ R+ AIK++++ E+ E +++ RL P+
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
+ L D KL Y NG L +++ D E LE
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-------SFDETCTRFYTAEIVSALE 122
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+LH +IHRD K NILL+++ H +++DFG AK+ S ++ + +GT YV+P
Sbjct: 123 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
E SD+++ G ++ +L+ G P
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 3e-49
Identities = 61/298 (20%), Positives = 107/298 (35%), Gaps = 37/298 (12%)
Query: 91 NVVGHGGFGLVYRGV------LSNGRKVAIKLMDQAGKQGED-EFKMEVELLGRLRSPYL 143
+G G FG V + R VA+K++ + E E+++L +
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 144 LALLGYC---SDRRKLLVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRLR 191
+ L +++ ++ G L +L Y + L E +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 192 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTR 251
+ + AKG+EFL IHRD + NILL + K+ DFGLA+
Sbjct: 139 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 252 VLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311
++APE T +SDV+S+GV+L E+ + P +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---------------PGV 240
Query: 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369
E+ + + ++ C E RP +++V+ L L++ N
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (422), Expect = 7e-49
Identities = 65/311 (20%), Positives = 124/311 (39%), Gaps = 35/311 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
+ +G G FG+V+R + G A K + + ++ + E++ + LR P L+
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 146 LLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L D ++ ++Y++M+ G L E + + K+ + + + KGL +H
Sbjct: 88 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHN------KMSEDEAVEYMRQVCKGLCHMH 141
Query: 205 EHCSPPVIHRDFKSSNILL--DKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE 262
E+ +H D K NI+ ++ K+ DFGL K V+T GT + APE
Sbjct: 142 ENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPE 195
Query: 263 YALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322
A + +D++S GV+ LL+G P + + L + + +
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFG--GENDDETLRNVKSCDWNMDDSAFSGIS 253
Query: 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSPSFH 382
K+ I+ + + + R + ++ P + + + S PS
Sbjct: 254 EDG------KDFIR------KLLLADPNTRMTIHQALEH--PWLTPGNAPGRDSQIPS-- 297
Query: 383 ASRSPAFPDKV 393
SR D +
Sbjct: 298 -SRYTKIRDSI 307
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 2e-48
Identities = 64/292 (21%), Positives = 121/292 (41%), Gaps = 39/292 (13%)
Query: 91 NVVGHGGFGLVYRGVL--------SNGRKVAIKLMD-QAGKQGEDEFKMEVELLGRL-RS 140
+G G FG V + KVA+K++ A ++ + E+E++ + +
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 141 PYLLALLGYCSDRRKL-LVYDYMANGGLQEHL---------YPANGSNSVASKLDWETRL 190
++ LLG C+ L ++ +Y + G L+E+L Y N S++ +L + +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 191 RIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVST 250
A + A+G+E+L IHRD + N+L+ ++ K++DFGLA+ +T
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 251 RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 310
++APE T +SDV+S+GV+L E+ T P
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------------- 242
Query: 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
E++ +++ ++ + C RP +V+ L
Sbjct: 243 ---VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 164 bits (417), Expect = 5e-48
Identities = 67/313 (21%), Positives = 124/313 (39%), Gaps = 42/313 (13%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G FG+V+R V + GR K ++ + K E+ ++ +L P L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 151 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
D+ ++ L+ ++++ G L + + + K+ + +A +GL+ +HEH
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY------KMSEAEVINYMRQACEGLKHMHEH--- 146
Query: 210 PVIHRDFKSSNILLD--KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 267
++H D K NI+ + K K+ DFGLA + + T + APE
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIVDRE 203
Query: 268 HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327
+ +D+++ GV+ LL+G P L + E + P
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFA--GEDDLETLQNVKRCDWEFDEDAFSSVSPEA-- 259
Query: 328 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ------------SLVPLVKYNRSTPKI 375
K+ I+ +Q E R + D ++ S +P +YN+ KI
Sbjct: 260 ----KDFIK------NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKI 309
Query: 376 SSSPSFHASRSPA 388
+ + PA
Sbjct: 310 KEKYADWPAPQPA 322
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (390), Expect = 2e-44
Identities = 49/208 (23%), Positives = 85/208 (40%), Gaps = 13/208 (6%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQG-EDEFKMEVELLGRLRSPYLL 144
+ +V+G G F V + VAIK + + +G E + E+ +L +++ P ++
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 145 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
AL L L+ ++ G L + + R+ + +++L
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-------FYTERDASRLIFQVLDAVKYL 123
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H+ + LD++ +SDFGL+K+ G V + GT GYVAPE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGYVAPEV 180
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVP 291
+ D +S GV+ LL G P
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 153 bits (387), Expect = 2e-44
Identities = 62/284 (21%), Positives = 110/284 (38%), Gaps = 34/284 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED---EFKMEVELLGRLRSPY 142
+ ++G GG V+ L R VA+K++ + F+ E + L P
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 143 LLALLGYCSDRRKL-----LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAA 197
++A+ +V +Y+ L++ ++ + + + + +A
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-------PMTPKRAIEVIADAC 121
Query: 198 KGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVSTRVLGTQ 256
+ L F H++ +IHRD K +NI++ KV DFG+A+ I + V+GT
Sbjct: 122 QALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 257 GYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316
Y++PE A + +SDVYS G VL E+LTG P + P V
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVREDPIPPSA 236
Query: 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360
E + L V+ + + R A ++
Sbjct: 237 RHEGLSADL------DAVVL------KALAKNPENRYQTAAEMR 268
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (388), Expect = 1e-43
Identities = 69/232 (29%), Positives = 99/232 (42%), Gaps = 23/232 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA---GKQGEDEFKMEVE---LLGRLR 139
FS ++G GGFG VY G+ A+K +D+ KQGE E L+
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 140 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 198
P+++ + KL + D M G L HL A E
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-------VFSEADMRFYAAEIIL 118
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
GLE +H V++RD K +NILLD++ H ++SD GLA S K +GT GY
Sbjct: 119 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGY 171
Query: 259 VAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 309
+APE G + +D +S G +L +LL G P +K + + L
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-43
Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGR-LRSP 141
F ++G G FG V+ + AIK + + +D+ +E +L P
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 142 YLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
+L + + L V +Y+ G L H+ + K D A E GL
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-------KFDLSRATFYAAEIILGL 116
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260
+FLH +++RD K NILLDK+ H K++DFG+ K G + GT Y+A
Sbjct: 117 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIA 171
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
PE L D +S+GV+L E+L G+ P
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 5e-43
Identities = 52/273 (19%), Positives = 110/273 (40%), Gaps = 31/273 (11%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G FG+V+R V S+ + K + G + K E+ +L R +L L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 151 SDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
+L +++++++ + E + N+ A +L+ + + + L+FLH H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI------NTSAFELNEREIVSYVHQVCEALQFLHSH--- 121
Query: 210 PVIHRDFKSSNILLD--KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG 267
+ H D + NI+ ++ K+ +FG A+ G + Y APE
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHD 178
Query: 268 HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPALEG 327
++T +D++S G ++ LL+G P + + ++ + T E+ + +
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFL--AETNQQIIENIMNAEYTFDEEAFKEISIEA-- 234
Query: 328 QYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQ 360
+ + + E R ++ +Q
Sbjct: 235 ----MDFVD------RLLVKERKSRMTASEALQ 257
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (376), Expect = 1e-42
Identities = 58/281 (20%), Positives = 102/281 (36%), Gaps = 31/281 (11%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G FG +Y G ++ G +VAIKL K + +E ++ ++ + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 151 -SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSP 209
++ ++ + L++ + K +T L +A + +E++H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSR------KFSLKTVLLLADQMISRIEYIHSKN-- 123
Query: 210 PVIHRDFKSSNIL---LDKNFHAKVSDFGLAKIGSDKAGG-----HVSTRVLGTQGYVAP 261
IHRD K N L K + DFGLAK D + + GT Y +
Sbjct: 124 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321
L + + D+ S G VL+ G +P K + + EK +
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER------ISEKKMSTP 236
Query: 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSL 362
L Y + A C D +P + + Q
Sbjct: 237 IEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-42
Identities = 58/264 (21%), Positives = 102/264 (38%), Gaps = 20/264 (7%)
Query: 79 QLHSATGGFSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGE-DEFKMEVELLG 136
Q+ ++ + +G G +G+V N +VAIK + Q E+++L
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 137 RLRSPYLLALLGYC-----SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLR 191
R R ++ + + + + ++ L + L L +
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--------TQHLSNDHICY 113
Query: 192 IALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK-IGSDKAGGHVST 250
+ +GL+++H V+HRD K SN+LL+ K+ DFGLA+ D T
Sbjct: 114 FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170
Query: 251 RVLGTQGYVAPEYALTGHLTTKS-DVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALP 309
+ T+ Y APE L TKS D++S G +L E+L+ R + + L
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230
Query: 310 RLTDREKILEIMDPALEGQYSMKE 333
+ + I A S+
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPH 254
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 147 bits (372), Expect = 2e-42
Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 31/223 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMD---------QAGKQGEDEFKMEVELLG 136
+ ++G G +V R + ++ A+K++D + ++ + EV++L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 137 RLRS-PYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL 194
++ P ++ L LV+D M G L ++L L + +I
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-------TLSEKETRKIMR 117
Query: 195 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLG 254
+ + LH+ ++HRD K NILLD + + K++DFG + G V G
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCG 171
Query: 255 TQGYVAPEYALTGHL------TTKSDVYSYGVVLLELLTGRVP 291
T Y+APE + D++S GV++ LL G P
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (374), Expect = 4e-42
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQ---AGKQGEDEFKMEVELLGRLRSPY 142
F +G G FG V+ NGR A+K++ + + + E +L + P+
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 143 LLALLGYCSDRRKLL-VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
++ + G D +++ + DY+ G L L + + A E LE
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYAAEVCLALE 118
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+LH +I+RD K NILLDKN H K++DFG AK D + + GT Y+AP
Sbjct: 119 YLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAP 170
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
E T D +S+G+++ E+L G P
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 144 bits (363), Expect = 6e-41
Identities = 51/287 (17%), Positives = 91/287 (31%), Gaps = 31/287 (10%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G FG+++ G L N ++VAIK + + + + E L + + Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 151 SDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPP 210
V G E L G K +T A + ++ +HE
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKS--- 121
Query: 211 VIHRDFKSSNILLDKNFH-----AKVSDFGLAKIGSDKAGG-----HVSTRVLGTQGYVA 260
+++RD K N L+ + V DFG+ K D + GT Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 261 PEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320
L + + D+ + G V + L G +P K + E+I E
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY----------ERIGEK 231
Query: 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367
+ + D P + +++
Sbjct: 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 8e-41
Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 12/208 (5%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYL 143
F K +G G +G+VY+ G VA+K + D + E+ LL L P +
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 144 LALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
+ LL KL + + L++ + S + + + +GL F
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMD-----ASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H H V+HRD K N+L++ K++DFGLA+ + V+
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPEIL 174
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVP 291
+ +T D++S G + E++T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (357), Expect = 4e-40
Identities = 44/287 (15%), Positives = 109/287 (37%), Gaps = 23/287 (8%)
Query: 87 FSKSNVVGHGGFGLVYRGVLSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYLL 144
+ +G G +G+VY+ + G A+K + ++ + E+ +L L+ ++
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 145 ALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
L +++L++ + L++ L G L+ T L+ G+ + H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCH 117
Query: 205 EHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYA 264
+ V+HRD K N+L+++ K++DFGLA+ + ++
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLARA-FGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 265 LTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324
+ +T D++S G + E++ G + + + + L + P
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 325 LEGQYSMKEVIQVAAIA-----------AMCVQPEADYRPLMADVVQ 360
+ +++ E + + + ++ + + R ++
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-39
Identities = 63/308 (20%), Positives = 115/308 (37%), Gaps = 42/308 (13%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED------EFKMEVELLGRLR 139
+ +G G F +V + S G + A K + + + + + EV +L ++
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 140 SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 198
P ++ L ++ + L+ + +A G L + L L E +
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-------SLTEEEATEFLKQILN 124
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKN----FHAKVSDFGLAKIGSDKAGGHVSTRVLG 254
G+ +LH + H D K NI+L K+ DFGLA G+ + G
Sbjct: 125 GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKNIFG 178
Query: 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314
T +VAPE L ++D++S GV+ LL+G P + + L + +
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANVSAVNYEFE 236
Query: 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPK 374
++ K+ I+ + + R + D +Q P +K + T +
Sbjct: 237 DEYFSNTSALA------KDFIR------RLLVKDPKKRMTIQDSLQH--PWIK-PKDTQQ 281
Query: 375 ISSSPSFH 382
SS H
Sbjct: 282 ALSSAWSH 289
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-39
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 20/209 (9%)
Query: 91 NVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE-----FKMEVELLGRLRSPYLL 144
+ +G G F VY+ + + VAIK + + + E++LL L P ++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 145 ALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
LL + + LV+D+M + L L +GLE+L
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-------VLTPSHIKAYMLMTLQGLEYL 116
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H+H ++HRD K +N+LLD+N K++DFGLAK T + T+ Y APE
Sbjct: 117 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPEL 171
Query: 264 ALTGHL-TTKSDVYSYGVVLLELLTGRVP 291
+ D+++ G +L ELL
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-39
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 22/214 (10%)
Query: 87 FSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLA 145
++ + V+G+G FG+VY+ L +G VAIK + Q + E++++ +L ++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77
Query: 146 LLGYCSDRRKL-------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 198
L + + LV DY+ + + + L + +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ----TLPVIYVKLYMYQLFR 133
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQG 257
L ++H + HRD K N+LLD + K+ DFG AK G + +
Sbjct: 134 SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYY 188
Query: 258 YVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
T+ DV+S G VL ELL G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-39
Identities = 66/289 (22%), Positives = 116/289 (40%), Gaps = 36/289 (12%)
Query: 87 FSKSNVVGHGGFGLVYRG--VLSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRS-- 140
+ +G G +G V++ + + GR VA+K + + EV +L L +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 141 -PYLLALLGYCSDRR-----KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL 194
P ++ L C+ R KL + + L +L + ET +
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTETIKDMMF 123
Query: 195 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLG 254
+ +GL+FLH H V+HRD K NIL+ + K++DFGLA+I S + T V+
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVV 177
Query: 255 TQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR 314
T Y APE L T D++S G + E+ + + +
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-------------L 224
Query: 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363
KIL+++ E + + A + QP + + ++ + L+
Sbjct: 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 273
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-39
Identities = 62/283 (21%), Positives = 105/283 (37%), Gaps = 53/283 (18%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE------FKMEVELLGRLRSPY-- 142
++G GGFG VY G+ +S+ VAIK +++ E MEV LL ++ S +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 143 LLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
++ LL + L+ + G L E + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVR 124
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260
H V+HRD K NIL+D N K+ DFG + D V T GT+ Y
Sbjct: 125 HCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTRVYSP 177
Query: 261 PEYALTGHLTTKS-DVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319
PE+ +S V+S G++L +++ G +P E
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--------------------------FE 211
Query: 320 IMDPALEGQYSMKEVI--QVAAIAAMCVQPEADYRPLMADVVQ 360
+ + GQ ++ + + + C+ RP ++
Sbjct: 212 HDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-38
Identities = 64/210 (30%), Positives = 89/210 (42%), Gaps = 17/210 (8%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGRLRSPY 142
F ++G G FG V + GR A+K++ + +DE E +L R P+
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 143 LLALLGYCSDRRKLLVYDYMANGG-LQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
L AL +L ANGG L HL E E LE
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-------VFTEERARFYGAEIVSALE 119
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+LH V++RD K N++LDK+ H K++DFGL K G G GT Y+AP
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAP 174
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
E D + GVV+ E++ GR+P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 7e-38
Identities = 61/299 (20%), Positives = 107/299 (35%), Gaps = 38/299 (12%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGY 149
V+G G G V + K A+K++ + + EVEL R + P+++ ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73
Query: 150 CSDRRK-----LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLH 204
+ L+V + + G L + I + +++LH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----AFTEREASEIMKSIGEAIQYLH 128
Query: 205 EHCSPPVIHRDFKSSNILLDK---NFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+ HRD K N+L N K++DFG AK + + T T YVAP
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAP 182
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321
E D++S GV++ LL G P N P + R ++ +
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-------LAISPGMKTRIRMGQYE 235
Query: 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRSTPKISSSPS 380
P E +EV + ++ E R + + + P + + P+ S
Sbjct: 236 FPNPEWSEVSEEVKM---LIRNLLKTEPTQRMTITEFMNH--PWIMQSTKVPQTPLHTS 289
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 9e-37
Identities = 49/220 (22%), Positives = 90/220 (40%), Gaps = 25/220 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIK--LMDQAGKQGEDEFKMEVELLGRLRSPYL 143
+ K +G G FG V++ G+KVA+K LM+ + E+++L L+ +
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 144 LALLGYCSDRRKL---------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIAL 194
+ L+ C + LV+D+ + K R+
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-------KFTLSEIKRVMQ 124
Query: 195 EAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVS--TRV 252
GL ++H + ++HRD K++N+L+ ++ K++DFGLA+ S + T
Sbjct: 125 MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 253 LGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVP 291
+ T Y PE L D++ G ++ E+ T
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 7e-36
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 20/216 (9%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDE---FKMEVELLGRLRSPY 142
F + +G G FG V +G A+K++D+ + E +L + P+
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 143 LLALLGYCSDRRKLL-VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
L+ L D L V +Y+A G + HL + A + E
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-------RFSEPHARFYAAQIVLTFE 155
Query: 202 FLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAP 261
+LH +I+RD K N+L+D+ + +V+DFG AK + + + GT +AP
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAP 207
Query: 262 EYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKP 297
E L+ D ++ GV++ E+ G P ++P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 7e-35
Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYL 143
+ VG G +G V V G KVAIK + + E+ LL +R +
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 144 LALLGYCSDRRKL-------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 196
+ LL + L LV +M G L KL + + +
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE-------KLGEDRIQFLVYQM 130
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 256
KGL ++H HRD K N+ ++++ K+ DFGLA+ + G+V T+
Sbjct: 131 LKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV-----VTR 182
Query: 257 GYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVP 291
Y APE L T D++S G ++ E++TG+
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-34
Identities = 48/209 (22%), Positives = 82/209 (39%), Gaps = 13/209 (6%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLM--DQAGKQGEDEFKMEVELLGRLRSPYL 143
+ K +G G +G V++ VA+K + D + E+ LL L+ +
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 144 LALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFL 203
+ L +KL + + L+++ NG D E + KGL F
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL------DPEIVKSFLFQLLKGLGFC 117
Query: 204 HEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEY 263
H V+HRD K N+L+++N K+++FGLA+ S V+
Sbjct: 118 HSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVL 173
Query: 264 ALTGHLTTKSDVYSYGVVLLELLTGRVPI 292
+T D++S G + EL P+
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 124 bits (311), Expect = 5e-33
Identities = 42/213 (19%), Positives = 89/213 (41%), Gaps = 26/213 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLL 144
+ +G G + V+ + ++N KV +K++ + + K E+++L LR P ++
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNII 93
Query: 145 ALLGYCSD---RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLE 201
L D R LV++++ N ++ L E K L+
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALD 143
Query: 202 FLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVA 260
+ H ++HRD K N+++D ++ ++ D+GLA+ G + ++ +
Sbjct: 144 YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASRYFKG 197
Query: 261 PEYALT-GHLTTKSDVYSYGVVLLELLTGRVPI 292
PE + D++S G +L ++ + P
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 7e-33
Identities = 48/215 (22%), Positives = 85/215 (39%), Gaps = 26/215 (12%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYL 143
+ +G G G+V R VAIK + + + E+ L+ + +
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 144 LALLGYCSDRRKL-------LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 196
++LL + ++ L LV + M Q D E + +
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----------DHERMSYLLYQM 128
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 256
G++ LH +IHRD K SNI++ + K+ DFGLA+ + T + T+
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTR 182
Query: 257 GYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
Y APE L D++S G ++ E++ ++
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-31
Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 24/214 (11%)
Query: 87 FSKSNVVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGED--EFKMEVELLGRLRSPYL 143
+ + VG G +G V G +VA+K + + + E+ LL ++ +
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 144 LALLGYCSDRRKLLVYDYM-----ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAK 198
+ LL + R L ++ + G ++ KL + + + +
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILR 132
Query: 199 GLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGY 258
GL+++H HRD K SN+ ++++ K+ DFGLA+ D+ G+V+TR Y
Sbjct: 133 GLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 259 VAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVP 291
APE L H D++S G ++ ELLTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 5e-30
Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 87 FSKSNVVGHGGFGLVYRGVL----SNGRKVAIKLMDQAG----KQGEDEFKMEVELLGRL 138
F V+G G +G V+ G+ A+K++ +A + + + E ++L +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 139 R-SPYLLALLGYCSDRRKL-LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEA 196
R SP+L+ L KL L+ DY+ G L HL + E
Sbjct: 86 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-------RFTEHEVQIYVGEI 138
Query: 197 AKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQ 256
LE LH+ +I+RD K NILLD N H ++DFGL+K + GT
Sbjct: 139 VLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERAYDFCGTI 194
Query: 257 GYVAPEYALTGH--LTTKSDVYSYGVVLLELLTGRVP 291
Y+AP+ G D +S GV++ ELLTG P
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (289), Expect = 1e-29
Identities = 40/212 (18%), Positives = 86/212 (40%), Gaps = 15/212 (7%)
Query: 92 VVGHGGFGLVYRGV-LSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYC 150
+G G F V+ + N VA+K++ K + + E++LL R+
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 151 SDR--RKLLVYDYMANGGLQEHLYPANGSNSVASKL--------DWETRLRIALEAAKGL 200
++ + L +++ G+ + ++ + + +I+ + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYV 259
+++H C +IH D K N+L++ + +A +G+ T + T+ Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 260 APEYALTGHLTTKSDVYSYGVVLLELLTGRVP 291
+PE L +D++S ++ EL+TG
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.7 bits (193), Expect = 8e-18
Identities = 21/158 (13%), Positives = 41/158 (25%), Gaps = 23/158 (14%)
Query: 91 NVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG----------KQGEDEFKMEVELLGRLRS 140
++G G V+ + +K G+ F + R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 141 PYLLALLGYCSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGL 200
L L G + Y + N L E + E + + +
Sbjct: 66 RALQKLQGLAVPKV----YAWEGNAVLMELIDAKELYRV-----RVENPDEVLDMILEEV 116
Query: 201 EFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238
+ ++H D N+L+ + DF +
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 395 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.67 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.04 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.39 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.03 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.99 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-57 Score=406.16 Aligned_cols=262 Identities=29% Similarity=0.516 Sum_probs=206.3
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~ 161 (395)
.++|++.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||++++++.+++.++||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey 84 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQW 84 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEec
Confidence 467999999999999999999864 35999998643 34445789999999999999999999999988888999999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 85 CEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp CCEEEHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred CCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 99999999996433 4699999999999999999999998 99999999999999999999999999998755
Q ss_pred CCCCCceeeccccccccccchhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
............||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ...... ..
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~~~--------~~ 224 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFMV--------GR 224 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHH--------HH
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHHHHH--------hc
Confidence 4433334455679999999999864 358999999999999999999999997543211 010000 00
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
....+.+ ...+...+..+.+|+.+||+.||++|||+.+|+++|+.+.+.
T Consensus 225 ~~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 225 GYLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp TSCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 0111111 112223445789999999999999999999999999998863
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=398.51 Aligned_cols=255 Identities=28% Similarity=0.448 Sum_probs=199.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
++|++.+.||+|+||+||+|.+.+++.||||++... ....++|.+|++++++++||||++++|+|.+. ..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 467888999999999999999988999999999764 34567899999999999999999999998765 6779999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~g~L~~~l~~~~------~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 84 HGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp TCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred CCcHHHHhhccc------cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC
Confidence 999999985432 4689999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTG-RVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.. .......||+.|+|||++.+..++.++|||||||++|||+|+ .+||..... ..... .+.
T Consensus 155 ~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~--------------~i~ 216 (263)
T d1sm2a_ 155 QY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVE--------------DIS 216 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHH--------------HHH
T ss_pred Cc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHH--------------HHH
Confidence 22 122345689999999999999999999999999999999995 555442211 01111 111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.......+...+.++.+|+.+||+.||++||||++|+++|+++++
T Consensus 217 ~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 217 TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 111111222334578999999999999999999999999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-56 Score=398.62 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=209.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccC
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMAN 164 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~ 164 (395)
++|++.+.||+|+||+||+|.+++++.||||++... ....+.|.+|++++++++|||||++++++.++..++||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCC
Confidence 467888999999999999999988899999999754 3456789999999999999999999999988888999999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|.+++.... ...+++..++.++.|+++||.|||++ +|+||||||+||||++++.+||+|||+++......
T Consensus 92 g~L~~~~~~~~-----~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 92 GSLVDFLKTPS-----GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CBHHHHTTSHH-----HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CcHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999884322 23589999999999999999999999 99999999999999999999999999998754322
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
........||+.|+|||++.+..++.++|||||||++|||+||..|+...... .... .. +...
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~-------------~~-i~~~ 226 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVI-------------QN-LERG 226 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH-------------HH-HHTT
T ss_pred -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHH-------------HH-HHhc
Confidence 12233456889999999999999999999999999999999966554322110 0000 01 1111
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.....+...+.++.+|+.+||+.||++||||.+|++.|++++.
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1112222344578999999999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-56 Score=396.27 Aligned_cols=252 Identities=23% Similarity=0.320 Sum_probs=200.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|++.+.||+|+||+||+|.+. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.++ ..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56889999999999999999975 78999999986542 22345688999999999999999999998877 45699999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~gg~L~~~l~~-------~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 85 CSGGELFDRIEP-------DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp CTTEEGGGGSBT-------TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred cCCCcHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeec
Confidence 999999999943 24699999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCceeeccccccccccchhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
...........+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... . ..
T Consensus 155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~--------------~~ 219 (271)
T d1nvra_ 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-S--------------DW 219 (271)
T ss_dssp ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-H--------------HH
T ss_pred cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-H--------------HH
Confidence 4333333455789999999999988876 578999999999999999999997543221100 0 00
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.............+.++.+|+.+||+.||++|||++|++++
T Consensus 220 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 220 KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred hcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00000001111223567899999999999999999999863
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-55 Score=387.56 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=209.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEccc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYMA 163 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~~ 163 (395)
++|++.+.||+|+||+||+|++++++.||||+++.. ....++|.+|+.++++++||||++++|+|.+. ..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 578999999999999999999988889999999865 33567899999999999999999999999876 6679999999
Q ss_pred CCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCC
Q 016117 164 NGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDK 243 (395)
Q Consensus 164 ~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~ 243 (395)
+|+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 83 ~g~l~~~~~~~------~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 83 NGCLLNYLREM------RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp TEEHHHHHHSG------GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred CCcHHHhhhcc------ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 99999997543 34689999999999999999999999 9999999999999999999999999999865443
Q ss_pred CCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhcc
Q 016117 244 AGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMD 322 (395)
Q Consensus 244 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 322 (395)
.. .......||+.|+|||.+.+..++.++||||||+++|||+| |+.||...... ... ..+..
T Consensus 154 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~-------------~~i~~ 216 (258)
T d1k2pa_ 154 EY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETA-------------EHIAQ 216 (258)
T ss_dssp SC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHH-------------HHHHT
T ss_pred Cc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH---HHH-------------HHHHh
Confidence 22 22334568999999999999999999999999999999998 89999754321 000 01111
Q ss_pred ccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 323 PALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 323 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
......+...+..+.+|+.+||+.||++|||+++|+++|.++
T Consensus 217 -~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 217 -GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -CCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 111122223345789999999999999999999999998653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-55 Score=399.24 Aligned_cols=258 Identities=24% Similarity=0.415 Sum_probs=197.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CC---cEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NG---RKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv 158 (395)
++|++.++||+|+||+||+|.+. ++ ..||||.+... .....+.|.+|+++|++++|||||++++++.+. ..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 34667789999999999999975 23 35889988653 333456799999999999999999999999766 67799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+++|+|.+++.... ..+++.+++.++.|+++||.|||++ +++||||||+|||++.++.+||+|||+++
T Consensus 106 ~Ey~~~g~L~~~~~~~~------~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp EECCTTEEHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEecCCCcceeeecccc------CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccce
Confidence 99999999999886432 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCce---eeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccc
Q 016117 239 IGSDKAGGHV---STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDR 314 (395)
Q Consensus 239 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 314 (395)
.......... .....||+.|+|||.+.+..++.++|||||||++|||+| |..||...... .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~------------ 241 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---D------------ 241 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---H------------
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---H------------
Confidence 6544322211 122457899999999999999999999999999999998 89999754321 0
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 315 EKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 315 ~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
+...+........+.+.+..+.+|+.+||+.||++|||+.+|++.|+++++.
T Consensus 242 --~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 242 --VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1111111111223334556789999999999999999999999999999873
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-55 Score=396.87 Aligned_cols=259 Identities=24% Similarity=0.383 Sum_probs=212.5
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
.++|++.+.||+|+||+||+|.+. +|+.||||+++.. ....++|.+|+.++++++|||||++++++.++ ..+++|||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 346788899999999999999975 5889999998754 34567899999999999999999999998876 67799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 95 ~~~g~l~~~l~~~~-----~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 95 MTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp CTTCBHHHHHHHSC-----TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred ccCcchHHHhhhcc-----ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence 99999999996533 24789999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
... ........|++.|+|||++.+..++.++|||||||++|||++|..||..... ...+.+.+
T Consensus 167 ~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----------------~~~~~~~i 229 (287)
T d1opja_ 167 GDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----------------LSQVYELL 229 (287)
T ss_dssp SSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----------------HHHHHHHH
T ss_pred CCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----------------HHHHHHHH
Confidence 332 2223345588999999999999999999999999999999998777643221 11111222
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
........+...+.++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 22222233334456799999999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=394.18 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=208.1
Q ss_pred CCCCCCe-eeccCCeEEEEEEEc---CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEE
Q 016117 86 GFSKSNV-VGHGGFGLVYRGVLS---NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYD 160 (395)
Q Consensus 86 ~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e 160 (395)
+|.+.+. ||+|+||+||+|.+. ++..||||+++... ....+.|.+|++++++++|||||++++++.++..++|||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE 88 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVME 88 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEE
Confidence 4555564 999999999999853 45579999997543 334567999999999999999999999999888899999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+++|+|.+++...+ ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 89 MAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp CCTTEEHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred eCCCCcHHHHhhccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999985332 4699999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCC-ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 241 SDKAGG-HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 241 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... .......||+.|+|||++.+..++.++|||||||++|||+| |..||...... ...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~-------------- 222 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM-------------- 222 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH--------------
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHH--------------
Confidence 443221 12234568899999999999999999999999999999998 99999754321 111
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
..+........+...+.++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 223 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11111111122334456789999999999999999999999999877653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-55 Score=394.13 Aligned_cols=252 Identities=24% Similarity=0.383 Sum_probs=207.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
++|++.+.||+|+||+||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++.+. ..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999995 47999999999765555667899999999999999999999998776 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++|+|.+++.. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 100 ~gg~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 100 AGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp TTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 99999998742 3589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhc-
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM- 321 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 321 (395)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....... .. ..+.
T Consensus 169 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~-------------~~~~~ 230 (293)
T d1yhwa1 169 EQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---AL-------------YLIAT 230 (293)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH-------------HHHHH
T ss_pred cc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH---HH-------------HHHHh
Confidence 32 22345679999999999999999999999999999999999999996433110 00 0000
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
........+...+..+.+|+.+||+.||++|||+.|++++ .+++
T Consensus 231 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H--p~~~ 274 (293)
T d1yhwa1 231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH--QFLK 274 (293)
T ss_dssp HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC--GGGG
T ss_pred CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC--HhhC
Confidence 0001111222334678899999999999999999999875 5554
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=388.68 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=201.6
Q ss_pred CeeeccCCeEEEEEEEc---CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccCC
Q 016117 91 NVVGHGGFGLVYRGVLS---NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMANG 165 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~g 165 (395)
++||+|+||+||+|.+. .++.||||+++... ....+.|.+|++++++++|||||+++++|.++..++||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence 46999999999999864 34689999986432 23346799999999999999999999999888889999999999
Q ss_pred ChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCCC
Q 016117 166 GLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKAG 245 (395)
Q Consensus 166 ~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~ 245 (395)
+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 93 ~L~~~l~~~-------~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 93 PLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred cHHHHHhhc-------cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 999998533 4699999999999999999999999 999999999999999999999999999986544332
Q ss_pred Cc-eeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhccc
Q 016117 246 GH-VSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDP 323 (395)
Q Consensus 246 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 323 (395)
.. ......||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+...+..
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-----------------~~~~~i~~ 225 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----------------EVTAMLEK 225 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----------------HHHHHHHT
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-----------------HHHHHHHc
Confidence 22 2233568999999999999999999999999999999998 89999754311 11111111
Q ss_pred cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 324 ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 324 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
......+...+.++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 226 ~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 11122333445678999999999999999999999999887654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-55 Score=386.79 Aligned_cols=245 Identities=27% Similarity=0.415 Sum_probs=202.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|+++++.++||||+++++++.++ ..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 35888899999999999999975 6899999998632 233456788999999999999999999999887 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 86 Ey~~~g~L~~~l~~-------~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~ 155 (263)
T d2j4za1 86 EYAPLGTVYRELQK-------LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 155 (263)
T ss_dssp ECCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred eecCCCcHHHHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeee
Confidence 99999999999953 24699999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ....
T Consensus 156 ~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----------------~~~~ 215 (263)
T d2j4za1 156 APSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----------------TYKR 215 (263)
T ss_dssp CCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----------------HHHH
T ss_pred cCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH----------------HHHH
Confidence 4432 2345679999999999999999999999999999999999999997543210 0111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+..... ..+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 216 i~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 216 ISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp HHTTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHcCCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 111111 1222234578899999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=392.30 Aligned_cols=255 Identities=23% Similarity=0.349 Sum_probs=193.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC---ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR---RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---~~~lv 158 (395)
++|++.+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+. ..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56889999999999999999964 78999999987543 23345688999999999999999999988643 46799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC--SPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
|||+++|+|.+++..... ....+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+
T Consensus 84 mEy~~~g~L~~~i~~~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 84 MEYCEGGDLASVITKGTK---ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EECCTTEEHHHHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EecCCCCcHHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999854321 2346999999999999999999999861 11499999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ..
T Consensus 161 a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~------------- 222 (269)
T d2java1 161 ARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---EL------------- 222 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH-------------
T ss_pred eeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HH-------------
Confidence 98754332 2234567999999999999999999999999999999999999999743311 00
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+.+.... ..+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 223 ~~~i~~~~~~-~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 223 AGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1111111111 1222334578999999999999999999999863
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=389.74 Aligned_cols=258 Identities=25% Similarity=0.374 Sum_probs=207.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEEEcccC
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVYDYMAN 164 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~e~~~~ 164 (395)
++|++.+.||+|+||+||+|.+++++.||||++... ....+.|.+|+.++++++|||||++++++.+++.++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCC
Confidence 468889999999999999999988889999999754 4456789999999999999999999999988888999999999
Q ss_pred CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCCCC
Q 016117 165 GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSDKA 244 (395)
Q Consensus 165 g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~ 244 (395)
|+|..++.... ...+++.+++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 96 g~l~~~~~~~~-----~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 96 GSLLDFLKGET-----GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CBHHHHHSHHH-----HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred Cchhhhhhhcc-----cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999985432 24699999999999999999999999 99999999999999999999999999998654322
Q ss_pred CCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhhcccc
Q 016117 245 GGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEIMDPA 324 (395)
Q Consensus 245 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 324 (395)
. .......||+.|+|||++....++.++|||||||++|||++|..|+...... .... ..+...
T Consensus 168 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~--------------~~i~~~ 230 (285)
T d1fmka3 168 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVL--------------DQVERG 230 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH--------------HHHHTT
T ss_pred c-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHH--------------HHHHhc
Confidence 1 2233456899999999999999999999999999999999976665432211 0011 111111
Q ss_pred ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 325 LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 325 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.....+...+.++.+|+.+||+.||++|||+++|++.|++++..
T Consensus 231 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 231 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 12223334456789999999999999999999999999998864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-54 Score=387.62 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=201.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCC-----cEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNG-----RKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~l 157 (395)
+.|+..++||+|+||+||+|.+.++ ..||||++.... ......|.+|++++++++|||||+++|++.+. ..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3577789999999999999996532 479999986533 23345788999999999999999999999776 6679
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
++||+.+|++.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 87 v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp EEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEecccCcchhhhhccc------ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchh
Confidence 999999999999885433 4699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchh
Q 016117 238 KIGSDKAG-GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREK 316 (395)
Q Consensus 238 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 316 (395)
+....... ........||+.|+|||++.+..++.++|||||||++|||++|..|+...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----------------~~ 221 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------HE 221 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----------------HH
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----------------HH
Confidence 86543322 12233456899999999999999999999999999999999976665432210 11
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 317 ILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
+...+........+...+..+.+|+.+||+.||++||||.+|++.|+++++.
T Consensus 222 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111222222233444556799999999999999999999999999998873
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=396.25 Aligned_cols=261 Identities=24% Similarity=0.390 Sum_probs=207.1
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEcC-C-----cEEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-c
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLSN-G-----RKVAIKLMDQA-GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-R 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~ 154 (395)
.++|++.+.||+|+||+||+|++.. + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+. .
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578889999999999999999642 2 36999988643 333456788999999998 899999999999876 6
Q ss_pred eEEEEEcccCCChhhhcccCCCCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCC
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSN----------------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKS 218 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~ 218 (395)
.++||||+++|+|.+++....... .....+++..++.++.|++.||+|||++ +|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence 779999999999999997654211 1224689999999999999999999999 999999999
Q ss_pred CCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCC
Q 016117 219 SNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKP 297 (395)
Q Consensus 219 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~ 297 (395)
+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986655444344445678999999999999999999999999999999998 8999975432
Q ss_pred CCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 016117 298 SGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLV 363 (395)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~ 363 (395)
. ..+..++........+...+.++.+|+.+||+.||++|||++||+++|.
T Consensus 273 ~----------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 D----------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp S----------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H----------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 1111122222222233344567999999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=394.59 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=207.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCc----EEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGR----KVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv 158 (395)
.+|++.++||+|+||+||+|.+. +|+ +||+|.+... .....+.|.+|++++++++|||||+++++|.++..+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence 35888999999999999999964 444 6899988643 34456789999999999999999999999999999999
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
++|+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EECCTTCBHHHHHHHTS------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred EEeccCCcccccccccc------cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence 99999999999886433 5789999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
...............||+.|+|||++.+..++.++|||||||++|||+| |..||...... .+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-----------------~~ 222 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----------------EI 222 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-----------------GH
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-----------------HH
Confidence 7654443333444568999999999999999999999999999999998 78888654321 11
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
...+........+...+..+.+|+.+||+.||++|||+.+|+++|+++...
T Consensus 223 ~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 223 SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 111111111223334556789999999999999999999999999988753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=390.72 Aligned_cols=250 Identities=21% Similarity=0.359 Sum_probs=202.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
+.|++.+.||+|+||+||+|... +|+.||+|++........+.+.+|++++++++|||||++++++.+. ..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45888899999999999999964 7899999999876666667889999999999999999999998776 566999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 92 ~~g~L~~~~~~~~------~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 92 AGGAVDAVMLELE------RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp TTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred CCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 9999999985432 4699999999999999999999999 999999999999999999999999999975332
Q ss_pred CCCCceeeccccccccccchhhc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYAL-----TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
.. .......||+.|+|||++. +..|+.++|||||||++|||++|+.||....+.. . .
T Consensus 163 ~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~-------------~ 224 (288)
T d2jfla1 163 TI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---V-------------L 224 (288)
T ss_dssp HH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H-------------H
T ss_pred Cc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---H-------------H
Confidence 11 1123467999999999984 4568899999999999999999999997543211 0 0
Q ss_pred hhhcccc-ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 318 LEIMDPA-LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 318 ~~~~d~~-~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+.... .....+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 225 ~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 225 LKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111000 0111122334578999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=388.52 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=200.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++.+. ..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 45889999999999999999974 7899999998642 233456789999999999999999999998877 566999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 88 Ey~~gg~L~~~~~~-------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~ 157 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK-------IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKV 157 (288)
T ss_dssp CCCTTEEHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EccCCCCHHHhhhc-------cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEeccccccee
Confidence 99999999999853 34699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.............+||+.|+|||++.+..++.++|||||||++|||++|..||...+.. . ....
T Consensus 158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~-------------~~~~ 221 (288)
T d1uu3a_ 158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---L-------------IFQK 221 (288)
T ss_dssp CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H-------------HHHH
T ss_pred cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---H-------------HHHH
Confidence 65444333445567999999999999999999999999999999999999999754311 0 0111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+..... .++...+.++.+|+.+||+.||++|||++|++.+
T Consensus 222 i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 222 IIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp HHTTCC--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred HHcCCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 111111 1222234568899999999999999999997643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=379.92 Aligned_cols=246 Identities=26% Similarity=0.437 Sum_probs=192.4
Q ss_pred CCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEec----C-ceEEEE
Q 016117 88 SKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSD----R-RKLLVY 159 (395)
Q Consensus 88 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~-~~~lv~ 159 (395)
++.+.||+|+||+||+|.+. +++.||+|.+... .....+.+.+|++++++++|||||++++++.+ . ..++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999965 6889999998643 23344678899999999999999999998754 2 357999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC-CCCcEEEecccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD-KNFHAKVSDFGLAK 238 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~-~~~~~kl~Dfg~~~ 238 (395)
||+++|+|.+++... ..+++..++.++.|++.||+|||++ .++|+||||||+|||++ +++.+||+|||+++
T Consensus 92 E~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCcHHHHHhcc-------ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999532 4689999999999999999999998 22399999999999996 58899999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
..... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||....... ..... ...
T Consensus 164 ~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~----i~~----- 227 (270)
T d1t4ha_ 164 LKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRR----VTS----- 227 (270)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHH----HTT-----
T ss_pred eccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHH----HHc-----
Confidence 54322 2345679999999998865 59999999999999999999999996432110 00000 000
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
......+... .+.++.+|+.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~----~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 228 GVKPASFDKV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TCCCGGGGGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCcccCcc----CCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 0000111111 23358899999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=395.04 Aligned_cols=264 Identities=23% Similarity=0.366 Sum_probs=202.2
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.++|++.+.||+|+||+||+|... +|+.||+|+++... ....+.+.+|+.+|++++|||||++++++.+. +.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 457899999999999999999964 78999999987542 33456788999999999999999999999877 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
|+++|+|.+++... ..+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+|..
T Consensus 85 y~~gg~L~~~l~~~-------~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp CCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred cCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 99999999999533 469999999999999999999996 5 899999999999999999999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhh-h----------
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWA-L---------- 308 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~-~---------- 308 (395)
.... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+........... .
T Consensus 155 ~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 155 LIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp HHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred cCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 4332 123467999999999999999999999999999999999999999764432110000000 0
Q ss_pred ---------------cccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 309 ---------------PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 309 ---------------~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+..........+.............+.++.+|+.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000000000010000000001123568899999999999999999999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-53 Score=387.79 Aligned_cols=268 Identities=24% Similarity=0.371 Sum_probs=210.8
Q ss_pred HHHHhCCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCCcc-cHHHHHHHHHHHhccCCCcceeEEEEEec
Q 016117 80 LHSATGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAGKQ-GEDEFKMEVELLGRLRSPYLLALLGYCSD 152 (395)
Q Consensus 80 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 152 (395)
++-..++|++.+.||+|+||+||+|+.. +++.||||++...... ..+.|.+|++++++++||||+++++++.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3345678999999999999999999863 3578999998754332 34679999999999999999999999877
Q ss_pred C-ceEEEEEcccCCChhhhcccCCCC-----------------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeC
Q 016117 153 R-RKLLVYDYMANGGLQEHLYPANGS-----------------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHR 214 (395)
Q Consensus 153 ~-~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~ 214 (395)
. ..++++||+.+|+|.+++...... ......+++..++.++.|++.||+|||++ +++||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence 6 677999999999999999654321 11234589999999999999999999999 99999
Q ss_pred CCCCCCEEeCCCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCC-CCCC
Q 016117 215 DFKSSNILLDKNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR-VPID 293 (395)
Q Consensus 215 dlk~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~-~pf~ 293 (395)
||||+|||++.++.+||+|||+++...............|++.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999998654433333444567889999999999999999999999999999999986 5665
Q ss_pred CCCCCCCchhhhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 294 VNKPSGEGVLVSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.....+ ....+.+.. ....+...+.++.+|+.+||+.+|++||||.+|+++|+++.+
T Consensus 245 ~~~~~e----------------~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 245 GMAHEE----------------VIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TSCHHH----------------HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCHHH----------------HHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 432110 111111111 112223344578999999999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=382.15 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=200.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcC----CcEEEEEEeccCCc-ccHHHHHHHHHHHhccCCCcceeEEEEEecCceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSN----GRKVAIKLMDQAGK-QGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~lv~ 159 (395)
++|++.+.||+|+||+||+|.+.. +..||+|.+..... ...+.|.+|++++++++||||+++++++.++..++||
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~ 86 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIM 86 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEE
Confidence 468888999999999999998642 35689998865433 3346789999999999999999999999888889999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.
T Consensus 87 E~~~~g~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp ECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EeccCCcHHhhhhccC------CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence 9999999999875433 4689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||....... .. .
T Consensus 158 ~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~-------------~ 220 (273)
T d1mp8a_ 158 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI-------------G 220 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH-------------H
T ss_pred ccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HH-------------H
Confidence 543221 22334568999999999999999999999999999999998 899987544211 11 1
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.+.+. .....+...+..+.+|+.+||+.||++|||+.+|+++|+++++.+
T Consensus 221 ~i~~~-~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 221 RIENG-ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp HHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHcC-CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11110 111223334567999999999999999999999999999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=375.90 Aligned_cols=251 Identities=28% Similarity=0.412 Sum_probs=199.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC--ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~lv~e~~ 162 (395)
++|++.+.||+|+||.||+|.+ .|+.||||+++.. ...+.|.+|++++++++||||++++|+|.+. ..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 3577788999999999999998 5789999999753 3456799999999999999999999998653 467999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++|+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~l~~~~-----~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 84 AKGSLVDYLRSRG-----RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp TTEEHHHHHHHHH-----HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC
Confidence 9999999995432 23589999999999999999999998 999999999999999999999999999986433
Q ss_pred CCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccchhhhhhc
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDREKILEIM 321 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (395)
. .....++..|+|||++.+..++.++||||||+++|||+| |+.||...... .... .+
T Consensus 156 ~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~--------------~i 213 (262)
T d1byga_ 156 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP--------------RV 213 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH--------------HH
T ss_pred C-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHH--------------HH
Confidence 2 223457889999999999999999999999999999998 68877643211 1111 11
Q ss_pred cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 322 DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 322 d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
........+...+..+.+|+.+||+.||++|||+.+|+++|++++..
T Consensus 214 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 214 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 11111223333446789999999999999999999999999998753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-53 Score=385.30 Aligned_cols=244 Identities=29% Similarity=0.373 Sum_probs=196.9
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc---cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ---GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.|+..+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|++++++++|||||++++++.+. ..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888899999999999999964 7889999998754332 235688999999999999999999998776 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.+|+|..++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 96 ~~~~g~l~~~~~~-------~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-------KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp CCSEEHHHHHHHH-------TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred ecCCCchHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccccccc
Confidence 9999998776632 24699999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCCCceeeccccccccccchhhcc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALT---GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
... ....||+.|+|||++.+ ..|+.++|||||||++|||++|..||...... ..+
T Consensus 166 ~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~----------------~~~ 223 (309)
T d1u5ra_ 166 APA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----------------SAL 223 (309)
T ss_dssp SSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----------------HHH
T ss_pred CCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH----------------HHH
Confidence 332 24579999999999864 46899999999999999999999999643211 011
Q ss_pred hhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 318 LEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 318 ~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+.........+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 224 ~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 224 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp HHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11111111111112234578899999999999999999999863
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-52 Score=387.98 Aligned_cols=249 Identities=21% Similarity=0.333 Sum_probs=204.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
++|++.+.||+|+||+||+|... +|+.||+|++........+.+.+|+.++++++|||||++++++.+. ..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47899999999999999999964 7899999999876555667889999999999999999999998776 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC--CCCcEEEecccccccc
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD--KNFHAKVSDFGLAKIG 240 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~~~~~ 240 (395)
++|+|.+++.... ..+++..++.++.||+.||.|||++ +++||||||+|||++ .++.+||+|||++...
T Consensus 106 ~gg~L~~~l~~~~------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 106 SGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CSCBHHHHHTCTT------SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred CCCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 9999999985332 4699999999999999999999999 999999999999995 4688999999999865
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ... ..+
T Consensus 177 ~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~-------------~~i 237 (350)
T d1koaa2 177 DPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETL-------------RNV 237 (350)
T ss_dssp CTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH-------------HHH
T ss_pred cccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHH-------------HHH
Confidence 4332 334567999999999999999999999999999999999999999754321 001 111
Q ss_pred ccc--cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 MDP--ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~d~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
... .+........+.++.+|+.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 238 KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 100 00111111234568899999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-53 Score=382.73 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=187.8
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
.+.|++.+.||+|+||+||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.++ ..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356889999999999999999975 68999999987533 22345677899999999999999999999877 5669999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC---CCCcEEEeccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD---KNFHAKVSDFGLA 237 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~---~~~~~kl~Dfg~~ 237 (395)
|+++|+|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+. +++.+||+|||++
T Consensus 88 ~~~gg~L~~~l~~-------~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 88 LVSGGELFDRIVE-------KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp CCCSCBHHHHHHT-------CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred ccCCCcHHHhhhc-------ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEecccee
Confidence 9999999999953 24699999999999999999999999 999999999999994 5789999999999
Q ss_pred cccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhh
Q 016117 238 KIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKI 317 (395)
Q Consensus 238 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (395)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||...... .. .
T Consensus 158 ~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~-------------~ 218 (307)
T d1a06a_ 158 KMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KL-------------F 218 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH-------------H
T ss_pred EEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HH-------------H
Confidence 8644322 234567999999999999999999999999999999999999999753311 00 1
Q ss_pred hhhccc--cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 318 LEIMDP--ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 318 ~~~~d~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..+... .+........+.++.+|+.+||+.||++|||+.|++++
T Consensus 219 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111111 11111222334578999999999999999999999975
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-53 Score=382.12 Aligned_cols=267 Identities=23% Similarity=0.335 Sum_probs=200.8
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHhcc-CCCcceeEEEEEecC--
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-- 153 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-- 153 (395)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+..|..++.++ +|+||+.+++++.+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 457889999999999999999853 34689999987533 23345677888888887 688999999988654
Q ss_pred ceEEEEEcccCCChhhhcccCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 224 (395)
..+++|||+++|+|.+++...... ......+++..++.++.|++.||.|||++ +|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 467999999999999999654321 11234689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCC-CCCCCCCCCCCchh
Q 016117 225 KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR-VPIDVNKPSGEGVL 303 (395)
Q Consensus 225 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~-~pf~~~~~~~~~~~ 303 (395)
+++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|. .||.......
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---- 244 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---- 244 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH----
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH----
Confidence 99999999999998655444333344567999999999999999999999999999999999975 5675433211
Q ss_pred hhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 304 VSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
.+...+........+...+.++.+++.+||+.||++|||+.+|+++|+++++.+
T Consensus 245 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 245 ------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp ------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 011111111111222334457899999999999999999999999999998743
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.4e-52 Score=385.78 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=205.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
+.|++.+.||+|+||+||+|.. .+|+.||+|++..........+.+|++++++++|||||++++++.++ ..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 4689999999999999999996 47999999999765555566788999999999999999999998877 566999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC--CCCcEEEecccccccc
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD--KNFHAKVSDFGLAKIG 240 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~--~~~~~kl~Dfg~~~~~ 240 (395)
++|+|.+++... ...+++.+++.++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 109 ~gg~L~~~~~~~------~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 109 SGGELFDRIAAE------DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp CCCBHHHHTTCT------TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred CCChHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence 999999987533 24699999999999999999999999 999999999999997 6789999999999875
Q ss_pred CCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||...... . ....+
T Consensus 180 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~-------------~~~~i 240 (352)
T d1koba_ 180 NPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---E-------------TLQNV 240 (352)
T ss_dssp CTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---H-------------HHHHH
T ss_pred CCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---H-------------HHHHH
Confidence 5432 344567999999999999999999999999999999999999999744311 0 01111
Q ss_pred c--cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 321 M--DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 321 ~--d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
. +..+........+.++.+|+.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 241 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1111112222334578899999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=378.44 Aligned_cols=256 Identities=24% Similarity=0.326 Sum_probs=198.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc--CC--cEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecCceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS--NG--RKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRRKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~l 157 (395)
++|++.+.||+|+||+||+|++. ++ ..||||++... .....+.|.+|+.++++++||||++++|++.+...++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchhe
Confidence 45888899999999999999853 22 37899988643 2333468899999999999999999999998888889
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
||||+++|++.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 88 v~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp EEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeeecCcchhhhhhccc------CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhh
Confidence 999999999999885432 4699999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCce-eeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 238 KIGSDKAGGHV-STRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 238 ~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
+.......... .....|+..|+|||++.+..++.++||||||+++|||+| |..||...+.. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----------------~ 222 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----------------Q 222 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------H
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH----------------H
Confidence 87654433222 233567889999999999999999999999999999998 89999644321 1
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHh
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPL 365 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~ 365 (395)
....+.........+...+..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus 223 ~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 223 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111111111122233445789999999999999999999999988764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=376.46 Aligned_cols=265 Identities=25% Similarity=0.368 Sum_probs=213.9
Q ss_pred CCCCCCCeeeccCCeEEEEEEE------cCCcEEEEEEeccCCc-ccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ce
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL------SNGRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~ 155 (395)
++|++.++||+|+||.||+|++ .+++.||||+++.... .....|.+|+.+++.+ +|||||+++++|.+. ..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5688889999999999999985 2457899999975433 3445788999999999 699999999999877 56
Q ss_pred EEEEEcccCCChhhhcccCCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC
Q 016117 156 LLVYDYMANGGLQEHLYPANGSN-----------SVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 224 (395)
+++|||+++|+|.+++....... .....+++..+..++.||+.||+|||++ +++||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 79999999999999997654221 1234689999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCCCCCchh
Q 016117 225 KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTG-RVPIDVNKPSGEGVL 303 (395)
Q Consensus 225 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g-~~pf~~~~~~~~~~~ 303 (395)
.++.+|++|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|+ .+||......
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~----- 254 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----- 254 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-----
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-----
Confidence 9999999999999876655444445557889999999999999999999999999999999995 5555433221
Q ss_pred hhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 304 VSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
..+..+++.......+...+..+.+|+.+||+.||++|||+.+|+++|++++..
T Consensus 255 -----------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 255 -----------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp -----------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 112222222222233334456799999999999999999999999999998875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=372.99 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=202.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC------cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG------KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~ 156 (395)
+.|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+.++++++|||||++++++.+. ..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56899999999999999999974 78999999986421 22357899999999999999999999999887 456
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC----cEEEe
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF----HAKVS 232 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~----~~kl~ 232 (395)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 90 iv~E~~~gg~L~~~i~~~-------~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEcCCCccccchhccc-------cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEec
Confidence 999999999999999532 4699999999999999999999999 999999999999998776 59999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 160 DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------------- 223 (293)
T d1jksa_ 160 DFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------------- 223 (293)
T ss_dssp CCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------------
T ss_pred chhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-------------
Confidence 999998654332 2334578999999999999999999999999999999999999997543210
Q ss_pred cchhhhhhccccccCCCCH----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 313 DREKILEIMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
....+..... ..+. ..+..+.+|+.+||+.||++|||+.|++++ .+++
T Consensus 224 ---~~~~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h--p~~~ 275 (293)
T d1jksa_ 224 ---TLANVSAVNY--EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH--PWIK 275 (293)
T ss_dssp ---HHHHHHTTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS--TTTC
T ss_pred ---HHHHHHhcCC--CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC--cccC
Confidence 0011110000 1111 123468899999999999999999999874 4444
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-52 Score=374.99 Aligned_cols=263 Identities=23% Similarity=0.369 Sum_probs=206.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcC--------CcEEEEEEeccCCc-ccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSN--------GRKVAIKLMDQAGK-QGEDEFKMEVELLGRL-RSPYLLALLGYCSDR- 153 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 153 (395)
++|.+.+.||+|+||.||+|+... +..||||++..... ....++.+|...+.++ +|||||+++++|.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 467888999999999999998532 24799999875433 3346788899999888 899999999999876
Q ss_pred ceEEEEEcccCCChhhhcccCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeC
Q 016117 154 RKLLVYDYMANGGLQEHLYPANGS---------NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLD 224 (395)
Q Consensus 154 ~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~ 224 (395)
..++||||+.+|+|.+++...... ......+++.+++.++.|++.||+|||++ +++||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 577999999999999999655421 12345799999999999999999999999 999999999999999
Q ss_pred CCCcEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCCCCCchh
Q 016117 225 KNFHAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLT-GRVPIDVNKPSGEGVL 303 (395)
Q Consensus 225 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~-g~~pf~~~~~~~~~~~ 303 (395)
.++.+||+|||++................+++.|+|||.+.++.|+.++||||||+++|||++ |..||......
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~----- 244 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----- 244 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-----
Confidence 999999999999987655544444455678999999999999999999999999999999998 78888643311
Q ss_pred hhhhhcccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhh
Q 016117 304 VSWALPRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVK 367 (395)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~ 367 (395)
.+...+........+...+..+.+|+.+||+.||++|||+.||++.|++++.
T Consensus 245 ------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 ------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1111111111112222334578999999999999999999999999999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=377.34 Aligned_cols=247 Identities=27% Similarity=0.377 Sum_probs=203.4
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|.+.+.||+|+||+||+|+. .+|+.||+|++... .....+.+.+|+.+|+.++||||+++++++.+. ..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4688999999999999999996 47999999998642 233456788999999999999999999999887 456999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+++|+|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||+++.
T Consensus 85 ey~~gg~L~~~~~~~-------~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~ 154 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp ECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred eccCCCchhhhhhcc-------cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccc
Confidence 999999999998543 4689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
..... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+... + ...
T Consensus 155 ~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~-------------~~~ 216 (337)
T d1o6la_ 155 GISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L-------------FEL 216 (337)
T ss_dssp SCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H-------------HHH
T ss_pred cccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---H-------------HHH
Confidence 54322 23345789999999999999999999999999999999999999997543210 0 011
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~vl~~ 361 (395)
+....+ .++...+.++.+|+.+||+.||.+||+ +.+++++
T Consensus 217 i~~~~~--~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 217 ILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HhcCCC--CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 111111 122233456889999999999999995 7888864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-51 Score=370.34 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=201.4
Q ss_pred CCeeeccCCeEEEEEEEcCC----cEEEEEEeccC-CcccHHHHHHHHHHHhccCCCcceeEEEEEecC--ceEEEEEcc
Q 016117 90 SNVVGHGGFGLVYRGVLSNG----RKVAIKLMDQA-GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR--RKLLVYDYM 162 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~lv~e~~ 162 (395)
.++||+|+||+||+|.+.++ ..||||++... .....+.|.+|++++++++||||++++|++.+. ..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999996432 35899998743 344457899999999999999999999987643 567999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
++|+|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 112 ~~g~l~~~~~~~~------~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 112 KHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp TTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred ecCchhhhhcccc------ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 9999999986433 4678899999999999999999999 999999999999999999999999999986543
Q ss_pred CCCC--ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhhh
Q 016117 243 KAGG--HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILEI 320 (395)
Q Consensus 243 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (395)
.... .......||+.|+|||.+....++.++||||||+++|||++|..||....... ......
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i------------- 247 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL------------- 247 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH-------------
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH-------------
Confidence 3221 12233568999999999999999999999999999999999888876432111 111110
Q ss_pred ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 321 MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 321 ~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
... .....+...+..+.+|+.+||+.||++||||.||+++|+++++..
T Consensus 248 ~~g-~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 248 LQG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HcC-CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 000 001112223457899999999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=374.64 Aligned_cols=264 Identities=28% Similarity=0.428 Sum_probs=205.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCc--EEEEEEeccC-CcccHHHHHHHHHHHhcc-CCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGR--KVAIKLMDQA-GKQGEDEFKMEVELLGRL-RSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~lv 158 (395)
++|++.++||+|+||+||+|.+. +|. .||||.+... .....+.|.+|+++|+++ +||||+++++++.++ ..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56888899999999999999965 444 4778877543 233456789999999998 799999999998877 56799
Q ss_pred EEcccCCChhhhcccCCC---------CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcE
Q 016117 159 YDYMANGGLQEHLYPANG---------SNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~---------~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 229 (395)
|||+++|+|.+++..... .......+++..++.++.|++.||.|||++ +++||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 999999999999965421 012346799999999999999999999999 99999999999999999999
Q ss_pred EEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCC-CCCCCCCCCCchhhhhhh
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRV-PIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~-pf~~~~~~~~~~~~~~~~ 308 (395)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||......
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~---------- 233 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---------- 233 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH----------
Confidence 999999997543222 1223468999999999999999999999999999999999764 56533211
Q ss_pred cccccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcCC
Q 016117 309 PRLTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNRS 371 (395)
Q Consensus 309 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~~ 371 (395)
.+...+........+...+.++.+|+.+||+.||++||||.+|+++|+++++....
T Consensus 234 -------~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 234 -------ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp -------HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred -------HHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 11111111111222333456799999999999999999999999999999986443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-51 Score=373.07 Aligned_cols=244 Identities=27% Similarity=0.405 Sum_probs=202.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~ 159 (395)
++|++.+.||+|+||+||+|+.. +|+.||+|++... .....+.+.+|+.+++.++||||+++++++.+. ..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 35888999999999999999974 6999999998642 233456788999999999999999999998877 567999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+|+|..++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 84 E~~~gg~l~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~ 153 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY 153 (316)
T ss_dssp CCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eecCCcccccccccc-------ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceE
Confidence 999999999988533 4688999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .....
T Consensus 154 ~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----------------~~~~~ 212 (316)
T d1fota_ 154 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----------------KTYEK 212 (316)
T ss_dssp CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHH
T ss_pred eccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH----------------HHHHH
Confidence 5432 23467999999999999999999999999999999999999999754321 01111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
+..... ..+...+.++.+++.+||+.||.+|| |+++++++
T Consensus 213 i~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 213 ILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp HHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHcCCC--CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111111 12223345688999999999999996 89999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.9e-51 Score=367.92 Aligned_cols=260 Identities=24% Similarity=0.370 Sum_probs=199.6
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCc---ccHHHHHHHHHHHhccCCCcceeEEEEEecC-----c
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK---QGEDEFKMEVELLGRLRSPYLLALLGYCSDR-----R 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 154 (395)
.++|++.+.||+|+||+||+|.. .+|+.||+|++..... ...+.+.+|+++++.++||||+++++++... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35799999999999999999996 4799999999975432 2345688999999999999999999987643 2
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++||||+++|+|.+++... ..+++.+++.++.|++.||+|||++ +|+||||||+|||++.++..+++||
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-------~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred EEEEEECCCCCEehhhhccc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence 57999999999999988533 4699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCC-CceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 235 GLAKIGSDKAG-GHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 235 g~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
|.+........ ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~---~~~~- 228 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---VAY---QHVR- 228 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHH-
T ss_pred hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH---HHH---HHHh-
Confidence 99875433222 223345679999999999999999999999999999999999999997543210 000 0000
Q ss_pred chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHHHhhh
Q 016117 314 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-LMADVVQSLVPLVK 367 (395)
Q Consensus 314 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~~vl~~L~~~~~ 367 (395)
. ++..........+.++.+|+.+||+.||++|| |++++++.|.++.+
T Consensus 229 -----~--~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 229 -----E--DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp -----C--CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred -----c--CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 0 00000111112345688999999999999999 89999999988764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=370.61 Aligned_cols=271 Identities=24% Similarity=0.326 Sum_probs=200.5
Q ss_pred CCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHH--HHHHhccCCCcceeEEEEEecC-----ceEEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKME--VELLGRLRSPYLLALLGYCSDR-----RKLLV 158 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e--~~~l~~l~h~niv~l~~~~~~~-----~~~lv 158 (395)
+|.+.+.||+|+||+||+|++ +|+.||||++... ..+.+..| +..+..++||||++++++|.+. ..++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 467778999999999999997 7899999998643 23344444 4455678999999999998653 35799
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCceeCCCCCCCEEeCCCCcEEEec
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEH-----CSPPVIHRDFKSSNILLDKNFHAKVSD 233 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~dlk~~Nill~~~~~~kl~D 233 (395)
|||+++|+|.+++.. ..++|..++.++.|++.||+|||+. ..++|+||||||+||||+.++.+||+|
T Consensus 80 ~Ey~~~g~L~~~l~~--------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EecccCCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 999999999999953 3589999999999999999999963 123899999999999999999999999
Q ss_pred cccccccCCCCCCc--eeeccccccccccchhhccCC------CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhh
Q 016117 234 FGLAKIGSDKAGGH--VSTRVLGTQGYVAPEYALTGH------LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVS 305 (395)
Q Consensus 234 fg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~------~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~ 305 (395)
||+++......... ......||+.|+|||++.+.. ++.++|||||||+||||+||..||........... .
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~-~ 230 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-D 230 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-T
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-h
Confidence 99998654433211 233467999999999987643 56789999999999999999988864332211110 0
Q ss_pred hhhcccccchhhhhhccccccCCC-----CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 306 WALPRLTDREKILEIMDPALEGQY-----SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 306 ~~~~~~~~~~~~~~~~d~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
................+..++... +.+....+.+|+.+||+.||++|||+.||++.|+++.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 000000000111112222222111 2345567999999999999999999999999999998754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-51 Score=372.81 Aligned_cols=265 Identities=25% Similarity=0.380 Sum_probs=209.7
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc------CCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ce
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS------NGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RK 155 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~ 155 (395)
.++|.+.+.||+|+||+||+|.+. +++.||||++.... ......|.+|++++++++||||+++++++... ..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 356788899999999999999863 35789999997542 33345688999999999999999999998765 67
Q ss_pred EEEEEcccCCChhhhcccCCCC---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 156 LLVYDYMANGGLQEHLYPANGS---NSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
++||||+.+|+|.+++...... ......+++..+..++.|+++||.|||++ +|+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 7999999999999998643210 11234579999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCC-CCCCCCCCCCCchhhhhhhccc
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGR-VPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~-~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||. .||......
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------------- 242 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------------- 242 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------------
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-------------
Confidence 999998654443333334456899999999999999999999999999999999985 666533211
Q ss_pred ccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.....+.+... ...+...+..+.+++.+||+.+|++|||+.+|+++|++.++.
T Consensus 243 ---~~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 243 ---QVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp ---HHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred ---HHHHHHHhCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11111112111 112223446799999999999999999999999999888663
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=368.75 Aligned_cols=247 Identities=20% Similarity=0.312 Sum_probs=202.0
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
.++|++.+.||+|+||+||+|... +|+.||+|++.... .....+.+|+++|+.++||||+++++++.+. ..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467999999999999999999975 68899999997643 3345688999999999999999999988766 56799999
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC--CCcEEEeccccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK--NFHAKVSDFGLAKI 239 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~--~~~~kl~Dfg~~~~ 239 (395)
+++|+|.+++.... ..+++.+++.++.|++.||.|||++ +|+||||||+|||++. ...+||+|||++..
T Consensus 83 ~~gg~L~~~i~~~~------~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 83 ISGLDIFERINTSA------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp CCCCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred CCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhc
Confidence 99999999995332 3689999999999999999999999 9999999999999975 45899999999986
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.... .......+|+.|+|||.+.+..++.++||||+||++|+|++|..||...... .....
T Consensus 154 ~~~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~----------------~~~~~ 214 (321)
T d1tkia_ 154 LKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----------------QIIEN 214 (321)
T ss_dssp CCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----------------HHHHH
T ss_pred cccC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH----------------HHHHH
Confidence 5432 2344567899999999999999999999999999999999999999754321 01111
Q ss_pred hccccccCCCCH----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 320 IMDPALEGQYSM----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
+..... .++. ..+.++.+|+.+||+.||++|||+.|++++
T Consensus 215 i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 215 IMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHhCCC--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111 1111 123468899999999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-50 Score=373.94 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=201.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHhccCCCcceeEEEEEecCc-eEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~ 159 (395)
++|++.+.||+|+||+||+|++. +|+.||||++... .....+.+.+|+.+|+.++||||+++++++.+.. .++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46889999999999999999974 7999999998632 2234567889999999999999999999988774 56999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
||+.+|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 121 e~~~~g~l~~~l~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~ 190 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp ECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ccccccchhhhHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence 999999999999543 3699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhhh
Q 016117 240 GSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKILE 319 (395)
Q Consensus 240 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (395)
.... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+.. . ....
T Consensus 191 ~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~-------------~~~~ 249 (350)
T d1rdqe_ 191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---Q-------------IYEK 249 (350)
T ss_dssp CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H-------------HHHH
T ss_pred cccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---H-------------HHHH
Confidence 5432 23467999999999999999999999999999999999999999754311 0 1111
Q ss_pred hccccccCCCCHHHHHHHHHHHhhcCCCCCCCCC-----CHHHHHHH
Q 016117 320 IMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRP-----LMADVVQS 361 (395)
Q Consensus 320 ~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~~vl~~ 361 (395)
+..... ..+...+.++.+|+.+||+.||.+|+ |+++++++
T Consensus 250 i~~~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 250 IVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp HHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred HhcCCC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 111111 11223345688999999999999994 89999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-50 Score=361.15 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=200.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcc---------cHHHHHHHHHHHhccC-CCcceeEEEEEecC
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQ---------GEDEFKMEVELLGRLR-SPYLLALLGYCSDR 153 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 153 (395)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5789999999999999999996 47899999998643211 1235778999999996 99999999999887
Q ss_pred -ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEe
Q 016117 154 -RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVS 232 (395)
Q Consensus 154 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~ 232 (395)
..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-------~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~ 152 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-------KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT 152 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-------HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred cceEEEEEcCCCchHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEc
Confidence 55799999999999999953 24699999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCCCceeeccccccccccchhhcc------CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhh
Q 016117 233 DFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALT------GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSW 306 (395)
Q Consensus 233 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~ 306 (395)
|||++....... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.......
T Consensus 153 DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------- 222 (277)
T d1phka_ 153 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------- 222 (277)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------
T ss_pred cchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------
Confidence 999998754432 2344679999999999863 356889999999999999999999997543210
Q ss_pred hhcccccchhhhhhcccc--ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 307 ALPRLTDREKILEIMDPA--LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 307 ~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....+.... +........+.++.+|+.+||+.||++|||+.||+++
T Consensus 223 ---------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 223 ---------MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp ---------HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ---------HHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 011111111 1111222344678999999999999999999999865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5e-50 Score=372.11 Aligned_cols=248 Identities=28% Similarity=0.378 Sum_probs=196.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC---cccHHHHHH---HHHHHhccCCCcceeEEEEEecC-ceE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG---KQGEDEFKM---EVELLGRLRSPYLLALLGYCSDR-RKL 156 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~-~~~ 156 (395)
++|++.+.||+|+||+||+|+.. +|+.||+|++.... ......+.+ ++.+++.++|||||++++++.+. ..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57889999999999999999965 69999999986321 122233444 46777778899999999998877 567
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccc
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGL 236 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~ 236 (395)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||+
T Consensus 84 ivmE~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGl 153 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL 153 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred EEEEecCCCcHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeece
Confidence 999999999999999533 4688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
+....... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||.............
T Consensus 154 a~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---------- 219 (364)
T d1omwa3 154 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---------- 219 (364)
T ss_dssp CEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH----------
T ss_pred eeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence 98654332 234579999999999974 568999999999999999999999997544321111000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 016117 316 KILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 361 (395)
Q Consensus 316 ~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~vl~~ 361 (395)
...... ...+...+.++.+|+.+||+.||++||| +++++++
T Consensus 220 ---~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 220 ---MTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---HSSSCC--CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---hcccCC--CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 111110 1112223456899999999999999999 6888864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=368.94 Aligned_cols=249 Identities=22% Similarity=0.275 Sum_probs=195.8
Q ss_pred CCCCCC-CeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhcc-CCCcceeEEEEEec-----CceE
Q 016117 85 GGFSKS-NVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRL-RSPYLLALLGYCSD-----RRKL 156 (395)
Q Consensus 85 ~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~~~ 156 (395)
++|.+. +.||+|+||+||+|.. .+++.||||+++.. ..+.+|++++.++ +||||+++++++.+ ...+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 468776 4699999999999996 47899999998642 4577899987655 89999999998864 2467
Q ss_pred EEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC---CCcEEEec
Q 016117 157 LVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSD 233 (395)
Q Consensus 157 lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~D 233 (395)
+|||||++|+|.+++.... ...+++.+++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG-----DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS-----CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEECCCCCcHHHHHHhcC-----CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence 9999999999999996432 24699999999999999999999999 9999999999999975 56799999
Q ss_pred cccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 234 FGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 234 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
||+++...... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||............
T Consensus 158 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~--------- 225 (335)
T d2ozaa1 158 FGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------- 225 (335)
T ss_dssp CTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred cceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH---------
Confidence 99998654432 234567999999999999999999999999999999999999999754432111000
Q ss_pred chhhhhhccccc--cCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 314 REKILEIMDPAL--EGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 314 ~~~~~~~~d~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
...+..... ........+.++.+|+.+||+.||++|||+.|++++
T Consensus 226 ---~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 ---KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000000000 011112335679999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=367.46 Aligned_cols=246 Identities=26% Similarity=0.392 Sum_probs=198.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccC---CcccHHHHHHHHHHHh-ccCCCcceeEEEEEecC-ceEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA---GKQGEDEFKMEVELLG-RLRSPYLLALLGYCSDR-RKLLV 158 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~-~~~lv 158 (395)
++|.+.+.||+|+||+||+|+.. +|+.||||++... .....+.+..|..++. .++||||+++++++.++ ..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46889999999999999999965 7899999999642 1233455666777665 68999999999999877 46699
Q ss_pred EEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 159 YDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 159 ~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
|||+++|+|.+++... ..+++..++.++.||+.||.|||++ +++||||||+|||+++++.+||+|||++.
T Consensus 82 mEy~~~g~L~~~i~~~-------~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~ 151 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 151 (320)
T ss_dssp EECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EeecCCCcHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhh
Confidence 9999999999999533 4689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccchhhh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDREKIL 318 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (395)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... + ..
T Consensus 152 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~-------------~~ 213 (320)
T d1xjda_ 152 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---L-------------FH 213 (320)
T ss_dssp CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H-------------HH
T ss_pred hccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---H-------------HH
Confidence 544322 22344679999999999999999999999999999999999999997543210 0 00
Q ss_pred hhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHH-HHHH
Q 016117 319 EIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMA-DVVQ 360 (395)
Q Consensus 319 ~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-~vl~ 360 (395)
.+..... .++...+.++.+|+.+||+.||++|||+. ++++
T Consensus 214 ~i~~~~~--~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 214 SIRMDNP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHCCC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHcCCC--CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1110111 11222345688999999999999999996 6764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=358.14 Aligned_cols=265 Identities=23% Similarity=0.225 Sum_probs=193.6
Q ss_pred CCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc-----cHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEcc
Q 016117 90 SNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ-----GEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDYM 162 (395)
Q Consensus 90 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~~ 162 (395)
.++||+|+||+||+|... +|+.||||++...... ..+.+.+|+.++++++|||||++++++.++ ..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999964 6999999998643221 124688999999999999999999999876 677999999
Q ss_pred cCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccCC
Q 016117 163 ANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGSD 242 (395)
Q Consensus 163 ~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~~ 242 (395)
.++++..+.. ....+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~~~~~~~~-------~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~ 152 (299)
T d1ua2a_ 83 ETDLEVIIKD-------NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 152 (299)
T ss_dssp SEEHHHHHTT-------CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred cchHHhhhhh-------cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCC
Confidence 9887776663 234688899999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc-----cchh
Q 016117 243 KAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT-----DREK 316 (395)
Q Consensus 243 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~ 316 (395)
.. ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||......+....+........ ....
T Consensus 153 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 153 PN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp CC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred Cc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence 32 22234579999999999875 4679999999999999999999999975432111000000000000 0000
Q ss_pred hhhhccccccCCCCH-----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 317 ILEIMDPALEGQYSM-----KEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 317 ~~~~~d~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
.............+. ..+.++.+|+.+||+.||++|||+.|++++ .++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H--p~f~~ 285 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM--KYFSN 285 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS--GGGTS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC--HhhCC
Confidence 000000000001111 123578999999999999999999999875 55553
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=359.18 Aligned_cols=266 Identities=21% Similarity=0.319 Sum_probs=195.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e 160 (395)
++|++.+.||+|+||+||+|+. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.++ ..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4788999999999999999996 479999999986432 23356788999999999999999999999877 5679999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
|+.++ +.+++... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~~-~~~~~~~~-----~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 82 FLHQD-LKKFMDAS-----ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF 152 (298)
T ss_dssp CCSEE-HHHHHHHT-----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred ecCCc-hhhhhhhh-----cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceec
Confidence 99765 44444322 124699999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCceeeccccccccccchhhccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc--chhh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGH-LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD--REKI 317 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~ 317 (395)
.... .......||+.|+|||.+.... ++.++||||+||++|+|++|+.||...+................+ ....
T Consensus 153 ~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 153 GVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp CCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred cCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 4322 2333457999999999887665 578999999999999999999999754321100000000000000 0000
Q ss_pred hhhcc--cccc--CCCC-----HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 318 LEIMD--PALE--GQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 318 ~~~~d--~~~~--~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
....+ .... .... ...+.++.+|+.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 0000 0000 1123568899999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5e-49 Score=355.13 Aligned_cols=265 Identities=18% Similarity=0.269 Sum_probs=196.2
Q ss_pred CCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|.+.+.||+|+||+||+|++++|+.||||++.... ....+.+.+|+.+|++++||||+++++++.+. ..+++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999999899999999986532 23356889999999999999999999998876 56688998
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccccccC
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIGS 241 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~~ 241 (395)
+.++.+..+.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++....
T Consensus 82 ~~~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~ 151 (286)
T d1ob3a_ 82 LDQDLKKLLDV-------CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151 (286)
T ss_dssp CSEEHHHHHHT-------STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred ehhhhHHHHHh-------hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecc
Confidence 88776666653 235799999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcc--cccchhhh
Q 016117 242 DKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR--LTDREKIL 318 (395)
Q Consensus 242 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~ 318 (395)
... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+...... ........
T Consensus 152 ~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 152 IPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp C-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 332 222345688999999998754 5689999999999999999999999754321110000000000 00000000
Q ss_pred hh---------ccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 319 EI---------MDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 319 ~~---------~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. ..+..........+..+.+|+.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00000011111223568899999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=352.60 Aligned_cols=240 Identities=23% Similarity=0.379 Sum_probs=192.2
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcc------cHHHHHHHHHHHhccC--CCcceeEEEEEecC-
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQ------GEDEFKMEVELLGRLR--SPYLLALLGYCSDR- 153 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~- 153 (395)
.++|++.+.||+|+||+||+|+.. +|+.||||++...... ....+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357999999999999999999964 7899999998643211 1233567999999986 89999999999877
Q ss_pred ceEEEEEcccC-CChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-CCcEEE
Q 016117 154 RKLLVYDYMAN-GGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-NFHAKV 231 (395)
Q Consensus 154 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-~~~~kl 231 (395)
..++||||+.+ +++.+++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~-------~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl 152 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE-------RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL 152 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH-------HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred eEEEEEEeccCcchHHHHHhc-------cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEE
Confidence 56799999976 577777743 24699999999999999999999999 9999999999999985 579999
Q ss_pred eccccccccCCCCCCceeeccccccccccchhhccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcc
Q 016117 232 SDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHL-TTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 310 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~ 310 (395)
+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+. .
T Consensus 153 ~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i------- 216 (273)
T d1xwsa_ 153 IDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I------- 216 (273)
T ss_dssp CCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------
T ss_pred Cccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H-------
Confidence 999999864332 2345679999999999987765 5678999999999999999999964210 0
Q ss_pred cccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 311 LTDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 311 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
... ...+.... +.++.+|+.+||+.||++|||++|++++
T Consensus 217 ------~~~--~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 217 ------IRG--QVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------HHC--CCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------hhc--ccCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 000 00111122 3568899999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-49 Score=357.19 Aligned_cols=266 Identities=22% Similarity=0.247 Sum_probs=194.1
Q ss_pred hCCCCCCCeeeccCCeEEEEEEEc-C-CcEEEEEEeccC--CcccHHHHHHHHHHHhcc---CCCcceeEEEEEec----
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVLS-N-GRKVAIKLMDQA--GKQGEDEFKMEVELLGRL---RSPYLLALLGYCSD---- 152 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 152 (395)
.++|++.+.||+|+||+||+|++. + ++.||||++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999973 4 667999998642 122233456777777766 79999999998752
Q ss_pred --CceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEE
Q 016117 153 --RRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAK 230 (395)
Q Consensus 153 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~k 230 (395)
...++++||+.++.+...... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~------~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~k 156 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV------PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 156 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS------CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cCceEEEEEEeccCCchhhhhhc------cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCee
Confidence 145699999988876554432 235689999999999999999999999 999999999999999999999
Q ss_pred EeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcc
Q 016117 231 VSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR 310 (395)
Q Consensus 231 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~ 310 (395)
|+|||++...... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||...+.......+......
T Consensus 157 l~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 157 LADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp ECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred ecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 9999998753322 2334567999999999999999999999999999999999999999754322111100000000
Q ss_pred cc-----cchh-hhhhc---cccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 311 LT-----DREK-ILEIM---DPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 311 ~~-----~~~~-~~~~~---d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. .... ..... ............+..+.+|+.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000 00000 0000001112233568889999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=351.07 Aligned_cols=267 Identities=24% Similarity=0.285 Sum_probs=192.7
Q ss_pred CCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEEEecC-------ceEE
Q 016117 86 GFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------RKLL 157 (395)
Q Consensus 86 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------~~~l 157 (395)
+|+..++||+|+||+||+|++. +|+.||||++...... +.+|+++|++++||||+++++++... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4777889999999999999975 7999999999754322 34699999999999999999987432 2469
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCC-cEEEecccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNF-HAKVSDFGL 236 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~-~~kl~Dfg~ 236 (395)
||||++++.+........ ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus 97 v~Ey~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSR----AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEECCSEEHHHHHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEeccCCccHHHHHhhhh----ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccc
Confidence 999998764433332111 234799999999999999999999998 999999999999999765 899999999
Q ss_pred ccccCCCCCCceeeccccccccccchhhcc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccch
Q 016117 237 AKIGSDKAGGHVSTRVLGTQGYVAPEYALT-GHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDRE 315 (395)
Q Consensus 237 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 315 (395)
+....... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...........+........ ..
T Consensus 170 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~-~~ 245 (350)
T d1q5ka_ 170 AKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT-RE 245 (350)
T ss_dssp CEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC-HH
T ss_pred hhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCCh-HH
Confidence 98654332 2334679999999998875 5789999999999999999999999975432111000000000000 00
Q ss_pred hhhhh----cccc--------ccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHHhhh
Q 016117 316 KILEI----MDPA--------LEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS--LVPLVK 367 (395)
Q Consensus 316 ~~~~~----~d~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~--L~~~~~ 367 (395)
..... .+.. .........+.++.+|+.+||+.||++|||+.|++++ ++++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 00000 0000 0001112234568899999999999999999999975 444443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-47 Score=344.76 Aligned_cols=264 Identities=21% Similarity=0.272 Sum_probs=197.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcceeEEEE-EecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYLLALLGY-CSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~-~~~lv~e~ 161 (395)
++|++.+.||+|+||+||+|.+ .+|+.||||++..... ...+..|+++++.++|+|++..+.. ..+. ..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4699999999999999999996 4689999998875432 2357889999999988876666554 4444 45689998
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC---CCcEEEecccccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK---NFHAKVSDFGLAK 238 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~---~~~~kl~Dfg~~~ 238 (395)
+ +++|...+... ...+++..+..++.|++.||+|||++ +|+||||||+|||++. +..++|+|||+++
T Consensus 85 ~-~~~l~~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 85 L-GPSLEDLFNFC------SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp C-CCBHHHHHHHT------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred c-CCchhhhhhhc------cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 8 55666665432 24699999999999999999999999 9999999999999864 5679999999998
Q ss_pred ccCCCCCC-----ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccccc
Q 016117 239 IGSDKAGG-----HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTD 313 (395)
Q Consensus 239 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 313 (395)
........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~---- 230 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---- 230 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH----
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc----
Confidence 75543221 123346799999999999999999999999999999999999999976543322211110000
Q ss_pred chhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 314 REKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 314 ~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
.......+.+... .+.++.+|+..||+.+|++||++.++.+.|+.+...+.
T Consensus 231 --~~~~~~~~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 231 --KKMSTPIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp --HHHHSCHHHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred --ccCCCChhHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 0000000111112 23568899999999999999999999999999876543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=344.58 Aligned_cols=274 Identities=20% Similarity=0.256 Sum_probs=198.9
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccC--CcccHHHHHHHHHHHhccCCCcceeEEEEEecC-------
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQA--GKQGEDEFKMEVELLGRLRSPYLLALLGYCSDR------- 153 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 153 (395)
.++|++.+.||+|+||+||+|+. .+|+.||||++... .......+.+|+++|++++|||++++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 36799999999999999999996 47999999998543 233456788999999999999999999987542
Q ss_pred --ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEE
Q 016117 154 --RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKV 231 (395)
Q Consensus 154 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl 231 (395)
..+++|||+.++.+..... ....++...+..++.|++.||.|||++ +|+||||||+|||++.++.+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~-------~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl 158 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN-------VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 158 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC-------TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred CceEEEEEeccCCCccchhhh-------cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEe
Confidence 4579999998877765552 234689999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCCCC--CceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhh
Q 016117 232 SDFGLAKIGSDKAG--GHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL 308 (395)
Q Consensus 232 ~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~ 308 (395)
+|||++........ .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||................
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~ 238 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999976543221 1223345799999999998765 68999999999999999999999997543211111111100
Q ss_pred ccccc-------chhhhhhccccccCCCCHH-------HHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhc
Q 016117 309 PRLTD-------REKILEIMDPALEGQYSMK-------EVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYN 369 (395)
Q Consensus 309 ~~~~~-------~~~~~~~~d~~~~~~~~~~-------~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~ 369 (395)
..... .......+........... ....+.+|+.+||+.||++|||++|++++ .++..+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H--pff~~~ 311 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH--DFFWSD 311 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS--GGGSSS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC--hhhccC
Confidence 00000 0000000000000011111 12467789999999999999999999975 566543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-47 Score=349.65 Aligned_cols=266 Identities=20% Similarity=0.274 Sum_probs=195.8
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC-cccHHHHHHHHHHHhccCCCcceeEEEEEecC-----ceEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG-KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-----RKLL 157 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~l 157 (395)
.+|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+++|++++|||++++++++... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4688999999999999999996 489999999997543 23345788999999999999999999998653 2456
Q ss_pred EEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEeccccc
Q 016117 158 VYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLA 237 (395)
Q Consensus 158 v~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~ 237 (395)
+++|+.+|+|.+++.. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 88 l~~~~~~g~L~~~l~~--------~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EEEECCCEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEeecCCchhhhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence 6778889999999942 3699999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCC-ceeeccccccccccchhhc-cCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccccc-
Q 016117 238 KIGSDKAGG-HVSTRVLGTQGYVAPEYAL-TGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLTDR- 314 (395)
Q Consensus 238 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 314 (395)
......... .......||+.|+|||++. +..++.++||||+||++|||++|+.||......................
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 764432211 1234467899999999985 4567899999999999999999999997544221111100000000000
Q ss_pred ------hhhhh-hccccccCCCCH-----HHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 315 ------EKILE-IMDPALEGQYSM-----KEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 315 ------~~~~~-~~d~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..... ..........+. ....++.+|+.+||+.||.+|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000000011111 112468899999999999999999999976
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.9e-47 Score=341.66 Aligned_cols=264 Identities=18% Similarity=0.230 Sum_probs=205.0
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCCcccHHHHHHHHHHHhccCC-CcceeEEEEEecC-ceEEEEEc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS-PYLLALLGYCSDR-RKLLVYDY 161 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~-~~~lv~e~ 161 (395)
++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+|++.++.++| +|++.+++++.++ ..++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57999999999999999999965 68999999886432 22356789999999965 8999999988776 45689998
Q ss_pred ccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCC-----CCcEEEecccc
Q 016117 162 MANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDK-----NFHAKVSDFGL 236 (395)
Q Consensus 162 ~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~-----~~~~kl~Dfg~ 236 (395)
+ +++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 83 ~-~~~l~~~~~~~~------~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 83 L-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp C-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred c-CCCHHHHHHhhc------cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence 8 689999885433 4689999999999999999999999 9999999999999964 57899999999
Q ss_pred ccccCCCCCC-----ceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhccc
Q 016117 237 AKIGSDKAGG-----HVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRL 311 (395)
Q Consensus 237 ~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 311 (395)
++........ .......||+.|+|||++.+..++.++||||||+++|||++|..||................
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~--- 229 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG--- 229 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH---
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH---
Confidence 9875433221 12334679999999999999999999999999999999999999997554332211111100
Q ss_pred ccchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhhcC
Q 016117 312 TDREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKYNR 370 (395)
Q Consensus 312 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~~~ 370 (395)
... ....-+.+.... +.++.+++..|++.+|++||+++.+.+.|+++++...
T Consensus 230 -~~~--~~~~~~~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 230 -EKK--QSTPLRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp -HHH--HHSCHHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -hcc--CCCChHHhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 000 000001111122 3468899999999999999999999999999887543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-47 Score=349.76 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=190.1
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecC-------c
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDR-------R 154 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------~ 154 (395)
++|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+++|++++|||||++++++... .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 57889999999999999999964 69999999997532 23345788999999999999999999998654 3
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++||||+ +.+|..++. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|++||
T Consensus 98 ~~lv~e~~-~~~l~~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMK--------HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CEEEEECC-SEEHHHHHH--------HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEecc-cccHHHHHH--------hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccc
Confidence 57999999 556776663 24699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhh-----
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWAL----- 308 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~----- 308 (395)
|++...... .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||...+............
T Consensus 166 g~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 166 GLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp TTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 999865432 2345789999999998764 57899999999999999999999997543211100000000
Q ss_pred ---ccccc--chhhhhhcccccc---CCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 309 ---PRLTD--REKILEIMDPALE---GQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 309 ---~~~~~--~~~~~~~~d~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
..... .......+..... ..........+.+|+.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 0000000000000 01111223467899999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3e-46 Score=343.47 Aligned_cols=258 Identities=16% Similarity=0.278 Sum_probs=195.3
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCcceeEEEEEecC---ceEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR---RKLLVY 159 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~---~~~lv~ 159 (395)
++|++.+.||+|+||+||+|+. .+|+.||+|+++.. ..+.+.+|+++|+.++ ||||+++++++... ..++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 4799999999999999999996 47899999998743 3567889999999995 99999999988643 477999
Q ss_pred EcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCC-CcEEEecccccc
Q 016117 160 DYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKN-FHAKVSDFGLAK 238 (395)
Q Consensus 160 e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~-~~~kl~Dfg~~~ 238 (395)
||+.+++|..+. ..+++..++.++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++.
T Consensus 112 e~~~~~~L~~~~----------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 112 EHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp ECCCSCBGGGTT----------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred eecCCCcHHHHh----------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence 999999998765 3689999999999999999999999 99999999999999865 469999999998
Q ss_pred ccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCch-hh----------hh
Q 016117 239 IGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV-LV----------SW 306 (395)
Q Consensus 239 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~-~~----------~~ 306 (395)
...... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......... .. .+
T Consensus 179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 179 FYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp ECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred eccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 654332 23345789999999998765 57999999999999999999999997543221100 00 00
Q ss_pred hh-cccccchhhhhhccc--------cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 307 AL-PRLTDREKILEIMDP--------ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 307 ~~-~~~~~~~~~~~~~d~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.. ............... ..........+.++.+|+.+||+.||++|||++|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000000000000000 00011111223568899999999999999999999863
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=342.00 Aligned_cols=252 Identities=26% Similarity=0.367 Sum_probs=197.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc----CCcEEEEEEeccCC----cccHHHHHHHHHHHhccCC-CcceeEEEEEecC-c
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS----NGRKVAIKLMDQAG----KQGEDEFKMEVELLGRLRS-PYLLALLGYCSDR-R 154 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~-~ 154 (395)
++|++.+.||+|+||+||+|+.. +|+.||+|++.... ....+.+.+|++++++++| |||+++++++.+. .
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 45889999999999999999852 47899999986421 2234567889999999977 7999999998776 5
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++++||+.+|+|.+++... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+||
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-------~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DF 173 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF 173 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCS
T ss_pred eeeeeecccccHHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeec
Confidence 66999999999999999533 4678899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcccc
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG--HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPRLT 312 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 312 (395)
|++....... ........|++.|+|||.+.+. .++.++|||||||+||||++|+.||...........+.
T Consensus 174 G~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~------- 245 (322)
T d1vzoa_ 174 GLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS------- 245 (322)
T ss_dssp SEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH-------
T ss_pred cchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------
Confidence 9997643322 1223446789999999999764 46889999999999999999999997655432211111
Q ss_pred cchhhhhhccccccCCCCHHHHHHHHHHHhhcCCCCCCCCCC-----HHHHHHH
Q 016117 313 DREKILEIMDPALEGQYSMKEVIQVAAIAAMCVQPEADYRPL-----MADVVQS 361 (395)
Q Consensus 313 ~~~~~~~~~d~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~~vl~~ 361 (395)
....... ...+...+.++.+|+.+||+.||++||| ++|++++
T Consensus 246 -----~~~~~~~--~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 246 -----RRILKSE--PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----HhcccCC--CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0011111 1222334567899999999999999995 7888763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=334.30 Aligned_cols=265 Identities=20% Similarity=0.222 Sum_probs=198.6
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEecCc-eEEEEE
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSDRR-KLLVYD 160 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~lv~e 160 (395)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ......+.+|+.+++.++||||+++++++.+.. .+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4788999999999999999996 478999999986432 334568889999999999999999999998874 569999
Q ss_pred cccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecccccccc
Q 016117 161 YMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAKIG 240 (395)
Q Consensus 161 ~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~~ 240 (395)
++.+++|..++.. ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+...
T Consensus 82 ~~~~~~l~~~~~~-------~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 82 FCDQDLKKYFDSC-------NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp CCSEEHHHHHHHT-------TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecccccccccccc-------ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcc
Confidence 9999988887743 24688999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCceeeccccccccccchhhccCC-CCccchhHHHHHHHHHHHhCCCCCCCCCCCCCc-hhhhhhhccccc--chh
Q 016117 241 SDKAGGHVSTRVLGTQGYVAPEYALTGH-LTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEG-VLVSWALPRLTD--REK 316 (395)
Q Consensus 241 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~--~~~ 316 (395)
.... .......++..|+|||.+.+.. ++.++|||||||++|||++|+.||......... ..+......... ...
T Consensus 152 ~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 152 GIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp CSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred cCCC--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence 4332 1223345778899999987654 689999999999999999999997532211100 000000000000 000
Q ss_pred hhhhccc---------cccCCCCHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 016117 317 ILEIMDP---------ALEGQYSMKEVIQVAAIAAMCVQPEADYRPLMADVVQS 361 (395)
Q Consensus 317 ~~~~~d~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~ 361 (395)
.....+. .............+.+|+.+||+.||.+|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 00011122234568899999999999999999999865
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-45 Score=338.84 Aligned_cols=266 Identities=20% Similarity=0.253 Sum_probs=190.7
Q ss_pred CCCCCCCeeeccCCeEEEEEEEc-CCcEEEEEEeccCC--cccHHHHHHHHHHHhccCCCcceeEEEEEec-------Cc
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVLS-NGRKVAIKLMDQAG--KQGEDEFKMEVELLGRLRSPYLLALLGYCSD-------RR 154 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------~~ 154 (395)
++|++.++||+|+||+||+|.+. +|+.||||++.... ......+.+|+.++++++||||+++++++.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57899999999999999999975 69999999997542 2334568899999999999999999998853 24
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.++||||+.++.+ +.+. ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++++||
T Consensus 97 ~~iv~Ey~~~~l~-~~~~---------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ---------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp EEEEEECCSEEHH-HHHT---------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEeccchHHH-Hhhh---------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeech
Confidence 6799999976544 4442 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhh---------h
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLV---------S 305 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~---------~ 305 (395)
|++...... .......+|+.|+|||++.+..++.++||||+||++|+|++|+.||...+.......+ .
T Consensus 164 ~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 164 GLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp CC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred hhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence 998754432 2334567899999999999999999999999999999999999999754321100000 0
Q ss_pred hhhcc------------cccchhhhhhccccccCCC---CHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 306 WALPR------------LTDREKILEIMDPALEGQY---SMKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 306 ~~~~~------------~~~~~~~~~~~d~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
++... ................... ....+.++.+|+.+||+.||++|||++|++++ .++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H--pw~~~ 316 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH--PYINV 316 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS--TTTGG
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC--cccCC
Confidence 00000 0000001111111111111 12345688999999999999999999999976 45543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=339.23 Aligned_cols=267 Identities=21% Similarity=0.302 Sum_probs=195.9
Q ss_pred hCCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCc--ccHHHHHHHHHHHhccCCCcceeEEEEEec------Cc
Q 016117 84 TGGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGK--QGEDEFKMEVELLGRLRSPYLLALLGYCSD------RR 154 (395)
Q Consensus 84 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 154 (395)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++++|||++++++++.. ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 35799999999999999999996 4799999999975422 234567899999999999999999998853 23
Q ss_pred eEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcEEEecc
Q 016117 155 KLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHAKVSDF 234 (395)
Q Consensus 155 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~kl~Df 234 (395)
.+++++|+.+|+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++||
T Consensus 97 ~~~i~~~~~gg~L~~~~~--------~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK--------CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp CCEEEEECCSEEHHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEeecCCchhhhcc--------cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccccccc
Confidence 467888899999999983 23699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCCceeeccccccccccchhhccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCchhhhhhhcc---
Q 016117 235 GLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTG-HLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGVLVSWALPR--- 310 (395)
Q Consensus 235 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~~~~~~~~~--- 310 (395)
|++..... ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+......
T Consensus 166 g~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 166 GLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp ----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred chhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 99875432 22345688999999987765 4688999999999999999999999754321111100000000
Q ss_pred ----cccchhhhhhcccccc-CCCC-----HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHhhhh
Q 016117 311 ----LTDREKILEIMDPALE-GQYS-----MKEVIQVAAIAAMCVQPEADYRPLMADVVQSLVPLVKY 368 (395)
Q Consensus 311 ----~~~~~~~~~~~d~~~~-~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~~vl~~L~~~~~~ 368 (395)
................ .... ...+..+.+|+.+||+.||++|||+.|++++ .++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H--p~f~~ 306 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH--AYFAQ 306 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS--GGGTT
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC--HhhCC
Confidence 0000000000000000 0011 1123468899999999999999999999975 55554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8e-41 Score=311.56 Aligned_cols=264 Identities=20% Similarity=0.248 Sum_probs=187.5
Q ss_pred CCCCCCCeeeccCCeEEEEEEE-cCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-----------CCcceeEEEEEec
Q 016117 85 GGFSKSNVVGHGGFGLVYRGVL-SNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-----------SPYLLALLGYCSD 152 (395)
Q Consensus 85 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~ 152 (395)
++|++.++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4589999999999999999996 47999999999754 223456778999888875 5789999887754
Q ss_pred C---ceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCCEEeCCCC-
Q 016117 153 R---RKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNF- 227 (395)
Q Consensus 153 ~---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~- 227 (395)
. ..+++++++..+......... .....+++..+..++.|++.||.|||+ . +|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK----YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH----TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEET
T ss_pred ccccceeeeeeeccccccccccccc----ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCc
Confidence 3 344666665544332222211 123578999999999999999999998 5 899999999999997654
Q ss_pred -----cEEEeccccccccCCCCCCceeeccccccccccchhhccCCCCccchhHHHHHHHHHHHhCCCCCCCCCCCCCch
Q 016117 228 -----HAKVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPIDVNKPSGEGV 302 (395)
Q Consensus 228 -----~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~~l~ell~g~~pf~~~~~~~~~~ 302 (395)
.++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||..........
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred ccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 3999999998754322 234569999999999999999999999999999999999999997654322111
Q ss_pred hhhhh------hccccc-----chhhhhhccc-------------------cccCCCCHHHHHHHHHHHhhcCCCCCCCC
Q 016117 303 LVSWA------LPRLTD-----REKILEIMDP-------------------ALEGQYSMKEVIQVAAIAAMCVQPEADYR 352 (395)
Q Consensus 303 ~~~~~------~~~~~~-----~~~~~~~~d~-------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~R 352 (395)
..... ...... ........+. ..........+..+.+|+.+||+.||++|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 10000 000000 0000000000 00123345677889999999999999999
Q ss_pred CCHHHHHHH
Q 016117 353 PLMADVVQS 361 (395)
Q Consensus 353 Pt~~~vl~~ 361 (395)
||+.|++++
T Consensus 320 pta~e~L~H 328 (362)
T d1q8ya_ 320 ADAGGLVNH 328 (362)
T ss_dssp BCHHHHHTC
T ss_pred cCHHHHhcC
Confidence 999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=9.2e-25 Score=183.42 Aligned_cols=163 Identities=11% Similarity=0.113 Sum_probs=119.0
Q ss_pred CCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcc------------------cHHHHHHHHHHHhccCCCcceeEEEE
Q 016117 88 SKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQ------------------GEDEFKMEVELLGRLRSPYLLALLGY 149 (395)
Q Consensus 88 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~l~~~ 149 (395)
.+.+.||+|+||+||+|...+|+.||||+++..... .......|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456899999999999999889999999987532110 01234468888999999999988765
Q ss_pred EecCceEEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceeCCCCCCCEEeCCCCcE
Q 016117 150 CSDRRKLLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHCSPPVIHRDFKSSNILLDKNFHA 229 (395)
Q Consensus 150 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~dlk~~Nill~~~~~~ 229 (395)
. ..+++|||+.+..+.+ ++......++.|++.+|+|||++ +++||||||+|||++++ .+
T Consensus 83 ~---~~~lvme~~~~~~~~~--------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 83 E---GNAVLMELIDAKELYR--------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp E---TTEEEEECCCCEEGGG--------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EE
T ss_pred c---CCEEEEEeeccccccc--------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CE
Confidence 3 3479999998765443 22334567899999999999999 99999999999999865 58
Q ss_pred EEeccccccccCCCCCCceeeccccccccccch--h---hccCCCCccchhHHHHHH
Q 016117 230 KVSDFGLAKIGSDKAGGHVSTRVLGTQGYVAPE--Y---ALTGHLTTKSDVYSYGVV 281 (395)
Q Consensus 230 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE--~---~~~~~~~~~~DvwslG~~ 281 (395)
+|+|||++.......... |.... . ...+.|+.++|+||+.--
T Consensus 142 ~liDFG~a~~~~~~~~~~----------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWRE----------ILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp EECCCTTCEETTSTTHHH----------HHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred EEEECCCcccCCCCCcHH----------HHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 999999997644322111 11110 0 123567889999997543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.67 E-value=4.7e-08 Score=84.25 Aligned_cols=149 Identities=15% Similarity=0.081 Sum_probs=99.2
Q ss_pred HHHHHHhCCCCCCCeeeccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccC-CCcceeEEEEEecC-ce
Q 016117 78 KQLHSATGGFSKSNVVGHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLR-SPYLLALLGYCSDR-RK 155 (395)
Q Consensus 78 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~-~~ 155 (395)
.++...-..|+..+..+.++.+.||+... +++.+++|+...........+..|...+..+. +--+.+++.+..++ ..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 35555566777665544455578998764 66678889876543333445677888888774 33356677776554 56
Q ss_pred EEEEEcccCCChhhhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------
Q 016117 156 LLVYDYMANGGLQEHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC---------------------------- 207 (395)
Q Consensus 156 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------- 207 (395)
++||++.++.++.+..... . ....++.+++..++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~---------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE---------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC---------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred EEEEEeccccccccccccc---------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 7999999998876654211 1 12234555666666666421
Q ss_pred ----------------------------CCCceeCCCCCCCEEeCCCCcEEEeccccccc
Q 016117 208 ----------------------------SPPVIHRDFKSSNILLDKNFHAKVSDFGLAKI 239 (395)
Q Consensus 208 ----------------------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~~ 239 (395)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11379999999999999877677999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.04 E-value=1.8e-05 Score=67.05 Aligned_cols=128 Identities=19% Similarity=0.107 Sum_probs=83.6
Q ss_pred eeccC-CeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCC--CcceeEEEEEecC-ceEEEEEcccCCChh
Q 016117 93 VGHGG-FGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRS--PYLLALLGYCSDR-RKLLVYDYMANGGLQ 168 (395)
Q Consensus 93 lg~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~-~~~lv~e~~~~g~L~ 168 (395)
+..|. .+.||+....++..+++|...... ...+..|...++.+.. -.+.+++.+..+. ..+++|+++++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 44444 367899988788889999876432 2346678888877743 2356667776655 667999999886654
Q ss_pred hhcccCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 016117 169 EHLYPANGSNSVASKLDWETRLRIALEAAKGLEFLHEHC----------------------------------------- 207 (395)
Q Consensus 169 ~~l~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------- 207 (395)
+.. ... ...+.+++..|+-||+..
T Consensus 95 ~~~------------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 95 SSH------------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp TSC------------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred ccc------------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 422 111 112233444444444211
Q ss_pred --------------CCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 208 --------------SPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 208 --------------~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
.+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1247999999999999887667899998775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.79 E-value=6.3e-05 Score=68.10 Aligned_cols=75 Identities=17% Similarity=0.189 Sum_probs=47.2
Q ss_pred CeeeccCCeEEEEEEEc-CCcEEEEEEeccC----C---cccHHHHHHHHHHHhccC-C-C-cceeEEEEEecCceEEEE
Q 016117 91 NVVGHGGFGLVYRGVLS-NGRKVAIKLMDQA----G---KQGEDEFKMEVELLGRLR-S-P-YLLALLGYCSDRRKLLVY 159 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~----~---~~~~~~~~~e~~~l~~l~-h-~-niv~l~~~~~~~~~~lv~ 159 (395)
+.||.|....||+.... +++.+++|.-... . .........|.+.|+.+. + | .+.+++.+ .....+++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-d~~~~~lvm 110 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-DTEMAVTVM 110 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-ETTTTEEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-cCCCCEEEE
Confidence 46899999999999854 4678999965321 1 112234456888887763 2 3 34455544 445668999
Q ss_pred EcccCCC
Q 016117 160 DYMANGG 166 (395)
Q Consensus 160 e~~~~g~ 166 (395)
|++.+..
T Consensus 111 E~L~~~~ 117 (392)
T d2pula1 111 EDLSHLK 117 (392)
T ss_dssp CCCTTSE
T ss_pred eccCCcc
Confidence 9997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.39 E-value=0.0002 Score=62.87 Aligned_cols=68 Identities=13% Similarity=0.093 Sum_probs=45.1
Q ss_pred CeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcc--eeEEE------EEecCceEEEEEcccCCC
Q 016117 98 FGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL--LALLG------YCSDRRKLLVYDYMANGG 166 (395)
Q Consensus 98 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~------~~~~~~~~lv~e~~~~g~ 166 (395)
--.||++...+|+.+++|+.... ....+++..|...+..|...++ +..+. +..++..+.+++++.|..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 46899999989999999998754 3345678889988888753222 11111 122334568889887643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.03 E-value=0.0019 Score=57.98 Aligned_cols=72 Identities=19% Similarity=0.220 Sum_probs=49.2
Q ss_pred CeeeccCCeEEEEEEEcC--------CcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcc-eeEEEEEecCceEEEEEc
Q 016117 91 NVVGHGGFGLVYRGVLSN--------GRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL-LALLGYCSDRRKLLVYDY 161 (395)
Q Consensus 91 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~lv~e~ 161 (395)
+.|+.|-.-.+|+....+ ++.|++++.... .......+|..+++.+.-.++ .++++++.+ .+|++|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG---GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT---EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC---ceEEEE
Confidence 468888899999998654 356777776532 233455679999988854444 466776643 678899
Q ss_pred ccCCCh
Q 016117 162 MANGGL 167 (395)
Q Consensus 162 ~~~g~L 167 (395)
+++..|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 877544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.99 E-value=0.006 Score=52.68 Aligned_cols=161 Identities=13% Similarity=0.076 Sum_probs=82.0
Q ss_pred ecHHHHHHHhCCCCCCCee-----eccCCeEEEEEEEcCCcEEEEEEeccCCcccHHHHHHHHHHHhccCCCcc--eeEE
Q 016117 75 FTFKQLHSATGGFSKSNVV-----GHGGFGLVYRGVLSNGRKVAIKLMDQAGKQGEDEFKMEVELLGRLRSPYL--LALL 147 (395)
Q Consensus 75 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~ 147 (395)
.+.+++.....+|.+.+.. ..|---+.|+....+| .+++|+...... .+++..|++++..+...++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence 3456777777888775544 3566688899988665 489999865322 2345557777777643222 1111
Q ss_pred E-------EEecCceEEEEEcccCCChhhh--------------cccCCCC--CCCCCCCCHH-----------------
Q 016117 148 G-------YCSDRRKLLVYDYMANGGLQEH--------------LYPANGS--NSVASKLDWE----------------- 187 (395)
Q Consensus 148 ~-------~~~~~~~~lv~e~~~~g~L~~~--------------l~~~~~~--~~~~~~l~~~----------------- 187 (395)
. .........++.+..+...... ++..... ..........
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 1122334556666655332111 0000000 0000000000
Q ss_pred -HHHHHHHHHHHHHHHHhc-CCCCCceeCCCCCCCEEeCCCCcEEEecccccc
Q 016117 188 -TRLRIALEAAKGLEFLHE-HCSPPVIHRDFKSSNILLDKNFHAKVSDFGLAK 238 (395)
Q Consensus 188 -~~~~i~~~i~~~l~~LH~-~~~~~i~H~dlk~~Nill~~~~~~kl~Dfg~~~ 238 (395)
.....+......+.-.+. ....+++|+|+.++||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111122222222222221 123479999999999999988777899999875
|